Recite me link

Freedom of Information (FOI)

The Freedom of Information Act 2000 (FOI) came fully into force in January 2005. All bodies must have in place a Publication Scheme (a list of classes of information available to the public).

The act also gave individuals and corporate bodies the right of access to all types of recorded information held by public sector bodies, with the exception of certain specified exemptions (for instance, personal information and commercially sensitive information). For more information about the act please visit the Information Commissioner’s website: www.ico.org.uk/for-the-public/official-information

Our Publication Scheme has most of the information frequently asked for by members of the public.

Before making a formal request to the Trust, please check our website to make sure that the information you require isn’t already available by clicking here.  This data will be updated on a six monthly basis and FOI requests for this information will be exempt under Section 22 – Information intended for future publication.

You can also search this site below for information disclosed by the Trust following requests made under the Freedom of Information Act 2000 since 1 April 2015.

It is important that the public realises that the provision of recorded information from the Trust, requires busy Trust staff to spend time away from the core business of clinical, management and clerical functions that support patient care, in order to retrieve this information from complex data sources.

If the information you require is not held on our website, you can contact us either by emailing us at mtw-tr.foiadmin@nhs.net or writing to us at Freedom of Information Officer, Trust Headquarters, Maidstone and Tunbridge Wells NHS Trust, Hermitage Lane, Maidstone ME16 9QQ.

Once we have received your request, we will send you an acknowledgement letter. We are required to give you a response within 20 working days of our acknowledgement letter. We will try to respond as quickly as possible. Sometimes, some or all of the information cannot be provided. If this is the case, we will explain the reasons why.

We are able to charge fees for requests, outlined in the Freedom of Information Guide. We will generally only charge you for hard copies or copying onto media, e.g. USB drive. The charges will vary according to how information is made available. Legally, if the cost of obtaining and sending you the information is more than £450, we do not have to provide you with the information you requested. This amount is based on the DCA’s (Department of Constitutional Affairs) regulations of a national cost of 18 hours work at £25 per hour.

In the first instance you should appeal to us directly, in line with our FOI appeal process. Download a copy of the appeals process document, or email us at mtw-tr.foiadmin@nhs.net for a copy to be sent to you. If you are still dissatisfied after the appeals process, you have the right, under section 50 of the Act, to apply to the Information Commissioner to seek resolution to the matter.

You can search our FOI database below, or alternatively you can look through our recent responses here or by clicking on the right hand column.

Cyber security

We have a dedicated Cyber Security team (within our IT department) and have purchased and installed many different solutions to help protect us against cyber threats. However, we will not be publicising or sharing the details of these products, solutions or vendors because we believe that doing so, poses a risk to the Trust.

We will also not be publishing details around any system such as hardware or software that is either end of life or is coming to end of life, as we believe that publishing this information also puts the Trust at risk. This would include – but is not limited to – queries such as “does the Trust have any machines running an out of date operating system or unsupported hardware?”.

 

Search our FOI database

Choose a category:

Agency staff

Agency Staff

1) Total spend on agency staff split by each of the following staffing groups:
2) Total spend on internal bank staff (split by the following categories)
3) Total number of staff employed on the bank, and of which, the number that also hold substantive contracts with the trust.
4) Does the trust outsource bank staff to NHSP? If so, how much was spent on outsourced bank staff?
5) Does the trust use rostering software, if so which provider (Allocate, SMART, DRS, SMI etc.)?
6) Does the trust directly engage locum staff? If so, how much of the trust’s medical locum spend was put through direct engagement in the last financial year?

Download response Agency Staff 170815

3rd Party Temporary Staffing Providers. 110222.docx

Please can you provide the following information for financial years FY2016/17, FY2017/18, FY2018/19, FY2019/20, FY2020/21, current financial year to date (FY2021/22 YTD):
1) Please provide the top 5 ON framework 3rd Party providers for nursing staff, by name, used by your trust for each of the listed financial years
2) Please provide the total annual expenditure for each of the top 5 ON framework 3rd Party providers, for nursing staff, used by your trust for each of the listed financial years
3) Please provide the top 5 OFF framework 3rd Party providers for nursing staff, by name, used by your trust for each of the listed financial years
4) Please provide the total annual expenditure for each of the top 5 OFF framework 3rd Party providers, for nursing staff, used by your trust for each of the listed financial years

3rd Party Temporary Staffing Providers. 110222.docx

A&E agency staff 2016. 290317

1. The amount spent on employing agency/temporary/locum doctors in A&E departments in each month in 2016.
2. The number of FTE roles covered by agency/temporary/locum doctors in each month in 2016
3. The total number of FTE doctors working in the A&E department in each month in 2016.

Download response A&E agency staff 2016. 290317

A&E agency staff and cost. 141021.docx

1. The amount spent on employing agency, temporary and/or locum doctors in A&E departments in each month in 2019 and 2020.
2. The number of FTE roles in A&E departments covered by agency, temporary and/or locum doctors in each month in 2019 and 2020.
3. The total number of FTE doctors (including agency, temporary and/or locum and permanent staff) working in A&E departments in each month in 2019 and 2020.

Download response A&E agency staff and cost. 141021.docx

A&E staffing. 080519

1. The amount spent on employing agency, temporary and/or locum doctors in A&E departments in each month in 2017 and 2018
2. The number of FTE roles in A&E departments covered by agency, temporary and/or locum doctors in each month in 2017 and 2018
3. The total number of FTE doctors (including agency, temporary and/or locum and permanent staff) working in A&E departments in each month in 2017 and 2018

Download response A&E staffing. 080519

Agency and Bank Doctors. 051218

You asked:
1) The total amount you spend on Agency Locum Doctors for 2017-2018: – £
2) For the above information to be broken down by grade and specialty (example provided below)
Specialty FY1/2 ST1/2 ST3-6 Staff Grade Consultant
A&E
Medicine
Anaesthetics
Medicine
Surgery
Paeds
Pathology
O & G
Ophthalmology
3) Your Bank spend on Doctors for 2017-2018 broken down as question (2): – £
4) The total number of hours filled and unfilled each month for Agency medical locums for 2017-2018.
5) The highest bank rate paid in 2017-2018, providing confirmation of the grade and speciality.
6) Your current Bank rates for each grade and speciality, including any specialities or sub specialities which have an escalated Bank rate.
7) The Trusts average rates for Agency medical locums from September, October, November and December collectively broken down by grade and specialty (example provided below).
Specialty FY1/2 ST1/2 ST3-6 Staff Grade Consultant
A&E
Medicine
Anaesthetics
Medicine
Surgery
Paeds
Pathology
O & G
Ophthalmology
(8) The spend for medical locums through off-framework agencies for 2017-2018 and confirmation of the off-framework agencies used.
(9) Please confirm any contracts you have in place for medical locums and please confirm the list of suppliers used for medical locums.

Download response Agency and Bank Doctors. 051218

Agency and bank pay rates. 130421

Would you be able to provide me with the highest and lowest rates that have been paid for the below specialities please.
Could you please cover from January 2020 to present
General Nurse Band 5
ITU Nurse Band 6
Theatre Nurse Band 6
ODP Band 6
Advanced Scrub Practitioner
Radiographer Band 8
Pharmacist Band 8

Download response Agency and bank pay rates. 130421

Agency and bank staff. 021019

Sourced Staffing Arrangements
1a. Do you have a master vendor or neutral vendor arrangement in place for sourcing agency staff? If so, please state which arrangement is in place
1b. Please state the name of the appointed supplier for the above arrangement
1c. Please state the start date of the contract with this supplier
1d. Please state the end date of the contract with this supplier
1e. Annual cost of your supplier in 18/19?

Agency Spend and Supply
2a. Please state the organisations total expenditure on agency (non-contract) staff for the financial year 18/19 (April 2018 – March 2019). Split by the following staffing groups
2b. Please state the name of the framework(s) you source your agency staff under, for each of the following staffing groups

Direct Engagement
3a. Does the organisation use a third party to provide a Direct Engagement/Outsourced Employment Solution? (This is where the NHS organisation sources agency staff via a recruitment agency but hold a direct contract between the organisation and the worker – there is often VAT savings associated to this employment model)
3b. Please state the name of the Direct Engagement/Outsourced Employment supplier (e.g. 247Time/Allocate, PlusUs, Retinue, Liaison etc.)
3c. Please state all staffing groups that are managed via your direct engagement provider; for example; Medical, Admin, Scientific staff
3d. Please state the start date of the contract with the DE supplier
3e. Please state the end date of the contract with the DE supplier
3f. What was the annual cost to the organisation for the provision of the direct engagement service in 18/19?
3g. Did the organisation procure these services via a framework? If so, please provide the full name of the framework

Internal Bank Spend
4. Please state the organisations total expenditure on internal bank staff for the financial year 18/19 (April 2018 – March 2019). Split by the following staffing groups

Medical Bank Supplier
5a. Please state the name of the technology provider used to manage the supply of your medical bank staff, inclusive of any outsourced or managed arrangements (i.e. NHSP, Patchwork, Allocate, Liaison, PlusUs, Locum’s Nest etc., please state if in-house)
5b. Please state the start date of the contract with your medical bank provider
5c. Please state the end date of the contract with your medical bank provider
5d. What was the annual cost to the organisations for the provision of bank provider services/software in 18/19
5e. Did the organisation procure these services via a framework? If so, please provide the full name of the framework

Download response Agency and bank staff. 021019

Agency and Bank staff.100223.docx

1. The total amount spent on agency temporary staff for the year 2021/22 (April ’21 to March ‘22) and between 31/10/2021 to 31/10/2022 for the following categories:
• Doctors
• Nurses
• AHP (all categories)
• Health Care Assistants
2. Bank Spend – Total amount spent on bank staff for the year 2021/22 (April ’21 to March ‘22) and between 31/10/2021 and 31/10/2022 year split into the Trusts’ staff groups (E.g. Medical, Nursing, Admin, AHP etc.) and speciality/grade (E.g. Consultants, GP, ICU Nurse, Acute Nurse, Occupational therapists, Pharmacists, Health Care Assistants, etc.) depending on how this is reported within the Trust.
3. Confirmation on whether the trust bank is currently operated by the trust themselves or by a private provider. If the latter please confirm the name of the provider.
The names and contact information of the individual divisional directors of Surgery covering the following treatment areas:
• General Surgery
• Urology
• Trauma and Orthopaedic
• Ear, Nose and Throat
• Ophthalmology
• Oral Surgery
• Neurosurgical Service
• Cardiothoracic
• Cardiology Service
• Dermatology Service
• Respiratory Medicine Service
• Gynaecology Service
• Rheumatology Service

Agency and Bank staff.100223.docx

Agency and Bank Staff. 120320

1. Please quantify Agency recruitment splits (total spending and total WTE numbers) for medical, nursing and other employees (Forecasts 2019/20 and 2018/2019, and actuals 2018/19, 2017/2018, and 2016/2017)
2. Please quantify Bank recruitment splits (total spending and total WTE numbers) for medical, nursing and other employees (Forecasts 2019/20 and 2018/2019, and actuals 2018/19, 2017/2018, and 2016/2017)

Download response Agency and Bank Staff. 120320

Agency and Bank Staff costs.290623.docx

Q1: Please can you confirm what percentage of your wage bill is spent on
(a) Agency staff?
(b) Bank staff?
Q2: What does the answer to Q1 (a) equate to in Pounds Sterling (£)?
Q3: What percentage of all your medical and clinical patient facing shifts are filled with staff that are paid above the ‘break glass’ ceiling rate (above the agency rules pay cap)?

Agency and Bank Staff costs.290623.docx

Agency and Bank staff spend.181022.docx

1)The total amount spent by the Trust on bank staff in 2021/22
2) The total amount spent by the Trust on agency staff in 2021/22
3) The total amount spent by the Trust on bank nurses in 2021/22
4) The total amount spent by the Trust on agency nurses in 2021/22
5) The largest amount spent by the Trust on a single agency nurse shift in 2021/22

Agency and Bank staff spend.181022.docx

Agency and Bank staffing. 240620

1. Please provide agency spend for the staff group for 2019-20
2. Please provide bank spend for the staff group for 2019-20
3. Please confirm which model you have in place for managing the staff group: Email to preferred supplier List, a Master Vendor, a Neutral Vendor, or a Software cascade to a preferred supplier list
4. If you have a master vendor or neutral vendor in place, please confirm who this contract is with and the date on which this contract expires
5. Please confirm what percentage of bookings over the last 6 months have been within the NHSI/E agency caps (an approximation based on NHSI data submissions is fine)
6. Please confirm which provider manages your direct engagement process, the fee for the service and the date on which this contract expires (no this is not relevant for Nursing)
7. Please confirm what percentage of bookings are processed with a VAT savings by your direct engagement provider
8. Is your bank managed by an external bank provider (e.g. NHS Professionals, Bank Partners) or in-house? Please confirm who is the external bank provider and when the contract expires if relevant
9. Is your bank managed via software? If so, please confirm which software.
Is the Trust likely to undertake any procurement activity over the next 18 months related to provision or bank or agency services or software for the relevant staff group.

Download response Agency and Bank staffing. 240620

Agency and Bank staffing. 240620

1. Please provide agency spend for the staff group for 2019-20
2. Please provide bank spend for the staff group for 2019-20
3. Please confirm which model you have in place for managing the staff group: Email to preferred supplier List, a Master Vendor, a Neutral Vendor, or a Software cascade to a preferred supplier list
4. If you have a master vendor or neutral vendor in place, please confirm who this contract is with and the date on which this contract expires
5. Please confirm what percentage of bookings over the last 6 months have been within the NHSI/E agency caps (an approximation based on NHSI data submissions is fine)
6. Please confirm which provider manages your direct engagement process, the fee for the service and the date on which this contract expires (no this is not relevant for Nursing)
7. Please confirm what percentage of bookings are processed with a VAT savings by your direct engagement provider
8. Is your bank managed by an external bank provider (e.g. NHS Professionals, Bank Partners) or in-house? Please confirm who is the external bank provider and when the contract expires if relevant
9. Is your bank managed via software? If so, please confirm which software.
Is the Trust likely to undertake any procurement activity over the next 18 months related to provision or bank or agency services or software for the relevant staff group.

Download response Agency and Bank staffing. 240620

Agency and Bank staffing and spend.150822.docx

1. Please provide agency spend for the staff group for the Financial Year 2021-22 (please specify your start and end date used) Financial Year indicating what percentage is on and off-framework (for example, “£4,650,000 – c80% framework / 20% off-framework”).
2. Please provide bank spend for the staff group for Financial Year 2021-22 (please specify your start and end date used)
3. Please confirm which model you have in place for managing agency within the staff group: Email to preferred supplier List, a Master Vendor, a Neutral Vendor, or a Software cascade to a preferred supplier list
4. Please confirm what percentage of bookings over the last 6 months have been within the NHSI agency caps (an approximation based on NHSI data submissions is fine)
5. Please confirm which provider manages your direct engagement process, the fee for the service and the date on which this contract expires (no this is not relevant for Nursing)
6. Please confirm what percentage of bookings are processed with a VAT savings by your direct engagement (DE) provider (average for last 3 months –December, January and February)
7. Is your bank managed by an external bank provider (e.g., NHS Professionals, Bank Partners) or in-house? Please confirm who is the external bank provider and when the contract expires if relevant
8. Is your bank managed via software? If so, please confirm which software.
9. Is the Trust likely to undertake any procurement activity over the next 18 months related to provision or bank or agency services or software for the relevant staff group?
10. If you have a managed service, master vendor or neutral vendor in place for Agency medics/Agency doctors please confirm who this contract is with and the date on which this contract expires
11. If you have a managed service, master vendor or neutral vendor in place for Agency Nurses please confirm who this contract is with and the date on which this contract expires

Agency and Bank staffing and spend.150822.docx

Agency and insourcing spend.260723.docx

1. What is the total value of spend by your NHS Trust with on-framework and off-framework recruitment agencies by staff group (see staff groups below) on a temporary basis? Please provide this information for the following years (please fill in the tables below).
Note: Please provide total spend inclusive of salaries and agency margin / fees.
Note: If cannot provide split of spend by on- vs off- framework agencies, please provide total spend.
2. Do you use insourcing providers?
Note: Insourcing definition: Insourcing of Clinical Services – NHS SBS
3. If yes to previous question (use of insourcing providers), what is the total value of spend, listed by speciality and insourcing provider used for Apr-22 to Mar-23?
Note: If an insourcing provider covers multiple specialities, please list that provider multiple times (one row for each speciality).

Agency and insourcing spend.260723.docx

Agency and Staff details.260423.docx

1.) A) Last financial year agency locum spend
B) Please break down into Specialty and Grade
2.) A) The retention rates for permanent and fixed term staff – Doctors and Nurses only
B) Please break down into Specialty and Grade
3.) A) Please provide the Names of agencies used to fill vacancies
B) how much each agency charges
4.) Please provide your trust wide budgeted establishment per specialty and grade for Doctors
– Name of Speciality / Division or Directorate
– Consultants, Locum Consultant Contract and Associate Specialists
– CT/ST3 – CT/ST7, Specialty Doctors, Senior Clinical Fellows, CESR Fellow or Middle Grade Level
– FY1-ST2, Trust Grade, Junior Clinical Fellow or SHO level
5.) Please what is your actual current establishment for Doctor
– Name of Speciality / Division or Directorate
– Consultants, Locum Consultant Contract and Associate Specialists
– CT/ST3 – CT/ST7, Specialty Doctors, Senior Clinical Fellows, CESR Fellow or Middle Grade Level
– FY1-ST2, Trust Grade, Junior Clinical Fellow or SHO level

Agency and Staff details.260423.docx

Agency costs 2014/2015

1. Staff Numbers (Average over the whole year or the count on Tuesday, March 31st 2015)
2. Staff Cost
3. Agency Hours
4. Agency Spend
I would greatly appreciate it if you could supply this information for the year 2014/15 (April ’14 to March ‘15).

Download response Agency costs 2014/2015 040216

Agency costs during industrial action.030823.docx

How much have you spent on agency staff during days in which industrial action was taken by staff in your trust since 1st December 2022?

Agency costs during industrial action.030823.docx

Agency costs during industrial action.170823.docx

All questions are shown as received by the Trust.
How much have you spent on agency staff during days in which industrial action was taken by staff in your trust since 1st December 2022?

Agency costs during industrial action.170823.docx

Agency details.230623.docx

1. The Trust’s spend on agency workers (both on-framework and off-framework);
2. By role type;
3. With which provider/s and how much the Trust spends;
4. and when the current contract ends with your agency staffing provider.

Agency details.230623.docx

Agency doctor pay rates. 130421

1) Since 1st April 2020, what are the top three / most expensive hourly rates (including all cost elements i.e. pay, agency fee, NI, PAYE taxes, VAT and any associated managed service / master vendor fee) paid for agency doctors working at each of the following grades?
Please respond to question one by populating the template below as per the example.
Please clarify the Specialty for which each of the rates was paid as shown.

2) Since 1st April 2020, what are the bottom three / least expensive hourly rates (including all cost elements i.e. pay, agency fee, NI, PAYE taxes, VAT and any associated managed service / master vendor fee) paid for agency doctors working at each of the following grades?
Please respond to question one by populating the template below as per the example.
Please clarify the Specialty for which each of the rates was paid as shown.

3) For each of the “job titles” (Grade / Specialty) mention in your response to questions 1 and 2, please disclose the average hourly rate paid for agency doctors of the same Grade and Specialty since 1st April 2020.
There should be a maximum of 18 unique “job titles” in the tables above; please use the template below as per the example given at the bottom.

Download response Agency doctor pay rates. 130421

Agency doctors and nurses 2016-2017. 231117

• The total amount you spend on Agency Doctors & Nurses for the financial year 16/17 (April – March)

• For the above information to be broken down by Banding / Grade and also specialty

Download response Agency doctors and nurses 2016-2017. 231117

Agency expenditure 2016-2017. 050717

1. The trust’s completed ‘Detailed agency collection” for month 12 of 2016-17, showing the year to date figures. (Example attached)
If for any reason the trust is minded not to provide this document, please list the five specialties for which the trust had the highest agency staff costs – as a % of total pay costs for the specialty – in 2016-17 in the table below. Please also fill in the cells detailing expenditure. If the trust’s accounts have not yet been audited, please use the unaudited figures.
2. Please state the total number of shifts for which the trust breached the national pay cap for medical agency staff in 2016-17 (55% above basic rates), and break this total down for each specialty where the breach occurred (its fine to only detail the top five specialties).
3. Please state the total number of shifts for the trust breached the national pay cap for agency nursing staff in 2016-17 (55% above basic rates), and break this total down for each specialty where the breach occurred. (It’s fine to only detail the top five specialties).
4. Please state the total number of shifts which required CEO sign off, and break these down for each specialty.
5. Please state the ten shifts for agency medical staff for which the highest hourly rate was paid. Please state the rate paid and the specialty.
6. For individual medical locums who have incurred the greatest total expenditure for the trust in 2016-17, please state the total amounts paid by the trust in the year in relation to these individuals’ work. Please also state their specialty. E.g. Medical locum 1, emergency medicine, total expenditure by the trust in 2016-17; £196,000

Download response Agency expenditure 2016-2017. 050717

Agency Locum Doctor spend for 2015-2016.

• The total amount you spend on Agency Locum Doctors for the financial year 15/16 (April – March)
• For the above information to be broken down by grade and specialty (example provided below)

Download response Agency Locum Doctor spend for 2015-2016 270616

Agency locum doctor supply. 151118

You asked:
1. What percentage fill rates (doctors) were reached between January and present?
2. Does your organisation use a Direct Engagement scheme? If so, who provides it and when does their contract expire?
3. What percentage of bookings are made outside of the DE model (non-DE)?
4. Do you outsource any of the following services to external companies:
• Provision of Residential Medical Officers
• Gastroenterology/Endoscopy
• Dermatology
• Radiology
5. Do you use agencies for national and international permanent doctor and/or nursing recruitment? If so, do you employ nurses from the Philippines?

Download response Agency locum doctor supply. 151118

Agency locum doctors and consultants spend for 2015-2016.

Please can you let us know what the Trust as a whole (including hospitals that are run by you) spent on employing agency locum Doctors and Consultants last year.

Download response Agency locum doctors and consultants spend for 2015-2016 010716

Agency, locum or bank staff. 181019

1. Over the last 5 years, broken down by year, the total number of hours of work provided to the trust by non-substantive doctors, either via a locum agency or a bank staffing system, and the total cost to the trust of those hours.
2. The above information broken down by staff sourced through agency and those sourced through your bank staffing arrangement.
3. The figures (hours and spend for each of locum and bank) provided in answer to 2. broken down first by specialty and then grade of doctor.
4. The standard hospital hourly rate of pay for each of the specialties and grades listed in answer to 3.
5. The hospital and NHS capped rates for each of the specialties and grades listed in 3. if different to the rate listed in 4.
6. For each category created in response to 3. (i.e bank haematology registrars), the percentage of hours worked at standard rate, above the standard rate, and above the capped rate if different from the standard rate.
7. What penalties, if any, are levied against the trust if it exceeds the ‘capped’ rate.
8. What penalties were levied against the trust for breaking the cap in each of the years for which data has been provided.
9. If the trust utilises a Bank Partner, what is the cost of said Partner and how does this cost manifest e.g. lump sum, fee per position filled etc.

Download response Agency, locum or bank staff. 181019

Agency locum spend. 010818

How much did the trust spend on agency locums last year? Broken down into SHO, Middle Grade and Consultants

If I could please have this information on the following specialities: A&E, Acute Medicine, General Medicine, Radiology and Paediatrics I would be appreciative.

Download response Agency locum spend. 010818

Agency locum spend 2015-2016.

Please could you send me the agency locum spend for the trust for the last financial year. I would like the spend for doctors only.

Please include the agency spend in each specialty breaking it down into the different grades (SHO, Middle Grade, Consultant).

Please could you also provide the spend on introductory fees for doctors for each specialty based on Doctors taken onto NHS contracts.

Download response Agency locum spend 2015-2016 050816

Agency locum spend in Cardiology. 040717

Could you please let me know the locum agency spend from May 2016 – Present? This refers directly to the cardiology department only; the staff will be Cardiographers, Cardiac Physiologists, Echo cardiographers, please note this is not referring to locum doctors or specialists.

These staff will fall under AHP/HSS or healthcare.

Download response Agency locum spend in Cardiology. 040717

Agency locums and Doctors. 301120

1. Last financial year agency locum and bank spend
• Please break down into Specialty and grade
2. Names of agencies used to fill vacancies
– How much does each agency charge
3. What is your trust wide budgeted establishment per specialty and grade for doctors
– Name of Speciality / Division or Directorate:
– Consultants, Locum Consultant Contract and Associate Specialists:
– CT/ST3 – CT/ST7, Specialty Doctors, Senior Clinical Fellows, CESR Fellow or Middle Grade Level:
– FY1-ST2, Trust Grade, Junior Clinical Fellow or SHO level:
4. What is your actual current establishment for doctor
• Name of Speciality / Division or Directorate:
– Consultants, Locum Consultant Contract and Associate Specialists:
– CT/ST3 – CT/ST7, Specialty Doctors, Senior Clinical Fellows, CESR Fellow or Middle Grade Level:
– FY1-ST2, Trust Grade, Junior Clinical Fellow or SHO level:

Download response Agency locums and Doctors. 301120

Agency midwives.140923.docx

You asked: All questions are shown as received by the Trust.
1. How much have you spent on agency midwives each of the last five years?

2. What was the most expensive agency midwife shift over the last five years?

Agency midwives.140923.docx

Agency midwives and pay 2015.

1. What was the total cost for your trust, including fees and any other on-costs, for midwives supplied by an agency, broken down by the months in the table below?

2. What was the cost for your trust for the fees and any other on-costs, for midwives supplied by an agency, broken down by the months in the table below?

3. What was the total number of hours worked by midwives supplied by an agency, broken down by the months in the table below?

4. What was the total cost for your trust for midwives working overtime, broken down by the months in the table below?

5. What was the total number of hours worked by midwives working overtime, broken down by the months in the table below?

6. What was the total cost for your trust, for midwives supplied by the bank, broken down by the months in the table below?

7. What was the total number of hours worked by midwives supplied by the bank, broken down by the months in the table below?

8. Does your trust pay bank rates at the individual’s actual pay point or higher or lower than their pay point?

Download response Agency midwives and pay 2015 140316

Agency Midwives and pay 2016. 300117

1. What was the total cost for your trust, including fees and any other on-costs, for midwives supplied by an agency, broken down by the months in the table below?
2. What was the total number of hours worked by midwives supplied by an agency, broken down by the months in the table below?
3. What was the total cost for your trust for midwives working overtime, broken down by the months in the table below?
4. What was the total number of hours worked by midwives working overtime, broken down by the months in the table below?
5. What was the total cost for your trust, for midwives supplied by the bank, broken down by the months in the table below?
6. What was the total number of hours worked by midwives supplied by the bank, broken down by the months in the table below?

Download response Agency Midwives and pay 2016. 300117

Agency nurse and locum doctor expenditure. 261020

1. On how many occasions in the 2019/20 financial year did you spend £1,500 or more to employ an agency nurse for a single shift? For each occasion, please state the amount paid, how many hours they were asked to work as well as the job title and department the nurse was deployed in.
2. On how many occasions in the 2019/20 financial year did you spend £3,000 or more to employ an agency doctor for a single shift? For each occasion, please state the amount paid, how many hours they were asked to work as well as the job title and department the nurse was deployed in.

Download response Agency nurse and locum doctor expenditure. 261020

Agency nurse cover November 2015 – April 2016. 061216

1. Are off frame work agencies used to cover nurse shifts?
2. On a month by month basis, what was your spend on agencies supplying off frame work nurses from 1st November 2015 to date? Please break down this information by RGN, ITU, CRITICAL, ODP’S, SCRUBS, PAEDS, HDU, A&E, AMU, ADVANCED NURSE PRACTITIONER, HCA’S ETC. If this is not possible then please break down by nurse bands.
3. Which agencies supply off frame work nurses?
4. On a month by month basis, how many times was the break glass clause used from 1st November 2015 to date?
5. Please pick 10 random shifts which were filled via off frame work agencies between 1st November 2015 to date and provide the following for each of the 10 shifts picked at random (it is not essential to name the specific agencies which relate to the chosen shifts):
• Amount that was paid to the agency to fill each shift or the hourly rate paid to the agency
• Number of hours in the shift
• Date shift filled
• The type of nurse used to fill the shift e.g. RGN, ITU, HDU, CRITICAL, A&E, PAEDS etc.
• The type of shift or shift start time e.g. Long Day or Long Night or alternatively shift start time e.g. 08:00 etc.

Download response Agency nurse cover November 2015 – April 2016. 061216

Agency nurse expenditure for 2015-2016.

• The total amount you spend on Agency Nurses for the financial year 15/16 (April – March)
• For the above information to be broken down by banding and specialty (example provided below)

Download response Agency nurse expenditure for 2015-2016 010716

Agency Nurse Rates and hours. 130421

Average Band 5 Agency Nurse Rates
Please respond to question one by populating the template below.
a) Average cost per hour (inclusive of base pay, agency margin, NI, PAYE etc. but excluding VAT) paid for Band 5 agency Nurses for Standard Day hours between 1st April 2020 and 31st January 2021
b) Average cost per hour (inclusive of base pay, agency margin, NI, PAYE etc. but excluding VAT) paid for Band 5 agency Nurses for Saturday & Evening hours between 1st April 2020 and 31st January 2021.
c) Average cost per hour (inclusive of base pay, agency margin, NI, PAYE etc. but excluding VAT) paid for Band 5 agency Nurses for Sunday & Bank Holiday hours between 1st April 2020 and 31st January 2021

Part 2 – High Rate Band 5 Nurse Hours
For the below questions, please answer number of shifts rather than number of hours if this figure is easier to obtain – please clarify which unit you’re referring to within your response. Please also indicate how many individual nurses make up the figure in response to each of the below.
a) For Band 5 Agency Nurses, regardless of rate type (i.e. Days, Nights, Bank Holidays etc.), how many hours since 1st April cost £50 per hour or more?
b) For Band 5 Agency Nurses, regardless of rate type (i.e. Days, Nights, Bank Holidays etc.), how many hours since 1st April cost £75 per hour or more?
c) For Band 5 Agency Nurses, regardless of rate type (i.e. Days, Nights, Bank Holidays etc.), how many hours since 1st April cost £100 per hour or more?

Download response Agency Nurse Rates and hours. 130421

Agency nurses. 041019

Could the trust please provide information on how much has been spent on agency nurses?

1) This financial year to date
2) 2018/19 financial year
3) 2017/18 financial year

Are these amounts higher, lower or within the budgets allocated for agency staff?

Are there any measures being implemented to lower the reliance or use of agency staff?

Download response Agency nurses. 041019

Agency nurses and midwives.240523.docx

Could you provide me with a breakdown of spend on agency nurses and midwives between May 2022 and May 2023 as below
1. Number of shifts invoiced by each provider trust has used for agency nursing
2. Framework spend on agency nursing and midwifery broken down to spend per Framework provider
3. Off-framework spend on agency nursing and midwifery broken down to spend per off-framework provider

Agency nurses and midwives.240523.docx

Agency nursing costs – January and February and July to December 2015?

Please could you tell me what the cost was in wages to the trust for agency nursing during the months of January and February and July to December 2015? (Could the cost per month be separated, please?)

Please include the wage bill for the two sites, and, if at all possible, please can you break them down into departments and sites?

However, if this is not possible, please still provide me with the overall cost.

Please could you tell me what the cost was in wages to the trust for all agency staff during the months of January to December 2015? (Could the cost per month be separated, please?)

Please include the wage bill for the two sites, and, if at all possible, please can you break them down into departments and sites?

However, if this is not possible, please still provide me with the overall cost.

Download response Agency nursing costs – January and February and July to December 2015 080116

Agency nursing. 130421

1) How many agency nursing shifts have your Trust used SNG or Thornbury Nursing Services for between 1st October 2020 and 30th November 2020?
2) Please provide a breakdown of the amount of shifts per ward or department where SNG or Thornbury Nursing Services were used in 1st October and 30th November 2020?
3) How many agency nursing shifts have your Trust used Nutrix nursing agency for between 1st October 2020 and 30th November 2020?
4) Please provide a breakdown of the amount of shifts per ward or department where Nutrix were used between 1st October 2020 and 30th November 2020.
5) Please name any other OFF CONTRACT SUPPLIERS who have been utilised by the Trust between 1st October 2020 and 30th November 2020 above the NHS Improvement + 50% caps and how many shifts each of these agencies have filled.

Download response Agency nursing. 130421

Agency nursing.160823.docx

All questions are shown as received by the Trust.
Please can you confirm how much was spent on agency nursing between the period April 1st 2023 and 31st June 2023?

Further to this, please can you confirm how much of this total was spent with Off-framework agencies?

Agency nursing.160823.docx

Agency Nursing.200723.docx

Please could you answer the following questions in relation to the trusts agency nursing usage in financial year 2022-2023
1. How much in total did the trust spend on agency nursing supply?
2. How was that total split between Community/ Acute/ Mental Health Nursing (please delete as appropriate)?
3. Of the total spend, how much of it was spent with off-framework agencies?
4. Who within the trust is responsible for reporting on off-framework usage?

Agency Nursing.200723.docx

Agency Nursing.230823.docx

All questions are shown as received by the Trust.
Please answer all questions with the relevant data for the month of March 2023 ( 1st to the 31st March ) for your nursing – inclusive of Adult, Mental Health, Critical, Community and District where applicable for both frameworks and off frameworks Agencies.
Information requested :
1. The total number and spend of nursing shifts sent to agencies to fill ( frameworks and off frameworks ) Please provide these totals separately
2. The total number and spend of nursing shifts filled by agencies ( frameworks and off frameworks ) Please provide these totals separately
3. The total number and spend of critical banded nursing shifts sent to agencies to fill. ( frameworks and off frameworks ) Please provide these totals separately
4. The total number and spend of critical banded nursing shifts filled by agencies. ( frameworks and off frameworks ) Please provide these totals separately
5. The total number and spend of ‘breaches’ for filling a shift with agency nurses (Registered Nurses) not within the NHSI capped charge rates.
6. Please provide a list of all frameworks agencies that are currently ‘breaching’ ‘breaches’ when filling a shift with agency nurses (Registered Nurses) not within the NHSI capped charge rates.
7. Please provide a list of all frameworks agencies which supply the trust with nursing staff.
8. Please provide a list of off framework agencies which have supplied (from 1st January 2023 to 31st March 2023) into the trust with nursing staff across all sites.
9. From 1st March 2023 to 31st March 2023, please list the wards/ departments you have requested shifts for off framework agencies.

Agency Nursing.230823.docx

Agency Nursing, Master Vendor and Neutral Vendor.160823.docx

All questions are shown as received by the Trust.
For nursing registered and unregistered please could you share the below agency data:
1. For registered Nursing
a. How many hours were used in the last year?
b. What is your spend over the corresponding period?
2. For unregistered Nursing
a. How many hours were used in the last year?
b. What is your spend over the corresponding period?
Please could you also confirm if you have a:
3. Master vendor and their contract end date?
4. Neutral vendor and their contract end date?

Agency Nursing, Master Vendor and Neutral Vendor.160823.docx

Agency nursing shifts. 130421

1) How many agency nursing shifts have your Trust used SNG or Thornbury Nursing Services for between 01 December 2020 and 10 February 2021
2) Please provide a breakdown of the amount of shifts per ward or department where SNG or Thornbury Nursing Services were used between 01 December and 10 February 2021
3) How many agency nursing shifts have your Trust used Nutrix or Greenstaff for between 01 December 2020 and 10 February 2021?
4) Please provide a breakdown of the amount of shifts per ward or department where Nutrix, or Greenstaff were used between 01 December 2020 and 10 February 2021
5) Please name any other OFF CONTRACT SUPPLIERS who have been utilised by the Trust between 01 December 2020 and 10 February 2021above the NHS Improvement + 50% caps and how many shifts each of these agencies have filled.
6) If for any reason you are unable to supply data up until 10 February please provide the data until 31 January 2021

Download response Agency nursing shifts. 130421

Agency nursing shifts. 210222.docx

1) How many agency nursing shifts have your Trust used SNG or Thornbury Nursing Services for between 1st December 2021 and 10th February 2022
2) Please provide a breakdown of the number of shifts per ward or department where SNG or Thornbury Nursing Services were used between 1st December 2021 and 10th February 2022
3) How many agency nursing shifts have your Trust used Nutrix, MED GEN, Greenstaff for between 1st December 2021 and 10th February 2022?
4) Please provide a breakdown of the number of shifts per ward or department where Nutrix, or Greenstaff were used between 1st December 2021 and 10th February 2022
5) Please name any other OFF CONTRACT SUPPLIERS who have been utilised by the Trust between 1st December 2021 and 10th February 2022
6) If for any reason you are unable to supply data up until 10th February please provide the data until 31st January 2022

Agency nursing shifts. 210222.docx

Agency nursing shifts. 260919

1) How many agency nursing shifts have your Trust used Thornbury nursing services for between 1st July 2019 and 31st July 2019?

2) How many agency nursing shifts have your Trust used Thornbury nursing services for between the dates of 1/8/2019 and 18/8/2019?

3) Please provide a breakdown of the amount of shifts per ward or department where Thornbury were used in July 2019 and 1/8/19- 18/8/19/.

4) Please provide a breakdown for July 2019 of the amount of shifts filled at your Trust by other off contract nursing providers (ie non-framework). Please break this down in the same format (i.e. by ward or department) as question 3.

Download response Agency nursing shifts. 260919

Agency Nursing shifts. 2609192

1. Which agency filled the most nursing shifts at your Trust in the last 30 days and how many hours or shifts did they fill?
2. How many of the shifts filled by agency nurses in the last 30 days were above cap?
3. Which wards or departments and sites within your Trust utilised agency nurses in the last 30 days and how many shifts were booked on each?
4. How many nursing shifts were filled by Framework agencies above the 50% NHS Improvement increased caps in the last 30 days?
5. Please list the nursing agencies utilised in the last 30 days above the 50% increased NHS Improvement capped rates by your Trust.

Download response Agency Nursing shifts. 2609192

Agency nursing shifts. 2609193

1. How many agency nursing shifts have your Trust used Thornbury nursing services for in the last 30 days?
2. Please provide a breakdown of the amount of shifts per ward or Departments that Thornbury filled for agency nurses in the last 30 days.
3. What other nursing agencies do you use off contract/off framework?
4. How many nursing shifts did other off contract agencies fill in the last 30 days?
5. Are there any other services linked to your Trust that utilise TNS or any other off contract supplier re Prisons, or community based services? If so please provide a list of these services and the amount of nursing shifts filled in each over the last 30 days

Download response Agency nursing shifts. 2609193

 

Agency Nursing Spend.260822.docx

1. Can you confirm names of all agencies supplying into the trust directly or via the NHS Professionals platform for nursing staff specifically for both Band 2 and Band 5 requirements, including off-framework agencies.
a. With the above information, can this be broken down by
• Volume of supply (per month for the last 12 months)
• Total trust spend per agency (per month for the last 12 months)
• By AfC banding of shift request and speciality of nurse
2. Please can you confirm how many shifts have been filled by agencies supplying Band 5 Registered Nursing staff at or below NHSI agency capped rates within the last 12 month period?
3. Please can you confirm how many shifts have been filled by agencies supplying Band 5 Registered Nursing staff above NHSI agency capped rates within the last 12 month period?
4. For the same 12 month period, can you confirm the average charge rate per hour for Band 5 Nursing agency staff across:
Week Days:
Night Shift/Saturday shifts:
Sunday shift/Bank Holiday:
5. Lastly can you confirm the highest agency nurse hourly charge rate, and their speciality?

Agency Nursing Spend.260822.docx

Agency nursing spending rules from October 01 2015

Questions on the trust’s ceiling for agency nurse spend, as per the rules introduced from October 1, 2015:

1) How many applications has your trust made to increase its ceiling for agency nurse spend?
2) How many of these applications were successful?
Questions on the agency pay caps – specifically regarding nurses – as per the rules introduced on November 23, 2015:
3) On how many shifts has your trust overridden the rules for hourly rate agency caps – specifically for nurses – since the rules were introduced?
4) Across how many weeks have these breaches (in question 3 above) occurred? .
5) How many band five nurses has your trust overridden the rules for?
6) How many band six nurses has your trust overridden the rules for?
7) How many band seven nurses has your trust overridden the rules for?
8) How many band eight nurses has your trust overridden the rules for?

Download response Agency nursing spending rules from October 01 2015 150216

Agency nursing usage. 250521

1. Breakdown of shifts (Numbers only) filled by individual Nursing Agencies (by name of agency) in Trust operated theatre wards for ‘Surgical First Assistants’, Operating Department Practitioners’ and ‘SCRUB Nurses’ for March 1st 2021- April 30th 2021
2. Individual Charge rates for nursing agencies for theatre staff March 1st 2021- April 30th 2021
3. Number of shifts filled by individual ‘Off Framework Agencies’ March 1st 2021-April 30th 2021
4. Total Cost for each Nursing Agency used by theatre departments financial year April 2020- April 2021

Download response Agency nursing usage. 250521

Agency Payments. 090419

1. Please provide the 10 largest individual agency payments for core hours your trust has authorised above the agency worker price caps set by NHS Improvement for each of the following medical grades for (a) 2017-18 and (b) 2018-19 (to date).
• Foundation Year 1
• Foundation Year 2
• Registrar ST1-2
• Registrar ST3
• Speciality staff/staff grade
• Associate specialist
• Consultant

Please provide the figures excluding VAT, as a rate per hour, what the cap was at that particular point in time, the month it was paid and the type of shift being filled.

2. Please provide the 10 largest individual agency payments for unsocial hours your trust has authorised above the agency worker price caps set by NHS Improvement for each of the following medical grades for (a) 2017-18 and (b) 2018-19 (to date).
• Foundation Year 1
• Foundation Year 2
• Registrar ST1-2
• Registrar ST3
• Speciality staff/staff grade
• Associate specialist
• Consultant

Download response Agency Payments. 090419

Agency Pharmacists and Pharmacy Technicians. 240119

I would like you to send me the locum agency spend in the AHP/HSS division of the hospital for Pharmacists and Pharmacy Technicians. I would like to know the spend for 2018 with each agency- if this is not possible then I’d like to know overall spend for the year for both Pharmacists and Pharmacy Technicians.

Download response Agency Pharmacists and Pharmacy Technicians. 240119

Agency price caps. 100821.docx

1. Can you provide the total number of times you have exceeded the agency price cap limits for each year from 2016 -2020 broken down by each quarter right up to the most recent available data?
2. Can you provide the maximum amount paid on a per hour basis for an agency shift for each year from 2016 -2020 broken down by each quarter right up to the most recent available data?
3. I am aware that there are country wide NHSI caps but for some areas (such as medical), there are agreed Pan London ceiling rates which are higher than the NHSI caps. Could another column in the data be provided to show when those London caps are exceeded?

Download response Agency price caps. 100821.docx

Agency Recruitment. 051218

You asked:
1. How many doctors have been booked outside of IR35 since April 2017?
2. What is your yearly trust spend on agency locum doctors via framework agencies, broken down into grade and specialty?
3. What is your yearly trust spend on agency locum doctors via OFF-framework agencies, broken down into grade and specialty?
4. What is your average total charge rate for a locum consultant doctor?
5. Who is the highest paid locum Consultant, what is the hourly rate and in what specialty do they practice?
6. Please can you outline your spend per agency, broken down by grade and specialty of doctor over the past 12 months?

Download response Agency Recruitment. 051218

Agency Shift Cost

1. What was the highest amount you paid (including any agency commission/charges) for a single shift filled by each of the following a. a doctor b. a GP (if employed) c. a registered nurse and d. a non-registered support worker/healthcare assistant in the period March 28th to April 19th 2015? Please include date and length of shift and grade of doctor/nurse involved, the department they were needed for (e.g. A&E) and the agency which supplied the doctor/nurse in each case.
2. What percentage of shifts covered by agency staff during this time period were paid in accordance with either an NHS wide or a local framework, and what proportion were off framework?
3. What was your total spend on temporary (locum, agency and bank) clinical staff for 2014-15? Please include doctors, nurses and healthcare assistants/support workers in your answer. What were the comparable figures for 2013-14 and 2012-13?

Download response Agency Shift Cost 050515

Agency shifts. 250817

I am making a Freedom of Information Request to gain information on the volume of shifts that have been filled by agencies within nursing and medical locums (Doctors) at your organisation.

Further to this what is the percentage of shifts filled for Medical and for Nursing above the NHSi Cap.

Download response Agency shifts. 250817

Agency spend.260219

Please can you outline your agency spend into each 52 weeks or 12 months for the year 2018 (I understand the year has not finished yet so up to OCTOBER 2018) would be sufficient.
1. How many agencies did your trust use in the year of 2018?
2. How much was spent on agency nurses in 2018?
3. On December 25th 2017, how many shifts went nursing shifts went unfilled?
4. What is the highest hourly rate paid to a locum agency in 2018 and what band was this nurse i.e. band 5 general.
5. Please list the names of agencies that we used in year 2018 and list the total amount of spend for each used.
6. What is the total number of different nurse locums did the trust use in 2018.
7. What was the highest hourly rate paid to an agency for a nurse in 2018 – Please state what agency this was and what band they were.
8. Of all agencies used, were any off framework? If so, what are the agencies called?
9. Who is the head of procurement at your Trust who approves agency use?
10. Who approves above-cap and/or off-framework usage?
11. Who are your tier 1 and tier 2 agencies?

Download response Agency spend.260219

Agency spend.300623.docx

Please can I have the following information under The Freedom of Information Act (FOIA)
Total Spend on Temporary Locums broken down into the following specialties and sites of the Trust – From April 2022 – April 2023
Medicine
Surgery
Trauma & Orthopaedics
Paediatrics
A&E
Anaesthetics
Obstetrics & Gynaecology

Agency spend.300623.docx

Agency spend for 2022-2023.210623.docx

I would like to request the following information:

The trusts total temp agency spend for the financial year 22/23 broken down by Doctors, Nursing and AHP spend.

Agency spend for 2022-2023.210623.docx

Agency spend for doctors. 240119

I would like you to send me the locum agency spend for Doctors for the hospital in acute settings as well as the community for each specialism.

I would like to know the spend from January 2018 – present, also including the amount of locums that this refers to per month, broken down on a monthly basis. In the breakdown if you could please include the agencies that provide the locums also broken down numerically.

Download response Agency spend for doctors. 240119

Agency Spend for Doctors, Nurses and Allied Health Professionals. 070222.docx

The total amount spent on agency temporary staff between January 21 – December 21 for the following categories:
Doctors
Nurses
AHP’s

Agency Spend for Doctors, Nurses and Allied Health Professionals. 070222.docx

Agency spend for nursing and midwifery.211122.docx

I would like to request the below information from the trust for year 2021/2022.
1. What was your agency spend for nursing and midwifery for the year April 2021- April 2022?
2. How much of the spend was above the NHSI rate caps April 2021- April 2022?
3. Have you used off-framework in the last 6 months?
4. If so, what was the total spend?
5. Which off-framework agencies have you used?
6. How many unfilled shifts have you had for:
a. A&E
b. ITU
c. General
d. Theatres
e. Mental Health
f. CPN
g. Midwifery
h. Paediatrics
i. Neonatal
j. HCA
7. If this cannot be provided via speciality, please could I have an over-all number?
8. How many vacancies do you have for band 5/6 nurses in the following areas?
a. A&E
b. ITU
c. General
d. Theatres
e. Mental Health
f. CPN
g. Midwifery
h. Paediatrics
i. Neonatal
j. HCA
9. How many incident/critical incidents have been declared as a result of staffing?
10. Who is the nurse bank/temporary staffing manager?
11. What are the contact details for the Nurse Bank / Temporary Staffing Manager?

Agency spend for nursing and midwifery.211122.docx

Agency spend for Radiology locum doctors December 2015 to May 2016.

Can you please assist me with retrieving the total Agency spend for Locum Doctors only within Radiology over the following months, within your Trust or Health Board?

Download response Agency spend for Radiology locum doctors December 2015 to May 2016 060916

Agency spend in Radiology August 2016 – January 2017. 240317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Radiology over the following months, within your Trust or Health Board?
August 2016
September 2016
October 2016
November 2016
December 2016
January 2017

Download response Agency spend in Radiology August 2016 – January 2017. 240317

Agency spend and substantive vacancies. 091117

1. The total amount of agency spend on medical locums in the 2016/2017 tax year
2. The total amount of spend on agency nurses in the 2016/2017 tax year
3. The total amount of spend on agency AHPs in the 2016/2017 tax year
4. The percentage of substantive Doctor positions that are currently unfilled
5. The percentage of substantive Nurse positions that are currently unfilled
6. Do you have a managed service or master vendor arrangement, or an outsourced staff bank for any clinical staff groups and if so, who is/are the supplier(s)?
7. Do you have a Direct Engagement supplier and if so, who?

Download response Agency spend and substantive vacancies. 091117

Agency spend within Gastroenterology.

Can you please assist me with retrieving the total Agency spend within Gastroenterology over the following months, within your Trust or Health Board?

Download response Agency spend within Gastroenterology

Agency staff. 010818

1. Since January 2018, have you allowed an Agency to fill a shift or booking above the April Cap (implemented in 2016) via the CPP Framework (otherwise known as the National Clinical Staffing Framework Agreement (Reference CPP2015/01))? For reference the term ‘shift’ can include any general nursing or critical nursing role.

2. If the answer is yes to the above question, please inform us of how many such shifts have been filled above cap via the CPP Framework.

3. What was the total value of charges paid under all of the call-off agreements identified in response to request 1 (above)?

4. Any information relating to the decision(s) of the Trust to enter into call-off agreements that include pay rates that exceed the maximum pay rates allowed under the Framework Agreement.

Download response Agency staff. 010818

Agency staff.01118

1. In relation to the value of the contracts in your previous response of 1 August 2018, the value of which was £514,072.20, please state the total costs that the Trust paid in excess of the rates allowed under the fee caps (those fee caps being the April Caps (implemented in 2016) for the National Clinical Staffing Framework Agreement (Reference CPP20 15/011) (otherwise known as CPP Framework) (the “Framework Agreement”).
2. In relation to your answer to point 1, please state how much of this sum was attributed to shifts for Nursing & Midwifery staff.
3. In the event that the anticipated costs of providing all of the information requested under points 1 and 2 above are likely to exceed the appropriate limit specified in Regulation 3 of the Freedom of Information and Data Protection (Appropriate Limit and Fees) Regulations 2004, please provide instead the total costs that the Trust paid in excess of the rates allowed under the fee caps in June 2018.
4. In the event that you provided a substantive response to point 3, please provide us with how many such shifts have been filled above cap via the Framework Agreement in June 2018.
5. In the event that the anticipated costs of providing all of the information requested under point 3 above is likely to exceed the appropriate limit specified in Regulation 3 of the Freedom of Information and Data Protection (Appropriate Limit and Fees) Regulations 2004, please provide instead the total costs that the Trust paid in excess of the rates allowed under the fee caps for the period Monday 4 June 2018 to Sunday 10 June 2018.
6. In the event that you provided a substantive response to point 5, please provide us with how many such shifts have been filled above cap via the Framework Agreement, for the period Monday 4 June 2018 to Sunday 10 June 2018.
7. In your response of 1 August 2018, you stated that 16,754 shifts were for Medical & Dental staff. Please provide a breakdown of this figure and categorise the shifts into grades of staff.

Download response Agency staff.01118

Agency staff.040923.docx

All questions are shown as received by the Trust.
1. How much have you spent on agency staff each of the last five years?
a. What was the most expensive agency midwife shift last year?
b. How much on bank midwives each of the past five years?

Agency staff.040923.docx

Agency Staff.100822.docx

Please can you provide the following information regarding use of agency staff in your NHS Trust.
Please note there are three parts to this request.
1. Please can you provide the total spend on agency staff in your NHS Trust in the financial year ending April 2022
2. Please can you provide the total spend on agency staff in your NHS Trust in the financial year ending April 2019
3. Please can you provide the total spend on agency staff in your NHS Trust in the financial year ending April 2017

Agency Staff.100822.docx

Agency Staff.210323.docx

1. What was your trust spend on agency for the period 1 January 2022 to 31 December 2022 inclusive for the following staff groups: –
a. Registered nurse (RN)
b. Health care support workers/healthcare assistants/nursing associates?

2. What was your trust spend on agency for the period 1 January 2021 to 31 December 2021 inclusive for the following staff groups: –
a. Registered nurse (RN)
b. Health care support workers/healthcare assistants/nursing associates?

3. What was your trust spend on agency for the period I January 2020 to 31 December 2020 inclusive for the following staff groups: –
a. Registered nurse (RN)
b. Health care support workers/healthcare assistants/nursing associates?

Agency Staff.210323.docx

Agency Staff.210823.docx

Nurses:
1. Total number of hours of agency nurses used by the Trust in the month of February 2023
2. Of the total number of agency nurse hours used, the number of hours procured ‘off-framework’
3. Of the total number of agency nurse hours used, the number of hours procured at ‘break glass’ or rates above the NHSI rate caps.
4. Of the total number of agency nurse hours used, the number of hours procured at an increased AFC banding i.e. band 5 offered band 6 as an incentive
Healthcare Assistants:
1. Total number of hours of agency healthcare assistants used by the Trust in the month of February 2023
2. Of the total number of agency healthcare assistants hours used, the number of hours procured ‘off-framework’
3. Of the total number of agency healthcare assistants hours used, the number of hours procured at ‘break glass’ or rates above the NHSI rate caps.
Pharmacy Staff:
1. Total number of hours of agency pharmacy staff used by the Trust in the month of February 2023
2. Of the total number of agency pharmacy staff hours used, the number of hours procured ‘off-framework’
3. Of the total number of agency pharmacy staff hours used, the number of hours procured at ‘break glass’ or rates above the NHSI rate caps.

Agency Staff.210823.docx

Agency Staff. 210917

I am looking at the other positions supplied, starting with AHP and HSS staff.
Namely:
Allied Health Professionals Health Science Services
Dieticians Biomedical Scientists
Occupational Therapists Cytologists
Orthoptists Dental Service Staff (excluding dental nurses)
Physiotherapists Genetic Counsellors
Podiatrists Healthcare Scientists
Psychologists Medical Technologists
Radiographers Optometrists
Speech and Language Therapists Pathologists
Pharmacy Services Staff

Please could you provide me with the following information:
1. Names of Agencies used to provide AHP or HSS staff over the last 12 months
2. Monthly spend, on Agency Staff, per job role over the last 12 months
3. Hours, per job role, filled each month by Agency over the last 12 months
4. Number of shifts offered to Agencies for each role, monthly for the last 12 months.
5. Number of shifts filled by Agency for each role, monthly for the last 12 months.

Download response letter Agency Staff. 210917

Agency staff. 260919

Please could you advise the number of hours or shifts filled from 01th April 2018 – 31st March 2019 with qualified nursing staff within the Trust with agency staff?

Download response Agency staff. 260919

Agency Staff Bank.250322.docx

For Hospitals
1. Hospitals in trust
2. Names of off-framework agencies used between 2021- to date
3. Names of on-framework agencies used between 2021- to date
4. Do you have a master vendor in place?
5. If yes, please provide your account manager’s email
6. Temporary agency staff manager full name
7. Temporary agency staff manager email
8. Temporary agency staff manager telephone
9. Permanent agency staff manager full name
10. Permanent agency staff manager email
11. Permanent agency staff manager telephone
12. Off-framework agency spend between Feb 2021-date
13. Framework agency spend between Feb 2021 – date
14. Total agency shift cancelations Feb 2021-date
For Urgent Care Centres/Walk-in Clinics
1. Urgent treatment / walk-in centres
2. Names of off-framework agencies used between 2021- to date
3. Names of on-framework agencies used between 2021- to date
4. Do you have a master vendor in place?
5. If yes, please provide your account manager’s email
6. Temporary agency staff manager full name
7. Temporary agency staff manager email
8. Temporary agency staff manager telephone
9. Permanent agency staff manager full name
10. Permanent agency staff manager email
11. Permanent agency staff manager telephone
12. Off-framework agency spend between Feb 2021-date
13. Framework agency spend between Feb 2021 – date
14. Total agency shift cancelations Feb 2021-date

Agency Staff Bank.250322.docx

Agency Staff Cost

Under the freedom of information act 2000, I am writing to formally request the following information:
1. Staff Numbers
2. Staff Cost
3. Agency Hours
4. Agency Spend
I would greatly appreciate it if you could supply this information for the year 2013/14 (April ’13 to March ‘14).

Download response Agency Staff Cost 040815

Agency Staff costs.101122.docx

The total amount spent on agency temporary staff for the year 2021/22 (April ’21 to March ‘22) and between 31/10/2021 to 31/10/2022 for the following categories:
• Doctors
• Nurses
• AHP (all categories)
• Health Care Assistants

Agency Staff costs.101122.docx

Agency staff spend.050224.docx

All questions are shown as received by the Trust.
For the most recent month available please provide your usage in terms of financial spend of agency staff for the job types below. Where the information is available, indicate the percentages ‘on-framework’ and ‘off-framework’.

The job types are:
1. Nursing
2. HCAs
3. Pharmacists
4. Pharmacy Technicians

Agency staff spend.050224.docx

Agency staff spend 2013-2016. 221116

Please can you confirm your monthly Hospital and/or Trust spend on agency staff during the last three financial years (FYE Mar-14, Mar-15, & Mar-16). Ideally, this should be broken down into spend by Hospitals/Trusts, the agency supplying the staff and by month.

Download response letter Agency staff spend 2013-2016. 221116

Agency Staffing. 050718

1. Agency spend on Medical Locums/Doctors
2. Agency spend on AHP’s (Allied Health Professionals) and HSS (Health and Social Sciences)
3. Agency spend on Nursing
4. Agency spend on NMNC (Non-Medical, Non Clinical)
5. Do you use a Direct Engagement model to engage locum staff?
6. If so, please state the name of the company used
7. What is the expiry date for this contract?

Download response Agency Staffing. 050718

Agency Staffing. 260919

1. (a) Who is the head of procurement at your trust responsible for approving Nursing agency usage?
(b)Secondly, who is the temporary / flexible staffing lead responsible for the management of this service?
2. Please can you provide the contact information in relation to both question 1 (a) and (b)
3. Please can you outline your Off-Framework agency spend for each of the following staff groups between April 2019 – June 2019: (a) RGN’s (b) RCN’s (c) RN’s and (d) HealthCare Assistants (e) RMN (f) Specialist RN (ITU) (g) Medical Locums
4. Following the same breakdown of staff groups in Question 3, how many Off-framework shifts have been unfilled between April 2019 – June 2019
5. Since the start of January 2019 – present, please provide the current charge rates from your Off Framework, Nursing providers, providing a clear breakdown between the workers pay rate and agency commission
6. Based on the above information, who are your current Nursing Off-Framework agencies and how many shifts have been booked for each month from January 2019 – June 2019

Download response Agency Staffing. 260919

Agency staffing. 280621

1. Please can you confirm whether the Trust is contracted to a managed service provider for the supply of agency staff under each of the following categories
a. Medical Locums
b. Nurses
c. Allied Health Professionals or Health Scientists
2. Please confirm which company provides the managed service for each staff category and the contract expiry date
a. Medical Locums
b. Nurses
c. Allied Health Professionals or Health Scientists
3. For Medical Locums and for AHPs, please confirm whether the Trust utilises a Direct Engagement solution for VAT efficiency
a. Medical Locums
b. Nurses
c. Allied Health Professionals or Health Scientists
4. Please confirm which company provides the Direct Engagement solution and the contract expiry date

Download response Agency staffing. 280621

Agency staffing. 290621

1. What contractual relationships are in place for supplying agency Nursing and who is responsible for managing them?
2. Who is your primary point of contact for decision making regarding supply chain for Agency Nursing?
3. How many agencies are used to supply agency doctors?
4. Of these agencies, how many are off framework – please list them?
5. Over the past 6 months, how many shifts have been filled via an off framework agency?
6. Who is your highest paid agency nurse, what is their speciality and their hourly charge?
7. Please outline your spend per agency, broken down by grade and speciality of nurse over the past 6 months?
8. Do you have a Master Vendor for Agency Nurses In place? If so, who are they and when are they contracted until?
9. If you have a Master Vendor in place, how many hours of work for Nursing have been booked outside of your Master Vendor arrangement in the past 6 months?
10. If you have a Master Vendor in place, what % of bookings by your Master Vendor Provider are at the NHSI capped rates in the past 6 months?
11. What is your total (£) off framework agency spend for Agency Nursing?

Download response Agency staffing. 290621

Agency staffing and vacancies. 061119

1. Please can you confirm how and how regularly you confirm you and your suppliers are IR35 compliant?
2. Please can you confirm the percentage of agency shifts in the past financial year that were NHSI cap compliant? Please could you break this down by staff group?
a. Nursing
b. Doctors
c. AHP/HSS
d. Other clinical
3. Please can you confirm the number of permanent vacancies you have in the following staff groups?
a. Nursing
b. AHP/HSS

Download response Agency staffing and vacancies. 061119

Agency usage. 240418

1. How many agencies do you engage with for your recruitment of temporary nurses and health care assistants and can you please list them?
2. How many agencies do you engage with for your recruitment of permanent nurses and can you please list them?
3. What has your spend been on temporary nurses?
4. What has your spend been on permanent nurses in 2017?
5. How many temporary shifts have been released to agencies for mental health nurses?
6. How many temporary shifts have been released to agencies for general nurses?
7. How many temporary shifts have been released to agencies for theaters nurses?
8. How many temporary shifts have been released to agencies for A&E nurses?
9. How many temporary shifts have been released to agencies for Community nurses?
10. How many temporary shifts that have been released to agencies for mental health nurses go unfilled?
11. How many temporary shifts that have been released to agencies for general nurses go unfilled?
12. How many temporary shifts that have been released to agencies for theaters nurses go unfilled?
13. How many temporary shifts that have been released to agencies for A&E nurses go unfilled?
14. How many temporary shifts that have been released to agencies for Community nurses go unfilled?
15. Are all temporary shifts released to all agencies at the same time or is there a tiering system?
16. Do you have any off framework spend for temporary agency staff?

Download response Agency usage. 240418

Agency usage. 270521

1. For the last year (2020-2021) please supply a list of the agencies the trust uses for medical locums.
2. A breakdown of the monetary spend per agency for Medical Locums
3. Please supply the total number of days worked by locum RMO’s or junior doctors for 2020-2021 at your trust.
4. The hourly rate paid to agencies supplying casual RMO’s or junior doctors.

Download response Agency usage. 270521

Agency usage for Physiotherapy, Occupational Therapy, Pharmacy, Radiography, Speech and Language Therapy and Sterile Services.220422.docx

1. Who is the head of procurement responsible for approving agency usage for Physiotherapy, Occupational Therapy, Pharmacy, Radiography, Speech and Language Therapy and Sterile Services?
2. Who are the managers responsible for agency usage (on and off framework) for the following departments at all hospitals associated with the Trust:
(a) Physiotherapy
(b) Occupational Therapy
(c) Pharmacy
(d) Radiography
(e) Sterile Services
(d) Speech and Language Therapy
3. Please can you provide the contact number and email addresses for the managers listed in relation to question 1 and 2?
4. Have you used off-framework agency staff between March 2021 – March 2022 in the following departments:
(a) Physiotherapy
(b) Occupational Therapy
(c) Pharmacy
(d) Radiography
(e) Sterile Services
(d) Speech and Language Therapy
5. How much was your Off-Framework agency spend for each of the following staff groups between March 2021 – March 2022?
(a) Physiotherapy
(b) Occupational Therapy
(c) Pharmacy
(d) Radiography
(e) Sterile Services
(d) Speech and Language Therapy
6. How many unfilled agency roles did you have between March 2021 – March 2022 for each of the departments outlined in question 5?

Agency usage for Physiotherapy, Occupational Therapy, Pharmacy, Radiography, Speech and Language Therapy and Sterile Services.220422.docx

Agency usage for the Decontamination department.200723.docx

1. Who is the person in charge for approving agency usage for the Decontamination department at your trust?
2. Who is responsible for agency usage (on and off framework) in the Decontamination department at all hospitals associated with the Trust?
3. If the decontamination service is not managed by the trust, please confirm which company runs your decontamination service.
4. Please can you provide the contact number and email address for the manager(s) in question 1 and 2.
5. Have you used off-framework agency staff between March 2022 – March 2023 in Decontamination and endoscopy?
6. How much was your Off-Framework agency spend for Decontamination and Endoscopy from March 2022 – March 2023?

Agency usage for the Decontamination department.200723.docx

Agency usage for the Physiotherapy department.040823.docx

1. Who is the head of procurement responsible for approving agency usage for the Physiotherapy department?
2. Who is responsible for agency usage (on and off framework) in the Physiotherapy department at all hospitals associated with the Trust for the following areas within Physiotherapy?
– Musculoskeletal
– Community
– Rehabilitation
– Neurology
– Paediatrics
– Trauma and Orthopaedics
– Acute Medical/Surgical/inpatient
– Respiratory
3. Please can you provide the contact number and email address for the manager(s) in question 1 and 2.
4. How much was your Off-Framework agency spend for Physiotherapy from June 2022-June2023
5. What agencies were providing the Off-Framework services.

Agency usage for the Physiotherapy department.040823.docx

Agency usage for the Sonography and Ultrasound department.310323.docx

1. Who is the head of procurement responsible for approving agency usage for the Sonography/Ultrasound department at your trust?
2. Who is responsible for agency usage (on and off framework) in the Sonography/Ultrasound department at all hospitals associated with the Trust? 3. Please can you provide the contact number and email address for the manager(s) in question 1 and 2. 4. Have you used off-framework agency staff between March 2022 – March 2023 in Sonography/Ultrasound?
5. How much was your Off-Framework agency spend for Sonography/Ultrasound from March 2022 – March 2023?

Agency usage for the Sonography and Ultrasound department.310323.docx

Agency use. 010818

1) Which Frameworks do you use for the supply of;
a) Locum Doctors
b) Locum Nurses
2) Do you operate a master vend arrangement or preferred supplier list?
3) Please list the agencies on your preferred supplier list for a and b. Please provide the supply list in tearing order or PSL if applicable.
a) Locum Doctors
b) Locum Nurses
4) Please provide contact details for the member of staff in charge of this process.

Download response Agency use. 010818

AHP agency staff spend 2015-2016

Question 1
Please can you confirm what your total spend on Allied Health Professional (AHP) agency staff was during the financial year April 2015-January 2016?
Can you please break this financial information down by AHP specialism:
• Arts Therapists,
• Chiropodist/Podiatrist,
• Dietician,
• Occupational Therapist,
• Physiotherapist,
• Prosthetist / Orthotist,
• Imaging Professionals,
• Speech / Language Professionals.
Question 2
Please can you confirm the names of the organisation/s you procure temporary Allied Health Professionals (AHP) from and the total spend for each organisation/s. To provide additional clarity on my request, ‘temporary Allied Health Professionals’ is to mean all persons who are AHPs and are not on permanent contracts of employment with the Board, but are supplied via employment agencies.

Download response AHP agency staff spend 2015-2016 150316

Altrix and agency spend. 240919

For the last 12 months can you provide me details on the Trusts agreement with Altrix.

Specifically:
The monthly spend for the last 12 months.
The number of hours covered monthly for the last 12 months.
Agreed rates for shifts covered.
Clarification on workers under this models Tax/IR35 status and if they are paid in line with the NHS Frameworks expectations.

Download response Altrix and agency spend. 240919

Amount spent on employing agency/temporary/locum doctors in A&E departments 2014 and 2015

Under the Freedom of Information Act, please can you provide me with the amount spent on employing agency/temporary/locum doctors in A&E departments, and the number of FTE roles covered by agency doctors, if possible for each month in 2014 and 2015, or for 2014 and for 2015 as whole years.

Please can you provide me with the number of FTE doctors working in the A&E department, if possible for each month in 2014 and 2015, or for 2014 and for 2015 as whole years?

If possible, please provide a breakdown between junior doctors and consultants.

Download response Amount spent on employing agency/temporary/locum doctors in A&E departments 2014 and 2015 140316

Annual spend on agency nursing staff. 070417

1) What is your annual spend on Agency Nurses?
2) How is this spend on agency Nurses broken down by individual supplier and what status are they? (i.e. PSL, Tier 1, Tier 2, Master Vendor, or Managed Service Provider?
3) What is the end / renewal date of the current contract you have in place for agency nursing?
4) Which framework do you currently use? (CCS, HTE, LPP, other)
5) Who is your senior procurement contact?
6) Who is your senior medical staffing/ nurse bank contact?

Download response Annual spend on agency nursing staff. 070417

Bank and Agency spend 2016. 070417

1. The number of hours filled by agency for all categories of Allied Health Professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

2. The number of hours filled by bank for all categories of Allied Health Professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

3. The Trusts total spend on agency staff for all categories of Allied Health professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

4. The Trusts total spend on bank staff for all categories of Allied Health professionals and Health Science Services for calendar year 2016 – broken down by month, Job Title and Job Band

5. The number of hours filled by agency for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band

6. The number of hours filled by bank for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band

7. The Trusts total spend on agency staff for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band
8. The Trusts total spend on bank staff for all Nursing Staff for calendar year 2016 – broken down by month, Job Title and Job Band

Download response Bank and Agency spend 2016. 070417

Bank and agency costs.070324.docx

All questions are shown as received by the Trust.
I. The total amount spent by the Trust on bank and agency doctors in each of the last 5 financial years (including 2023/24 so far)
II. The total amount spent by the Trust on bank and agency nurses in in each of the last 5 financial years (including 2023/24 so far)
III. The largest amount spent by the Trust on a single agency nurse shift in 2023/24
IV. The largest amount spent by the Trust on a single agency doctor’s shift in 2023/24

Bank and agency costs.070324.docx

Bank and Agency Midwife spend. 110319

How much did the Trust spend on a) agency midwives b) bank midwives in each calendar month in 2018 (calendar year)?

Download response Bank and Agency Midwife spend. 110319

Bank and Agency spend.050423.docx

Please disclose the information listed in the below table rows for each of the 4 staff groups in the table columns by return email within 20 days as per the Freedom of Information Act 2000.
1. Please provide agency spend for the staff group for the year 2022.
2. Please provide bank spend for the staff group for the year 2022.
3. Please confirm which model you have in place for managing the staff group: Email to preferred supplier List, a Master Vendor, a Neutral Vendor, or a Software cascade to a preferred supplier list.
4. If you have a master vendor or neutral vendor in place, please confirm who this contract is with and the date on which this contract expires.
5. Please confirm what percentage of bookings over the last 6 months have been within the NHSI/E agency caps (an approximation based on NHSI data submissions is fine).
6. Please confirm which provider manages your direct engagement process, the fee for the service and the date on which this contract expires (no this is not relevant for Nursing).
7. Please confirm what percentage of bookings are processed with a VAT savings by your direct engagement provider
8. Is your bank managed by an external bank provider (eg. NHS Professionals, Bank Partners) or in-house? Please confirm who is the external bank provider and when the contract expires if relevant.
9. Is your bank managed via software? If so, please confirm which software.
10. Please confirm what the percentage is on framework (for example, “£6,650,000 – 99% framework /20% off-framework”) for the year 2022.
11. Please confirm what percentage is off-framework (for example, “£6,650,000 – 99% framework /20% off-framework”) for the year 2022.
12. Please confirm the direct engagement- DE% uptake for the year 2022.
13. Please confirm the direct engagement- DE provider.
14. Please confirm the direct engagement- DE contract end date.

Bank and Agency spend.050423.docx

Bank and agency spend and usage. 260421

1) Please detail your Bank and Agency Spend in the format provided by the following NHSIE Staff Groups for the past financial year (April 2020 – March 2021)
2) Please detail your Bank and Agency usage in hours in the format provided by the following NHSIE Staff Groups for the past financial year (April 2020 – March 2021)

Download response Bank and agency spend and usage. 260421

Bank and Agency Staff 221116

Staff Bank
1. Do you use a nurse bank?
2. Is it outsourced?
a. If yes, who is the provider?
b. Is your outsourced bank used via a framework, e.g., CCS, HTE, LPP?
c. Do you use the bank for other staff groups?
d. What was the spend on your staff bank in 2015/2016?
3. Do you use Agency Nurses?
a. What was your spend on agency nurses during 2015/2016?
b. Which framework do you use for agency nursing staff? E.g.: CCS, HTE, LPP, NOECPP
4. Are you meeting the NHS Improvement price caps on?
a. Band 5 general nurses
b. Band 5 specialist nurses
c. HCAs

Download response letter Bank and Agency Staff 221116

Bank and Agency staff in Audiology. 161120

1. The number of agency staff used in the Audiology department
2. The number of hours filled by agency staff in the Audiology department.
3. The number of hours filled by bank staff in the Audiology department.
4. The Trusts total spend on agency workers in the audiology department
5. The Trusts total spend on bank workers in the audiology department
I would like the above information for the 2019 calendar year (Jan-Dec) if possible.

Download response Bank and Agency staff in Audiology. 161120

Bank and Agency Staffing. 181019

1. Please could you confirm your current bank spend (FY 18/19), broken down by the following staff groups:
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
2. Please confirm your current bank fill rate (FY 18/19), broken down by the following staff groups:
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
3. Please could you confirm your current agency spend (FY 18/19), broken down by the following staff groups:
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
4. Please could you confirm your current agency engagement procedure (i.e. MV, PSL etc) and which agencies you are currently working with, broken down by the following staff groups:
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
5. Do you have DE supplier, if so who, broken down by staff group? When is the expiry date for this contract?
6. Do you have an MV supplier, if so who, broken down by staff group? When is the expiry date for this contract?
7. Do you have an external Bank supplier, if so who, broken down by staff group? When is the expiry date for this contract?
8. Please could you confirm what your agency spend is for permanent staff in the past 24 months, broken down by the following staff groups. How much of this is international recruitment?
a. Nursing staff
b. Medical locums (Doctors)
c. AHP/HSS
d. Other clinical
e. Non-clinical
9. How many permanent vacancies do you have as per the below table. Do you have a current supplier for these roles?

Download response Bank and Agency Staffing. 181019

Bank and agency systems.080323.docx

1. Please confirm which model is in place for managing each staff group: preferred supplier list, master vendor or neutral vendor
Locum
Nurse
Allied Health Professionals
Non-medical/non-clinical
2. If you have a master vendor or neutral vendor in place, please confirm who this contract is with
3. Please confirm the contract end date with the provider
4. Is your bank managed by an external bank provider (e.g., NHS Professionals,
Bank Partners).
5. Please confirm who is the external bank provider and when the contract expires if relevant
6. Is your bank managed via software? If so, please confirm which software.

Bank and agency systems.080323.docx

Bank staff. 310320

1. The total internal bank spend broken down by Dr, Nurses and AHP for period Jan 19 – Dec 19
2. Is this contracted to a third party or ran by the Trust (e.g. NHSP, Bank Partners etc.)
a. If contracted to a third party the expiry date of the agreement

Download response Bank staff. 310320

Bank Staff costs.101122.docx

1. Bank Spend – Total amount spent on bank staff for the year 2021/22 (April ’21 to March ‘22) and between 31/10/2021 and 31/10/2022 year split into the Trusts’ staff groups (E.g. Medical, Nursing, Admin, AHP etc.) and speciality/grade (E.g. Consultants, GP, ICU Nurse, Acute Nurse, Occupational therapists, Pharmacists, Health Care Assistants, etc.) depending on how this is reported within the Trust.
2. Confirmation on whether the trust bank is currently operated by the trust themselves or by a private provider. If the latter please confirm the name of the provider.

Bank Staff costs.101122.docx

Bank Staff (Medical Locums) Maidstone Hospital

Please complete the attached table with the relevant information regarding Bank Staff (Medical Locums) at your Trust.

Grade Core Hours Pay rate Unsocial Pay Rates
FY1
+FY2
Sp1-2
Sp3+
Dental Core Training
Specialty Doctor/staff grade
Associate Specialist
Consultant

Download response Bank Staff (Medical Locums) Maidstone Hospital 010216

Bank Staff (Medical Locums) Tunbridge Wells Hospital

Please complete the attached table with the relevant information regarding Bank Staff (Medical Locums) at your Trust.

Grade Core Hours Pay rate Unsocial Pay Rates
FY1
FY2
Sp1-2
Sp3+
Dental Core Training
Specialty Doctor/staff grade
Associate Specialist
Consultant

Download response Bank Staff (Medical Locums) Tunbridge Wells Hospital 010216

Bank Workforce & VMS Arrangements. 190421

1. Do you have a Master Vendor or Neutral Vendor arrangement in place?
2. If yes, who is your current Master Vendor or Neutral Vendor Provider and which disciplines do they supply?
3. What fill rates are achieved with your Master Vendor or Neutral Vendor Provider in the various disciplines?
4. Are you charged a fee for the service and if so, what is the cost?
5. What is the expiry date for your current contract/contracts?
6. Do you use any external/3rd parties to manage your bank workforce?
7. If so, please provide the name of the provider and contract start and end dates.
8. Which bank software do you use and how long are you in contract with them?

Download response Bank Workforce & VMS Arrangements. 190421

Break glass and escalated agency rates. 171218

1. Could you please provide me with a breakdown of all the healthcare staffing disciplines provided by agencies in which the trust are breaking glass / being charged escalated rates?
2. Could you please state how many agency workers, per discipline, the break glass / escalated rates applies to re question 1?
3. Could you please state how many healthcare agency workers, per discipline, the Trust are being charged the maximum capped rate as stipulated by their governed framework?

Download response Break glass and escalated agency rates. 171218

Clinical Coding staff. 060220

1. How many staff do you have in your clinical coding department?
2. How many vacancies do you currently have in your clinical coding department?
3. Do you have any 3rd party’s providing you with clinical coding service?
A. If yes, which external organisations (3rd parties or other NHS) provide you with clinical coding services?
B. When did you start these contracts, how long are they for and what procurement framework did you use?
4. How much did the Trust spend last year on bank staff for clinical coding?
5. How much did the Trust spend on consultancy relating to clinical coding last year?

Download response Clinical Coding staff. 060220

Cloud21. 120422.docx

We would like to understand how much money MTW have spent with Cloud21 Broken Down for each financial year
16/17
17/18
18/19
19/20
20/21
21/22

Cloud21. 120422.docx

Community Nursing. 010618

1. What was your trust spend for temporary community agency nursing in 2017?
2. How many rgn shifts are released to temporary agencies?
3. How many rgn shifts released to agency go unfilled?
4. How many hca shifts are released to temporary agencies?
5. How many hca shifts released to agency go unfilled?
6. How many agencies are on your proffered suppliers list for these requirements?

Download response Community Nursing. 010618

Cost of strike cover.120523.docx

Please could you tell me how much money your trust spent on bank and/or agency and/or locum staff – and/or non-contractual rates to consultants or other medical staff employed by the trust – to cover junior doctors’ shifts during industrial action by the British Medical Association on:
A) March 13-15 2023
and
B) April 11-15 2023
Please provide as much detail as possible on the staff category (i.e. agency or bank), department of the hospital and the day(s) of employment.

Cost of strike cover.120523.docx

Dermatology locum doctors 060317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Dermatology over the following months, within your Trust or Health Board?

Download response Dermatology locum doctors 060317

Diagnostic radiology staff details. 260919

1. How many permanent staff are employed by the Radiography/Imaging department (Radiographers & Sonographers, not Radiologists)?
2. How many permanent vacancies are currently open/unfilled within the Radiography/Imaging department (Radiographers & Sonographers, not Radiologists)?
3. How many agency staff/locums are currently being used across the Radiography/Imaging department (Radiographers & Sonographers, not Radiologists)?
4. For agency staff/locums, what is the split in numbers between radiographers and sonographers?
5. How many bank temps are being used across the Radiography/Imaging department?
6. During the 2017-2018 financial year, how much did the Radiography/Imaging department spend on temporary agency staff?
7. During the 2018-2019 financial year, how much did the Radiography/Imaging department spend on temporary agency staff?
8. During the 2018-2019 financial year, how much did the Radiography/Imaging department spend on temporary bank staff?
9. During the 2018-2019 financial year, how much did the Radiography/Imaging department spend on permanent finders/introduction fees through recruitment agencies?
10. Does the Radiography/Imaging department have a dedicated breast screening unit?
11. Please provide me with the following contact names within the authority:
a) The name of the senior manager (Radiology Services Manager / Imaging Services Manager) with overall responsibility for the Radiography/Imaging department.
b) The name of the head of temporary staffing.

Download response Diagnostic radiology staff details. 260919

Engagement of locum staff using third parties. 181718

1. Does your organization use a Direct Engagement scheme?
2. If so, who provides it? And when did you start using it?
3. Did you take external legal advice before entering into it and, if so, from whom did you take external legal advice?
4. What has your total locum/temporary staffing spend since you started using the scheme? If you started using the scheme before April 2017 please also state the total locum/temporary staffing spend since April 2017.
5. How does the third party direct engagement facilitator save you money on the agency spend? Please answer in short point form
6. How much has been paid to the third party direct engagement facilitator thus far?
7. Was this payment calculated as a percentage of the savings generated by employing the services of the third party direct engagement facilitator? If so, what percentage is this?

Download response Engagement of locum staff using third parties. 181718

External management, business consultants and recruitment agency fees.060224.docx

All questions are shown as received by the Trust.
1) Since the beginning of the calendar year 2023, how much has the trust spent on external management/business consultants, including commitments that cover the rest of the calendar year?
2) Since the beginning the calendar year 2023, how much has the trust spent fees to recruitment agencies, including commitments that cover the rest of the calendar of the calendar year?

External management, business consultants and recruitment agency fees.060224.docx

External temporary staff. 220321

1. A list of all the areas across the Trust that use external temporary staff.
2. The monthly and annual cost of having these staff supplied, averages are fine if exact data is unavailable.
3. The types of staff that are supplied.
4. Whether these staff are supplied via an approved NHS Framework, if not what is the nature of the contract or agreement in place.

Download response External temporary staff. 220321

Flexible staffing 071216

1. Does your Trust currently utilise a Direct Engagement (DE) model? – YES / NO
2. If Yes, who currently provides the service;
a. Brookson
b. Liaison/ PWC (StafFlow)
c. Liaison (TEMPre)
d. 24/7 Time
e. Other (please specify here)………………………..
3. What proportion (in percentage) of your agency workers for the following staff groups are directly engaged:
a. Medical Locums/Doctors (e.g. Acute, Emergency, General Surgery, Paediatrics, Gynaecology, Neurosurgery, Dermatology, Cardiology)
b. Allied Health Professionals/Health Science Staff (e.g. Biomedical Science, Clinical Physiology (Cardiology), Dietician, Occupational Therapy, Pharmacy, Physiotherapy, Radiography, Talking Therapy, Speech & Language Therapy, Psychology, Anatomical Pathology)
4. What percentage are you charged for the management of these services?
5. When was the DE contract awarded?
6. What is the contract duration?
7. What was the motivation with engaging with these services?

Download response Flexible staffing 071216

Framework and non-framework locum agencies

What framework and non-framework locum agencies you use for:
Doctors
Nursing staff
Doctors and nursing staff

I also want to know do you have a staff bank. Do you with any particular agencies as a rule and others when simply in need?

Download response Framework and non-framework locum agencies 260116

Full contact details for the HR staff member responsible for locum appointments

Please can you give me the contact details for the HR person that deals with Locum appointments?

Please can I have their full name, job title, email address and direct dial telephone number.

Download response Full contact details for the HR staff member responsible for locum appointments 180516

HCA agency fees.180823.docx

Question 1 – For the timescale from the 1st April 2023 until 30th April 2023, details of the lowest, highest and average fee paid to agencies providing HCA’s for band 5, 6 and 7.

Question 2 – For the single week of the 16th July 2023 until 22nd July 2023, details only of the average fee paid to agencies providing HCA’s for band 5, 6 and 7.

HCA agency fees.180823.docx

 

Cancelled operations

Cancelled appointments and procedures. 091220

1. How many of the following scheduled procedures/appointments were cancelled by the Trust:
i) Elective operations
ii) Appointments made via urgent cancer referrals
iii) Mammograms
iv) Organ transplant operations
v) Optical appointments/procedures
During the following periods:
i) 2019-2020
ii) 2020-to date
NB. I do not require the reasons for the cancellations.
2. How many of the following scheduled procedures/appointments were pushed back by the Trust:
i) Elective operations
ii) Appointments made via urgent cancer referrals
iii) Mammograms
iv) Organ transplant operations
v) Optical appointments/procedures
NB. I do not require the reasons behind the delay/re-scheduling.
For the following time frames:
i) Up to one month
ii) Up to three months
iii) Up to six months
iv) Up to a year
v) Indefinitely
During the following periods:
i) 2019-2020
ii) 2020-to date

Download response Cancelled appointments and procedures. 091220

Cancelled cancer operations.061223.docx

1. How many cancer operations have been cancelled by your NHS Trust in each of the past four financial years:
a. 2022/23
b. 2021/22
c. 2020/21
d. 2019/20
2. Please could you provide a breakdown for the reasons these operations were cancelled e.g. lack of staff, lack of beds, or equipment issues, again broken down by the financial years:
a. 2022/23
b. 2021/22
c. 2020/21
d. 2019/20

Cancelled cancer operations.061223.docx

Cancelled cancer operations. 220920

I would like to know how many cancer operations have been cancelled by your NHS Trust since March 1st 2020?

Download response Cancelled cancer operations. 220920

Cancelled Cancer operations.290224.docx

All questions are shown as received by the Trust.
1. How many cancer operations have been cancelled by your NHS Trust in each of the past four financial years:
a. 2022/23
b. 2021/22
c. 2020/21
d. 2019/20
2. The highest number of times a patient’s operation has been cancelled at your NHS Trust since the start of 2022.
3. Please could you provide a breakdown for the reasons these operations were cancelled e.g. lack of staff, lack of beds, or equipment issues.
a. 2022/23
b. 2021/22
c. 2020/21
d. 2019/20

Cancelled Cancer operations.290224.docx

Cancelled children’s operations – 01.07.16. 050517

1. How many children’s operations have been cancelled each month since 1st July 2016? Please give additional details as to what the main reasons for the cancellations were, how many were urgent operations or elective operations, and what type of illness did they involve, e.g. cancer, breathing problems, broken limbs etc.

2. How many children’s operations have been cancelled over the last four financial years to date?

Kindly note a child is anyone up to the age of 18.

Download response Cancelled children’s operations – 01.07.16. 050517

Cancelled children’s operations. 131020

The total number of children’s operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures. Please provide this information for each of the past three financial years 2017/18, 2018/19, 2019/20). In the total number of operations, broken down by cancellation reason, please include:

· Elective children’s operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.

· Cancelled urgent children’s operations.

For the purposes of this FOI, Children will be defined as under 18’s.

Download response Cancelled children’s operations. 131020

Cancelled children’s operations.140323.docx

You asked: All questions are shown as received by the Trust.
1. The number of children (under 18s) who have an operation cancelled or delayed at your trust for non-clinical reasons, in each of the past five calendar years (2022, 2021, 2020, 2019, 2018).
2. For each of these years, please could you provide figures broken down by the reason behind the cancellation or delay, e.g. lack of staff, lack of bed capacity, or lack of equipment.
3. Please could you provide figures on the five longest waits for an operation currently faced by under-18s at your trust, e.g. 118 days, 116 days, 113 days. For each of these waits, please could you provide a summary of the surgical procedure in question, e.g. heart surgery.

Cancelled children’s operations.140323.docx

Cancelled elective admissions and outpatient attendances. 150118

1) In the months of October, November and December, how many elective admissions and outpatient attendances had to be cancelled due to non-clinical reasons?
2) How many of these were able to be rescheduled within 28 days (please give actual figure)?
3) And how many were not able to be rescheduled within 28 days?

Download response Cancelled elective admissions and outpatient attendances. 150118

Cancelled elective operations 2010-2016. 200417

1. Since 1st April 2010 what has been the maximum cost to the Trust of an elective operation being cancelled last-minute for non-clinical reasons? Please give additional detail as to what the operation was and how many members of staff were supposed to be working on the operation.
2. Please provide the total number of elective operations cancelled last-minute for non-clinical reasons for each quarter going back to 2010.
3. Please provide the total quarterly cost of elective operations being cancelled last-minute for non-clinical reasons for each quarter going back to 2010.

Download response Cancelled elective operations 2010-2016. 200417

Cancelled elective operations for December 2015 and January 2016.

I would like to ask for each day over the past two months how many elective operations have had to be cancelled and what reasons were given?

And for each of those days, how many elective operations had been originally planned?

Download response Cancelled elective operations for December 2015 and January 2016 190416

Cancelled elective procedures.270722.docx

Question 1
How many booked elective invasive procedures (this includes but is not limited to procedures being performed in operating theatres, interventional radiology or other radiology suites, cardiac catheter labs, endoscopy and any other site not mentioned involving an invasive procedure, whether under local anaesthetic, general anaesthetic, spinal or epidural anaesthetic, peripheral nerve block, or sedation) did your trust cancel in the calendar years:
a. 2017
b. 2018
c. 2019
d. 2020
e. 2021
Question 2
How many booked elective invasive procedures (this includes but is not limited to procedures being performed in operating theatres, interventional radiology or other radiology suites, cardiac catheter labs, endoscopy and any other site not mentioned involving an invasive procedure, whether under local anaesthetic, general anaesthetic, spinal or epidural anaesthetic, peripheral nerve block, or sedation) did your trust cancel at the date of this request in this calendar year?

Cancelled elective procedures.270722.docx

Cancelled operations. 011018

I would like to request the total number of operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures.

Please provide this information for each of the past five financial years (i.e. years running from April to March – 2013/14, 2014/15, 2015/16, 2016/17, 2017/18).

In the total number of operations, broken down by cancellation reason, please include:
1. Elective operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.
2. Cancelled urgent operations.
If the data is collected by the trust, please also provide a separate total for each year for all operations cancelled for non-clinical reasons, regardless of how soon before the scheduled operation time the cancellation occurred.

Download response Cancelled operations. 011018

Cancelled operations.021222.docx

a) How many elective operations were cancelled for a non-clinical reason at the Trust in 2021/22, broken down by reason for cancellation?
b) Of the total elective operations cancelled for a non-clinical reason at the Trust in 2021/22, how many were:
i. urgent surgery
ii. paediatric surgery
iii. surgical oncology

Cancelled operations.021222.docx

Cancelled operations. 070721

a) How many operations in total has your Trust cancelled from 1 March 2020 – 1 March 2021 and can you give a breakdown of reasons for the cancellations? How many were urgent operations?
b) How many operations in total has your Trust cancelled from 1 March 2019 – 28 February 2020 and can you give a breakdown of reasons for the cancellations? How many were urgent operations?
c) How many operations in total has your trust cancelled for Under 16s from 1 March 2020 – 1 March 2021 and can you give a breakdown of reasons for the cancellations? How many were urgent operations?
d) How many operations in total has your trust cancelled for Under 16s from 1 March 2019 – 28 February 2020 and can you give a breakdown of reasons for the cancellations? How many were urgent operations?

Download response Cancelled operations. 070721

Cancelled operations. 131021.docx

1. Please can you tell me the number of last minute elective operations cancelled for non clinical reasons at your trust or board for each month of 2020 and 2021 to date.
2. Please can you tell me the number of urgent operations cancelled for non-medical reasons during each month.
If giving the full data requested would be likely to exceed the costs cap, please provide data for the most recent month and then as many months as possible working backwards until the limit is reached.
3. If possible, please let me know how many of the cancelled elective operations had still not been carried out 28 days later.
4. If possible, please let me know how many of the cancelled urgent operations had still not been carried out 28 days later.

Download response Cancelled operations. 131021.docx

Cancelled operations.140323.docx

1. The number of people who have had an operation cancelled or delayed at your trust for non-clinical reasons, in each of the past five calendar years (2022, 2021, 2020, 2019, 2018).
2. For each of these years, please could you provide figures broken down by the reason behind the cancellation or delay, e.g. lack of staff, lack of bed capacity, or lack of equipment.
3. Please could you provide figures on the five longest waits for an operation currently faced by under-18s at your trust, e.g. 110 days, 98 days, 200 days. For each of these waits, please could you provide a summary of the surgical procedure in question, e.g. heart surgery.

Cancelled operations.140323.docx

Cancelled operations.2. 140323.docx

1. The number of elective operations scheduled. I would like this information for January 2022 to end of December 2022 broken down by week i.e. the total number of elective operations that were planned for Week 1, January 2022, Week 2 etc.
2. The number of elective operations performed. January 2022 to end of December 2022 broken down by week i.e. the total number of elective operations that were planned for Week 1, January 2022, Week 2, etc
3. The number of elective operations cancelled at the “last minute”, as defined by the NHS when providing data on cancelled elective operations. I would like this information for January 2022 to end of December 2022 broken down by week i.e. the total number of elective operations planned for Week 1, January 2022, Week 2 etc.
4. The total number of elective operations cancelled, regardless of how long cancellations were made before scheduled operation times, if this information is also collected. I would like this information for January 2022 to the end of December 2022 broken down by week i.e. the total number of elective operations planned for Week 1, January 2022, Week 2 etc.

Cancelled operations.2. 140323.docx

Cancelled operations 2011 – 2016. 141216

1. Over the past five financial years (2011-12, 2012-13, 2013-14, 2014-15, 2015-16) please state the number of last minute elective surgery cancellations there have been for non-clinical reasons for the following branches of surgery: trauma and orthopaedics, neurology, cancer, and ophthalmology. Please break down by year and surgery type.
2. Over the past five financial years (2011-12, 2012-13, 2013-14, 2014-15, 2015-16) please state how many patients were not treated within 28 days of last minute elective cancellation of an operation for the following branches of surgery: trauma and orthopaedics, neurology, cancer, and ophthalmology. Please break down by year and surgery type.

Download response Cancelled operations 2011 – 2016. 141216

Cancelled operations 2012-2017. 200917

1. The number of elective operations carried out by the Trust in the following financial years:
2012/13
2013/14
2014/15
2015/16
2016/17

2. The number of elective operations cancelled at the last minute* due to non-clinical reasons, in the following financial years:
2012/13
2013/14
2014/15
2015/16
2016/17
NOTE: Please use NHS England’s standard definition of last minute cancellations, “Last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.” See: https://www.england.nhs.uk/statistics/statistical-work-areas/cancelled-elective-operations/

3. The number of elective operations cancelled at the last minute due to non-clinical reasons per financial year (2012/13 to 2016/17 inclusive), split into the following categories:
– Staff unavailable or sick (either anaesthetist, surgeon, theatre staff or other)
– Lack of available bed (either general or HDU, critical, or intensive care)
– Theatre list over-ran or no space on it (e.g. due to emergency case(s) coming in)
– Equipment missing / failure
– Any other reason

Download response Cancelled operations 2012-2017. 200917

Cancelled operations 2013 to 2016.

1. In relation to (i) 2013/14, (ii) 2014/15 and (iii) 2015/16 financial year please provide me with the number of operations cancelled at your Trust on the day of operation or admission where the reason is recorded as there being no post-operative bed available for the patient.
2. For each year please state if possible how many of these cancellations were due to the fact that there was no critical care bed or intensive care bed available rather than the unavailability of a general ward bed?

Download response Cancelled operations 2013 to 2016 250716

Cancelled operations 2014 – April 2017. 050517

How many operations have been cancelled for non-clinical reasons IN THE 3 DAYS BEFORE a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within 1 month?
How many operations have been cancelled for non-clinical reasons ON THE DAY a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within the statutory time limit – e.g. 28 days?
Please provide this data by month for 2014, 2015, 2016 and 2017 – up to and including April 2017.
The following should be included in the figures for ‘operations’:
All planned or elective operations and day surgery
For ‘non-clinical reasons’ please include a break-down of the following:
· Bed-ward not available
· Staff unavailable
· Emergency operations taking priority
· Maintenance needed on equipment
· Patient unavailable
· Admin error

Download response Cancelled operations 2014 – April 2017. 050517

Cancelled operations.280923.docx

1. Please can you provide figures on the total number of patients who have had their operation cancelled for a second time. I would like these figures broken down by year for each of the past five years:
a. 2022,
b. 2021,
c. 2020,
d. 2019,
e. 2018.
For context, I am looking for incidents where the surgery was cancelled for non-clinical reasons (i.e. staff shortages, equipment problems, lack of theatre capacity) and also not at the request of the patient.
2. In addition, please can you provide the largest number of times that a single patient has had their operation cancelled for non-clinical reasons, over the past five years.
a. Please could you name the operation in question (e.g. hip replacement),
b. The year that the last cancellation took place (e.g. 2022).

Cancelled operations.280923.docx

Cancelled operations and appointments. 210218

The National Emergency Preparedness Panel warned on 22 December that non-urgent operations should be cancelled, with a further update on 2 January advising that “day case and outpatient procedures” should also be put on hold to preserve emergency care.

Could the trust please provide the following details about cancellations for non-clinical reasons, and last minute (on the scheduled day of arrival at hospital or later) non-clinical cancellations.

Download response Cancelled operations and appointments. 210218

Cancelled operations for non-clinical reasons. 050919

The total number of operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures. Please provide this information for each of the past three financial years (2016/17, 2017/18, 2018/19). In the total number of operations, broken down by cancellation reason, please include:
• Elective operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.
• Cancelled urgent operations.

Download response Cancelled operations for non-clinical reasons. 050919

Cancelled operations for non-clinical reasons.2 050919

I would like to request the total number of operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures, in 2018/19 (financial year, April to March).

In the total number of operations, broken down by cancellation reason, please include:
• Elective operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.
• Cancelled urgent operations.
If the data is collected by the trust, please also provide a separate total for each year for all operations cancelled for non-clinical reasons, regardless of how soon before the scheduled operation time the cancellation occurred.

Download response Cancelled operations for non-clinical reasons.2 050919

Cancelled operations for non-clinical reasons 2013 to March 2016. 170516

How many operations have been cancelled for non-clinical reasons IN THE 3 DAY BEFORE a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within 1 month?
How many operations have been cancelled for non-clinical reasons ON THE DAY a patient was due to be admitted?
Out of those cancellations, how many were rescheduled within the statutory time limit – e.g. 28 days?
Please provide this data by month for 2013, 2014, 2015 and 2016 – up to and including March 2016.
The following should be included in the figures for ‘operations’:
• All planned or elective operations and day surgery
For ‘non-clinical reasons’ please include a break-down of the following:
Bed-ward not available
Staff unavailable
Emergency operations taking priority
Maintenance needed on equipment
Patient unavailable
Admin error

Download response Cancelled operations for non-clinical reasons 2013 to March 2016. 170516

Cancelled operations March – September 2019 and 2020. 141020

a) How many adult’s operations were cancelled at your Trust from 1 March 2020 – 31 August 2020?
b) How many adult’s operations were cancelled at your Trust from 1 March 2019 – 31 August 2019?
c) How many children’s operations were cancelled at your Trust from 1 March 2020 – 31 August 2020?
d) How many children’s operations were cancelled at your Trust from 1 March 2019 – 31 August 2019?

Download response Cancelled operations March – September 2019 and 2020. 141020

Cancelled planned operations. 210318

How many planned operations were cancelled in January 2018 due to winter pressures? If possible, please provide a specific reason for each case.

Download response Cancelled planned operations. 210318

 

Cancer and Haematology & Radiology

2-week urgent referral policy. 031121.docx

I have been looking on the MTW website for your “2 week urgent referral policy”. I have not been able to locate this or a leaflet. Would you please be able to email me a copy of this?

Download response 2-week urgent referral policy. 031121.docx

Active surveillance for prostate cancer. 260717

Please outline details of the active surveillance protocol below (or attach the protocol document when replying to our request email):

Download response Active surveillance for prostate cancer. 260717

Acute myeloid leukaemia (AML) and chronic lymphocytic leukaemia (CLL).171123.docx

All questions are shown as received by the Trust.
Patients with acute myeloid leukaemia (AML)
1. How many patients with AML, in total, have been treated with the following therapies during the last 6 months, irrespective of start date or line of therapy?
• Azacitidine monotherapy
• Low dose cytarabine (LoDAC) monotherapy
• Venetoclax + azacitidine
• Venetoclax + LoDAC
• Ivosidenib
• Intensive chemotherapy-based regimen
• Other
2. How many newly diagnosed patients with AML have started first-line treatment with the following therapies during the last 6 months?
• Azacitidine monotherapy
• Low dose cytarabine (LoDAC) monotherapy
• Venetoclax + azacitidine
• Venetoclax + LoDAC
• Ivosidenib
• Intensive chemotherapy-based regimen
• Other
3. (a) Of the patients with AML treated with venetoclax (venetoclax + azacitidine or venetoclax + LoDAC) in the last 6 months, how many are approved for treatment via Blueteq?
Patients with chronic lymphocytic leukaemia (CLL)
4. How many patients with CLL have received treatment with venetoclax in the past 6 months (including venetoclax monotherapy, venetoclax + rituximab, venetoclax + obinutuzumab or venetoclax + ibrutinib)?
5. How many patients with CLL who were new to all lines of treatment received venetoclax in the past 6 months (including venetoclax monotherapy, venetoclax + rituximab, venetoclax + obinutuzumab or venetoclax + ibrutinib)?

Acute myeloid leukaemia (AML) and chronic lymphocytic leukaemia (CLL).171123.docx

Adult Haematology services.190522.docx

Please note the questionnaire refers only to Adult Haematology services.
1) Does your Trust have a Clinical Haematology service for Adults?
Yes / No (delete as appropriate)
If No, please return the questionnaire at this stage – there are no further questions that need to be answered.
2) If Yes, please complete the staffing table below:
3) If you have Haematology Clinical Nurse Specialists, please advise on how their jobs are split, for example 1.0WTE Myeloma CNS, 0.8WTE BMT CNS etc.
4) Which of the below haematological services does your Haematology service cover?
5) In the last 3 years, how many ‘New’ patients were seen by your Clinical Haematology Team?
6) If you have a BMT service, how many patients do you treat on average per year?

Adult Haematology services.190522.docx

Advanced breast cancer.041122.docx

1) In the past 3 months, how many advanced/metastatic breast cancer patients have the status of;
a) HR+ and HER2+ [Hormone receptor-positive and human epidermal growth factor 2-positive]
b) HR- and HER2+ [Hormone receptor-negative and human epidermal growth factor 2-positive]
2) In the past 3 months, how many breast cancer patients were treated with:
a. Abemaciclib (Verzenios) + aromatase inhibitor *
b. Abemaciclib (Verzenios) + Fulvestrant
c. (Faslodex) Alpelisib (Piqray) + Fulvestrant (Faslodex)
d. Atezolizumab (Tecentriq)**
e. Bevacizumab (Avastin)
f. Eribulin (Halaven)
g. Everolimus (Afinitor) + Exemestane
h. Fulvestrant (Faslodex) as a single agent
i. Gemcitabine + paclitaxel
j. Lapatinib (Tyverb)
k. Neratinib (Nerlynx)
l. Olaparib (Lynparza)
m. Palbociclib (Ibrance) + aromatase inhibitor*
n. Pertuzumab (Perjeta) + trastuzumab + docetaxel
o. Ribociclib (Kisqali) + aromatase inhibitor*
p. Ribociclib (Kisqali) + Fulvestrant (Faslodex)
q. Talazoparib (Talzenna)
r. Trastuzumab + paclitaxel Trastuzumab as a single agent
s. Trastuzumab emtansine (Kadcyla)
t. Trastuzumab Deruxtecan (Enhertu)
u. Tucatinib + Trastuzumab + Capecitabine (Tukysa)
v. Other active systemic anti-cancer therapy ** *aromatase inhibitor e.g. Anastrozole, Exemestane or Letrozole **e.g. docetaxel, vinorelbine or capecitabine as a single agent

Advanced breast cancer.041122.docx

Advanced Breast Cancer. 221019

1a. Does your trust treat advanced breast cancer?
1b. If none, where are your patients referred?
2. In the past 3 months, how many advanced breast cancer patients [Stage IV] have the status of;
HR+ and HER2+ [Hormone receptor-positive and human epidermal growth factor 2-positive]
HR+ and HER2- [Hormone receptor-positive and human epidermal growth factor 2-negative]
HR- and HER2+ [Hormone receptor-negative and human epidermal growth factor 2-positive]
HR- and HER2- [Hormone receptor-negative and human epidermal growth factor 2-negative] – Triple negative disease
Not Known
3. In the past 3 months, how many breast cancer patients were treated with:
Abemaciclib (Verzenios) + aromatase inhibitor *
Abemaciclib (Verzenios) + Fulvestrant (Faslodex)
Alpelisib (Piqray) + Fulvestrant (Faslodex)
Atezolizumab (Tecentriq)**
Bevacizumab (Avastin)
Eribulin (Halaven)
Everolimus (Afinitor) + Exemestane
Fulvestrant (Faslodex) as a single agent
Gemcitabine + paclitaxel
Lapatinib (Tyverb)
Neratinib (Nerlynx)
Olaparib (Lynparza)
Palbociclib (Ibrance) + aromatase inhibitor*
Pertuzumab (Perjeta) + trastuzumab + docetaxel
Ribociclib (Kisqali) + aromatase inhibitor*
Ribociclib (Kisqali) + Fulvestrant (Faslodex)
Talazoparib (Talzenna)
Trastuzumab + paclitaxel
Trastuzumab as a single agent
Trastuzumab emtansine (Kadcyla)
Other active systemic anti-cancer therapy **
*aromatase inhibitor e.g. Anastrozole, Exemestane or Letrozole
**e.g. docetaxel, vinorelbine or capecitabine as a single agent

Download response Advanced Breast Cancer. 221019

Advanced hepatocellular carcinoma (Stage 3b and 4).230522.docx

Q1. How many patients have been diagnosed with advanced hepatocellular carcinoma (Stage 3b and 4) in the last 6 months?
Q2. How many hepatocellular carcinoma patients (any stage) have been treated in the last 6 months with the following treatments:
a. Lenvatinib
b. Sorafenib
c. Regorafenib
d. Atezolizumab + Bevacizumab
Q3. In the last 6 months, how many patients has your trust treated (for any condition) with the following treatments:
a. Avatrombopag
b. Eltrombopag
c. Fostamatinib
d. Romiplostim
Q4. In the last 6 months, how many patients has your trust treated for Immune thrombocytopenia (ICD10 code D69.3) ONLY with the following treatments:
a. Avatrombopag
b. Mycophenolate mofetil
c. Rituximab
d. Surgery (splenectomy)
Q5. Does your trust participate in any clinical trials for the treatment of hepatocellular carcinoma? If so, can you please provide the name of each trial and the number of patients taking part.

Advanced hepatocellular carcinoma (Stage 3b and 4).230522.docx

Advanced Prostate Cancer 070317

1. Within your trust how many unique patients with Advanced Prostate Cancer have been treated in the past 12 months?

2. How many patients with Advanced Prostate Cancer have received:
Abiraterone (Zytiga)
Cabazitaxel (Jevtana)
Docetaxel (Taxotere)
Enzalutamide (Xtandi)
Radium-223 (Xofigo)
Bicalutamide (Casodex)

Download response Advanced Prostate Cancer 070317

Advanced prostate cancer June 2016 to May 2017. 090617

Within your trust how many unique patients with Advanced Prostate Cancer have been treated in the past 12 months?

How many patients with Advanced Prostate Cancer have received;
Abiraterone (Zytiga)
Cabazitaxel (Jevtana)
Docetaxel (Taxotere)
Enzalutamide (Xtandi)
Radium-223 (Xofigo)
Bicalutamide (Casodex)
Advanced prostate cancer is cancer that has spread outside the prostate to other parts of the body such as the bones

Download response Advanced prostate cancer June 2016 to May 2017. 090617

AI software within radiology.110821.docx

1. Does your trust use any AI software within radiology? If so could you please specify programme and its application?
2. If you use AI software within radiology – how often do/would you update, upgrade or swap them?
3. What is the decision-making criteria of choosing which AI software to use?
4. Do you make purchasing decision on your own and if not, what are the other stakeholders involved?

Download response AI software within radiology.110821.docx

ALK-positive lung cancer.150923.docx

All questions are shown as received by the Trust.
I should be grateful if you could inform me of the number of ALK-positive lung cancer patients that your Trust is currently treating. Would it be possible to separate out NHS and private patients?

ALK-positive lung cancer.150923.docx

Antiretroviral therapies. 140521

Q1. How many patients were treated (for any condition) in the latest 6-month period with the following drugs:
a. Juluca (rilpivirine/dolutegravir)
b. Dovato (lamivudine/dolutegravir)
c. Triumeq (abacavir/lamivudine/dolutegravir)
d. Tivicay (dolutegravir)
e. Isentress (raltegravir)
f. Biktarvy (TAF/emtricitabine/bictegravir)
g. Genvoya (TAF/emtricitabine/elvitegravir/cobisistat)
h. Symtuza (TAF/emtricitabine/darunavir/cobisistat)
i. Odefsey (TAF/emtricitabine/rilpivirine)
j. Descovy (TAF/emtricitabine)
k. Truvada or generic TDF/emtricitabine
Q2. How many patients received any antiretroviral (ART) therapy for HIV treatment (excluding pre-exposure prophylaxis):
a. for the latest 6-month period
b. for the 6 months from July-December 2019
Q3. How many patients were treated in the latest 6-months period with Truvada or generic TDF/emtricitabine for?
a. HIV treatment
b. Pre-exposure prophylaxis (PrEP)
Q4. How many packs of Truvada or generic TDF/emtricitabine were dispensed in latest 6-month period for?
a. HIV treatment
b. Pre-exposure prophylaxis (PrEP)

Download response Antiretroviral therapies. 140521

Autoclaves.130223.docx

1. The number of Autoclaves commissioned and commissioned date.
2. The departments where Autoclaves are used.

Autoclaves.130223.docx

Average and longest waiting times for cancer treatment. 141217

Firstly, in days what is the a) average and b) longest a single patient has waited to receive a First Consultant Appointment following a GP Urgent Referral (two week target) in calendar year 2017 (Year to Date), 2016, 2015, 2010 and 2009.
Secondly, in days what is the a) average and b) longest a single patient has waited for a First Treatment for Cancer following a Decision to Treat (31 days target) in calendar year 2017 (Year to Date), 2016, 2015, 2010 and 2009.
Thirdly, in days what is the a) average and b) longest a single patient has waited for a First Treatment for Cancer following a GP Urgent Referral (62 days target) in calendar year 2017 (Year to Date), 2016, 2015, 2010 and 2009.

Download response Average and longest waiting times for cancer treatment. 141217

Bevacizumab. 290121

1. How many patients have been treated by your trust (for any medical condition) in the past 6 months with Bevacizumab?
2. Please provide the number of patients treated in the past 6 months with Bevacizumab for the following conditions:
a. Colorectal cancer
b. Breast cancer
c. Renal cell carcinoma
d. Non-small cell lung cancer
e. Ovarian cancer (epithelial, fallopian tube or primary peritoneal)
f. Carcinoma of the cervix

Download response Bevacizumab. 290121

Biliary tract cancer.281223.docx

All questions are shown as received by the Trust.
1. In the last 12 months, how many individual patients were treated for biliary tract cancer with the following Diagnosis Codes:
A) C22.1 Intrahepatic Bile Duct Cardinoma
B) C23 Malignant Neoplasm of Gallbladder
C) C24 Malignant Neoplasm of unspecified biliary tract (If possible, could this please be further split to C24.0 Extrahepatic bile duct, C24.8 Overlapping lesion of Biliary Tract, C24.9 Biloary Tract, Unspecified).

Could you please also provide a total unique patient number for all of the diagnosis codes above, in case they have been coded multiple times.
2. In the last 12 months, how many patients were treated for Oesophagus Oesophagogastric Junction Cancer? (C16.7)

Biliary tract cancer.281223.docx

Bisphosphonates. 160818

1. Does your Trust routinely provide bisphosphonates to postmenopausal women with primary breast cancer to reduce the risk of their cancer spreading to other parts of the body?
2. If your Trust does routinely provide bisphosphonates to reduce the risk of primary breast cancer spreading to other parts of the body, but is not providing them for all postmenopausal women, how is eligibility defined? For example, women at increased risk of recurrence.
3. If your Trust does routinely provide bisphosphonates for postmenopausal women to reduce the risk of primary breast cancer spreading to other parts of the body, which bisphosphonates do you prescribe? For example, zoledronic acid, ibandronic acid, sodium clodronate.
4. If your Trust does not routinely provide bisphosphonates for postmenopausal women to reduce the risk of primary breast cancer spreading to other parts of the body, what are your reasons for not doing so?

Download response Bisphosphonates. 160818

Bladder cancer.081223.docx

All questions are shown as received by the Trust.
In the past three months, how many patients have been treated for Bladder cancer with the below:
a) Avelumab
b) Atezolizumab
c) Carboplatin with Gemcitabine
d) Carboplatin single or in any other combination
e) Cisplatin with Gemcitabine
f) Cisplatin single or in any other combination
g) Nivolumab
h) Pembrolizumab
i) Any other systemic anti-cancer therapy
j) Palliative care only

Bladder cancer.081223.docx

Blood collection tubes for liquid biopsies. 250521

1. How do you obtain blood collection tubes for liquid biopsies on cancer patients?
2. From what suppliers do you obtain these products?
3. Were these products purchased through a tender or framework? If so, which one? Please provide details including the name, reference and where this was published.
4. Are you under contract with your current supplier(s) for the above? If so, what is the start and end date of the contract?
5. Can you provide the name and contact details for the person(s) responsible for procuring these products?
6. Can you provide contact details for the department responsible for managing this service?

Download response Blood collection tubes for liquid biopsies. 250521

Blood Gas Analysers.111022.docx

Please provide details of the type (manufacturer and model), quantity, department, site where they are located and age of all Blood Gas Analysers listed on your trust’s asset register (or equivalent).

Blood Gas Analysers.111022.docx

Bone Metastases. 240919

1. Within your health trust how many metastatic breast cancer patients are currently [within the past 6 months] being treated, with any therapy, surgery or palliative care.
2. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
a. disodium pamidronate (Arcadia)
b. ibandronic acid or ibandronate (Bondronat)
c. sodium clodronate (Bonefos, Clasteon, Loron)
d. zoledronic acid or zoledronate (Zometa)
e. denosumab (Xgeva)
3. Within your health trust how many breast cancer patients are currently [within the past 6 months] being treated with adjuvant therapy with the following treatments;
a. disodium pamidronate (Aredia)
b. ibandronic acid or ibandronate (Bondronat)
c. sodium clodronate (Bonefos, Clasteon, Loron)
d. zoledronic acid or zoledronate (Zometa)
4. Within your health trust how many metastatic lung cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.
5. Within your health trust how many lung cancer patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
a. disodium pamidronate (Aredia)
b. ibandronic acid or ibandronate (Bondronat)
c. sodium clodronate (Bonefos, Clasteon, Loron)
d. zoledronic acid or zoledronate (Zometa)
e. denosumab (Xgeva)
6. Within your health trust how many metastatic renal cell cancer patients are currently [within the past 6 months] being treated with any therapy, surgery or palliative care.
7. Within your health trust how many renal cell carcinoma [RCC] patients are currently [within the past 6 months] being treated for bone metastases with the following treatments;
a. disodium pamidronate (Aredia)
b. ibandronic acid or ibandronate (Bondronat)
c. sodium clodronate (Bonefos, Clasteon, Loron)
d. zoledronic acid or zoledronate (Zometa)
e. denosumab (Xgeva)

Download response Bone Metastases. 240919

Brain Cancer Treatment.051022.docx

1. How many patients have been treated for glioblastoma brain cancer in the last 12 months, in your trust/ health board?
2. Which consultant is the nominated medical lead for the treatment or referral of glioblastoma brain cancer?
3.Does your trust/ health board treat all referred glioblastoma brain cancer cases, or are they referred to different centre’s? If so, which treatment centre(s) are they referred to?

Brain Cancer Treatment.051022.docx

Breast Biopsy. 280317

Under the Freedom of Information Act, please could you provide the following information for your Trust?
1. How many benign breast lesions has your Trust diagnosed per annum in the last three years?
2. How many benign breast lesions have been removed surgically per annum within your Trust in the last three years?
a. Of this total number, how many of these are classified as B2?
b. Of this total number, how many of these are classified as B3?
3. How many benign breast lesions have not been removed per annum in the last three years?
4. How many benign breast lesions have been removed by vacuum assisted excision (VEA) per annum in the last three years?
a. Of this total number, how many of these are classified as B2 (definition below)?
b. Of this total number, how many of these are classified as B3 (definition below)?
5. Is the Trust aware of NICE guidance promoting the use of VAE for removal of benign lesions?
6. Does the Trust have a referral pathway in place for vacuum assisted percutaneous excision of benign breast lesions?

With regards to this request, please note the following:

B3 Breast Lesion – Lesion of Uncertain Malignant Potential
Findings typical of this category include:
1. Clusters of tiny calcifications – round or oval
2. Non-calcified solid nodules (no size limitation but non palpable on physical examination), round, ovoid and well-defined.
3. Selected focal asymmetrical areas of fibroglandular densities (not palpable): This might include concave-outward defined margins, interspersed with fat and without central increased fibular density on two projections.
4. Miscellaneous focal findings, such as a dilated duct or post biopsy architectural distortion without central density
5. Generalized distribution in both breasts. For example, multiple similar lesions with tiny calcifications or nodules distributed randomly

B2 Breast Lesion – Benign Lesion
A definitive benign finding indicating something abnormal on a mammogram but not something that is breast cancer or malignant in any way. Findings often include:
1. Round opacities with macrocalcifications (typical calcified fibroadenoma or cyst)
2. Round opacities corresponding to a typical cyst at ultrasonography
3. Oval opacities with a radiolucent center
4. Fatty densities or partially fatty images (lipoma, galactocele, oil cyst, hamartoma )
5. Surgical scar
6. Scattered macrocalcifications (fibroadenoma, cyst, cytosteatonecrosis, secretory ductal ectasia);
7. Vascular calcifications
8. Breast implants, silicone granuloma

Download response Breast Biopsy. 280317

Breast cancer.021123.docx

Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Abemaciclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
b. Abemaciclib + Fulvestrant
c. Alpelisib + Fulvestrant
d. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
e. Atezolizumab +Nab-paclitaxel/Paclitaxel
f. Capecitabine as a single agent
g. Eribulin as a single agent or in combination
h. Everolimus + Exemestane
i. Fulvestrant as a single agent
j. Lapatinib
k. Neratinib
l. Parp Inhibitors (Olaparib/Talazoparib)
m. Palbociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
n. Palbociclib + Fulvestrant
o. Pembrolizumab
p. Platinum (e.g. carboplatin or cisplatin) as a single agent
q. Ribociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
r. Ribociclib + Fulvestrant
s. Sacituzumab Govitecan
t. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
u. Taxane and/or Anthracycline in combination
v. Trastuzumab as a single agent or in combination
w. Trastuzumab emtansine
x. Transtuzumab deruxtecan
y. Any other active systemic anti-cancer therapy

Breast cancer.021123.docx

Breast Cancer.030723.docx

Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Abemaciclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
b. Abemaciclib + Fulvestrant
c. Alpelisib + Fulvestrant
d. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
e. Atezolizumab +Nab-paclitaxel/Paclitaxel
f. Capecitabine as a single agent
g. Eribulin as a single agent or in combination
h. Everolimus + Exemestane
i. Fulvestrant as a single agent
j. Lapatinib
k. Neratinib
l. Parp Inhibitors (Olaparib/Talazoparib)
m. Palbociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
n. Palbociclib + Fulvestrant
o. Pembrolizumab
p. Platinum (e.g. carboplatin or cisplatin) as a single agent
q. Ribociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
r. Ribociclib + Fulvestrant
s. Sacituzumab Govitecan
t. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
u. Taxane and/or Anthracycline in combination
v. Trastuzumab as a single agent or in combination
w. Trastuzumab emtansine
x. Transtuzumab deruxtecan
y. Any other active systemic anti-cancer therapy
Q2. Does your trust participate in any clinical trials for the treatment of breast cancer? If so, please provide the name of each trial and the number of patients taking part.

Breast Cancer.030723.docx

Breast cancer.090323.docx

Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Abemaciclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
b. Abemaciclib + Fulvestrant
c. Alpelisib + Fulvestrant
d. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
e. Atezolizumab + Nab-paclitaxel/Paclitaxel
f. Capecitabine as a single agent
g. Eribulin as a single agent or in combination
h. Everolimus + Exemestane
i. Fulvestrant as a single agent
j. Lapatinib
k. Neratinib
l. Parp Inhibitors (Olaparib/Talazoparib)
m. Palbociclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
n. Palbociclib + Fulvestrant
o. Pembrolizumab
p. Platinum (e.g. carboplatin or cisplatin) as a single agent
q. Ribociclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
r. Ribociclib + Fulvestrant
s. Sacituzumab Govitecan
t. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
u. Taxane and/or Anthracycline in combination
v. Trastuzumab as a single agent or in combination
w. Trastuzumab emtansine
x. Transtuzumab deruxtecan
y. Any other active systemic anti-cancer therapy

Q2. Of the patients treated for breast cancer with Abemaciclib + Aromatase Inhibitor in the past the 3 months, please provide the number of patients with:
a. early/locally advanced breast cancer (Stages 1 to 3B)
b. advanced/metastatic breast cancer (Stages 3C and 4)

Breast cancer.090323.docx

Breast cancer.090922.docx

1. In the past 3 months, how many Breast Cancer patients (any stage) were treated with:
a. Abemaciclib monotherapy
b. Aromatase inhibitor monotherapy (e.g. anastrazole, exemestane, letrozole)
c. Tamoxifen monotherapy
d. Abemaciclib + Tamoxifen
e. Abemaciclib + Tamoxifen + Goserelin
f. Abemaciclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole) + Goserelin
g. Aromatase inhibitor + Goserelin
h. Tamoxifen+ Goserelin
2. How many patients have been treated for Triple-Negative Breast Cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
b. Atezolizumab +Nab-paclitaxel/Paclitaxel
c. Pembrolizumab
d. Sacituzumab Govitecan
e. Parp Inhibitors (Olaparib/Talazoparib)
f. Eribulin as a single agent or in combination
g. Capecitabine as a single agent
h. Platinum (e.g. carboplatin or cisplatin) as a single agent
i. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
j. Taxane and/or Anthracycline in combination
k. Any other active systemic anti-cancer therapy

Breast cancer.090922.docx

Breast Cancer.151223.docx

Q1. How many patients were treated in total, regardless of diagnosis, with the following medicines in the 3 months between the start of June 2023 and end of August 2023?
Please provide data for the latest 3-month period, if Jun to Aug is not available yet
1.1 Abemaciclib (Verzenios)
1.2 Alpelisib (Piqray)
1.3 Fulvestrant (fulvestrant or Faslodex)
1.4 Palbociclib (Ibrance)
1.5 Ribociclib (Kisqali)
Q2. How many patients received abemaciclib (Verzenios) for early breast cancer in the 3 months between the start of June 2023 and end of August 2023?
Please provide data for the latest 3-month period, if Jun to Aug is not available yet
Q3. How many patients received abemaciclib (Verzenios) as adjuvant treatment for early breast cancer in the 3 months between the start of June 2023 and end of August 2023?
Please provide data for the latest 3-month period, if Jun to Aug is not available yet
Q4. How many patients received abemaciclib (Verzenios) with the following treatment intent in the 3 months between the start of June 2023 and end of August 2023?
Please provide data for the latest 3-month period, if Jun to Aug is not available yet
4.1 Curative
4.2 Palliative
4.3 Not known / stated
Q5. How many patients were treated with the following medicines in combination in the 3 months between the start of June 2023 and end of August 2023?
Please provide data for the latest 3-month period, if Jun to Aug is not available yet
5.1 Abemaciclib (Verzenios) + Fulvestrant (fulvestrant or Faslodex)
5.2 Abemaciclib (Verzenios) + an aromatase inhibitor (anastrozole, letrozole or exemestane)
5.3 Abemaciclib (Verzenois) + tamoxifen
5.4 Abemaciclib monotherapy
5.5 Alpelisib (Piqray) + Fulvestrant (fulvestrant or Faslodex)
5.6 Palbociclib (Ibrance) + Fulvestrant (fulvestrant or Faslodex)
5.7 Palbociclib (Ibrance) + an aromatase inhibitor (anastrozole, letrozole or exemestane)
5.8 Ribociclib (Kisqali) + Fulvestrant (fulvestrant or Faslodex)
5.9 Ribociclib (Kisqali) + an aromatase inhibitor (anastrozole, letrozole or exemestane)

Breast Cancer.151223.docx

Breast cancer. 181019

1. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with early breast cancer in each year from 2013 to 2018.
If confirm, please release this data.
2. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with early breast cancer that were offered tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018. If confirm, please release this data.
3. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with early breast cancer that were tested with tumour profiling tests to guide adjuvant chemotherapy decisions, in each year from 2013 to 2018. If confirm, please release this data.
4. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer in each year from 2013 to 2018. If confirm, please release this data.
5. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the numbers of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer that were offered tumour profiling tests to guide adjuvant chemotherapy decisions in each year from 2013 to 2018. If confirm, please release this data.
6. Please confirm or deny if Maidstone and Tunbridge Wells NHS Trust holds information on the number of people diagnosed in Maidstone and Tunbridge Wells NHS Trust with oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node (LN)-negative (including micrometastatic disease) early breast cancer that were tested with tumour profiling tests to guide adjuvant chemotherapy decisions in each year from 2013 to 2018. If confirm, please release this data.

Download response Breast cancer. 181019

Breast Cancer.181122.docx

1. In the past 3 months, how many Breast Cancer patients (at any stage) were treated with:
a. Abemaciclib monotherapy
b. Aromatase inhibitor monotherapy (e.g. anastrazole, exemestane, letrozole)
c. Tamoxifen monotherapy
d. Abemaciclib + Tamoxifen
2. In the past 3 months, how many early/locally advanced Breast Cancer (Stages 1 to 3B) patients were treated with:
a. Abemaciclib + Aromatase inhibitor (e.g. anastrazole, exemestane, letrozole)
b. Taxane and/or Anthracycline (monotherapy or in combination)
c. Any other active systemic anti cancer therapy
3. How many patients have been treated for Triple Negative Breast Cancer (any stage) in the past 3 months with the following systemic anti cancer therapies:
a. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
b. Atezolizumab +Nab-paclitaxel/Paclitaxel
c. Pembrolizumab
d. Sacituzumab Govitecan
e. Parp Inhibitors (Olaparib/Talazoparib)
f. Eribulin as a single agent or in combination
g. Capecitabine as a single agent
h. Platinum (e.g. carboplatin or cisplatin) as a single agent
i. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
j. Taxane and/or Anthracycline in combination
k. Any other active systemic anti-cancer therapy

Breast Cancer.181122.docx

Breast cancer. 251021.docx

Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the systemic anti-cancer therapies listed below?
a. Aromatase Inhibitor (e.g. anastrozole, exemestane, letrozole) as a single agent
b. Abemaciclib + Aromatase Inhibitor (e.g. anastrozole, exemestane, letrozole)
c. Abemaciclib + Fulvestrant
d. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
e. Atezolizumab +Nab-paclitaxel/Paclitaxel
f. Capecitabine as a single agent
g. Carboplatin or Cisplatin as a single agent
h. Eribulin as a single agent or in combination
i. Everolimus + Exemestane
j. Fluorouracil
k. Fulvestrant as a single agent
l. Goserelin
m. Lapatinib
n. Neratinib
o. Olaparib
p. Palbociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
q. Palbociclib + Fulvestrant
r. Pertuzumab + Trastuzumab + Docetaxel
s. Platinum (e.g. carboplatin or cisplatin) as a single agent
t. Ribociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
u. Ribociclib + Fulvestrant
v. Talazoparib
w. Tamoxifen
x. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
y. Transtuzumab as a single agent
z. Trastuzumab emtansine
aa. Transtuzumab deruxtecan
bb. Any other active systemic anti-cancer therapy

Q2. In the past 3 months, how many early/locally advanced (Stages I to IIIc) breast cancer patients were treated with an Aromatase Inhibitor (anastrozole, exemestane, Letrozole) as a single agent?

Download response Breast cancer. 251021.docx

Breast Cancer.270224.docx

Breast Cancer.

You asked: All questions are shown as received by the Trust.
1) In the past 3 months, how many advanced/metastatic breast cancer patients have the status of;
a) HR+ and HER2+ [Hormone receptor-positive and human epidermal growth factor 2-positive]
b) HR- and HER2+ [Hormone receptor-negative and human epidermal growth factor 2-positive]
c) The total number of Metastatic breast cancer patients of any type.

2) In the past 3 months, how many metastatic breast cancer patients were treated with:
a) Trastuzumab + Pertuzumab + paclitaxel
b) Trastuzumab + paclitaxel Trastuzumab as a single agent
c) Trastuzumab emtansine
d) Trastuzumab Deruxtecan
e) Tucatinib + Trastuzumab + Capecitabine

Breast Cancer.270224.docx

Breast cancer.280224.docx

All questions are shown as received by the Trust.
Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Abemaciclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
b. Abemaciclib + Fulvestrant
c. Alpelisib + Fulvestrant
d. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
e. Atezolizumab +Nab-paclitaxel/Paclitaxel
f. Capecitabine as a single agent
g. Eribulin as a single agent or in combination
h. Everolimus + Exemestane
i. Fulvestrant as a single agent
j. Lapatinib
k. Neratinib
l. Parp Inhibitors (Olaparib/Talazoparib)
m. Palbociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
n. Palbociclib + Fulvestrant
o. Pembrolizumab
p. Platinum (e.g. carboplatin or cisplatin) as a single agent
q. Ribociclib + Aromatase Inhibitor (e.g. anastrazole, exemestane, letrozole)
r. Ribociclib + Fulvestrant
s. Sacituzumab Govitecan
t. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
u. Taxane and/or Anthracycline in combination
v. Trastuzumab as a single agent or in combination
w. Trastuzumab emtansine
x. Transtuzumab deruxtecan
y. Any other active systemic anti-cancer therapy
Q2. Does your trust participate in any clinical trials for breast cancer? If so, please provide the name of each trial, and the number of patients taking part.

Breast cancer.280224.docx

Breast Cancer.310323.docx

Q1. How many patients were treated in total, regardless of diagnosis, with the following medicines in the latest three months for which you have data?
Name of medicine
1.1 Abemaciclib (Verzenios)
1.2 Alpelisib (Piqray)
1.3 Anastrozole (anastrozole or Arimidex)
1.4 Exemestane (exemestane or Aromasin)
1.5 Fulvestrant (fulvestrant or Faslodex)
1.6 Letrozole (letrozole or Femara)
1.7 Palbociclib (Ibrance)
1.8 Ribociclib (Kisqali)
Q2. How many patients received abemaciclib (Verzenios) as adjuvant treatment for early breast cancer in the latest three months for which you have data?
If you do not have data on early breast cancer, please state how many patients received abemaciclib (Verzenios) as adjuvant treatment.
Q3. How many patients received abemaciclib in combination with an aromatase inhibitor (anastrozole or exemestane or letrozole) for early breast cancer and locally advanced or metastatic breast cancer in the latest three months for which you have data?
3.1 Abemaciclib + aromatase inhibitor (anastrozole or exemestane or letrozole)
3.2 Abemaciclib + aromatase inhibitor (anastrozole or exemestane or letrozole)
Q4. How many patients received Olaparib (Lynparza) as adjuvant treatment for early breast cancer in the latest three months for which you have data?
If you do not have data on early breast cancer, please state how many patients received Olaparib (Lynparza) as adjuvant treatment.
Q5. How many patients were treated with the following medicines in combination in the latest three months for which you have data?
Name of combination
4.1 Abemaciclib (Verzenios) + Fulvestrant (fulvestrant or Faslodex)
4.2 Abemaciclib (Verzenios) + Anastrozole (anastrozole or Arimidex)
4.3 Abemaciclib (Verzenios) + Exemestane (exemestane or Aromasin)
4.4 Abemaciclib (Verzenios) + Letrozole (letrozole or Femara)
4.7 Alpelisib (Piqray) + Fulvestrant (fulvestrant or Faslodex)
4.8 Palbociclib (Ibrance) + Fulvestrant (fulvestrant or Faslodex)
4.9 Palbociclib (Ibrance) + Anastrozole (anastrozole or Arimidex)
4.10 Palbociclib (Ibrance) + Exemestane (exemestane or Aromasin)
4.11 Palbociclib (Ibrance) + Letrozole (letrozole or Femara)
4.12 Ribociclib (Kisqali) + Fulvestrant (fulvestrant or Faslodex)
4.13 Ribociclib (Kisqali) + Anastrozole (anastrozole or Arimidex)
4.14 Ribociclib (Kisqali) + Exemestane (exemestane or Aromasin)
4.15 Ribociclib (Kisqali) + Letrozole (letrozole or Femara)
Q5. How many patients were treated with Olaparib (Lynparza) as monotherapy for locally advanced or metastatic breast cancer in the latest three months for which you have data?
Q6. Which of these protocols does your Trust follow when issuing prescriptions for aromatase inhibitors (anastrozole or exemestane or letrozole) prescribed in combination with CDK4/6 inhibitors (abemaciclib or palbociclib or ribociclib)?
6.1 Aromatase inhibitors and CDK4/6 inhibitors are issued together To Take Out at the hospital
6.2 Aromatase inhibitors and CDK4/6 inhibitors are issued separately. The CDK4/6 inhibitors (abemaciclib or palbociclib or ribociclib) are issued To Take Out at the hospital. The aromatase inhibitors (anastrozole or exemestane or letrozole) are issued as an FP10 to the patient or a request is sent to the GP to issue in the community
6.3 Both protocols above

Breast Cancer.310323.docx

Breast Cancer Services. 070417

Can you please tell me how many women were diagnosed and received treatment between the years 2014 – 2015 and 2015 – 2016. How many women in each year were treated by breast conserving surgery (lumpectomy) and how many by mastectomy. Of the women who underwent mastectomy how many received an immediate reconstruction.

Download response Breast Cancer Services. 070417

Breast Cancer Surgery. 051017

Do you have data showing the outcome of breast cancer surgery at your trust in relation to?

1. Survival rates for patients five years after surgery?
1a. Can you tell me what the figure is?
1b. Do you have results for individual surgeons?

2. Survival rates for patients ten years after surgery?
2a. Can you tell me what the figure is?
2b. Do you have results for individual surgeons?

Do you have data showing the outcome of breast cancer surgery at your trust in relation to:

3. Local Recurrence rates for patients five years after mastectomy and breast conserving surgery.
3a. Can you tell me what the figures are.
3b. Do you have figures for individual surgeons?

Download response Breast Cancer Surgery. 051017

Breast cancer treatment.110722.docx

Q1. How many patients have been treated for breast cancer (any stage) in the past 3 months with the following systemic anti-cancer therapies:
a. Abemaciclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
b. Abemaciclib + Fulvestrant
c. Anthracycline (e.g. doxorubicin or epirubicin) as a single agent
d. Atezolizumab +Nab-paclitaxel/Paclitaxel
e. Capecitabine as a single agent
f. Eribulin as a single agent or in combination
g. Everolimus + Exemestane
h. Fulvestrant as a single agent
i. Lapatinib
j. Neratinib
k. Parp Inhibitors (Olaparib/Talazoparib)
l. Palbociclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
m. Palbociclib + Fulvestrant
n. Pembrolizumab
o. Platinum (e.g. carboplatin or cisplatin) as a single agent
p. Ribociclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
q. Ribociclib + Fulvestrant
r. Sacituzumab Govitecan
s. Taxane (e.g. docetaxel, paclitaxel, nab-paclitaxel) as a single agent
t. Taxane and/or Anthracycline in combination
u. Trastuzumab as a single agent or in combination
v. Trastuzumab emtansine
w. Transtuzumab deruxtecan
x. Any other active systemic anti-cancer therapy
Q2. In the past 3 months, how many early/locally advanced breast cancer (Stages 1 to 3B) patients were treated with:
a. Abemaciclib + Aromatase Inhibitor (e.g. Anastrozole, exemestane, letrozole)
b. Taxane and/or Anthracycline (monotherapy or in combination)
c. Any other active systemic anti-cancer therapy

Breast cancer treatment.110722.docx

Breast Cancer treatments.241219

1. Within your health trust how many patients are currently [within the past 3 months] being treated with the following for breast cancer?
Abemaciclib + aromatase inhibitor *
Abemaciclib + Fulvestrant
Alpelisib + Fulvestrant
Atezolizumab
Bevacizumab
Eribulin
Everolimus + Exemestane
Fulvestrant as a single agent
Gemcitabine + paclitaxel
Lapatinib
Neratinib
Olaparib
Palbociclib + aromatase inhibitor*
Pertuzumab + trastuzumab + docetaxel
Ribociclib + aromatase inhibitor*
Ribociclib + Fulvestrant
Talazoparib
Herceptin SC
Herceptin IV
Transtuzumab biosimilar SC
Transtuzumab biosimilar IV
Trastuzumab emtansine
Other active systemic anti-cancer therapy **
*aromatase inhibitor e.g. Anastrozole, Exemestane or Letrozole
**e.g. docetaxel, vinorelbine or capecitabine as a single agent

2. How many patients are being treated for
2a Neo-adjuvant breast cancer;
Transtuzumab total SC
Transtuzumab total IV
2.b Adjuvant breast cancer;
Transtuzumab total SC
Transtuzumab total IV

Download response Breast Cancer treatments.241219

Breast radiotherapy access. 170120

1. In November and December 2019 how many requests/bookings for radical radiotherapy to the breast or chestwall were received by the radiotherapy department?
2. For those patients requested/booked in November and December 2019, how many commenced treatment?
3. Of those who received treatment what was the average length of time between the request/booking being made and the patient receiving treatment?
4. What is your average length of time for all radical radiotherapy requests/bookings to starting treatment?

Download response Breast radiotherapy access. 170120

Breast Screening & Breast Clinics. 031219

Breast Screening – (Asymptomatic)
1. Does the trust have a dedicated breast screening service/unit (Asymptomatic mammograms) – This could be separate from the main x-ray department?
2. If so, what is the name of the service?
3. Is this run in a static unit or on breast screening vans (Or Both)? How many vans does the service run? How many static sites does the service run?
4. How many ladies are scanned/screened on average, per day on each van/static unit?
5. Does the service scan on a 5 day or 7 day week?
6. Who has the overall responsibility for the breast screening service?
7. Please provide an organisational chart for the team/department with overall responsibility for the breast screening service

Symptomatic Mammography & Breast Clinics
1. Which department has the responsibility for symptomatic mammograms / Symptomatic Breast Lists/Clinics? Does this come under the breast screening unit or the main radiography department of the trust?
2. How many ladies are assessed on average per day in the symptomatic breast clinic?
3. Does the service scan on a 5 day or 7 day week?
4. Who has the overall responsibility for the symptomatic breast clinics?
5. Please provide an organisational chart for the team/department with overall responsibility for the symptomatic breast clinics

Download response Breast Screening & Breast Clinics. 031219

C-Arm provision. 250220

Please can you answer the following questions regarding the Mobile C-arm medical imaging equipment used within the Trust?
Please can you provide the following information for each piece of Mobile C-arm medical imaging equipment? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Type (Image Intensifier, Flat Panel Detector)
d. Generator Power
e. Location – Hospital Name
f. Location – Department
g. Method of Finance at Procurement
h. Initial cost of Equipment
i. Annual Maintenance cost
j. Acquisition Date
k. Planned Replacement Date

Download response C-Arm provision. 250220

Cancelled cancer operations.061223.docx

1. How many cancer operations have been cancelled by your NHS Trust in each of the past four financial years:
a. 2022/23
b. 2021/22
c. 2020/21
d. 2019/20
2. Please could you provide a breakdown for the reasons these operations were cancelled e.g. lack of staff, lack of beds, or equipment issues, again broken down by the financial years:
a. 2022/23
b. 2021/22
c. 2020/21
d. 2019/20

Cancelled cancer operations.061223.docx

Cancelled cancer operations. 220920

I would like to know how many cancer operations have been cancelled by your NHS Trust since March 1st 2020?

Download response Cancelled cancer operations. 220920

Cancelled Cancer operations.290224.docx

All questions are shown as received by the Trust.
1. How many cancer operations have been cancelled by your NHS Trust in each of the past four financial years:
a. 2022/23
b. 2021/22
c. 2020/21
d. 2019/20
2. The highest number of times a patient’s operation has been cancelled at your NHS Trust since the start of 2022.
3. Please could you provide a breakdown for the reasons these operations were cancelled e.g. lack of staff, lack of beds, or equipment issues.
a. 2022/23
b. 2021/22
c. 2020/21
d. 2019/20

Cancelled Cancer operations.290224.docx

Cancer appointments.081223.docx

All questions are shown as received by the Trust.
1. The number of (a) first consultant appointments after an urgent referral, (b) first definitive cancer treatments, and (c) subsequent cancer treatments, that were cancelled or rescheduled by your trust in financial year 2022/23:
(i) once
(b) twice
(c) three times or more
2. The most amount of times the date was changed on a single one of the above cancer appointments by your trust in FY 2022/23.

Cancer appointments.081223.docx

Cancer care or treatment 2015-2016. 020317

1. In the years 2015 & 2016 of the patients that became resident for Cancer care/treatment with inside a hospital managed by your trust, please list the annual total for the patients as described?

2. Further to the above please also provide the annual total for those patients’ families who received a pass entitling free parking during the patients stay to reduce the financial burden on the family visiting?

Download response Cancer care or treatment 2015-2016. 020317

Cancer care or treatment 2015-2016. 020317

1. In the years 2015 & 2016 of the patients that became resident for Cancer care/treatment with inside a hospital managed by your trust, please list the annual total for the patients as described?

2. Further to the above please also provide the annual total for those patients’ families who received a pass entitling free parking during the patients stay to reduce the financial burden on the family visiting?

Download response Cancer care or treatment 2015-2016. 020317

Cancer complaints. 021121.docx

1) How many PALS enquiries and official complaints your Trust has received from patients concerned about
a) the impact of the coronavirus pandemic and your Trust’s response on their or their family member’s access to cancer treatment
b) and access to cancer testing – including tests to find out whether their or their family member’s cancer has spread, returned or occurred for the first time
2) For the five most recent PALS enquiries/official complaints received, please provide me with
a) a summary of the complaint (e.g. a patient with stage 4 lung and breast cancer has contacted PALS to complain about their chemotherapy being postponed for a month)
b) the exact wording of the complaint, with redactions to remove potentially identifying information
c) what action the Trust took in response

Download response Cancer complaints. 021121.docx

Cancer complaints. 170820

Could you please tell me between 1st March 2020 and the date of this email (31st July 2020):
1) How many PALS enquiries and official complaints your Trust has received from patients concerned about
a) the impact of the coronavirus pandemic and your Trust’s response on their access to cancer treatment
b) and access to cancer testing – including tests to find out whether their cancer has spread, returned or occurred for the first time
NOTE: I suggest you search for these complaints by using the keywords ‘cancer treatment’, ‘chemotherapy’, ‘cancer testing’, ‘coronavirus’, ‘COVID-19’ and other relevant terms.
2) For the five most recent PALS enquiries/official complaints received, please provide me with
a) a summary of the complaint (e.g. a patient with stage 4 lung and breast cancer has contacted PALS to complain about their chemotherapy being indefinitely suspended)
b) the exact wording of the complaint, with redactions to remove potentially identifying information
c) what action the Trust took in response

Download response Cancer complaints. 170820

Cancer diagnostic tests.021123.docx

1. How many patients are currently on your trust’s waiting list for a cancer diagnostic test?
2. How many patients were on your trust’s waiting list for a cancer diagnostic test 12 months ago?
3. What is the longest time a patient has had to wait for a cancer diagnostic test in the last 12 months?
4. How many cancer diagnostic tests have been cancelled by your trust for non-clinical reasons in the last 12 months?
5. What is the highest number of times a cancer diagnostic test for one patient has been cancelled by your trust for non-clinical reasons in the last 12 months?

Cancer diagnostic tests.021123.docx

Cancer funding.140324.docx

All questions are shown as received by the Trust.
“The total amount of your Trusts budget in pounds-sterling (£) that is allocated for all cancer funding in each of the financial years a) 2023-2024, b) 2023-2022, c) 2022-2021, d) 2021-2020, e) 2020-2019
The percentage of your Trusts total budget that is allocated for all cancer funding in each of the financial years a) 2023-2024, b) 2023-2022, c) 2022-2021, d) 2021-2020, e) 2020-2019”

Cancer funding.140324.docx

Cancer – Longest Wait.310823.docx

All questions are shown as received by the Trust.
1. The number of people at your trust currently receiving treatment for cancer?
2. The number of people at your trust currently waiting to receive treatment for cancer?
3. How long has the person who has waited the longest been waiting?
4. The number of people waiting to start cancer treatment, as measured from the date of urgent referral, who have waited longer than:
a. 62 days,
b. 3 months,
c. 4 months
d. 6 months,
e. 12 months.
5. The single longest wait to start cancer treatment, as measured from the date of the urgent referral, for each of the last three years?

Cancer – Longest Wait.310823.docx

Cancer operations – Annual cancellations. 310117

In the years 2015, 2016 & 2017 from January 1st until the current date could you please provide me with the total number per month of cancer operations cancelled by Hospitals under the umbrella of your Acute NHS Trust?

Download response Cancer operations – Annual cancellations. 310117

Cancer pathway and treatment. 270821.docx

1. How many patients on the cancer pathway started treatment within the 62 days and over 62 days, from urgent GP referral to starting treatment in each month of 2020 and 2021.
2. How many patients referred under the 2 weeks wait pathway were seen within 14 days in each month of 2020 and 2021.
3. How many patients started cancer treatment in each month of:
a. 2019
b. 2020
c. 2021

Download response Cancer pathway and treatment. 270821.docx

Cancer patients. 240920

Please send me:
1. The total number of cancer patients receiving treatment within 62 days.
2. The total number of cancer patients waiting more than 104 days for treatment.

Download response Cancer patients. 240920

Cancer referrals.280521

What percentage of cancer referrals received an appointment within 12 weeks of the original referral from a GP, for each month in 2019 and for each month in 2020.

Download response Cancer referrals.280521

Cancer Services. 110221

1) What support do you offer for the family members of patients being treated for cancer within your NHS trust? (Support can include anything that would contribute to the emotional well-being of an individual, such as support groups, counselling or advice).
2) Does your NHS Trust provide any tailored support specifically for young people (under 25s) who have family members being treated for cancer?
3) If so, please could you provide details.
4) Are services actively offered to patients’ family members, or do they have to approach the Trust themselves to request support?

Download response Cancer Services. 110221

Cancer services.180522.docx

1. Over all how many Cancer trackers are employed by your Trust (WTE)?
2. Over all how many cancer MDT co-ordinators are employed by your Trust (WTE)?
3. Please provide the split of cancer tracker WTE by each tumour site of responsibility
a. Lung
b. Breast
c. Head & Neck
d. Lower GI
e. Upper GI
f. Gynaelogical
g. Children’s
h. Acute leukaemia
i. Haematological malignancies (excluding acute leukaemia)
j. Testicular
k. Urological
4. Please provide the split of cancer MDT co-coordinators WTE by each tumour site of responsibility
a. Lung
b. Breast
c. Head & Neck
d. Lower GI
e. Upper GI
f. Gynaelogical
g. Children’s
h. Acute leukaemia
i. Haematological malignancies (excluding acute leukaemia)
j. Testicular
k. Urological
5. What cancer PAS system is used by your organisation? I.e. Somerset, Infoflex other. If other please specify.

Cancer services.180522.docx

Cancer Services and Radiotherapy policies. 090620

I wonder if you could get a complete copy including finance of the Trusts Cancer Policy.
On another issue, we are trying to get hold of copies of the two trusts Radiotherapy policy.

Download response Cancer Services and Radiotherapy policies. 090620

Cancer treatment. 040817

Please provide the following information:

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment privately at your trust (including directly and through private patient units located on trust premises), providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the total value of treatments received, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the five cancer treatments that were most commonly provided privately, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, please include a breakdown of patient numbers and value of treatment by type of cancer.

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment from any private provider, providing an annual total for each of the last five financial years.

Download response Cancer treatment. 040817

Cancer treatment. 081117

Please provide the following information:

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment privately at your trust (including directly and through private patient units located on trust premises), providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the total value of treatments received, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, the five cancer treatments that were most commonly provided privately, providing an annual total for each of the last five financial years.

-Where cancer treatment was provided privately for patients at your trust in addition to NHS-funded cancer treatment, please include a breakdown of patient numbers and value of treatment by type of cancer.

-The number of patients who have received NHS-funded treatment for cancer (including surgery, radiotherapy and medicines) at your trust who have also received cancer treatment from any private provider, providing an annual total for each of the last five financial years.

Download response Cancer treatment. 081117

Cancer Treatment.101023.docx

All questions are shown as received by the Trust.
1) Over the last 6 months, how many patients were treated with a combination of Dabrafenib + Trametinib for the following diseases:
A) Metastatic Melanoma
B) Adjuvant Melanoma
C) BRAF mutated Lung Cancer

2) Over the last 6 months, how many patients were treated with a combination of Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following diseases:
A) Metastatic Melanoma
B) Colorectal Cancer
C) Any other indications

Cancer Treatment.101023.docx

Cancer treatment. 181019

1 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Non-small cell Lung Cancer (NSCLC) with the following
Paclitaxel
Gemcitabine
Osimertinib
Carboplatin and Pemetrexed
Cisplatin and Pemetrexed
Pembrolizumab monotherapy
Pembrolizumab in combination
Atezolizumab
Nivolumab
Other active systemic anti-cancer therapy
2a – Does your Health Trust participate in any ongoing clinical trails for the treatment of Metastatic Non Small Cell Lung cancer patients ?
2b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
3 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Colorectal Cancer (CRC) with the following:
Cetuximab not in combination with FOLFIRIE or FOLOX
Cetuximab in combination with FOLFIRI
Cetuximab in combination with FOLFOX
Panitumumab not in combination with FOLFIRI or FOLFOX
Panitumumab in combination with FOLFIRI
Panitumumab in combination with FOLFOX
Nivolumab
Aflibercept
Bevacizumab
Ramucirumab
Regorafenib
Sorafenib
Other active systemic anti-cancer therapy (eg 5FU, CAPIRI, CAPOX, FOLFIRI, FOLFOX, Oxaliplatin, Irinotecan, Tegafur or Uracil + 5FU)
3a – Does your Health Trust participate in any ongoing clinical trials for the treatment of Colorectal cancer patients ?
3b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
4 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Head and Neck Cancer (Squamous Cell Carcinoma) ?
4a – If your Trust is able to split these patients, how many are locally advanced and how many are recurrent and or metastatic Head and Neck Cancer patients ?
Locally advanced
Recurrent metastatic
Unable to split
4b – Of the Head and Neck cancer patients please split by their current drug treatment (if you are unable to split by locally advanced and recurrent please state the total)
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab with / without chemotherapy
Cetuximab with radiotherapy
Pembrolizumab monotherapy
Pembrolizumab with chemotherapy
Nivolumab
Docetaxel (only or in combination with 5-FU)
Fluorouracil (5-FU)
Radiotherapy only
Other
4c – Does your Health Trust participate in any ongoing clinical trials for the treatment of Head and Neck cancer patients ?
4d – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
5 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Urothelial Carcinoma UCC) with the following:
Cisplatin single agent
Cisplatin in combination with another agent
Carboplatin single agent
Carboplatin in combination with another agent
Nivolumab
Pembrolizumab
Atezolizumab
Other active systemic anti-cancer therapy
5a – Does your Health Trust participate in any ongoing clinical trials for the treatment of Metastatic Urothelial Carcinoma patients ?
5b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?

Download response Cancer treatment. 181019

Cancer treatment. 181019

1 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Non-small cell Lung Cancer (NSCLC) with the following
Paclitaxel
Gemcitabine
Osimertinib
Carboplatin and Pemetrexed
Cisplatin and Pemetrexed
Pembrolizumab monotherapy
Pembrolizumab in combination
Atezolizumab
Nivolumab
Other active systemic anti-cancer therapy
2a – Does your Health Trust participate in any ongoing clinical trails for the treatment of Metastatic Non Small Cell Lung cancer patients ?
2b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
3 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Colorectal Cancer (CRC) with the following:
Cetuximab not in combination with FOLFIRIE or FOLOX
Cetuximab in combination with FOLFIRI
Cetuximab in combination with FOLFOX
Panitumumab not in combination with FOLFIRI or FOLFOX
Panitumumab in combination with FOLFIRI
Panitumumab in combination with FOLFOX
Nivolumab
Aflibercept
Bevacizumab
Ramucirumab
Regorafenib
Sorafenib
Other active systemic anti-cancer therapy (e.g. 5FU, CAPIRI, CAPOX, FOLFIRI, FOLFOX, Oxaliplatin, Irinotecan, Tegafur or Uracil + 5FU)
3a – Does your Health Trust participate in any ongoing clinical trials for the treatment of Colorectal cancer patients ?
3b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
4 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Head and Neck Cancer (Squamous Cell Carcinoma) ?
4a – If your Trust is able to split these patients, how many are locally advanced and how many are recurrent and or metastatic Head and Neck Cancer patients ?
Locally advanced
Recurrent metastatic
Unable to split
4b – Of the Head and Neck cancer patients please split by their current drug treatment (if you are unable to split by locally advanced and recurrent please state the total)
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab with / without chemotherapy
Cetuximab with radiotherapy
Pembrolizumab monotherapy
Pembrolizumab with chemotherapy
Nivolumab
Docetaxel (only or in combination with 5-FU)
Fluorouracil (5-FU)
Radiotherapy only
Other
4c – Does your Health Trust participate in any ongoing clinical trials for the treatment of Head and Neck cancer patients ?
4d – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?
5 – Within your Health Trust how many patients are currently (within the past 6 months available) being treated for Urothelial Carcinoma UCC) with the following:
Cisplatin single agent
Cisplatin in combination with another agent
Carboplatin single agent
Carboplatin in combination with another agent
Nivolumab
Pembrolizumab
Atezolizumab
Other active systemic anti-cancer therapy
5a – Does your Health Trust participate in any ongoing clinical trials for the treatment of Metastatic Urothelial Carcinoma patients ?
5b – If so how many patients are currently taking part in clinical trials / what is the name(s) of the trials ?

Download response Cancer treatment. 181019

Cancer treatment 2010 – 2016. 250917

How many patients were treated for cancer by your trust each year since 2010?

How many of these patients in each year were ‘self-funders’ or paid the trust for their treatment, either personally or through an insurer and other third party?

What was the total amount of money raised in this way for each year?

How many patients for each year were ordinary NHS patients, ie patients whose care was free at the point of delivery?

How many designated cancer wards does your trust have for each year since 2010?

How many wards, if any, were for ‘self-funders’ and how many were for ordinary NHS patients for each year since 2010?

Download response Cancer treatment 2010 – 2016. 250917

Cancer treatment. 291118

You asked:
1. In the past 3 months, how many mNSCLC patients were treated with?
Afatinib
Atezolizumab
Becacizumab
Ceritinib
Crizotinib
Erlotinib
Gefitinib
Nitendaninb
Nivolumab
Pembrolizumab
Pemetrexed
Ramucirumab
Metastatic hepatocellular carcinoma
2. In the past three months, how many patients were treated with?
Bevacizumab
Cisplatin
Doxorubicin
Everolimus
Lapatinib
Levantinib
Regorafenib
Sorafenib
Sunitinib
TACE
Other active systemic anti-cancer therapy
Metastatic Thyroid Cancer
3. In the past three months, how many patients were treated with?
Axitinib
Cabozantinib
Levantinib
Pazopanib
Sorafenib
Sunitinib
Vandetanib
Others

Download response Cancer treatment. 291118

Cancer Treatments. 040320

1a – How many melanoma patients undergoing treatment are BRAF+?
1b – In the past 3 months, how many melanoma patients were treated with the following:
Bevacizumab
Cobimetinib
Dabrafenib
Dabrafenib AND trametinib
Dacarbazine
Encorafenib AND binimetinib
Ipilimumab
Ipilimumab AND Nivolumab
Nivolumab
Pembrolizumab
Trametinib
Vemurafenib
Vemurafenib AND Cobimetinib
Other active systemic anti-cancer therapy
Palliative care
1c – In the past 3 months how many patients were seen who had stage III resectable melanoma
1d – Of all stage III patients seen, how many received a complete resection?
2 – In the past 3 months, how many Squamous Cell Non-small cell lung cancer (SqNSCLC) patients were treated with:
Afatinib
Atezolizumab monotherapy
Bevacizumab
Docetaxel monotherapy
Durvalumab
Erlotinib
Gemcitabine
Necitumumab
Nivolumab
Paclitaxel
Pembrolizumab monotherapy
Pembrolizumab chemo in combination
Pemetrexed
Ramucirumab
Vinorelbine and cisplatin / carboplatin
Other active systemic anti-cancer therapy [please state]
Palliative care only
3 – In the past 3 months, how many Non Squamous Cell Non-small cell lung cancer (Non SqNSCLC) patients were treated with:
Afatinib
Alectinib
Atezolizumab mono
Atezolizumab + bevacizumab + carboplatin + paclitaxel
Bevacizumab
Brigatinib
Ceritinib
Crizotinib
Dacomitinib
Docetaxel monotherapy
Erlotinib
Gefitinib
Nintedanib with docetaxel
Nivolumab
Osimertinib
Paclitaxel
Pembrolizumab monotherapy
Pembrolizumab chemo in combination
Pemetrexed with carboplatin
Pemetrexed with cisplatin
Ramucirumab
Other active systemic anti-cancer therapy [please state]
Palliative care only

Download response Cancer Treatments. 040320

Cancer treatments. 051121.docx

1. Within your health trust, how many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents?
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. For the patients treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the therapies listed in the first question, please provide:
a. Total number of head and neck cancer patients
b. Number of locally advanced head and neck cancer patients
c. Number of recurrent and/or metastatic head and neck cancer patients
3. Within your health trust, how many patients have been treated in the past 3 months with the following agents for colorectal cancer [CRC]?
a. Aflibercept
b. Bevacizumab
c. Capecitabine
d. CAPIRI
e. CAPOX (XELOX)
f. Cetuximab in combination with FOLFIRI
g. Cetuximab in combination with FOLFOX
h. Cetuximab not in combination with FOLFIRI or FOLFOX
i. Irinotecan only
j. FOLFIRI
k. FOLFOX
l. Fluorouracil (5FU) only
m. Oxaliplatin only
n. Panitumumab in combination with FOLFIRI
o. Panitumumab in combination with FOLFOX
p. Panitumumab not in combination with FOLFIRI or FOLFOX
q. Pembrolizumab
r. Nivolumab
s. Raltitrexed
t. Ramucirumab
u. Regorafenib
v. Sorafenib
w. Other SACT

Download response Cancer treatments. 051121.docx

Cancer treatments. 210920

1. Does your trust treat adult multiple myeloma [MM] ? – if you refer your multiple myeloma patients to another centre, please state which.
2. If yes, then how many multiple myeloma patients, have been treated in the past 6 months with the following;
· Bortezomib [Velcade]
· Carfilzomib [Kyprolis]
· Ixazomib [Ninlaro]
· Lenalidomide [Revlimid]
· Daratumumab [Darzalex]
· Melphalan, prednisolone and thalidomide (known as MPT)
· Cyclophosphamide, thalidomide and dexamethasone (known as CTD)
· Pomalidomide [Imnovid]
3. Over the past 6 months [latest possible], how many chronic lymphocytic leukaemia (CLL) patients have you treated?
If possible, how many CLL patients treated were new to therapy in the past 3 months?
4. How many chronic lymphocytic leukaemia patients, have been treated in the past 6 months with the following;
· Fludarabine (Fludara), cyclophosphamide (Cytoxan), and rituximab (known as FCR)
· Bendamustine and rituximab (known as BR)
· Ibrutinib [Imbruvica]
· Chlorambucil
· Venetoclax
· Obinutuzumab
· Idelalisib
· Fludarabine and rituximab (known as FR)
· High-dose prednisone and rituximab
· Pentostatin (Nipent), cyclophosphamide, and rituximab (known as PCR)
· Alemtuzumab (Campath) with rituximab

Download response Cancer treatments. 210920

Cancer treatments. 220120

1. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
Locally advanced
Recurrent metastatic
Unknown
3. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma) with the following agents?
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab with/without chemotherapy
Cetuximab with radiotherapy
Pembrolizumab monotherapy
Pembrolizumab with chemotherapy
Nivolumab
Docetaxel (only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy only
Other
Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?
4. Within your health trust how many patients have been treated in the past 6 months with the following agent for colorectal cancer [CRC];
Aflibercept
Bevacizumab
Capecitabine
CAPIRI
CAPOX
Cetuximab not in combination with FOLFIRI or FOLFOX
Cetuximab in combination with FOLFIRI
Cetuximab in combination with FOLFOX
Irinotecan
FOLFIRI
FOLFOX
Oxaliplatin
Panitumumab not in combination with FOLFIRI or FOLFOX
Panitumumab in combination with FOLFIRI
Panitumumab in combination with FOLFOX
Nivolumab
Raltitrexed
Ramucirumab
Regorafenib
Sorafenib
5FU only
Tegafur Uracil + 5FU
Trifluridine–tipiracil
XELOX
Other
5. Within your health trust how many patients have been treated in the past 6 months with the following agent for Renal Cell Carcinoma :
Sunitinib
Avelumab + Axitinib
Axinitib
Cabozantinib
Everolimus
Lenvantinib + Everolimus
Nivolumab
Nivolumab + Ipilimumab
Pazopanib
Pembrolizumab + Axitinib
Sunitinib
Temsirolimus
Tivozanib
6. Does your health trust participate in any ongoing clinical trials for the treatment of renal cell cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?

Download response Cancer treatments. 220120

Cancer treatments. 241019

1 – Within your Health Trust how many patients are currently (within the past 3 months) being treated with the following treatments for Kidney Carcinoma (Renal Cell – RCC);
If you do not treat, where do you refer these patients?
2 – Within your Health Trust how many patients are currently (within the past 3 months) being treated with the following treatments for Melanoma?
If you do not treat, where do you refer these patients?
2a – In the past 3 months, how many Melanoma patients were BRAF+?
3 – Within your Health Trust how many patients are currently (within the past 3 months) being treated with the following treatments for Liver Cancer (Hepatic Cell – HCC);
If you do not treat, where do you refer these patients?
4 – Within your Health Trust how many patients are currently (within the past 3 months) being treated with the following treatments for Thyroid Cancer;
If you do not treat, where do you refer these patients?

Download response Cancer treatments. 241019

Cancer treatments. 260620

1. In the past 3 months, how many metastatic melanoma patients were treated by your Trust?
a. Dabrafenib
b. Dabrafenib + Trametinib
c. Densoumab
d. Encorafenib + Binimetinib
e. Ipilimumab
f. Ipilimumab + Nivolumab
g. Nivolumab
h. Pembrolizumab
i. Trametinib
j. Vemurafenib
k. Vemurafenib + Cobimetinib
l. Other active systemic anti-cancer therapy
Palliative care only
2. Within your health trust how many patients are currently [within the past 3 months] being treated for metastatic Non-small-cell lung cancer (NSCLC) with the following:
a. Afatinib
b. Atezolizumab monotherapy or combination
c. Brigatinib
d. Ceretinib
e. Crizotinib
f. Docetaxel monotherapy or combination
g. Erlotinib
h. Gefitinib
i. Gemcitabine
j. Nitendanib + docetaxel
k. Nivolumab
l. Osimertinib
m. Paclitaxel
n. Pembrolizumab monotherapy
o. Pembrolizumab chemo in combination
p. Pembrolizumab monotherapy
q. Pemetrexed monotherapy or combination
r. Ramucirumab
s. Vinorelbine monotherapy or combination
t. Other active systemic anti-cancer therapy
u. Palliative care only
3. Out of the metastatic NSCLC patients currently [within the past 3 months] being treated, are you able to provide the number of patients being treated for Squamous Cell Non-small-cell lung cancer (SqNSCLC ) with the following products?
a. Afatinib
b. Atezolizumab monotherapy or combination
c. Brigatinib
d. Ceretinib
e. Crizotinib
f. Docetaxel monotherapy or combination
g. Erlotinib
h. Gefitinib
i. Gemcitabine
j. Nitendanib + docetaxel
k. Nivolumab
l. Osimertinib
m. Paclitaxel
n. Pembrolizumab monotherapy
o. Pembrolizumab chemo in combination
p. Pembrolizumab monotherapy
q. Pemetrexed monotherapy or combination
r. Ramucirumab
s. Vinorelbine mono or combination
t. Other active systemic anti-cancer therapy
u. Palliative care only

Download response Cancer treatments. 260620

Cancer treatments.270224.docx

All questions are shown as received by the Trust.
1) in the past 6 months, how many patients were treated with a combination of both Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following diseases:

A) Metastatic Melanoma
B) Colorectal Cancer
C) Any other indications

2) In the past 6 months, how many patients were treated with a combination of Dabrafenib + Trametinib for the following diseases:
A) Metastatic Melanoma
B) Adjuvant Melanoma
C) BRAF mutated Lung Cancer

Cancer treatments.270224.docx

Cancer treatments.270923.docx

All questions are shown as received by the Trust.
I writing to request, under the Freedom of Information Act, the number of cancer treatments started at each cancer stage in each of the last five years in your trust.

Cancer treatments.270923.docx

Cancer treatments. 291020

1. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced, recurrent, metastatic and unresectable head and neck cancer patients?
a. Locally advanced
b. Recurrent
c. Metastatic
d. Unresectable
e. Unknown
3. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma) with the following agents?
a. Carboplatin (only or in combination with 5-FU)
b. Cisplatin (only or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (only or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
3b. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?
4. Within your health trust how many patients have been treated in the past 6 months with the following agent for colorectal cancer [CRC];
a. Aflibercept
b. Bevacizumab
c. Capecitabine
d. CAPIRI
e. CAPOX
f. Cetuximab not in combination with FOLFIRI or FOLFOX
g. Cetuximab in combination with FOLFIRI
h. Cetuximab in combination with FOLFOX
i. Irinotecan
j. FOLFIRI
k. FOLFOX
l. Oxaliplatin
m. Panitumumab not in combination with FOLFIRI or FOLFOX
n. Panitumumab in combination with FOLFIRI
o. Panitumumab in combination with FOLFOX
p. Nivolumab
q. Raltitrexed
r. Ramucirumab
s. Regorafenib
t. Sorafenib
u. 5FU only
v. Tegafur Uracil + 5FU
w. Trifluridine–tipiracil
x. XELOX
y. Other
5. Within your health trust how many patients have been treated in the past 6 months with the following agent for Renal Cell Carcinoma:
a. Sunitinib
b. Avelumab + Axitinib
c. Axinitib
d. Cabozantinib
e. Everolimus
f. Lenvantinib + Everolimus
g. Nivolumab
h. Nivolumab + Ipilimumab
i. Pazopanib
j. Pembrolizumab + Axitinib
k. Sunitinib
l. Temsirolimus
m. Tivozanib
5b. Does your health trust participate in any ongoing clinical trials for the treatment of renal cell cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?

Download response Cancer treatments. 291020

Cancer two week wait referral.110822.docx

Please can you let me know what your success rate in meeting the cancer two week wait referral is? What % of patients referred are actually seen within the two weeks?

Cancer two week wait referral.110822.docx

Cancers. 050718

1. How many individuals diagnosed in the last 5 years with prostate cancer?
2. How many deaths attributable to prostate cancer in the last 5 years?
3. How many individuals diagnosed in the last 5 years with breast cancer?
4. How many deaths attributable to breast cancer in the last 5 years?
5. How many individuals diagnosed with brain cancer in the last 5 years?
6. Of those diagnosed with brain cancer how many with GBM4?
7. How many deaths attributable to brain cancer in the last 5 years?
8. Of those deaths how many due to GBM4?
9. How many children diagnosed with brain cancer in the last 5 years?
10. How many child deaths attributable to brain cancer in the last 5 years?
Download response Cancers. 050718

Carcinoma and melanoma

1. The number of patients with NON SMALL CELL LUNG CARCINOMA (Stage IIIB/Stage IV) treated in the last 6 months with the following:
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Pemetrexed (Alimta)
Nivolumab (Opdivo)
Nintedanib (Vargatef)

2. The number of patients with METASTATIC MELANOMA Stage IV (advanced or metastatic), treated in the last 6 months with the following:
Ipilimumab (Yervoy)
Nivolumab (Opdivo)
Ipilimumab AND Nivolumab
Pembrolizumab (Keytruda)
Vemurafenib (Zelboraf)
Vemurafenib AND Cobimetinib
Dabrafenib (Taflinar)
Trametinib (Mekinist)
Dabrafenib AND trametinib
Dacarbazine (DTIC)
For the period 1/1/2016-30/06/2016

Download response Carcinoma and melanoma 230916

Cervical cancer and Endometrial cancer.171022.docx

Q1. Does your trust provide SACT (systemic anti-cancer therapy) treatments for the following conditions?
a. Cervical cancer
b. Endometrial cancer
In case you do not provide SACT treatments for either of the above conditions, which other trust do you refer patients to for these treatments?
Q2. How many patients were treated for cervical cancer in the past 6 months with the following treatments:
a. Paclitaxel in combination with Platinum and/or Bevacizumab
b. Pembrolizumab in combination with Platinum and/or Bevacizumab
c. Platinum standalone or in combination with Bevacizumab
d. Toptecan in combination with Platinum and/or Bevacizumab
e. Any other SACT
Q3. How many patients were treated for endometrial cancer in the past 6 months with the following treatments:
a. Dostarlimab
b. Hormone therapy (Progesterone or Letrozole)
c. Pembrolizumab in combination with Lenvatinib
d. Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)
e. Any other SACT
Q4. How many endometrial cancer patients received the following therapies as 1st Line treatment in the past 6 months:
a. Hormone therapy (Progesterone or Letrozole)
b. Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)
c. Any other SACT
Q5. Does your trust participate in any clinical trials for the treatment of cervical cancer? If so, can you please provide the name of each trial and the number of patients taking part.
Q6. Does your trust participate in any clinical trials for the treatment of endometrial cancer? If so, can you please provide the name of each trial and the number of patients taking part.

Cervical cancer and Endometrial cancer.171022.docx

Chemotherapies and anything specific to carboplatin. 170322.docx

We are seeking information for both general advice relevant to all chemotherapies and anything specific to carboplatin.
As part of this guidance and information we are seeking data including but not limited to:
1. The % and number of patients having the kidney function tests before chemo has begun and after it has begun, with associated outcomes, including mortality rates, split by chemo cycle stage undertaken.
2. The % and number of patients whose GFR tests taken prior to chemo starting, have indicated their kidneys were not functioning sufficiently to enable progression of chemotherapy.
3. It would then be helpful to understand which of those patients guided chemo cannot be progressed, did not progress and those that did (going against doctors wishes if that is possible to do?) and their outcomes.
It needs to reflect a time pre covid that is representative of more ‘normal’ time in treatment of cancers patients and also post pandemic peak when hospitals have been ramping up recovery.
We’d therefore be looking at two periods of data 1) 12 rolling months, February 2018 to Feb 2019 and then 5 months May 2021 to September 2021.
In addition to our questions below we’d like:
4. The specific data on number of patients during those periods who did not have a kidney function test prior to the first chemo cycle e.g total patients given chemo and not given chemo and the numbers of those that had gfr test before and those that did not.
5. For those patients that did not, also confirm of any subsequent kidney failure experienced and at what stage of chemo it was experienced.
6. To make a fair comparison, we’d welcome data of those who experienced kidney failure from chemo and at what stage chemo this happened – who undertook a gfr test prior and whose kidneys were deemed fit enough to withstand chemo treatment.

Chemotherapies and anything specific to carboplatin. 170322.docx

Chronic Myeloid Leukaemia (CML) 2015.

1. In your organisation, how many patients diagnosed with Chronic Myeloid Leukaemia (CML) have been treated in calendar year 2015?

2. Of these patients, how many are currently being treated with each of the following tyrosine kinase inhibitors (TKIs)?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)

3. If possible, of these patients on a TKI, how many have had treatment with a previous TKI?

4. In your organisation, how many patients diagnosed with Philadelphia positive (Ph+) Acute Lymphoblastic Leukaemia (ALL) have been treated in calendar year 2015?

5. Of these patients how many are currently being treated with each of the following TKIs?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)
· Other (i.e. not on a TKI)

Download response Chronic Myeloid Leukaemia (CML) 2015 190416

Clinical Imaging Equipment. 150322.docx

A list of the current medical imaging equipment held by the Trust across all hospital sites, providing the following information:
Q1: What is your overall spend on medical imaging products and services for the current year?
Q2: How much do you spend on each modality requested below for the current year:
a) Computed Tomography (CT)
b) Magnetic Resonance Imaging (MRI)
c) Ultrasound
d) Fluoroscopy
e) Mammography
f) Nuclear
g) Mobile X-ray
h) Static X-ray
Q3: A list of the current equipment held by the Trust across all hospital sites for each of the following:
a) Supplier
b) Product
c) Contract start date
d) Contract expiry date
e) Number of devices
f) Age of product
Example Response: 3 x Siemens Acuson SC2000, Initial cost £ 29,000, Contract start date 10/02/2022 Contract end date 10/02/2026, 6 years old
Q4: Annual cost of maintenance of equipment
Q5: What percentage of your imaging equipment has an element of Artificial Intelligence?

Clinical Imaging Equipment. 150322.docx

Clinical Insourcing and Outsourcing. 111121.docx

1. Do you insource clinical services and if so, which ones?
2. Do you have any current contracts in place with a company for these insourced services, and if so which services?
3. How much have you spent on insourcing clinical services per annum for the past 3 years?
4. Do you outsource clinical services and if so, which ones?
5. Do you have any current contracts in place with a company for these outsourced services, and if so which services?
6. How much have you spent on outsourcing clinical services per annum for the past 3 years?

Download response Clinical Insourcing and Outsourcing. 111121.docx

Colonoscopies and colorectal cancer. 160322.docx

1. The total number of colonoscopies undertaken in Maidstone and Tunbridge Wells NHS Trust for the period
i) April 2019-March 2020
ii) April 2020-March 2021.
2. The total number of people diagnosed with colorectal cancer (or other clearly defined indications) within Maidstone and Tunbridge Wells NHS Trust for the period
i) April 2019-March 2020
ii) April 2020-March 2021.
3. The average adenoma detection rate (ADR) and post-colonoscopy colorectal cancer rate (PCCRC) for Maidstone and Tunbridge Wells NHS Trust for the period
i) April 2019-March 2020
ii) April 2020-March 2021
4. The total number of cancers detected, against cancer stage (e.g. 1,2,3 or 4), against colonoscopies performed in the prior three years within Maidstone and Tunbridge Wells NHS Trust in the period
i) April 2019-March 2020
ii) April 2020-March 2021

Colonoscopies and colorectal cancer. 160322.docx

Colorectal Cancer.041223.docx

In the past 3 months, how many patients have been treated for Colorectal Cancer [CRC] with the following regimens? If possible, please also provide the split of metastatic vs non-metastatic patients for each regimen.
Regimens
a. Capecitabine
b. CAPIRI
c. CAPOX
d. Cetuximab with FOLFIRI
e. Cetuximab with FOLFOX
f. Cetuximab as a single agent
g. Cetuximab with Encorafenib
h. Irinotecan as a single agent
i. FOLFIRI
j. FOLFOX
k. Fluorouracil (5FU) as a single agent
l. Oxaliplatin as a single agent
m. Nivolumab with Ipilimumab
n. Panitumumab with FOLFIRI
o. Panitumumab with FOLFOX
p. Panitumumab as a single agent
q. Pembrolizumab
r. Any other systemic anti-cancer therapy
s. Palliative care only

Colorectal Cancer.041223.docx

Colorectal Cancer. 280520

Name of organisation (NHS Trust):
Please list the acute hospital site/s within the Trust:
PLEASE ANSWER THE FOLLOWING QUESTIONS FOR EACH ACUTE HOSPITAL SITE LISTED ABOVE
HOSPITAL AND SERVICES
1. The hospital would be described as a:
District general
Teaching hospital
2. Total number of inpatient beds at this hospital:
3. Does the hospital provide colorectal cancer services
4. Is the hospital a specialist colorectal cancer care centre
5. How many dietitians are employed in the hospital (please answer in FTE units):
6. How many dietitians are commissioned to provide dietetic services in each cancer type (please answer in FTE units. Where no time is commissioned, please enter 0):
7. a. Is there any band 5, general dietetic cover for colorectal cancer care
b. If yes, how many dietitians are commissioned (please answer in FTE units):
8. If there is dietetic time commissioned for colorectal cancer care at the hospital, does this include outpatient or community follow up after discharge?
9. If dietetic time is commissioned for colorectal cancer care, where does the funding come from?

Download response Colorectal Cancer. 280520

Colorectal cancer [CRC]. 091220

1. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced, recurrent, metastatic and unresectable head and neck cancer patients?
Locally advanced
Recurrent
Metastatic
Unresectable
Unknown
3. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma) with the following agents?
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab with/without chemotherapy
Cetuximab with radiotherapy
Pembrolizumab monotherapy
Pembrolizumab with chemotherapy
Nivolumab
Docetaxel (only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy only
Other
4. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?
5. Within your health trust how many patients have been treated in the past 6 months with the following agent for colorectal cancer [CRC];
Aflibercept
Bevacizumab
Capecitabine
CAPIRI
CAPOX
Cetuximab not in combination with FOLFIRI or FOLFOX
Cetuximab in combination with FOLFIRI
Cetuximab in combination with FOLFOX
Irinotecan
FOLFIRI
FOLFOX
Oxaliplatin
Panitumumab not in combination with FOLFIRI or FOLFOX
Panitumumab in combination with FOLFIRI
Panitumumab in combination with FOLFOX
Nivolumab
Raltitrexed
Ramucirumab
Regorafenib
Sorafenib
5FU only
Tegafur Uracil + 5FU
Trifluridine–tipiracil
XELOX
Other
6. Within your health trust how many patients have been treated in the past 6 months with the following agent for Renal Cell Carcinoma :
Sunitinib
Avelumab + Axitinib
Axinitib
Cabozantinib
Everolimus
Lenvantinib + Everolimus
Nivolumab
Nivolumab + Ipilimumab
Pazopanib
Pembrolizumab + Axitinib
Sunitinib
Temsirolimus
Tivozanib
7. Does your health trust participate in any ongoing clinical trials for the treatment of renal cell cancer patients, if so how many patients are currently taking part in clinical trials / what is the name/s of the trials?

Download response Colorectal cancer [CRC]. 091220

Colorectal cancer [CRC].160922.docx

Q1. Within your health trust, how many patients have been treated in the past 3 months with the following agents for colorectal cancer [CRC]?
a. Aflibercept
b. Bevacizumab
c. Capecitabine
d. CAPIRI
e. CAPOX (XELOX)
f. Cetuximab in combination with FOLFIRI
g. Cetuximab in combination with FOLFOX
h. Cetuximab not in combination with FOLFIRI or FOLFOX
i. Irinotecan only
j. FOLFIRI
k. FOLFOX
l. Fluorouracil (5FU) only
m. Oxaliplatin only
n. Panitumumab in combination with FOLFIRI
o. Panitumumab in combination with FOLFOX
p. Panitumumab not in combination with FOLFIRI or FOLFOX
q. Pembrolizumab
r. Nivolumab
s. Raltitrexed
t. Ramucirumab
u. Regorafenib
v. Sorafenib
w. Other SACT
Q2. In the last 3 months, how many patients has your trust treated (for any condition) with the following treatments
a. Avatrombopag
b. Eltrombopag
c. Fostamatinib
d. Romiplostim
Q3. In the last 3 months, how many patients has your trust treated for Immune thrombocytopenia (ICD10 code D69.3)?
Q4. In the last 3 months, how many patients has your trust treated for Immune thrombocytopenia (ICD10 code D69.3) ONLY with the following treatments:
a. Avatrombopag
b. Mycophenolate mofetil
c. Rituximab
d. Surgery (splenectomy)

Colorectal cancer [CRC].160922.docx

Colposcopy appointments. 140421

I was wondering if you’d be able to share with me a copy of the letter and information leaflet that you send out to patients who receive a colposcopy appointment.

Download response Colposcopy appointments. 140421

Community Diagnostic Centre.080922.docx

Please could you provide me with a copy of the business case for the Trust’s Community Diagnostic Centre project, including the capital budget for the entire project.

Community Diagnostic Centre.080922.docx

Complementary and Alternative Medicine (CAM) services.101022.docx

I am writing to obtain information, under the Freedom of Information Act, about your Trust’s funding of Complementary and Alternative Medicine (CAM) services they provided.
To outline my query as clearly as possible, I am requesting:
1. How much the Trust has spent on CAM services for the following financial years:
a. 2019-20
b. 2020-21
c. 2021-22
This includes salaries for those employed to carry out these services, costs of medicine, equipment and any additional costs involved.
2. A list of all services provided under CAM.

Complementary and Alternative Medicine (CAM) services.101022.docx

Consultations. 240521

1. What percentage of consultations were carried out in April 2021 via:
a. Phone
b. Video
c. Face-to-face
2. Did you carry out any patient satisfaction survey on each of the channels in April 2021:
a. Phone
b. Video
c. Face-to-Face
3. Did you introduce digital services (either as new services or expanding into new departments) as a response to the pandemic?
Yes (highlight below):
a. Telephone consultations
b. Video consultations
c. Online appointment booking/management
d. E-prescription services
4. Who are your suppliers for:
a. Telephone consultations
b. Video consultations
c. Online appointment booking/management
d. E-prescription services
5. What are the most common barriers to technology use within your trust?
a. The service requires face-to-face interactions
b. The staff member is unable to use the technology
c. The patient is unable to use the technology
d. Lack of funding
e. Other (please explain)
6. Are you collecting patient feedback following interactions with the digital services you offer?
a. Yes – feedback obtained for all services
b. Feedback obtained for some services:
c. Telephone consultations
d. Video consultations
e. Online appointment booking/management
f. E-prescription services
g. No – we are not collecting this feedback
h. If no – do you plan to introduce this feedback data collection in the next six months? yes/no
i. If yes, how do you collect feedback?
7. Did you stop your FFT during the pandemic when the requirement to submit data was paused?
a. If yes, why?
b. If no, why?
8. Will you be deploying PIFU?
9. Will you be collecting feedback on PIFU?
10. Who is your FFT supplier?
11. If the FFT contract is outsourced, when was the contract initiated?
12. When does the FFT contract with your current supplier end?
13. What is the expected value of this contract (£)?

Download response Consultations. 240521

Coronary CT angiography scans. 270918

1) How many Coronary CT angiography scans were performed in the trust in the financial year 2011-12?
2) How many Coronary CT angiography scans were performed in the trust in the financial year 2012-13?
3) How many Coronary CT angiography scans were performed in the trust in the financial year 2013-14?
4) How many Coronary CT angiography scans were performed in the trust in the financial year 2014-15?
5) How many Coronary CT angiography scans were performed in the trust in the financial year 2015-16?

Download response Coronary CT angiography scans. 270918

CT and MRI machines.310124.docx

All questions are shown as received by the Trust.
I kindly request that you provide the number of CT and MRI machines, categorised based on ownership (owned or rented) for the years 2019, 2020, 2021, 2022, and 2023, along with details regarding the age of the owned machinery for the year 2023 only.

CT and MRI machines.310124.docx

CT and MRI machines.311022.docx

1) How many of each of the following machines do you have in use:
i) CT
ii) MRI
iii) X-ray
2) How many of each of the following machines are you using that are older than ten years old:
i) CT
ii) MRI
iii) X-ray
3) How old is your oldest in-use machine for each of:
i) CT
ii) MRI
iii) X-ray
4) How many of each of the following machines have you purchased in the past year:
i) CT
ii) MRI
iii) X-ray
5) How much did you spend repairing CT, MRI and X-ray machines in each of the past three years?

CT and MRI machines.311022.docx

CT, MRI and Ultrasound Scanners and X-Ray machines. 170921.docx

1) The number of CT scanners in your Trust, where relevant please provide a number for each hospital.
2) The number of MRI scanners in your Trust, where relevant please provide a number for each hospital.
3) The number of ultrasound scanners in your Trust, where relevant please provide a number for each hospital.
4) The number of x-ray machines in your Trust, where relevant please provide a number for each hospital.
5) For each of the items 1-4, please also provide the number of machines that are more than 10 years old and if available the year that the machine was purchased.

Download response CT, MRI and Ultrasound Scanners and X-Ray machines. 170921.docx

CT, MRI, Nuclear Medicine and Ultrasound clinical imaging equipment.130324.docx

Tab 1:
MES Contract
1. Supplier
2. Contract Start Date
3. Contract End Date
4. Initial Cost
5. Interest rates (%)
6. Consumables included?
7. Accessories included?
8. Maintenance included?
Tab 2:
Clinical Imaging Asset Details
1. Local Identifier
2. Modality
3. Equipment detail
4. Asset name
5. Manufacturer
6. Age
7. First in Service
8. Planned replacement date
9. Replacement schedule
10. Ownership structure
11. How is the ownership accounted for?
12. Capital purchase cost
13. Maintenance type (drop-down list)
14. Maintenance provider
15. Maintenance Service Contract Start Date
16. Maintenance Service Contract End Date
17. Maintenance Cost
Tab 3:
Clinical Imaging Accessories
1. Local Identifier
2. Modality
3. Equipment detail
4. Asset name
5. Manufacturer
6. Age
7. First in Service
8. Planned replacement date
9. Replacement schedule
10. Ownership structure
11. How is the ownership accounted for?
12. Capital purchase cost
13. Maintenance type (drop-down list)
14. Maintenance provider
15. Maintenance Service Contract Start Date
16. Maintenance Service Contract End Date
17. Maintenance Cost

CT, MRI, Nuclear Medicine and Ultrasound clinical imaging equipment.130324.docx

CTCL (cutaneous T cell lymphoma) treatment centres. 110322.docx

We are looking to produce a map of the CTCL (cutaneous T cell lymphoma) treatment centres in the UK.
To help with this, please could you provide the following:
1. Which centre/s in your NHS Trust offer treatment for CTCL, if any
2. The type of CTCL treatment these centres offer (TSEB or ECP)
3. A contact phone number for referrals for each centre

CTCL (cutaneous T cell lymphoma) treatment centres. 110322.docx

Cutaneous Squamous Cell Carcinoma. 270220

1. How many patients with cutaneous squamous cell carcinoma have you treated?
2. How many adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma have you treated?
3. Of these how many are not candidates for curative surgery or curative radiation?
4. In the past 3 months, how many adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation have you treated with the following;
Libtayo (cemiplimab)
Non curative surgery only
Non curative surgery + chemotherapy*
Non curative surgery + radiotherapy
Non curative surgery + chemotherapy* + radiotherapy
Chemotherapy* only
Chemotherapy* + radiotherapy
Non curative radiotherapy only
No treatment
Palliative Care / Best Supportive care
Other [please state]
*chemotherapy such as cisplatin, doxorubicin, 5-fluorouracil (5-FU), capecitabine, topotecan, or etoposide
5. Does your trust treat adult multiple myeloma [MM]? – if you refer your multiple myeloma patients to another centre, please state which.
6. If yes, then how many multiple myeloma patients, have been treated in the past 6 months with the following;
Bortezomib [Velcade]
Carfilzomib [Kyprolis]
Ixazomib [Ninlaro]
Lenalidomide [Revlimid]
Daratumumab [Darzalex]
Melphalan, prednisolone and thalidomide (known as MPT)
Cyclophosphamide, thalidomide and dexamethasone (known as CTD)
Pomalidomide [Imnovid]
7. Over the past 6 months [latest possible], how many chronic lymphocytic leukaemia (CLL) patients have you treated?
If possible how many CLL patients treated were new to therapy in the past 3 months?
8 How many chronic lymphocytic leukaemia patients, have been treated in the past 6 months with the following;
Fludarabine (Fludara), cyclophosphamide (Cytoxan), and rituximab (known as FCR)
Bendamustine and rituximab (known as BR)
Ibrutinib [Imbruvica]
Chlorambucil
Venetoclax
Obinutuzumab
Idelalisib
Fludarabine and rituximab (known as FR)
High-dose prednisone and rituximab
Pentostatin (Nipent), cyclophosphamide, and rituximab (known as PCR)
Alemtuzumab (Campath) with rituximab

Download response Cutaneous Squamous Cell Carcinoma. 270220

Cutaneous Squamous Cell Carcinoma. 271119

Question 1 – How many adult patients with Cutaneous Squamous Cell Carcinoma have you seen / treated (example Surgery, Radiotherapy, Chemotherapy or combinations of these) in the last 6 months?
Question 2 – How many adult patients with locally advanced (patients with Perineural invasion and local Lymphovascular or Bone involvement) or Metastatic Cutaneous Squamous Cell Carcinoma (patients with both local and distant Nodal involvement, as well as any other organ involvement) have you seen / treated (example Surgery, Radiotherapy, Chemotherapy or combinations of these) in the last 6 months?
Question 3 – Of these how many are not candidates for Curative surgery or Curative Radiation? *
Question 4 – In the past 6 months, how many adult patients with locally advanced or metastatic Cutaneous Squamous Cell Carcinoma have you treated with the following:
Question 5 – Are you participating in any clinical trials for Cutaneous Squamous Cell Carcinoma (CSCC)?
If yes, please state which?
*Example of factors to consider when deciding if locally advanced patients are suitable candidates for surgery: Disease recurrence after two or more surgical procedures and the treating clinicians expected that curative resection would be unlikely
CSCC in a anatomically challenging location where surgery would result in substantial complications or deformity or dysfunction significant local invasion that precludes complete resection
* Example of factors to consider when deciding if locally advanced patients are suitable candidates for radiation:
CSCC in a anatomically challenging location where radiation would be associated with unacceptable toxicity risk in context of the patients overall condition
Clinical judgement that tumour might not respond to RT
Factors / conditions contradicting for RT
Prior treatment with RT for CSCC, and further RT would exceed the threshold of acceptable cumulative does
** Chemotherapy such as Cisplatin, Doxorubicin, 5-Fluorouracil (5-FU), Capecitabine, Topotecan, Methotrexate or Etoposide

Download response Cutaneous Squamous Cell Carcinoma. 271119

Da vinchi surgical robots. 100419

1. The number of da Vinci surgical robots in use throughout your trust and the number of each model (e.g. Si, X, Xi, SP)
2. The number of yearly procedures carried out using da Vinci systems with a breakdown by procedure type for the last 5 years
3. A breakdown of the cost per procedure using da Vinci systems including instrumentation, servicing, disposable accessories, sterilisation costs, depreciation and other costs incurred
4. The upfront cost of da Vinci system instruments per surgery or on a per instrument basis
5. Historical number/rate of occurrence of incidences where cross infection has resulted from improper sterilisation and the number of associated adverse events
6. The rate of surgical site infections associated with procedures where a da Vinci system has been used.

Download response Da vinchi surgical robots. 100419

Dabrafenib + Trametinib.050722.docx

Please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.
A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer

Dabrafenib + Trametinib.050722.docx

Dabrafenib + Trametinib.110423.docx

A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer

Dabrafenib + Trametinib.110423.docx

Dental X-Ray equipment. 210519

Please can you answer the following questions regarding the Dental X-Ray equipment used within the Trust?
1. Please can you provide the following information for each piece of Dental X-Ray equipment within the Trust or associated sites? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Location – Hospital Name or Site Name
d. Department equipment is primarily used in
e. Method of Finance at Procurement (Trust/Lease/MES/Charity/PFI)
f. Initial cost of Equipment
g. Annual Maintenance cost
h. Acquisition Date
i. Planned Replacement Date

2. Please can you provide the following information for each Cone Beam CT Imaging equipment within the Trust or associated sites? (Please complete the attached spreadsheet)
a. Manufacturer
b. Model
c. Location – Hospital Name or Site Name
d. Department equipment is primarily used in
e. Method of Finance at Procurement (Trust/Lease/MES/Charity/PFI)
f. Initial cost of Equipment
g. Annual Maintenance cost
h. Acquisition Date
i. Planned Replacement Date

Download response Dental X-Ray equipment. 210519

Diagnoses of cancer. 020822.docx

Please could you provide the figures for diagnoses of cancer within your hospital from January 2010 to date.
Please could you present these figures in a yearly format.

Diagnoses of cancer. 020822.docx

Diagnostic data on an MRI technique for men with suspected prostate cancer.270318

1. Please tell us which Trust, Health Board or Health and Social Care Trust you are responding on behalf of?
2. What percentage of men receive mpMRI before biopsy as part of the initial diagnostic process using T2-weighted, diffusion-weighted (multi-b ADC and high/long b) and dynamic contrast enhanced (DCE) sequences?
3. What are your eligibility criteria/exclusion criteria for men to receive pre-biopsy mpMRI?
4. Are you using mpMRI before biopsy to rule some men out of biopsy as part of the initial diagnostic process?
5. What mpMRI scores and/or other clinical factors are used to rule men out of biopsy?
6. Do you intend to use mpMRI to rule men out of biopsy in the future?
7. How many men annually are referred?
8. If you are unable to provide numbers for question 6, please estimate the percentage of all men referred for b, c and d.
9. Do you carry out targeted biopsies in men with mpMRI lesions in addition to systematic biopsies?
(Please indicate with a X below)
If No, what are the reasons for not carrying this out? (e.g. expertise, equipment, don’t believe it makes a difference)
10. If you do not currently carry out targeted biopsies, but wish to in the future, what are the current barriers to doing so?
(Please indicate with a X below)
11. Please indicate the number of uroradiologists undertaking prostate MRI
12. How many scanners do you have available for mpMRI before biopsy?
Has this increased in the last 12 months?
13. What percentage of scanner time is dedicated to mpMRI before biopsy?

Download response Diagnostic data on an MRI technique for men with suspected prostate cancer.270318

Diagnostic equipment spend.251023.docx

All questions are shown as received by the Trust.
1. How much has your trust spent on new diagnostic equipment in each of the past three financial years, e.g. x ray machines, CT scanners, MRIs etc?
2. How much has your trust spent on maintaining and repairing old equipment in the past three financial years?
3. How many diagnostic machines did you purchase in the last financial year?

Diagnostic equipment spend.251023.docx

Diffuse Large B Cell Lymphoma (DLBCL).270722.docx

Q1. Does your trust treat patients with Diffuse Large B Cell Lymphoma (DLBCL)? If not, then which trust do you refer DLBCL patients to?
Q2. In the last 6 months, how many patients have you treated for Diffuse Large B Cell Lymphoma (DLBCL)?
Q3. In the last 6 months, how many patients have you treated for Diffuse Large B Cell Lymphoma (DLBCL) with the following treatments:
a. R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine and prednisolone)
b. R-mini-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine and prednisolone)
c. Other immuno-chemotherapy
d. Other chemotherapy
e. Stem cell transplant or bone marrow transplant (autologous or allogeneic)
f. Pola-BR (polatuzumab vedotin with rituximab and bendamustine) – any line of treatment
g. Pola-BR (polatuzumab vedotin with rituximab and bendamustine) – third-line treatment only
h. Tisagenlecleucel
i. Axicabtegene ciloleucel
j. Lisocabtagene maraleucel
Q4. In the last 6 months, how many Diffuse Large B Cell Lymphoma (DLBCL) patients have you referred to other trusts for:
a. Stem cell transplant or bone marrow transplant (autologous or allogeneic)
b. CAR-T therapy (Tisagenlecleucel, Axicabtegene ciloleucel, Lisocabtagene maraleucel)
Q5. Do you participate in any active clinical trials for Diffuse Large B-Cell Lymphoma (DLBCL)? If so, can you please provide the name of each trial along with the number of patients taking part?

Diffuse Large B Cell Lymphoma (DLBCL).270722.docx

DXA Facilities Audit.020323.docx

Infrastructure:
1) Do you outsource your DXA scans? If Yes- please state the organisation providing this service and forward this FOI to your provider for completion (please continue to complete for any of the elements of the DXA pathway that are provided by your Trust/board)
2) In January 2023 how many DXA scanning machines did you have at your trust/board for clinical use?
a. n. Operational
b. n. not in use
c. n. accessible outside of Trust
3) What is the average weekly capacity for clinical scans? (N. of scans per week)
4) What was your average DNA rate over the last 3 months? (n. DNA/total n. scans booked)
5) What age range do you include in your clinical scans? Please tick all that apply
a. <20 years b. 20-40 years c. 40-60 years d. 60-75 years e. 75-80 years f. >80 years
6) What is the duration of your routine DXA appointment:
a. 15 minutes or less
b. 16-25 minutes
c. 26-30 minutes
d. >30 minutes
7) What was the average wait for clinical patients from referral to scan in January 2023?
a. <2 weeks (move to Q9) b. 2-6 weeks (move to Q9) c. 6-13 weeks d. >13 weeks
8) What are your perceived barriers to delivering DXA scans within 6 weeks from referral? Please tick all that apply
a. Scanner capacity (DXA equipment)
b. Clinical capacity (operator)
c. Other- please state
9) What was the average time from the scan to the report being available to the referrer in January 2023?
a. <3 weeks (move to Q11) b. 4-6 week c. 6-13 weeks d. >13 weeks
10) What are your perceived barriers to referrers receiving DXA scan reports within 3 weeks from scan? Please tick all that apply
a. Clerical- internal
b. Clinical- internal
c. Factors external to this service (please state)
d. Other (please state)
11) What hospital department is responsible for delivery of DXA scans:
a. Radiology
b. Medical physics
c. Nuclear medicine
d. Rheumatology
e. Other- please state
12) Which DXA examinations are included in routine protocols for the clinical service? Please tick all that apply
a. Lumbar spine
b. Proximal femur
c. Long femur (AFF assessment)
d. Total body
e. Vertebral fracture assessment (VFA)
f. Peripheral/forearm
13) What access facilities do you have available? Please tick all that apply
a. Overhead hoist
b. Portable hoist
c. Wheelchair transfers
d. Bed/trolley transfers
e. Changing room
f. Assistance for transfers
g. Other- please state
Workforce:
1)
i) What professional groups perform DXA scan measurements at your centre? (DXA operators)
a. Radiographer
b. DXA technician
c. Assistant practitioner
d. Clinical scientist
e. Nurse
f. Medical Dr- please state specialism
g. Other- please state
h. Unknown]
ii) Please indicate WTE for each group selected
2) What DXA-specific training (outside of professional training) have the DXA operators performing scans had?
a. In house
b. Manufacturers applications training
c. Recognized/accredited national training programme (please state the name of the training programme/provider)
d. Other- please state
e. Unknown
3) What professional groups report your DXA scans at your centre? ()
a. Radiographer – internal
b. Radiographer – external
c. DXA technician – internal
d. DXA technician – external
e. Assistant practitioner – internal
f. Assistant practitioner – external
g. Clinical scientist – internal
h. Clinical scientist – external
i. Nurse -internal
j. Nurse – external
k. Medical Dr – internal – please state specialism(s)
l. Medical Dr – external – please state specialism(s)
m. Other- please state
n. Reporting is outsourced
o. Unknown
4) What training (outside of professional training) have those reporting DXA scans had- specifically in DXA reporting?
a. In house
b. Manufacturers applications training
c. Recognized/accredited national training programme (please state the name of the training programme/provider)
d. Other- please state
e. Unknown
5) What professional group provides clinical leadership for your service?
a. Radiographer
b. DXA technician
c. Assistant practitioner
d. Clinical scientist
e. Nurse
f. Medical Dr- please state specialism(s)
g. Other- please state
h. Unknown
6) Please indicate how many (WTE) clinical vacancies in your DXA service do you have in January 2023? (Free text)
Quality:
1) Is your service accredited as part of a national programme?
a. ISAS
b. IOS
c. Other- please state
d. None
e. Unknown
2) What clinical audits do you routinely undertake? Please tick all that apply
a. DXA scan technique
b. Reporting (double reporting)
c. Reporting (clinical review)
d. Scanner QA review
e. Other- please state
f. Unknown
3) What IR(ME)R audits do you routinely undertake? Please tick all that apply
a. Patient pregnancy
b. DXA dose audit
c. Referrer entitlement
d. Scan justification
e. Other- please state
f. Unknown
4) What clinical protocols do you have in place? Please tick all that apply
a. Scan site
b. Scan mode
c. Reference data selection
d. Patient positioning
e. Scan analysis
f. Interpretation- T&Z-scores
g. Reporting
h. Other- please state
i. Unknown
5) Which of the following are routinely included in the DXA report issued to the PRIMARY CARE referrer? Please tick all that apply
A. Admin. details
i. Date of assessment
ii. Patient ID and demographics
iii. Reason for referral
iv. Reporter’s ID
B. BMD results for each measurement site
i. T score (after peak bone mass)
ii. Z score
iii. Rate of change for serial measurements
C. Comment on reliability of measurements
i. BMD results
ii. Documentation of excluded measurements eg. vertebrae
iii. Statistical significance of rate of change
iv. Clinical significance of rate of change
D. WHO diagnostic category (for adults after peak bone mass)
E. Results of additional investigations performed at DXA appointment
i. VFA
ii. X-ray or other imaging
iii. Laboratory tests
F. Summary of clinical risk factors for fracture
G. Summary of fracture history
H. Clinical interpretation to quantify absolute fracture risk
i. FRAX+BMD
ii. FRAX + TBS
iii. FRAX+BMD plus comment on additional adjustment
iv. Statement on level of risk based on clinical judgement (eg. low/moderate/high)
I. Management advice
i. Reference to national guideline (NICE/NOGG/ROS)
ii. Reference to local management guideline
iii. Individualised advice
J. Recommendations on:
i. Need for onward referral eg. falls assessment or additional investigation
ii. Timing of future scan
6) Which of the following are routinely included in the DXA report issued to the SECONDARY CARE referrer? Please tick all that apply
A. Admin. details
i. Date of assessment
ii. Patient ID and demographics
iii. Reason for referral
iv. Reporter’s ID
B. BMD results for each measurement site
i. T score (after peak bone mass)
ii. Z score
iii. Rate of change for serial measurements
C. Comment on reliability of measurements
i. BMD results
ii. Documentation of excluded measurements eg. vertebrae
iii. Statistical significance of rate of change
iv. Clinical significance of rate of change
D. WHO diagnostic category (for adults after peak bone mass)
E. Results of additional investigations performed at DXA appointment
i. VFA
ii. X-ray or other imaging
iii. Laboratory tests
F. Summary of clinical risk factors for fracture
G. Summary of fracture history
H. Clinical interpretation to quantify absolute fracture risk
i. FRAX+BMD
ii. FRAX + TBS
iii. FRAX+BMD plus comment on additional adjustment
iv. Statement on level of risk based on clinical judgement (eg. low/moderate/high)
I. Management advice
i. Reference to national guideline
ii. Reference to local management guideline
iii. Individualised advice
J. Recommendations on:
i. Need for onward referral eg. falls assessment or additional investigation
ii. Timing of future scan
K. The secondary care report is the same as the primary care report

DXA Facilities Audit.020323.docx

Early Melanoma.020323.docx

Q1. I am researching the usage of Pembrolizumab for the treatment of Melanoma. How many patients have you treated with Pembrolizumab in the three months from October to December 2022 for:
a. Melanoma – any stage
b. Melanoma – Stage IIb/IIc
c. Melanoma – Stage III
d. Melanoma – Metastatic
Q2. How many Stage IIb/IIc melanoma patients were on a “Watch and Wait” strategy in the three months from October to December 2022? These would be patients where a decision has been made to wait before commencing any treatment.

Early Melanoma.020323.docx

Elastomeric Infusion Devices (E.I.D) 020320

Information request in respect to Elastomeric Infusion Devices

Please could you kindly advise which departments and healthcare professionals within your Trust use elastomeric infusion devices?

Information request in respect of Elastomeric Infusion Devices

1. Please could you also advise if you purchase E.I.D and if so:
a. What brand(s) do you purchase?
b. What quantities do you purchase on an annual basis?
c. Who are the main clinicians responsible within your Trust for the prescribing and administration of elastomeric devices?
d. What medicines do you fill the devices with?
e. Do you fill elastomeric devices in your pharmacy aseptic unit if you have one?
2. Please could you also advise if you purchase pre-filled elastomeric devices from a commercial compounder and if so:
a. What drugs are provided pre-filled?
b. What quantities do you purchase on an annual basis?

Download response Elastomeric Infusion Devices (E.I.D) 020320

Elective theatres and scans.300124.docx

All questions are shown as received by the Trust.
1. Which hospitals in your Trust open elective theatres at the weekend? (please list the name of the hospital followed by a Y/N as to whether elective theatres are open at the weekend)
2. How many of the following scans has your Trust carried out in the last year, broken down by daily activity?
a. CT Scans
b. MRI Scans
c. X Rays

Elective theatres and scans.300124.docx

EMB Biopsy 060317

Do any hospitals in the trust perform Endomyocardial Biopsy?
– Yes
– No
a) If so how many were performed in 2014-15 financial year?
b) How many were performed for investigation of Myocarditis?
2) How many patients in 2014-15 were diagnosed with Myocarditis in the trust?
3) Does the Trust refer patients to other centres or trusts for Endomyocardial Biopsy?
4) If so which centres or trusts do you refer to?
5) Does your trust receive referrals from other centres or trusts for Endomyocardial biopsy?

Download response EMB Biopsy 060317

Endometrial Cancer.020623.docx

1. Does your trust provide SACT (systemic anti-cancer therapy) treatments for endometrial cancer? If not, which other trust do you refer endometrial cancer patients to for SACT treatments?
2. How many patients were treated for endometrial cancer in the past 6 months with the following treatments:
a. Dostarlimab
b. Hormone therapy (Progesterone or Letrozole)
c. Pembrolizumab monotherapy
d. Pembrolizumab in combination with Lenvatinib
e. Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)
f. Any other SACT
3. How many endometrial cancer patients received the following therapies as 1st Line treatment in the past 6 months:
a. Hormone therapy (Progesterone or Letrozole)
b. Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide)
c. Any other SACT
4. Of the patients treated for endometrial cancer in the past 6 months with any SACT regimen, how many patients had high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR)?
5. Does your trust participate in any clinical trials for the treatment of endometrial cancer? If so, can you please provide the name of each trial and the number of patients taking part.

Endometrial Cancer.020623.docx

Ensuring MHRA Compliance.190422.docx

1. Please state what software/ systems the Trust utilises for managing medical equipment/ devices in order to be compliant with MHRA Guidance (see URL below) from the list below. If not listed, please specify:
a. EMAT
b. F2
c. RAM
d. e-Quip
e. Other – please specify
2. Please state the name and contact for the person responsible for ensuring compliance with the MHRA guidance quoted above.

Ensuring MHRA Compliance.190422.docx

Extravasation Incidents. 310118

Name of person completing request:
Hospital Trust/Health Board:
Telephone No:
E-mail Address:
1. Does your organisation provide a chemotherapy service – this may include inpatient, outpatient or a community service? 0 Yes 0 No
2. In the past financial year, how many doses of chemotherapy did you deliver? (April 2016 – March 2017)
3. In the past financial year, how many doses of anthracyclines did you administer? (April 2016 – March 2017)
4. In the past financial year, how many anthracycline extravasations have been reported due to chemotherapy? (April 2016 – March 2017)
5. In the past 3 financial years, how many patients have submitted a claim for medical negligence and/or damages against the Trust/Health Board due to an anthracycline extravasation injury?
6. In the past 3 financial years, how much compensation has the Trust/Health Board had to pay to those claimants who have suffered an anthracycline extravasation injury and have been successful in their medical negligence and/or damages case?
7. Does your Trust/Health Board have in place guidelines as to how to recognise and manage an extravasation injury? If not, is this available via your Cancer Alliance/Network or another source? If other, please state source ………………………………………………….
Trust/Health Board Guidelines 0 Yes 0 No If yes, when were they last updated?…………………………………………
8. Does your Trust/Health Board stock or have readily available any of the following extravasation treatments for chemotherapy?
a. Sodium Thiosulfate 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
b. Hyaluronidase 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
c. DMSO 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
d. Dexrazoxane (Savene) 0 Yes 0 No If yes, how often used in the past financial year? (April 2016 – March 2017)……………………
9. In the past 3 financial years, how many annual reconstruction operations have been carried out by the Trust/Health Board due to an extravasation injury?
10. Does your Trust/Health Board’s plastics and/or nursing team have the expertise/core competency to undertake the wash-out/flush-out technique if an extravasation occurs?
0 Yes 0 No
11. If you answered yes to question 10, in the past 3 financial years, how many wash-out/flush-out procedures have been carried out by the Trust/Health Board due to an extravasation incident?

Download response Extravasation Incidents. 310118

Flushing and locking of intravenous catheters.010722.docx

Could you please tell me, do you have such services as ‘Flushing and locking of intravenous catheters’ in your clinic?

Flushing and locking of intravenous catheters.010722.docx

Fundus and Optical Biometer. 220421

1. Fundus Camera
a. How many devices do you have and which model?
b. When were these devices installed?
c. When are these due to be replaced?
d. Is there a replacement budget allocated?
e. Do you have a service contract? When does it expire?
2. Optical Biometer
a. How many devices do you have and which model?
b. When were these devices installed?
c. When are these due to be replaced?
d. Is there a replacement budget allocated?
e. Do you have a service contract? When does it expire?
3. Capsular Tension Ring
a. Which Brand do you use?
b. How many did you use in 2019?

Download response Fundus and Optical Biometer. 220421

Gamma camera (Nuclear Medicine imaging system). 080422.docx

1 The manufacturer & model name of each gamma camera (Nuclear Medicine imaging system) installed in your Trust
2 The hospital name where each system is installed
3 The date that the current service/maintenance contract on each gamma camera started
4 The date that the current service/maintenance contract on each gamma camera expires

Gamma camera (Nuclear Medicine imaging system). 080422.docx

Gastric Oesophageal cancer and Ovarian cancer.161123.docx

Q1. How many patients were treated in the past 3 months for gastric and gastro-oesophageal junction cancer (any stage) with:
a. CAPOX (Capecitabine with Oxaliplatin)
b. FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin)
c. Lonsurf (Trifluridine – tipiracil)
d. Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine)
e. Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine)
f. Any other systemic anti-cancer therapy
g. Palliative care only
Q2. How many patients were treated in the past 3 months for Oesophageal cancer (any stage) with:
a. Nivolumab monotherapy or combination with Ipilimumab
b. Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidene (5-Fluorouracil or Capecitabine)
c. Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidene (5-Fluorouracil or Capecitabine)
d. Platinum and Fluoropyrimidene based combination treatments (Cisplatin or Oxaliplatin with 5-Fluorouracil or Capecitabine)
e. Any other systemic anti-cancer therapy
f. Palliative care only
Q3. How many patients were treated in the past 3 months for ovarian cancer (any stage) with:
a. Paclitaxel in combination with a platinum-based compound
b. Platinum-based therapy alone (cisplatin or carboplatin)
c. Bevacizumab in combination with paclitaxel and carboplatin
d. Olaparib
e. Olaparib + Bevacizumab
f. Niraparib
g. Rucaparib
Q4. If data for HRD (homologous recombination deficiency) testing is available, please provide how many HRD positive ovarian cancer patients were treated in the last 3 months with:
a. Olaparib
b. Olaparib + Bevacizumab
c. Niraparib
d. Other treatments
Q5. Does your trust participate in any clinical trials for the treatment of ovarian cancer? If so, please provide the name of each trial along with the number of patients taking part.

Gastric Oesophageal cancer and Ovarian cancer.161123.docx

General Anaesthetics. 180319

1. How many general anaesthetics were administered by your NHS Trust in 2018, 2017, 2016 and 2015?
2. How many patients died as a result of general anaesthesia in 2018, 2017, 2016 and 2015?
3. How many patients were given a general anaesthetic for the purpose of carrying out a diagnostic scan/test (MRI, CT etc.) in 2018, 2017, 2016 and 2015?
4. How many patients died as a result of being given a general anaesthetic for the purpose of carrying out a diagnostic scan/test (MRI, CT etc.) in 2018, 2017, 2016 and 2015?
5. How many patients were given a general anaesthetic for the purpose of carrying out an MRI scan in 2018, 2017, 2016 and 2015?
6. How many patients died as a result of being given a general anaesthetic for the purpose of carrying out an MRI scan in 2018, 2017, 2016 and 2015?
7. How many patients were given any other form of sedation for the purpose of carrying out a diagnostic scan/test (MRI, CT etc.) in 2018, 2017, 2016 and 2015?
8. How many patients were given any other form of sedation for the purpose of carrying out an MRI scan in 2018, 2017, 2016 and 2015?
9. How many diagnostic scans/tests (MRI, CT etc.) were aborted at your NHS Trust in 2018, 2017, 2016 and 2015 as a result of patients failing to attend the appointment or the process being stopped mid-way.
10. How many MRI scans were aborted at your NHS Trust in 2018, 2017, 2016 and 2015 as a result of patients failing to attend the appointment or the process being stopped mid-way.

Download response General Anaesthetics. 180319

Genesiscare. 270919

1. Please can you tell me if the Trust sends NHS Patients to GenesisCare for Cancer treatment?
2. Does the Trust send private patients to GenesisCare for cancer treatment?
3. How many Maidstone & Tunbridge Wells NHS Trust patients were treated by GenesisCare in 2018 and 2019? Please break the numbers down into NHS and private.
4. How long is the Trusts contract with GenesisCare?

Download response Genesiscare. 270919

Genetic Haemochromatosis. 190320

a. For the period 1st January 2018 to 31st December 2018 (or the most recent 12 month period available), the number of patients diagnosed with genetic haemochromatosis (GH) under your care.
b. For the period 1st January 2018 to 31st December 2018 (or the most recent 12 month period available), the average time in days from first referral from primary care to the patient’s first appointment within your trust.
c. A copy of the protocol and/or patient pathway applicable to the care of people with genetic haemochromatosis.
d. The date that your protocol/patient pathway for genetic haemochromatosis was last reviewed or revised.
e. A copy of your clinical protocol(s) for therapeutic venesection.
f. The date that your protocol(s) for therapeutic venesection were last reviewed or revised.

Download response Genetic Haemochromatosis. 190320

Gonadorelin (GnRH) Analogues.

1 Within your organisation, which healthcare professional (role) clinically recommends the LHRH that is prescribed?
2 Which healthcare professional (role) within your organisation usually administers the first injection?
3 Where is the first injection usually given (hospital or primary care)?
4 Which healthcare professional (role) within your organisation usually administers subsequent injections?
5 Where are subsequent injections usually given (hospital or primary care)?
6 For subsequent injections, does the patient still remain under the care of the hospital (e.g. attends hospital clinics although injections are given in primary care), and if so, for how long?
7 If injections are administered in primary care, what recommendation/advice comes from the hospital?

Download response Gonadorelin (GnRH) Analogues 300316

Haematology.281222.docx

I am researching the use of certain types of drugs used in haematology. Could you please provide the number of patients treated (for any disease in the past 3 months with:
1. Aragam
2. Berinert
3. Cinryze
4. Cutaquig
5. Cuvitru
6. Firazyr
7. Flebogamma DIF
8. Gammagard
9. Gammanorm
10. Gammaplex
11. Gamunex
12. Hizentra
13. Hyqvia
14. Intratect
15. Iqymune
16. Kiovig
17. Octagam
18. Orladeyo
19. Panzyga
20. Privigen
21. Ruconest
22. Subgam
23. Takhzyro

Haematology.281222.docx

Haemonetics. 311019

1. Please can you tell me how many of the following two devices – MCS+ 9000 Mobile Platelet Collection System and/or MCS+ 8150 Multicomponent Collection System both from a company called Haemonetics – the trust has used over the last 10 years and how many of these devices are currently in operation.

2. Please provide a figure for each device and each year over the last 10 years. If possible, please also state how many patients have had this device used on them.

Download response Haemonetics. 311019

Haemonetics plasma device. 220120

Please can you tell me how many deaths have been reviewed by the trust or reported to a coroner in the past 10 calendar years where the hospital used a Haemonetics plasma device (any model number) on the patient before they died.

Where the death was investigated please can you send me the report (redacted to remove personal details if necessary) and include the age, gender and diagnosis of the patient. If the death was reported to the coroner please include a copy of their report.

Download response Haemonetics plasma device. 220120

Head and neck and urothelial cancer.030822.docx

1. How many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents:
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. For the patients treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the therapies listed in the first question, please provide:
a. Total number of head and neck cancer patients
b. Number of locally advanced head and neck cancer patients
c. Number of unresectable recurrent and/or metastatic head and neck cancer patients
3. How many Urothelial cancer patients have been treated in the past 3 months with the following agents:
a. Avelumab
b. Atezolizumab
c. Carboplatin with Gemcitabine
d. Carboplatin single or in any other combination
e. Cisplatin with Gemcitabine
f. Cisplatin single or in any other combination
g. Nivolumab
h. Pembrolizumab
i. Any other regimen including Paclitaxel
j. Any other chemotherapy regimen
k. Other active systemic anti-cancer therapy [please state]
l. Palliative care only
4. Does your trust participate in any ongoing clinical trials for the treatment of head and neck cancer? If so, can you please provide the name of each trial along with the number of patients taking part?

Head and neck and urothelial cancer.030822.docx

Head and Neck Cancer

Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
April to September 2015 – 26 patients
Of these how many are treated with the following therapies;
Carboplatin
Cetuximab
Cisplatin
Docetaxel
5-Fluorouracil (5FU)
Radiotherapy Only
Please see the table below:
If your health trust has a protocol or pathway for the treatment of head and neck cancer patients [including referral pathway to other trusts], please could you provide details?
Please see the attached document.
Within your health trust how many patients are currently [within the past 6 months] being treated for Colorectal Cancer?
April to September 2015 – 136 patients
Of these how many are treated with the following therapies;
Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)

Download response letter Head and Neck Cancer 201115

Head and Neck Cancer (Squamous cell carcinoma).

1. Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
A. Locally advanced
B. Recurrent and/or metastatic
Of the these patients please split by their current drug treatment;
Carboplatin (Only or in combination with 5-FU)
Cetuximab (Erbitux) and chemotherapy or radiotherapy
Cetuximab (Erbitux) Only
Cisplatin (Only or in combination with 5-FU)
Docetaxel (Taxotere), (Only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy Only
Other – Specify
3. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so please could you provide details?
4. Within your health trust how many patients are currently [within the past 6 months] being treated for metastatic Colorectal Cancer?
Of those patients please split by their current drug treatment;

Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)
Other – Specify

Download response Head and Neck Cancer (Squamous cell carcinoma) 270616

Head and Neck Cancer (Squamous Cell Carcinoma). 081116

1. Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
A. Locally advanced
B. Recurrent and/or metastatic
Of these patients please split by their current drug treatment;
Carboplatin (Only or in combination with 5-FU)
Cetuximab (Erbitux) and chemotherapy or radiotherapy
Cetuximab (Erbitux) Only
Cisplatin (Only or in combination with 5-FU)
Docetaxel (Taxotere), (Only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy Only
Other – Specify
2. Within your health trust how many patients are currently [within the past 6 months] being treated for metastatic Colorectal Cancer?
Of those patients please split by their current drug treatment;
Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)
Other – Specify

Download response Head and Neck Cancer (Squamous Cell Carcinoma). 081116

Head and neck cancer (squamous cell carcinoma). 301120

1. Within your health trust, how many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma)? Of these patients, how many are locally advanced, recurrent and/or metastatic?
a. Total squamous cell carcinoma
b. Locally advanced
c. Recurrent and/or metastatic
2. For the metastatic head and neck cancer patients treated in the past 3 months, could you specify (if possible) how many received first-line treatment versus second-line treatment?
3. Within your health trust, how many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents?
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
4. Within your health trust, how many patients have been treated in the past 3 months with the following agents for renal cell carcinoma:
a. Sunitinib
b. Avelumab + Axitinib
c. Axinitib
d. Cabozantinib
e. Everolimus
f. Lenvantinib + Everolimus
g. Nivolumab
h. Nivolumab + Ipilimumab
i. Pazopanib
j. Pembrolizumab + Axitinib
k. Sunitinib
l. Temsirolimus
m. Tivozanib
n. Other
5. Does your trust participate in any ongoing clinical trials for the treatment of head and neck cancer? If so, can you please provide the name of each trial along with the number of patients taking part?
6. Does your trust participate in any ongoing clinical trials for the treatment of renal cell carcinoma? If so, can you please provide the name of each trial along with the number of patients taking part?

Download response Head and neck cancer (squamous cell carcinoma). 301120

Head and Neck cancer (squamous cell carcinoma) and Urothelial cancer. 140422.docx

1. How many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents:
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. For the patients treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the therapies listed in the first question, please provide:
a. Total number of head and neck cancer patients
b. Number of locally advanced head and neck cancer patients
c. Number of recurrent and/or metastatic head and neck cancer patients
3. How many Urothelial cancer patients have been treated in the past 3 months with the following agents:
a. Atezolizumab
b. Carboplatin with Gemcitabine
c. Carboplatin single or in any other combination
d. Cisplatin with Gemcitabine
e. Cisplatin single or in any other combination
f. Nivolumab
g. Pembrolizumab
h. Any other regimen including Paclitaxel
i. Any other chemotherapy regimen
j. Other active systemic anti-cancer therapy [please state]
k. Palliative care only
4. Does your trust participate in any ongoing clinical trials for the treatment of urothelial cancer? If so, can you please provide the name of each trial along with the number of patients taking part?

Head and Neck cancer (squamous cell carcinoma) and Urothelial cancer. 140422.docx

Head & neck and urothelial cancer.281122.docx

1. How many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents:
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. For the patients treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the therapies listed in the first question, please provide:
a. Total number of head and neck cancer patients
b. Number of locally advanced head and neck cancer patients
c. Number of unresectable recurrent and/or metastatic head and neck cancer patients
3. How many Urothelial cancer patients have been treated in the past 3 months with the following agents:
a. Avelumab
b. Atezolizumab
c. Carboplatin with Gemcitabine
d. Carboplatin single or in any other combination
e. Cisplatin with Gemcitabine
f. Cisplatin single or in any other combination
g. Nivolumab
h. Pembrolizumab
i. Any other regimen including Paclitaxel
j. Any other chemotherapy regimen
k. Other active systemic anti-cancer therapy [please state]
l. Palliative care only
4. Does your trust participate in any ongoing clinical trials for the treatment of head and neck cancer? If so, can you please provide the name of each trial along with the number of patients taking part?
5. Does your trust participate in any ongoing clinical trials for the treatment of urothelial cancer? If so, can you please provide the name of each trial along with the number of patients taking part?

Head & neck and urothelial cancer.281122.docx

Head & Neck Cancer (H&N), Renal Cancer (RCC) and Colorectal Cancer (CRC). 050321

We are researching the incidence and treatment of Head & Neck Cancer (H&N), Renal Cancer (RCC) and Colorectal Cancer (CRC). Could you please answer the following questions for patients treated by your trust?
1. Within your health trust, how many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following agents?
a. Carboplatin (monotherapy or in combination with 5-FU)
b. Cisplatin (monotherapy or in combination with 5-FU)
c. Cetuximab with/without chemotherapy
d. Cetuximab with radiotherapy
e. Pembrolizumab monotherapy
f. Pembrolizumab with chemotherapy
g. Nivolumab
h. Docetaxel (monotherapy or in combination with 5-FU)
i. Fluorouracil (5FU)
j. Radiotherapy only
k. Other
2. Within your health trust, how many patients have been treated in the past 3 months with the following agents for renal cell carcinoma :
a. Sunitinib
b. Avelumab + Axitinib
c. Axinitib
d. Cabozantinib
e. Everolimus
f. Lenvantinib + Everolimus
g. Nivolumab
h. Nivolumab + Ipilimumab
i. Pazopanib
j. Pembrolizumab + Axitinib
k. Sunitinib
l. Temsirolimus
m. Tivozanib
n. Other
3. Within your health trust, how many patients have been treated in the past 3 months with the following agents for colorectal cancer [CRC]?
a. Aflibercept
b. Bevacizumab
c. Cetuximab monotherapy
d. Cetuximab in combination with FOLFOX or FOLFIRI
e. Panitumumab monotherapy
f. Panitumumab in combination with FOLFOX or FOLFIRI
g. Nivolumab
h. Ramucirumab
i. Regorafenib
j. Sorafenib

Download response Head & Neck Cancer (H&N), Renal Cancer (RCC) and Colorectal Cancer (CRC). 050321

Head and Neck Cancer (Squamous cell carcinoma). 260418

1. Within your health trust how many patients are currently [within the past 6 months available] being treated for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
a. Locally advanced
b. Recurrent metastatic
3. Of the locally advanced/ recurrent or metastatic head and neck cancer patients how many are currently [within the past 6 months available]
Carboplatin (only or in combination with 5-FU)
Cisplatin (only or in combination with 5-FU)
Cetuximab (Erbitux) with/without chemotherapy
Cetuximab (Erbitux) with radiotherapy
Docetaxel (Taxotere) -only or in combination with 5-FU
Fluorouracil (5FU)
Radiotherapy only
Other
4. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so how many patients are currently taking part in clinical trials?
5. Within your health trust how many patients are currently [within the past 6 months available] being drug treated for metastatic colorectal cancer?
Of those patients please split by their drug treatment;
Cetuximab (Erbitux) with/without chemotherapy
Panitumumab (Vectibix) with/without chemotherapy
Nivolumab (Opdivo) with/without chemotherapy
Chemotherapy + other mAb
Chemotherapy alone
Other
6. Does your health trust participate in any ongoing clinical trials for the treatment of colorectal cancer patients, if so how many patients are currently taking part in clinical trials?
Download response Head and Neck Cancer (Squamous cell carcinoma). 260418

 

Car parking

Car Parking Charges

How much money did the trust raise from car parking charges in each of the last four years (state the amount and the years for which figures are available)?
Do you charge for disabled parking? If so, how much of the total amount raised by the trust from car parking charges came from disabled parking?
Do you employ a private firm to run the car park for you? If so, how much of the money generated by parking fees is taken by the private firm?
Please provide a breakdown of your car park charges – per hour/per day/per week.
Do you provide concessions for long-term visitors? What are these?

Download response Car Parking Charges 181115

Hospital Parking Charges

How much money was generated by your hospital trust through parking charges in the hospital car parks during 2013-14 and 2014-15?
How many parking fines were issued for parking infringements in your car parks during 2013-14 and 2014-15?
How many parking fines were written off during 2013-14 and 2014-15?

Download response Hospital Parking Charges 200515

Abandoned motor vehicles

1) How many instances of abandoned motor vehicles were recorded between 2004-15? If the data doesn’t stretch back to 2004, please use the earliest you have.

2) If a 3rd party was called to recover, what was the average cost involved?

Download response Abandoned motor vehicles 181215

Cancer care or treatment 2015-2016. 020317

1. In the years 2015 & 2016 of the patients that became resident for Cancer care/treatment with inside a hospital managed by your trust, please list the annual total for the patients as described?

2. Further to the above please also provide the annual total for those patients’ families who received a pass entitling free parking during the patients stay to reduce the financial burden on the family visiting?

Download response Cancer care or treatment 2015-2016. 020317

Car park management 070317

1. Please could you confirm when your contract for Car Park Management will expire and also when the contract will be re-tendered?

2. Do you currently manage your own car parks or use a Car Park Management company?

3. Which Portal does the trust use when they tender the Car Park Management out?

Download response Car park management 070317

Car park management contract.140923.docx

1. What are the contractual performance KPI’s for this contract?
2. Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages
3. Actual spend on this contract/framework (and any sub lots), from the start of the contract to the current date
4. Start date & duration of framework/contract?
5. Could you please provide a copy of the service/product specification given to all bidders for when this contract was last advertised?
6. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
7. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
8. Who is the senior officer (outside of procurement) responsible for this contract?

Car park management contract.140923.docx

Car parking

1. Please state what the income was to the Trust from parking income in patient car parks in (i) the (14/15) financial year and (ii) the (15/16) financial year?
2. What is the highest hourly rate for parking charged to patients in any of your car parks?

Download response Car parking 090916

Car parking 071116

1. How much revenue did the Trust receive from car parking fees between 1st October 2015 and 1st October 2016?
2. What are the Trusts rates per hour and per day (can you indicate if this varies between hospitals in the Trust)? Is there any way to get a reduction in this rate?
3. Has the Trust increased the parking charge in the last two years and if so by how much?
4. If the Trust car parks are run by an outside firm and can you please say who that is?

Download response letter Car parking 071116

Car parking 071116

1. How much revenue did the Trust receive from car parking fees between 1st October 2015 and 1st October 2016?
2. What are the Trusts rates per hour and per day (can you indicate if this varies between hospitals in the Trust)? Is there any way to get a reduction in this rate?
3. Has the Trust increased the parking charge in the last two years and if so by how much?
4. If the Trust car parks are run by an outside firm and can you please say who that is?

Download response Car parking 071116

Car parking. 091220

1. Do you currently manage your car parking in-house or do you contract to a third party?
2. If you do employ a parking operator to manage your parking services, who is your current parking provider?
3. What is the exact date your current contract/s terminate?
4. Does the Trust receive the income generated from the hospital parking and notice charges or does the income go to a third party?
5. Please confirm the revenue amount generated from the third-party provider if there is one
6. What are the key challenges that the Trust face with regards to the parking provision?
7. Can you confirm the expenditure on maintenance for the car park equipment for 2019/2020?
8. Overall what was the profit generated by the trust after the cost of maintaining and staffing the car park for 2019/2020?

Download response Car parking. 091220

Car parking.110324.docx

Based on your latest available data,
1. How many fines have been handed out to members of staff at your Trust over the past five years for issues related to car parking? This could include parking in the wrong area, not having a permit etc.
2. How many staff does your Trust currently have
3. How many of these currently have a car parking permit?
4. How many are on the waiting list to receive a permit?
If possible, please provide data broken down by year by calendar year. Spreadsheet format preferred if possible.

Car parking.110324.docx

Car parking.140224.docx

All questions are shown as received by the Trust.
1. a list of all of the measurements you record to understand parking demand and availability
2. the data for those measurements for the past 5 years.
3. a copy of the any plans you have in respect of parking improvement

Car parking.140224.docx

Car parking. 190717

1. Hourly Car Parking Charges
2. Daily Car Parking Charges
3. Weekly Car Parking Charges
4. Car Parking Charges for Blue Badge Holders
5. Car Parking Charges for Staff

Download response Car parking. 190717

Car parking 2015-2016 221216

1. Are your carparks managed by a private contractor? If yes, please provide the name of the contractor.
2. How many parking enforcement tickets were issued in your carparks between 1st April 2015 and 31st March 2016?
3. What is the cost of a parking enforcement fine in your carparks?
4. How many parking enforcement ticket appeals did you receive between 1st April 2015 and 31st March 2016?
5. How many parking enforcement ticket appeals were successful between 1st April 2015 and 31st March 2016?

Download response Car parking 2015-2016 221216

Car parking. 210318

1. The income earned from hospital car parking charges for the financial years:
1. 2014-2015
2. 2015-2016
3. 2016-2017
2. The money spent on maintenance for car parking facilities in the financial years:
1. 2014-2015
2. 2015-2016
3. 2016-2017
3. Where the income earned from hospital car parking facilities was spent in the financial years:
1. 2014-2015
2. 2015-2016
3. 2016-2017

Download response Car parking. 210318

Car parking. 240119

Subject to the Freedom of Information Act, I would like to request the following information in the relation to the Trust and associated hospitals.
1. Do you currently manage your car parking in-house or do you contract to a third party?
2. If you do employ a parking operator to manage your parking services, who is your current parking provider?
3. What is the exact date/s your current contract/s terminate?
4. What date do you expect to go to tender?

Download response Car parking. 240119

Car parking at the Trust sites 261015

Under the Freedom of Information Act 2000, I am seeking the following pieces of information in relation to parking at the hospitals covered under your trust.
1. The parking ticket costs at the hospitals under your trust.
2. How much does your trust – or a third party contracted by the trust – charge in fines and/or penalty notices if people are deemed to have breached parking rules?
3. What is the revenue from visitors paying for parking tickets? I would like this broken down for each hospital. I would like this information annually for 2012-2013, 2013-2014, and 2014-2015.
4. What is the revenue received from the payment of fines and/or penalty notices? I would like this broken down for each hospital. I would like this information annually for 2012-2013, 2013-2014, and 2014-2015.

Car parking at the Trust sites 261015

Car parking charges. 011118

1. Do hospitals in your area charge patients/visitors to park in their own car park?
2. If so, how much do they charge?
3. Do the hospitals operate their car park under a PFI contract?

Download response Car parking charges. 011118

Car parking charges 041116

How much money did the trust raise from car parking charges in each of the last four financial years (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient parking if possible.

How much money was raised from parking fines in each of the last four financial years (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient fines if possible.

Do you charge for disabled parking?

Do you employ a private firm to run the car park for you? If so, how much of the money generated by parking fees is taken by the private firm?

Download response Car parking charges 041116

Car parking charges. 111217

1. How much money did the trust raise from car parking charges in each of the last four financial years – up to and including 2016/17 (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient parking if possible.

2. How much money was raised from parking fines in each of the last four financial years (state the amount and the years for which figures are available)? Include a breakdown of staff and visitor/patient fines if possible.

3. Do you charge for disabled parking?

4. Do you employ a private firm to run the car park for you? If so, how much of the money generated by parking fees is taken by the private firm?

Download response Car parking charges. 111217

Car parking charges. 160519

1. How much money did the trust raise from car parking charges in each of the last two financial years – 2017/18 and 2018/19? Include a breakdown of staff and visitor/patient parking if possible.
2. How much money was raised from parking fines in each of the last two financial years – 2017/18 and 2018/19? Include a breakdown of staff and visitor/patient fines if possible.
3. Have you increased the cost of parking in your car parks during the last financial year – between 2017/18 and 2018/19? Please give a breakdown of how much parking has increased by.
4. Do you charge for disabled parking?
5. Is your car park managed by a private firm? If so, what proportion of revenue created by a) parking income and b) parking fines does the firm take?

Download response Car parking charges. 160519

Car parking charges. 181019

1. How much money did the trust raise from car parking charges in each of the last two financial years – 2017/18 and 2018/19? Include a breakdown of staff and visitor/patient parking if possible.
2. How much money was raised from parking fines in each of the last two financial years – 2017/18 and 2018/19? Include a breakdown of staff and visitor/patient fines if possible.
3. Have you increased the cost of parking in your car parks during the last financial year – between 2017/18 and 2018/19? Please give a breakdown of how much parking has increased by.
4. Do you charge for disabled parking?
5. Is your car park managed by a private firm? If so, what proportion of revenue created by a) parking income and b) parking fines does the firm take?

Download response Car parking charges. 181019

Car parking charges 2015/2016 to date.

1. How much money has the trust raised from car parking charges so far this year?
2. How many parking fines were issued for parking infringements in your car parks so far this year?
3. How many parking fines were written off so far this year?

Download response Car parking charges 2015/2016 to date 100516

Car parking charges 2016. 140317

1. Name of your organisation
2. Does your Trust use a private contractor to oversee the car park?
Yes (if yes please provide name of contractor)
No
Parking Charges
3. Parking charges made to general public (patients, visitors, etc.)
4. Parking charges made to staff
5. Agreed exemptions from charges
6. How income from charges is used
Parking Fines (fines issued from 1 January 2016 to date)
7. Number of fines issued to the general public
8. Income from those fines
9. Number of fines issued to staff
Income from those fines
10. How income from fines is used
11. Does the policy for fining staff differ from the fines policy for the general public?
Yes (if yes, please advise how the policy differs) No
12. Please provide details of any policy or agreements covering car parking charges (e.g. collective agreement with NHS Trade Unions)

Download response Car parking charges 2016. 140317

Car parking charges. 280918

1. How much money did the trust raise from car parking charges in each of the last two financial years – 2016/17 and 2017/18? Include a breakdown of staff and visitor/patient parking if possible.

2. How much money was raised from parking fines in each of the last two financial years – 2016/17 and 2017/18? Include a breakdown of staff and visitor/patient fines if possible.

3. Have you increased the cost of parking in your car parks during the last financial year – between 2016/17 and 2017/18? Please give a breakdown of how much parking has increased by.

4. Do you charge for disabled parking?

Download response Car parking charges. 280918

Car parking charges and fines. 070618

1) How much revenue was made by Maidstone and Tunbridge Wells NHS Trust on all car parking charges and fines in 2015, 2016 and 2017. Please break this down by charges and fines.

2) How much profit was made by Maidstone and Tunbridge Wells NHS Trust on all car parking charges and fines in 2015, 2016 and 2017. Please break this down by charges and fines.

Download response Car parking charges and fines. 070618

Car parking contract. 051021.docx

Can you please confirm if you planning to extend the current contract with APCOA or extend, if so could you please confirm for how long?

Download response Car parking contract. 051021.docx

Car parking contractor

Could you please advise me if you manage the Car Parking facilities on your own or do you employ a contractor to manage the facilities for you? I.e. ANPR, POF’s and PCN’s etc.  If you use a contractor can you please advise me who they are and when their existing contract with yourselves expire?

Download response Car parking contractor 080515

Car parking facilities.180123.docx

1. Could you please advise me if you manage the car parking facilities on your own, or do you employ a private operator/contractor to manage the facilities for you i.e., ANPR, POFs and PCNs etc?
2. If you use a private operator/contractor, can you please advise me who they are and when their existing contract with yourselves expires?

Car parking facilities.180123.docx

Car parking income. 290620

1. How much money was generated by your hospital trust through parking charges in the hospital car parks during 2019-20?
2. How many parking fines were issued for parking infringements in your car parks during the year stated above?
3. How many parking fines were written off during the year stated above?

Download response Car parking income. 290620

Car Parking Management Services and Security Services Management. 150421

Car Parking Management Services and Security Services Management for Maidstone & Tunbridge Wells NHS Trust:
https://procontract.due-north.com/Advert?advertId=db2f64cd-fa28-e711-80df-005056b64545

The details we require are:

1. Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages
2. Actual spend on this contract/framework (and any sub lots), from the start of the contract to the current date
3. Start date & duration of framework
4. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
5. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
6. Who is the senior officer (outside of procurement) responsible for this contract?

Download response Car Parking Management Services and Security Services Management. 150421

Car parking revenue. 241017

How much revenue the hospital trust made through the charging of hospital car parking in 2016?

Download response Car parking revenue. 241017

Cost and revenue of car parking 2010 – 2016

1. The total amount of revenue generated by in each of the last 5 years by car parking.
2. What was the cost for an hour of car parking in 2010 and 2016?

Download response Cost and revenue of car parking 2010 – 2016 060916

Disabled parking for staff. 030719

1. How many staff members at the trust are declared disabled?
2. How many staff members with a disability use the staff car park?
3. Do the trust charge disabled staff for parking?
4. If yes in Q3 is this charge at a discounted rate compared to a non-disabled staff member?
5. How much is staff car parking for disabled staff and non-disabled staff?

Download response Disabled parking for staff. 030719

Disclosure and Barring checks and staff parking. 221116

1) How many nurses and midwives (from Band 5 upwards) waiting to take up employment with your trust are awaiting completion of Disclosure and Barring Service (DBS) checks?
2) How long is the average wait for DBS approval for new starters at your organisation?
3) How many parking spaces at your hospitals are exclusively for staff use and how much do they pay to use them?
4) What is your FTE nursing and midwifery staff establishment (from Band 5 upwards)?

Download response Disclosure and Barring checks and staff parking. 221116

Electric Vehicle charging points.

1) Does your organisation already offer charging facilities (Electric Vehicle Charging Points EVCP) for electric vehicles and if so, how many charge points?
2) If there is currently no charging provision, what plans do you have to install EVCP and when?
3) Will the charge points be for fleet usage or public charging?
4) Within your organisation, which department is responsible for the selection and installation of EVCP?

Download response Electric Vehicle charging points 060916

Free NHS Staff Parking.220722.docx

1. Do you provide free parking for NHS staff and/or patients?
2. If not, how much do you charge staff to park?
3. how long does it take for staff to be issued a permit when joining your trust?

Free NHS Staff Parking.220722.docx

 

Children's Services

6-in-1 vaccine. 170718

a) The number of 6-in-1 vaccines offered to be given to babies in the financial years 2017/18, 2016/17, and 2015/16.

b)The number of 6-in-1 vaccines that were refused by parents or guardians of the baby in the financial year 2017/18, 2016/17, and 2015/16.

c) The number of children diagnosed with any of the following in 2017/18 alone, who had not received the 6-in-1 vaccine when they were a baby because their parent or guardian had refused it. If a child was diagnosed with more than one of the below, please provide that information: diphtheria, hepatitis B, Hib, polio, tetanus, or whooping cough

Download response 6-in-1 vaccine. 170718

Acute Trust CYP Healthcare. 050821.docx

For every month from 1 January 2019 to 31 May 2021, please answer the following questions:
1 In that month, how many children and young people (CYP) aged 18 and under did you refer to CAMH services after they arrived in your emergency department(s)?
2 In that months, of these CYP in question one, how many were referred to CAMH services for treatment of a suspected or confirmed eating disorder? If helpful, please search against the ICD Code F50.0, which may be included in the referral.
3 In that month, how many CYP were admitted to or treated by your acute hospital trust for the following:
3 a Treatment of an eating disorder, such as refeeding and medical stabilisation? If helpful, please search against the ICD Code F.50, which should cover all relevant eating disorder diagnoses.
3 b Treatment of self-inflicted injury? If helpful, please search against ICD Codes X60 to X69.
3 c Treatment of drug or other toxic substance overdose, whether accidental or intentional? If helpful, please search against ICD Codes X70 to X84.
4 In this month, how many CYP were admitted to your acute trust for compulsory treatment with use of the Mental Health Act?
5 In this month, of those CYP admitted to your acute trust for compulsory treatment with use of the Mental Health Act, how many had an eating disorder diagnosis (ICD Code in the F50 category)?

Download response Acute Trust CYP Healthcare. 050821.docx

A&E and Outpatient Paediatric attendances. 250419

1- Number of paediatric patient attended A/E in 2018, Tunbridge wells hospital
2- Number of patient attended paediatric OPD (outpatient department) in 2018, Tunbridge wells hospital

Download response A&E and Outpatient Paediatric attendances. 250419

Ankylossia (tongue-tie). 270918

1. How many babies (i.e.) below the age of 1) were diagnosed with issues of Ankylossia (tongue-tie) in each financial year since 2013/14.
2. Of the babies diagnosed with issues of Ankylossia (tongue-tie) in 2017 how many had a surgical procedure carried out by NHS surgeons to resolve these specific issues, and how long did they wait (on average, in calendar days) for the procedure following diagnosis?
3. In 2017, what was the mean age of babies with such issues when the Ankylossia (tongue-tie) procedure was performed?

Download response Ankylossia (tongue-tie). 270918

Anorexia and bulimia in under 14 year olds.

The number of children under the age of 14 your trust has treated for anorexia and bulimia from 1 January 2010 up until the date this request was received.
Please provide the information in yearly breakdowns;
Please break the numbers down by age and, if possible, by gender;
Please keep the data for anorexia and bulimia separate;

Download response Anorexia and bulimia in under 14 year olds 060916

Ante natal screening or diagnostic results for Down syndrome. 100519

Please send me an example of all of the following that are in use:
a) Letter/email reporting low chance combined or quadruple screen results
b) Letter/email reporting high chance combined or quadruple screen results
c) Letter/email reporting low chance NIPT results
d) Letter/email reporting high chance NIPT results
e) Letter/email reporting ‘no result’ NIPT results
f) Letter/email reporting negative QF-PCR/FISH CVS results
g) Letter/email reporting positive QF-PCR/FISH CVS results
h) Letter/email reporting negative full karyotype CVS results
i) Letter/email reporting positive full karyotype CVS results
j) Letter/email reporting negative amniocentesis result
k) Letter/email reporting positive amniocentesis result

Download response Ante natal screening or diagnostic results for Down syndrome. 100519

ASD waiting times.230522.docx

QUESTION 1
A. How many children are currently waiting to receive a first assessment appointment?
B. What is the average wait time for these children, starting from the point of initial referral?
C. How many of these children have been waiting longer than 13 weeks?
D. What are the longest three wait times for these children?
QUESTION 2
A. How many children are currently waiting to receive a second assessment appointment?
B. What is the average wait time for these children to receive a second appointment, since their first appointment?
C. What are the longest three wait times for these children, since their first appointment?
QUESTION 3
A. How many children are currently waiting to receive a diagnosis (ie. waiting for an assessment outcome to find out whether they do or do not have ASD)?
B. What is the average wait time, since the point of initial referral?
C. What are the longest three wait times for these children, since their initial referral?
QUESTION 4
A. In the year up to 31 March 2022, how many children with suspected autism received a first assessment appointment?
B. What was the average wait time for these children to receive a first assessment appointment, since their initial referral?
C. What were the longest three wait times for these children to receive a first diagnostic appointment, since their initial referral??
QUESTION 5
A. In the year up to 31 March 2022, how many children with suspected autism received a second assessment appointment?
B. What was the average wait time for these children to receive a second diagnostic appointment, since their first appointment?
C. What were the longest three wait times for these children to receive a second assessment appointment, since their first appointment?
QUESTION 6
A. In the year up to 31 March 2022, how many children with suspected autism received an ASD diagnosis?
B. What was the average wait time for these children to receive an ASD diagnosis, since their initial referral?
C. What were the longest three wait times for these children to receive an ASD diagnosis, since their initial referral?
QUESTION 7
A. In the year up to 31 March 2021, how many children with suspected autism received a first assessment appointment?
B. What was the average wait time for these children to receive a first assessment appointment, since their initial referral?
QUESTION 8
A. In the year up to 31 March 2021, how many children with suspected autism received a second assessment appointment?
B. What was the average wait time for these children to receive a second diagnostic appointment, since their first appointment?
QUESTION 9
A. In the year up to 31 March 2021, how many children with suspected autism received an ASD diagnosis?
B. What was the average wait time for these children to receive an ASD diagnosis, since their initial referral?
QUESTION 10
A. In the year up to 31 March 2020, how many children with suspected autism received a first assessment appointment?
B. What was the average wait time for these children to receive a first assessment appointment, since their initial referral?
QUESTION 11
A. In the year up to 31 March 2020, how many children with suspected autism received a second assessment appointment?
B. What was the average wait time for these children to receive a second diagnostic appointment, since their first appointment?
QUESTION 12
A. In the year up to 31 March 2019, how many children with suspected autism received an ASD diagnosis?
B. What was the average wait time for these children to receive an ASD diagnosis, since their initial referral?
QUESTION 13
A. In the year up to 31 March 2020, how many children with suspected autism received an ASD diagnosis?
B. What was the average wait time for these children to receive an ASD diagnosis, since their initial referral?
QUESTION 14
A. In the year up to 31 March 2019, how many children with suspected autism received a first assessment appointment?
B. What was the average wait time for these children to receive a first assessment appointment, since their initial referral?
QUESTION 15
A. In the year up to 31 March 2019, how many children with suspected autism received a second assessment appointment?
B. What was the average wait time for these children to receive a second diagnostic appointment, since their first appointment?

ASD waiting times.230522.docx

Asthma treatment and care for Children. 240321

Please provide numbers spanning the last 3 years – please segment by year where possible (i.e. 2018, 2019, 2020 – to date) for the following questions:
1. How many children age 7 and under have been admitted/treated for asthmatic symptoms in your Trust in these 3 instances:
a. Have been diagnosed as displaying asthmatic symptoms
b. Have been prescribed home treatment (reliever at home)
c. Have been admitted to A&E / ER for emergency treatment
2. For what number of children aged 7 and under was their admission to A&E/ER/Emergency GP (for asthmatic symptoms) their first instance of having asthmatic symptoms diagnosed and treated (i.e. the first instance of the NHS being made aware of asthmatic symptoms)?
3. How many children age 7 or under have had to be treated due over-medication of prescribed asthma medication?
4. How many children age 7 or under have had to be treated due under-medication of prescribed asthma medication?
5. What number of children age 7 and under are referred to a paediatrician/3rd party to help manage their asthmatic symptoms?
6. Yes/No: Has your trust seen a decline in parents seeking medical help for children aged 7 and under with asthma/asthmatic symptoms since March 2020?

Download response Asthma treatment and care for Children. 240321

Audiology services for children and young people.150317

1. Thinking about the 2015/16 financial year, did your service experience longer waiting times for?
2. Were there any changes in policy or practice in what your audiology service provided in 2015/16?
3. If you have ticked yes to any of the above, please tell us what has changed and the reasons for the
Change
4. At what age does your service transfer deaf young people to adult services?
5. Were there any changes to how your audiology service for deaf children is commissioned in 2015/16?
6. Were there any changes in the number and skill-mix of full time equivalent (FTE) staff in your team, including administrative staff, in 2015/16?
7. If you have ticked yes to any of the above, please describe in more detail what has changed (including the number of staff reductions, if any) and the reasons for the change.
8. Was there a training programme in place for audiologists in your service in 2015/16?
9. If yes, were there any changes to the availability of training in 2015/16?
10. Looking ahead to the 2016/17 financial year, are you aware of any planned changes to any of the below?
11. Did your service provide informal family support services such as parent coffee mornings, playgroups, use of voluntary sector, etc. in 2015/16?
12. If yes, were there any reductions in informal family support services in 2015/16?
13. Is anyone from the audiology team involved in the development of Education Health and Care plans?
14. Have you faced any barriers to being involved in developing Education Health and Care plans?
15. If yes, what were the barriers?
16. Did your service provide any assistive listening devices or take any action to ensure they work effectively with the child’s personal amplification in 2015/16?
17. If you have ticked any of the above, were there any reductions in the provision of assistive learning devices or services to ensure they work effectively with the child’s personal amplification in 2015/16
18. Has your service gained accreditation with (Improving Quality in Physiological Diagnostic Services) IQIPS?
19. Has your service registered for the IQIPS process?
20. Has your service started using the Self-Assessment and Improvement Tool (SAIT)?
21. Has your service applied to UKAS to begin the accreditation peer review process?
22. Has your service booked or completed its onsite assessment with UKAS?
23. If you have not registered with the SAIT for IQIPS, what are your reasons for not doing so?
24. What are the most successful aspects of your audiology service at the moment?
25. What are main challenges or problems facing your audiology service at the moment?
26. Is there anything else you would like to tell us about the audiology service and any future plans?
* 27. Your name:
* 28. Your role:
* 29. Name of audiology service (please don’t use abbreviations):
* 30. Name of Trust that provides the paediatric audiology service (please don’t use abbreviations):
* 31. Sites where paediatric audiology is delivered by your service (please don’t use abbreviations):

Download response Audiology services for children and young people.150317

Babies born in 2015 whose birth-weight was 12lbs or 5443g or more.

In the 2015 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birth-weights were.

Download response Babies born in 2015 whose birth-weight was 12lbs or 5443g or more 280416

Babies born with neonatal abstinence syndrome 2016-2017. 150517

How many babies were born with neonatal abstinence syndrome (showing signs of drug addiction because of their mother taking drugs during pregnancy) at hospitals run by your trust in the past financial year, April 2016 to April 2017? Please break the figures down by hospital.

Download response letter Babies born with neonatal abstinence syndrome 2016-2017. 150517

Babies born to drug dependent mothers. 151118

You asked:
For each year between 2009 and up-to the end of 2017, how many babies born under your trust were born to drug dependent mothers and once born, were transferred to a drug treatment programme to wean them off their addiction?

Download response Babies born to drug dependent mothers. 151118

Babies injured during assisted delivery. 280317

1) Please state the number of babies that were injured during delivery when tools to assist in delivery were used, for example a vacuum extractor or forceps.
Please provide information for each of the following calendar years:
i) 2014
ii) 2015
iii) 2016
iv) 2017 to date
2) Of these babies injured, please provide a breakdown of injuries that they suffered. Please provide a summary of each incident, including the cause of the injury.
Please provide information for each of the following calendar years:
i) 2014
ii) 2015
iii) 2016
iv) 2017 to date
3) Please state the number of babies injured during delivery due to hospital error.
Please provide information for each of the following calendar years:
i) 2014
ii) 2015
iii) 2016
iv) 2017 to date

Download response Babies injured during assisted delivery. 280317

Babies over 12lbs (5443g) at birth. 070421

1. In the 2018 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.
2. In the 2019 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.
3. In the 2020 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.

Download response Babies over 12lbs (5443g) at birth. 070421

Babies weighing 12lbs (5443g) or more at birth 2016. 250417

In the 2016 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.

Download response Babies weighing 12lbs (5443g) or more at birth 2016. 250417

Baby weights 2015-2016

I would like to know the following regarding live births:
1. The weights of the five heaviest babies that were born in the Trust last year – financial (2015-16) or calendar (2015) year, whichever is easiest.
2. The weights of the five lightest babies that were born in the Trust last year for pregnancies that reached around full term (i.e. that weren’t born prematurely).

Download response Baby weights 2015-2016 090916

Bed shortages and overcrowding. 310117

1. Do you have any strategy or informal policy that allows adults to be treated in beds/wards that are usually used for paediatric care to help with overcrowding?
2. What is that wording of that strategy?
3. When as it first drawn up?
4. How many times since January 2016 year has this been implemented? If applicable, how many times was it implemented between Jan 2015 and Jan 2016?
5. How many individual adult patients since January 2016 have been treated on child wards/bed -with dates if possible? And the same figure Jan 2015-16.
6. Were there any occasions when adults and children were treated on the same ward?
7. How many times has the hospital been on a) black alert and b) red alert for capacity since January 2016? How many times was it put on a and b from January 2015 – 2016?

Download response Bed shortages and overcrowding. 310117

Bereavement of babies

(a) Does your trust have a bereavement suite available for use by parents in the event of limited life expectancy of an anticipated birth of a child?

(b) If the answer to (a) is no, what alternative arrangements are available?

(c) If the answer to (a) is yes, would parents of a baby who turn up at hospital with a sudden infant death be allowed to use the bereavement suite?

(d) If the answer is yes to (a) where in relation to the Labour ward is the suite located?

(e) Do you have bereavement trained midwives? If yes, how many?

(f) Do you have a trained bereavement councillor at the hospital? If yes, what is the average waiting time to be able access support from that councillor?

(g) Do you provide any written information to parents following the loss of a baby? If yes, please name the third sector organisation information is provided from.

(h) Can you list the guidelines around infant death which are implemented by the hospital?

(i) Does the hospital provide support around funeral arrangements for infants or babies who have died at the hospital?

Download response Bereavement of babies 030216

Births and deaths.100223.docx

For the time period 1 April 2022 to 31 December 2022, if you do not have figures available for the whole period, please provide the most up-to-date figures and state the period they cover.
LIVE BIRTHS
1. How many live births were there at your hospital Trust in the following periods?
(Please exclude home births from this number and detail them separately in brackets.)
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
STILL BIRTHS
2a. How many stillbirths were there at your hospital Trust in the same periods?
Stillbirth is defined as occurring when a baby is born dead after 24 completed weeks of pregnancy.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
2b. Of these stillbirths (in answer 2a) how many were Intrapartum stillbirths?
Intrapartum stillbirth is defined as when a baby was thought to be alive at the start of labour but was born, beyond 37 weeks of gestation, with no signs of life.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
2c. Of the Intrapartum stillbirths (in answer 2b) how many were referred to HSIB?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
2d. Of the Intrapartum stillbirths referred to HSIB (in answer 2c), how many did HSIB investigate?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
NEONATAL DEATHS
3a. In the same periods, how many Neonatal deaths were there at your hospital Trust?
Neonatal deaths are defined as a baby that dies within 28 days of birth of any cause or, for the purposes of this process, a baby who dies that has not left hospital since birth.
If a baby was born at your hospital Trust and was transferred to another hospital and died at another hospital Trust, please exclude them from these numbers and specify the number separately in brackets.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
3b. Of these Neonatal deaths (in answer 3a) how many were ‘early Neonatal deaths’?
Early Neonatal deaths are defined as a baby that dies within the first week of life (0-6 days) of any cause.
If a baby was born at your hospital Trust and was transferred to another hospital and died at another hospital Trust, please exclude them from these numbers and specify the number separately in brackets.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
4a. Of the Neonatal deaths (in answer 3a) at your hospital Trust, in how many cases was the medical cause identified?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
4b. Of the Early Neonatal deaths (in answer 3b) at your hospital Trust, in how many cases was the medical cause identified?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
5a. Of the Neonatal deaths at your hospital Trust, where the medical cause was identified (in answer 4a), how many were referred to the Coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
5b. Of the Early Neonatal deaths at your hospital Trust, where the medical cause was identified (in answer 4b), how many were referred to the Coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
6a. Of the Neonatal deaths at your hospital Trust, in how many cases was the medical cause not identified?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
6b. Of the Early Neonatal deaths at your hospital Trust, in how many cases was the medical cause not identified?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
7a. Of the Neonatal deaths at your hospital Trust, where the medical cause was not identified, how many were referred to the Coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
7b. Of the Early Neonatal deaths at your hospital Trust, where the medical cause was not identified, how many were referred to the Coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
8a. Of the Early Neonatal deaths (in answer 3b) at your hospital Trust, how many were referred to HSIB?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
8b Of the Early Neonatal deaths referred to HSIB (in answer 8a), how many did HSIB investigate?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
HYPOXIC ISCHEMIC ENCEPHALOPATHY
9a. Of the Neonatal deaths at your hospital Trust, in how many cases was the cause of death recorded as Hypoxic Ischemic Encephalopathy?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
9b. Of the Neonatal deaths at your hospital Trust, where the cause of death was recorded as Hypoxic Ischemic Encephalopathy, how many were referred to the coroner?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
9c. Of the Neonatal deaths at your hospital Trust, where the cause of death was recorded as Hypoxic Ischemic Encephalopathy (in answer 9a), how many were referred to HSIB?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
9d. Of the Neonatal deaths at your hospital Trust, where the cause of death was recorded as Hypoxic Ischemic Encephalopathy (in answer 9c), how many did HSIB investigate?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
Please provide a copy of your hospital Trust’s current policy in respect of referring Neonatal deaths to a coroner and advise the date it was last updated.
MATERNAL DEATHS
10a. How many maternal deaths were there at your hospital Trust in the same periods?
Maternal deaths are defined as the death of a woman while pregnant or within 42 days of the end of the pregnancy from any cause related to or aggravated by the pregnancy or its management, and not from accidental or incidental causes. Excludes death by suicide.
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
10b. In how many cases of maternal death was a Neonatal death also recorded?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
10c. In how many cases of maternal death where a Neonatal death also recorded, was the death an Early Neonatal death?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?
11. Of the maternal deaths at your hospital Trust (in answer 10a), how many were referred to HSIB?
• 1 April 2019 to 31 March 2020?
• 1 April 2020 to 31 March 2021?
• 1 April 2021 to 31 March 2022?
• 1 April 2022 to 31 December 2022?

Births and deaths.100223.docx

Birthweights. 250419

In the 2018 calendar year were there any babies born at your hospitals where the weight of the baby was 12lbs (5443g) or more? If so please state how many and what their birthweights were.

Download response Birthweights. 250419

Bounty. 110219

In the 12 months to date (23.08.18) please confirm the following:
1) Whether the Trust currently is, or has been in the past 12 months, engaged in a contract or written agreement with Bounty UK Limited. If the Trust is currently engaged in a contract please attach a copy of it, making necessary redactions in order to comply with the Act. Please provide the date that the contract began and/ or ended. Please provide an overview of the terms of payment. (i.e. per mother visited / per photo pack purchased).
2) Please confirm how much money has been paid to the Trust by Bounty UK Limited in the past 12 months and how many new mothers are recorded as having been approached by Bounty representatives (if held).
3) Please provide details of the policies the Trust has in place with regards to protecting new mothers (i.e. are representatives allowed on any ward at any time, or do they have restricted access? Are mothers given the option to opt out of being visited?)
4) Please confirm the number of complaints made to the Trust by new parents. If not time prohibitive, please provide details of the complaints.

Download response Bounty. 110219

Bounty Packs. 110219

Q1) Please provide the name of your Trust
Q2) Do you have a contract with Bounty, whose representatives hand out ‘Bounty Packs’ to new mothers on maternity wards?
Q3) If you answered YES to Question 2, how much money did your trust receive from Bounty in the financial years;
Q4) Please explain how the payment from Bounty is calculated (i.e. a pre-agreed figure, or a set payment per child born in your care).
Q5) How many babies were born in your care during the financial years?

Download response Bounty Packs. 110219

Brain cooling in babies. 011217

1. Please provide the number full term babies at 36 weeks or later who , because of HIE, were transferred for consideration of brain cooling to a tertiary centre for the following calendar years 2014,2015, 2016 and 2017 to date. ( if you are already one of those tertiary centres then please let me know how many babies were considered for brain cooling because of HIE.)
2. For those same babies, and years, please let me know how many were subject to a serious incident report relating to childbirth?

Download response Brain cooling in babies. 011217

Breast milk.100823.docx

Please provide the number of cases where breast milk of a new mother was given to a child who is not her own at all maternity wards in your Trust.

For clarity, I am asking you to please provide the number of instances where a child on a maternity ward was given breast milk from a person who was not their mother.

Please provide annual figures for how many times this happened at your Trust for 2017, 2018, 2019, 2020, 2021, 2022 and so far in 2023.

Please also give the number of times disciplinary action was taken on a member of staff over these instances. Please provide a breakdown of the outcome of any disciplinary action: How many were cautioned, suspended, terminated etc as a direct result of the mistake.

Breast milk.100823.docx

CAMHS. 170818

1) How many children received treatment from your local CAMHS in the financial years:
a. 2014/15
b. 2015/16
c. 2016/17
d. 2017/18

2) Please can you breakdown the figures given in answer to Q1a-d by (i) the type of mental health issue that was being treated, and (ii) the ethnicity of the child?

Download response CAMHS. 170818

CAMHS. 270618

How many referrals were made to CAMHS from any possible referrer for the last three financial years (April 1 2015 – March 31 2016, April 1 2016 – March 31 2017, April 1 2017 – March 31 2018)?
How many were accepted for each of the years above?
Of those accepted, how many had any of the below factors known or believed to be evident (if information is available), for each of the years above?
– Previous contact with CAMHS
– Recurrent threats or acts of self-harm
– High levels of risk
– Eating disorders
How many accepted were from each type of referrer (e.g. GP, A&E etc.) for each of the years above?
What was the mean and median waiting time between referral and treatment for each of the years above?
How many were declined for each of the years above?
Of those rejected, how many had any of the below factors known or believed to be evident (if information is available), for each of the years above?
– Previous contact with CAMHS
– Recurrent threats or acts of self-harm
– High levels of risk
– Eating disorders
How many rejected were from each type of referrer (e.g. GP, A&E etc.) for each of the years above?

Download response CAMHS. 270618

CAMHS treatment.160721.docx

For each month between (and including) January 2018 and June 2021, please could you tell me the mean average number of days to elapse between a patient being assessed by your CAMHS service and that patient having their first appointment with an appropriate specialist as part of an ongoing treatment plan under CAMHS (as opposed to an appointment with a non-specialist; or supportive care while waiting for therapist availability; or an unscheduled call, letter or other contact that does not qualify as a treatment appointment)?

For each month, please could you specify which specialist or specialists were in attendance at those first treatment appointments, expressed as percentages of the total number of first treatment appointments that month (e.g., 74% of patients had their initial appointment as part of an ongoing treatment plan with a clinical psychologist, 20% with a CBT therapist etc)

Download response CAMHS treatment.160721.docx

Cancelled children’s operations – 01.07.16. 050517

1. How many children’s operations have been cancelled each month since 1st July 2016? Please give additional details as to what the main reasons for the cancellations were, how many were urgent operations or elective operations, and what type of illness did they involve, e.g. cancer, breathing problems, broken limbs etc.

2. How many children’s operations have been cancelled over the last four financial years to date?

Kindly note a child is anyone up to the age of 18.

Download response Cancelled children’s operations – 01.07.16. 050517

Cancelled children’s operations. 131020

The total number of children’s operations cancelled for non-clinical reasons, broken down by the cause of the cancellation, for example due to lack of beds, operating theatre capacity, staffing issues, and equipment failures. Please provide this information for each of the past three financial years 2017/18, 2018/19, 2019/20). In the total number of operations, broken down by cancellation reason, please include:

· Elective children’s operations cancelled at the last minute. For the purposes of this request, last minute means on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery.

· Cancelled urgent children’s operations.

For the purposes of this FOI, Children will be defined as under 18’s.

Download response Cancelled children’s operations. 131020

Cerebral Palsy (CP). 270618

1. What is the total number of children and young people diagnosed with Cerebral Palsy by your Trust/Health Board in the last five years? (N.B.: this should be recorded as a total figure rather than figures for each year individually.)
2. What is the care pathway for children and young people with cerebral palsy in your Trust/Health Board? Please provide a copy of this if possible.
3. Is there a specific timescale set out in your care pathway for referral to a child development service for diagnosis of cerebral palsy from the point when symptoms are initially identified? If so, please provide this data.
4. What is the total number of:
a. Health visitors employed by your Trust/Health Board?
b. Specialist health visitors for children with special needs employed by your Trust/Health Board?
5. What training is given to healthcare professionals, including health visitors and GP’s, to recognise the risk factors and possible symptoms for Cerebral Palsy?
6. What is the total number of specialist staff employed by your Trust/Health Board, who are trained to work with children and young people with Cerebral Palsy, from the following disciplines:
a. Paediatric speech and language therapy
b. Paediatric physiotherapy
c. Paediatric occupational therapy
7. How many children and young people with Cerebral Palsy are currently on a waiting list to access any of the above services within your Trust/Health Board?

Download response Cerebral Palsy (CP). 270618

Child and Adult Mental Health Services. 260218

How many people under specialist Child and Adolescent Mental Health Services were issued with the ICD-10 code F12. – ‘mental and behavioural disorders due to use of cannabinoids’, during the 2016/17, 2015/2016, 2014/2015, 2013/2014, 2012/2013, 2011/2012, 2010/ 2011, 2009/ 2010, 2008/ 2009, 2007/ 2008, 2006/ 2007 periods?

Download response Child and Adult Mental Health Services. 260218

Child and Adolescent Mental Health Services (CAMHS).

For the purposes of this request we define children and young adults as being between the ages of 0 and 25 years.
1. The information request:
Please can you provide us with the following information?
• The (a) budget and (b) expenditure for all mental health services.
• The (a) budget and (b) expenditure for Child and Adolescent Mental Health (CAMHS) services (total spend) – if you attribute to a CAMHs Tier 1-4 please specify.
• The (a) budget and (b) expenditure for mental health urgent and emergency care (including mental health crisis care) for children and young people – if only total spend is available please approximate proportion that is spent on children and young adults.
• Any additional, discretionary monies (a) budgeted for and (b) spent on child, adolescent or young adult mental health – please specify source.
We are requesting information for the financial years: 2010/11, 2011/12, 2012/13, 2014/15, 2015/16, 2016/17.
And if available – we are also requesting the projected budget (or settlement) for the financial years covering the remainder of Future in Mind and the Five Year Forward View for Mental Health, which includes: 2017/18, 2018/19, 2019/2020, 2020/21.
2. Clarifications:
If the requested information does not relate to your activity, please answer ‘not applicable’ (N/A).
If you share a budget with another organisation, please specify:
a. The name of the other organisation(s) (for example a Clinical Commissioning Group, Local Authority or NHS Trust).
b. Whether the expenditure / budget reported is the total amount of the shared budget, or your organisation’s contribution to the shared budget.

Download response Child and Adolescent Mental Health Services (CAMHS) 270616

Child drug and alcohol related admissions. 241016

This request relates to drug and alcohol related admissions of children. Please include cases where the relevant diagnoses were recorded as both the primary and secondary condition.

I) Broken down by each of the following calendar years a) 2012, b) 2013, c) 2014, d) 2015 and e) 2016 so far, please state the total number of children aged under 13 admitted to hospitals in your trust due to:

1. The toxic effect of alcohol
2. Mental and behavioural disorders due to use of alcohol
3. Poisoning by drugs, medicaments and biological substances
4. Mental and behavioural disorders due to drug and psychoactive substance use
5. Poisoning by antidepressants (subset of question 3)
6. Poisoning by ecstasy (subset of question 3)

II) Broken down by each of the following calendar years a) 2012, b) 2013, c) 2014, d) 2015 and e) 2016 so far, please state the total number of children aged 13-16 admitted to hospitals in your trust due to:

1. The toxic effect of alcohol
2. Mental and behavioural disorders due to use of alcohol
3. Poisoning by drugs, medicaments and biological substances
4. Mental and behavioural disorders due to drug and psychoactive substance use
5. Poisoning by antidepressants (subset of question 3)
6. Poisoning by ecstasy (subset of question 3)

III) Broken down by each of the following calendar years a) 2012, b) 2013, c) 2014, d) 2015 and e) 2016 so far, please state the total number of children aged 16-17 admitted to hospitals in your trust due to:

1. The toxic effect of alcohol
2. Mental and behavioural disorders due to use of alcohol
3. Poisoning by drugs, medicaments and biological substances
4. Mental and behavioural disorders due to drug and psychoactive substance use
5. Poisoning by antidepressants (subset of question 3)
6. Poisoning by ecstasy (subset of question 3)

Download response Child drug and alcohol related admissions. 241016

Child and Mental Health Services. 170817

What was the average waiting time for patients referred to the Child and Mental Health Services at your trust between May 31st 2016 and May 30th 2017?
What was the average waiting time for patients referred to the Child and Mental Health Services at at your trust between May 31st 2015 and May 30th 2016?
What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust between May 31st 2016 and May 30th 2017?
What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust between May 31st 2015 and May 30th 2016?
How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services between May 31st 2016 and May 30th 2017?
How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services between May 31st 2015 and May 30th 2016?
What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services between May 31st 2016 and May 30th 2017, having been turned away due to a lack of resources?
What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services between May 31st 2015 and May 30th 2016, having been turned away due to a lack of resources?
What age was the youngest patient dealt with by the Child and Mental Health Services at your trust between May 31st 2016 and May 30th 2017?

Download response Child and Mental Health Services. 170817

Child and Mental Health Services. 200418

1.a. What was the average waiting time for patients referred to the Child and Mental Health Services at your trust during the financial year 2017-2018, and what was their age and gender?
1.b. What was the average waiting time for patients referred to the Child and Mental Health Services at your trust during the financial year 2016-2017, and what was their age and gender?
1.c. What was the average waiting time for patients referred to the Child and Mental Health Services at your trust during the financial year 2015-2016, and what was their age and gender?
2.a. What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust during the financial year 2017-2018, and what was their age and gender?
2.b. What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust during the financial year 2016-2017, and what was their age and gender?
2.c. What was the longest waiting time for a patient referred to the Child and Mental Health Services at your trust during the financial year 2015-2016, and what was their age and gender?
3.a. How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services during the financial year 2017-2018?
3.b. How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services during the financial year 2016-2017?
3.c. How often did limited capacity mean your trust had to decline access to services for patients referred to the Child and Mental Health Services during the financial year 2015-2016?
4.a. What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services during the financial year 2017-2018, having been turned away due to a lack of resources, and what was their age and gender?
4.b. What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services during the financial year 2016-2017, having been turned away due to a lack of resources, and what was their age and gender?
4.c. What’s the furthest distance a patient has had to travel from your trust to find adequate, available care from the Child and Mental Health Services during the financial year 2015-2016, having been turned away due to a lack of resources, and what was their age and gender?
5.a. What age was the youngest patient dealt with by the Child and Mental Health Services at your trust during the financial year 2017-2018?
5.b. What age was the youngest patient dealt with by the Child and Mental Health Services at your trust during the financial year 2016-2017?
5.c. What age was the youngest patient dealt with by the Child and Mental Health Services at your trust during the financial year 2015-2016?

Download response Child and Mental Health Services. 200418

Childhood obesity services. 160320

What is the name of your acute trust?
(1) Does your trust provide a weight management service for children living with obesity?
Yes ☐ No ☐
If No, you need not answer further.
If yes, what is the name of the service and where delivered:
Who leads this service?
It is a hospital ☐ or community-based☐ clinic
(2) What if any are the criteria for eligibility to attend (for instance BMI >98th percentile)?
None ☐
Eligible if:
(3) Through what mechanism is the service funded?
CCG ☐
NHS England ☐
Research ☐
Charity ☐
Trust Self-Funding ☐
Other ☐
Please specify
(4) Who are the key personnel providing service? Please tick all who apply:
a. Paediatricians ☐
b. Dieticians ☐
c. Psychologists ☐
d. Trained volunteers ☐
e. Hospital or Community based Nursing staff ☐
f. Exercise specialists ☐
g. Social workers ☐
h. CAHMS ☐
i. Youth workers ☐
(5) How many new cases are seen each year?
(6) Over how many weeks is the clinic intervention delivered?
(7) What is the usual follow up period (entry to discharge?)
(8) What final outcomes are collected: Examples: change in BMI, BMI SDS, Self Esteem, Waist Circumference, recruitment, retention.
Please list all.

Download response Childhood obesity services. 160320

Children and Adolescent Mental Health Service (CAMHS). 051021.docx

1. The number of low secure Children and Adolescent Mental Health Service (CAMHS) and medium secure CAMHS beds within your Authority or Trust and how many of those are currently available for new admissions.
2. The number of low secure CAMHS beds within your Authority or Trust and how many of those are currently available for new admissions.
3. The number of medium secure CAMHS Service beds within your Authority or Trust and how many of those are currently available for new admissions.
4. The number of welfare social care secure beds within your Authority or Trust and how many of those are currently available for new admissions.
5. The number of forensic secure beds within your Authority or Trust and how many of those are currently available for new admissions.
Further, please could you kindly provide details of:
6. The number of young people within your Authority area or Trust area who have been assessed as requiring a CAMHS Tier 4 mental health bed but have not been admitted due to a shortage in resource (we do not require personal details or reasons for the conclusion reached, just numbers).
7. The number of young people within your Authority area or Trust area who have been assessed as requiring a CAMHS low secure mental health bed but have not been admitted due to a shortage in resource.
8. The number of children accommodated within your Authority area or Trust area in unapproved, unregulated settings.

Download response Children and Adolescent Mental Health Service (CAMHS). 051021.docx

Children attending A&E due to mental health. 120422.docx

1. Number of children attending A&E per month, since Jan 2019 due to a mental health related issue.
2. The top 10 longest stays in A&E of a child who is presenting a mental health issue over the last 12 months.

Children attending A&E due to mental health. 120422.docx

Children treated for alcohol dependency or misuse. 151118

You asked:
Please may you tell me the number of people, under the age of 18, who were treated by the trust for alcohol dependence and/or alcohol misuse in 2012, 2013, 2014, 2015, 2016, 2017, and 2018?

May you please tell me the youngest person you treated for this in 2016, 2017 and 2018?

Download response Children treated for alcohol dependency or misuse. 151118

Children’s Dental Hospital. 250417

1. As of March 31st, 2017, can you tell me how many children were on the waiting list to visit the Trust’s children’s dental hospital?
2. How long is the present waiting list, in terms of months/weeks to be seen?
3. How long is the wait for teeth extractions?
4. How many children are affected by the wait for teeth extractions?
5. Is there a wait for youngsters to be added to the waiting list? if, so how many children are waiting to be placed on to the waiting list?
6. How many dental nurses does the Trust employ at the children’s dental hospital?
7. How many vacancies does it have at present?
8. How many children were on the waiting list to visit the Trust’s children’s dental hospital on?
a) March 31st, 2016?
b) March 31st 2015?
c) March 31st 2014?
d) March 31st 2013?
9. How many children received treatment at the children’s dental hospital between January 1, 2016 and December 31, 2016?

Download response Children’s Dental Hospital. 250417

Children’s Unit. 250919

1. Between 1st April 2018 and 31st March 2019 how many visits to/patients were/are seen at Riverbank Children’s unit? (Volume)
2. Between 1st April 2018 and 31st March 2019 how many individual patients were/are seen at Riverbank Children’s unit? (Reach)
3. How many of these were transferred to Pembury?
4. On a typical day / on average how many patients are transferred from Riverbank to woodlands every day?
5. What are the main reasons for these transfers?
6. On a typical day/ on average many patients transfer each day due to the Riverbank closing time?
7. How often/ on average how many times a week do the staff at Riverbank have to stay past 8.00pm to accommodate patients needs/ transfer to Pembury?
8. Between 1st April 2018 and 31st March 2019 how many visits to/patients were/are seen at Woodlands and hedgehog Children’s unit? (Volume)
9. Between 1st April 2018 and 31st March 2019 how many individual patients were are seen at Woodlands and hedgehog Children’s unit? (Reach)
10. How many of these were transferred from Riverbank?

Download response Children’s Unit. 250919

Congenital cytomegalovirus screening and treatment practices and data.300124.docx

All questions are shown as received by the Trust.
The purpose of this FOI request is to ascertain your Trust’s approach to screening for and treating congenital cytomegalovirus (cCMV).

The questions have been designed so that they can be answered within the limits (on time, cost, type of information etc.) set out in the Freedom of Information Act and the Information Commissioner’s Guidelines. If it is not possible to provide the exact information requested, please supply the underlying information in narrative form or whichever format you have available.

Definitions of acronyms and terms used in the FOI request:
CMV: cytomegalovirus
cCMV: congenital cytomegalovirus
SNHL: sensorineural hearing loss
‘Practices’ refers to any standard operating procedures or clinical protocols, guidelines, practices or pathways.
‘Information’ refers to any recorded information required to be disclosed in response to requests under the Freedom of Information Act.

If different hospitals or services within your Trust have different Practices or data availability, please provide separate Information or data for each hospital or service (indicating clearly which hospital or service the Information relates to).

Q1. Please provide copies of any Information containing or evidencing Practices used within your Trust whereby newborns who are referred to audiology following their newborn hearing screening test, or newborns/children who demonstrate abnormal hearing at a later stage, are tested for cCMV. Such Practices could include, but are not limited to, early cCMV detection pathways whereby newborns are tested at point of referral to audiology from the newborn hearing screening programme. Please include details about the intended timescales for testing, carrying out tests and returning test results, if this information is recorded.

Q2. If your Trust does employ Practices whereby newborns/children with abnormal hearing are tested for cCMV, please indicate at which stage samples are taken (you may select more than one):
❏ By the newborn hearing screener at the point of referral ❏ By the audiologist at the first appointment after babies have been referred from the newborn hearing screen ❏ By the audiologist at detection of SNHL in a baby referred from the newborn hearing screen ❏ By another healthcare professional (not an audiologist) following detection of SNHL in a baby referred from the newborn hearing screen ❏ At detection of SNHL in older babies and children (i.e. after the newborn hearing screening and testing period) ❏ Unknown ❏ Other, please provide details:

Q3. If your Trust does employ Practices whereby newborns/children with abnormal hearing are tested for cCMV, please indicate what type of sample is taken (you may select more than one):
❏ Saliva swab
❏ Urine
❏ Blood test for the infant
❏ Blood test for the mother
❏ Infant blood spot (Guthrie) card testing ❏ Unknown ❏ Other, please provide details:

Q4. Please provide copies of any Information containing or evidencing Practices used within your Trust whereby children are tested for cCMV as part of investigations of symptoms (in either the mother or child) that are unrelated to hearing. These could include:
Maternal symptoms of CMV (flu-like symptoms) Symptoms of congenital infection identified before or after birth, such as:
• Antenatal abnormalities e.g. on ultrasound scan
• Characteristic rashes caused by cCMV (petechiae or blueberry muffin rash)
• Intrauterine Growth Restriction
• Microcephaly
• Jaundice
• Hepatosplenomegaly
• Neonatal visual signs/symptoms
• Neonatal seizures
Symptoms of congenital infection in older children, such as:
• Neurodevelopmental delays
• Special educational needs and disabilities (e.g. autism, ADHD)
• Cerebral palsy
• Seizures
• Visual or sensory impairment

Q5. Please provide copies of any Information containing or evidencing Practices used within your Trust following a diagnosis of cCMV in a child. This could include, but is not limited to:
• Information about any Practices involving the prescribing of antiviral treatments
• Details of the department(s) that the child would be referred to

Questions 6-9 relate to the provision of data for a specific five-year period. If you do not hold data for this time period, please supply data for any period for which you have available data (preferably a recent five-year period) and specify the beginning and end dates. If the answer to any question is between 1 and 5 (and therefore the true figure cannot be shared in accordance with Section 40 of the Freedom of Information Act), please indicate this by giving the answer “<5”. Please also indicate if the relevant hospitals or services within your Trust have changed during this period.

Q6. Between 1 January 2018 and 31 December 2022, how many children were diagnosed with cCMV within 28 days of birth, within your Trust? This should include children born outside of your Trust who were diagnosed by services within your Trust.

Q7. Of the children who were diagnosed with cCMV within 28 days of birth in this time period (Q6), how many:
a. Previously had a newborn hearing screening test
b. Had been referred to audiology following their newborn hearing screening test
c. Were given antiviral treatment for cCMV following diagnosis

Q8. Between 1 January 2018 and 31 December 2022, how many children were diagnosed with cCMV between 28 days and 18 years of age, within your Trust? This should include children born outside of your Trust who were diagnosed by services within your Trust.

Q9. Of the children who were diagnosed with cCMV between 28 days and 18 years of age in this time period (Q8), how many:
a. Previously had a newborn hearing screening test
b. Had been referred to audiology following their newborn hearing screening test
c. Were given antiviral treatment for cCMV following diagnosis

Congenital cytomegalovirus screening and treatment practices and data.300124.docx

Cooling-Therapeutic Hypothermia Protocol. 101220

We require sight of the Cooling/Therapeutic hypothermia protocol in the neonatal and/or Special Care Baby Unit at Maidstone & Tunbridge Wells NHS Trust, that was in force in November 2015. We are merely requesting this to provide us with knowledge in accordance with the act.

Download response Cooling-Therapeutic Hypothermia Protocol. 101220

Cord blood stem cells. 300819

1) Do you allow private stem cell companies to promote their services on your sites, e.g. leaflets?
2) Do you allow representatives from stem cell companies on any of your sites to promote or collect cord blood, e.g. in delivery suites?
3) Does the Trust allow its staff to work for stem cell companies, e.g. collecting umbilical cord blood for private companies?
4) How long (how many minutes) does the Trust consider ‘optimal’ cord clamping?
5) Please supply the following information for each of the individual calendar years: 2015, 2016, 2017, 2018 and 2019 to date:
a) The number of babies born whose umbilical cord blood was collected for banking by a private company.
b) The number of babies born whose umbilical cord blood was collected for banking by the NHS.
c) The income received from stem cell companies.

Download response Cord blood stem cells. 300819

Cord clamping. 011121.docx

Please provide under the FOI act, the figures for each of the last 5 years (please provide data for each calendar year data 2015-2020)
Please provide the following figures per calendar year:
1. How many live births occurred in your organisation (please break this down to premature and term babies)
2. How many of these live births had cord clamping as being recorded at being at or after one minute? (please break this down to premature and term babies)
3. Please provide the numbers where cord clamping occurred before one minute (please break this down to premature and term babies)
4. How many times this was not documented (please break this down to premature and term babies)
5. Please provide any audits in the last 5 years on cord clamping times.
6. Is it mandatory to record the cord clamping time on any of your systems?

Download response Cord clamping. 011121.docx

Court intervention. 141119

1. “Since 01 January 2017, please specify the number of individual cases where the Court has had to intervene in the treatment of a critically ill child, when there has been a difference of opinion between parents and doctors, over the course of treatment for that child?”

Download response Court intervention. 141119

Cow’s milk protein Allergy (CMPA) 090916

1) Does your organisation use any guidelines when prescribing specialised infant formula for cow’s milk protein allergy (CMPA)?

2) If yes, please provide a link to, or a copy of the guidelines referenced by your organisation.

3) Please can you confirm whether we are permitted to reuse any information provided under the Open Government Licence?

Download response Cow’s milk protein Allergy (CMPA) 090916

Digital devices inside Paediatric Wards. 081121.docx

PART 1: ABOUT PAEDIATRIC COMMUNICATION

1. Is there a psychologist dedicated to paediatric wards?
2. Who is in charge to communicate about care and hospitalization practices? (multiple answers)
3. What kind of communication material do you use inside your ward in order to support and enhance the experience of the child and his/her family in hospital, providing information on his/her clinical condition, exams and treatment?
* If you choose “Paper” or “We don’t use communication material” go to PART 3

PART 2: ABOUT THE USE OF TECHNOLOGICAL DEVICES

1. IF YOU USE TECHNOLOGICAL DEVICES, which of the following ones are used in the ward to communicate with and support THE CHILD : (multiple answers)
2. If you use technological devices, which of the following ones are used in the ward to communicate with THE PARENTS: (multiple answers)
3. If you use technological devices, which of the following ones are used in the ward to communicate with THE SIBLINGS: (multiple answers)
4. If you use technological devices, which of the following ones are used in the ward to communicate with THE CHILDREN OF HOSPITALIZED PARENTS: (multiple answers)
5. If you use technological devices to communicate with the child and his family, what do they apply to, CONSIDERING THE CLINICAL CONDITIONS? (multiple answers)
6. If you use technological devices to communicate with the child and his family, what do they apply to, CONSIDERING THE TYPE OF INTERVENTION? (multiple answers)
7. What are the goals of the technological devices you use? (multiple answers)
8. Can you mention some examples of the technological devices you use?
9. Have you published an assessment study on the efficacy of the tool?
10. If your answer was YES, could you please give us references?
* If you use technological devices DON’T answer to PART 3

PART 3: ABOUT THE EVENTUAL USE OF TECHNOLOGICAL DEVICES

1. IF YOU DON’T USE TECHNOLOGICAL DEVICES – Do you think they could be useful tools to improve the quality of communication directed to the child and his family?
2. IF YOUR ANSWER WAS YES – For which clinical conditions? (multiple answers)
3. AND – For which type of intervention? (multiple answers)
4. Which purpose should they set themselves? (up to 3 answers)
5. Why don’t you use technological devices to communicate with the children and their families? (up to 3 answers)

Download response Digital devices inside Paediatric Wards. 081121.docx

Disorders of Sex Development in Children. 150222.docx

We seek information about the evaluation and care given to those with Disorders of Sex Development. In particular, we would like to know more about the number of international referral requests received by your trust from Malta.
We have put together a list of questions, which we would be grateful if you could answer in this order:
1) Since 2015, how many children receiving diagnostic tests and/or treatment for DSDs have been referred to this trust from Malta?
2) Of these children, how many are government-sponsored patients?
a. How many pay privately?
3) Of these referrals, how many have undergone genital surgeries?
4) Which specific DSDs have been referred from Malta? (e.g. Congenital Adrenal Hyperplasia, Androgen Insensitivity Syndrome, Turners Syndrome). If possible, please list them.
5) Are there specific legal or ethical guidelines tailored for Maltese patients?

Disorders of Sex Development in Children. 150222.docx

Disorders of Sex Development in the UK. 070818

1. Who provides expert evaluation of gender assignment in newborns with Disorders of Sex Development?

2. Does the trust use a multidisciplinary team that deals with the evaluation and long-term management and needs of patients with Disorders of Sex Development?

3. If yes to question 2, can you provide contact details for the team?

4. What specialties are represented on the multidisciplinary team (e.g. paediatric subspecialists in endocrinology, surgery, and/or urology, psychology/psychiatry, gynaecology, genetics, neonatology, and, if available, social work, nursing, and medical ethics)? Please list them.

5. When dealing with Disorders of Sex Development, what guidelines, if any, do decision makers follow?

6. How many people are referred to this team per year (please give numbers for the last five years)?

Download response Disorders of Sex Development in the UK. 070818

Drug and alcoholism in children aged under 15 2013-2017. 280417

Can I ask for the following information: for each of the last four financial years (including the current one) I request disclosure of data relating to children aged 15 and under who have been diagnosed with alcoholism or drug related conditions.
1. For each year I would like a table containing patients’ ages, from 0 to 15 years old accompanied by a figure for the number of children of that age who were diagnosed as alcoholic, alcohol poisoning, treated for alcoholism or excessive alcohol consumption (for example 2016/17: Age 15– 33 Age 14 – 3). Can you outline the figures for each?
2. For each financial year I would also like a table set out in the same way detailing the numbers of children aged 15 or below who were admitted to A&E suffering alcohol-related illness.
3. For each year I would like a table containing patients’ ages, from 0 to 15 years old accompanied by a figure for the number of children of that age who were diagnosed for drug related illnesses or over-consumption (for example 2016/17: Age 15– 33 Age 14 – 3).
4. For each financial year I would also like a table set out in the same way detailing the numbers of children aged 15 or below who were admitted to A&E suffering drug-related illness. Can you outline the figures for each?
5. For each admission in Q1 and Q3, please tell me a) the sex of the child c) a brief summary of the problem, e.g. child was drunk

Download response Drug and alcoholism in children aged under 15 2013-2017. 280417

Each Baby Counts. 140322.docx

The Royal College of Obstetricians and Gynaecologists ran an initiative called Each Baby Counts aimed at reducing the number of intrapartum stillbirths, early neo-natal deaths and babies born with severe brain injuries. Please provide the total number of notifiable cases reported to the initiative by your organisation and the time period the data relates to, e.g. 1 January 2015 – 31 December 2019.

Each Baby Counts. 140322.docx

Eating disorders. 160119

1) How many admissions of children (under 18’s) presenting with eating disorders your trust has recorded in the past five years?
2) I would like to know how many of these children treated were male/female/transgender.
3) Please present all this information simply and clearly and break it down by year. Please provide as much detail as possible about the nature of their illness (I understand that some children may present with multiple illnesses). I would like this information broken down by type of eating disorder e.g. bulimia, anorexia etc.

Download response Eating disorders. 160119

Eating disorders in paediatric patients 2014-2016.

The number of paediatric patients you have seen between January 1st 2014 and December 31st 2014 for the treatment of eating disorders
The number of paediatric patients you have seen between January 1st 2015 and December 31st 2015 for the treatment of eating disorders
The number of paediatric patients you have seen between January 1st 2016 and December 31st 2016 for the treatment of eating disorders
How many of the paediatric patients were aged 10 and under between January 1st 2014 and December 31st 2014
How many of the paediatric patients were aged 10 and under between January 1st 2015 and December 31st 2015
How many of the paediatric patients were aged 10 and under between January 1st 2016 and December 31st 2016
How many of the paediatric patients were aged 11-16 between January 1st 2014 and December 31st 2014
How many of the paediatric patients were aged 11 -16 between January 1st 2015 and December 31st 2015
How many of the paediatric patients were aged 11 -16 between January 1st 2016 and December 31st 2016

Download response Eating disorders in paediatric patients 2014-2016.

Electronic Patient Records systems in Mental Health, Community Health or Child Health.

1. What are the main Electronic Patient Records systems you operate in Mental Health, Community Health or Child Health?
2. Can you provide a name for these systems?
3. How much are you currently spending on these systems annually for licensing and support fees?
4. What is the date of contract expiry for the systems?
5. How many users? (An estimation if unsure)
6. How are the systems hosted?
7. Who is responsible for your local implementation of the objectives set out by the NHS in the Five Year Forward View?

Download response Electronic Patient Records systems in Mental Health, Community Health or Child Health 270616

FGM C 2013-2016

1) How many females have you treated in connection to/relating to/as a result of FGM/C (female genital mutilation or cutting) practices?
2) Please can you break your answer down by financial years:
– 2015/16
– 2014/15
– 2013/14
3) Can you also break down and categorise the numbers by “reason for treatment”? So for example, i. bleeding ii. infection
4) Can you break down and categorise the numbers by what the treatment was? So for example, i. amputation ii. cosmetic surgery
5) Can you break down and categorise the numbers by the females’ ages? Ideally in these age brackets: i. 0 – 9 ii. 10 – 18 iii. 19 – 27 (and continue by nine-year age brackets)

Download response FGM C 2013-2016

FGM in England and Wales.300124.docx

Please provide the following for the last five years, from Jan 1 2019 until December 31 2023.
Please break each of the following down by year (i.e. January 1 2023-December 31 2023; January 1 2022- December 31 2022, etc), and only include each case once (i.e. not the number of occasions one individual attempts to access services):
1. How many cases or suspected cases of FGM have been identified?
2. How many of these cases were identified of children under 18?
3. Of the cases identified in children under 18, how many cases were referred to the police?
4. Of all the cases recorded, how many cases were referred to the police?
5. Of the cases identified, how many individuals requested reconstructive surgery via the NHS? Please include the type of reconstructive surgery.
6. How many of these individuals underwent reconstructive surgery via the NHS? Please include the type of reconstructive surgery.
7. Where this data is recorded, please provide the number of individuals who underwent reconstructive surgery out of the NHS.
8. How many of the people identified as victims of, or likely victims of, FGM were referred to psychological or mental health support services?
9. How many people were referred to specialist FGM support clinics?
Again, please provide all the above for the last 5 years (from Jan 1 2019-Dec 31 2023), broken down by each year.

FGM in England and Wales.300124.docx

Foetal Alcohol Syndrome 2014-2016. 070417

1. For 2016,
a) How many people were diagnosed as being on the Foetal Alcohol Spectrum. With a breakdown of ages and hospitals.

2. and 3. Same for 2015/2014

Download response Foetal Alcohol Syndrome 2014-2016. 070417

Foetuses that were miscarried, stillborn or aborted and children up to one year old from 1988 to the present day (Nov 2016). 011216

Please supply information for all of the questions below relevant to – foetuses that were miscarried, stillborn or aborted and children up to one year old from 1988 to the present day (Nov 2016).

1. Are you holding organs or tissue samples or bodies of foetuses that were miscarried, stillborn, aborted or of children up to one year old, pending disposal?

2. If yes to Q1, please report how many organs, tissue samples, body parts or bodies of foetuses that were miscarried, stillborn, aborted or of children up to one year old you have retained and still have?

3. In how many of these cases of foetuses that were miscarried, stillborn or aborted or of children up to one year old which have been retained and you still have was consent given by the nearest relatives to take, use and dispose of organs or tissue samples or body parts or bodies?

4. In how many of these cases of foetuses that were miscarried, stillborn or aborted or of children up to one year old which were retained but have since been disposed of was consent given by the nearest relatives to take, use and dispose of organs or tissue samples or body parts or bodies?

Download response Foetuses that were miscarried, stillborn or aborted and children up to one year old from 1988 to the present day (Nov 2016). 011216

Free promotional disposable nappies.260219

1. Do you distribute any free promotional disposable nappies (such as Pampers) or reusable nappies to parents at any services, including (but not exhaustive of) antenatal, maternity, midwife, post-natal and family services?
If the answer is yes to 1, please answer questions 2-7.
2. Which disposable or reusable nappy brand do you allow to distribute their promotional nappies?
3. Which services are they distributed at and how many parents use these facilities annually?
4. How frequently a year have these disposable or reusable nappy brands been able to distribute their promotional material at these services?
5. What is the process for allowing disposable or reusable nappy brands to distribute at your services and who signs it off?
6. Is there any remuneration for the NHS from these disposable or reusable nappy brands for distributing their promotional material?

Download response Free promotional disposable nappies.260219

General anaesthesia (GA) paediatric dental waiting times.140223.docx

1. Total number of children currently on your waiting lists and for each of the past five years.
2. The average waiting time from referral to treatment by year for each of the past five years.
3. The total number of children currently on the waiting list who have waited more than a) six months b) one year c) 18 months
3. The five longest waits faced by people currently on the waiting list in days.
4. The number of children (under 18s) who have a surgical procedure cancelled or delayed at your trust, in each of the past five calendar years (2022, 2021, 2020, 2019, 2018).

General anaesthesia (GA) paediatric dental waiting times.140223.docx

Haemolytic disease of the newborn (HDN) also known as Rhesus Disease-Maternal Antibodies. 300920

I write under the Freedom of Information Act to request copies of all Clinical policies and procedures, guidelines and standards that were in use to govern the clinical decisions concerning the treatment of Haemolytic disease of the newborn (HDN) also known as Rhesus Disease/Maternal Antibodies made in the Neo-natal units within the Maidstone & Tunbridge Wells NHS Trust from 1998 to 2002.

These documents will include but not be limited to the management of :

Rhesus Disease
Haemolytic Disease of the newborn (HDN)
Neo natal jaundice in pre-term and term neonates
Hyperbilirubinemia in the newborn
Phototherapy
Exchange transfusions in neonates

And any other interventions/guidelines into how to treat Haemolytic Jaundice in newborns.

These documents pre-date NICE guidelines and the parameters of 1998 – 2002 are especially important.

Download response Haemolytic disease of the newborn (HDN) also known as Rhesus Disease-Maternal Antibodies. 300920

 

Complaints, PALS and Legal Services

Allegations of misconduct. 081117

For each of the past five financial years (12/13 – 16/17) please tell me the following:

The total number of allegations of misconduct made by employees of your trust against another employee, broken down by:
• The job category of the complainant, for example doctor, nurse, porter, receptionist.
• The nature of the alleged misconduct. For example sexual harassment, sexual assault, physical assault, theft, bullying, racism.
• The outcome of the complaint. For example, unsubstantiated, written warning, dismissed, training requirement, police informed.

Download response Allegations of misconduct. 081117

Allegations of sexual misconduct.040123.docx

1. Between 1 September 2018 and 1 September 2022, how many complaints of sexual misconduct were made by patients, visitors and Trust employees against staff members in your NHS Trust.
2. How many of the complaints were upheld?
3. What was the outcome of the upheld complaints? Outcomes can include but are not limited to verbal warning, written warning, suspension, or dismissal
If it does not push the request over the cost limit, please can you also include:
4. The nature of the allegation
5. The gender of the complainant
6. The gender of the staff member

Allegations of sexual misconduct.040123.docx

Allegations of sexual assault or sexual harassment. 081117

1- How many allegations of a) sexual assault and b) sexual harassment has your trust received against staff members in each of the past four years?
2- In how many of the cases were any of the alleged victims aged 18 or under at the time of the alleged offence?
3- In how many of the cases were any of the alleged victims current or former patients?
4- For each case, did it lead to i) internal disciplinary proceedings, ii) external disciplinary proceedings (i.e. through a regulator) and/or iii) a financial settlement.
5- For each case, please provide a broad description of the allegations involved, including the number of alleged victims / alleged perpetrators; their age (within a 10-year band); the date of the alleged offence and whether the alleged perpetrator occupied a managerial position.
6- For each case, please list the gender of the alleged perpetrator and the alleged victim. Alternatively, provide totals for the genders of the alleged perpetrators and alleged victims across all of your cases.
7- For each case which was dealt with by disciplinary proceedings, how many alleged offenders were i) fired; ii) suspended, iii) received written or verbal warnings.
8- Please provide the value of any financial settlement in each case.
9- Did any settlements (financial or otherwise) include clauses placing any restriction on the ability of the alleged victim to discuss the events involved or the institution? If so, how many?

Download response Allegations of sexual assault or sexual harassment. 081117

Amputation operations. 201119

1. A list of every amputation operation at your hospital over the past ten years.
2. The amount of cases of the above that have resulted in claims of medical negligence.
3. The amount of cases of the above that have resulted in your informing your insurers of a possible claim for medical negligence.
4. The details of each incident.

Download response Amputation operations. 201119

Breaches of the Data Protection Act.

1a.Approximately how many members of staff do you have?
1b.Approximately how many contractors have routine access to your information?

2a.Do you have an information security incident/event reporting policy/guidance/management document(s) that includes categorisation/classification of such incidents?
2b.Can you provide me with the information or document(s) referred to in 2a? (This can be an email attachment of the document(s), a link to the document(s) on your publicly facing web site or a ‘cut and paste’ of the relevant section of these document(s))

3a.Do you know how many data protection incidents your organisation has had since April 2011? (Incidents reported to the Information Commissioners Office (ICO) as a Data Protection Act (DPA) breach)
Answer: Yes, No, Only since (date):
3b.How many breaches occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

4a.Do you know how many other information security incidents your organisation has had since April 2011? (A breach resulting in the loss of organisational information other than an incident reported to the ICO, eg compromise of sensitive contracts or encryption by malware. )
Answer: Yes, No, Only since (date):
4b.How many incidents occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

5a.Do you know how many information security events/anomaly your organisation has had since April 2011? (Events where information loss did not occur but resources were assigned to investigate or recover, eg nuisance malware or locating misfiled documents.)
Answer: Yes, No, Only since (date):
5b.How many events occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

6a.Do you know how many information security near misses your organisation has had since April 2011? (Problems reported to the information security teams that indicate a possible technical, administrative or procedural issue.)
Answer: Yes, No, Only since (date):
6b.How many near-misses occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

Download response Breaches of the Data Protection Act 230516

Breast augmentation claims. 010319

1. How much money has been paid out in compensation for botched breast augmentation or botched breast enlargements? Please provide information for the last three years.
2. How many people have made successful compensation claims for botched breast augmentation or botched breast enlargements? Please provide information for the last three years.
3. How many unsuccessful claims for compensation for botched breast augmentation or botched breast enlargements has there been in the last three years?
By last three years I mean 2015, 2016 and 2017. Please provide information for each calendar year.

Download response Breast augmentation claims. 010319

Cancer complaints. 170820

Could you please tell me between 1st March 2020 and the date of this email (31st July 2020):
1) How many PALS enquiries and official complaints your Trust has received from patients concerned about
a) the impact of the coronavirus pandemic and your Trust’s response on their access to cancer treatment
b) and access to cancer testing – including tests to find out whether their cancer has spread, returned or occurred for the first time
NOTE: I suggest you search for these complaints by using the keywords ‘cancer treatment’, ‘chemotherapy’, ‘cancer testing’, ‘coronavirus’, ‘COVID-19’ and other relevant terms.
2) For the five most recent PALS enquiries/official complaints received, please provide me with
a) a summary of the complaint (e.g. a patient with stage 4 lung and breast cancer has contacted PALS to complain about their chemotherapy being indefinitely suspended)
b) the exact wording of the complaint, with redactions to remove potentially identifying information
c) what action the Trust took in response

Download response Cancer complaints. 170820

Claims relating to deep vein thrombosis (DVT) and pulmonary embolism (PE). 010319

1. How many hospital negligence claims have been made against the Trust relating to deep vein thrombosis and pulmonary embolism (blood clots) in the last five financial years?
2. Of the legal claims referred to in question 1, how much money has been paid to those who have brought claims against the Trust?
3. Please break down the data to questions 1 and 2 by hospital.

Download response Claims relating to deep vein thrombosis (DVT) and pulmonary embolism (PE). 010319

Communication and consent. 031117

1. In the past 5 years how many complaints have you had regarding communication with or supplying information to patients (written and oral)?
2. In the past 5 years how many complaints have you had regarding the inappropriate or incorrect taking of consent?
3. If the level of detail in questions 1 and 2 is unknown then please say how many complaints have you had in the past 5 years categorised as communication complaints?
4. In the past 5 years how many claims for compensation have you had involving the inappropriate or incorrect taking of consent?
5. If the level of detail in question 4 is unknown please say how many claims for compensation have you had categorised as communication claims?
6. How much did you pay the NHSLA for insurance last year?
7. Can I have a copy of your Consent to Examination or Treatment Policy?
8. If no Consent to Examination or Treatment Policy exists then can you supply me with your approved documented process for obtaining consent, as specified in the NHSLA Risk Management Standards 2013-14?
9. Can you tell me how information is provided to patients to support their decision making, including risks, benefits and alternatives where appropriate?
10. Can you tell me how the discussion and provision of information to patients is recorded?
11. Can you tell me the process for recording that consent has been given?
12. Can you tell me how your organisation monitors compliance with points 9 to 11?
13. Who has overall responsibility for your Consent to Examination or Treatment Policy? (There name would helpful)?

Download response Communication and consent. 031117

Compensation claims by staff. 070417

I would like information on the number and nature of compensation claims brought against your organisation by members of staff who have sustained an injury or contracted a disease while employed your organisation in the past five years.
I would like a year by year breakdown, preferably on an excel document via email, detailing:
Details of the injury (i.e. moving and handling injury, slips/trips/falls and so on)
Staff role if known (i.e. staff nurse, doctor)
Whether compensation was paid
The total amount of compensation paid
If information available, any action taking following the incident (i.e. additional training, non-slip flooring and so on)

Download response Compensation claims by staff. 070417

Compensation pay outs and court costs.010422.docx

1. Between January 2018 and February 2022 how much in total did the Trust spend on compensation pay outs, including court costs
2. Could you also provide the number of claims by category and the total amount of compensation for this category since 2018? e.g. ‘inadequate nursing care’ or ‘maternity

Compensation pay outs and court costs.010422.docx

Complaints. 090719

1) How many compliments did your trust receive in 2017?
2) Do you have a procedure for handling compliments?
3) Do you respond to the authors?
4) Do you pass the compliments onto to the complimentees?
5) Do management see copies of compliments?
6) Do you analyse the content of compliments?

Download response Complaints. 090719

Complaints.220323.docx

I am seeking information about the number of complaints received by your hospital trust in the past five years for the following specialties: neurosurgery, orthopaedic surgery, cardiothoracic surgery, and vascular surgery.
Specifically, I would like to request the following information for each specialty:
1. The total number of complaints received for each specialty in each of the past five years;
2. The nature of the complaint;
3. The outcome of the complaint, including any actions taken by the hospital trust to address the issue;
I did have a quick question as to whether I could incorporate two further questions into my request. This would put any complaint data you able to provide into an appropriate context (e.g. to contextualise 10 complaints with the fact 1,000 operations were performed):
4. Number of operations performed in the past five calendar years for the following specialties: neurosurgery, orthopaedic surgery, cardiothoracic surgery, and vascular surgery;
5. Number of reportable / recordable patient safety incidents in the past five calendar years for the following specialties: neurosurgery, orthopaedic surgery, cardiothoracic surgery, and vascular surgery
a. Breakdown by incident category (if available);
Complaints.220323.docx

Complaints.241123.docx

All questions are shown as received by the Trust.
Between 1st September 2022 and 31st August 2023 (inclusive). Specifically, I would like to know:

How many women inpatients complained that a trans woman inpatient was being cared for in the same ward as the complainant?

For the avoidance of doubt, it may be helpful for me to note that my question is in reference to written complaints (which may have been originally made orally and subsequently recorded in writing) received by the Trust.

Complaints.241123.docx

Complaints. 280119

1. Does the Trust routinely publish the complaints data it reports to NHS Digital (KO41a) via any other public channel, i.e. on your website (please indicate YES or NO in the box below)? If YES, please provide details of where and how frequently you publish this data.
Further information on publication:
2. Does the Trust routinely publish, make public or evidence the outcomes and/or learning taken from complaints received (please indicate YES or NO in the box below)? If YES, please provide details of where and how frequently you publish this data.
Further information on publication:
3. Do you record complaints made by third parties who don’t have the expressed consent of the patient(s)? I.e. members of the public, people visiting other patients and/or external non-medical contractors who have concerns about the way patients are being treated or cared for.
4. If you record complaints made by third parties, please could you provide the numbers of complaints received by your NHS Trust for the following financial years?
5. Do you record complaints made by third parties in your official complaints figures as reported to NHS Digital (KO41a)?

Download response Complaints. 280119

Complaints about noise for 2013 – 2016.

How many noise-related complaints the organisation has received in the past three years? For each year, I would like to know:
The department/ward the noise-related complaint refers to
Who made the complaint (patient/relative/staff member etc.)
The nature of the complaint – i.e. if it is noise from staff, noise from another patient, equipment, building work etc.
I would also to know if your organisation has a noise policy or any noise-reduction measures in place – for example soft-closing doors, not transferring patients at night, ‘sleep kits’ for patients and so on.

Download response Complaints about noise for 2013 – 2016 270616

Complaints against consultants.270422.docx

I would like to know how many complaints/issues have been lodged or raised in any way about this/these consultants.

Complaints against consultants.270422.docx

Complaints and Claims.131023.docx

All questions are shown as received by the Trust.
1. How many complaints has the trust received from July 2022 to July 2023?
2. How many of these complaints are related to poor or substandard care?
3. How many medical negligence claims were lodged against the trust in the same period?
4. How much compensation has the trust paid out in medical negligence claims in the past 12 months irrespective of when the claim was made?

Complaints and Claims.131023.docx

Complaints and Racism. 040121

1) Please can you tell me the name of your Trust?
2) How many patient complaints has your Trust received, for any given reason?
Please break down into the following calendar years
2017
2018
2019
3) How many patient complaints has your Trust received, citing racism as one of the problems during the patient’s treatment?
Please break down into the following calendar years
2017
2018
2019
4) How many complaints relate to the treatment of women who have given birth in your Trust?
Please break down into the following calendar years
2017
2018
2019
5) How many of those from Q4 included racism in their complaint?
2017
2018
2019
6) How many members of staff have received some form of disciplinary action due to a complaint by a patient?
Please break down into the following calendar years and please list what action was taken.
2017
2018
2019
7) How many members of staff have received some form of disciplinary action, whereby racist behaviour towards the patient was included? Please break down into the following calendar years and please list what action was taken where possible.
2017
2018
2019
8) How many members of staff have made a complaint regarding racism from a patient?
Please break down into the following calendar years
2017
2018
2019

Download response Complaints and Racism. 040121

Complaints data for 2018-19. 151119

1. How many complaints were upheld by the Ombudsman?
2. How many complaints were partly upheld by the Ombudsman?
3. What was your complaints (3 working days) performance as a percentage?
4. What was your complaints (final response) performance target in days?
5. What was your performance as a percentage in response to this target? (e.g. 75% of complaints are answered within 25 working days or as agreed with the complainant)
6.How many days does it take on average for you to respond to a complaint?

Download response Complaints data for 2018-19. 151119

Complaints for patients admitted to A&E.241219

1. For each of the last three calendar years (2019, 2018, 2017), please provide a monthly list of the chief complaints for patients admitted to A&E, broken down by:
• The name of the chief complaint.
• The number of patients admitted to A&E for each chief complaint.
• The number of male patients admitted for each chief complaint.
• The number of female patients admitted for each chief complaint.
Please note that the Chief Complaint is the presenting symptom rather than the primary diagnosis.
2. For each of the last three calendar years (2019, 2018, 2017) please disclose the total number of patients that were admitted to A and E.
3. For each of the last three calendar years (2019, 2018, 2017) please disclose the total number of patients admitted to A and E that were not GP registered.

Download response Complaints for patients admitted to A&E.241219

Complaints made regarding communication.201222.docx

1. In your trust, in each of the last 5 calendar years, how many formal patient/family complaints were made regarding communication?
2. How many of these complaints were regarding lack of updates to Next of kin or patient families?
3. In your trust in the last 5 years, what were the top 5 categories for complaints? For example, ‘communication’ or ‘clinical care’ may be examples

Complaints made regarding communication.201222.docx

Complaints made to the End of Life Care Strategy Group. 070219

Please detail the number and type of complaints made to your End of Life Care Strategy Group in the last four years. Please break the information down into complaints per month (where possible) and whether the complaint was to do with, for example poor communication, issues to do with consent or the care itself etc. Where recorded, please also detail the outcome of the complaint.

Download response Complaints made to the End of Life Care Strategy Group. 070219

Complaints or concerns raised by staff members

1) Name of:
a) Your trust
b) The hospitals in your trust
2) Between April and October 2015, how many complaints/concerns were raised by Trust staff members regarding?
a) Staffing levels/staffing shortages
b) Shifts being filled by under-qualified staff/staff “acting up”/agency staff/locums
c) Staff overwork/unpaid overtime
d) Staff not being able to take breaks
3) What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) from September 2014 to September 2015?
4) What was the age of the patient (from question 3) and the reason for delay?
5) What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) from September 2013 to September 2015?
6) What was the age of the patient (from question 5) and the reason for delay?

Download response Complaints or concerns raised by staff members 270516

Complaints reported by members of staff (including locums, agency workers or casual staff) against other members of staff. 030322.docx

Q1.) For each of the past five years please state the number of complaints reported by members of staff (including locums, agency workers or casual staff) against other members of staff received of:
2016 2017 2018 2019 2021
a) Sexual Misconduct
b) Sexual Harassment
c) Sexual Assault
d) Rape Allegation
Q2.) By year for each of the complaints recorded above can you state the outcome following each allegation:
a) Complaint withdrawn
b) Insufficient evidence to make a finding of fact.
c) Perpetrator cautioned – or similar note made on their employment file
d) Disciplinary action
e) Sacked
Q3.) By year can you state in each category in the table how many of the complaints were referred to the police?
Q4.) By year, please state the number of settlement/compromise agreements which contain non-disclosure clauses your organisation made with current or former staff which involve or relate to sexual misconduct, sexual harassment, sexual assault, rape. For each of these, please state the number and financial value of the settlements.

Complaints reported by members of staff (including locums, agency workers or casual staff) against other members of staff. 030322.docx

Counter Fraud. 030619

1. How many people does your organisation employ?
2. What is the total annual expenditure budget of your organisation?
3. How many full-time employment staff does your organisation employ dedicated to counter fraud activities?
4. If you employ such staff, how many full-time employment staff are directly employed by your organisation?
5. If any of your counter fraud staff are supplied by another organisation, could you identify the name of the organisation(s) which supplies them?
6. Approximately how much did you spend on counter fraud activities in the last reporting year?
7. How many referrals for fraud investigation has your counter fraud team received in the last reporting year?
8. How many fraud cases has your counter fraud team successfully investigated? I.e. leading to sanction and/or recovery of monies in the last reporting year.

Download response Counter Fraud. 030619

Counter fraud provision. 230920

1. Staff headcount at your organisation?
2. Annual budget of your organisation for the financial year 2019-2020?
3. What is your organisation provider type (as recorded on your SRT submission – i.e. Acute teaching, Ambulance)?
4. Who provides your organisations counter fraud provision? (In house – NHS consortium – Private provider)
5. How many days were recorded for proactive counter fraud work (Strategic governance, Inform and Involve & Prevent & Deter) carried out at your organisation during the financial year 2019-20?
6. How many days were recorded for carrying out reactive investigation work at your organisation during the financial year 2019-20 (hold to account)?
7. How many counter fraud referrals did your organisation receive during the financial year 2019-2020?
8. What was the recorded fraud loss identified by your organisation during the financial year 2019-2020?
9. What was the amount of fraud losses recovered by your organisation during the financial year 2019-2020?
10. How many criminal sanctions relating to fraud, bribery and corruption did your organisation apply during the financial year 2019-2020?
11. How many disciplinary sanctions relating to fraud, bribery and corruption did your organisation apply during the financial year 2019-2020?
12. What was the cost of counter fraud staffing or outsourced counter fraud provision to your organisation during 2019-2020 for – Strategic Governance, Inform and Involve and Prevent and Deter?
13. What was the cost of counter fraud staffing or outsourced counter fraud provision to your organisation during 2019-20 for – Hold to Account?

Download response Counter fraud provision. 230920

Court intervention. 141119

1. “Since 01 January 2017, please specify the number of individual cases where the Court has had to intervene in the treatment of a critically ill child, when there has been a difference of opinion between parents and doctors, over the course of treatment for that child?”

Download response Court intervention. 141119

Delayed discharge and court action. 070317

1. Since 1.1.15 how many times have you taken court action to evict a patient from a hospital in your trust because you believe they are fit for discharge but they have failed to leave their hospital bed? For each occurrence please state how many days they had occupied a hospital day for while considered fit for discharge?
2. Of those patients discharged from your hospital in either 2014/15 or 2015/16 please state how many patients had been considered fit to discharge but remained in hospital in excess of one full calendar year before they were discharged? For each patient please state how many days they occupied a hospital bed while considered fit to discharge?
3. Using the most recent convenient date do you have any patients in your hospital who are considered fit to discharge but have been in hospital and been fit to discharge in excess of one full calendar year? For each patient please state how many days they have occupied a hospital bed while considered fit to discharge?

Download response Delayed discharge and court action. 070317

Employees who have left the Trust as a result of judicial mediation 2011 – 2016

1. For each of the past five financial years, what was the total number of employees that left your trust through judicial mediation?
2. For each of the last five financial years how much was paid to departing employees through judicial mediation? Again, I am looking for annual breakdowns of the data.
The annual breakdown should include the following three elements;
A – The statutory amount the employee received (i.e. the sum to which they were legally entitled for redundancy).
B – The amount paid in special severance payments.
C – The overall total of statutory and special severance payments.
3. For each of the past five financial years, how many of the employees who left through judicial mediation signed a settlement agreement (formerly known as a compromise agreement)?
4. For each of the past five financial years, how many employees who left through judicial mediation agreed a confidentiality clause?
5. Taking the definition of confidentiality clauses used in Question 4, for each of the past five financial years, how many fell under the definition 1? 2? 3? Other?
6. For each of the past five financial years, how many staff who left via judicial mediation received an agreed reference?
7. For each of the past five financial years, how many of the judicial mediation cases were referred to the Department for Health/Treasury for sign off?

Download response Employees who have left the Trust as a result of judicial mediation 2011 – 2016

Employment tribunal claims and costs.081123.docx

All questions are shown as received by the Trust.
I am requesting information from the following financial years: 2018/19; 2019/20; 2020/21; 2021/22; 2022/23; and 2023/24 to the present day.
Please disclose the following:
1. How many employment tribunal (ET1) claims have been made against the organisation since 2018/19;
If possible, please break this down by type (e.g., public interest disclosure, unfair dismissal, discrimination). If this breakdown takes too long to respond to the FOI then please omit it.
2. Of those ET1 claims, how many have been defended against by the organisation since 2018/19;
Again, continue with a breakdown by type. If this exceeds the time limit then please omit it from the FOI request.
3. The outcomes from each claim (e.g., 12 were in favour of the claimant, 24 were in favour of the respondent, 53 were discontinued/settled out of court);
4. How much (£) has the organisation spent on defending claims since 2018/19; and
If possible, please provide total figures based on case outcomes (e.g., £200,000 where the tribunal favoured claimant, £120,000 where the tribunal favoured respondent).

If this takes too much time, please provide the total figure for each financial year (e.g., £500,000 in 2018/19, £250,000 in 2019/20).
5. Of the cases defended, how many led to an employment tribunal ruling the organisation must pay costs to the claimant;
If possible, please provide figures for each individual case alongside the total. If this takes too much time, please provide the total figure for each financial year (e.g., £500,000 in 2018/19, £250,000 in 2019/20).
Please also break this down by case type. However, as with above, if this takes too long then please omit it from the FOI.
If question 5 takes too long to answer alongside questions 1-4, then please omit it from the FOI request.

Employment tribunal claims and costs.081123.docx

Enforced DNR. 300317

The number of patients who have been taken to the Royal Courts of Justice Court of Protection, to have a DNR placed upon their lives by your hospital. I would like to know if the patient had a Lasting Power of Attorney and the sex, age, ethnicity of the patients and the length of time each case took & outcomes of each case. From when the hospital opened to the present day.

Download response Enforced DNR. 300317

Ethnicity or national identity of the perpetrators and the victims in cases of sexual misconduct and violence.060723.docx

In the recent BBC health news, published on 23rd May 2023, suggesting that more than 35,000 incidents of sexual misconduct and sexual violence were recorded on NHS premises between 2017 to 2023.
I seek information regarding the ethnicity or national identity of the perpetrators and the victims in cases of sexual misconduct and violence in your Trust.

Ethnicity or national identity of the perpetrators and the victims in cases of sexual misconduct and violence.060723.docx

External law firm services. 161121.docx

1. What is your spend with external law firms
2. Do you use eBilling technology to manage your law firms billing (e.g. systems such as Legal Tracker, Brightflag, Apperio, CT Tymetrix, Mitratech etc.)
3. Who is your head of legal / general counsel
4. Do you have a law firm panel / preferred supplier list / use a framework to buy your external law firm services

Download response External law firm services. 161121.docx

External Law Firms.030124.docx

All questions are shown as received by the Trust.
1. What is your spend with external law firms (please provide for the last 4 financial years)?
2. Do you use eBilling technology to manage your law firms billing (e.g. systems such as Legal Tracker, Brightflag, Apperio, CT Tymetrix, Mitratech etc.)?
3. Who is your head of legal / general counsel (please provide email address)?
4. Do you have a law firm panel / preferred supplier list / use a framework to buy your external law firm services? Please provide details where possible.

External Law Firms.030124.docx

External legal advice

1. How many members of staff are directly employed at the Trust at present as of 24 August 2015?
2. What was your external legal advice expenditure from 01/04/2014 to 31/03/2015?
3. What is your budget for external legal advice for the current financial year?
4. Please provide the list of the solicitors instructed for external legal advice from 01/04/2014 to 31/03/2015.
5. Please provide the full structure of your legal services team (titles of the positions- no names are required).
6. Please provide your Trust’s policy which relates to the process of provision of internal legal advice to the members of staff within your Trust.
7. Please provide the name of the software or system which you use for the claims management.
8. Please provide the annual cost of your claims management system.
9. Please provide the name of the software or system which you use for the complaints management.
10. Please provide the annual cost of your claims management system.
11. How many active Coroner’s Inquest cases are you managing at your Trust as of 24 August 2015?
12. How many active clinical negligence claims against your Trust as of 24 August 2015 (claims reported to the NHSLA)?
13. How many active clinical negligence claims against your Trust as of 24 August 2015 (claims not reported to the NHSLA)?
14. How many active Employer’s Liability claims against your Trust as of 24 August 2015 (claims reported to the NHSLA)?
15. How many active Employer’s Liability claims against your Trust as of 24 August 2015 (claims not reported to the NHSLA)?
16. How many active Public Liability claims against your Trust as of 24 August 2015 (claims reported to the NHSLA)?
17. How many active Public Liability claims against your Trust as of 24 August 2015 (claims not reported to the NHSLA)?
18. Please attach a relevant policy and a flowchart which describe the process of how your legal services team communicates the lessons learned from the claims and coroner’s inquests to the relevant teams across the Trust, to ensure the effective risk management and prevention of similar incidents and to improve care provided.
19. Please provide two, most recent, monthly claims management/ legal services reports. If you do not have monthly reports please provide two most recent quarterly reports.

Download response External legal advice 280716

External legal spend

1. What does your organisation spend on legal fees e.g. external legal advice and what is the breakdown of fees and expenses.
2. What is the breakdown of spend e.g. what percentage of work is completed on an hourly rate basis, capped fee, fixed fee etc. We do not break it down in these terms.
3. Who in your organisation is responsible for managing external legal spend-
4. What controls do you have in place to manage external legal counsel spend?
5. Do you use any of the eBilling (also known as Enterprise Legal Management or Legal Spend Management) tools (e.g. Serengetti, Mitratech, CT Tymetrix, Datacert etc.) available in the market to manage your legal spend – if yes what are you currently paying for this system and does the vendor charge your firms to use the same
6. Do you use a matter management system and if yes how much do you pay for the system.
7. How do you decide if work is completed internally or by external counsel?
8. What performance management do you complete with your external legal counsel to ensure you are receiving value for money?
9. What is the breakdown of spend e.g. % of time billed by partner, by senior associate, junior associate, trainee and paralegals etc.
10. What is the breakdown of your legal spend by location e.g. how much work is performed in London, Manchester, Birmingham, Edinburgh, Glasgow, Cardiff, Belfast etc.
11. How do you measure what value added services law firms provide to you (e.g. free advice, free training, free secondees etc.)
12. Do you use external consultants to advice on how to manage your legal spend more effectively. If yes, who and what have you spent with them in the last 12 months

Download response External legal spend 180216

Fat shaming 2021.270522.docx

1) How many official complaints and PALS concerns your Trust received from patients alleging they had been discriminated against or badly treated by a member of staff because of their being overweight or obese
2) Can you select the first five such complaints from 2021 and provide me with the following details:
a. What type of staff member was the complaint levelled against? E.g. healthcare assistant, junior doctor, consultant, cleaner, kitchen staff
b. Please quote the words allegedly used by the hospital staff or summarise the offending action
c. Please tell me what, if any, action was taken by your trust in response to these five sample complaints from the beginning of 2021

Fat shaming 2021.270522.docx

Fat shaming complaints. 020620

Could you please tell me for the calendar year 2019:
1) How many complaints through the patient advice and liaison system (PALS) your Trust received from patients alleging they had been discriminated against or badly treated by a member of staff because of their being overweight or obese
Please do this by searching for complaints containing any of the words “weight”, “fat”, “obese”, “overweight” and “bariatric” and filtering these to find those that refer to fat-shaming comments made by a member of staff.
2) Can you select the first five such complaints from 2019 and provide me with the following details:
a. What type of staff member was the complaint levelled against? E.g. healthcare assistant, junior doctor, consultant, cleaner, kitchen staff
b. Please quote the words allegedly used by the hospital staff or summarise the offending action
c. Please tell me what, if any, action was taken by your trust in response to these five sample complaints from the beginning of 2018

Download response Fat shaming complaints. 020620

Fat shaming complaints. 140521

1) How many complaints through the patient advice and liaison system (PALS) your Trust received from patients alleging they had been discriminated against or badly treated by a member of staff because of their being overweight or obese
Please do this by searching for complaints containing any of the words “weight”, “fat”, “obese”, “overweight” and “bariatric” and filtering these to find those that refer to fat-shaming comments made by a member of staff.
2) Can you select the first five such complaints from 2020 and provide me with the following details:
a. What type of staff member was the complaint levelled against? E.g. healthcare assistant, junior doctor, consultant, cleaner, kitchen staff
b. Please quote the words allegedly used by the hospital staff or summarise the offending action
c. Please tell me what, if any, action was taken by your trust in response to these five sample complaints from the beginning of 2020

Download response Fat shaming complaints. 140521

Fat-shaming complaints. 210519

Could you please tell me for each of the years 2016, 2017 and 2018

How many complaints through the patient advice and liaison system (PALS) your trust received from patients alleging they had been discriminated against or badly treated by a member of staff because of their being overweight or obese.

Please do this by searching for complaints containing any of the words “weight”, “fat”, “obese”, “overweight” and “bariatric” and filtering these to find those that refer to fat-shaming comments made by a member of staff.

Can you select the first five such complaints from 2018 and provide me with the following details:

1. What type of staff member was the complaint levelled against? E.g. healthcare assistant, junior doctor, consultant, cleaner, kitchen staff

2. Please quote the words allegedly used by the hospital staff or summarise the offending action

3. Please tell me what, if any, action was taken by your trust in response to these five sample complaints from the beginning of 2018

Download response Fat-shaming complaints. 210519

Food poisoning. 020819

1. How many inpatients developed food poisoning (relating to E.coli, listeria, campylobacter, salmonella or other) during a stay at the hospitals in your trust between the end of May 2018 and the end of May 2019?
2. How many inpatients developed food poisoning (relating to E. coli, listeria, campylobacter, salmonella or other) during a stay at the hospitals in your trust between the end of May 2013 and the end of May 2014?
3. Are meals prepared on site or off the premises by an outside provider?
4. How many complaints did you receive about hospital food between the end of May 2019 and the end of May 2018?
5. How many complaints did you receive about hospital food between the end of May 2013 and the end of May 2014?

Download response Food poisoning. 020819

Formal Grievances.080923.docx

All questions are shown as received by the Trust.
1. The number of Formal Grievances lodged by employees at Maidstone and Tunbridge Wells NHS Trust since the 1st January 2015.
2. The number of occasions on which the Trust employed the use of a protected conversation in their handling of a Formal Grievance by an employee in the same time period.
3. The number of those protected conversations which went on to lose their legal protection as a result of improper behaviour on behalf of the Trust’s representative. Improper conduct includes but is not limited to:
• all forms of harassment, bullying and intimidation, including through the use of offensive words or aggressive behaviour;
• physical assault or the threat of physical assault and other criminal behaviour;
• all forms of victimisation;
• discrimination because of age, sex, race, disability, sexual orientation, religion or belief, transgender, pregnancy and maternity and marriage or civil partnership; and
• putting undue pressure on a party

Formal Grievances.080923.docx

Grievance complaints in the last five years.

1. The number of all the Grievance complaint cases dealt with by MTW Trust in the last five years?
2. The outcome of these cases:
a. Numbers and percentage of Grievance cases accepted
b. Numbers and percentage of Grievance cases upheld
c. Number of staff members suspended, demoted or sacked within a year of making a grievance complaint.
3. Numbers and percentage of cases made by BME members of staff.
4. Outcome of BME grievance complaints in numbers and percentage as successful or upheld
5. Number of BME staff members suspended, demoted or sacked within a year of making a grievance complaint.

Download response Grievance complaints in the last five years 270616

Grievances and bullying and harassment complaints.141222.docx

1. Please can you detail the number of grievances & bullying and harassment complaints that have been raised in the last 5 years.
1st April 2018 – 31st March 2019
1st April 2019 – 31st March 2020
1st April 2020 – 31st March 2021
1st April 2021 – 31st March 2022
1st April 2022 – 31st November 2022
2. How many of the above cases remain unresolved as of 31st November 2022.
3. What number of employees, who have raised a grievance or B&H complaint since 1st April 2018, remained at the Trust, in their same role, one year after their complaint was concluded?
4. What number of respondents* involved in grievance or B&H complaints since 1st April 2018, remained at the Trust, in their same role, one year after their complaint was concluded?
*respondent refers to the person who is the subject of the grievance or bullying and harassment complaint.

Grievances and bullying and harassment complaints.141222.docx

 

Coronavirus COVID-19

BAME staff. 131120

Background Information:
How many clinical staff do you employ and how many are BAME? (inc locum/bank/agency)?
Questions:
1.How many BAME staff and how many non BAME staff have been working in ‘Covid wards’:
• In March/In April/In May so far.
2.How many redeployment requests were received from BAME and non BAME staff (inc locums/bank/agency)? And how many have been redeployed as a result?
• In March/In April/In May so far.
3.Since the NHS England guidance on Risk Assessments was issued during the Covid crisis, how many Risk Assessments have you carried out of your BAME staff?
4.How many BAME staff (inc locums/bank/agency) have been successfully redeployed since this Risk Assessments guidance was issued, as a direct result of it?
5.How many complaints or reports of discrimination by BAME and non BAME staff (inc locum/bank/agency) have been made regarding deployment since Covid hit i.e start of March?

Download response BAME staff. 131120

BAME staff risk assessments. 100620

Q1. Please state (yes or no) whether your trust has carried out a risk-assessment of staff at potentially greater risk of COVID-19, including people from Black, Asian and Minority Ethnic backgrounds. [If answer to Q1 is yes, please answer questions 2-5]
Q2. Please state when this risk assessment was carried out.
Q3. Please provide a short summary of what the risk assessment entailed.
Q4. Please provide a copy of the findings of the risk assessment.
Q5. Please list and provide brief details of any measures that your trust has subsequently put in place to offer protection to staff who are at higher risk from COVID-19.

Download response BAME staff risk assessments. 100620

Bed capacity and hospital admissions.110722.docx

“1) Bed Capacity – last 5 years: Please provide average bed capacity for the previous five years as follows:
Total Bed Capacity (all wards).
Covid-19 Bed Capacity
2) Bed Capacity for 2021: Please provide bed capacity for the current year so far. For comparative purposes please use the following period each month: The first Wednesday of every month between the hours of 12noon and 4.00pm.
Total Bed Capacity (all wards)
Covid-19 Bed Capacity
3) Hospital Admissions – last 5 years: Please provide number of Admissions (all causes) for the previous five years as follows:
All Admissions
Admissions – where the patient has received 1 or more dose of an authorised Covid-19 Vaccination
Admissions – where the patient has NOT received any Covid-19 vaccination
4) Hospital Admissions for 2021: Please provide total number of admissions (for all causes) by month for the current year so far, split by Covid-19 vaccinated and unvaccinated.
All Admissions
Admissions – where the patient has received 1 or more dose of an authorised Covid-19 Vaccination
Admissions – where the patient has NOT received any Covid-19 vaccination
5) PCR Result of Hospital Admissions: Please provide breakdown of number of patients testing positive/negative with a Covid-19 PCR Test 2019 and 2020
Number of Patients testing positive with a Covid-19 PCR Test
Number of Patients testing negative with a Covid-19 PCR Test
6) PCR Result of Hospital Admissions for 2021: Please provide breakdown of number of patients testing positive/negative with a PCR test for the current year
At the time of Admission
No of Patients testing positive
No of patients testing Negative
7) Covid-19 Specific Admissions: Please provide total number of patients admitted where the primary reason for treatment was Covid-19 in 2019 and 2020.
Total number of Admissions where the primary treatment was for Covid-19
8) Covid-19 Admissions for 2021: Please provide number of Covid-19 admissions for 2021 where the primary reason for treatment was Covid-19
Total number of patients admitted where the primary reason for treatment was Covid-19”

Bed capacity and hospital admissions.110722.docx

Completely unvaccinated Covid-19 admissions and those who have had one or more vaccinations. 170322.docx

Could I please ask for an honest breakdown of your covid admissions? A surgeon in your employment has shared the above information and I’d just like to know how many are completely unvaccinated and who have had one or more vaccinations.

Completely unvaccinated Covid-19 admissions and those who have had one or more vaccinations. 170322.docx

Coronavirus outreach working. 310320

Due to recent concerns and government changes in advice related to working (regarding the Coronavirus), we are putting together our plan for our staff that are working from outreach locations.

We are getting in touch with all outreach locations our staff work from to ask for their plans/policies in light of the Coronavirus. Are we able to get your plan also?

Download response Coronavirus outreach working. 310320

Coronavirus transmission in hospital. 071020

1. The number of patients in your hospital(s) who tested positive for Covid-19, having tested negative at their time of admission
2. The number of these patients who subsequently died from Covid-19.

Download response Coronavirus transmission in hospital. 071020

Covid-19. 020321

1. Confirmation that all reported cases of SARS-COV2 in your Trust have been diagnosed and confirmed by PCR test;
2. If not with a PCR test, provide details of what method was employed to confirm the presence of SARS-COV2;
3. Details of the laboratories performing the PCR tests producing the confirmation of SARS-COV2 on behalf of your Trust;
4. Details of the Ct thesholds currently employed in the PCR tests performed by the labs at 3.;
5. Details of the Ct thresholds used to confirm all reported cases of SARS-COV2 in your Trust between 01/01/2020 and 18/12/2020;
6. Details of the manufacturers of the PCR tests used to confirm the presence of SARS-COV2 in your Trust;
7. In the document “Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR” published on the UK government website, page 7 includes the statement “Some commercial RT-PCR techniques are closed ‘black box’ systems whereby the operator cannot observe the reaction in real-time and the result is interpreted by software into a qualitative non-interrogatable positive or negative result.”
a. Please confirm which manufacturers have been engaged that employ such a ‘black box’ method,
b. which labs have used such a manufacturer, and
c. which results confirming the presence of SARS-COV2 in the UK have been based on such techniques;
8. Where such results have been produced using the ‘black box’ method, please describe what further action was taken to confirm the results produced by the ‘black box’ method.

Download response Covid-19. 020321

Covid-19. 040221

1. The number of hospital patients who tested positive for Covid-19 after initially testing negative between November 30 2020 and 31 January 2021.
2. The number of these patients who subsequently died
3. If available, please could I have details of the date of admission, the reason for their initial hospital admission e.g. fractured bone, chest infection, the date of the positive test and the date of their death.

Download response Covid-19. 040221

Covid-19. 110621

1. How many people have dies from Covid-19 in the Maidstone & Tunbridge Wells NHS Trust hospitals from 1st January 2020 to 1 May 2021? This is only to include patients who have had Covid-19 tests and have not died with pre-existing conditions.
2. How many patients at Maidstone & Tunbridge Wells NHS Trust hospitals are currently there, currently confirmed with Covid-19?

Download response Covid-19. 110621

Covid-19. 130121

1. Please can you provide a breakdown of data of actual Covid-19 cases that the Maidstone and Tunbridge Wells Trust have dealt with since the start of the pandemic? This includes the following:
Actual cases
By age group
Survival rates by age group
Death rates by age group and if they have underlying conditions (comorbidities)

2. Can you also confirm what treatments you are using to treat real cases.

Download response Covid-19. 130121

Covid-19. 150221

1. Number of beds that are currently being used for COVID-19 patients across the health authority covering Tunbridge Wells and Maidstone
2. The information for the number of beds that were being used for the same winter period last year
3. The actual number of fatalities due to COVID-19 this year for this area.
4. The number of flu cases last year that resulted in death for the same period
5. The numbers of COVID-19 cases pre lockdown and post lockdown

Download response Covid-19. 150221

Covid-19. 181220

1. How many people have died from Covid 19, without any pre-existing medical conditions?
2. How many Covid 19 patients are you currently treating at hospitals in the Trust (Maidstone and Tunbridge Wells)?
3. How many of those patients are in intensive care units?
4. What is the total number of beds available in the Trust?

Download response Covid-19. 181220

Covid-19. 220421

Since 1 March 2020 up to the present day (17th December)
1. Please can you tell me how many patients with respiratory conditions were admitted to covid-19 wards at the trust.
a. Please include the date they were admitted.
b. Please can you also tell me how many of these patients were tested for covid-19
c. please also include the date of the first test,
d. the date of the result
e. whether the result was positive or negative.
If you are unable to answer these questions,
2. Please could you tell me how many patients with respiratory conditions were admitted to covid-19 wards at the trust?
3. How many of these patients tested positive for covid-19 before they were admitted to a covid-19 ward.

Download response Covid-19. 220421

COVID-19. 220920

How many people have been admitted to the Trust’s Hospitals with Covid 19 since the 1st August 2020 and how many have survived or died as a consequence please up to today’s date of the 18th August 2020.

Download response COVID-19. 220920

Covid-19. 260321

You asked:
Please can you supply me with the following monthly data for the trust, for March, April, May, June, July, August, September, October, November and December 2020?
1. How many people were unable to have treatments for illnesses and conditions due to the Covid-19/Coronavirus crisis?
2. How many of these cases were for life threatening illnesses and conditions?
3. How many people had further health complications because of missing these treatments?
4. How many people died because of missing these treatments?
5. How many mental health admissions were due to COVID 19/coronavirus issues?
6. How many Covid 19/Coronavirus patients were in intensive care units?
7. Total number of beds in the trust at the time?
8. How many of these beds were occupied?
If applicable, could you also provide the following:
9. Community Occupancy %
10. Adult Mental Health Beds Occupancy %
11. Older Adult Mental Health Occupancy %
12. How many of the patients died FROM Coronavirus/Covid-19
13. How many of the patients died WITH Coronavirus/Covid-19

Download response Covid-19. 260321

Covid-19. 30.04.21

1) Between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available), how many Covid-19 infections in patients were hospital acquired?
i) of these, how many were probable infections (i.e. within 8-14 days of admission to hospital)?
ii) and how many were definite infections (15 days or more after admission to hospital)?
2) Of those who acquired Covid-19 while in hospital between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available), how many died?
3) What was the total number of Covid-19 deaths at your trust between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available)?
4) How many members of staff contracted Covid-19 between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available)?
5) How many members of staff were absent from work due to Covid-19 between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available)?
6) How many members of staff died due to Covid-19 between 1 March 2020 and 1 March 2021 (or the most recent date for which figures are available)?
7) What is the total number of Covid-19 infections a) among patients and b) among staff recorded at your trust between 1 March 2020 and 1 March 2021?

Download response Covid-19. 30.04.21

Covid-19. 300421

Please provide me with freedom of information on the evidence that COVID-19 has been isolated (a pure sample containing no other genetic material other than COVID-19 i.e. just COVID-19).

Download response Covid-19. 300421

Covid-19 and patients resident in care homes. 240620

1) How many covid-19 outbreaks have there been in care homes in your region between March 1st and June 16th 2020?
2) How many care homes did you provide oxygen to as a result of covid-19 outbreaks between?
a) March 1st to April 15th
b) April 15th to June 16th
3) How many hospital patients were discharged to care homes between?
a) March 1st to April 15th
b) April 15th to June 16th
4) How many hospital patients discharged to care homes were tested for covid-19? Please give totals for:
a) March 1st to April 15th
b) April 15th to June 16th
5) How many of the test results in Q4 were:
a) positive
b) negative
c) inconclusive/ void
6) How many of the hospital patients discharged to care homes who tested positive for covid-19 were asymptomatic?
7) How many covid-19 related ambulance call-out requests did you receive from care homes between?
a) March 1st to April 15th
b) April 15th to June 16th
8) How many of the call-out requests referred to in Q6 did you send an ambulance to between?
a) March 1st to April 15th
b) April 15th to June 16th
9) How many care home residents did you admit to hospital between March 1st to June 16th. Please give totals for:
a) Those with suspected or confirmed covid-19
b)Non-covid-19 related patients

Download response Covid-19 and patients resident in care homes. 240620

Covid-19 and pregnancy. 310321

1. The number of pregnant women your trust has treated for Covid-19 between 1st March 2020 and 31st January 2021?
2. The number of pregnant women your trust has treated in ICU for Covid-19 between 1st March 2020 and 31st January 2021?
3. The number of women who had recently given birth that required treatment for Covid-19 by your trust between 1st March 2020 and 31st January 2021?
4. The number of women that had recently given birth and required treatment for Covid-19 in ICU at your trust between 1st March 2020 and 31st January 2021?
5. The number of maternal deaths in your trust where Covid-19 or a Covid-19 related illness was recorded as the cause of death between 1st March 2020 and 31st January 2021?
6. The total number of maternal deaths (from all causes) in your trust for the period 1st March 2020 to 31st January 2021?
7. The total number of maternal deaths (from all causes) in your trust for the period 1st March 2019 to 31st January 2020?
8. The number of pregnant workers in your trust (employees, agency workers, self-employed or locum) that are currently in patient-facing roles?

Download response Covid-19 and pregnancy. 310321

Covid-19 and suicide deaths. 160621

I would like to know how many people died of covid-19 in this trust with no pre-existing health conditions from march 2020 until present and how many suicide deaths you have had vs the same time frame can I also have this in age breakdown please.

Download response Covid-19 and suicide deaths. 160621

Covid-19 antibody testing. 150720

Of the Covid-19 antibody tests conducted to date among staff at your trust, please provide information on:

• The proportion of staff that are antibody positive
• The proportion of BAME staff who are antibody positive

Download response Covid-19 antibody testing. 150720

Covid-19 deaths. 101220

1. The number of actual deaths within the trust (for both hospitals) due to Covid-19 for the period February 2020 to September 2020 (inclusive).
2. All Deaths from October 2020 to present.

Download response Covid-19 deaths. 101220

Covid-19 deaths. 1012202

I would like to know how many deaths the hospital has recorded of Covid 19 in the months between February 1st and December 1st.

Download response Covid-19 deaths. 1012202

Covid-19 deaths. 1012203

The actual number of Covid-19 deaths for the period- February 2020 to November 2020 within the Maidstone and Tunbridge Wells Trust In addition the number of Covid-19 deaths with underlining medical conditions.

Download response Covid-19 deaths. 1012203

Covid-19 deaths. 130121

How many people have died in your hospitals from Covid 19 alone? As in they died only due to Covid 19. I can see the figures that you publish online, but these are deaths within 28 days of a positive Covid test, so they could have died from other causes. I just want to know the exact figure from 1st February 2020 until the 20th December of people that have died due to Covid-19 and not anything else please.

Download response Covid-19 deaths. 130121

Covid-19 deaths. 151220

I would like to enquire as to the amount of Covid 19 deaths with no pre-existing health conditions.

Download response Covid-19 deaths. 151220

Covid-19 deaths. 151220

I am writing to ask how many deaths you have had of covid-19 or coronavirus since March 2020.

Download response Covid-19 deaths. 151220

Covid-19 deaths.200522.docx

All questions pertain to the following dates: 01/12/2019 to 30/11/2021. I would like to know the following:
1.a) How many people have died in your hospitals within 28 days of testing positive for COVID-19?
1.b) Of those people, how many had underlying health conditions / co-morbidities and how many did not? Please provide absolute numbers and percentages.
1.c) Please also state the top 5 underlying health conditions / co-morbidities of those people.
1.d) Please state how many of those people were vaccinated and how many were not. Please provide absolute numbers and percentages. For vaccinated people, please break down the response in the following way: i) received one dose, ii) received two or more doses.
2.a) How many people have died in your hospitals purely and only due to COVID-19?
2.b) Of those people, how many had underlying health conditions / co-morbidities and how many did not? Please provide absolute numbers and percentages.
2.c) Please also state the top 5 underlying health conditions / co-morbidities of those people.
2.d) Please state how many of those people were vaccinated and how many were not. Please provide absolute numbers and percentages. For vaccinated people, please break down the response in the following way: i) received one dose, ii) received two or more doses.

Please keep the numbers/figures/percentages/etc. provided in response to questions 2.a-d separate from the numbers/figures/percentages/etc. provided in response to questions 1.a-d. If that is not possible, please clearly indicate which numbers are combined.

Covid-19 deaths.200522.docx

Covid-19 deaths. 221221.docx

I am requesting that within the dates of 01/03/2020 – 01/11/2021 can you supply the total number of deaths from COVID-19 alone, not within 28 days of a positive test, from all the hospitals in your trust.

Download response Covid-19 deaths. 221221.docx

Covid-19 deaths. 241220

I am writing to ask how many patients admitted to the Trusts hospitals to date have died of COVID-19 (SARS COV2) I am excluding patients who died from something else and at the time tested positive for covid-19.
I am excluding cases where covid-19 is mentioned on the death certificate but the patient did not test positive.

Download response Covid-19 deaths. 241220

Covid-19 deaths. 311220

• How many people have died in your hospital only due to Covid 19 alone? As in they died only due to Covid 19.
I can see the figures that you publish online, but these are deaths within 28 days of a positive covid test, so they could have died from other causes. I just want to know the exact figure from 1st February 2020 until 30th November 2020 of people that have died due to covid 19 and NOT anything else please.

Download response Covid-19 deaths. 311220

Covid-19 deaths. 311220 2

Under the freedom of information act, please could you send me the exact numbers of people who have died of Covid 19 or Corona virus from February 2020 to December 31st 2020.

I would like the numbers you provide to only include people who have died without any other underlined illnesses.

Download response Covid-19 deaths. 311220 2

Covid-19 deaths and adverse vaccination effects. 020721

1. How many patients have been reported to have died from “Covid -19” as the main / primary cause of death with no major underlying health issues between March 2020 – December 2020?
2. How many patients have been reported to have died from “Covid -19” as the main / primary cause of death with no major underlying health issues between January 2021 – June 2021?
3. How many patients have been reported to have died having suffered severe adverse effects from the covid-19 “vaccinations? From January 2021 – June 2021?
4. How many patients have reported and been hospitalised following adverse effects from the Covid-19 “vaccinations? From January 2021 – June 2021?

Download response Covid-19 deaths and adverse vaccination effects. 020721

Covid-19 deaths and PCR testing. 020721

1. Please could you give me the number of deaths whereby covid is the sole cause of death listed. There were no pre-existing conditions or comorbidities noted on the death certificate covering the period March 2020 until present day. Please also provide the average age of death.

2. I would also like the number of cycles you run your PCR tests on normally as well as the number of cycles you run when you are aware the patient has been vaccinated.

If there is a difference between cycles used on patients compared to vaccinated patients please explain why.

Download response Covid-19 deaths and PCR testing. 020721

Covid-19 deaths and still births. 041021.docx

Please could you send me the figures for all hospitals covered under the Maidstone and Tunbridge Wells trust.
1. How many pregnant ladies have died of covid with no pre-existing medical conditions in 2020 and 2021.
2. How many new born babies with no medical conditions have died of covid in 2020 and 2021.
3. How many still births you have had as a result of a pregnant mother having covid in 2020 and 2021.
4. The total number of still births for the last 5 years per year.

Download response Covid-19 deaths and still births. 041021.docx

Covid-19 deaths and suicides. 160621

1. I would like to know how many people died of cover 19 in this trust with no pre-existing health conditions from March 2020 until present.
2. How many suicide deaths you have had vs the same time frame can I also have this in age breakdown please.

Download response Covid-19 deaths and suicides. 160621

Covid-19 deaths and vaccinations. 060421

1. I would like to know how many people have died in your hospitals from COVID-19 alone. As in they died only due to COVID-19. I can see the figures that you publish online, but these are deaths within 28 days of a positive COVID test, so they could have died from other causes. I just want to know the exact figure from 1st February 2020 until 28th March 2021 of people that have died due to COVID-19 and not anything else.
2. The percentage & number of people with underlying health conditions in the overall total.
3. The percentage & number of those without underlying health conditions.
4. If someone had died outside of the 28 days of testing positive would COVID-19 still be their cause of death i.e. Covid-19 (pneumonia) or would it just be pneumonia?
5. Lastly, the vaccination is authorised for emergency use only and is still in live clinical trials until 2023, do you make patients aware of this before they are given their vaccine?

Download response Covid-19 deaths and vaccinations. 060421

Covid-19 deaths of staff members. 170321

We would like to know between the dates of Jan 1st 2020 and March 1st 2021 the number of healthcare workers employees within your trust have died due to COVID-19.

Download response Covid-19 deaths of staff members. 170321

COVID-19 discharges into care homes. 120820

1) Between 01/02/2020 to 01/07/2020, how many patients were discharged from hospitals run by your Trust into care homes? Please provide a weekly breakdown.
2) Of those patients who were discharged into care homes in the specified period, how many were tested for COVID-19 prior to leaving hospital? Please provide a weekly breakdown.
3) Finally, please tell me how many tested positive but were nonetheless discharged into care homes. Please provide a weekly breakdown.

Download response COVID-19 discharges into care homes. 120820

Covid 19 Local guidelines. 140422.docx

Could you please reply to this email attaching a copy of your hospital’s full local guidelines on the following topics?
1. Current local guidelines for the treatment and management of Covid 19.
2. Current local infection control guidelines regarding testing and quarantining/isolation of Covid positive patients

Covid 19 Local guidelines. 140422.docx

Covid-19 PCRs, treatments and deaths.130622.docx

1) Is your hospital still running the PCR tests for SARS-Cov-2 at 40-45ct cycles?
2) Is the NHS still classifying any death as a Covid death for anyone who has tested positive with a PCR test within the past 28 days, as previously stated in the March 2020 update on the NHS website about dealing with excess deaths?
3) Is the NHS aware that the PCR is a non-diagnostic test and becomes 100% unreliable after 27ct cycles?
4) How does the NHS testing system determine which variant a patient has and is this via the PCR tests?
I am aware of the online statistics site where a lot of information can be found, however i would like some more detailed information regarding specifics so my following questions are;
5.a) How many people have died in your hospital from Covid alone since February 1st 2020 to December12th 2021 without any other underlying conditions or possible causes of death?
b) How many of these patients were prescribed Midazolam?
6) What are the annual numbers of prescriptions of Midazolam for the past 10 years within your hospital?
7) What are the annual numbers of DNR’s issued in the past 10 years at your hospital?
8) Have the following viruses/strains, to your knowledge, been isolated or purified;
-SARS-Cov-2?
-Kent variant B117?
-Delta variant?
-Omicron variant?
9.a) How many patients have been admitted to your hospital for Covid and were vaccinated against it since December 5th 2020?
b) How many died while in your care?
10.a) How many patients have been admitted to your hospital for Covid and were unvaccinated against it since December 5th 2020?
b) How many of them died while in your care?
11) What are the annual numbers of patients diagnosed with myocarditis for the past 10 years within your hospital?
12) What are the annual numbers of blood clot related deaths for the past 10 years within your hospital?
13) What are the annual numbers of miscarriages for the past 10 years within your hospital?
14) What percentage of your beds are allocated for Covid patients?

Covid-19 PCRs, treatments and deaths.130622.docx

COVID-19 positive staff. 101220

1) How many of your clinical staff have tested positive for COVID-19 at your Trust?
2 How many of those staff who tested positive, worked in clinical areas designed to cater for positive / likely positive Covid Cases?
3 How many of these positive staff, work directly in areas not designated to cater for non COVID-19 patients?

Download response COVID-19 positive staff. 101220

COVID-19 recoveries. 150520

1 – The number of people who have entered MTW NHS Trust ICU’s with Covid-19 and been released back to wards alive and on the road to recovery.
2 – The number of patients who have recovered from Covid-19 and released from MTW NHS Trust hospitals.
3 – The numbers of people who have had a second infection from covid-19 and returned to a MTW NHS Trust hospital.

Download response COVID-19 recoveries. 150520

COVID-19 recoveries. 150520

1 – The number of people who have entered MTW NHS Trust ICU’s with Covid-19 and been released back to wards alive and on the road to recovery.
2 – The number of patients who have recovered from Covid-19 and released from MTW NHS Trust hospitals.
3 – The numbers of people who have had a second infection from covid-19 and returned to a MTW NHS Trust hospital.

Download response COVID-19 recoveries. 150520

Covid-19 related admissions, deaths and vaccinations. 070122.docx

1) Please provide the number of patients admitted to any hospitals within your trust between 1st January 2021 and 21st December 2021, where the reason for hospitalisation is solely COVID-19 or any complication of this and not due to any other underlying issues. Please exclude from this number any patients who have had any complications or adverse reactions following the COVID-19 vaccine.
2) Please provide a breakdown of how many of those patients, during the period between 1st January 2021 and 21st December 2021, have been admitted after receiving one dose of the COVID vaccination, 2 doses, 3 doses and how many have not been vaccinated at all.
In order that there is no room for misunderstanding here about vaccination status, please use the following definitions in your reply:
• Unvaccinated means the patient has had no COVID-19 jab/vaccine/injection
• 1st Dose solely means a patient has been injected once against COVID-19, regardless of how many days have passed since the intervention or how many subsequent doses are available. (i.e., a single dose when a second one is available does not render them unvaccinated for the purpose of this FOI request)

• 2nd Dose solely means a patient has been injected twice against COVID-19, regardless of how many days have passed since the interventions or how many subsequent doses are available. (i.e., a double dose when a third one is available does not render them unvaccinated for the purpose of this FOI request)
3) Please provide the number of patients who have died at any hospital in your trust between 1st January 2021 and 21st December 2021 that are solely as a result of COVID-19 or any complications thereof and not due to other underlying health issues. Please also exclude any patients who have died as a complication of the COVID-19 vaccine.
4) Please provide the number of patients, for the same period mentioned above, who have died as a result of reactions or complications from the COVID-19 vaccine.
5) Please provide the number of patients who have died at any hospital in your trust from complications or adverse reactions arising from the COVID-19 vaccine.
6) Please note that for all the above questions, any reference to a patient with COVID-19 is a patient that has been confirmed as someone who has tested positive to a PCR test or Lateral Flow Test.
7) When there is confirmation of a positive test, please include whether it was through PCR or LFT and the number of cycles of amplification used when processing the results.

Download response Covid-19 related admissions, deaths and vaccinations. 070122.docx

COVID-19 staff risk assessment. 020620

1. Has your organisation completed risk assessments on all Black Asian and Minority Ethnic (BAME) staff?
2. What precautions, if any, have you put in place to protect BAME staff once they’ve been risk assessed?”

Download response COVID-19 staff risk assessment. 020620

COVID-19 testing. 300720

1. Please can you tell me how many coronavirus tests the trust has used on patients between 1st March 2020 and today’s date (4th June 2020).
2. Please can you tell me both the number of patients that have been tested, and the number of tests carried out (i.e. if a patient has been tested more than once).
3. In each case, please can you tell me how long it took for the trust to receive the patients’ test result. If you do not have data for every patient please can you provide me with the average length of time it has taken to get test results for all patients.

Download response COVID-19 testing. 300720

Covid-19 treatments. 301220

Can you advise when it comes to Covid, are your hospitals actually treating cases and if you are not why not?

Download response Covid-19 treatments. 301220

Covid-19 vaccinated and unvaccinated deaths. 270821.docx

1. Please can you provide me with all admissions in Maidstone hospital in the past 5 Years 2016-2020 with the current year so far?
2. Of those who died of any cause this year, how many had received the Covid -19 vaccine and how many were unvaccinated?
3. Out of those admitted in 2021 how many of them had got the vaccine?

Download response Covid-19 vaccinated and unvaccinated deaths. 270821.docx

Covid-19 vaccination status of Trust staff. 220222.docx

1) What percentage of Trust all staff have had a) one dose b) two doses c) three doses of the Covid-19 vaccine
2) What percentage of each the following staff members have had two or more doses- Medical and dental, nursing and midwifery, healthcare scientists, pharmacists, admin and clerical, estates and ancillary, allied health professionals, students, additional professional scientific and technical, additional clinical services.

Covid-19 vaccination status of Trust staff. 220222.docx

Covid-19 vaccinations. 030321

Please can you tell me how many of your staff have declined to have a coronavirus vaccine. If possible, please give the reason why the vaccine was declined.

Download response Covid-19 vaccinations. 030321

Covid-19 vaccinations. 130121

Would it be possible to be provided with the following information please in relation to the hospital vaccination hubs being run by your trust?
1. Between 8 December and 8 January, how many doses of the Pfizer Covid vaccine were administered at each of your hospital vaccination hubs?
2. Between 8 December and 8 January, how many doses of the Pfizer Covid vaccine were destroyed/discarded/thrown away at each of your hospital vaccination hubs? Do you have a daily breakdown of these figures? If so, can I be sent these please?
3. In those instances where doses were destroyed/discarded/thrown away, what reasons were given for staff not being able to administer them to patients?

Download response Covid-19 vaccinations. 130121

Covid-19, vaccinations and Healthcare acquired infection (HCAI). 081221.docx

1. How many NHS staff currently working at your trust remain unvaccinated with a Covid19 vaccine? Including bank/agency workers.
2. What percentage of your overall staff does this equate to?
3. Since the start of the pandemic (01/03/20), with your data from staff absence due to Covid19, contact tracing and Healthcare acquired infection (HCAI), what percentage of HCAI is directly attributable to Covid19 infection in an NHS frontline worker?
4. Since the vaccination programme has started (Approx. Dec 2020), what is the breakdown of this being from
a. a covid 19 vaccinated NHS worker
b. unvaccinated NHS worker?
5. If not directly attributable, what is the rate of your patients in non Covid19 wards/area getting a HCAI and becoming infected with Covid19 within a set time frame (~10days) of an NHS worker in that ward/area testing positive for Covid 19?
6. What is the breakdown of this being
a. a Covid19 vaccinated NHS worker
b. non-vaccinated NHS worker?

Download response Covid-19, vaccinations and Healthcare acquired infection (HCAI). 081221.docx

Covid-19 vaccine uptake. 200521

1. Please tell me what percentage of front-line staff at your trust have received their first dose of the Covid vaccine?
2. If possible, please tell me what percentage of a) doctors b) nurses and midwives c) other front-line staff have received their first dose of the Covid vaccine?
3. Please also tell me the total numbers of front-line staff who have received their first dose of the Covid vaccine and the total numbers of front-line staff who have not received their first dose of the Covid vaccine
4. If possible, please tell me the total numbers of staff who have received the first dose of the vaccine and who have not yet been vaccinated broken down by a) doctors b) nurses and midwives c) other front-line staff.
5. Please tell me what percentage of front-line staff at your trust have received their second dose of the Covid vaccine?
6. Again, if possible, please break this down by a) doctors b) nurses and midwives c) other front-line staff
7. Please also tell me the total numbers of front-line staff who have received their second dose of the Covid vaccine and the total numbers of front-line staff who have not received their second dose of the Covid vaccine
8. Please provide the total numbers for staff who have received their second dose and not yet received their second dose broken down by a) doctors b) nurses and midwives c) other front-line staff

Download response Covid-19 vaccine uptake. 200521

Covid Booster Informed Consent.131022.docx

What steps you and your organisation will be taking to fulfil your ethical and legal obligations to ensure patient and staff submission to Covid vaccination is given with free, voluntary, and fully informed consent.

Covid Booster Informed Consent.131022.docx

Covid cycle testing for vaccinated and unvaccinated people.221122.docx

All questions are shown exactly as received by the Trust.
i would like all latest data on covid cycle testing for vaccinated and unvaccinated people i am aware there will be 2 separate test cycles of amplification thank you.
Your response is in correct.i asked what are the current test cycle to date for omnicrom variant you have a base number for cycle amplification that you start with .you dont get a cycle numbed AFTER the test ,you have a start point and that is the data i am asking for. The starting amplification cycle number for un vaccinated people and the cycle start number for vaccinated.thank you..this will be fact checked by my associates thank you.

Covid cycle testing for vaccinated and unvaccinated people.221122.docx

Covid-related capital bids. 091220

I would like to know how many Covid-related capital bids have been approved centrally since March 17 and was hoping you could answer a few questions.

To avoid confusion, covid-19 related capital refers to bids submitted in respect of the covid-19 capital expenditure scheme https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/04/COVID-19-capital-reimbursement-process-27-04-20.pdf. All other types of capital bids should not be included.

In addition, can you please tell me?

• The total value of your Covid-related capital bids
• The total in funding you’ve received for Covid-related capital bids.
• How many bids you have made and how many are awaiting central approval.

Download response Covid-related capital bids. 091220

Covid Swab Tests. 101220

1. Is my DATA/DNA etc. kept on file, stored and shared in any way?
2. On the swab/tube (or before being placed into the tube) have the following: “Hydrogel”. or “Quantum Dot” used and or applied?
3. Do you have a “Magnetic Testing System” which “alters” your “DNA” via these “Covid Swab Tests”?
4. Are these `one hour Covid Swab Tests` (or for all tests?) stored and shared with my DNA and other information, third party or otherwise?

Download response Covid Swab Tests. 101220

Covid, vaccination and deaths 280122.docx

1. Please confirm how many of the 1367 patients admitted from 1 January to 21 December 2021 were admitted where the sole reason for hospitalisation was COVID-19 or any complication of this, who were then confirmed by positive PCR test within 8 days. Please exclude from this figure any patients who were admitted due to other reasons who tested positive within 8 days, as well as any patients who may have been admitted due to adverse reactions following the COVID-19 vaccine.

2. According to your breakdown below, the grand total of patients who have received at least one COVID-19 vaccine was 651. Since you claim 1367 patients were admitted during the stated period who tested positive within 8 days, this would render 716 patients who were unvaccinated.
2a. The 10th column on your table stated 267 patients had no vaccine. Can you please confirm this is the case and also explain why these 267 patients have a category of “no vaccine” on their own and why the other 716 patients (total admissions – grand total provided by you) have not been included in this category?
2b. Can you confirm that the 716 patients, that is, the total admissions of patients who tested positive within 8 days (1367) minus the grand total of patients on your table (651) had not received any COVID-19 injection or booster? Just to clear and avoid misunderstandings, I am asking you to use the word unvaccinated to mean somebody who has not had any vaccine injected in their body at any time and conversely, vaccinated means someone who has had a vaccine irrespective of how long it has been since they had received it or the number of vaccines they have received.

3. Your answer to my third question was “Total number of patients admitted within 8 days of a positive swab from 1 January to 21 December 2021 who died – 149”.
Similarly, to question 1, this may include patients who had died due to complications of other issues such as cancer, a road traffic accident or a heart attack who had tested positive within 8 days of admission.
3a. Please confirm how many of the 149 patients you stated died solely due to COVID-19 or any complication thereof and exclude from this number any patient who died due to other medical conditions, including complications from taking a COVID-19 vaccine.

4. Your reply to my last question was “Confirmation of Sars CoV2 is by PCR testing. Cut off for positive is 28 CT”.
4a. Can you please confirm that all 1367 patients who were admitted to hospital between 1st January 2021 and 21st December 2021 had tested positive by returning a positive PCR test result at 28 CT?
4b. Has the CT cut off benchmark varied within the period in question? If so, please provide a breakdown of any periods where the cut off benchmark has been altered.

Download response Covid, vaccination and deaths 280122.docx

Covid vaccine wastage. 110122.docx

1. Between 8 December 2020 and 31 December 2021, how many doses of the Pfizer Covid vaccine were administered at each of your vaccination centres/hospital sites?
2. Between 8 December 2020 and 31 December 2021, how many doses of the Pfizer Covid vaccine were destroyed/discarded/thrown away at each of your vaccination centres/hospital sites? Do you have a weekly/monthly breakdown of these figures? If so, can I be sent these please?
3. Between 4 January 2021 and 31 December 2021, how many doses of the AstraZeneca Covid vaccine were administered at each of your vaccination centres/hospital sites?
4. Between 4 January 2021 and 31 December 2021, how many doses of the AstraZeneca Covid vaccine were destroyed/discarded/thrown away at each of your vaccination centres/hospital sites? Do you have a weekly/monthly breakdown of these figures? If so, can I be sent these please?
5. Between 7 April 2021 and 31 December 2021, how many doses of the Moderna Covid vaccine were administered at each of your vaccination centres/hospital sites?
6. Between 7 April 2021 and 31 December 2021, how many doses of the Moderna Covid vaccine were destroyed/discarded/thrown away at each of your vaccination centres/hospital sites? Do you have a weekly/monthly breakdown of these figures? If so, can I be sent these please?
7. In those instances where doses of the Pfizer/AstraZeneca/Moderna vaccines were destroyed/discarded/thrown away, what reasons were given for staff not being able to administer them to patients?

Download response Covid vaccine wastage. 110122.docx

Covid Visiting Policies. 070122.docx

1) In the period 1 February 2020 to 31 October 2021 what is the total number of complaints that your Trust has received from the public including service users (i.e. complaints on any issue)?
2) In the period 1 February 2020 to 31 October 2021 how many complaints from the public including service users has your Trust received about (or that include mention of) restrictions to patient visiting or patient visiting policies?
3) In the period 1 February 2020 to 31 October 2021 how many incident reports (including Datix, Ulysses or other internal reporting system) have been raised by staff regarding abuse received from the public including service users that include mention of restrictions to patient visiting or patient visiting policies (i.e. where visiting restrictions may have contributed to the cause of the abuse)?
4) Does your Trust know what circumstances, or have a set of defined criteria, under which it would revert patient visiting policy back to what it was before the emergence of Covid 19?

Download response Covid Visiting Policies. 070122.docx

Ct (Cycle Threshold) being used for PCR testing of SARS Covid-19. 280621

I would like to know the Ct (Cycle Threshold) being used for PCR testing of Sars Covid at the moment and in the past.

Download response Ct (Cycle Threshold) being used for PCR testing of SARS Covid-19. 280621

Cycle threshold (Ct) PCR testing. 280621

1. The Cycle threshold (Ct) used by your organisation since 01 March 2020 for each of the Government Pillar classifications.

2. Any changes made to the Ct during this period and when any such changes were made.

Download response Cycle threshold (Ct) PCR testing. 280621

Cycle threshold in PCR tests for patients and staff. 040122.docx

which cycle threshold(ct) are you using in your hospital in PCR test for patient and staff since the declaration of the pandemic in 2020.

Download response Cycle threshold in PCR tests for patients and staff. 040122.docx

Data analytics to support in the management of the response to Covid 19. 220620

1) Is your Trust using data analytics to support in the management of its response to Covid 19?
2) If so, please could you confirm the use cases (i.e. medical resource management, monitoring patients that have tested for the virus and those that have tested positive, tracking the patient journey for those that have tested positive for the virus, ward management for patients that have test positive for the virus, identifying which healthcare workers have been exposed to the virus, etc.)?
3) If so, please could you confirm which roles in the Trust will have access to your Trust’s data analytics results regarding Covid 19 (please confirm for each of the following roles listed): Physician, Nurse, Pharmacist, Management, Accountant/Finance, HR and Recruitment, IT Office, Administrative Assistants, Data analyst/scientist (including roles such as Performance Reporting and Informatics)

Download response Data analytics to support in the management of the response to Covid 19. 220620

Date of discharge or date of death of patients with hospital acquired Covid-19 since 1st March 2020. 260321

In relation to patients who had caught the virus in hospital and their outcome e.g. the date the first positive test result came back and the date they died or were discharged. Is it possible to provide the outcome dates please?

Download response Date of discharge or date of death of patients with hospital acquired Covid-19 since 1st March 2020. 260321

Deaths associated to Covid, flu and all other causes. 020721

I am asking for the real number of covid deaths ,?how many died with covid and underlying issues ? How many died with covid with no underlying issues ?
How many off covid with underlaying issues ? How many died off covid with no underlaying issues ? How many people died of flu in between Dec 2019 and to present date ?
I would like to know all off these number is statics in between November 2019 up until present date ? How many people died in this time frame off other illnesses not related to covid ?

Download response Deaths associated to Covid, flu and all other causes. 020721

Deaths that occurred due to Covid 19. 101220

I am trying to gather information regarding actual deaths within the trust due to Covid 19 for the period 1st February 2020 to 1st October 2020.

By this I mean the deaths that occurred due to Covid 19 alone without any comorbidities.

Download response Deaths that occurred due to Covid 19. 101220

Discharge of known and possible COVID-19 patients by the trust into care homes. 271020

1) Of those 233 patients discharged to care homes as above, how many were coded as having a diagnosis of
a) COVID-19 or
b) Suspected COVID-19 but did not receive a test before being discharged to a care home?

2. NHS Providers reports that it approached all NHS trusts for information about how trusts discharged possible COVID-19 patients into care homes

Please confirm if NHS Providers approached Maidstone and Tunbridge Wells NHS Trust for such information

Please share the records of NHS Providers’ enquiry to the trust, and the trust’s response

3. Has Maidstone and Tunbridge Wells NHS Trust been advised by local Public Health services, Public Health England or care home providers of any care home COVID-19 outbreaks that have been traced back to patients discharged from a trust hospital to the care homes in question?

Specifically, is the trust aware of any transmission from any of the 24 COVID-19 positive patients, discharged by the trust to care homes, to other care home residents following discharge into those care homes?

If so, please advise of the details.

Download response Discharge of known and possible COVID-19 patients by the trust into care homes. 271020

Fit testing. 060520

1) The sex-breakdown of all those who failed fit tests for all available masks at your trust between 1st February 2020 and 30th April 2020.
2) The sex-breakdown of all those who had to use a powered air purifying respirator at your trust between 1st February 2020 and 30th April 2020.
3) The sex-breakdown of all those who failed their fit test for a FFP3 mask at your trust between 1st February 2020 and 30th April 2020.
4) The sex breakdown of all those who failed their fit test for a Disposable Healthcare Respirator, FFP3, Valved, 1873V+ at your trust between 1st February 2020 and 30th April 2020.
5) The sex breakdown of all those who failed their fit test for a Disposable Healthcare Respirator, FFP3, Type IIR, 1863+ at your trust between 1st February 2020 and 30th April 2020.
6) And finally, during the period 1st February 2020 to 30th April 2020, has your trust been doing fit tests or just fit checks?

Download response Fit testing. 060520

Fit-testing of respiratory protective equipment. 160720

1. How many medical staff were working with tight-fitting respiratory protective equipment in February 2020, March 2020, April 2020 and May 2020? Please give the numbers broken down by the months; and, if it is possible, please break it down by type of staff member (nurse, doctor, etc) and setting. If it is possible, please separate out those working in Covid-affected environments (I do not know if you hold a separate register for Covid and non-Covid).
2. How many of the medical staff working with tight-fitting respiratory protective equipment in Covid-affected environments were fit-tested for that equipment in February 2020, March 2020, April 2020 and May 2020? Please give the numbers broken down by the months; and, if it is possible, please break it down by type of staff member (nurse, doctor, etc) and setting. Again, if it is possible, please separate out those working in Covid-affected environments
If the data is sensitive enough to show where the same staff were fit-tested multiple times, please include that information.
3. Do you collect data on medical staff working with tight-fitting respiratory protective equipment being fit-tested when they change brand/type of RPE? If so, please give the figures for Feb, March, April and May 2020 as above.
4. Do you track the ethnicity of the staff member with this data? If so, please give the ethnicity breakdowns for the above data for all questions.

Download response Fit-testing of respiratory protective equipment. 160720

 

Critical Care

Acute venous thromboembolism (VTE).170322.docx

Acute management of Venous thromboembolism:
1. Confirm whether the Trust routinely prescribes direct oral anticoagulants (DOACs) in preference to low molecular weight heparin (LMWH) and warfarin for the management of standard acute venous thromboembolism (VTE)?
2. Please provide a copy of the Trusts’ management policy on management of acute venous thromboembolism (VTE).
3. Does the Trust provide all patients with an unprovoked VTE a medical opinion from a thrombosis physician?
4. Does the Trust definition of an ‘unprovoked VTE’ include women using the combined oral contraceptive pill or hormone replacement therapy (HRT)?
5. Do investigations after an unprovoked VTE follow NICE guidance?
6. Per week, how many clinics are devoted to seeing patients with VTE in the Trust?
7. How many full-time equivalents are employed by the Trust to provide thromboprophylaxis and care of thrombosis patients from?
a) Nursing
b) Pharmacists
c) Medical
Thromboprophylaxis
8. Does the Trust routinely meet the 95% VTE Risk Assessment level required by NHS England?
9. Please provide the monthly percentage (admissions numbers/VTE risk assessments carried out) for VTE risk assessments carried across the Trust between 1st October 2021 – 31 December 2022.
10. Does the Trust have dedicated funding for a team ensuring VTE prevention occurs?
COVID-19
11. Please provide a copy of the Trust’s thromboprophylaxis protocols used to treat in-patients with COVID- 19 pneumonia.
Psychological care
12. Do VTE patients within the Trust have access to clinical psychological support?
13. How many sessions per week are provided by the Trust for VTE clinical psychological support?
Cancer-associated VTE
14. Does the Trust have a dedicated clinical lead for cancer associated thrombosis (CAT)?
15. Does a protocol exist for managing VTE in those with cancer?
16. Please provide a copy of the Trusts’ protocol for managing VTE in those with cancer.
VTE prevention and management in the community
17. Please provide copies of VTE care pathways developed to support community clinicians with regards to:
(i) Anticoagulation medication changes
(ii) Anticoagulation dosing.
18. Does the Trust have specific VTE guidance for:
(i) System wide protocols?
(ii) E-consultation facilities?
(iii) On call clinician to discuss problems and seek advice from?
19. Please provide copies of the Trust’s protocol documents for VTE prevention and management in
(i) System wide protocols
(ii) E-consultation facilities
(iii) On call clinician to discuss problems and seek advice from

Acute venous thromboembolism (VTE).170322.docx

Adult Dying and Deceased Patient Policy and Procedure and Bereavement procedures. 230821.docx

1] My question 2 was to supply email copies of appendices to the Adult Dying and Deceased Patient Policy and Procedure. The response was aimed at those using a windows-based computer system. I use a Mac so I was unable to access any of them. Please find a way for me to access the documents requested.

Not being able to access them and requesting them in a different format so that I can access them does not, in my view, constitute a DIFFERENT or FURTHER request. It is still the original request which was not met. Millions of people use Mac computers. A pdf format would, I believe, have allowed universal access, where the assumption of Windows use, automatically cuts out a whole swathe of the population.

2] In response to my question 5, point number 1, of the response, states that:

‘ On the day death notified to Bereavement, healthcare records are removed from the ward/unit, taken to bereavement for scanning ready for scrutiny by the Medical Examiner ‘

Then on the last page it states ” Previously and before the ME service started…’

So:
A] I would like to know when the ME service started.
B] i. Did Bereavement use the scanning process of healthcare records in April/May 2020?
B] ii. If so, what system did they scan the healthcare records onto during April/May 2020?
B] iii. If not, then when did Bereavement start scanning healthcare records?

Download response Adult Dying and Deceased Patient Policy and Procedure and Bereavement procedures. 230821.docx

Adult Level three Critical Care beds.240522.docx

1. How many Adult Level three Critical Care beds do you currently have with an invasive ventilator?
2. How many of these are currently staffed and therefore available for use (either vacant or occupied)?
3. When considering relevant guidelines concerning these beds, how many have Carbon Dioxide (CO2) monitoring available for Invasively ventilated patients?
4. Thinking about the new (January 2022) NICE Guidelines concerning inhaled sedation, how many of your Level three beds have inhaled anaesthetic gas monitoring available?

Adult Level three Critical Care beds.240522.docx

Agency spend for locum doctors in Acute Medicine. 240317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Acute medicine over the following months, within your Trust or Health Board?
August 2016
September 2016
October 2016
November 2016
December 2016
January 2017

Download response Agency spend for locum doctors in Acute Medicine. 240317

Anchors. 050418

Name of your Trust
Hospitals within Trust (select multiples as needed)
The number of anchors used between Jan 2017-Dec 2017
The supplier name(s) of knotless anchors (select multiple suppliers as needed)
The supplier name(s) of knot tying anchors (select multiple suppliers as needed)
Procurement Route
Procurement agreement end date (DD/MM/YY)
Estimated annual value, Jan 2017-Dec 2017 (£s)
Number of Rotator Cuff repairs completed between Jan 2017-Dec 2017
Number of instability/stability repairs completed between Jan 2017-Dec 2017

Download response Anchors. 050418

Antiseptic skin preparation prior to invasive surgery. 150721.docx

1) Please confirm if Maidstone and Tunbridge Wells NHS Trust follows NICE guidance 125 (Surgical Site Infections: Prevention and Treatment) when carrying out antiseptic skin preparation?
a. If yes, please provide a copy of Maidstone and Tunbridge Wells NHS Trust s most up-to-date surgical site infection prevention protocol.
2) How does Maidstone and Tunbridge Wells NHS Trust communicate the category difference between antiseptic products that are medicines vs biocides and their intended use?
a. Please share any communication materials.
3) Can you please specify which antiseptic skin preparation products are used in Maidstone and Tunbridge Wells NHS Trust s operating theatres for the purposes of prevention of surgical site infections?
4) Does Maidstone and Tunbridge Wells NHS Trust obtain patient consent prior to surgical procedures?
a. If yes, please provide the written material that Maidstone and Tunbridge Wells NHS Trust uses to obtain consent.

Download response Antiseptic skin preparation prior to invasive surgery. 150721.docx

Cardiology digital systems.241219

1) Regarding echocardiograms:
a) Which digital system is used by healthcare professionals in your trust to request echocardiograms?
b) On what digital system(s) are echocardiogram images stored?
c) On what system are echocardiograms reported?
d) On what system(s) are the reports for echocardiograms available for review?

2) Regarding coronary angiograms:
a) Which digital system is used by healthcare professionals in your trust to request coronary angiograms?
b) On what digital system(s) are images from coronary angiograms stored?
c) On what system are coronary angiograms reported?
d) On what system(s) are the reports from coronary angiograms available for review?

3) Regarding cardiac pacemakers:
a) Which digital system is used by healthcare professionals in your trust to request pacemaker insertion?
b) On what system are pacemaker procedure reports written?
c) On what system(s) are pacemaker procedure reports available for review?
d) On what system(s) are cardiac pacemaker routine outpatient checks available for review?

4) Regarding cardiology patient documentation:
a) On what system(s) are outpatient letters available for review?
b) On what system(s) are discharge letters available for review?
c) Are copies of ECGs stored electronically? If so, on what system(s) are they available?

5) Regarding CT coronary angiograms:
a) Which digital system is used by healthcare professionals in your trust to request CT coronary angiograms?
b) On what digital system(s) are images from CT coronary angiograms stored?
c) On what system are CT coronary angiograms reported?
d) On what system(s) are the reports from CT coronary angiograms available for review?

6) What RIS system does your hospital use?
7) What PACS system does your hospital use?

Download response Cardiology digital systems.241219

Cardiopulmonary Resuscitation of Elderly and Vulnerable Patients. 260820

I am making a formal written request for a complete copy of the Maidstone and Tunbridge Wells NHS Trust policy regarding the Cardiopulmonary Resuscitation of Elderly and Vulnerable Patients.

Download response Cardiopulmonary Resuscitation of Elderly and Vulnerable Patients. 260820

Clinically Artificial Nutrition and Hydration (CANH). 170120

• In your Trust is there any formal register kept of deaths occurring as a result of withdrawal of Clinically Artificial Nutrition and Hydration (CANH) that occur under the provisions of the Mental Capacity Act 2005 and BMA/RCP/GMC Guidelines 2018?
• If such a register is kept can you advise if there is any independent internal or external audit made of such deaths and the degree to which there Is compliance with the BMA/RCP/GMC Guidelines, 2018 when such deaths occur?
• Where deaths due to withdrawal of CANH are recorded and an audit is made of these, can you give an indication of the number such deaths in 2018 and in 2019 and the percentage of cases where the BMA/RCP/GMC Guideline Checklist has been used and fully completed?

Download response Clinically Artificial Nutrition and Hydration (CANH). 170120

Complaints regarding end of life care.

1. How many complaints in the following years has the Trust received relating to the end of life care/palliative care of a patient? Please answer each year by breaking down month by month e.g. January: 9, February 10…
a) In 2015
b) So far in 2016 (up to 16/5/2016)
2. Of the number of complaints above what numbers were related to:
a) Communication that the patient is actually dying
b) The patient or relatives was unaware that lifesaving drugs had been withdrawn
c) Care, including dignity, respect and privacy
d) Lack of pain relief
e) Access to specialised support and information
f) Lack of access to care through the night, at weekends and over holiday’s periods

Download response Complaints regarding end of life care 060616

Continuous renal replacement therapy (CRRT). 010217

1. How many machines do you have for continual renal replacement (CRRT) in the intensive care unit/critical care unit?
1. a. Can you split these by manufacturer and age of machine please?
2. Are you in a contract for your machines, if so when does the contract expire?
3. How many CRRT treatments were carried out in 2016 (or the latest 12 month period you have data for)?
4. How many bags of fluid did you use for CRRT in 2016 (or the latest 12 month period you have data for)?
5. Who is your current manufacturer of fluids for CRRT? And for Vascular access? (Double Lumen catheters)
6. Are you in a contract for fluids, if so, when does this expire and is it linked in with the machine contract?
7. What was your total spend on CRRT fluids in 2016 (or the latest 12 month period you have data for)?
8. What was your total spend on CRRT consumables (e.g. consumable sets for the machines) in 2016 (or the latest 12 month period you have data for)?
9. What is the typical renal dose you prescribe to the patients? (In ml/kg/h)
10. Are your units using Citrate Anticoagulation? If yes how frequent (in % vs. Heparin).

Download response Continuous renal replacement therapy (CRRT). 010217

Continuous Renal Replacement Therapy (CRRT) machine. 070921.docx

I’m seeking potential solutions for a customer to replace their existing Continuous Renal Replacement Therapy (CRRT) machine.

The machine must be capable of offering both CVVH (Continuous Veno-Venous Hemofiltration) and CVVHDF (Continuous Veno-Venous Hemodiafiltration).

Also, of equal importance is for the machine to use volumetric rather than gravimetric (weights and balances) technology to ensure accurate and safe fluid loss.
This system will not be used in a hospital environment, so it cannot use weights and balances for its accuracy.

Download response Continuous Renal Replacement Therapy (CRRT) machine. 070921.docx

Covered stents. 030118

What is the total number of Covered stents deployed in Arterio venous (AV) fistula/graft access procedures in 2016-17?

Download response Covered stents. 030118

Critical care. 200718

The hospitals under your trust?
Number and types of operating theatres.
Number of beds within the critical/intensive care unit(s).
Number of endoscopy treatment rooms/theatres.
If possible I would like to know the make, model and age of the following equipment if applicable:
1.0 Ultra clean ventilation systems
2.0 General Theatres
3.0 Ceiling mounted medical service pendants
4.0 Operating lights
5.0 Theatre control panels
6.0 AHU Units
7.0 Class 1,2 & 3 Cabinets

Download response Critical care. 200718

Critical care bed capacity. 090617

Question 1: What is the total number of critical care beds (Level 2 and Level 3) per 100,000 of the population your trust serves?
1. If you cover both secondary and tertiary care, please provide your TOTAL bed:population ratio for the whole trust, AND a figure for both types of service
Question 2: How many critically ill patients were transferred from your hospital to another hospital’s critical care unit for non-clinical reasons in 2016-17?
Question 3: How many days in 2016-17 was the occupancy of your critical care beds over 85% at least one point during those 24 hours?
Question 4: How many patients had an elective operation cancelled due to lack of a critical care bed capacity in 2016-17?
Question 5: How many days in 2016-17 was at least one critical care bed closed due to lack of staff for at least part of the day?

Download response Critical care bed capacity. 090617

Do Not Attempt Resuscitation (DNAR) notices. 101220

1. Please can you tell me how many Do Not Attempt Resuscitation (DNAR) notices were issued by the Trust between 1st March 2020 and the present date (8th December 2020)? Please include the date each DNAR was issued.
2. Please can you also tell me how many DNARs were issued for the same period last year (i.e. 1st March 2019 – 8th December 2019).
3. Please can you also tell me how many complaints you have received related to a DNAR being issued at any point between 1st March 2019-8th December 2020 and please provide as much detail as possible about the nature of the complaint.

Download response Do Not Attempt Resuscitation (DNAR) notices. 101220

Domiciliary services for medicines review and palliative care. 281116

I am currently setting up (1) domiciliary visiting medicines review (focussing on both medicines optimisation and medicines adherence) and (2) palliative care services (to ensure the timely and appropriate availability of end of life medicines) within Norfolk using the community pharmacy network and GP practice based pharmacy network, working in conjunction with our NHS community services teams.  I am therefore writing to ask if you could send me any reports (service specifications, audit reports, service evaluations etc.) which you may have relating to any services of a similar nature delivered in your area.

Download response Domiciliary services for medicines review and palliative care. 281116

Emergency admissions for Asthma, Epilepsy and Diabetes 2014 – 2016. 270317

1. For the last 4 quarters from January 2016 – December 2016, please provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
2. For the last 4 quarters from January 2016 – December 2016, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
3. For the 4 quarters January 2015 – December 2015, please could you provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
4. For the 4 quarters January 2015 – December 2015, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
5. For the 4 quarters January 2014 – December 2014, please could you provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.

6. For the 4 quarters January 2014 – December 2014, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2?

Download response Emergency admissions for Asthma, Epilepsy and Diabetes 2014 – 2016. 270317

Escalation procedures for ITU/ICU/HDU.

This is FOI request, please tell me what happens if you get patients for ITU / ICU / HDU but they are full with other patients, what do you do?

Download response Escalation procedures for ITU/ICU/HDU 190416

EVAS for AAA repairs. 220920

Has your Trust ever used the Nellix Endovascular Aneurysm Sealing (EVAS) System in patients to treat abdominal aortic aneurysms (AAA)?

Download response EVAS for AAA repairs. 220920

Follow-up of Critical Care patients.

Please could you send me any policies relating to intensive care/ critical care follow up of patients?

Download response Follow-up of Critical Care patients 130116

 

Delayed transfer of care

12 hour trolley waits. 141217

a) How many patients spent longer than 12 hours from decision to admit to admission at your Trust between October 2016 and October 2017?
b) Of those patients waiting longer than 12 hours from decision to admit to admission, what was the longest wait over 12 hours between October 2016 and October 2017?
c) If possible, please provide a reason for the delay.

Download response 12 hour trolley waits. 141217

Delayed discharge. 160119

1) How many delayed discharges from inpatient wards were recorded by your trust during the following date ranges (please break down the data into the date ranges specified below):
a. 1st November 2017 to October 31st 2018
b. 1st November 2016 to October 31st 2017
c. 1st November 2015 to October 31st 2016
2) What was the total amount of time spent by delayed discharge patients in hospital wards managed by your trust between patients being ready for transfer and the patients being fully discharged from hospital during the following date ranges (please break down the data into the date ranges specified below. Please use whichever time measurement is used by default by your trust):
a. 1st November 2017 to October 31st 2018
b. 1st November 2016 to October 31st 2017
c. 1st November 2015 to October 31st 2016
3) What is the average cost per day to your trust of a patient staying in hospital to your trust, excluding costs specific to their medical condition (i.e. the basic cost of providing a bed, food and care but excluding condition specific drugs, care or medical procedures)
4) Does your trust currently have a plan in place to reduce the delayed discharge of patients in the future?

Download response Delayed discharge. 160119

Delayed discharge 2013-2017 150217

What is the longest continual stretch of days that have been lost to delayed discharge by one patient in?
a) 2013/14
b) 2014/15
c) 2015/16
d) 2016/17 (YTD)

Download response Delayed discharge 2013-2017 150217

Delayed discharge and court action. 070317

1. Since 1.1.15 how many times have you taken court action to evict a patient from a hospital in your trust because you believe they are fit for discharge but they have failed to leave their hospital bed? For each occurrence please state how many days they had occupied a hospital day for while considered fit for discharge?
2. Of those patients discharged from your hospital in either 2014/15 or 2015/16 please state how many patients had been considered fit to discharge but remained in hospital in excess of one full calendar year before they were discharged? For each patient please state how many days they occupied a hospital bed while considered fit to discharge?
3. Using the most recent convenient date do you have any patients in your hospital who are considered fit to discharge but have been in hospital and been fit to discharge in excess of one full calendar year? For each patient please state how many days they have occupied a hospital bed while considered fit to discharge?

Download response Delayed discharge and court action. 070317

Delayed discharge from the stroke rehabilitation unit at Tunbridge Wells Hospital at Pembury. 011216

1. Please could you provide details of the current number of patients whose discharge from the stroke rehabilitation unit at Pembury Hospital is being delayed while social services arrange personal care packages?
2. Please could you provide details of the number of patients whose discharge has been delayed for more than 7, 14, 21 and 28 days for the same reasons for each month of 2016?
3. Please state the longest number of days for which an individual patient had to wait for a discharge from the stroke rehabilitation unit at Pembury hospital due to a lack of social services capacity to provide personal care 2016?

Download response Delayed discharge from the stroke rehabilitation unit at Tunbridge Wells Hospital at Pembury. 011216

Delayed discharges.070722.docx

1) the total number of patients in hospital on 30 November whose discharge was delayed because they were awaiting residential home placement or availability, awaiting nursing home placement or availability, or awaiting a care package in their own home.
2) For each of the last 12 months (starting with November 2020 and ending with November 2021), can you please provide the number of hospital patients whose discharge was delayed because they were awaiting residential home placement or availability, awaiting nursing home placement or availability, or awaiting a care package in their own home.

Delayed discharges.070722.docx

Delayed discharges. 080517

1 – Number of adult patients who are medically fit to leave hospital but are currently unable to be safely discharged. Most recent figures are preferential however the latest on record would also be of use.

2 – Please provide the number of packages of care that are currently delayed due to lack of staffing resources within the community.

3 – Data on agency spend between March 2016 to present date for nursing services within the community.

Download response Delayed discharges. 080517

Delayed discharges. 081020

1. Please could you provide the number of patients whose discharge has been delayed by 28 days or more in the year to March 31 2020?
2. Please including the longest number of days for which an individual patient had to wait for a discharge?
3. Would you please state on April 1 2020 how many beds were occupied in your trust by patients who were classed as a DTOC?

Download response Delayed discharges. 081020

Delayed discharges. 091117

For the financial year 16/17 how many people were classed as bed-blocking; who was responsible for delayed discharges and over the length of time they were bed blocking by weeks. A simple table showing councils/relevant body holding up the discharge down the side and weeks along the top and number of patients in the data will suffice.

Download response Delayed discharges. 091117

Delayed discharges.130922.docx

Please can I get data on all of the patients discharged in August 2022, broken down by the number of days by which their discharges were delayed.

Delayed discharges.130922.docx

Delayed discharges 2014-2017 111116

In two of the questions we ask for information collected on 28th September, 2016. This date has been chosen because it is the most recent data collection day for NHS England.

When giving reasons for the delay in discharging a patient, please chose one of the ten categories used by NHS England – awaiting completion of assessment, awaiting public funding, awaiting further non-acute NHS care, awaiting residential home placement or availability, awaiting care package in own home, awaiting community equipment and adaptations, patient or family choice, disputes or housing.
If you record it differently please supply information using the official categories for your nation.

1) Please state the five longest delays (in days) which patients who were ready for discharge, have had before they were able to leave the hospital during the period 1st April 2014 to 31st September 2016.
For each of these delayed discharges, please state:
i) The age of the person concerned.
ii) The original reason for admission to hospital.
iii) The reason for the delayed discharge.
iv) The date on which the patient was ready for discharge.
v) The date on which they were in fact discharged.
2) Please state how many patients, who were ready for discharge, had to wait 28 days or more to leave the hospital.
Please break these figures down by the cause of the delay.
Please provide this information for the following financial years:
i) 2014/15
ii) 2015/16
iii) 2016/17 to date
3) On the day of the 28th September 2016, please state:
i) The five longest waits in days that patients ready for discharge had had as of this date.
ii) For each of these waits, please state the age of the person concerned and the reason for their admission.
iii) For each of these waits, please state the reason for the delay.
4) Please state how much your trust spent on delayed discharges in each of the following financial years.
i) 2011/12
ii) 2012/13
iii) 2013/14
iv) 2014/15
v) 2015/16
vi) 2016/17 to date.
5)
i) On the 28th September 2016, how many of your acute beds were occupied by people who were ready for discharge?
ii) What proportion of your overall number of acute beds were being used by people who were ready for discharge?
iii) Have you had to open extra transitional, reablement or similar beds to meet the additional demand caused by delayed discharges?
iv) If yes, please state how many beds and the cost of providing these.

Download response Delayed discharges 2014-2017 111116

Delayed discharges. 210218

1. Between 1.2.16 and 31.1.17 how many times have you written to a patient, or the family members of a patient, or the legal guardians of a patient, stating that in the Trust’s view they are fit for discharge and should vacate their hospital bed? For each occurrence please state how many days they had occupied a hospital day for while considered fit for discharge prior to the date of the letter being sent to them or their representatives? For the most recent occasion that a letter was sent please provide me with a copy of the letter accepting that any details that might identify the patient will be redacted to comply with S.40.
2. Of those patients discharged from your hospital in either 2014/15 or 2015/16 please state how many patients had been considered fit to discharge but remained in hospital in excess of one full calendar year before they were discharged? For each patient please state how many days they occupied a hospital bed while considered fit to discharge?
3. Using the most recent convenient date do you have any patients in your hospital who are considered fit to discharge but have been in hospital and been fit to discharge in excess of one full calendar year? For each patient please state how many days they have occupied a hospital bed while considered fit to discharge?

Download response Delayed discharges. 210218

Delayed discharges. 300519

Are you able to let me know the number of bed days lost because medically fit patients are waiting for placements in care homes? If you have this data for the most current reporting period that would be useful.

I’m not sure if the data includes the number of patients who are medically fit but need accommodation due to dementia. Would that data include the average length of delay for dementia patients or just all patients?

Download response Delayed discharges. 300519

Delayed transfer of care 2013-2016. 070317

1. Over the last 3 years (2013-2016) how many patients have been involved in long-term delayed transfer of care (broken down into a delay of over six months; over one year; over two years etc.)
2. Over the last three years (2013-2016) what is the longest someone has been medically fit to be discharged but is still in the hospital?
3. Currently, what is the longest duration a patient has occupied a hospital bed because they are refusing to leave/disputing/family or patient not accepting the care package available?
4. How many times has the Trust applied for court orders to evict a patient over the last three years?
5. (If this figure is available) How much a year does delayed transfer for care cost the Trust?

Download response Delayed transfer of care 2013-2016. 070317

Delayed transfer of care. 190320

1. The number of patients stuck in hospital due to delayed transfers of care, also known as bed blocking. Please tell me the reasons for their delayed transfer and be as specific as possible.
2. The length of time these patients were stuck in hospital.
3. The number of patients stuck in hospital due to delayed transfers of care (bed blocking) because they have hoarding disorder.
4. The length of time these patients were stuck in hospital.

I request the information for the following years:
2015-16
2016-17
2017-18
2018-19
2019-20
2020-present

Download response Delayed transfer of care. 190320

Delayed transfers of care 060317

1. The number of patients who have died in hospital while experiencing a delayed transfer of care. Please could I have these figures for the years 2014, 2015 and 2016, broken down by year?

Download response Delayed transfers of care 060317

Delayed transfers of care 2016-2017. 150517

What is the longest amount of time in days a patient had been kept in hospital due to delayed transfer in the past 12 months?

Could you give me details for the three longest delayed transfer stays, the name of the hospital concerned and if possible the age and gender of the patients concerned and the department they were in (i.e. elderly care/general surgery, paediatrics etc.)?

Are you also able to give a brief reason for the delay in each instance (i.e. lack of beds in care facility/delay equipping home etc.)?

Download response Delayed transfers of care 2016-2017. 150517

Delayed transfers of care. 041121.docx

1. For each month in 2021 for which data is held, please state the number of ‘delayed days’ in acute care that month due to delayed transfers of care
2. Please provide any breakdown the Trust holds of the question 1 data by reason for the delay (e.g. awaiting care package in own home, patient or family choice etc)
3. For each month in 2021 for which data is held, please state the number of ‘delayed days’ in non-acute care that month due to delayed transfers of care
4. Please provide any breakdown the Trust holds of the question 3 data by reason for the delay (e.g. awaiting care package in own home, patient or family choice etc)
5. For each month in 2021 for which data is held, please state the number of ‘DTOC beds’ in acute care that month
6. For each month in 2021 for which data is held, please state the number of ‘DTOC beds’ in non-acute care that month

Download response Delayed transfers of care. 041121.docx

Delayed transfers of care.150523.docx

1. (FOI TO ALL NHS PROVIDERS – DELAYED TRANSFERS OF CARE)
Under the FOI Act please provide me with the information below.
Please confirm receipt of this request as soon as possible.

The number of inpatients who are currently medically fit to leave hospital in your area, but still reside there.

Please provide this as a series of data points for the last calendar year and the year to date, broken down by day. For each day, please break the data into further categories which detail the reason behind the delayed discharge.

Delayed transfers of care.150523.docx

Delays in transfer of care (DTOC) in 2013-14, 2014-15, 2015-16.

1. What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16;

2. In each case, please provide the age of the patient and reason for delay.

Download response Delays in transfer of care (DTOC) in 2013-14, 2014-15, 2015-16.

Delays in transfer of care (DTOC) in 2013-14, 2014-15, 2015-16. 190417

1. What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16;

2. In each case, please provide the age of the patient and reason for delay.

Download response Delays in transfer of care (DTOC) in 2013-14, 2014-15, 2015-16. 190417

Delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16.190416

1. What is the longest time (in days) one patient has remained in a bed at your NHS Trust due to delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16;

2. In each case, please provide the age of the patient and reason for delay.

Download response Delays in transfer of care (DTOC) in 2013/14, 2014/15, 2015/16.190416

DTOC and missed target fines. 280119

1) What is the name of?
a) Your trust
b) The hospitals run by your trust
2) What is the longest time (in days) one patient has remained in a bed at your trust due to delays in transfer of care (DTOC) from October 2016 to October 2018?
3) What was the age of the patient (from question 2) and the reason for delay?
4) How much money has your trust been fined or had withdrawn/withheld for not meeting the percentage target for A&E waiting time (4 hours) in the following financial years: (If possible please breakdown by quarters, if not just give the whole sum for that period)
a) 2017/2018
b) so far 2018
5) How much money has your trust been fined or had withdrawn/withheld for not meeting the percentage target for referral to treatment time of 18 weeks for patients in the following financial years: (If possible please breakdown by quarters, if not just give the whole sum for that period)
a) 2017/2018
b) so far 2018
6) How much money has your trust been fined or had withdrawn/withheld for not meeting the 15 minute target of handing over a patient from an ambulance to your hospital in the following financial years: (If possible please breakdown by quarters, if not just give the whole sum for that period)
a) 2017/2018
b) so far 2018

Download response DTOC and missed target fines. 280119

DTOC patients. 300819

1. Could the authority state how they use agencies and/or software to expedite the discharge of DTOC patients?
2. How much did they spend with agencies to arrange placements with care homes or home care for DTOC patients in each of the last three financial years?
3. Do they use Capacity Tracker or any other software of services to identify care homes or home care packages? Please state which software or services are used.

Download response DTOC patients. 300819

DTOC and self-funding patients. 240817

DTOC and Self-Funding Patients
1. How many self-funding adult social care patients waiting for placements causing DTOCs in 2015-16, 2016-17 and 2017 to date?
2. Are there currently any care home placements and / or care package brokerage services being offered to the self-funders at the moment?
MH / Alcohol Related A&E Admissions
3. How many Alcohol and Mental Health A&E admissions and related occupied bed days? And total cost for this?
4. Is there an Alcohol Nurse Liaison service available at the hospital?
Acute Bed Days DTOCs
5. What is the average cost of an acute hospital bed in your NHS Trust
6. The gross cost to the Trust due to delayed transfers of care (DTOC) (before taking into account reimbursements from local authorities).
7. The gross cost to the Trust due to delayed transfers of care where Social Care was responsible for the delay (before taking into account reimbursements from local authorities).
8. The total sum received from local authorities in reimbursements for delayed transfers of care.
9. How many bed days were lost as a result of delayed transfers of care in your NHS Trust for the years 2014/2015 , 2015/2016 & 2016 /2017
10. What is the longest time (in days) one patient has been a delayed transfer of care (DTOC) in your NHS Trust for the years 2014/2015 2015/2016 2016/2017
11. In each case, please provide the age of the patient and reason for the delay and responsible CCG/local authority.
12. What is the longest time in (in days) one patient has been a delayed transfer of care awaiting further assessment in your NHS Trust for the years 2014/2015 2015/2016 2016/2017.
13. In each case, please provide the age of the patient and responsible CCG/ Local authority
14. Has the Trust ever taken legal action to remove a patient whose transfer of care was delayed? a) If so please provide details of when and the reason for delay in transfer of care and responsible CCG/local authority
Contact Details
15. Discharge and DTOC lead within the Trust
16. Alcohol Liaison Service

Download response DTOC and self-funding patients. 240817

Elderly patients delayed transfer of care (DTOC). 040117

I would like some information on the number of elderly patients who have been kept in hospital when they are well enough to be discharged due to a lack of suitable social care provision in the last 5 years.

Download response Elderly patients delayed transfer of care (DTOC). 040117

 

Diagnostics, Therapies, Pathology & Pharmacy

Pain relief prescriptions 031016

For each of the questions, please can you provide answers for each of the financial years 2013/14, 2014/15 and 2015/16:

1. PARACETAMOL

a. Which suppliers did you buy paracetamol from?
b. How many packets of paracetamol did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of paracetamol did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for paracetamol?
e. How much did you spend on paracetamol in total?
f. How many prescriptions in total did you make for paracetamol?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for paracetamol?

2. IBRUPROFEN

a. Which suppliers did you buy ibuprofen from?
b. How many packets of ibuprofen did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of ibuprofen did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for ibuprofen?
e. How much did you spend on ibuprofen in total?
f. How many prescriptions in total did you make for ibuprofen?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for ibuprofen?

3. ASPIRIN

a. Which suppliers did you buy aspirin from?
b. How many packets of aspirin did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of aspirin did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for aspirin?
e. How much did you spend on aspirin in total?
f. How many prescriptions in total did you make for aspirin?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for aspirin?

4. CODEINE PHOSPHATE

a. Which suppliers did you buy codeine phosphate from?
b. How many packets of codeine phosphate did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of codeine phosphate did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for codeine phosphate?
e. How much did you spend on codeine phosphate in total?
f. How many prescriptions in total did you make for codeine phosphate?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for codeine phosphate?

Download response Pain relief prescriptions 031016

Aciclovir sodium. 170420

Information request 1
Has your hospital dispensed the products listed below from March 1, 2019 till February 29, 2020?
1. Aciclovir sodium 250mg/5ml powder for intravenous infusion B.P.
2. Aciclovir sodium 500mg/5ml powder for intravenous infusion B.P.

Download response Aciclovir sodium. 170420

ACR Laboratory Device.080922.docx

1) The name of the laboratory device that is used to analyse albumin:creatinine ratio in the urine.
2) The name of the chemistry kit (if not included in the first question) that is used to analyse albumin:creatinine ratio in the urine.

ACR Laboratory Device.080922.docx

Acromegaly. 070918

1. Does your trust treat patients for Acromegaly
2. Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs;
• Ocreotide
• Lanreotide
• Pasireotide
• Pegvisomant

Download response Acromegaly. 070918

Acupuncture treatments 2010 to 2015

Please provide the following for the years 2010 to 2015 inclusive:
1. The names of the hospitals, clinics or other settings in which you provided acupuncture treatments.
2. The number of acupuncture treatments provided and the number of patients treated at each of these locations.
3. The types of clinicians who provided these treatments, e.g. physiotherapists, doctors, acupuncturists.
4. The total cost of providing acupuncture treatments at each of these locations.
5. The cost of acupuncture needles purchased included in the total cost.

Download response Acupuncture treatments 2010 to 2015 241016

Administration of medicines.241123.docx

All questions are shown as received by the Trust.
I request that a copy of the following documents (or documents containing the following information) be provided to me please:

All Trust policies that include information on the checking of medicines when they are being administered to patients, and any associated documents e.g. medicines policy, specific medicine/ clinical area policies, codes, appendices to the relevant policies etc.

Administration of medicines.241123.docx

Adult allergy services. 250321

1. Does your trust offer an adult allergy service? Yes/ No
2. Does this service cover more than one hospital? Yes/ No
2a. If yes, which other hospitals are covered by this service?
3. Who is the lead consultant for this service?

Download response Adult allergy services. 250321

Adult formulary

We would like to request the following information regarding the prescribing of growth hormones within Maidstone and Tunbridge Wells NHS Trust

1. We have the following formularies listed as used by your organisation. Please confirm if they are correct and if not, please provide a link/copy of relevant formularies.

West Kent Interface Adult Formulary

2. Please provide a copy or link to any supporting guidelines containing growth hormone product prescribing recommendations that are in addition to the published formulary. If none are available, please confirm if they are currently being developed/drafted.

3. Where guidelines are held in addition to the published formulary, please confirm which has dominance when prescribing growth hormones.

Download response Adult formulary 170815

AeroChamber with and without mask January – December 2015. 290617

I am writing to request the prescribed annual units (for the period January 2015 – December 2015) of the below:

• AeroChamber with Mask
• AeroChamber without Mask

Download response AeroChamber with and without mask January – December 2015. 290617

Agency Pharmacists and Pharmacy Technicians. 240119

I would like you to send me the locum agency spend in the AHP/HSS division of the hospital for Pharmacists and Pharmacy Technicians. I would like to know the spend for 2018 with each agency- if this is not possible then I’d like to know overall spend for the year for both Pharmacists and Pharmacy Technicians.

Download response Agency Pharmacists and Pharmacy Technicians. 240119

Agency spend in Radiology August 2016 – January 2017. 240317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Radiology over the following months, within your Trust or Health Board?
August 2016
September 2016
October 2016
November 2016
December 2016
January 2017

Download response Agency spend in Radiology August 2016 – January 2017. 240317

Agency usage for Radiography.180822.docx

1. Who is the head of procurement responsible for approving agency usage for the Radiography Department at your trust?
2. Who is responsible for agency usage (on and off framework) in the Radiography department at all hospitals associated with the Trust:
3. Please can you provide the contact number and email address for the manager(s) in questions 1 and 2.
4. Have you used off-framework agency staff between March 2021 – March 2022 in Radiography?
5. How much was your Off-Framework agency spend for Radiography between August 2021 and August 2022?

Agency usage for Radiography.180822.docx

Aimovig (Erenumab). 130619

Does your trust treat patients with Aimovig [Erenumab]?
If yes, how many patients have been treated in the past 12 months?

Download response Aimovig (Erenumab). 130619

Alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase and gamma GT.120224.docx

All questions are shown as received by the Trust.
1. The normal range (adults and children) for the following liver enzymes: alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase and gamma GT.
2. The method and machine used with reference so it can be identified.
3. How was your local normal range determined?
a. From the reference range specified by the manufacturer
b. By the lab of a large group of normal volunteers
c. From historical data
d. Other – please describe.
4. Do your liver function tests automatically include measurement of AST?
5. How many sets of liver function tests, which include measurement of ALT and alkaline phosphatase, does your hospital or laboratory complete each year? How many patients does this represent?
6. How many requests for measurement of AST does your hospital or laboratory complete each year? How many patients does this represent?
7. How many values exceed the upper limit of normal for each liver function test?
8. If you do not hold this information because you consider the analyses to be done externally by an outside laboratory, please provide the name of the laboratory and email address for their FOI officer.

Alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase and gamma GT.120224.docx

Alternative medicine

1. Do you offer complementary therapies within the trust?
2. If yes, do you offer Reiki therapy?
3. Which types of services or departments offer Reiki therapy?
4. Have you conducted a formal evaluation of the Reiki service? If so, please provide brief details.

Download response Alternative medicine 060916

Anaemia and blood transfusions. 290118

1. Number of RBC units utilised by ward and/ or department in a) 2015 and b) 2016
2. Number of elective surgical procedures cancelled in 2016 due to the patient being identified as anaemic
3. Number of elective surgical procedures occurring for patients who were anaemic on the day of surgery
4. Of the above, the number of these procedures that required a blood transfusion
5. Following the NICE Quality Standards published in December 2016 on blood transfusion, is able to meet Quality Standard 1? Please see Quality Standard Review form attached. We are partially compliant with Standard 1. The Pre-Assessment Teams are referring patients for IV iron if they are found to be anaemic at Clinic, if there is time pre-operatively. Post-op iron therapy does not appear to be standard practice as yet.

Download response Anaemia and blood transfusions. 290118

Anti-infective medications. 090421

Q1. How many patients have been treated in the last 6 months for Urinary Tract Infections (ICD10 code N39.0) with the following?
a. Ceftazidime/avibactam (Zavicefta)
b. Ceftolozane/tazobactam (Zerbaxa)
c. Meropenem/vaborbactam (Vaborem)
d. Cefiderocol (Fetcroja)
e. Meropenem
Q2. How many patients have been treated in the last 6 months for Post-procedural Respiratory Disorders (ICD10 code J95.8) with the following?
a. Ceftazidime/avibactam (Zavicefta)
b. Ceftolozane/tazobactam (Zerbaxa)
c. Meropenem/vaborbactam (Vaborem)
d. Cefiderocol (Fetcroja)
e. Meropenem
Q3. How many patients have been treated in the last 6 months for Hospital Acquired Pneumonia (ICD10 codes J15 and Y95 in the same inpatient spell) with the following?
a. Ceftazidime/avibactam (Zavicefta)
b. Ceftolozane/tazobactam (Zerbaxa)
c. Meropenem/vaborbactam (Vaborem)
d. Cefiderocol (Fetcroja)
e. Meropenem
Q4. How many patients who underwent a laparotomy/laparoscopic approach to the abdominal cavity (any one of OPCS codes Y502, Y751, Y752 or Y755) in the last 6 months, were treated with the following?
a. Ceftazidime/avibactam (Zavicefta)
b. Ceftolozane/tazobactam (Zerbaxa)
c. Meropenem/vaborbactam (Vaborem)
d. Cefiderocol (Fetcroja)
e. Meropenem

Download response Anti-infective medications. 090421

Anti Infectives. 221020

1 – How many patients have you treated in the last 12 months for complicated Intra Abdominal Infections with the following:
Drug Name Total
Amoxicillin/clauvanate
Piperacillin/tazobactam
Ceftazidime/avibactam (Zavicefta)
Ceftolozane/tazobactam (Zerbaxa)
Carbapenems (such as: Meropenem, Imipenem/cilastatin, Ertapenem)
Aminoglycosides (such as: Gentamicin, Amikacin, Tobramycin)
Cephalosporins (such as: Cefotaxime, Ceftazidime, Ceftriaxone)
Quinolones (such as: Ciprofloxacin, Levofloxacin, Ofloxacin)
Polymixins (such as: Colistin)
2 – How many patients have you treated in the last 12 months for Complicated Urinary Tract Infections with the following:
Drug Name Total
Amoxicillin/clauvanate
Piperacillin/tazobactam
Ceftazidime/avibactam (Zavicefta)
Ceftolozane/tazobactam (Zerbaxa)
Carbapenems (such as: Meropenem, Imipenem/cilastatin, Ertapenem)
Aminoglycosides (such as: Gentamicin, Amikacin, Tobramycin)
Cephalosporins (such as: Cefotaxime, Ceftazidime, Ceftriaxone)
Quinolones (such as: Ciprofloxacin, Levofloxacin, Ofloxacin)
Polymixins (such as: Colistin)

3 – How many patients have you treated in the last 12 months for hospital acquired Pneumonia and / or Ventilator acquired Pneumonia (HAP/VAP) with the following
Drug Name Total
Amoxicillin/clauvanate
Piperacillin/tazobactam
Ceftazidime/avibactam (Zavicefta)
Ceftolozane/tazobactam (Zerbaxa)
Carbapenems (such as: Meropenem, Imipenem/cilastatin, Ertapenem)
Aminoglycosides (such as: Gentamicin, Amikacin, Tobramycin)
Cephalosporins (such as: Cefotaxime, Ceftazidime, Ceftriaxone)
Quinolones (such as: Ciprofloxacin, Levofloxacin, Ofloxacin)
Polymixins (such as: Colistin)

Download response Anti Infectives. 221020

Anti-microbial resistance. 230817

Please could you provide me with the number of cases between 2010-2017?

– In which patients were unable to be treated with anti-biotics due to anti-microbial resistance.
– In which patients had to undergo an operation to remove the site of resistance due to anti-microbial resistance.
– In which patients had amputations due to anti-microbial resistance.

Download response Anti-microbial resistance. 230817

ANTI TNF (originator and biosimilar). 200820

1 How many patients (in the Trust) were initiated on ANTI TNF (originator and biosimilar) over the last 12 months?
2 How many patients (in the Trust) have been initiated on biosimilar adalimumab?
• and what is the split by brand in the last 12 months for the following products?
o Amgevita
o Imraldi
o Hulio
o Hyrmioz
o Idacio
3 How many patients have been initiated on these products?
o guselkumab (Tremfya)
o risankizumab (Skyrizi)
o brodalumab (Kyntheum)
o ixekizumab (Taltz)

Download response ANTI TNF (originator and biosimilar). 200820

Anti-VEFG treatments for eye conditions. 011221.docx

1. For the 4-month period from January to April 2021, how many patients has your trust treated with the following anti-VEGF treatments:
2. For the patients above, how many were new to anti-VEGF therapy? Please provide the patient numbers by the treatments listed below, excluding patients who previously had any anti-VEGF therapy.
3. Within your trust, how many intra-vitreal injections/implants of each the following treatments have been used (for any eye condition) in the four-month period from January to April 2021:
4. If your trust is able to identify intra-vitreal injections/implants by eye condition, please provide the number of injections/implants used in the four-month period from January to April 2021 for each of the following conditions:
Diabetic Macular Oedema (DMO)
Retinal Vein Occlusion – Central (CRVO) or Branch (BRVO)

Download response Anti-VEFG treatments for eye conditions. 011221.docx

Anti-VEFG treatments for eye conditions. 081221.docx

1. For the 4-month period from September to December 2020, how many patients has your trust treated with the following anti-VEGF treatments:
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Fluocinolone acetonide
f. Ranibizumab
2. Within your trust how many intra-vitreal injections/implants of each of the following treatments have been used in the four-month period from September to December 2020:
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Fluocinolone
f. Ranibizumab
3. If your trust is able to identify intra-vitreal injections/implants by eye condition, please provide the number of injections/implants used in the four-month period from September to December 2020 for each of the following conditions:
Wet Age Related Macular Degeneration (wAMD)
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Ranibizumab
Diabetic Macular Oedema (DMO)
a. Aflibercept
b. Bevacizumab
c. Dexamethasone
d. Ranibizumab
Retinal Vein Occlusion – Central (CRVO) or Branch (BRVO)
a. Aflibercept
b. Bevacizumab
c. Dexamethasone
d. Ranibizumab

Download response Anti-VEFG treatments for eye conditions. 081221.docx

Anti-VEGF treatment. 240720

1. Within your Trust, how many patients, in the most recent 12-month period for which data are available, have received anti-VEGF treatment for the first time (i.e., excluding patients who previously had any anti-VEGF therapy)?

2. Of these first-time patients, please provide a breakdown by the treatments listed below:
Aflibercept
Brolucizumab
Dexamethasone
Ranibizumab
All other anti-VEGF treatments

3. Of these first-time patients, how many were treated for Wet Age-Related Macular Degeneration (wAMD) by each treatment?
Aflibercept
Brolucizumab
Dexamethasone
Ranibizumab
All Other anti-VEGF treatments

Download response Anti-VEGF treatment. 240720

Antibiotic guidelines. 040117

1) Please provide, in full, the antibiotic guidelines used by your trust.
2) Is antibiotic prophylaxis routinely given for urinary catheter removal after any joint replacement? : yes/no
3) If yes, which is given and how?
4) If yes, what proportion of patients with urinary catheters receive it?

Download response Antibiotic guidelines. 040117

Antibiotic prescribing. 220118

Could you please supply me with the number of each antibiotic prescribed in hospital for the past 10 years?
Could you please break this information down by the name of the drug (eg vancomycin) for each year in the past 10 years? For 2016 could you please give the number of each antibiotic prescribed so far?
Could you also provide me with the cost of each drug for each year?
Please note I am not seeking antibiotics dispensed in the community, but antibiotics prescribed in hospitals.
Download response Antibiotic prescribing. 220118

Antibiotic resistant NDM 2014-2016. 280217

Can you please send details of any cases of antibiotic resistant NDM (New Delhi metallo-ß-lactamase) “superbugs” you have reported to Public Health England in 2014, 2015 and 2016.

We are particularly interested in NDM-1, but would appreciate details of any other NDM incidents if available.

Please break the information down into the three years listed.

Download response Antibiotic resistant NDM 2014-2016. 280217

Antibiotics. 270617

Please could you provide me with a list of all companies currently supplying antibiotics – or that have supplied antibiotics in the last three years – to Maidstone & Tunbridge Wells NHS Trust.

Plus:

– The details, where possible, of the antibiotic products these companies supply or have supplied.

Download response Antibiotics. 270617

Antifungal Treatments.110722.docx

1) What is the number of patients in the last 12 months treated with the following product lines:
A) anidulafungin
B) caspofungin
C) micafungin
2) What is the split of indication over the last 12 months for the following product lines:
A) anidulafungin
B) caspofungin
C) micafungin
3) For each of the indication splits of the 3 product lines mentioned previously (anidulafungin, caspofungin and micafungin from Q2), please list the average length of treatment time.

Antifungal Treatments.110722.docx

Aquatic physiotherapy (hydrotherapy) provision. 280122.docx

1. On behalf of which NHS Trust / Health Board are you responding?
2. Does your Trust / Health Board have access to a hydrotherapy pool?
3. If you do have access are your hydrotherapy pools onsite or offsite? (Tick all that apply)
4. Were all your hydrotherapy pools open prior to the COVID-19 pandemic?
5. If you do not have access to hydrotherapy pools, please tick all answers that apply to answer why that is.
6. How many hydrotherapy pools exist on your NHS Trust / Board’s estate? Include those closed prior to COVID-19.
7. What are your closed hydrotherapy pools / departments now used for?
REOPENING OF HYDROTHERAPY POOLS
8. Will all your hydrotherapy pools be re-opening?
9. When are your hydrotherapy pools scheduled to re-open?
10. If your hydrotherapy pools are not scheduled to reopen, why is that? (Please select all that apply)
11. If your hydrotherapy pools are not scheduled to reopen, has a full public consultation taken place?
12. If your hydrotherapy pools are not scheduled to reopen has an equality impact assessment taken place?
OPERATING HYDROTHERAPY POOLS
13. If your hydrotherapy pools are open or scheduled to open is / will your aquatic physiotherapy (hydrotherapy) service capacity be reduced as a result of COVID-19?
14. What capacity are / will you be able to offer compared to pre pandemic?
Please enter a percentage (%).
15. Is / will your service be provided on a 1:1 basis?
16. Is / will your service be provided with the therapist instructing from poolside
17. Approximately how many sessions did you have access to your hydrotherapy pools on a weekly basis pre pandemic? (Where one session = one morning, afternoon or evening clinic)
18. Approximately how many sessions do you currently have access to your hydrotherapy pools on a weekly basis?
19. Which services use your hydrotherapy pools?
20. Are your hydrotherapy pools used by inpatient or outpatient services?
21. Prior to the pandemic did you provide out of hours access to your hydrotherapy pools to patient groups or private groups? e.g. NASS, Private Clinics (Please provide a list)
22. Have these sessions restarted? (Please provide a list of those which have restarted)
23. Do you currently audit the use and effectiveness of aquatic physiotherapy (hydrotherapy)?
24. Please list outcome measures or tools used to audit the use and effectiveness of aquatic physiotherapy (hydrotherapy)?
25. If you are happy to be contacted for further information to support aquatic physiotherapy (hydrotherapy) services remobilise please provide an email address below.
Aquatic physiotherapy (hydrotherapy) provision. 280122.docx

Aseptic drug compounding or preparation. 290617

1. How much does your aseptic unit cost to run annually?
2. How many aseptically prepared doses does your unit produce per annum?
3. What types of aseptically prepared products does your aseptic unit produce? E.g Parenteral nutrition, antibiotics, cancer chemotherapy?
4. What IT systems does your Aseptic unit currently use to manage the compounding process or help with your prescribing?
5. How many staff do you employ in your aseptic department?
6. How many members of staff are full time equivalents?
7. How many clean rooms do you have in your department?
8. How many isolators do you have in your department?
9. Do you do any outsourcing? Or is all of your compounding carried out in house?
10. Are you a licensed unit? If so, do you compound for any other customers? If yes, who and for how long?
11. What is your unit’s annual drug spend?

Download response Aseptic drug compounding or preparation. 290617

Aseptic pharmaceutical services.081223.docx

All questions are shown as received by the Trust.
A number of IV drugs are reconstituted or prepared before administration Pharmacy aseptic services.
If your Trust procures all or some of their aseptic pharmaceutical services from licenced compounders both NHS and Private.
1 If so, can you list the Providers your Trust Currently uses.
2 Can you indicate if your Trust has a preferred or preferred provider if so please list them.
3 Does your Trust have any documentation that falls within the Scope of a competent FOI request relating to how you choose compounders if so, can I have copies. Please feel free to redact as necessary.

Aseptic pharmaceutical services.081223.docx

Asthma.250823.docx

All questions are shown as received by the Trust.
Q1. How many patients have been treated (for any condition) in the last 4 months with:
• Benralizumab
• Dupilumab
• Omalizumab
• Reslizumab
• Mepolizumab
• Tezepelumab

Q2. Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age groups:
• Age 6 – 11
• Age 12 – 17
• Age 18 and above

Q3. How many patients have been treated in the last 4 months by the Respiratory Medicines Department ONLY with:
• Dupilumab
• Omalizumab

Asthma.250823.docx

Autopsies. 080519

For each of the years 2017 and 2018 please may you provide me with-

1. The total number of adult (aged 17 and above) deaths within your Trust (on Trust sites) between 1st January and 31st December of each year.
2. The number of Hospital (consent) autopsies carried out on adult (aged 17 and above) deaths which occurred between 1st January and 31st December of each year.

Download response Autopsies. 080519

Benzodiazepines. 270617

Prescription of Benzodiazepines (class of psychoactive drugs)
How many patients were given any form of benzodiazepines during treatment in hospital?
Please provide broken-down figures (if possible) for up to the past five years and at least for the past 3 years

Download response Benzodiazepines. 270617

Biologic and biosimilar product prescribing in Rheumatology. 211020

Q1. How many patients have been treated with biologics or biosimilar products in the last 12 months for the following conditions:
· Rheumatoid Arthritis
· Psoriatic Arthritis
· Ankylosing Spondylitis
· Non-Radiographic Axial Spondyloarthritis
Q2. Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 12 months with the following drugs.
· Abatacept [Orencia]
· Adalimumab [Amgevita]
· Adalimumab [Humira]
· Adalimumab [Hyrimoz]
· Adalimumab [Imraldi]
· Apremilast [Otezla]
· Baricitinib [Olumiant]
· Certolizumab [Cimzia]
· Etanercept [Benepali]
· Etanercept [Enbrel]
· Etanercept [Erelzi]
· Golimumab [Simponi]
· Infliximab [Flixabi]
· Infliximab [Inflectra]
· Infliximab [Remicade]
· Infliximab [Remsima]
· Ixekizumab [Taltz]
· Rituximab [MabThera]
· Rituximab [Rixathon]
· Rituximab [Truxima]
· Sarilumab [Kevzara]
· Secukinumab [Cosentyx]
· Tocilizumab [Ro Actemra]
· Tofacitinib [Xeljanz]
· Upadacitinib [Rinvoq]
· Ustekinumab [Stelara]

Download response Biologic and biosimilar product prescribing in Rheumatology. 211020

Biologic and biosimilar products within Rheumatology. 020222.docx

Q1. Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:
a. Abatacept [Orencia]
b. Adalimumab [Humira]
c. Adalimumab Biosimilars
d. Apremilast [Otezla]
e. Baricitinib [Olumiant]
f. Certolizumab [Cimzia]
g. Etanercept [Enbrel]
h. Etanercept Biosimilars
i. Filgotinib [Jyseleca]
j. Golimumab [Simponi]
k. Guselkumab [Tremfya]
l. Infliximab [Remicade]
m. Infliximab Biosimilars
n. Ixekizumab [Taltz]
o. Risankizumab [Skyrizi]
p. Rituximab [MabThera]
q. Rituximab Biosimilars
r. Sarilumab [Kevzara]
s. Secukinumab [Cosentyx]
t. Tocilizumab [Ro Actemra]
u. Tofacitinib [Xeljanz]
v. Upadacitinib [Rinvoq]
w. Ustekinumab [Stelara]
Q2. Could you please provide the numbers of patients treated for Axial Spondyloarthritis ONLY in the last 3 months with the following drugs.
a. Adalimumab [Humira]
b. Adalimumab Biosimilars
c. Certolizumab [Cimzia]
d. Etanercept [Enbrel]
e. Etanercept Biosimilars
f. Golimumab [Simponi]
g. Infliximab [Remicade]
h. Infliximab Biosimilars
i. Ixekizumab [Taltz]
j. Secukinumab [Cosentyx]
k. Upadacitinib [Rinvoq]

Biologic and biosimilar products within Rheumatology. 020222.docx

Biologic and biosimilar products within Rheumatology. 081021.docx

Q1. Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:
a. Abatacept [Orencia]
b. Adalimumab [Humira]
c. Adalimumab Biosimilars
d. Apremilast [Otezla]
e. Baricitinib [Olumiant]
f. Certolizumab [Cimzia]
g. Etanercept [Enbrel]
h. Etanercept Biosimilars
i. Filgotinib [Jyseleca]
j. Golimumab [Simponi]
k. Guselkumab [Tremfya]
l. Infliximab [Remicade]
m. Infliximab Biosimilars
n. Ixekizumab [Taltz]
o. Risankizumab [Skyrizi]
p. Rituximab [MabThera]
q. Rituximab Biosimilars
r. Sarilumab [Kevzara]
s. Secukinumab [Cosentyx]
t. Tocilizumab [Ro Actemra]
u. Tofacitinib [Xeljanz]
v. Upadacitinib [Rinvoq]
w. Ustekinumab [Stelara]
Q2. Could you please provide the numbers of patients treated for Psoriatic Arthritis ONLY in the last 3 months with the following drugs.
a. Abatacept [Orencia]
b. Adalimumab [Humira]
c. Adalimumab Biosimilars
d. Apremilast [Otezla]
e. Certolizumab [Cimzia]
f. Etanercept [Enbrel]
g. Etanercept Biosimilars
h. Golimumab [Simponi]
i. Guselkumab [Tremfya]
j. Infliximab [Remicade]
k. Infliximab Biosimilars
l. Ixekizumab [Taltz]
m. Risankizumab [Skyrizi]
n. Secukinumab [Cosentyx]
o. Tofacitinib [Xeljanz]
p. Upadacitinib [Rinvoq]
q. Ustekinumab [Stelara]

Download response Biologic and biosimilar products within Rheumatology. 081021.docx

Biologic and biosimilar products within Rheumatology..docx

We are analysing the usage of biologic and biosimilar products within Rheumatology. It would be really helpful if you could provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:
• Abatacept [Orencia]
• Adalimumab [Humira]
• Adalimumab Biosimilars
• Apremilast [Otezla]
• Baricitinib [Olumiant]
• Certolizumab [Cimzia]
• Etanercept [Enbrel]
• Etanercept Biosimilars
• Filgotinib [Jyseleca]
• Golimumab [Simponi]
• Guselkumab [Tremfya]
• Infliximab [Remicade]
• Infliximab Biosimilars
• Ixekizumab [Taltz]
• Risankizumab [Skyrizi]
• Rituximab [MabThera]
• Rituximab Biosimilars
• Sarilumab [Kevzara]
• Secukinumab [Cosentyx]
• Tocilizumab [Ro Actemra]
• Tofacitinib [Xeljanz]
• Upadacitinib [Rinvoq]
• Ustekinumab [Stelara]

Biologic and biosimilar products within Rheumatology..docx

Biologic drugs. 010421

Q1. Could you please provide the numbers of patients treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Apremilast
d. Brodalumab
e. Certolizumab
f. Dimethyl fumarate
g. Etanercept – Enbrel
h. Etanercept Biosimilar
i. Guselkumab
j. Infliximab – Remicade
k. Infliximab Biosimilar
l. Ixekizumab
m. Risankizumab
n. Secukinumab
o. Tildrakizumab
p. Ustekinumab
Q2. Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Golimumab
d. Infliximab – Remicade
e. Infliximab Biosimilar
f. Tofacitinib
g. Ustekinumab
h. Vedolizumab
Q3. If possible, could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for Ulcerative Colitis ONLY with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Golimumab
d. Infliximab – Remicade
e. Infliximab Biosimilar
f. Tofacitinib
g. Ustekinumab
h. Vedolizumab

Download response Biologic drugs. 010421

biologic drugs. 100621

Q1. Could you please provide the numbers of patients treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Apremilast
d. Brodalumab
e. Certolizumab
f. Dimethyl fumarate
g. Etanercept – Enbrel
h. Etanercept Biosimilar
i. Guselkumab
j. Infliximab – Remicade
k. Infliximab Biosimilar
l. Ixekizumab
m. Risankizumab
n. Secukinumab
o. Tildrakizumab
p. Ustekinumab
Q2. For the patients treated by the Dermatology department in the last three months with any of the above drugs, can you please provide the total number of paediatric (up to age 16) versus adult patients?
Q3. Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Golimumab
d. Infliximab – Remicade
e. Infliximab Biosimilar
f. Tofacitinib
g. Ustekinumab
h. Vedolizumab

Download response biologic drugs. 100621

Biologic drugs. 151220

Q1. Could you please provide the numbers of patients treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs:
· Adalimumab – Humira
· Adalimumab Biosimilar
· Apremilast
· Brodalumab
· Certolizumab
· Dimethyl fumarate
· Etanercept – Enbrel
· Etanercept Biosimilar
· Guselkumab
· Infliximab – Remicade
· Infliximab Biosimilar
· Ixekizumab
· Risankizumab
· Secukinumab
· Tildrakizumab
· Ustekinumab
Q2. For the patients treated by the Dermatology department in the last three months with any of the above drugs, can you please provide the total number of paediatric (up to age 16) versus adult patients?
Q3. Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Golimumab
d. Infliximab – Remicade
e. Infliximab Biosimilar
f. Tofacitinib
g. Ustekinumab
h. Vedolizumab

Download response Biologic drugs. 151220

Biologic drugs in Gastroenterology.140322.docx

Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for any medical condition, and if possible, for Ulcerative Colitis, with the following biologic drugs:
1. Total Gastroenterology Patients
2. Ulcerative Colitis Patients
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Filgotinib
d. Golimumab
e. Infliximab – Remicade
f. Infliximab Biosimilar
g. Ozanimod
h. Tofacitinib
i. Ustekinumab
j. Vedolizumab
Biologic drugs in Gastroenterology.140322.docx

Biologic medicines in gastroenterology.030622.docx

Q1. How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Filgotinib
d. Golimumab
e. Infliximab – Remicade
f. Infliximab Biosimilar
g. Ozanimod
h. Tofacitinib
i. Ustekinumab
j. Vedolizumab
Q2 How many patients were treated in the last 3 months for Crohn’s Disease ONLY with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Golimumab
d. Infliximab – Remicade
e. Infliximab Biosimilars
f. Ustekinumab
g. Vedolizumab

Biologic medicines in gastroenterology.030622.docx

Biologic medicines in gastroenterology.031122.docx

Q1. How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Filgotinib
d. Golimumab
e. Infliximab – Remicade
f. Infliximab Biosimilar
g. Ozanimod
h. Tofacitinib
i. Ustekinumab
j. Vedolizumab
Q2 If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Ulcerative Colitis ONLY with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Filgotinib
d. Golimumab
e. Infliximab – Remicade
f. Infliximab Biosimilar
g. Ozanimod
h. Tofacitinib
i. Ustekinumab
j. Vedolizumab

Biologic medicines in gastroenterology.031122.docx

Biologic products in respiratory medicine. 100921.docx

Q1. How many patients have been treated (for any condition) in the last four months with:
a. Benralizumab
b. Dupilumab
c. Omalizumab
d. Reslizumab
e. Mepolizumab
Q2. Of the total patients treated in the last four months with any of the products listed in Q1, please can you provide the split of the number of patients in the following age groups:
a. Age 6-11
b. Age 12-17
c. Age 18 and above
Q3. How many patients have been treated in the last four months for asthma ONLY with:
a. Dupilumab

Download response Biologic products in respiratory medicine. 100921.docx

Biological and Biosimilar medicines. 070818

1 – In your Trust, how much did you spend on Biological and biosimilar medicines, in the past financial year ending April 2018?
2 – Have you developed a policy on how prescribers can switch their patients to biosimilars and support them in making informed choices to save resources?
If yes, please provide details
3 – Do you have any specific plans in place for the launch of biosimilar Adalimumab later in 2018?
4 – Are there any agreements in place between you the Provider and CCG that would enable savings in drug costs to be made? (For example, Gainshare agreements where the benefits associated with more efficient use of medicines not reimbursed through national prices is shared between the Provider and the Clinical Commissioning Group party to the agreement. This included agreements for the switch to biosimilar products)
If “Yes”, then please provide the following details:
5 – Are there any other agreements with a CCG, not included in the above, for the following services?
If “Yes”, then please provide the following details:

Download response Biological and Biosimilar medicines. 070818

Biologics 101016

We would like to request from Maidstone and Tunbridge Wells NHS Trust (MTW) the numbers of patients treated in the last 12 months with the following drugs for the conditions listed below:

Download response Biologics 101016

Biologics and Biosimilar

1. Does your trust run a dedicated Gastroenterology infusion clinic for the treatment of patients with Infliximab [or Vedolizumab] If Yes, how frequently are they run?
2. Could you please provide me with the following numbers of patients treated in the last six months with the following drugs for the conditions listed below?

Rheumatology [Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis] Dermatology [Psoriasis] Hidradenitis suppurativa (sometimes known as acne inversa) L73.2 Gastroenterology
[Crohns / Ulcerative Colitis]
Abatacept (Orencia)
Adalimumab (Humira)
Apremilast (Otezla)
Certolizumab Pegol (Cimzia)
Etanercept (Enbrel)
Golimumab (Simponi)
Infliximab (Remicade)
Infliximab biosimilar (Inflectra)
Infliximab biosimilar (Remsima)
Rituximab (MabThera)
Secukinumab (Cosentyx)
Tocilizumab (RoActemra)
Tofacitinib [Xeljanz]
Ustekinumab (Stelara)
Vedolizumab (Entyvio)

Download response Biologics and Biosimilar 120116

Biologics and Biosimilar. 120919

I have a Freedom of Information request regarding biologics and biosimilar prescribing. Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs regardless of diagnosis?

Download response Biologics and Biosimilar. 120919

Biologics and biosimilar prescribing 01.06.2015 – 31.05.2016

Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs for the conditions listed below?

• Psoriasis
• Hidradenitis Suppurativa
• Crohn’s disease
• Ulcerative Colitis

Download response Biologics and biosimilar prescribing 01.06.2015 – 31.05.2016 250716

Biologics and Biosimilar prescribing. 031219

Could you please provide me with following numbers of patients treated in the last 12 months (latest) 12 months possible) with the following drugs for either Rheumatology, Dermatology and Gastroenterology departments:
Abatacept (Orencia)
Adalimumab biosimilar (Amgevita)
Adalimumab biosimilar (Hulio)
Adalimumab (Humira)
Adalimumab biosimilar (Hyrimoz)
Adalimumab biosimilar (Imraldi)
Apremilast (Otezla)
Baricitinib (Olumiant)
Brodalumab (Kyntheum)
Certolizumab (Cimzia)
Dimethyl Fumarate (Skilarence)
Etanercept (Enbrel)
Etanercept Biosimilar (Benepali)
Etanercept Biosimilar (Erelzi)
Golimuab (Simponi)
Guselkumab (Tremfya)
Infliximab (Flixabi)
Infliximab (Inflectra)
Infliximab (Remicade)
Infliximab (Remsima)
Ixekizumab (Taltz)
Rituximab (Mabthera)
Rituximab Biosimilar (Rixathon)
Rituximab Biosimilar (Truxima)
Sarilumab (Kevzara)
Secukinumab (Cosentyx)
Tildrakizumab (Ilumetri)
Tocilizumab (Ro Actemra)
Tofacitinib (Xeljanz)
Ustekinumab (Stelara)
Vedolizumab (Entyvio)

Download response Biologics and Biosimilar prescribing. 031219

Biologics and Biosimilar prescribing. 170119

Could you please provide me with the following numbers of patients treated for Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Psoriasis, Crohn’s Disease, Ulcerative Colitis in the last 12 months (latest 12 months possible) with the following drugs;
Abatacept (Orencia)
Adalimumab (Biosimilar)
Adalimumab (Humira)
Apremilast (Otezla)
Baricitinib (Olumiant)
Brodalumab (Kyntheum)
Certolizumab (Cimzia)
Dimethyl Fumarate (Skilarence)
Etanercept (Enbrel)
Etanercept Biosimilar (Benepali or Erelzi)
Golimumab (Simponi)
Guselkumab (Tremfya)
Infliximab (Remicade)
Infliximab Biosimilar (Inflectra, Remsima or Flixabi)
Ixekizumab (Taltz)
Rituximab (Mabthera)
Rituximab Biosimilar (Rixathon or Truxima)
Sarilumab (Kevzara)
Secukinumab (Cosentyx)
Tildrakizumab (Ilumetri)
Tocilizumab (Ro Actemra)
Tofacitinib (Xeljanz)
Ustekinumab (Stelara)
Vedolizumab (Entyvio)

Download response Biologics and Biosimilar prescribing. 170119

Biologics and biosimilar prescribing in Rheumatology. 020320

Could you please provide me with the following numbers of patients treated in the last 12 months with the following drugs.
· Abatacept [Orencia]
· Adalimumab [Amgevita]
· Adalimumab [Hulio]
· Adalimumab [Humira]
· Adalimumab [Hyrimoz]
· Adalimumab [Imraldi]
· Apremilast [Otezla]
· Baricitinib [Olumiant]
· Brodalumab [Kyntheum]
· Certolizumab [Cimzia]
· Dimethyl fumarate [Skilarence]
· Etanercept [Benepali]
· Etanercept [Enbrel]
· Etanercept [Erelzi]
· Golimumab [Simponi]
· Guselkumab [Tremfya]
· Infliximab [Flixabi]
· Infliximab [Inflectra]
· Infliximab [Remicade]
· Infliximab [Remsima]
· Ixekizumab [Taltz]
· Risankizumab [Skyrizi]
· Rituximab [MabThera]
· Rituximab [Rixathon]
· Rituximab [Truxima]
· Sarilumab [Kevzara]
· Secukinumab [Cosentyx]
· Tildrakizumab [Ilumetri]
· Tocilizumab [Ro Actemra]
· Tofacitinib [Xeljanz]
· Upadacitinib [Rinvoq]
· Ustekinumab [Stelara]

Download response Biologics and biosimilar prescribing in Rheumatology. 020320

Biologics and Biosimilar prescribing. 050718

Could you please provide me with the following numbers of patients treated in the last 12 months (latest 12 months possible) with the following drugs for either Rheumatology, Dermatology or Gastroenterology departments.

Download response Biologics and Biosimilar prescribing. 050718

Biologics and Biosimilar prescribing. 210917

Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs for the conditions listed below?

• Psoriasis
• Hidradenitis Suppurativa
• Crohn’s disease
• Ulcerative Colitis

Download response Biologics and Biosimilar prescribing. 210917

Biologics and Biosimilar prescribing. 250517

Could you please provide me with the following numbers of patients treated in the last six months (to date) with the following drugs for the conditions listed below?

Rheumatoid arthritis Ankylosing spondylitis Psoriatic arthritis
Abatacept (Orencia)
Adalimumab (Humira)
Apremilast (Otezla)
Certolizumab Pegol (Cimzia)
Etanercept (Enbrel)
Etanercept biosimilar (Benepali)
Golimumab (Simponi)
Infliximab (Remicade)
Infliximab biosimilar (Inflectra)
Infliximab biosimilar (Remsima)
Rituximab (MabThera)
Secukinumab (Cosentyx)
Ixekizumab (Taltz)
Tocilizumab (RoActemra)
Ustekinumab (Stelara)
Vedolizumab (Entyvio)

Download response Biologics and Biosimilar prescribing. 250517

Biologics and biosimilar prescribing. 290617

Could you please provide me with the numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs within the dermatology or gastroenterology departments?
Abatacept (Orencia)
Adalimumab (Humira)
Apremilast (Otezla)
Certolizumab Pegol (Cimzia)
Etanercept (Enbrel)
Etanercept biosimilar (Benepali)
Fumaric Acid Esters N/A
Golimumab (Simponi)
Infliximab (Remicade)
Infliximab biosimilar (Inflectra)
Infliximab biosimilar (Remsima)
Rituximab (MabThera)
Secukinumab (Cosentyx)
Ixekizumab (Taltz)
Tocilizumab (RoActemra)
Ustekinumab (Stelara)
Vedolizumab (Entyvio)

Download response Biologics and biosimilar prescribing. 290617

Biologics drugs used in the Gastroenterology department. 081021.docx

1. Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Filgotinib
d. Golimumab
e. Infliximab – Remicade
f. Infliximab Biosimilar
g. Tofacitinib
h. Ustekinumab
i. Vedolizumab
2. How many patients were treated in the last 3 months for Crohn’s Disease ONLY with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Golimumab
d. Infliximab – Remicade
e. Infliximab Biosimilars
f. Ustekinumab
g. Vedolizumab

Download response Biologics drugs used in the Gastroenterology department. 081021.docx

Biologics and Homecare. 290118

1. What is the Trust’s annual spend on anti-TNF drugs (most recent year available)?
2. How many patients has the Trust treated with anti-TNF drugs in the last 12 months?
3. What is the % split of anti-TNF patients by the following channels?
4. How many patients has the Trust treated with the following conditions in last 12 months?
5. Are there any gain share agreements in place between the Trust and CCGs for anti-TNF biosimilars?
If yes, please provide:

Biologics and Homecare. 290118

Biomarker testing. 270318

1. Do you currently offer a biomarker testing for the following, as of the beginning of 2018?
PD-L1 in NSCLC
ALK in NSCLC
BRAF in Melanoma
2. Is predictive biomarker testing conducted at the same lab (or similar location such as in same building) as the initial cytological and histological (H&E stain) assessment, or is this done at a different site?
IHC
FISH /ISH/ NGS / PCR
3. Is biomarker testing performed reflexively or upon request for the following biomarkers?
PD-L1 in NSCLC
ALK for NSCLC
BRAF in Melanoma
4. Which of the following biomarkers are assessed in lung cancer patients in your laboratory? (please select all that apply)
5. Which of the following testing platforms are used at this this laboratory?
6. What IHC staining platform(s) are used in the laboratory for biomarker testing? (please select all that apply)
7. What type of test does the institution prefer to use for biomarker-predictive IHCs?
What is the main factor in this decision?
8. Does your lab / trust seek separate reimbursement from NHS under the “high-cost medicines and tests” provision for biomarker tests that have been excluded from tariff?
9. What is the number of samples being tested (or sent-out) are tested for the following biomarkers?
ALK
EGFR
PD-L1
BRAF
10. Where are archived tissues from lung cancer patients stored?
11. If on-site; how long are tissues stored on site until transferred to other storage facility?
12. What is the typical turn-around time from tissue/specimen extraction to the report of biomarker testing results in lung cancer patients?
13. How are the following biomarker testing funded at your lab?

Download response Biomarker testing. 270318

Biomarker testing.290922.docx

As Maidstone and Tunbridge Wells NHS Trust, is part of the South East Genomic Laboratory Hub, could you please answer the following three questions about biomarker testing that the Trust conducts as part of the NHS England Genomic Laboratory Hubs.
Q1. How many patients has the Trust tested for the following Non-Small Cell Lung Cancer biomarkers in the last 6 months?
a. MET (Test Code M4.3)
b. ALK (Test Code M4.11)
c. ROS1 (Test Code M4.6)
d. EGFR (Test Code M4.4 AND M4.5)
e. RET (Test Code M4.7)
f. BRAF V600E
g. NTRK
h. KRAS
i. HER2
Q2. Of the patients that were tested for each biomarker, how many patients tested positive?
a. MET (Test Code M4.3)
b. ALK (Test Code M4.11)
c. ROS1 (Test Code M4.6)
d. EGFR (Test Code M4.4 AND M4.5)
e. RET (Test Code M4.7)
f. BRAF V600E
g. NTRK
h. KRAS
i. HER2
Q3. Which NHS Trusts do you provide the genomic service for? i.e. Are you able to advise which trusts you carry out biomarker testing for as part of the NHS England Genomic Laboratory Hub network?

Biomarker testing.290922.docx

Biomedical Science and Pathology agency usage.210622

1: Who is the head of procurement responsible for approving Biomedical Science/Pathology agency usage at Maidstone and Tunbridge Wells NHS Trust?
2: Who are the managers responsible for agency approval for Pathology/Laboratory agency usage (on and off framework) for the following departments at all hospitals associated with the Trust:
– Blood Sciences (Haematology, Biochemistry, and Blood Transfusion):
– Infectious Sciences (Microbiology, Virology, Molecular, Serology, COVID):
– Cellular Pathology
3: Please provide the contact numbers and email addresses in relation to question 1 and 2.
4: Have you used off-framework agency staff for Biomedical Science/Pathology between January 2021 and January 2022?
5: How much was your off-framework agency spend for each of the following departments between January 2021 and January 2022:
(a) Blood Sciences (Haematology, Biochemistry and Blood Transfusion):
(b) Infectious Sciences (Microbiology, Virology, Molecular, Serology, COVID):
(c) Cellular Pathology
6: How many roles were filled by off-framework agency workers between January 2021 and January 2022 for each of the departments outlined in question 5?
7: How many unfilled roles did you have between January 2021 and January 2022 for each of the departments outlined in question 5?
Biomedical Science and Pathology agency usage.210622

Blood bank refrigerators. 030221

I would like to request a list of all blood bank refrigerators currently in use within the NHS trust please.
Specifically:
1. Hospital name
2. Department
3. Refrigerator manufacturer and model
4. Refrigerator serial number
5. Date purchased/installed

Download response Blood bank refrigerators. 030221

Blood collection tubes for liquid biopsies. 250521

1. How do you obtain blood collection tubes for liquid biopsies on cancer patients?
2. From what suppliers do you obtain these products?
3. Were these products purchased through a tender or framework? If so, which one? Please provide details including the name, reference and where this was published.
4. Are you under contract with your current supplier(s) for the above? If so, what is the start and end date of the contract?
5. Can you provide the name and contact details for the person(s) responsible for procuring these products?
6. Can you provide contact details for the department responsible for managing this service?

Download response Blood collection tubes for liquid biopsies. 250521

Blood Contamination.260124.docx

All questions are shown as received by the Trust.
1. Prior to blood culture collection, what skin asepsis solution does your hospital/Trust/Health Board use in the skin preparation/ cleaning process – (a) licensed skin antisepsis applicator (b) licensed skin disinfection wipe (c) non licensed wipe (d) other?
2. How long do you clean the patient’s skin for and what technique is used?
3. How long does your organisation allow the patients skin to dry before blood culture collection?
4. Do you know the percentage of contamination rate of blood cultures in your organisation?
5. What is the management process following a confirmed blood sample contamination. Is it escalation to (a) infection control team (b) microbiology (c) education and development (d) other, please specify or (e) no process?

Blood Contamination.260124.docx

Blood cultures. 090617

1. Who is the policy or clinical lead for blood culture best practice at your trust? Please provide a name, job title, postal address, email address and phone number.
2. Does your Trust follow the Public Health England SMI guidelines for blood cultures?
3. How many blood culture sets are taken for each suspected case of (a) sepsis and (b) other bacterial infection, and where there is more than one blood culture set taken are these taken from different sites – please provide an answer for both (a) and (b).
4. How many individual blood cultures were taken at your trust in the following years: (a) 2012/13 (b) 2013/14 (c) 2014/15 (d) 2015/16 (e) 2016/17?
5. How many individual blood cultures were identified as being contaminated in the following years: (a) 2012/13 (b) 2013/14 (c) 2014/15 (d) 2015/16 (e) 2016/17?

Download response Blood cultures. 090617

Blood grouping analyser. 291118

You asked:
Question 1: Does your Trust have a blood transfusion service?
If yes, please answer the following questions about your blood group analysers:
Question 2: Who is the analyser manufacturer?
Question 3: What is the make and model type of analyser?
Question 4: What percentage of false positive results do you see with this analyser for blood grouping and antibody screening? (Only include false positives caused by external contaminants or analyser failures)
Question 5: How many group and screen samples do you test per year?
Question 6: Do you provide electronic issue of red cells?
Question 7: Do you provide automated crossmatching using your analysers?
Question 8: Do you have an agreed blood ordering schedule?

Download response Blood grouping analyser. 291118

Blood pressure monitors

1. Total number of all types of blood pressure monitors in your institution (e.g. 1000 blood pressure monitors overall)
2. Can you please list all the types of blood pressure monitors and its quantities (e.g. NIBP – x20, SpO2 – x20), its brands (e.g. Omron – x20, Criticare – x20, Datascope – x20), and models (e.g. Criticare 506DXN – x10, Criticare 507DXN – x10, Datascope Accutorr + x20). We would like to ask you kindly if you can state this information in a separate spreadsheet document.
3. In which departments do you use blood pressure monitors? (e.g. 20 Omron in wards, 20 Criticare in ITU, 20 Datascope in outpatient surgery).
4. Types of devices acquired in period of 2014 – 2016 (e.g. 100 Omron monitors in 2014, 150 Criticare monitors in 2015.) if none please state when was the last purchase.
5. Minimum and maximum price of blood pressure monitors. If you can not provide this information, please give us an average price of a single blood pressure monitor
6. Please provide a full contract with supplier of blood pressure equipment
7. Which quality tests or quality standards a blood pressure device must pass in order for you to consider it as a good quality blood pressure monitor (e.g. CE Marked)
8. Can you please provide regulations and guidelines that your institution follow (we would like to know about national, local and your own guidelines + regulations (if it also possible can you please attach medical device management action card + medical equipment pre-registration form))
9. What creates extra costs for the usage of monitors on a yearly basis? Please break it down and relate the expenditure associated to it (e.g. cuffs = £2.000, hoses = £3.000, maintenance = £5.500)
10. Do you provide maintenance in-house or out?
11. How do you provide training to medical staff when a new blood pressure monitor is introduced in your hospital? (e.g. manual handbook, training sessions from suppliers)
12. How the supply chain is established in your organisation when you order new blood pressure monitors? (e.g. supplier delivers the products, currier or take out?)
13. Do you provide feedback to your suppliers? If “yes” how? (e.g. emailing, calling, submitting a form)
14. What is the average useful life of a single blood pressure monitor?

Download response Blood pressure monitors 090916

Blood test requests in A&E.080923.docx

All questions are shown as received by the Trust.
1. How many of the following tests were ordered by A&E/ED clinicians/staff (for A&E/ED attendees) within your Trust during the most recent 12 month (or other) period for which data is available. Please specify what period is being reported on in the case of each test.
(a) ANA (anti-nuclear antibody) test.
(b) ENA (extractable nuclear antigen) panel.
(c) Full Blood Count (FBC)
(d) C-reactive protein (CRP)

Blood test requests in A&E.080923.docx

Blood and Transfusion Service. 160818

In order to assess the savings to the taxpayer, could you please provide the number of overnight (19:00-07:00) pick-ups or deliveries, by the below mentioned services, to or from your hospital’s Transfusion Lab/Blood Bank on the date(s) below.

Please include a schedule of documents where possible.
Download response Blood and Transfusion Service. 160818

Bone Morphogenetic Protein BMP2. 070721

Please may you provide me with usage details for 2018-19 and 2019-20 financial year for BMP2, INFUSE (InductOS BMP2), manufacturer MEDTRONIC.

Download response Bone Morphogenetic Protein BMP2. 070721

Bowel Cleansers. 031019

Information request – 1
Has the pharmacy of your hospital dispensed any bowel cleansing preparations from January 1, 2018 till December 31, 2018?

Information request – 2
If the answer is ‘yes’ to request 1, could you please send me below details:
• Name of dispensed brand(s) and number of packs dispensed in the 12 month period (January 1, 2018 till December 31, 2018).

Download response Bowel Cleansers. 031019

Bronchial challenge testing 040117

Can you please advise if the trust performs Bronchial challenge testing? If the trust does perform these tests could you also advise?
1) The number of tests performed in the last 12 months?
2) Which products are used to perform the test?
3) Contact details for the sites performing the test?

Download response Bronchial challenge testing 040117

Candida Auris. 250419

1. Which hospitals within your Trust have reported Candida Auris cases since 2009?
2. How many patients have been infected with Candida Auris within your Trust since 2009?
3. How many patients have died after being infected with Candida Auris whilst being under the care of your Trust since 2009?

Download response Candida Auris. 250419

Candida Auris. 250817

I am attempting to discover whether the fungus ‘Candida Auris’ has been found in the Tunbridge Wells hospital.

Is it possible for you to give me any information regarding this matter?

Download response Candida Auris. 250817

Carboxyhaemoglobin levels

Under the Freedom of Information Act 2000 I request that the NHS Trust provides me with the following information:

• What methods of measuring carboxyhaemoglobin levels do each hospital covered by the Trust use
• Whether or not each hospital covered by the Trust has a Masimo Rad-57 Oximeter in its accident and emergency department.

Download response Carboxyhaemoglobin levels 181215

Cardiology, E-Rostering (staffing), Order Communications, Pathology, and Pharmacy systems.100722.docx

Please enter ‘No System Installed’ under supplier name if your trust does not use the system:
System type – Pharmacy
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender

Cardiology, E-Rostering (staffing), Order Communications, Pathology, and Pharmacy systems.100722.docx

Caspofungin (Generic) and Cancidas (May 2016-April 2017). 070917

I am writing to request details of the quantity of vials prescribed for below products by your Trust.

The period for which data is being requested is May 2016 – April 2017.

Data Requested for below products:
• Caspofungin 50mg powder for concentrate for solution for infusion
• Cancidas 50mg powder for concentrate for solution for infusion
• Caspofungin 70mg powder for concentrate for solution for infusion
• Cancidas 70mg powder for concentrate for solution for infusion

Download response Caspofungin (Generic) and Cancidas (May 2016-April 2017). 070917

CCG2 CQUIN scheme. 100522.docx

Will your NHS trust be collecting performance data for the CCG2 CQUIN scheme titled “Appropriate antibiotic prescribing for UTI in adults aged 16+” between 1st April 2022 and the 1st April 2023?

CCG2 CQUIN scheme. 100522.docx

Charges for ultrasound baby scan pictures for 2011, 2012, 2013, 2014 and 2015. 160617

1) The charges for ultrasound baby scan pictures for the years 2011, 2012, 2013, 2014 and 2015 until now (how much you charge expectant mums/dads).
2) The figures for how much profit has been made from the ultrasound charges for each year from 2011 to now.
3) An explanation for why the charges increased (if they did so).

Download response Charges for ultrasound baby scan pictures for 2011, 2012, 2013, 2014 and 2015. 160617

Chronic Lymphocytic Leukaemia (CLL).110523.docx

Question 1: How many patients has your Organisations treated in the past 3 months for Chronic Lymphocytic Leukaemia (CLL)? In case you do not treat CLL, which other Organisation do you refer patients needing treatment to?
Question 2: How many Chronic Lymphocytic Leukaemia (CLL) patients have been treated in the past 3 months with the following:
a. BR (bendamustine + rituximab)
b. Calquence (acalabrutinib)
c. FCR (fludarabine + cyclophosphamide + rituximab)
d. Gazyva (obinutuzumab) + chlorambucil
e. Imbruvica (ibrutinib)
f. Venclexta (venetoclax)
g. Venclexta (venetoclax) + Gazyva (obinutuzumab)
h. Venclexta (venetoclax) + rituximab
i. Zydelig (idelalisib) + rituximab
j. Any other systemic anti-cancer therapy
k. Wait and watch (monitoring only, no active treatment)
Question 3: If your Organisation does treat Chronic Lymphocytic Leukaemia patients, do you currently participate in any ongoing clinical trials for the treatment of CLL? If so, can you please provide the name of each trial along with the number of patients taking part?

Chronic Lymphocytic Leukaemia (CLL).110523.docx

Chronic Myeloid Leukaemia (CML) 2015 (follow up)

Following your reply, please could you provide the information requested in sections 2, 3 and 5 regardless of indication.

1. In your organisation, how many patients diagnosed with Chronic Myeloid Leukaemia (CML) have been treated in calendar year 2015?

2. Of these patients, how many are currently being treated with each of the following tyrosine kinase inhibitors (TKIs)?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)

3. If possible, of these patients on a TKI, how many have had treatment with a previous TKI?

4. In your organisation, how many patients diagnosed with Philadelphia positive (Ph+) Acute Lymphoblastic Leukaemia (ALL) have been treated in calendar year 2015?

5. Of these patients how many are currently being treated with each of the following TKIs?
· Dasatinib (Sprycel)
· Imatinib (Glivec)
· Nilotinib (Tasigna)
· Ponatinib (Iclusig)
· Bosutinib (Bosulif)
· Other (i.e. not on a TKI)

Download response Chronic Myeloid Leukaemia (CML) 2015 (follow up) 230516

Chronic pain service 031016

1. The definition of calculation used for new to follow up ratios for chronic pain referrals.
2. The data for new to follow up for chronic pain referrals for your trust for the years April 2010 to April 2015
3. Is the calculation used for new and follow-up in Chronic Pain a local or national definition?
4. Can you provide the wording of the definition used?
5. Does the New to follow up ratio calculation that is used by your organisation for Chronic Pain also apply to other specialties?
6. If no – please explain the differences in the calculations.

Download response Chronic pain service 031016

Clinical Insourcing. 260521

1. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the current 2020/21 financial year. Please breakdown this FY only into each month.
2. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2019/20 financial year.
3. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2018/19 financial year.
4. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2017/18 financial year.

Download response Clinical Insourcing. 260521

Clinical thromboembolic events. 020721

1) Please provide data of the absolute numbers of patients with laboratory results for each of the following clinical thromboembolic events, monthly from Jan 2019 until now, and by age cohort:
a) lymphopenia (low lymphocyte levels) (using local laboratory cut offs).
b) thrombocytopenia (low platelet levels) (using local laboratory cut offs).
c) D dimers at each of these levels: <500; 500-999; 1000-1499; 1500+
d) patients coded as having had thrombotic/embolic strokes
e) patients coded as having had a deep venous thrombosis
f) patients coded as having a pulmonary embolism including bilateral DVT
2) Please provide data for the following, monthly from Jan 2019 until now, and by age cohort:
a) the number of FBC requested
b) the number of D-dimer tests requested

Download response Clinical thromboembolic events. 020721

Coagulation testing.290622.docx

1. Does your Trust routinely offer Laboratory based Coagulation testing? (please answer either yes or no to this question).
2. If you answered yes to question 1, can you please provide us with a list of the tests that you perform.
3. If you answered yes to question 1, can you please tell us if any of these tests are sent away for testing outside of your trust (please also detail which tests are sent away).

Coagulation testing.290622.docx

Collection of prescription charges. 120320

1. Do you directly supply pre-labelled medication from stock against a PGD or FP10REC for patients who present at urgent care services?

2. Do you take a prescription charge for medicines directly supplied from stock against a PGD or FP10REC?

3. If the answer to question 2 is YES please provide a brief description of how you collect the prescription charge.

4. Please feel free to add any comments that you think would be useful or if you would like to discuss please do so using the contact details below.

Download response Collection of prescription charges. 120320

Community Diagnostic Centre (CDC).010623.docx

1. Do you currently have a Community Diagnostic Centre (CDC) in place? (Y/N)
2. If the answer to question 1 is yes:
a. Is the CDC operated in-house or by a third-party?
b. If the CDC is operated by a third-party, which partner(s) are involved in the operation of the CDC?
3. If the answer to question 1 is no:
a. Are you exploring the option of setting up a CDC? (Y/N)
b. If the answer to question 3a is yes, are you exploring the option of using third-party providers? (Y/N)
4. How many of the following scanners do you currently operate within your Trust?
5. Have you used a mobile MRI or CT service (that you operate or a third-party operates) in the last three years? (Y/N)
6. If the answer to question 5 is yes:
a. Approximately how many scans were undertaken on mobile scanners in the years 2020/21, 2021/22 and 2022/23?
b. Why have you used mobile scanning services over the last three years?
c. If you are using mobile scanning services to provide routine ongoing additional capacity, what is the primary reason for using a mobile service rather than installing a static scanner within your Trust/CDC?
d. Do you use any third-party providers for the provision of MRI or CT mobile scanning services and, if so, which providers and do they provide services for your CDC(s) as well (if applicable)?

Community Diagnostic Centre (CDC).010623.docx

Complementary therapy. 240418

1. Do you have a staff Health and Wellbeing Strategy for the Trust? If yes, can you supply an electronic copy?
2. As part of your strategy or through Occupational Health Department, do you or have you considered using Complementary Therapies to support staff? For example, holistic therapeutic massage for staff mental wellbeing and workplace stress, reflexology, sports massage for rehab and recovery or any others
3. If you do use complementary therapy – do you find it useful in reducing sickness absence, reducing stress related absences and expediting return to work?
4. If you don’t currently use complementary therapy, would you consider using them if they could help reduce sickness absence days, help manage workplace stress and help rehab/recovery from MSK related sickness?
5. Would you consider offering complementary therapy as a staff benefit at discounted rates or donations towards your hospital charity?
6. Would you consider employing a Complementary Therapist as part of your Occupational Health Team? If no, would you reconsider this if their qualification was gained via the NHS natural health school which is supported by NHS England?

Download response Complementary therapy. 240418

Complicated skin and soft tissue infections (cSSTI). 151019

1. How many patients have you treated for complicated skin and soft tissue infections (cSSTI ) in the last 12 months with the following:
Ceftaroline (Zinforo)
Flucloxacillin
Meropenem (Meronem)
Teicoplanin (Targocid)
Tigecycline
Vancomycin
2. How many patients have you treated for community acquired pneumonia in the last 12 months with the following:
Ceftaroline (Zinforo)
Ceftriaxone
Ceftobiprole (Zevtera)
Co-Amoxiclav
Isavuconazole (Cresemba)
Meropenem (Meronem)
3. How many patients have you treated mucormycosis with the following in the last 12 months
Amphotericin B/amphotericin liposomal (AmBisome )
Isavuconazole (Cresemba)
Posaconazole (Noxafil)
4. How many patients with Gram negative infections, have you treated in the last 12 months with:
Amoxicillin/clauvanate
Piperacillin/tazobactam
Ceftazidime/avibactam
Ceftolozane/tazobactam
Carbapenems (e.g. Ertapenem, Imipenem, Meropenem etc)
Aminoglycosides (e.g. Gentamicin, Amikacin, Tobramycin)
Cephalosporins (e.g. Cefotaxime, Ceftazidime, Ceftriaxone)
Quinolones (e.g.Ciprofloxacin, Levofloxacin, Ofloxacin)

Download response Complicated skin and soft tissue infections (cSSTI). 151019

Consented adult autopsies. 271020

This request is part of a project to determine the number of consented adult autopsies that took place in the United Kingdom in 2019.

Download response Consented adult autopsies. 271020

Continence Formulary. 100920

I would like to please request the Continence Formulary of the Maidstone and Tunbridge Wells NHS Trust. May I please have the Continence Formulary attached in a response or may I please be directed to where it is available online? By this, I am specifically interested in continence appliances (catheters etc.).

Download response Continence Formulary. 100920

Continence Product Formulary 011216

1) Does the Trust have a Continence Product Formulary?
2) If yes to Q1, please provide a copy
3) How often is the Continence Product Formulary reviewed?
4) What date was the Continence Product Formulary last reviewed?
5) What date will Continence Product Formulary be next reviewed?

Download response Continence Product Formulary 011216

Covid cycle testing for vaccinated and unvaccinated people.221122.docx

All questions are shown exactly as received by the Trust.
i would like all latest data on covid cycle testing for vaccinated and unvaccinated people i am aware there will be 2 separate test cycles of amplification thank you.
Your response is in correct.i asked what are the current test cycle to date for omnicrom variant you have a base number for cycle amplification that you start with .you dont get a cycle numbed AFTER the test ,you have a start point and that is the data i am asking for. The starting amplification cycle number for un vaccinated people and the cycle start number for vaccinated.thank you..this will be fact checked by my associates thank you.

Covid cycle testing for vaccinated and unvaccinated people.221122.docx

CRE infections. 181116

1. How many patients have been?
-colonised
-infected
With CRE infections for each of the past 10 years in your trust?
2. Does your trust have universal screening of patients for CRE when they are admitted, screening of patients with high risk factors or no formal screening policy?
3. How many patients were screened for CRE when they were admitted and deemed high risk for a CRE infection?
4. How many isolation rooms does your hospital have for isolating CRE patients?
5. How many isolation rooms have en suite bathrooms?
6. What is your policy if there is no side room available for isolating patients with CRE?

Download response CRE infections. 181116

Ct (Cycle Threshold) being used for PCR testing of SARS Covid-19. 280621

I would like to know the Ct (Cycle Threshold) being used for PCR testing of Sars Covid at the moment and in the past.

Download response Ct (Cycle Threshold) being used for PCR testing of SARS Covid-19. 280621

CT, MRI, Nuclear Medicine and Ultrasound clinical imaging equipment.130324.docx

Tab 1:
MES Contract
1. Supplier
2. Contract Start Date
3. Contract End Date
4. Initial Cost
5. Interest rates (%)
6. Consumables included?
7. Accessories included?
8. Maintenance included?
Tab 2:
Clinical Imaging Asset Details
1. Local Identifier
2. Modality
3. Equipment detail
4. Asset name
5. Manufacturer
6. Age
7. First in Service
8. Planned replacement date
9. Replacement schedule
10. Ownership structure
11. How is the ownership accounted for?
12. Capital purchase cost
13. Maintenance type (drop-down list)
14. Maintenance provider
15. Maintenance Service Contract Start Date
16. Maintenance Service Contract End Date
17. Maintenance Cost
Tab 3:
Clinical Imaging Accessories
1. Local Identifier
2. Modality
3. Equipment detail
4. Asset name
5. Manufacturer
6. Age
7. First in Service
8. Planned replacement date
9. Replacement schedule
10. Ownership structure
11. How is the ownership accounted for?
12. Capital purchase cost
13. Maintenance type (drop-down list)
14. Maintenance provider
15. Maintenance Service Contract Start Date
16. Maintenance Service Contract End Date
17. Maintenance Cost

CT, MRI, Nuclear Medicine and Ultrasound clinical imaging equipment.130324.docx

CT scanner. 301117

Q1. Does your trust have a 64-slice (or above) CT scanner?
Q2. Does your trust perform Coronary CT angiography?
Q3. How many Coronary CT Angiography scans have you performed in the past financial year? (2016-2017)
Q4. Does your Trust have access to Coronary CT Angiography with non-invasive FFR analysis or HeartFlow technology?
Q5. If so how many CT FFR scans have been performed in total in the past financial year (2016-2017)?

Download response  CT scanner. 301117

CT scanner information – June 2016

• How many CT scanners are in your hospitals?

• Who is the manufacturer of them and what is their model?

• Who has the service maintenance contract for the scanners – is it the supplier or an external service company?

Download response CT scanner information – June 2016 060616

Cyanide antidotes, Levothyroxine and Primidone. 210218

1) Does your trust hold stocks of the following Cyanide poisoning antidotes: Cyanokit (hydroxocobalamin), Sodium Nitrite, Sodium Thiosulfate and Dicobalt Edetate?
• If yes, what is your stock volume and total expenditure by financial year from FY11-12 to present day for each individual medication?
• If yes, what is the price paid per unit for each medication type?

2) Does your trust hold stocks of Levothyroxine in the following forms: Tablets (25mcg, 50mcg & 100mcg), Oral solution (25mcg/5ml, 50mcg/5ml, 100mcg/5ml) and Levothyroxine solution for injection (IV or IM)
• If yes, what is your stock volume and total expenditure by financial year from FY11-12 to present day for each individual medication?
• If yes, what is the price paid per unit for each medication type?

3) Does your trust hold stocks of Primidone in the following forms: tablets (50mg & 250mg?)
• If yes, what is your stock volume and total expenditure by financial year from FY11-12 to present day for each individual medication?
• If yes, what is the price paid per unit for each medication type?

Download response Cyanide antidotes, Levothyroxine and Primidone. 210218

Cycle threshold (Ct) PCR testing. 280621

1. The Cycle threshold (Ct) used by your organisation since 01 March 2020 for each of the Government Pillar classifications.

2. Any changes made to the Ct during this period and when any such changes were made.

Download response Cycle threshold (Ct) PCR testing. 280621

Cycle threshold in PCR tests for patients and staff. 040122.docx

which cycle threshold(ct) are you using in your hospital in PCR test for patient and staff since the declaration of the pandemic in 2020.

Download response Cycle threshold in PCR tests for patients and staff. 040122.docx

Cyclotron 221116

This FOI is about the use of Cyclotrons, used for the manufacture of radiopharmaceuticals in PET-CT scanning
Pertains to four main radiopharmaceuticals isotopes (radio-isotopes) used for PET-CT scanning:
18F-Fluorodeoxyglucose = FDG
18F-Choline = FEC for the diagnosis of prostate cancer
18F-Sodium Fluoride = NAF for the diagnosis of skeletal cancers
18F-Florbetaben = FBB for the diagnosis of Alzheimer’s

Download response Cyclotron 221116

Defibrillators. 101120

1. Manual Defibrillator Machines manufacturer
2. Manual Defibrillator model
3. Year of purchase
4. Proposed timeframe for replacement
5. AED Defibrillator Machines manufacturer
6. AED Defibrillator model
7. Year of purchase
8. Proposed timeframe for replacement

Download response Defibrillators. 101120

Dementia services and therapies. 070920

1. Are patients with dementia able to access any of the following therapies (i.e. from dementia services, memory services, memory clinics or mental health services within the Trust)?
a. Group cognitive stimulation therapy
b. Group reminiscence therapy
c. Cognitive rehabilitation or occupation therapy
d. Multi-sensory stimulation
e. Cognitive training

Download response Dementia services and therapies. 070920

Dermatology and Atopic Dermatitis. 010917

Funding pre-NICE;
For the attention of (FAO): Pharmacy / Dermatology Department Clinical Director
1. Is it your Trust/CCG policy to wait until 90 days post NICE guidance to fund new drugs or do they fund earlier?
2. What is your Trust/CCG policy re use of Zero Risk (ZR)/Early Use Schemes (EUS), i.e. where a medicine is made available free of charge or at a reduced price to the NHS whilst awaiting NICE/SMC approval, in lieu of NICE?
3. What is the process for getting such ZR/EUS schemes implemented/approved/signed off within your Trust/hospital? Who needs to sign the contracts for such schemes?
IFR/Cohort Funding;
FOA: Dermatology Lead Pharmacist / Dermatology Department Clinical Director
4. What is your Trust’s policy re Individual Funding Request and/or Cohort Funding policy? Ref: IFR/Cohort Funding
https://www.engage.england.nhs.uk/consultation/af642939/supporting_documents/genericcommissioningpolicies.pdf
5. Do you have a pathway/preferential prescribing list, illustrating sequential use of Biologics in Dermatology? What does this recommend?
6. How many lines/trials of biologics are allowed/funded for the management of psoriasis within your trust/CCG? What happens if a clinician needs to exceed this?
7. If there is a biologics psoriasis pathway – how often is it updated to reflect changes to NICE status of new therapies?
8. If there is no formulary/pathway – what do the Trust/CCG utilise in order to guide use of biologics in the management of psoriasis?
Atopic Dermatitis
FAO: Dermatology Service Manager
9. How many patients attended for a new outpatient appointment in dermatology Utilising ICD-10 classification – L20 Atopic Dermatitis (Eczema) – from April 2015 – March 2016?
10. The number of paediatric attendances of patients utilising ICD-10 classification – L20 for Atopic Dermatitis (Eczema) – from April 2015 – March 2016?
11. Does your Trust have a paediatric dermatologist? Does your Trust have a paediatrician with a dermatology interest/specialism?

Download response Dermatology and Atopic Dermatitis. 010917

Dermatology Biologics. 130220

I have a Freedom of Information request regarding biologics and biosimilar prescribing in dermatology.
Could you please provide me with the following numbers of patients treated in the last 12 months with the following drugs.
Adalimumab [Amgevita]
Adalimumab [Hulio]
Adalimumab [Humira]
Adalimumab [Hyrimoz]
Adalimumab [Imraldi]
Apremilast [Otezla]
Brodalumab [Kyntheum]
Certolizumab [Cimzia]
Dimethyl fumarate [Skilarence]
Dupilumab [Dupixient]
Etanercept [Benepali]
Etanercept [Enbrel]
Etanercept [Erelzi]
Golimumab [Simponi]
Guselkumab [Tremfya]
Infliximab [Flixabi]
Infliximab [Inflectra]
Infliximab [Remicade]
Infliximab [Remsima]
Ixekizumab [Taltz]
Risankizumab [Skyrizi]
Secukinumab [Cosentyx]
Tildrakizumab [Ilumetri]
Tocilizumab [Ro Actemra]
Upadacitinib [Rinvoq]
Ustekinumab [Stelara]
If you are unable to provide the information above with specific reference to dermatology then please provide me with the numbers of patients treated in the last 12 months with the above drugs, regardless of disease/indication.

Download response Dermatology Biologics. 130220

Diabetes. 091117

1. The number of patients with Type 1 diabetes that are currently treated as an outpatient in the hospitals in Maidstone and Tunbridge Wells NHS Trust.
2. The number of patients with Type 2 diabetes that are currently treated as an outpatient in the hospitals in Maidstone and Tunbridge Wells NHS Trust.
3. The number of patients with Type 1 diabetes in the hospitals in Maidstone and Tunbridge Wells NHS Trust with an Insulin Infusion Pump.
4. The number of patients with Type 2 diabetes in the hospitals in Maidstone and Tunbridge Wells NHS Trust with an Insulin Infusion Pump.
5. The number of Diabetes Specialist Nurses that are employed in Maidstone and Tunbridge Wells NHS Trust as of the 1st October 2017. Please break down the response to this question by pay band e.g. band 6, band 7.
6. Is structured education for patients with Type 1 diabetes offered within Maidstone and Tunbridge Wells NHS Trust?
7. The number of patients with Type 1 diabetes that have received structured education within Maidstone and Tunbridge Wells NHS Trust between the period October 1st 2016 to October 1st 2017.

Download response Diabetes. 091117

Diabetic retinopathy (including DMO).030622.docx

1. How many current diabetic retinopathy (including DMO) patients do you have? *
2. How many diabetic retinopathy (including DMO) patients do you have that are currently being monitored and held at “wait and see” but not yet progressed to needing any treatments (injections/laser/implant)? *
3. How many diabetic retinopathy (including DMO) patients do you have that have received treatment (injections/laser/implants) in the year April 2019-March 2020 inclusive (i.e. pre COVID-19)? *
4. How many diabetic retinopathy (including DMO) patients do you have that have received treatment (injections/laser/implants) in the year April 2020-March 2021 inclusive (i.e. during COVID-19)? *
5. How many injections (Avastin/bevacizumab, Eylea/aflibercept, Lucentis/ranibizumab) have been used for diabetic retinopathy (including DMO) patients in the year April 2019-March 2020 inclusive (i.e. pre COVID-19)? Please break down by treatment. *
6. How many injections (Avastin/bevacizumab, Eylea/aflibercept, Lucentis/ranibizumab) have been used for diabetic retinopathy (including DMO) patients in the year April 2020-March 2021 inclusive (i.e. pre COVID-19)? Please break down by treatment. *

Diabetic retinopathy (including DMO).030622.docx

Diagnosis of heart failure in 2015.

1. What was the size of the patient population covered by your Trust in 2015?
2. How many patients were diagnosed with heart failure by your Trust in 2015?
3. Does your Trust follow NICE guidelines to support the diagnosis of suspected heart failure? If not, what guidance does your Trust follow? Please provide a copy
4. Please provide the details – including the manufacturer and brand name – of those tests used to support the diagnosis of heart failure
5. Does your Trust follow NICE guidelines to support the management of chronic heart failure? If not, what guidance does your Trust follow? Please provide a copy
6. Please provide the details – including the manufacturer and brand name – of those tests used to support the management of chronic heart failure
7. Does your Trust use NTproBNP or BNP testing to support the diagnosis of heart failure in patients presenting through A&E?
8. How many NTproBNP tests were performed by your Trust in 2015? Please provide the manufacturer and brand name of the test used
9. Are there any restrictions for using NTproBNP or BNP tests? If yes, please explain
10. How many echocardiographs were performed at your Trust in 2015?
11. What was the average waiting time for an echocardiogram at your Trust in 2015?

Download response Diagnosis of heart failure in 2015 290416

Diagnostic data on an MRI technique for men with suspected prostate cancer.270318

1. Please tell us which Trust, Health Board or Health and Social Care Trust you are responding on behalf of?
2. What percentage of men receive mpMRI before biopsy as part of the initial diagnostic process using T2-weighted, diffusion-weighted (multi-b ADC and high/long b) and dynamic contrast enhanced (DCE) sequences?
3. What are your eligibility criteria/exclusion criteria for men to receive pre-biopsy mpMRI?
4. Are you using mpMRI before biopsy to rule some men out of biopsy as part of the initial diagnostic process?
5. What mpMRI scores and/or other clinical factors are used to rule men out of biopsy?
6. Do you intend to use mpMRI to rule men out of biopsy in the future?
7. How many men annually are referred?
8. If you are unable to provide numbers for question 6, please estimate the percentage of all men referred for b, c and d.
9. Do you carry out targeted biopsies in men with mpMRI lesions in addition to systematic biopsies?
(Please indicate with a X below)
If No, what are the reasons for not carrying this out? (e.g. expertise, equipment, don’t believe it makes a difference)
10. If you do not currently carry out targeted biopsies, but wish to in the future, what are the current barriers to doing so?
(Please indicate with a X below)
11. Please indicate the number of uroradiologists undertaking prostate MRI
12. How many scanners do you have available for mpMRI before biopsy?
Has this increased in the last 12 months?
13. What percentage of scanner time is dedicated to mpMRI before biopsy?

Download response Diagnostic data on an MRI technique for men with suspected prostate cancer.270318

Diagnostic imaging 150217

1. What is the approximate local population catchment your hospital trust provides services for?
2. For each MRI, CT, and PET-CT, please set out the location for each scanner located on Trust property using one line per machine:
3. For each scanner listed in Question 2 as per index, please set out the type of ownership and both the year of manufacture and the year of installation in your trust for each machine:
4. For each scanner listed in Question 3 that is not owned by the trust and as per index, please list the name of the company providing the service:
5. For each scanner listed in Question 2 as per index, please set out the current ‘normal opening hours’ of the service per week and indicate whether this includes a non-emergency weekend service or not:
6. Please set out the total number of MRI, CT, and PET/CT scans that were carried out on scanners within your trust in the financial years (April to March) 2012/13, 2013/14, 2014/15, and 2015/16:
7. Please set out the total number of MRI, CT, and PET/CT scans referred by clinicians from your trust, regardless of whether they were carried out at your trust or at another trust or provider, in the financial years (April to March) 2012/13, 2013/14, 2014/15, and 2015/16:
8. Please list the providers outside your trust below that carried out MRI, CT, and PET/CT scans on your trust’s patients trust during the financial year 2015/16:
9. For each of the hospital providers listed in Question 8 as per index, please set out the total number of MRI, CT, or PET/CT scans that were carried there on your behalf in the financial years (April to March) 2012/13, 2013/14, 2014/15, 2015/16:
10. Does your trust currently hold plans to extend its MRI, CT, or PET/CT capacity (e.g. increase number of scanners)?
11. If yes, what is the likely procurement method your trust is likely to take?
12. Does your trust currently hold plans to invest into high value (>£500k) capital diagnostic equipment (both radiological and non-radiological) over the next five years?
13. If your trust has done any assessment/forecasting of the evolution of demand for MRI, CT, and/or PET-CT scanning, either historic or future, please provide a copy.

Download response Diagnostic imaging 150217

Diagnostic Imaging (DI) for 2014/2015.

Please provide the information set out below in respect of Diagnostic Imaging (DI) at your Trust for the FY 2014/15:

For each of the key Points of Delivery categories (just EL, SSEL, NEL, SSNEL, DC and OP), the numbers and types (e.g. CT/MR/PET-CT/endoscopy) of DIs performed per Primary Diagnosis (ICD) and the number of patients so investigated in that ICD category.

We would only need the first three characters of the Primary Diagnosis code (e.g. C00 to D49 for Neoplasms).

Download response Diagnostic Imaging (DI) for 2014/2015 270516

Diagnostic imaging system.050523.docx

Could we clarify the new systems details for your new Diagnostic imaging system?
System type – Diagnostic imaging
Supplier name – Sectra
System name –
Date installed –
Contract expiration –
Notes – e.g. we are currently out to tender

Diagnostic imaging system.050523.docx

Diagnostic and procedure codes. 160518

1) Any diagnosis from the category Z38 (i.e. Z38.0 – Z38.8, I believe obtained by searching for Z38.X, but local procedures may vary). This diagnosis could be in any position, principle or secondary.
Explanation: This is looking at the number of live births in the time period in your trust.

2) The number of episodes from the results of part 1) that has also given the diagnosis code P39.9. This diagnosis could be in any position, principle or secondary.
Explanation: This is looking at the number of the above patients who were screened and treated for sepsis, without diagnosed bacteraemia.

3) The number of episodes from the results of part 1) that has also given a diagnosis from the category P36 (i.e. P36.0 – P36.9, I believe this is searched for by P36.X). This diagnosis could be in any position, principle or secondary.
Explanation: This is looking at the number of patients from part 1) that had a bacterial sepsis.

4) The number of episodes from the results of part 1), which also has the procedure code A55.8 or A55.9
Explanation: This is looking at the number of patients from parts 1) that have had a lumbar puncture, an investigation for meningitis.

5) The number of episodes from the results of part 1), which also has any diagnosis from the category G00, G01, G02, or G03. These diagnoses could be in any position, principle or secondary
Explanation: This is looking at the number of patients from parts 1) that actually were diagnosed with meningitis.

Notes to help complete request:

For each of 1) 2) 3) 4) and 5), you only need to provide one number for the number of episodes for each; they do not need to be broken down in to subcategories. If any of the answers is zero, please state as such (or state you do not hold any information on it). Kindly note this information is not publicly available from other sources, including NHS Digital.

Download response Diagnostic and procedure codes. 160518

Diagnostic services provided by external providers outside the UK. 260717

Does your trust have any diagnostic services provided by external providers outside the UK (e.g. radiology)?

If yes –

– What services?
– Which provider(s) have been chosen to provide these services?
– How much is each contract worth?
– For what time period will the contract run?
– When did you first enter into these arrangements?

Download response Diagnostic services provided by external providers outside the UK. 260717

Diagnostic ultrasound systems.290224.docx

All questions are shown as received by the Trust.
1. How many diagnostic ultrasound systems are used within the Trust?
I. Name of the Manufacturer and Model of these systems?
II. Which hospital are these based within and which department uses each of these systems?
III. Who is the responsible person for each ultrasound system?
IV. When were these systems purchased?
V. When are these systems due for renewal / replacement?

Diagnostic ultrasound systems.290224.docx

Discharge Summaries. 250419

1) How many digital discharge summaries from 1st November 2017 to 1st November 2018 included any of the following terms?
• GHB
• GBL
• gamma-hydroxybutyrate
• gamma-Hydroxybutyric acid
• 4-hydroxybutanoic acid
• 1,4-butanediol
• 1,4-BD

Download response Discharge Summaries. 250419

Discrete cylinder regulators. 070921.docx

Name of Trust:
Please note, ALL the following questions relate to Medical Oxygen cylinders ONLY
1. Does your Trust use Medical Oxygen cylinders that have a pin index cylinder valve and require a discrete (removable) regulator to function?
If ‘Yes’ please continue
2. On average, how many discrete regulator cylinders are rented each month on an annual basis?
3. On average, how many of this particular cylinder type is replenished each month?
4. How many discrete regulators are held on inventory for use with this type of cylinder?
5. Do you also rent ‘integrated valve’ cylinders? (e.g. cylinders with regulators already fitted as an integral part of the package – BOC CD cylinder for example)
6. If you have answered ‘yes’ to question 1. And question 5., what is the proportion of each type of cylinder in use? A ratio or percentage would do. (E.g. 70:30 in favour of discrete or 70% discrete, 30% integrated)
7. Has your Trust ever reported a failure to supply or an unexpected cylinder ‘runout’ whilst using a discrete regulator on a cylinder?

Download response Discrete cylinder regulators. 070921.docx

Dispensed drugs. 160119

1. Can I ask although the Trust is not commissioned to provide Dermatology services would it be possible to provide data for the number of drugs dispensed regardless of indication / condition in the last three months?
Drug Name
Acitretin
Alitretinoin
Pimecrolimus
Tacrolimus
Dupixent (Dupilumab)
Phototherapy including with ultraviolet (UVB) radiation or psoralen ultraviolet A (PUVA)
Potent Topical Corticosteroids (creams or ointments) total
Amcinonide 0.05% (Cyclocort)
Betamethasone diproprionate 0.05% (Diprosone)
Betamethasone valerate
Clobetasol proionate
Desoximetasone 0.25% (Topicort)
Diflucortolone valerate
Fluocinonide 0.05% (Lidex)
Fluticasone proprionate 0.005% (Cutivate)
Halcinonide 0.05% (Halog)
Mometasone furoate 0.1% (Elocon ointment)
Triamcinalone acetonide 0.5% (Kenalog, Aristocrt cream)
Betamethasone dipropionate 0.25% (Diprolene)
Clobetasol dipropionate 0.05% (Temovate)
Diflorasone diacetate 0.05% (Psorcon)
Halbetasol proprionate 0.05% (Ultravate)
Immunosppressive therapies total
Azathioprine
Ciclosporin
Methotrexate
2. The number of drugs dispensed regardless of indication / condition in the past 3 months?
Drug Name
Etanercept
Infliximab
Adalimumab
Ustekinumab

Download response Dispensed drugs. 160119

Disposal of drugs. 070818

1. Please can you provide me information on the quantity of prescription medications, drugs and any other dispensed medical substances (“Drugs”) disposed of during the summer heat wave (from the start of June 2018 until the most recent possible date when the search is made.
2. If you have a register of Drugs being disposed of including dates of the disposal, type and name of Drug, quantities involved, and value of each batch to be disposed of, please provide me with such a register for the given period.
3. Otherwise, please provide information as to the overall quantity and value of Drugs to be disposed, and provide as much of a breakdown into the fields given previously as is possible.
4. Please can you tell me whether (i) all, (ii) some, or (iii) which of the hospitals or medical centres that come under the Trust, have the appropriate facilities to refrigerate Drugs.

Download response Disposal of drugs. 070818

Drug Patient Level Contract Monitoring (DrPLCM) report and SACT Cancer report.090623.docx

I would be grateful if you could send me two datasets from your Trust, to inform this analysis:
(1) Drug Patient Level Contract Monitoring (DrPLCM) report
Data fields from the DrPLCM report, as specified in table 1 (below). Please do not send patient IDs or cost data, as I appreciate this would compromise data privacy and commercial sensitivity.
(2) SACT Cancer report
An extract from the chemotherapy ePMA system showing patients treated by drug and diagnosis, as specified in table 2 (below).

Drug Patient Level Contract Monitoring (DrPLCM) report and SACT Cancer report.090623.docx

Drug resistant infections. 250419

– How many cases of drug resistant infections (both bacterial and fungal) have there been at your NHS trust in each of the past five years (2018, 2017, 2016, 2015, 2014)?
– What were those infections?
– How many of those infections resulted in deaths?

Please could you break the results down by year, rather than providing them as one number?

The Trust requested clarification and received the following response:

The point of this question is to determine whether, in the wake of stories about so-called superbugs and drug-resistant fungi such as Candida Auris, there is any truth to speculation that drug-resistant infections are on the rise, and if so, to what extent.

So, of course I am interested to know about the number of cases of so-called superbugs but I am also looking for trends of other, less well-documented, cases of antimicrobial drug resistance.

Therefore, ideally I would like data on all such cases.
However, if this is impossible, then I would like the data as requested on cases of drug resistance in the following:
1. Acinetobacter baumannii
2. Pseudomonas aeruginosa
3. Enterobacteriaceae
4. Enterococcus faecium
5. Staphylococcus aureus
6. Helicobacter pylori
7. Campylobacter spp.
8. Salmonellae
9. Neisseria gonorrhoeae
10. Candida auris

Download response Drug resistant infections. 250419

Drug spend 2014-15 and 2015-16. 081117

a) Total drug spend for financial years 2014-15, and 2015-16
b) Total Off-tariff drug spend for financial years 2014-15, and 2015-16
c) Total Homecare drug spend for financial years 2014-15, and 2015-16

Download response Drug spend 2014-15 and 2015-16. 081117

Drug stock. 300518

1. Has your trust accepted or is it currently accepting manufacturer provision of free of charge drug stock between licensing and NICE funding? [Yes/No]
2. Has your trust accepted or is it currently accepting the following list of drugs in psoriasis:
Brodalumab [Kyntheum] [Yes/No]
Guselkumab [Tremfya] [Yes/No]
Ixekizumab [Taltz] [Yes/No]
Secukinumab [Cosentyx] [Yes/No]
3. Has your trust accepted or is it currently accepting the following list of drugs in Rheumatoid Arthritis:
Tofacitinib [Xeljanz] [Yes/No]
Baricitinib [Olumiant] [Yes/No]
Golimumab [Simponi] [Yes/No]
Certolizumab [Cimzia] [Yes/No]
Apremilast [Otezla] [Yes/No]
Tocilizumab [Ro Actemra] [Yes/No]
4. Has your trust accepted or is it currently accepting the following list of drugs in Ankylosing Spondylitis or Psoriatic Arthritis:
Secukinumab [Cosentyx] [Yes/No]
5. Has your trust accepted or is it currently accepting the following list of drugs in Ulcerative Colitis:
Golimumab [Simponi] [Yes/No]
6. If your trust has not accepted manufacturer provision of free of charge drug stock, what have been the reasons for this?
7. In future, will your trust be able to accept manufacturer provision of free of charge drug stock? [Yes/No]
8. What is the preferred distribution channel for the provision of free of charge drug stock?
Homecare [Yes/No]
Delivered directly to hospital/Trust [Yes/No]
Other (please provide details)
9. For how long is free of charge drug stock typically provided for each patient?
First dose [Yes/No]
First month [Yes/No]
First 3 months [Yes/No]
Other

Download response Drug stock. 300518

Drug treatments.030622.docx

Question 1.
How many patients were treated by your Trust (for any condition) in the last 3 months with the following drugs:
a. Adalimumab (Amgevita)
b. Adalimumab (Humira)
c. Adalimumab (Hyrimoz)
d. Adalimumab (Idacio)
e. Adalimumab (Imraldi)
Question 2.
How many patients were treated in the last 3 months by the Rheumatology department (for any condition) with the following drugs:
a. Adalimumab (Amgevita)
b. Adalimumab (Humira)
c. Adalimumab (Hyrimoz)
d. Adalimumab (Idacio)
e. Adalimumab (Imraldi)
Question 3.
How many patients were treated in the last 3 months by the Dermatology department (for any condition) with the following drugs:
a. Adalimumab (Amgevita)
b. Adalimumab (Humira)
c. Adalimumab (Hyrimoz)
d. Adalimumab (Idacio)
e. Adalimumab (Imraldi)

Drug treatments.030622.docx

Drug treatments.130522.docx

1. How many patients were treated by your Trust in the last 3 months with the following drugs:
Adalimumab (Amgevita)
Adalimumab (Humira)
Adalimumab (Hyrimoz)
Adalimumab (Idacio)
Adalimumab (Imraldi)
2. Of the patients treated with Humira in the last 3 months, how many were new to Adalimumab treatment (patients who had not been treated with any brand of Adalimumab in the past year)? If possible please provide new patients number by:
New Humira patients – all departments
New Humira patients – rheumatology
New Humira patients – dermatology
New Humira patients – gastroenterology
3. Of the patients treated with any Adalimumab Biosimilar (Amgevita, Hyrimioz, Idacio, Imraldi etc) in the last 3 months, how many patients were new to Adalimumab treatment (patients who had not been treated with any brand of Adalimumab in the past year)? If possible provide new patients numbers by department:
New Adalimumab Biosimilar patients – all departments
New Adalimumab Biosimilar patients – rheumatology
New Adalimumab Biosimilar patients – dermatology
New Adalimumab Biosimilar patients – gastroenterology

Drug treatments.130522.docx

Drug treatments 2.300522.docx

How many patients has your trust treated in the past 6 months for any disease with the following drugs:
1. Ponvory (ponesimod)
2. Tysabri (natalizumab) pre-filled syringes ONLY
3. Vumerity (diroximel fumarate)
4. Zeposia (ozanimod)

Drug treatments 2.300522.docx

Drug treatments.230922.docx

Question 1
How many patients were treated by your trust (for any condition) in the last 3 months with the following drugs:
a. Adalimumab (Amgevita)
b. Adalimumab (Humira)
c. Adalimumab (Hyrimoz)
d. Adalimumab (Idacio)
e. Adalimumab (Imraldi)
Question 2
How many patients were treated for Hidradenitis Suppurativa in the last 3 months with the following drugs:
a. Adalimumab (Humira)
b. Adalimumab Biosimilar
c. Infliximab (Remicade)
d. Infliximab Biosimilar
e. Ustekinumab (Stelara)
f. Secukinumab (Cosentyx)
Question 3
How many patients were treated for Psoriasis in the last 3 months with the following:
a. Ciclosporin
b. Methotrexate – any form and strength
c. Methotrexate injections 15mg and above

Drug treatments.230922.docx

Drug treatments.300522.docx

How many patients has your trust treated in the past 6 months (for any disease) with the following drugs:
a. Aubagio (teriflunomide)
b. Avonex (interferon beta-1a)
c. Betaferon (interferon beta-1b)
d. Brabio (glatiramer acetate)
e. Copaxone (glatiramer acetate)
f. Extavia (beta interferon-1b)
g. Fampyra (fampridine)
h. Gilenya (fingolimod)
i. Lemtrada (alemtuzumab)
j. Kesimpta (ofatumumab)
k. Mavenclad (cladribine)
l. Mayzent (siponimod)
m. Ocrevus (ocrelizumab)
n. Plegridy (peginterferon beta-1a)
o. Rebif (beta interferon-1a)
p. Tecfidera (dimethyl fumarate)
q. Tysabri (natalizumab)
r. Zeposia (ozanimod)

Drug treatments.300522.docx

Drug usage. 051119

How many patients have been treated with these drugs in the past 6 months, regardless of diagnosis:
a. Aubagio (teriflunomide)
b. Avonex (interferon beta-1a)
c. Betaferon (interferon beta-1b)
d. Brabio (glatiramer acetate)
e. Copaxone (glatiramer acetate)
f. Extavia (beta interferon-1b)
g. Gilenya (fingolimod)
h. Lemtrada (alemtuzumab)
i. Mavenclad (cladribine)
j. Ocrevus (Ocrelizumab)
k. Plegridy (Peginterferon beta-1a)
l. Rebif (beta interferon-1a)
m. Tecfidera (dimethyl fumarate)
n. Tysabri (natalizumab)
o. Zinbryta (daclizumab)
p. Ampyra (Fampyra)
q. Ozanimod

Download response Drug usage. 051119

Drug usage.100523.docx

How many patients has your trust/health board treated in the past 6 months (for any disease) with the following drugs:
1. Aubagio (teriflunomide)
2. Avonex (interferon beta-1a)
3. Betaferon (interferon beta-1b)
4. Brabio (glatiramer acetate)
5. Copaxone (glatiramer acetate)
6. Extavia (beta interferon-1b)
7. Gilenya (fingolimod)
8. Lemtrada (alemtuzumab)
9. Kesimpta (ofatumumab)
10. Mavenclad (cladribine)
11. Mayzent (siponimod)
12. Ocrevus (ocrelizumab)
13. Plegridy (peginterferon beta-1a)
14. Ponvory (ponesimod)
15. Rebif (beta interferon-1a)
16. Tecfidera (dimethyl fumarate)
17. Tysabri (natalizumab)
18. Tysabri (natalizumab) pre-filled syringes ONLY
19. Vumerity (diroximel fumarate)
20. Zeposia (ozanimod)

Drug usage.100523.docx

Drug usage. 130619

Within your health trust how many patients are, within the past 6 months that you have data available, being treated with the following treatments? This is regardless for the disease being treated.

Disodium pamidronate (Aredia)
Ibandronic acid or ibandronate (Bondronat)
Sodium clodronate (Bonefos, Clasteon, Loron)
Zoledronic acid or zoledronate (Zometa)
Denosumab (Xgeva)
Omalizumab [Xolair]
Mepolizumab [Nucala]
Reslizumab [Cinqaero]
Benralizumab [Fasenra]
How many paediatric patients have been treated in the last 6 months with Xolair/omalizumab?

Download response Drug usage. 130619

Drug usage. 151118

You asked:
This is a Freedom of Information request regarding usage of certain products in all NHS Trusts, these products are:
• Glycopyrronium bromide 1 mg tablets
• Glycopyrronium bromide 2 mg tablets
• Glycopyrronium bromide 1 mg/5 ml oral solution
• Glycopyrronium bromide 5 mg/5 ml oral solution
• Sialanar 320 mcg/ ml glycopyrronium (400 mcg/ml glycopyrronium bromide) oral solution
• Scopoderm (hyoscine) 1.5 mg patch
• Glycopyrronium bromide 200 micrograms/ml ampoule (for injection)
1. How many units* of these products were dispensed quarterly in 2016 – present?
*tablets: units as number of TABLETS or PACKS
• If packs, please specify pack size e.g. 14 tablets
*oral solution: units as number of bottles
• Please specify bottle size e.g. 60 ml
*patch: units as packs
• Please specify pack size e.g. 5 patches
*ampoule: units as number of AMPOULES or PACKS
• If packs, please specify pack size e.g. pack of 10

Download response Drug usage. 151118

Drug usage. 171220

1. How many patients has your trust treated in the last 12 months with the following drugs?
a. Octreotide
b. Lanreotide
c. Pasireotide
d. Pegvisomant
e. Genotropin
f. Humatrope
g. Norditropin
h. Nutropin
i. Omnitrope
j. Saizen
k. Zomacton
2. Please provide the number of patients under the age 16 that were treated in the last 12 months with each of the following drugs:
a. Genotropin
b. Humatrope
c. Norditropin
d. Nutropin
e. Omnitrope
f. Saizen
g. Zomacton
3. How many patients have been treated in the last 12 months with the following drugs for Acromegaly (ICD10 code E22.0) ONLY?
a. Sandostatin LAR
b. Octreotide Long-Acting (Generic)
c. Somatuline Autogel
d. Pasireotide

Download response Drug usage. 171220

Drug usage. 2 151118

You asked:
1. How many patients have been treated in the past 6 months [latest 6 months available] with the following, If possible please split by paediatric (less than 18 years) and adult 18+years;
• Genotropin
• Humatrope
• Norditropin
• NutropinAq
• Omnitrope
• Saizen
• Valtropin
• Zomacton

Download response Drug usage. 2 151118

Drugs free of charge or for a nominal charge. 310720

Question 1
Within the last 2 years, has the institution accepted or is it currently accepting any of the following drugs free of charge or for a nominal charge (eg £1):
Risankizumab (Skyrizi)
Guselkumab (Tremfya)
Brodalumab (Kyntheum)
Ixekizumab (Taltz)
Secukinumab (Cosentyx)
Tildrakizumab (Ilumetri)
Question 2
If yes to any of the above, are you able to say how long is the free of charge drug stock typically provided for each patient? For example, is it:
First dose
First month
First 3 months
Some other period?
Question 3
If the Institution has not accepted manufacturer provision of free of charge drug stock, are you able to say what have been the reasons for this?

Download response Drugs free of charge or for a nominal charge. 310720

Drugs usage. 061119

In the past 12 months, how many patients were treated with:
Avelumab + Axitinib
Axinitib
Bevacizumab
Cabozantinib
Doxorubicin
Everolimus
Lapatinib
Lenvantinib
Lenvantinib + Everolimus
Nivolumab
Nivolumab + Ipilimumab
Pazopanib
Pembrolizumab + Axitinib
Regorafenib
Sorafenib
Sunitinib
Temsirolimus
Tivozanib
Vandetanib

Download response Drugs usage. 061119

Drugs usage. 070318

This is a Freedom of Information request regarding usage of certain products in all NHS Trusts, these products are:
• Iloprost 0.5mg/0.5ml Ampoules
• Melatonin 1mg/ml oral solution,
• Melatonin 2mg Capsules,
• Melatonin 3mg Capsules,
• Melatonin 5mg Capsules,
• Melatonin 3mg Tablets
• Mexiletine 200mg capsules
• Diazoxide 50mg/ml oral suspension
1. How many packs of these products were dispensed quarterly in 2015?
2. How many packs of these products were dispensed quarterly in 2016?
3. How many packs of these products were dispensed quarterly in 2017?
4. What was the annual spend for each product between 2015 and 2017?
5. What was the cost per unit of each product between 2015 and 2017 to your organisation?

Download response Drugs usage. 070318

Drugs usage. 210218

This is a Freedom of Information request regarding usage of certain products in all NHS Trusts, these products are:
Iloprost 0.5mg/0.5ml Ampoules
Melatonin 1mg/ml oral solution,
Melatonin 2mg Capsules,
Melatonin 3mg Capsules,
Melatonin 5mg Capsules,
Melatonin 3mg Tablets
Mexiletine 200mg capsules
Diazoxide 50mg/ml oral suspension

1. How many packs of these products were dispensed quarterly in 2015?
2. How many packs of these products were dispensed quarterly in 2016?
3. How many packs of these products were dispensed quarterly in 2017?
4. What was the annual spend for each product between 2015 and 2017?
5. What was the cost per unit of each product between 2015 and 2017 to your organisation?

Download response Drugs usage. 210218

Drugs usage. 271119

Within your trust how many of the following intra-vitreal vials/implants have been used in the latest 4 months, if possible between May to August 2019;
Ranibizuma, Bevacizumab, Aflibercept, Fluocinolone & Dexamethasone

Download response Drugs usage. 271119

Drugs usage. 2711191

Within your health trust how many patients are currently [within the past 12 months] being treated with the following treatments, regardless of reason.
Amphotericin B/amphotericin liposomal (AmBisome )
Ceftaroline (Zinforo)
Ceftobiprole (Zevtera)
Ceftriaxone
Co-Amoxiclav
Flucloxacillin
Isavuconazole (Cresemba)
Meropenem (Meronem)
Posaconazole (Noxafil)
Teicoplanin (Targocid)
Tigecycline
Vancomycin
Amoxicillin/clauvanate
Piperacillin/tazobactam
Ceftazidime/avibactam
Ceftolozane/tazobactam
Carbapenems (e.g. Ertapenem, Imipenem, Meropenem etc)
Aminoglycosides (e.g. Gentamicin, Amikacin, Tobramycin)
Cephalosporins (e.g. Cefotaxime, Ceftazidime, Ceftriaxone)
Quinolones (e.g.Ciprofloxacin, Levofloxacin, Ofloxacin)

Download response Drugs usage. 2711191

Early Access to Medicines Scheme (EAMS).280423.docx

1) How many patients at your trust have been supplied medicines approved through the Early Access to Medicines Scheme (EAMS) each year between April 2014 and April 2023?
2) How many requests has your trust made to pharmaceutical companies for access to medicines offered through a company-led ‘compassionate use’ or ‘free of charge’ scheme each year between April 2014 and April 2023?
a. How many patients have received treatment with unlicensed medicines obtained this way each year between April 2014 and April 2023?
3) How many requests have clinicians at your trust submitted to pharmaceutical companies for access to an unlicensed medicine to treat patients each year between April 2014 and April 2023, outside of a company-led scheme?
a. How many patients have received treatment with unlicensed medicines obtained this way each year between April 2014 and April 2023?

Early Access to Medicines Scheme (EAMS).280423.docx

Eating Disorders. 130619

1. Please provide the number of women who were treated by the NHS for INPATIENT (TIER 4) and COMMUNITY (TIER 1, 2, 3) Eating Disorder services in your region in the last 3 years. Where possible, please provide separate sub-totals for those placed in-area and those placed out-of-area.
2. Please provide the number of men who were treated by the NHS for INPATIENT (TIER 4) and COMMUNITY (TIER 1, 2, 3) Eating Disorder services in your region in the last 3 years. Where possible, please provide separate sub-totals for those placed in-area and those placed out-of-area.
3. Please provide the average waiting time in weeks (time from referral to treatment) for ADULT INPATIENT (TIER 4) and ADULT COMMUNITY (TIER 1, 2, 3) Eating Disorder services in your region in the last 3 years.
4. Please provide a copy of your threshold criteria for access to ADULT INPATIENT (TIER 4) and ADULT COMMUNITY (TIER 1, 2, 3) Eating Disorder services.
5. Please provide the percentage of referrals to ADULT INPATIENT (TIER 4) and ADULT COMMUNITY (TIER 1, 2, 3) Eating Disorder services have been refused in your region in the last 3 years.
6. Please provide the total number of NHS beds in your region that are usable for ADULT INPATIENT (TIER 4) Eating Disorder patients. This does not refer to current occupancy levels, but rather the total capacity of beds.
7. Please provide the total amount spent by your organisation on treating ADULT Eating Disorder patients? Of this spend please can you advise the proportion allocated to ADULT INPATIENT (TIER 4) Eating Disorder services? Of this spend please can you advise the proportion allocated to ADULT COMMUNITY (TIER 1, 2, 3) Eating Disorder services?
8. For the last 3 years of which you have full accounts, please can you name the organisations that you have commissioned to provide ADULT Eating Disorder services?

Download response Eating Disorders. 130619

ECG equipment. 260418

1. The name or your current ECG equipment manufacturer and product name, the year of purchase and installation date?
Do you have plans and timescales to replace?

2. The name of your current Stress Exercise ECG equipment manufacturer and product name, the year of purchase and installation date?
Do you have plans and timescales to replace?

Download response ECG equipment. 260418

Elastomeric Infusion Devices (E.I.D) 020320

Information request in respect to Elastomeric Infusion Devices

Please could you kindly advise which departments and healthcare professionals within your Trust use elastomeric infusion devices?

Information request in respect of Elastomeric Infusion Devices

1. Please could you also advise if you purchase E.I.D and if so:
a. What brand(s) do you purchase?
b. What quantities do you purchase on an annual basis?
c. Who are the main clinicians responsible within your Trust for the prescribing and administration of elastomeric devices?
d. What medicines do you fill the devices with?
e. Do you fill elastomeric devices in your pharmacy aseptic unit if you have one?
2. Please could you also advise if you purchase pre-filled elastomeric devices from a commercial compounder and if so:
a. What drugs are provided pre-filled?
b. What quantities do you purchase on an annual basis?

Download response Elastomeric Infusion Devices (E.I.D) 020320

Electronic prescribing and medicines administration. 230419

1. Who is the Trust’s current supplier for their Electronic prescribing and medicines administration?
2. What is the contract start and end date for the Electronic prescribing and medicines administration?
3. What is the annual cost for the Electronic prescribing and medicines administration?

Download response Electronic prescribing and medicines administration. 230419

Electronic prescribing and medicines administration system (ePMA). 151221.docx

1. Does your Trust have an electronic prescribing and medicines administration system (ePMA)?
Please tick one option
a. Yes (go to Q2)
b. No (go to Q4)
2. What is the full name of this ePMA system?
Please specify the system name and supplier
3. Which of the following statements best describes the status the data integration of (i) the system that manages clinical patient notes and records and (ii) the pharmacy dispensing system at your Trust?
Please tick one option for (i) and one option for (ii).
(i) Clinical patient records / medical notes (ii) Pharmacy Dispensing System (PDS)
a. Electronic and fully integrated
b. Electronic and partially integrated
c. Electronic and not integrated
d. On paper
4. Which of the following statements best describes your Trust’s overall implementation of the ePMA system?
Please tick one option
a. ePMA system is fully implemented (Go to Q5)
b. ePMA system is partially implemented and progress is ongoing to complete it (Go to Q5)
c. ePMA system has been procured from a named supplier and awaiting implementation (Go to Q5)
d. Selection of suppliers and procurement of ePMA system is underway (Go to Q5)
e. Awaiting funding (Go to Q17)
f. No ePMA systems or plans in place (Go to Q17)
g. Other – please specify below
5. To the best of your knowledge when will an ePMA system be fully implemented at your Trust?
Estimated date of full implementation
6. Which of the following statements best describes the interface between the patient record system and the pharmacy dispensing system?
Please tick one option
a. Patient records are electronic and fully integrated with pharmacy dispensing system.
b. Patient records are electronic and partially integrated with pharmacy dispensing system.
c. Patient records are electronic, but not integrated with the pharmacy dispensing system. □=
d. On paper
7. What is the name of the pharmacy dispensing system at your Trust?
Please specify the system name and supplier
8. Can the Trust export data from these systems and, if so, in which of the following formats?
Please tick all that apply
(i) Patient records system (ii) Pharmacy Dispensing System (PDS)
a. .xls (Excel)
b. .csv or .txt (Text)
c. Not possible
9. In principle are the prescribing systems capable of producing an anonymised report of the number of patients treated by specific drug treatment and by diagnosis a single report?
Please tick one option
a. Yes
b. No
10. In the case of drugs with multiple indications, e.g., a drug indicated for rheumatoid arthritis and haematology, does the system record sufficient detail to report on how much is used for each indication?
Please tick one option
a. Yes
b. No
11. In the case of drugs that are used to treat more than one type of cancer, can the system produce a single report that shows the quantity of drug used for each tumour type?
Please tick one option
a. Yes
b. No
12. In the case of drugs that are used to treat more than one type of cancer, can the system produce a single report that shows the quantity of drug used for each tumour type by cancer stage?
Please tick one option
a. Yes
b. No
13. Which, if any, of the following fields can be exported from the ePMA system?
Please indicate yes or no per item
a. Date (month year)
b. Diagnosis or indication
c. Drug name (&/or SNOMED ID)
d. Drug formulation
e. Drug strength
f. Drug unit of measure (e.g., milligrams, micrograms, vials)
g. Quantity dispensed (in UOM)
h. Quantity prescribed (in UOM)
i. Number of patients treated
14. Do you already produce a report such as this within the Trust?
Please tick one option
c. Yes
d. No
15. What is the name of this report?
Please specify
16. Which team or department is responsible for producing this report?
17. In September 2021 we understand that a new standard is being implemented for the Drugs Patient Level Contract Monitoring (DrPLCM) report, which is submitted monthly by every NHS Trust. Please see DCB2212 Drugs Patient Level Contract Monitoring (DrPLCM) Version 2.0 released 8th April 2021.
To what extent will your Trust be able to submit the data field named ‘Therapeutic indication code (SNOMED CT)’, or a description of the indication, alongside details of drug treatment, as stipulated by NHS England by the end of 2021?
a. Fully
b. Partially
c. Not at all
18. Which of the following diagnoses or indications are detailed in the latest DrPLCM report for your Trust?
We are interested in the level of detail (e.g., medical oncology versus ovarian cancer) as well as the specific diagnoses.
Please indicate yes or no for each diagnosis description
Immunology
Atopic dermatitis
Crohn’s disease
Plaque psoriasis
Rheumatoid arthritis
Severe asthma
Ulcerative colitis
Multiple sclerosis
Primary progressive multiple sclerosis
Relapsing remitting multiple sclerosis
Ophthalmology
Wet age-related macular degeneration
Dry age-related macular degeneration
Diabetic macular oedema
Medical oncology
Breast cancer
Lung cancer
NSCLC
SCLC
Melanoma
Ovarian cancer
Prostate cancer
Renal carcinoma
Haematology
Non Hodgkin Lymphoma
Hodgkin’s Disease
Acute Myeloid Leukaemia
Chronic Lymphocytic Leukaemia
Multiple Myeloma

Download response Electronic prescribing and medicines administration system (ePMA). 151221.docx

Electrophysiology equipment. 300317

1. Does your Trust have an Electrophysiology Lab or perform Electrophysiology Procedures?
2. How many 3D Mapping Systems are installed in your Trust?
3. How many Electrophysiology Recording Systems are installed in your Trust?
On average, what is the lifespan of these EP Recording systems?
What brands are they?
Were there any EP Recording systems purchased in the last 12 months?
If yes, how many?
Were these to replace old machines or new purchases?
4. How many Intracardiac Echocardiography (ICE) Systems are installed in your Trust?
5. How many Radiofrequency (RF) Ablation Generators are installed in your Trust?
6. How many cardiac stimulators are installed in your Trust?
7. How many Remote Navigation Systems (from Stereotaxis) are installed in your Trust?

Download response Electrophysiology equipment. 300317

ePMA Pharmacy Technician role job description.101022.docx

Could you please provide me with your current job descriptions and banding information for your ePMA Pharmacy Technician role(s)

ePMA Pharmacy Technician role job description.101022.docx

ESBL and CPE infections. 181116

Can you please tell me how many people in your hospital trust:

1. Were admitted to hospital with an ESBL infection
2. Acquired an ESBL infection while in hospital
3. Were admitted to hospital with a CPE infection
4. Acquired a CPE infection while in hospital

Please provide the information for the past 10 years.

Download response ESBL and CPE infections. 181116

EU staff and medicines from the EEA. 151118

You asked:
1. How much does it cost in pounds sterling to recruit one doctor from an EEA country, as of October 2018?
2. How much does it cost in pounds sterling to recruit one nurse from an EEA country, as of October 2018?
3. How much did it cost in pounds sterling to recruit one doctor from an EEA country in October 2015?
4. How much did it cost in pounds sterling to recruit one nurse from an EEA country in October 2015?
5. How much of the overall budget is dedicated to recruitment?
6. How much did you spend on medicines from the EEA in 2015?
7. How much are you projecting to spend on medicines from the EEA in 2018?
8. What percentage of medication came from the EEA in 2015?
9. What percentage of medication came from the EEA in 2018?

Download response EU staff and medicines from the EEA. 151118

FEES (fibreoptic endoscopic evaluation of swallowing) assessments. 290721.docx

1.Please can you tell me whether your trust completes FEES (fibreoptic endoscopic evaluation of swallowing) assessments within the speech and language therapy department?
2.If so, on average, how many inpatient FEES assessments are completed per year and how many outpatient assessments are completed per year?

Download response FEES (fibreoptic endoscopic evaluation of swallowing) assessments. 290721.docx

Fibrinogen Concentrate, Prothrombin Complex Concentrate, DOAC Antidote, and blood products.120324.docx

I would like to submit an FOI request for the number of patients and vials for the below products at Maidstone and Tunbridge Wells NHS Trust used in 2023 (total January to December), broken down by brand, if possible.
If not all products are available at your institution, would it be possible to fill in the data that you have access to/ can share?
Product
Prothrombin Complex Concentrate (PCC)
Beriplex
Octaplex
Prothromplex
FEIBA
Others: (if any, please specify if any)
Reversal Agents
Ondexxya (andexanet alfa)
Praxbind (Idaracizumab)
Fibrinogen Concentrate (FC)
RiaSTAP
FibCLOT
Fibryga
Others: (if any, please specify)
Fresh Frozen Plasma (FFP)
Fresh Frozen Plasma
Octaplas
Cryoprecipitate
Cryoprecipitate
Labile Blood Products
Whole blood
Red blood cells
Platelets
Factor XIII
Fibrogammin

Fibrinogen Concentrate, Prothrombin Complex Concentrate, DOAC Antidote, and blood products.120324.docx

Foot protection team. 020617

1. Does your trust operate a foot protection service, as recommended by NICE guideline NG19 on ‘Diabetic foot problems: prevention and management’?

2. If the answer to Q1 is yes, please state the number of podiatrists and orthotists employed within this service.

3. If the answer to Q1 is yes, is this service led by a podiatrist with specialist training in diabetic foot problems, as recommended by NICE guideline NG19 on ‘Diabetic foot problems: prevention and management’?

4. If the answer to Q1 is no, please provide a reason for this.

Download response Foot protection team. 020617

Formaldehyde and Formalin

1. How many reported incidents involving formaldehyde and/or Formalin have occurred in the last 3 years at your trust? Please provide numbers of staff and patients involved in such incidents
2. How many reported illnesses or injury due to formaldehyde and/or formalin has your trust had?
3. Has your trust ever been subject to legal proceedings due to exposure to formaldehyde and and/or formalin? Please supply numbers of incidents
4. Does your trust have a policy or procedure in place to reduce exposure to formaldehyde and/or formalin in the treatment room setting whilst harvesting biopsy samples? If so please supply
5. Does your trust have a policy to purchase the safest practicable solution to reduce harmful exposure to Formaldehyde and/or formalin? If so please supply details

Download response Formaldehyde and Formalin 260216

Formularies and committees.241218

1) We understand the CCG/Trust has representation on the following medicines management / prescribing / formulary committees:
a. Maidstone and Tunbridge Wells NHS Trust Drugs and Therapeutic Committee
b. West Kent CCG Prescribing Interface Group
Please confirm if this is correct.
2) Does the CCG/Trust have representation on any other medicines management / prescribing / formulary committees? If so, please advise which.
3) We have the following formularies listed as used by the CCG/Trust:
a. West Kent Interface Adult Formulary
Please confirm if this is correct and if not, please provide a link/copy of relevant formularies.
4) Are any of the above formularies dominant when making prescribing decisions or does this depend on therapy area?

Download response Formularies and committees.241218

Formularies and Committees.260124.docx

All questions are shown as received by the Trust.
1) We understand the ICS/Trust has representation on the following Medicines Management / Prescribing / Formulary Committees:
• Kent and Medway Sub-ICB Prescribing Interface Group
• Maidstone and Tunbridge Wells NHS Trust Drugs and Therapeutic Committee
Please confirm if this is correct.
If not correct, please list the relevant Committess.
2) Does the Organisation have representation on any other medicines management / prescribing / formulary committees? If so, please advise which.
3) We have the following formularies listed as used by the Organisation:
• West Kent Interface Adult Formulary
Please confirm if this is correct and if not, please provide online link(s)/copy of relevant formularies.
4) Are any of the above formularies dominant when making prescribing decisions or does this depend on therapy area? Please say which is the relevant formulary of the Organisation.
5) If you use a PDF formulary, have you considered moving it to an online platform like Netformulary, and if yes, when are you planning to do so?

Formularies and Committees.260124.docx

Gamma cameras and SPECT-CT systems. 270821.docx

1. Make and model of all gamma cameras and SPECT-CT systems that are installed in your Nuclear Medicine, Radiology or Medical Physics Department within all your Trust’s locations
2. Date of purchase of above systems and expected replacement dates
3. Price paid for all above systems that have been purchased within the within the last 2 years
4. Names of Consultants, Physicists and Technologists responsible for above systems

Download response Gamma cameras and SPECT-CT systems. 270821.docx

Gaseous anaesthetic agents.011118

In particular, I would like to know the total volume and total amount spent in the last financial year on sevoflurane, Desflurane and isoflurane.
To avoid any commercial sensitivity, I do not want to know who the manufacturer or supplier is, simply the total volume and cost as shown below:
• Total volume purchased in 2017-2018, last 12 months (ml or litres if possible)
• Total amount spent on agent in 2017-2108
Regarding the volume of agent used, millilitres or litres would be preferred. If it is easier to provide another unit of measure, please provide details so that I can calculate the volume.
Also, could you please state whether the total amount spent includes or excludes VAT.

Download response Gaseous anaesthetic agents.011118

Gout and Bowel Cleanser products. 031219

Information request 1

Has your hospital dispensed the products listed below from January 1 2018 till December 31 2018? If the answer is ‘yes’, could you confirm the number of tablets dispensed?
1. Colchicine 500mcg tablets
2. Allopurinol 100mg tablets
3. Allopurinol 300mg tablets
4. Adenuric 80mg tablets (Febuxostat)
5. Adenuric 120mg tablets (Febuxostat)

Information request 2
Has your hospital dispensed the products listed below from January 1 2018 till December 31 2018? If the answer is ‘yes’, could you confirm the number of sachets dispensed?
1. Moviprep powder for oral solution
2. Moviprep Orange powder for oral solution
3. Klean-Prep 69g sachet powder for oral solution
4. Picolax powder for oral solution

Download response Gout and Bowel Cleanser products. 031219

Growth Hormone prescribing. 300720

1. In your Trust how many patients have been treated with the following Somatostatin Analogues in the latest 12-month period for which data are available?
a. Octreotide
b. Lanreotide
c. Pasireotide
2. In the latest 12-month period how many Acromegaly patients have been treated with the following drugs?
a. Sandostatin LAR
b. Octreotide Long-Acting (Generic)
c. Somatuline Autogel
d. Pasireotide
e. Pegvisomant
3. How many patients have received a somatropin treatment for growth hormone deficiency in the latest 12-month period?
a. Genotropin
b. Humatrope
c. Norditropin
d. Nutropin
e. Omnitrope
f. Saizen
g. Zomacton
4. If it is possible, can you provide the number of patients under the age 16 that were treated with each of the following drugs in the latest 12-month period?
a. Genotropin
b. Humatrope
c. Norditropin
d. Nutropin
e. Omnitrope
f. Saizen
g. Zomacton

Download response Growth Hormone prescribing. 300720

Growth Hormone Treatments. 111219

In your trust, in the past 12 months [latest 12 months available], how many patients have been treated with the following medications?
• Genotropin
• Humatrope
• Norditropin
• Nutropin
• Omnitrope
• Saizen
• Zomacton

Download response Growth Hormone Treatments. 111219

H.Pylori Testing.130324.docx

All questions are shown as received by the Trust.
1. How do you test for H. Pylori infection during upper GI endoscopies ? Please specify what tests you use, eg, Culture Biopsy (Pathology), Urease.
2. How many H. Pylori tests are performed in a typical month?
3. Who decides to purchase H. Pylori tests?
4. Which H.Pylori test(s) do you use most?
5. Why do you use these tests most?
6. Where in the hospital is the test usually done, and by whom?
7. What medication do you use to treat H, Pylori? Please give drug name and brand.
8. What is the typical cost per test? Please give an estimate for unbranded or laboratory own tests.
9. Do you use a Urease test for H. Pylori? If not, what type of test do you use? Eg breath test, culture, etc.
10. If you use a Urease test for H. Pylori, what type of Urease H. Pylori test do you use? Please give drug name and brand

H.Pylori Testing.130324.docx

Haemochromatosis. 261016

A. the number of patients treated with Haemochromatosis in 2015 who are in maintenance phase of the treatment (*)
B. the number of patients treated with Haemochromatosis in 2015 who are in PRE-maintenance phase of the treatment (+)
C. a copy of the clinical protocol(s) used to treat haemochromatosis
D. a copy of the clinical protocol(s) for therapeutic venesection

(*) “Maintenance phase” relates to patients whose ferritin is <=50 ug/L
(+) “PRE-maintenance phase” relates to patients whose ferritin is in excess of 50 ug/L

Download response Haemochromatosis. 261016

Hartmann IV solution.270422.docx

The total amount paid for Hartmann IV solution for each financial year since April 2017 and the individual bag cost charged for each of these tax years.

Hartmann IV solution.270422.docx

HCV testing 151216

1. Do you currently offer a clinical testing service for HCV?
o Yes, In-house service
o Yes, Send-out to another laboratory
o No
If you have selected send-out testing above, to which laboratory do you send samples for HCV testing?
2. What type of clinical HCV testing do you offer?
o HCV Antibody testing
o HCV RNA testing
o HCV Genotyping
o HCV Drug resistance testing
o Other. Please Specify:
3. If you are offering HCV antibody testing as well as HCV RNA testing, what is the laboratory algorithm used for testing?
o RNA testing is automatically performed as a reflex test dependant on the Antibody result
o The HCV antibody result is reported to the clinician and RNA testing is only performed when specifically requested by the clinician
4. HCV antibody testing details:
Is HCV antibody testing performed using a kit or laboratory developed technique?
If appropriate, please specify kit details:
What platform is used for HCV antibody testing?
What is the laboratory turnaround time for HCV antibody testing?
How frequently is HCV antibody testing performed
(on sample receipt, daily, twice a week, monthly)?
5. HCV RNA testing details:
Is HCV RNA testing performed using a kit or laboratory developed technique?
If appropriate, please specify kit details:
What platform is used for HCV RNA testing?
What is the laboratory turnaround time for HCV RNA testing?
How frequently is HCV RNA testing performed
(on sample receipt, daily, twice a week, monthly)?
6. HCV sample volume:
Annual Sample Volume
1st Nov 2015- 1st Nov 2016 Positivity Rate
1st Nov 2015- 1st Nov 2016
HCV
Antibody testing
HCV
RNA testing
HCV
Genotyping
(If applicable)
HCV
Drug resistance testing
(If applicable)

Download response HCV testing 151216

 

Emergency and Medical Services

Pain relief prescriptions 031016

For each of the questions, please can you provide answers for each of the financial years 2013/14, 2014/15 and 2015/16:

1. PARACETAMOL

a. Which suppliers did you buy paracetamol from?
b. How many packets of paracetamol did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of paracetamol did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for paracetamol?
e. How much did you spend on paracetamol in total?
f. How many prescriptions in total did you make for paracetamol?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for paracetamol?

2. IBRUPROFEN

a. Which suppliers did you buy ibuprofen from?
b. How many packets of ibuprofen did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of ibuprofen did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for ibuprofen?
e. How much did you spend on ibuprofen in total?
f. How many prescriptions in total did you make for ibuprofen?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for ibuprofen?

3. ASPIRIN

a. Which suppliers did you buy aspirin from?
b. How many packets of aspirin did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of aspirin did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for aspirin?
e. How much did you spend on aspirin in total?
f. How many prescriptions in total did you make for aspirin?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for aspirin?

4. CODEINE PHOSPHATE

a. Which suppliers did you buy codeine phosphate from?
b. How many packets of codeine phosphate did you buy from each supplier? Please disclose how many tablets were in the packets.
c. How many packets of codeine phosphate did you buy in total? Please disclose how many tablets were in the packets.
d. How much did you pay each supplier for codeine phosphate?
e. How much did you spend on codeine phosphate in total?
f. How many prescriptions in total did you make for codeine phosphate?
g. How many of these prescriptions were free for the patient?
h. How much money were you paid by patients for codeine phosphate?

Download response Pain relief prescriptions 031016

Abdominal aortic aneurysms. 160518

Are you able to provide me with a copy of the protocols the Trust use in terms of monitoring Abdominal Aortic Aneurysms (AAAs)?

Download response Abdominal aortic aneurysms. 160518

Acanthamoeba Keratitis (AK).241218

How many cases of acanthamoeba keratitis (AK) have been diagnosed within your trust over the past five years?

Download response Acanthamoeba Keratitis (AK).241218

Accident and emergency departments.190822.docx

You asked:
1. How many patients were triaged at your accident and emergency (ED) departments between 1st January 2016 and 30th June 2022?
2. How many patients arrived by ambulance at your accident and emergency departments between 1st January 2016 and 30th June 2022?

Accident and emergency departments.190822.docx

Accident and Emergency Diagnosis Code. 091221.docx

1. (a) With regard to the following Accident and Emergency Diagnosis Code (and/or treatment Code; whichever is applicable): ‘8582’ what is the specific name of the respective coding database/data set and the corresponding version and the applicable date range when the Trust used this code?
(b) What is the corresponding full diagnosis descriptor and/or if relevant, treatment descriptor?
(c) Please provide the corresponding word descriptor for each of the numbers within the code “8582”.
2. (a) with regard to the Accident and Emergency diagnosis descriptor: ‘Other Soft Tis Inj. Neck,’ what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) What is the corresponding code used within the Trust’s patient records?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
3. (a) With regard to the Accident and Emergency diagnosis descriptor: ‘Other Soft Tis Inj. Neck, Not applicable’ what is the specific name of the respective database/data set used in 2012 and the corresponding version and applicable date range in which the above diagnosis descriptor was used by the Trust?
(b) What is the corresponding Accident and Emergency diagnosis code relevant to the above diagnosis descriptor within the same database/dataset which was used within patient records by the Trust at the time?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data in 2012?
4(a) With regard to the Accident and Emergency Investigation descriptor: ‘X-ray or Blood tests’ what is the specific name of the database/data set and the corresponding version and applicable date range when this Investigation descriptor was used by the Trust?
(b) What is the corresponding code relevant to the above Investigation descriptor within the same database/dataset?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
5(a) With regard to the Accident and Emergency Investigation descriptor: ‘X-ray plain film’ what is the specific name of the database/data set and the corresponding version and applicable date range when the above Investigation descriptor was used by the Trust?
(b) What is the corresponding code relevant to the above Investigation descriptor within the same database/dataset?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data;
6(a) with regard to the possible Accident and Emergency diagnosis descriptor: ‘Other Soft Tis Inj. Shoulder,’
If this is a historically identified diagnosis descriptor, please confirm whether the Trust has ever used this and if so, what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) If applicable, what is the corresponding code used within the Trust’s patient records?
(c) If applicable, what was the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data from April 2012 onwards?
7(a) with regard to the Accident and Emergency diagnosis descriptor: ‘Acute limb injury*, leg,’ *ALI what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) What is the corresponding code used within the Trust’s patient records?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
8(a) with regard to the Accident and Emergency diagnosis descriptor: ‘Whiplash’ what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) What is the corresponding code used within the Trust’s patient records?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
9(a) with regard to the Accident and Emergency diagnosis descriptor: ‘Acute torticollis,’ what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) What is the corresponding code used within the Trust’s patient records?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
Additional questions:
2. Please confirm, so that I know I have understood the Trust’s response to question 14(a) correctly, that the software system which was in use by the Trust in December 2020, in respect of onsite storage, retrieval and printing of historical patient records was ‘eNotes’.
3. In respect of the Trust’s response to question 14(b), please clarify whether the ‘eNotes’ system which the Trust response refers to, accesses historical April 2012 patient letters, and whilst processing them, modifies elements of the original document data automatically, and if so, please specify which fields and how and why these fields are modified.
4. Please indicate if a patient’s original historical letter can be modified on ‘eNotes’ in real time by an individual Trust software user and then be printed off subsequently.
5. In respect of the ‘eNotes’ system that the Trust refers to, please specify the software company who supplies the Trust.
6. With regard to the Trust’s comments relating to software (see Appendix 5), although it is stated that the Trust migrated to Sunrise in July 2021, was this software ever utilised in conjunction with historical patient records, before July 2021?
7. What specific date range did the Trust use the Symphony system provided by EMIS?
8. What specific date range did the Trust use the Symphony system provided by Footman-Walker?
9. Would patient records have been processed by Symphony EMIS or Symphony Footman-Walker at the time in April 2012?
10. Although the A & E response explains that further diagnoses were hand written in the CAS card and scanned in following attendance, it is not clear from the response whether the further diagnoses which were hand written in the CAS card were the same as those original further diagnoses which would have been included in real time (April 2012) within the A & E record ‘Diagnosis Comments’ field’ (which I referred to in my FOI question (b), copied above).
Please provide precise and direct clarification on this point
i.e. was the further diagnoses data entered into both the A & E ‘Diagnosis Comments’ field in real time in April 2012, as well as being hand written subsequently in the CAS card?

Download response Accident and Emergency Diagnosis Code. 091221.docx

Accident and Emergency Diagnosis Coding and Descriptions. 131021.docx

1. (a)With regard to the following Accident and Emergency Diagnosis Code (and/or treatment Code; whichever is applicable): ‘8582’ what is the specific name of the respective coding database/data set and the corresponding version and the applicable date range when the Trust used this code?
(b) What is the corresponding full diagnosis descriptor and/or if relevant, treatment descriptor?
(c) Please provide the corresponding word descriptor for each of the numbers within the code “8582”.
2. (a) with regard to the Accident and Emergency diagnosis descriptor:
‘Other Soft Tis Inj. Neck,’
what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) What is the corresponding code used within the Trust’s patient records?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
3. (a) With regard to the Accident and Emergency diagnosis descriptor:
‘Other Soft Tis Inj. Neck, Not applicable’
what is the specific name of the respective database/data set used in 2012 and the corresponding version and applicable date range in which the above diagnosis descriptor was used by the Trust?
(b) What is the corresponding Accident and Emergency diagnosis code relevant to the above diagnosis descriptor within the same database/dataset which was used within patient records by the Trust at the time?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data in 2012?
4(a) With regard to the Accident and Emergency Investigation descriptor:
‘X-ray or Blood tests’
what is the specific name of the database/data set and the corresponding version and applicable date range when this Investigation descriptor was used by the Trust?
(b) What is the corresponding code relevant to the above Investigation descriptor within the same database/dataset?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
5(a) With regard to the Accident and Emergency Investigation descriptor:
‘X-ray plain film’
what is the specific name of the database/data set and the corresponding version and applicable date range when the above Investigation descriptor was used by the Trust?
(b) What is the corresponding code relevant to the above Investigation descriptor within the same database/dataset?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data;
6(a) with regard to the possible Accident and Emergency diagnosis descriptor:
‘Other Soft Tis Inj. Shoulder,’
If this is a historically identified diagnosis descriptor, please confirm whether the Trust has ever used this and if so, what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) If applicable, what is the corresponding code used within the Trust’s patient records?
(c) If applicable, what was the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data from April 2012 onwards?
7(a) with regard to the Accident and Emergency diagnosis descriptor:
‘Acute limb injury*, leg,’ *ALI what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) What is the corresponding code used within the Trust’s patient records?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
8(a) with regard to the Accident and Emergency diagnosis descriptor:
‘Whiplash’ what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) What is the corresponding code used within the Trust’s patient records?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
9(a) with regard to the Accident and Emergency diagnosis descriptor:
‘Acute torticollis,’
what is the specific name of the database/data set and the corresponding version and applicable date range when the Trust used this diagnosis descriptor?
(b) What is the corresponding code used within the Trust’s patient records?
(c) What is the corresponding code used within Trust information reported to the Secondary Use Service (SUS) and the Hospital Episode Statistics (HES) data?
10.(a) What is the corresponding descriptor for Code 19153 (which may be a LOCAL SUB-SPECIALTY CODE within CDS Trust use only?
11. Who, within the Trust, is responsible for the following?
(a) updating accident and emergency data bases
(b) managing and accessing archived data bases/sets
12. (a) who has authorised access to* historical individual patient records stored on the Trust’s onsite systems?
*including the facility to amend historical patient personal data
13. Who within the Trust is currently responsible for:
(a) investigating alleged breaches of the data legislation?
(b) rectifying inaccurate and incomplete personal data?
14. (a) What software system was in use by the Trust in December 2020, in respect of onsite storage, retrieval and printing of historical patient records?
(b) In what data format are historical patient records, which are held onsite, accessed, processed and printed off?
15. (a) Were all Accident & Emergency recorded patient diagnoses reported as diagnostic codes to the Secondary Use Service (and when applicable, the Hospital Episode Statistics) from April 2012 onwards?
(b) Within the Trust’s Accident and Emergency computer system used in April 2012, was there only the facility to record the ‘Primary Diagnosis’ and ‘Diagnosis Comments’, and no facility within the software to record specific secondary and third diagnoses when inputting the data in real time, other than within the ‘Diagnosis Comments’ field?
16. How many historical patient letters*, when copied and sent to patients under a Subject Access Request (SAR) or FOI Request, have been reported to the Trust as containing a different or missing diagnosis descriptor, and/or a different investigation descriptor, to that contained within the corresponding original letter?
*(which were originally written pre-2017 data changes).

Download response Accident and Emergency Diagnosis Coding and Descriptions. 131021.docx

Accident and emergency (ED) departments.300822.docx

1. How many patients were triaged at your accident and emergency (ED) departments between 1st January 2016 and 30th June 2022? Could you please provide a year-on-year breakdown?
2. How many patients arrived by ambulance at your accident and emergency departments between 1st January 2016 and 30th June 2022? Again, could I have a year-on-year breakdown.

Accident and emergency (ED) departments.300822.docx

Accident and Emergency Quality Indicators.

The indicators published by HSCIC’s report include:
Left department before being seen for treatment (Data quality)
– Total number of attendances in A&E HES (excluding planned follow-up attendances and attendances where the attendance category was unknown)
– Attendances with an unknown attendance disposal category
– % of attendances with unknown attendance disposal categories
– % of attendances with an attendance disposal category of “Other”
Left department before being seen for treatment (Performance)
– Total number of attendances in A&E HES (excluding planned follow-up attendances, attendances where the attendance category was unknown, and attendances where the attendance disposal category was unknown)
– Number of attendances with an attendance disposal of “Left Department before being seen for treatment”
– Left department before being seen for treatment
Re-attendance (Data quality)
– Total number of applicable attendances for this indicator (1st A&E attendance, unplanned follow up attendance and unknown attendance)
– Attendances with unknown attendance category
– % of attendances with an unknown attendance category
Re-attendance (Performance)
– Total number of attendances in A&E HES (excluding planned follow-up attendances and attendances where the attendance category was unknown)
– Number of re-attendances within 7 days of a previous attendance at A&E
– Re-attendance rate
Time to initial assessment [emergency ambulance cases only] (Data quality)
– Total number of attendances in A&E HES that were brought in by ambulance (excluding planned follow-up attendances and attendances where the attendance category was unknown)
– Attendances with an unknown duration to initial assessment
– % of attendances with unknown duration to assessment times
Time to initial assessment [emergency ambulance cases only] (Performance; minutes)
– Median
– 95th Percentile
– Longest wait
Time to Treatment (Data quality)
– Total number of attendances in A&E HES (excluding planned follow-up attendances, attendances where the attendance category was unknown, and attendances where the attendance disposal category was: Left Before Treatment, Left Refusing Treatment, or Unknown)”
– Attendances with unknown duration to treatment
– % of attendances with unknown duration to treatment times
Time to Treatment (Performance; minutes)
– Median
– 95th Percentile
– Longest wait
Total Time in A&E (minutes) [Admitted patients only]
– Median
– 95th Percentile
– Longest wait
Total Time in A&E (minutes) [Non-admitted patients only]
– Median
– 95th Percentile
– Longest wait
Total Time in A&E (Data quality) [All patients]
– Total number of attendances in A&E HES (excluding planned follow-up attendances and attendances where the attendance category was unknown)
– Attendances with unknown duration to departure
– % of attendances with unknown duration to departure times
Total Time in A&E (Performance; minutes) [All patients]
– Median
– 95th Percentile
– Longest wait

Download response Accident and Emergency Quality Indicators 290616

Accidents in the home. 071217

1. A: How many people have died in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
1. B: How many children aged 0-18 have died in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
1. C: How many people aged 65+ have died in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
2. A: How many people have attended A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
2. B: How many children aged 0-18 have attended A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
2. C: How many people aged 65+ have attended A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
3. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
3. B: How many children aged 0-18 have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
3. C: How many people over 65 years have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident in the home?”
4. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to leisure activities?”
4. B: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident in education settings?”
4. C: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident on the road?”
4. D: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident at work?”
5. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to a fall in the home?”
5. B: How many adults over 65 have attended A&E in the past year (Oct 2016 – Oct 2017) due to a fall in the home?”
5. C: How many people have died in the past year (Oct 2016 – Oct 2017) due to a fall in the home? ”
6. A: How many cases have attended A&E in the past year (Oct 2016 – Oct 2017) with suspected carbon monoxide poisoning?”
6. B: How many cases of carbon monoxide poisoning have been treated in A&E the past year (Oct 2016 – Oct 2017)?”
6. C: How many cases have been admitted from A&E in the past year (Oct 2016 – Oct 2017) for carbon monoxide poisoning treatment?”
6. D: How many people have died in the past year (Oct 2016 – Oct 2017) due to carbon monoxide poisoning?”
7. A: How many cases of asthma have been treated in A&E the past year (Oct 2016 – Oct 2017)?”
7. B: How many cases have been admitted from A&E in the past year (Oct 2016 – Oct 2017) for asthma? ”
7. C: How many people have died in the past year (Oct 2016 – Oct 2017) due to asthma?”
8. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an electrical accident in the home?”
9. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to a burn or scalding accident in the home?
10. A: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an injury caused while gardening?
10. B: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an accident with the lawn mower?
10. C: How many people have been treated in A&E in the past year (Oct 2016 – Oct 2017) due to an injury caused by a BBQ?

Download response Accidents in the home. 071217

Acopia and-or social admission or ICD 10 code z73. 250417

With regard to A&E statistics pertaining to presenting complaints can you please provide the number of times ‘acopia’ and/or ‘social admission’ or ICD 10 code z73 were recorded as causes for
a. Admission
b. Noted in the discharge summary
c. Recorded as a diagnosis for the periods of
January 2017- March 2017
2016
2015

Download response Acopia and-or social admission or ICD 10 code z73. 250417

Acquired Brain Injury (ABI).100124.docx

All questions are shown as received by the Trust.
I am currently researching the cost of care for conditions relating to Acquired Brain Injury (ABI) conditions for patients in a level-3 neuro-rehab facility who are occupying an in-patient bed. I am looking to obtain and explains the care type and funding condition for which I want to gather the information. The funding conditions are as follows:
Spot Purchase Price – In Area – This is classified as the prevailing (latest 2023) daily fee charged by you to the ICS for providing care to an individual who is from your ICS region and is occupying a bed under an immediate requirement and is not contracted for and is made ‘on the spot’.
Spot Purchase Price – Out of Area – This is classified as the prevailing (latest 2023) daily fee charged by you to the ICS for providing care to an individual who is an out-of-area patient from another ICS and is occupying a bed in your trust but is paid for by their home ICS, under an immediate requirement and is not contracted for and is made ‘on the spot’.
Block contract – This is classified as the average amount spent per individual under a contract that you agree upon as a trust with your home ICS to provide care for an individual needing an inpatient bed for an acquired brain injury treatment in a level-3 neuro-rehab facility.
If the data is unavailable in the format requested, please provide the information in the following format.
Overall Average (in £) – The overall average cost of a patient that occupies a bed in a level-3 neuro-rehab facility.

Acquired Brain Injury (ABI).100124.docx

Acute Myocardial Infarction (AMI).

Which test(s) does the Trust use to diagnose patients who present with suspected acute myocardial infarction (AMI)? Please give details of tests used – including the brand and name of the test(s).

What, if any, guidelines or protocols does the Trust follow to support the diagnosis of suspected AMI? Please give details.

Does your Trust use early rule-out protocols to diagnose AMI? If so, please give details.

What is the average waiting time for a diagnosis following a suspected AMI at the Trust?

What is the target turn-around-time for tests used in the diagnosis of AMI in the Trust? What percentage of tests are performed within this target turn-around-time?

How long has the Trust and/or hospitals within the Trust been using their current troponin test(s)?

Download response Acute Myocardial Infarction (AMI) 211215 (AMI)

ADHD and ASD diagnosis.260224.docx

All questions are shown as received by the Trust.
1) Does your trust deal with any of the following: (A yes/no is sufficient)
a) Adult ADHD diagnosis
b) Child and/or Adolescent ADHD diagnosis
c) Adult Autism Spectrum Disorder diagnosis
d) Child and/or Adolescent Autism Spectrum Disorder diagnosis
If Maidstone and Tunbridge Wells NHS Trust does deal with any of these diagnosis pathways, for all that apply, please provide:
i) average wait-time from referral to first appointment
ii) average wait-time from referral to decision on diagnosis/discharge from diagnostic service
iii) Number of individuals on the wait list as of 31 December 2023 (or nearest available date)
iv) average wait-time from first appointment to decision on diagnosis/discharge from diagnostic service

ADHD and ASD diagnosis.260224.docx

ADHD assessments.260224.docx

All questions are shown as received by the Trust.
1. How many people are currently on your waiting list for ADHD assessments?
Please break this down between children and adults.
2. How many assessments have you carried out every calendar year between 2018 and 2023?
If possible, please break this down between children and adults.
3. How many ADHD referrals did you receive each calendar year between 2018 and 2023?
Please break this down between children and adults.
4. How many ADHD referrals did you accept each calendar year between 2018 and 2023?
Please break this down between children and adults.
5. What is the (mean) average time patients wait between referral and an assessment for ADHD for each calendar year between 2018 and 2023?
If possible, please break this down between children and adults.

ADHD assessments.260224.docx

Admissions and Discharge policies and Venous Thromboembolism (VTE) policy.

Under the Freedom of Information Act, please may you send me a copy of your Admissions Policy and Discharge Policy?

If held, please may you send me your policy on preventing and treating venous thromboembolism (VTE’s).

Download response Admissions and Discharge policies and Venous Thromboembolism (VTE) policy 010216

Admissions of patients over the age of 65. 020518

1. How many people in the following categories had a fall as their primary reason for emergency admission in 2011/2012, 2015/2016, 2016/2017?
People over 65:
People over 65 and with dementia:
2. How many people in the following categories had a urinary tract infection as their primary reason for emergency admission in 2011/2012, 2015/2016 and 2016/2017?
People over 65:
People over 65 and with dementia:
3. How many people in the following categories had delirium as their primary reason for emergency admission in 2011/2012, 2015/2016 and 2016/2017?
People over 65:
People over 65 and with dementia:
4. How many people in the following categories had dehydration or gastroenteritis as their primary reason for emergency admission in 2011/2012, 2015/2016 and 2016/2017?
People over 65:
People over 65 and with dementia:
5. How many people in the following categories had a chest infection or pneumonia as their primary reason for emergency admission in 2011/2012, 2015/2016 and 2016/2017?
People over 65:
People over 65 and with dementia:

Download response Admissions of patients over the age of 65. 020518

Admissions via A&E.

1. How many patients visiting A&E each week who required admission were admitted within four hours? Please also provide the total number of patients attending A&E, for context.

2. What percentage of patients who required admission were admitted within four hours?

3. What was the average (mean) length of time between arrival and admission for patients who required admission each week?

4. How many patients who required admission were in A&E for more than 12 hours? Please note, I would like the number of patients who were in the department for more than 12 hours from the time they arrived, not those who waited more than 12 hours from decision to admit to admission.

Download response Admissions via A&E.

Admissions via A&E. 180221

1. How many patients visiting A&E each week who required admission were admitted within four hours? Please also provide the total number of patients attending A&E, for context.

2. What percentage of patients who required admission were admitted within four hours?
3. What was the average (mean) length of time between arrival and admission for patients who required admission each week?

4. How many patients who required admission were in A&E for more than 12 hours? Please note, I would like the number of patients who were in the department for more than 12 hours from the time they arrived, not those who waited more than 12 hours from decision to admit to admission.

5. Each week, what was the longest amount of time a patient spent in A&E between arrival and admission? I would like to know their age and sex.

6. I would appreciate it if you could provide the same information for the financial year 2017/18, 2019/20 and so on, back as far as records allow.

Download response Admissions via A&E. 180221

Admissions via A&E. 210218

1. How many patients visiting A&E each week who required admission were admitted within four hours? Please also provide the total number of patients attending A&E, for context.
2. What percentage of patients who required admission were admitted within four hours?
3. What was the average (mean) length of time between arrival and admission for patients who required admission each week?
4. How many patients who required admission were in A&E for more than 12 hours? Please note, I would like the number of patients who were in the department for more than 12 hours from the time they arrived, not those who waited more than 12 hours from decision to admit to admission.
5. Each week, what was the longest amount of time a patient spent in A&E between arrival and admission? I would like to know their age and sex.
6. I would appreciate it if you could provide the same information for the financial year 2016/17, 2015/16 and so on, back as far as records allow.

Download response Admissions via A&E. 210218

Adult elective patient pre-operative nil by mouth (or fasting or fluids and feeding) guideline. 150921.docx

Please would it be possible for you to share a copy of your trusts adult elective patient pre-operative nil by mouth (or fasting or fluids and feeding) guideline.

Download response Adult elective patient pre-operative nil by mouth (or fasting or fluids and feeding) guideline. 150921.docx

A&E admissions on 8 and 9 December 2016. 080517

How many admissions happened on 8 and 9 December and at what times and how many cubicles are available in A&E.

Download response A&E admissions on 8 and 9 December 2016. 080517 

A&E admissions for people in the last year of life. 270618

1. During the financial year 2016/2017 or last full year figures, what:
a. Was the total number of emergency admissions for people in the last year of life?
b. Was the total number of emergency bed days for people in the last year of life?
2. During the financial year 2016/2017 or last full year figures, what was the total number of people in the last year of life admitted from a care home setting as an emergency?

Download response  A&E admissions for people in the last year of life. 270618

A&E agency staff 2016. 290317

1. The amount spent on employing agency/temporary/locum doctors in A&E departments in each month in 2016.
2. The number of FTE roles covered by agency/temporary/locum doctors in each month in 2016
3. The total number of FTE doctors working in the A&E department in each month in 2016.

Download response A&E agency staff 2016. 290317

A&E alcohol related admissions.311023.docx

All questions are shown as received by the Trust.
“For the financial years 2022-23, 2021-22, 2020-21, 2019-20, , 2018-19

How many patients attended A&E for alcohol related problems – for each of the years above?

Can you please break down the figures by age categories – 18-30, 31-40, 41-50, 51-60, 61-70, 71-80, 81+

How many patients attended were under the age of 18 – for each of the years above?”

A&E alcohol related admissions.311023.docx

A&E and Mental Health.280722.docx

For each financial year in the period 2016-17, 2017-18, 2018-19, 2019-2020, 2021-22, please provide figures for:
The number of adults (aged 18 and over) attending your A&E department for mental health related issues. Please breakdown the figure according to:
i.) How many were treated/seen by a doctor within 4 hours;
ii.) How many waited longer than 4 hours to be treated – please provide a breakdown for how long those people were waiting by hour e.g. five hours, six hours etc:
2. Please detail the longest period of time an adult attending your A&E department for mental health related issues waited to be treated/seen by a doctor in the years stated above?
3. The number of children attending your A&E department for mental health related issues. Please breakdown the figure according to:
i.) How many were treated/seen by a doctor within 4 hours;
ii.) How many waited longer than 4 hours to be treated – please provide a breakdown for how long those people were waiting by hour e.g. five hours, six hours etc:
4. Please detail the longest period of time a child attending your A&E department for mental health related issues waited to be treated/seen by a doctor in the years stated above?

A&E and Mental Health.280722.docx

A&E attendance rates and high intensity users. 180920

• Which programmes or services (either internally developed or commissioned) to tackle high attendance rates at A&E do you possess and are in operation? e.g. To identify and address High Intensity Users (HIUs) at A&E, redirection to other services such as Minor Injury Units, etc.
• How effective have they been for the Trust?
• The cost (how much) of the programme or service to the Trust, per year

I wish for this information to be for the date ranges; April 2018 – March 2019, and, April 2019 – present day

Download response A&E attendance rates and high intensity users. 180920

A&E attendances for assault in 2016. 091216

The data we require are as follows (for period 1st January 2016 and 31st December 2016) in an electronic format that allows us to read the data into a database. Many hospitals respond to our survey and provide data in the form we require. Preferably this format is in an excel file or comma separated text file.

We require the gender of the patient (M or F), the date that they attended due to assault (dd/mm/yyyy) and their age. Age can either be numerical to the nearest year (preferred) or in age bands (“0-10”, “11-17”, “18-30”, “31-50”, “51+”), we can also accept date of birth.

To calculate the level of assault-related injury in England and Wales we also require the total number of attendances for any reason in the year of interest, i.e. 2016.

Download response A&E attendances for assault in 2016. 091216

A&E attendances associated to mental health. 210621

1. The number of patients who were brought to A&E (ED) by the ambulance service/paramedics with a presenting complaint related to mental health, each year, from 2010 to 2020.

Download response A&E attendances associated to mental health. 210621

A&E attendances for alcohol related problems. 010721

For the calendar years 2020, 2019, 2018, 2017 and 2016:
1. How many patients attended A&E for alcohol related problems – for each of the years above?
2. Please can you provide data for each of the A&E departments within your trust and please name them?
3. Can you please break down the figures by age categories – 18-30, 31-40, 41-50, 51-60, 61-70, 71-80, 81+
4. How many patients attended were under the age of 18 – for each of the years above?

Download response A&E attendances for alcohol related problems. 010721

A&E attendances for assault in 2015.

The data we require are as follows (for period 1st January 2015 and 31st December 2015)

ED attendance date
Age or date of birth
Gender
Reason for ED attendance

We also require the total ED attendances for 2015.

Download response A&E attendances for assault in 2015 080216  

A&E attendances with mental health issues. 070120

1. For each financial year in the period 2014-15 to 2018-19, please provide figures for:
a. The number of adults (aged 18 and over) attending your A&E department for mental health related issues.
Please breakdown the above figure according to:
i.) How many were treated/seen by a doctor within 4 hours;
ii.) How many waited longer than 4 hours to be treated.
b. For the people in (a.ii.), please provide a breakdown for how long those people were waiting by hour e.g. five hours, six hours etc.
2. Please detail the longest period of time an adult attending your A&E department for mental health related issues waited to be treated/seen by a doctor in
a. Each individual financial year from 2014-15 to 2018-19 inclusive;
b. 2019-2020 to date.

Download response A&E attendances with mental health issues. 070120

A&E attendees with no fixed abode 220818

1. The number of patients presenting at your A&E/urgent care centres whose address is recorded as no fixed abode or any other similar indicator the trust uses to categorise those who do not have a fixed address/are homeless.
2. The number of patients admitted into your hospital/s whose address is recorded as above.

Please provide these figures for each financial year from 2010/11 to the 2017-18.

Download response A&E attendees with no fixed abode 220818

A&E beds and upfront charging. 250417

Accident and Emergency

1. As of April 2010, the total number of Accident and Emergency beds within the Trust (including predecessor Trusts)
2. As of March 2011, the total number of Accident and Emergency beds within the Trust (including predecessor Trusts)
3. As of April 2017, the total number of Accident and Emergency beds within the Trust
Please split the figures for questions 1-3 into overnight beds and day-only beds. This request includes beds that were temporarily unavailable.
4. Please list any Accident and Emergency wards or units that have been permanently closed since April 2010. Please state how many A&E beds they included at point of closure.
5. Please provide the business case or management report/review underpinning each closure listed in response to question 4
6. Please list any Accident and Emergency wards or units that have been permanently opened since April 2010. Please state how many A&E beds they include.

In this request, Accident and Emergency beds, wards and units are those whose primary usage is for Accident and Emergency cases.

Upfront charging of non-residents

7. What is the Trust’s policy on treating overseas patients who are eligible to be charged upfront for care but are not able or willing to pay upfront?
8. What is the Trust’s policy on upfront charging for overseas patients where it is not possible to establish the cost of care upfront?
9. What is the Trust’s policy towards clinical staff who refuse to enforce upfront payment?
10. What is the Trust’s policy on identifying which patients need to be asked for proof of residency in relation to upfront charging, and what form does that proof take?

Download response A&E beds and upfront charging. 250417

A&E by people suffering with mental health related issues 2012-2016. 091216

How many attendances have there been at A&E by people suffering with mental health related issues (for example, categories including, psychiatric conditions, social problems, self-harm) over the last five calendar years (2012/2013/2014/2015/ January 1st – September 30th 2016)?

Please give the breakdown for under 18s and over 18s attendances (and if possible a further breakdown of ages for under 18s).

If possible, for each year, please state how many people waited longer than the four hour waiting target?

If the trust is in charge of more than one hospital, please give separate information per hospital please.

Download response A&E by people suffering with mental health related issues 2012-2016. 091216

A&E coding and diagnosis descriptions. 201021.docx

Within your FOI response letter dated 13 October 2021, you state:
“15.(b) I have been unable to get a response for this question. Please contact me again if you wish me to continue to chase a response.”
The above relates to my following FOI request question:
“(b) Within the Trust’s Accident and Emergency computer system used in April 2012, was there only the facility to record the ‘Primary Diagnosis’ and ‘Diagnosis Comments’, and no facility within the software to record specific secondary and third diagnoses when inputting the data in real time, other than within the ‘Diagnosis Comments’ field?”
I confirm that I would like you to continue to chase for the full and direct response to this question (i.e. not a generalised response).

Download response A&E coding and diagnosis descriptions. 201021.docx

A&E contact details. 270421

Could you please send me the e-mail contacts of all the Emergency Departments/A&Es of the hospitals within your trust.
Both, the e-mail contact of the GP in charge or the general e-mail contact of the EDs/A&Es would be fine.

Download response A&E contact details. 270421

A&E Department.241218

I would like to request the following information under the Freedom of Information Act.
In the week starting at 00.1am Sunday 7 August through to 11.59pm Saturday 13 August for how many hours was the most senior doctor present in your A&E department
*a consultant;
*a specialty registrar or other middle grade (please specify job title);
*a foundation year one or two doctor;
*a GP; or
*no doctor present.

Download response A&E Department.241218

A&E for alcohol related problems. 280122.docx

For the calendar years 2021, 2020, 2019, 2018, 2017 and 2016:
1. How many patients attended A&E for alcohol related problems – for each of the years above?
2. Can you please break down the figures by age categories – 18-30, 31-40, 41-50, 51-60, 61-70, 71-80, 81+
3. How many patients attended were under the age of 18 – for each of the years above?
4. What age was the youngest patient who attended?

Download response A&E for alcohol related problems. 280122.docx

A&E repeat attendees. 071217

For each of the following financial years – how many patients turned up repeatedly in A&E 2015-16, 2016-17 and 2017-18 to date?

1. How many patients turned up more than 10 times within a year?
2. How many patients turned up 20 times within a year?
3. How many patients turned up 50 times within a year?
4. How many patients turned up more than 100 times within a year?
5. What was the most number of occasions that a patient turned up within a year?

Download response A&E repeat attendees. 071217

A&E staffing. 080519

1. The amount spent on employing agency, temporary and/or locum doctors in A&E departments in each month in 2017 and 2018
2. The number of FTE roles in A&E departments covered by agency, temporary and/or locum doctors in each month in 2017 and 2018
3. The total number of FTE doctors (including agency, temporary and/or locum and permanent staff) working in A&E departments in each month in 2017 and 2018

Download response A&E staffing. 080519

A&E statistics

1. How many minors/see & treat patients are seen in the A&E per day? If no statistics available please provide an approximate amount estimated by the Clinical Lead of the department.
2. How many haematology blood test requests are sent from the A&E?
3. How many patients arrive to the A&E by ambulance?
4. How many ENPs/ANPs does the A&E employ?
5. Is the A&E paid by the CCG per patient according to the national tariff for type 1 A&Es? Are there any modifications to the tariff?
6. How big is the activity with regards to particular HRG codes in minors area? For example how many patients with VB08Z code are seen annually? Please provide figures for all A&E HRG codes.

Download response A&E statistics 010816

A&E Urgent Care and Technology. 200917

1. TOTAL Number of Attenders to A&E for the year 2015/2016
a. Of these attenders – how may attended Majors?
b. Of these attenders – how many attended Minors?
c. Of these attenders – how many attended Children’s Paed A&E?
d. Of the TOTAL attenders, how may were conveyed by ambulance?
e. Of the TOTAL attenders, how many self-presented (made their own way to A&E)
f. Of the TOTAL attenders, how many were discharged with advice only/self-discharged without being seen (metrics can be added together)
g. How many 12 hour breaches did you have?
h. How many 4 hour breaches did you have?
i. What was the primary cause of the breaches?
2. TOTAL Number of Attenders to A&E for the year 2016/2017
a. Of these attenders – how may attended Majors?
b. Of these attenders – how many attended Minors?
c. Of these attenders – how many attended Children’s Paed A&E?
d. Of the TOTAL attenders, how may were conveyed by ambulance?
e. Of the TOTAL attenders, how many self-presented (made their own way to A&E)
f. Of the TOTAL attenders, how many were discharged with advice only/self-discharged without being seen (metrics can be added together)
g. How many 12 hour breaches did you have?
h. How many 4 hour breaches did you have?
i. What was the primary cause of the breaches? Was this reason different from 2015/16?
3. TOTAL Number of Attenders to A&E for year 2017/18 – to-date
4. Please describe how your patients are triaged, what is their typical journey? Is there a streaming model? If yes, how effective is it and who streams e.g. GP or Nurse?
5. What would you like to see implemented in your health economy to deter avoidable admissions? I.e. those who have attended A&E but could have been seen and treated in a walk-in centre/MIU, Pharmacy or GP etc.
6. Do you have Self Check-in Kiosks in your A&E area?
7. Do you have publicly available WiFi in your A&E waiting areas?
a. What is the bandwidth?
b. If you don’t have publicly available WiFi in your A&E waiting area, is there a plan to install this? If yes, when? Is it on trajectory for delivery and what is the planned bandwidth? Please comment
8. Do you think technology has a role to play in preventing avoidable admissions?
If yes, please comment on what the value of technology would be.

Download response A&E Urgent Care and Technology. 200917

A&E visits by postcode. 040118

You asked for a breakdown of the 10 most and 10 fewest A&E visits by postcode and hospital in 2017.

Download response A&E visits by postcode. 040118

A&E wait times. 270317

1. What was the date the live A&E wait time information went live on the trust website?
2. For the year before the live A&E wait time information was live on the trust website how many ambulance diverts were requested?
3. For the year before the live A&E wait time information was live on the trust website how many ambulance diverts were granted?
4. For the year after the live A&E wait time information was live on the trust website how many ambulance diverts were requested?
5. For the year after the live A&E wait time information was live on the trust website how many ambulance diverts were granted?
6. How many occasions has the hospital breached 12 hour trolley waiting times, in the last calendar year, for patients that require a inpatient bed.
7. What specialism (directorate/division) were patients who required a inpatient bed if they breached 12 hour trolley waiting times within the last year. Example medical/surgical/ maternity etc. To clarify 12 hour breach time refers specifically to 12 hour trolley wait decision to admit to admission.
8. How many outlying patients were placed in areas due to lack of available beds in the correct specialty/area for the year before the live A&E wait time information was live on the trust website. An example of a outlier is a patient requiring a medical bed being placed in another specialist area such as surgery due to no available medical beds.
9. How many outlying patients were placed in areas due to lack of available beds in the correct specialty/area for the year After the live A&E wait time information was live on the trust website. An example of a outlier is a patient requiring a medical bed being placed in another specialist area such as surgery due to no available medical beds.
10. What system is used to collate the information for the A&E live wait times?
11. How often is this updated on the trust website?

Download response A&E wait times. 270317

A&E waiting times. 070921.docx

1. What is the longest period of time a single patient waited in A&E to be seen, treated, and admitted/discharged during calendar years 2018, 2019, 2020 and 2021 (Year to Date)? Please provide any details concerning why the patient waited this length of time and what their ailment/s were?
2. What are the top 10 longest periods of time a single patient waited to start consultant-led treatment from referral for non-urgent conditions during calendar years 2018, 2019, 2020 and 2021 (Year to Date)? Please provide any details concerning why the patient waited this length of time and what their ailment/s were.

Download response A&E waiting times. 070921.docx

A&E waiting times. 200720

Please could I have the average wait time in A and E for Tunbridge hospital for the date Sat 20th June 2020 between 10am and 18:00pm

The case would have been minor if that would impact on the waiting time.

Download response A&E waiting times. 200720

A&E waiting times 2013,2014 and 2015

1. How many patients have waited more than 12 hours in your A and E department in the last 3 years. Please break this down per month.
To be clear, this is since the patient arrived in A and E, not since decision to admit.

2. How many 12 hour decisions to admit patient did you report to NHS England in the last 3 years, please break this down per month.

This time frame is where you had to report a 12 hour breech to NHS England (it is typically taken after the patient has been in A and E more than 12 hours after decision to admit)

3. How many people came to A and E in the last 3 years, please break this down per month.
3a.Of these total number of patients, how many people were admitted to hospital for an inpatient stay – again please can you give me three years data, broken down per month.

4. Of those people that were admitted, in question 3 how many people breeched the 4 hour A and E target, per month for the last 3 years.

5. What was your percentage recorded rate of getting patients seen and out of the department in 4 hours, each month for the last 3 years? i.e. percentage of people who meet the 4 hour target.

Download response A&E waiting times 2013,2014 and 2015 160216

A&E waiting times. 221220

a) What is the longest period of time a patient has had to wait in A&E from decision to admit to admission in each of the past four financial years, 2016-17, 2017-18, 2018-19, 2019-20
b) Was this wait experienced by an adult or a child patient?
c) What reason is given, if any, for the length of the wait?

Download response A&E waiting times. 221220

A&E waiting times. 301117

1) For all patients who are admitted from A&E, what is the average time from arrival in A&E to getting a bed on a ward? I would like this data from the period of September 2011 to September 2012 and the period of September 2016 to September 2017
(i) How many of these admitted patients went from arrival to a bed in under 4 hours?
(ii) How many went from arrival to a bed in under 12 hours?
(iii) How many went from arrival to a bed in over 12 hours?

Download response A&E waiting times. 301117

A&E waits.251023.docx

All questions are shown as received by the Trust.
Since the beginning of 2021/22 until the end of August 2023/24, could you tell us
For admitted patients only:
1. How many patients in A&E waited between six and eight hours from time of arrival until admission?(between 6 hrs 00 mins 00 secs and 7 hours 59 mins 59 secs)
2. How many patients in A&E waited between eight and 12 hours from time of arrival until admission?(between 8 hrs 00 mins 00 secs and 11 hours 59 mins 59 secs)
3. How many patients in A&E waited more than 12 hours from time of arrival until admission?
4. How many patients in A&E waited 24 hours or more from time of arrival until admission?
Please split this data by quarter (so Q2 23/24 until end of August)

A&E waits.251023.docx

Agency spend for locum doctors in Acute Medicine. 240317

Can you please assist me with retrieving the total Agency spend for Medical Locum Doctors within Acute medicine over the following months, within your Trust or Health Board?
August 2016
September 2016
October 2016
November 2016
December 2016
January 2017

Download response Agency spend for locum doctors in Acute Medicine. 240317

Alcohol-related attendances and admissions. 121119

1. Within your Trust, how many alcohol-related A&E attendances (where alcohol is the primary attendance reason) per site between;
a) 1st November 2013 and 2nd January 2014
b) 1st November 2018 and 2nd January 2019
2. Within your Trust, how many alcohol-related A&E admissions (where alcohol is the primary admittance reason) per site between;
a) 1st November 2013 and 2nd January 2014
b) 1st November 2018 and 2nd January 2019

Download response Alcohol-related attendances and admissions. 121119

Alcohol related illness in the under 14 year olds.

1. How many people under the age of 14 have been treated for alcohol related illness at your hospitals in 2014 and (as a separate figure) so far this year?

2. What was the youngest person treated for alcohol related illness in those periods (separate figures)?

3. How many people under the age of 14 have been treated for drug related illness at your hospitals in 2014 and (as a separate figure) so far this year?

4. What was the youngest person treated in those periods (separate figures)?

Download response Alcohol related illness in the under 14 years olds 311215

Allergic reactions to medications in Hospital. 270122.docx

1. Which staff members may administer medication?
2. Are all medication administering staff trained in spotting allergic reactions to the medications they are administering?
3. What is the allergic reaction checklist the administering staff should use to tell if someone is having an allergic reaction?
4. Once a patient suffers an allergic reaction to medication administered in the hospital, how long should the hospital staff take to administer antihistamine, steroids or adrenaline?
5. Do the medication administering staff have access to antihistamines in case of emergency?
6. Are medication administering staff required to administer antihistamines immediately or are they required to wait until a doctor is present regardless of reaction getting worse?
7. How does a hospital know if someone is having an allergic reaction when entering A&E?
8. If there is no allergy testing done in A&E or anywhere else in Tunbridge Wells hospital and only inflammation markers are used, does that mean all allergies are treated as infections instead and treated with antibiotics?
9. What type of medical treatment should be offered to a patient suffering an allergic reaction to penicillin?
10. How long do allergic reactions to penicillin last in patients?
11. When a patient is suffering from itching and burning skin from an allergic reaction to penicillin, what treatment should be offered to the patient?

Download response Allergic reactions to medications in Hospital. 270122.docx

Aluminium Composite Material (ACM) cladding. 020818

Please can you tell me if any of your buildings are clad in Aluminium Composite Material, and if so how many?
If any buildings have ACM please can you tell me whether the trust will be removing the cladding and if you have estimated how much this will cost?

Download response Aluminium Composite Material (ACM) cladding. 020818

Alzheimer Disease 2012-2016

For the years between 2012 and 2016
1. How many people has your trust/hospital diagnosed with Alzheimer Disease for each of the years mentioned above? If possible could this be broken down by gender?
2. How many people are seen within 12 weeks of being referred by a GP?

Download response Alzheimer Disease 2012-2016 150317

Ambulatory Cardiac Monitoring.280922.docx

1. Can you confirm which modalities the hospital has at its disposal for ambulatory cardiac monitoring i.e. how many Holter Monitors does the hospital own or Zio Patch etc?
2. In the financial year 2020/2021 how many referrals from primary care were received for cardiac rhythm monitoring?
3. Can you provide the costs of each modality i.e. for Holter Monitoring, please provide the number of Holter Monitors, Zio patch etc at the Hospital, the purchase cost of each Holter Device, any costs associated with maintenance of the monitor such as, battery replacement, servicing etc.?
4. In the financial year 2020/2021 how many patients received ambulatory heart monitoring at 24h, 48h, 7days and 14days?
5. In the financial year 2020/2021, how many patients were monitored using each modality i.e. ECG, Holters, Zio, Bardy etc?
6. In the financial year 2020/2021 what was the total yearly NHS cost per patient undergoing ambulatory heart monitoring?
7. What is the average time from clinician receiving ECG data to patient prescribing?

Ambulatory Cardiac Monitoring.280922.docx

Ambulatory ECG’s 2015-2016. 090217

1. Total number of Ambulatory ECG’s (aka Holter tests, R-Tests, etc) performed in 2015 and to date in 2016 calendar year.
2. If possible, please indicate how many were for ≤24-hour duration; 24-72 hour duration; ≥ 72 hour duration.
3. Please also indicate what current waiting time is for fitting of device and reporting results.

Download response Ambulatory ECG’s 2015-2016. 090217

Ankylosing Spondylitis. 120121

Recognition and Referral
1. Does your Trust have a specified pathway from primary care to secondary care for inflammatory back pain in place?
If you answered ‘yes’, please give details below of the pathway and, if applicable, arrangements in place to raise awareness in primary care
If neither of the above response options apply to you, please provide more information on your local arrangements below
Diagnosis in specialist care settings
2. What is the average current waiting time to diagnosis for a patient referred with inflammatory back pain?
3. Are patients with suspected axial SpA (AS) routinely referred for a full spinal MRI?
If neither of the above response options apply to you, please provide more information on your local arrangements below
Information and Support
4. How do you ensure patients are given information and support following their diagnosis?
Pharmacological management of axial SpA (AS)
5. What guidance are patients with axial SpA (AS) given when deciding whether to access biologic treatment?
6. Bearing in mind the NICE anti TNF guidance for ankylosing spondylitis (TA383) states that, ‘Treatment with another anti TNF is recommended for people who cannot tolerate, or whose disease has not responded to, treatment with the first TNF-alpha inhibitor, or whose disease has stopped responding after an initial response’, after failure with one biologic,how many other biologics will your commissioners fund a patient with axial SpA (AS) to try, including IL 17As?
If none of the above response options apply to you, please provide more information on your local arrangements below
Non-pharmacological management of axial SpA
7. What proportion of adults with axial SpA (AS) are referred to a specialist physiotherapist for a structured exercise programme within your local area when first diagnosed?
Flare management
8. What percentage of patients with axial SpA (AS) have a written care plan to support them with a flare?
Organisation of care
9. Does the Trust have a dedicated axial SpA (AS) clinic?
If neither of the above response options apply to you, please provide more information on your local arrangements below
Mental health and well being
10. Are axial SpA (AS) patients under the care of a rheumatologist offered access to psychological services?
If you ticked ‘yes’, please specify the services on offer

download response Ankylosing Spondylitis. 120121

Annual Departmental activity statistics 2011-2013. 030117

In your trust in each of the following years (in 2011, 2012 & 2013)
– Financial year 2011/2012 and financial year 2012/2013
– Or Calendar year 2011, Calendar year 2012 and Calendar year 2013
Annual departmental activity statistics for Obstetrics & Gynaecology Department for the following data:
Obstetrics (Maternity)
1- Annual total number of all types of deliveries
2- Annual total number Instrumental/operative vaginal deliveries
3- Annual total number of Caesarean sections
4- Annual total number of vaginal deliveries
5- Annual total number of Antenatal out-patients
6- Annual total number of maternity inpatients admitted to wards/hospital
Gynaecology:
7- Annual total number of gynaecological surgical procedures undertaken annually
8- Annual total number of Gynaecology out-patients
9- Annual total number of gynaecology inpatients admitted to wards/hospital
As a Trust in general:
10- Annual total number of theatre cases (surgical procedures), across all specialties
11- Annual total number of patients attended or booked in the outpatient clinics, across all specialties
12- Annual total number of patients admitted to the hospital wards, across all specialties

Download response Annual Departmental activity statistics 2011-2013. 030117

Annual suture usage. 040117

I require suture manufacturer codes with description and total boxes/pack ordered annually/per year. An excel sheet will be ideal.

Any year in the last three year will be suitable.

Download response Annual suture usage. 040117

Anticoagulant Service.241219

1. Does your Trust have an Anticoagulant Service for:
a) In-patients and out-patients YES • NO •
b) In-patients only YES • NO•
c) Outpatient only YES • NO •
2. How many inpatient beds does your Trust have (at each site if more than 1 site)?
a) How many sites do you inpatient dose (if applicable)?
3. Who doses VKA for your inpatient population?
a) Doctors •
b) Advanced nurse practitioners •
c) Biomedical Scientists •
d) Clinical Nurse Specialists – if so are they nurse prescribers? •
e) Pharmacists – If so are they prescribers? •
f) Other – free text box
4. How many individuals who are not doctors perform this role in the groups specified above?
5. If you dose warfarin for out-patients, how many warfarin patients do you currently dose?
a. Which dosing software do you use – free text
6. Does your Trust run nurse led Anticoagulation clinics?
YES • NO •
7. If there are no nurse led clinics, who is responsible for management of patients taking VKA within your trust
8. Who completes your VTE Risk assessments?
a. Ward doctors •
b. Nurses •
c. Pharmacists •
d. ANP •
e. Other • – Please specify
9. What is your current VTE Risk assessment compliance rate?

Download response Anticoagulant Service.241219

 

Anticoagulation care Warfarin. 250917

1. Please confirm or deny whether your NHS Trust collects data on the number of patients diagnosed with atrial fibrillation who are treated with warfarin by i) gender and ii) age group.
a. If confirmed, please provide the number of i) male and ii) female patients
b. If confirmed, please provide the number of patients aged i) below 45 years old ii) 45-54 years old, iii) 55-64 years old, iv) 65-74 years old, v) 75-84 years old and vi) 85 years old and above
2. Please confirm or deny whether your NHS Trust collects data on the time in therapeutic range (TTR) of patients diagnosed with atrial fibrillation who are treated with warfarin.
a. If confirmed, please provide details of the number of patients with a TTR (calculated over a maintenance period of at least 6 months while excluding those initiated within the last 6 weeks, as per NICE Clinical Guideline 180 (CG180)) of i) 64.9-55 per cent, ii) 54.9-45 per cent, iii) 44.9-35 per cent and iv) 34.9 per cent and below.
3. Please confirm or deny whether your NHS Trust collects data on the International Normalised Ratio (INR) values of patients diagnosed with atrial fibrillation who are treated with warfarin.
a. If confirmed, please provide details of number of patients within the past six months recorded with i) two INR values higher than five, ii) one INR value higher than eight, or iii) two INR values less than 1.5.
4. Please confirm or deny whether your NHS Trust collects data on the frequency of blood tests for purposes of INR readings of patients diagnosed with atrial fibrillation.
a. If confirmed, please provide details of the average interval between blood tests for INR readings.
5. Please confirm or deny whether your NHS Trust collects data on the number of patients diagnosed with atrial fibrillation who are treated with warfarin and self-monitoring or self-managing their anticoagulation therapy.
a. If confirmed, please provide the number of patients diagnosed with atrial fibrillation who are treated with warfarin who are i) self-monitoring and receiving dosing instructions from a healthcare professional; and ii) self-managing their anticoagulation.
6. Please confirm or deny whether your NHS Trust has conducted a root cause analysis of adverse events related to anticoagulation treatment in atrial fibrillation patients.
a. If confirmed, please provide details of any root cause analysis of adverse events related to anticoagulation treatment in atrial fibrillation patients in the last 12 months.
7. Please confirm or deny whether your NHS Trust has written clinical protocols in place for reassessing patients diagnosed with atrial fibrillation who have poor warfarin anticoagulation control (as defined by NICE CG180) to determine why their TTR/INR are unstable.
a. If confirmed, please provide evidence of the protocol(s)
8. Please confirm or deny whether your NHS Trust has information, education and support tools available for patients diagnosed with atrial fibrillation to help them understand their treatment options and support adherence.
We supply BHF and Arrhythmia Alliance booklets to patients regarding AF and yellow warfarin booklets if they are put on warfarin. to patients
a. If confirmed, please provide evidence of the information, education and support tools that you use. see above

Download response Anticoagulation care Warfarin. 250917

Antiseptic preparations applied to the skin prior to a surgical procedure. 010518

Please would you tell me the number of units of the following products purchased by your hospital over the past 12 months:

Chlorhexidine 2% in IPA Biocide (Nex-Clorex 2%) Available in 200ml and 500ml bottles – Fannin UK Ltd

Chlorhexidine 2% in IPA Biocide Available in 200ml and 500ml bottles – Ecolab Ltd

Chlorhexidine 2% in IPA Licenced Medicine (ChloraPrep) Available in various sizes – Carefusion / BD

Red Staining Dye / Liquid Available in 12 x 12ml – Ecolab Ltd

Please would you tell me the pre-operative skin preparation (ie the name of the specific product) that you use for the following procedures? Please will you specify whether the manufacturer and whether the product is a biocide or a licensed medicine.

Procedure

• Abdominal hysterectomy –
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Breast surgery
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Caesarean section
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Gastric surgery
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Hip replacement
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Knee replacement
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Spinal surgery
o Products used?
o Biocide or licensed medicine?
o Brand name?

Download response Antiseptic preparations applied to the skin prior to a surgical procedure. 010518

Aortic dissection.180522.docx

1. Do you have a policy and/or written procedures for how your trust responds to patients presenting at A&E with chest pain or suspected heart related conditions?
2. Do you have a policy and/or written procedures for managing suspected aortic dissection?
3. Do you have a policy and/or written procedures for managing aortic dissection once diagnosed? Please provide a copy of these
4. If you have a policy or procedures in place regarding aortic dissection, what is the trust’s process for ensuring that all clinical staff are made aware and are reminded?
5. If you provide training, please provide a copy of the training material. Do you have any training / induction to ensure that all staff are familiar with it?

Aortic dissection.180522.docx

APPTG Annual Survey 2019. 250919

QUESTION ONE – VTE RISK ASSESSMENT AND DIAGNOSIS
a) Are in-patients who are considered to be at risk of VTE in your Trust routinely checked for both proximal and distal DVT? (Tick one box)
b) For in-patients diagnosed with VTE in your Trust between 1 April 2018 and 31 March 2019, what was the average time from first clinical suspicion of VTE to diagnosis?
c) For in-patients diagnosed with VTE in your Trust between 1 April 2018 and 31 March 2019, what was the average time from diagnosis to first treatment?
QUESTION TWO – ROOT CAUSE ANALYSIS OF HOSPITAL-ASSOCIATED THROMBOSIS
According to Service Condition 22 of the NHS Standard Contract 2017/19, the provider must:
“Perform Root Cause Analysis of all confirmed cases of pulmonary embolism and deep vein thrombosis acquired by Service Users while in hospital (both arising during a current hospital stay and where there is a history of hospital admission within the last 3 months, but not in respect of Service Users admitted to hospital with a confirmed venous thromboembolism but no history of an admission to hospital within the previous 3 months)…”
The provider must report the results of those Root Cause Analyses to the co-ordinating commissioner on a monthly basis.
a) How many cases of hospital-associated thrombosis (HAT) were recorded in your Trust in each of the following quarters?
b) How many Root Cause Analyses of confirmed cases of HAT were performed in each of the following quarters?
c) According to the Root Cause Analyses of confirmed HAT in your Trust between 1 April 2018 and 31 March 2019, in how many cases:
QUESTION THREE – ADMISSION TO HOSPITAL FOR VTE
a) How many patients were admitted to your Trust for VTE which occurred outside of a secondary care setting between 1 April 2018 and 31 March 2019?
b) Of these patients, how many:
c) Of the patients admitted to your Trust for VTE occurring between 1 April 2018 and 31 March 2019 who had a previous inpatient stay in your Trust up to 90 days prior to their admission, how many had their VTE risk status recorded in their discharge summary?
d) Please describe how your Trust displays a patient’s VTE risk status in its discharge summaries.
QUESTION FOUR – PHARMACOLOGICAL VTE PROPHYLAXIS
a) How many VTE patients who were eligible received pharmacological VTE prophylaxis between 1 April 2018 and 31 March 2019?
b) How many of VTE patients who were eligible received pharmacological VTE prophylaxis within 14 hours of admission between 1 April 2018 and 31 March 2019?
QUESTION FIVE – VTE AND CANCER
a) How many patients has your Trust treated for cancer (of all types) in each of the past three years?
b) Of the patients treated for cancer, how many also had a diagnosis of venous thromboembolism (VTE) {VTE is defined by the following ICD 10 codes: I80.0-I80.3, I80.8-I80.9, I82.9, O22.2 – O22.3, O87.0 – O87.1, I26.0, and I26.9} in each of the past three years?
c) Of the patients treated for cancer who also had a diagnosis of VTE in each of the past three years, how many:
d) In how many patient deaths within your Trust was cancer (of any type) listed as the primary cause of death in each of the past three years:
e) Of the patients who died within your Trust, in how many was VTE as well as cancer listed as a cause of death in each of the past three years:
f) Of the patients who died in your Trust who had both VTE and cancer listed as a cause of death, how many:
g) Are ambulatory cancer patients who are receiving chemotherapy in your Trust routinely risk assessed for their risk of developing CAT/VTE?
h) Are ambulatory cancer patients who are receiving chemotherapy AND deemed at high risk of developing CAT/VTE offered pharmacological thromboprophylaxis with? Please tick/cross all those appropriate.
QUESTION SIX – PATIENT INFORMATION
The NICE Quality Standard on VTE Prevention stipulates that patients/carers should be offered verbal and written information on VTE prevention as part of the admission as well as the discharge processes.
a) What steps does your Trust take to ensure patients are adequately informed about VTE prevention? (Tick each box that applies)
b) If your Trust provides written information on VTE prevention, does it provide information in languages other than English? (Tick each box that applies)
QUESTION SEVEN – COST OF VTE IN YOUR AREA
a) Does your Trust have an estimate of the cost of VTE to the NHS locally (including cost of treatment, hospital bed days and litigation costs) for 2018/19? (Please tick one box)
If ‘Yes’, please specify the estimated cost:
b) Please indicate the cost-estimate for the following areas of VTE management and care, as well as the corresponding number of VTE hospitalisations/ re-admissions/ treatments that occurred between 1 April 2018 and 31 March 2016.

Download response APPTG Annual Survey 2019. 250919

ASD (Autism spectrum disorder) services.301222.docx

I am writing to you under the Freedom of Information Act (2000) to request information relating to the provision of ASD (Autism spectrum disorder) services by Maidstone and Tunbridge Wells NHS Trust.
Please provide the following information to the email address specified below.
1. Please name the organisation(s) that deliver(s) CYP (children and young people) ASD assessment / diagnoses in your Trust area
a. When did the contract(s) begin and when is the contract(s) due to end
b. What is the annual spend for this service for 2022, and for the last 5 years?
c. How is the service contracted – is it Block, Activity-based, or AQP contracting?
d. If the service is commissioned with other CCGs, ICSs or Trusts, which are these?
e. At what prevalence (% of the child population) have the contracts been commissioned against?
2. Does the same organisation as for Question 1 also deliver CYP ASD prescriptions and post-diagnosis ASD support in your Trust area? If not, please provide the same information for this organisation.

3. Please outline the CYP ASD pathway in your area, including key referral sources
4. How many children and young people are currently waiting for a CYP ASD assessment in your area? What is the longest and median wait time from a referral?
a. Within the last year, how many children and young people were assessed within 12 weeks of referral?
b. Within the last year, how many children and young people were discharged without assessment?
c. Please answer Questions 4, 4a, 4b for as many historic years as possible, up to 5 years
5. For the last 5 years, please give the number of CYP patients per year in the Trust who were:
a. Referred for ASD assessment
b. Given an ASD assessment
c. Given an ASD assessment from a ‘Right to Choose’ provider, outside the service contracted
d. Diagnosed with ASD
6. For the last 5 years, what was the average number of ASD-qualified staff delivering services in the area? How does this split by role:
a. Qualified psychiatrists
b. Paediatricians
c. Speech and Language therapists
d. Clinical Psychologists
e. For a-d, please also give numbers of trainees
7. Please provide equivalent answers for Questions 1-6, but for Adult ASD services in the Trust. If the Trust does not distinguish between CYP and Adult ASD services, please answer Questions 1-6 for all patients collectively

ASD (Autism spectrum disorder) services.301222.docx

Aseptic Non Touch Technique (ANTT).260219

1. Does your organisation have a standard aseptic technique?
IF YES: Please continue to question 2.IF NO: Please go direct to question 9.
2. What is your standard aseptic technique called?
a) We use ANTT (If no go to 2b)
b) We use an alternative standard aseptic technique: (State what this standard technique is termed and where it is defined)
3. Is ANTT or your alternative standard aseptic technique stipulated in policy(s)?
4. Does your organisation provide specific education and training for ANTT or your alternative standard aseptic technique?
5. Does your organisation provide clinical competency assessment for ANTT or your alternative standard aseptic technique?
6. Is compliance to ANTT or your alternative standard aseptic technique audited?
7. Does your organisation provide a periodic competency assessment update?
8. Does your organisation use ANTT Procedure Guidelines?
If you answered ‘Yes’ to Question 1 you have completed the survey – thank you
If you answered ‘No’ to Question 1 please answer the below:
9. What best describes the different aseptic techniques used in your organisation:
Aseptic technique
ANTT
Sterile technique
Clean technique
Non-touch technique
A combination of the above
Other

Download response Aseptic Non Touch Technique (ANTT).260219

Assault attendances to Emergency Department 2017. 210218

We require the gender of the patient (M or F), the date that they attended due to assault (dd/mm/yyyy) and their age. Age can either be numerical to the nearest year (preferred) or in age bands (“0-10”, “11-17”, “18-30”, “31-50”, “51+”), we can also accept date of birth.

To calculate the level of assault-related injury in England and Wales we also require the total number of attendances for any reason in the year of interest, i.e. 2017.

Download response Assault attendances to Emergency Department 2017. 210218

Assault attendances in A&E. 160321

The data we require are as follows (for period 1st January 2020 and 31st December 2020) in an electronic format that allows us to read the data into a database.
We require:
1. the gender of the patient (M or F),
2. the date that they attended due to assault (dd/mm/yyyy)
3. their age. Age can either be numerical to the nearest year (preferred) or in age bands (“0-10”, “11-17”, “18-30”, “31-50”, “51+”), we can also accept date of birth.
To calculate the level of assault-related injury in England and Wales we also require the total number of attendances for any reason in the year of interest, i.e. 2020.
Please also include the names of hospitals providing assault data.

Download response Assault attendances in A&E. 160321

Assault attendances to A&E 2019. 160321

We are conducting an annual national study of attendances to Emergency Departments for assault-related injury and would be grateful if your department could provide us with attendance data for 2019.
The data we require are as follows (for period 1st January 2019 and 31st December 2019) in an electronic format that allows us to read the data into a database.
1. We require the gender of the patient (M or F), the date that they attended due to assault (dd/mm/yyyy) and their age. Age can either be numerical to the nearest year (preferred) or in age bands (“0-10”, “11-17”, “18-30”, “31-50”, “51+”), we can also accept date of birth.
2. To calculate the level of assault-related injury in England and Wales we also require the total number of attendances for any reason in the year of interest, i.e. 2019.
3. Please also include the names of hospitals providing assault data.

Download response Assault attendances to A&E 2019. 160321

Assault attendances to Emergency Department ED in 2021.300522.docx

Data required (for period between 1st January 2021 and 31st December 2021)
We require the gender of the patient (M or F), the date that they attended due to assault (dd/mm/yyyy) and their age. Age can either be numerical to the nearest year (preferred) or in age bands (“0-10”, “11-17”, “18-30”, “31-50”, “51+”), we can also accept date of birth.
To calculate the level of assault-related injury in England and Wales we also require the total number of attendances for any reason in the year of interest, i.e., 2021.
Please also include the names of hospitals providing assault data.

Assault attendances to Emergency Department ED in 2021.300522.docx

Asthma. 140422.docx

Q1. How many patients have been treated (for any condition) in the last 4 months with:
a. Benralizumab
b. Omalizumab
c. Reslizumab
d. Mepolizumab
Q2. Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups:
a. Age 6-11
b. Age 12-17
c. Age 18 and above
Q3. How many patients have been treated in the last four months with Dupilumab for Asthma ONLY?

Asthma. 140422.docx

 

Asthma.250823.docx

All questions are shown as received by the Trust.
Q1. How many patients have been treated (for any condition) in the last 4 months with:
• Benralizumab
• Dupilumab
• Omalizumab
• Reslizumab
• Mepolizumab
• Tezepelumab

Q2. Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age groups:
• Age 6 – 11
• Age 12 – 17
• Age 18 and above

Q3. How many patients have been treated in the last 4 months by the Respiratory Medicines Department ONLY with:
• Dupilumab
• Omalizumab

Asthma.250823.docx

Asthma, Chronic rhinosinusitis with nasal polyps and Chronic Spontaneous Urticaria.060922.docx

Q1. How many patients have been treated (for any condition) in the last 4 months with:
a. Benralizumab
b. Omalizumab
c. Reslizumab
d. Mepolizumab
Q2. Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups:
a. Age 6-11
b. Age 12-17
c. Age 18 and above
Q3. How many patients have been treated in the last 4 months with Dupilumab for:
a. Asthma ONLY
b. Chronic rhinosinusitis with nasal polyps ONLY
Q4. How many patients have been treated in the last 4 months with Omalizumab for:
a. Asthma ONLY
b. Chronic rhinosinusitis with nasal polyps ONLY
c. Chronic Spontaneous Urticaria ONLY

Asthma, Chronic rhinosinusitis with nasal polyps and Chronic Spontaneous Urticaria.060922.docx

Atopic dermatitis. 021220

1. How many patients were treated within your Trust with the following drugs within the specified time periods?
Number of patients treated between 01 February 2017 and 31 July 2018
Number of patients treated between 01 August 2018 and 31 January 2020
Apremilast
Adalimumab
Dupilumab
Etanercept
Infliximab
Secukinumab
Ustekinumab
2. How many patients were treated within your Trust for atopic dermatitis within the specified time periods?
Number of patients treated for atopic dermatitis between 01 February 2017 and 31 July 2018
Number of patients treated for atopic dermatitis between 01 August 2018 and 31 January 2020
3. How many patients were treated within your Trust with the following drugs for atopic dermatitis within the specified time periods?
Number of patients treated for atopic dermatitis between 01 February 2017 and 31 July 2018
Number of patients treated for atopic dermatitis between 01 August 2018 and 31 January 2020
Apremilast
Adalimumab
Dupilumab
Etanercept
Infliximab
Secukinumab
Ustekinumab
4. Please specify how patients treated with the following drugs are coded (OPCS code) within your trust:
OPCS code (e.g. X385 subcutaneous immunotherapy)
Apremilast
Adalimumab
Dupilumab
Etanercept
Infliximab
Secukinumab
Ustekinumab
5. Please provide the number of patients treated in the homecare setting for atopic dermatitis within the specified time periods:
Number of patients treated in the homecare setting for atopic dermatitis between 01 February 2017 and 31 July 2018
Number of patients treated in the homecare setting for atopic dermatitis between 01 August 2018 and 31 January 2020
6. How many of your Trust’s homecare patients were treated with the following drugs for atopic dermatitis within the specified time periods?
Number of patients treated for atopic dermatitis between 01 February 2017 and 31 July 2018

Download response Atopic dermatitis. 021220

Audit of patient urinary catheterisation.240322.docx

(A) For the financial year 2018-2019 whether an audit of patient urinary catheterisation was carried out by Maidstone and Tunbridge Wells NHS Trust?
(B) For the financial year 2019-2020 whether an audit of patient urinary catheterisation was carried out by Maidstone and Tunbridge Wells NHS Trust?
(C) For the financial year 2020-2021 whether an audit of patient urinary catheterisation was carried out by Maidstone and Tunbridge Wells NHS Trust?

Audit of patient urinary catheterisation.240322.docx

AUS implant 2014-2017. 010617

I am trying to find out, for each of the last three years of available data, how many AUS’ were implanted by the Trust and how many were infected.

Download response AUS implant 2014-2017. 010617

Axial Spondyloarthritis Services.220922.docx

1. On behalf of which NHS Trust are you responding?
2. Does your Trust have a local inflammatory back pain pathway in place?
3. Do you have a local education programme for primary care practitioners including GPs and first contact practitioners? Please give details.
4. Are you aware of the average current waiting time from when a patient is referred from their GP to receiving their diagnosis. By this we mean from the moment the referral is received by rheumatology until the patient receives an official diagnosis.
5. What is the average current waiting from when a patient is referred from their GP to receiving their diagnosis. By this we mean from the moment the referral is received by rheumatology until the patient receives an official diagnosis.
6. How do you ensure patients are given information and support following their diagnosis?
Please select all response options which apply
7. What guidance are patients with axial SpA given when deciding whether to access biologic treatment?
8. Does the rheumatology department have access to a specialist physiotherapist.
9. What percentage of adults with axial SpA (AS) are referred to a specialist physiotherapist as described above for a structured exercise programme within your local area when first diagnosed?
10. Do you provide patients with individual care plans when they are newly diagnosed?
11. Does this include specific information on flares?
12. Does the Trust have a dedicated axial SpA clinic? By this we mean a day or time when patients with axial SpA are seen by a multi-disciplinary team.
13. Which health professionals are available as part of the axial SpA clinic multi-disciplinary team?
14. Are axial SpA (AS) patients under the care of a rheumatologist offered access to psychological services?

Axial Spondyloarthritis Services.220922.docx

Bariatric procedures 2013-2017. 260417

Please can you tell me the following information for the last three financial years and current numbers i.e.; 2016/17, 2015/16, 2014/15 and 2013/14
1) Number of bariatric procedures carried out
2) Cost of procedure (s)
3) Age of those who had a bariatric procedure
4) Weight of those who have had a bariatric procedure

Download response Bariatric procedures 2013-2017. 260417

Bariatric surgery 2013-2017. 260417

1) Can you please provide a breakdown of the number of people given bariatric surgery in each of the following years by the health board – 2013, 2014, 2015, 2016, so far 2017?
2) For each year, can you please provide the sexes and age groups (twenties, thirties, forties, etc.) of each person who had the surgery. Please provide the number of people under 21 for each year, with the exact age of each.
3) For each year, please provide the number of people with a medical condition, which meant they needed bariatric surgery, including those with none (can the data please be displayed so that their age groups are given also).
4) Please provide the number of people for each year with a BMI of 35 or less, and of 30 or less, again giving their medical condition and age group (or exact age for under-21s) for each.
5) Please provide a list of the criteria the health board has for offering people bariatric surgery, and if this has changed in the last five years, state when it changed and what it changed from and to.
6) If the health board’s target for the number of people undergoing bariatric surgery has changed in the last five years, please state what it changed from and to, and when this happened.

Download response Bariatric surgery 2013-2017. 260417

Biologic medications in gastroenterology. 040122.docx

Q1. How many patients were treated in October 2021 (or latest available month) by the gastroenterology department with the following drugs:
a. Adalimumab (any brand or biosimilar)
b. Infliximab (any brand or biosimilar)
c. Ustekinumab (Stelara)
d. Vedolizumab (Entyvio)
e. Tofacitinib (Xeljanz)
f. Filgotinib (Jyseleca)
Q2. How many patients were treated in October 2021 (or latest available month) for Crohn’s Disease ONLY with the following drugs:
a. Adalimumab (any brand or biosimilar)
b. Infliximab (any brand or biosimilar)
c. Ustekinumab (Stelara)
d. Vedolizumab (Entyvio)

Download response Biologic medications in gastroenterology. 040122.docx

Blocked catheters and emergency admissions for 2012-2013, 2013-2014 and 2014-2015

1. The total number of emergency admissions in the Trust
2. The number of emergency admissions caused by a blocked catheter in the Trust
3. The number of emergency admissions caused by a urinary tract infections in the Trust
4. The estimated cost of (per day) of an emergency admission to hospital

Download response Blocked catheters and emergency admissions for 2012-2013, 2013-2014 and 2014-2015 270516

Blood pressure monitors

1. Total number of all types of blood pressure monitors in your institution (e.g. 1000 blood pressure monitors overall)
2. Can you please list all the types of blood pressure monitors and its quantities (e.g. NIBP – x20, SpO2 – x20), its brands (e.g. Omron – x20, Criticare – x20, Datascope – x20), and models (e.g. Criticare 506DXN – x10, Criticare 507DXN – x10, Datascope Accutorr + x20). We would like to ask you kindly if you can state this information in a separate spreadsheet document.
3. In which departments do you use blood pressure monitors? (e.g. 20 Omron in wards, 20 Criticare in ITU, 20 Datascope in outpatient surgery).
4. Types of devices acquired in period of 2014 – 2016 (e.g. 100 Omron monitors in 2014, 150 Criticare monitors in 2015.) if none please state when was the last purchase.
5. Minimum and maximum price of blood pressure monitors. If you can not provide this information, please give us an average price of a single blood pressure monitor
6. Please provide a full contract with supplier of blood pressure equipment
7. Which quality tests or quality standards a blood pressure device must pass in order for you to consider it as a good quality blood pressure monitor (e.g. CE Marked)
8. Can you please provide regulations and guidelines that your institution follow (we would like to know about national, local and your own guidelines + regulations (if it also possible can you please attach medical device management action card + medical equipment pre-registration form))
9. What creates extra costs for the usage of monitors on a yearly basis? Please break it down and relate the expenditure associated to it (e.g. cuffs = £2.000, hoses = £3.000, maintenance = £5.500)
10. Do you provide maintenance in-house or out?
11. How do you provide training to medical staff when a new blood pressure monitor is introduced in your hospital? (e.g. manual handbook, training sessions from suppliers)
12. How the supply chain is established in your organisation when you order new blood pressure monitors? (e.g. supplier delivers the products, currier or take out?)
13. Do you provide feedback to your suppliers? If “yes” how? (e.g. emailing, calling, submitting a form)
14. What is the average useful life of a single blood pressure monitor?

Download response Blood pressure monitors 090916

Blood test requests in A&E.080923.docx

All questions are shown as received by the Trust.
1. How many of the following tests were ordered by A&E/ED clinicians/staff (for A&E/ED attendees) within your Trust during the most recent 12 month (or other) period for which data is available. Please specify what period is being reported on in the case of each test.
(a) ANA (anti-nuclear antibody) test.
(b) ENA (extractable nuclear antigen) panel.
(c) Full Blood Count (FBC)
(d) C-reactive protein (CRP)

Blood test requests in A&E.080923.docx

Blood transfusion policy. 240919

I would be grateful if you could send me a copy of the transfusion policy for the Maidstone hospital.

Download response Blood transfusion policy. 240919

Bone densitometry. 040221

1. Number of bone densitometry units, DXA or DEXA bone densitometry, CT bone densitometry, US bone densitometry, or the units that perform bone densitometry examinations, across your NHS Trust/hospital facilities, stand-alone or integrated in other hospital departments (e.g. in radiology department, in rheumatology department, in endocrinology department etc).
2. Details of the bone densitometry units, DXA or DEXA bone densitometry, CT bone densitometry, US bone densitometry, across your NHS Trust/hospital facilities,
a. Trust name
b. Hospital name
c. Department where they are operationally/managerially belong to (e.g. radiology, endocrinology, rheumatology, orthopaedic surgery etc department)
d. Scanning equipment available
e. Examinations they provide (e.g. adult bone densitometry, paediatric bone densitometry, vertebral fracture assessment, CT bone densitometry, US bone densitometry, body composition)
f. Details of the employees working specifically at each of these bone densitometry units, DXA or DEXA bone densitometry, CT bone densitometry, US bone densitometry, across the NHS facilities in England
i. Gender
ii. Ethnicity
iii. Title
iv. Profession
v. Role
vi. Grade
vii. Pay band.
g. Details of the clinical lead of each of the bone densitometry units, DXA or DEXA bone densitometry, CT bone densitometry, US bone densitometry, across the NHS facilities in England
i. Gender
ii. Ethnicity
iii. Title
iv. Profession
v. Role
vi. Grade
vii. Pay band.

Download response Bone densitometry. 040221

Botulinum toxin injections.290224.docx

All questions are shown as received by the Trust.
Q1) How many patients are currently receiving botulinum toxin injections for cervical dystonia?
Q2) How many medical professionals currently administer the botulinum toxin injections?
Q3) What is the current average frequency between injections of botulinum toxin?
Q4) Are there any current delays to patients regular botulinum toxin injections? If so, by how many weeks

Botulinum toxin injections.290224.docx

Bowel management with spinal injured patients. 301017

1. Does the Trust have a formal written policy for digital rectal examination/check, digital rectal stimulation and the digital removal of faeces (manual bowel evacuation) in spinal cord injured and other patients with neurogenic bowel dysfunction?
2. If the Trust does, please supply a copy of this document.
3. If the Trust does not, how is bowel care managed in the above patient groups who present with this care need?
4. Does the Trust employ a specialist continence nurse(s)?
5. If the Trust employs a specialist continence nurse(s) can they (a) undertake digital rectal checks, digital rectal stimulation and digital removal of faeces (manual bowel evacuation), otherwise known as ‘intimate digital bowel care procedures’ (b) provide instruction to other nurses to enable them to perform intimate digital bowel care procedures’?
6. If the Trust does not employ a specialist continence nurse, is there another health care professional who undertakes intimate digital bowel care procedures including manual bowel evacuation? If yes, who does this?
7. Does your Trust have a policy in place that will allow your staff to do trans-anal irrigation (TAI) of the bowel as a method of bowel care management for spinal cord injured patients? Do you train your staff to do TAI/ bowel irrigation?
8. Do you run bowel care courses for your staff that allows them to deliver the full range of bowel care required by spinal cord injured patients or others with a neurogenic bowel?
9. If yes, please provide details. If no, does the Trust have a policy which allows for the personal care assistants (PAs) of spinal cord injured patients to assist with this element of the patient’s care?

Download response Bowel management with spinal injured patients. 301017

Bronchial challenge tests.051222.docx

1) The number of bronchial challenge tests performed by the trust, and at which sites within the Trust, during 2019 and 2021
2) The chemical agent used for the test e.g. mannitol or methacholine
3) The providers or bronchial challenge testing on behalf of the trust, should this be a procedure that is referred elsewhere
4) The contact details of the sites/departments performing the tests?

Bronchial challenge tests.051222.docx

C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

For the years 2014, 2015, and 2016 please details the following:

How many people and inpatients have been infected with and treated for a superbug.

List which superbug people were infected with.

In which hospital did they contract the infection?

How many of these people later died of the infection?

Download response C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

CAMHS. 170820

1. Breaking down the data by each month, how many young people were referred to CAMHS service for Tier 3 support from March 2019 to July 2020?
2. Breaking down the data by each month, how many young people were refused CAMHS services, because the service lacked capacity from March 2019 to July 2020?
3. Regarding CAMHS services in the financial year 2018-19:
i. How many patients waited more than 4 weeks for an initial assessment? (What percentage of the total is this?) ii. How many patients waited more than 18 weeks for an initial assessment? (What percentage of the total is this?) iii. How many patients waited more than 12 months for an initial assessment? (What percentage of the total is this?) iv. How many patients waited more than 4 weeks to start treatment? (What percentage of the total is this?) v. How many patients waited more than 18 weeks to start treatment? (What percentage of the total is this?) vi. How many patients waited more than 12 months to start treatment? (What percentage of the total is this?) vii. What was the longest wait time for treatment?
4. Regarding CAMHS services in the financial year 2019-2020:
i. How many patients waited more than 4 weeks for an initial assessment? (What percentage of the total is this?) ii. How many patients waited more than 18 weeks for an initial assessment? (What percentage of the total is this?) iii. How many patients waited more than 12 months for an initial assessment? (What percentage of the total is this?) iv. How many patients waited more than 4 weeks to start treatment? (What percentage of the total is this?) v. How many patients waited more than 18 weeks to start treatment? (What percentage of the total is this?) vi. How many patients waited more than 12 months to start treatment? (What percentage of the total is this?) vii. What was the longest wait time for treatment?

Download response CAMHS. 170820

Cannulas.060224.docx

All questions are shown as received by the Trust.
1. How many Adult or Paediatric cannulation procedures (Peripheral Cannula passed) were done in your trust in the past financial year? This can be estimated figure (from number of cannulas purchased) or actual if any such records are kept by the trust
2. Do you use any form of prepacked cannulation kits that provide all appropriate equipment needed? These are manufactured outside the hospital and delivered as one whole pack, or the items are purchased / used separately.
3. Which type of cannula is used / preferred at your trust or hospital? There are two types – one with safety mechanism E.g., BD or Vygon or ones without safety. The safety cannulas are designed to prevent needle stick injuries.
4. Does the trust / hospital use any particular cannula more than others and if so what is the name of manufacturer(s) and breakdown of their supply e-g leading manufactures are BD, Vygon, etc
5. Is there any breakdown of cannulas used by their size / gauge (e-g 22G Blue / 20G pink)?
6. Do you use the NHS supply chain or purchase these cannulas / cannulation packs directly independent suppliers / distributors or companies within your trust? If so, please can we be provided with the supplier(s) / distributor (s) name(s) and breakdown of items purchase in last financial year
7. What is the total number of hospital beds you have within your trust and its occupied capacity?
8. What is the total number of annual attendance in the following departments:
i) Accident and Emergency
ii) Surgical Assessments Unit
iii) Medical Day Unit / Medical Admission Units
9. What is the annual budget for clinical waste disposal?
10. Do you have any figures in weight (tons) of clinical waste disposed of by your trust?

Cannulas.060224.docx

Carbapenemase-producing organisms. 181116

1. How many patients have been infected with carbapenemase-producing organisms in your trust?

2. How many patients with an infection from a carbapenemase-producing organism have died?

Download response Carbapenemase-producing organisms. 181116

Carbon Monoxide poisoning. 070817

1. How many cases have attended A&E with suspected carbon monoxide poisoning between 1st July 2016- 30th June 2017?
2. How many cases have been treated in A&E with suspected carbon monoxide poisoning between 1st July 2016- 30th June 2017?

Download response Carbon Monoxide poisoning. 070817

Carbon Monoxide poisoning. 181019

1. How many cases have attended A&E with suspected carbon monoxide poisoning between 1st July 2018-30th June 2019?
2. How many cases have been treated in A&E with suspected carbon monoxide poisoning between 1st July 2018-30th June 2019?
3. How many confirmed deaths have there been as a result of carbon monoxide poisoning between 1st July 2014-30th June 2015?
4. How many confirmed deaths have there been as a result of carbon monoxide poisoning between 1st July 2015-30th June 2016?
5. How many confirmed deaths have there been as a result of carbon monoxide poisoning between 1st July 2016-30th June 2017?
6. How many confirmed deaths have there been as a result of carbon monoxide poisoning between 1st July 2017-30th June 2018?
7. How many confirmed deaths have there been as a result of carbon monoxide poisoning between 1st July 2018-30th June 2019?

Download response Carbon Monoxide poisoning. 181019

Cardiac arrest, myocarditis, stroke and generalised tonic clonic seizure. 081221.docx

1) In total, how many patients were admitted due to cardiac arrest (myocardial infarction) for the years 2019, 2020 and 2021?
2) In the year 2021, how many of these patients that were admitted with confirmed MI (myocardial infarction)/cardiac arrest) had been unvaccinated, had a single dose, had a double dose of covid19 vaccine prior to admission?
3) How many patients have been diagnosed with acute myocarditis (both inpatients and outpatients) in the following age brackets
4) For the year 2021 (in each of the age groups), how many patients with acute myocarditis were unvaccinated, had a single dose of covid19 vaccine and had a double dose of covid19 vaccine?
5) In total, how many patients were admitted due to stroke (cerebrovascular accident) for the years 2019, 2020 and 2021?
6) In the year 2021, how many of these patients that were admitted with Stroke (cerebrovascular accident) had been unvaccinated, had a single dose, had a double dose of covid19 vaccine prior to admission?
7) In the year 2021, how many of the above patients that were admitted with stroke (cerebrovascular accident), later died?
8) In total, how many patients attended the A&E Department with their first generalised tonic clonic Seizure (GTCS) in the years 2019, 2020 and 2021?
9) In the year 2021, how many patients admitted with their first generalised tonic clonic Seizure (GTCS) had been unvaccinated, had a single dose, had a double dose of covid19 vaccine prior to admission?

Download response Cardiac arrest, myocarditis, stroke and generalised tonic clonic seizure. 081221.docx

Cardiac equipment age and revenue 2014/2015.

Question 1
Hospital 1 (name)
No. operated No. leased / owned (If Applicable) number provided through a managed equipment provider) Year of manufacture (or installation, if yr of manufacture n/a)
Lab 1 Lab2 Lab3 Lab4 Lab5
Labs primarily serving PCI activity and coronary diagnostics
Labs primarily serving primary pacing & electrophysiology implantations, ablations and diagnostics
Labs primarily serving peripheral vascular angioplasty and diagnostics
All other
– of the above, labs within hybrid catheterisation lab / operating theatre

Question 2
Please provide the Trust’s revenue for the fiscal year 2014/15 from the HRGs below, broken down by source (NHS England or your local CCG) and by category: Coronary interventional cardiology, Pacing/Electrophysiology, Non-coronary catheter procedures, as follows:

Category Includes HRGs Trust’s Revenue 2014/15
From CCG From NHS England
Coronary interventional cardiology EA31Z Percutaneous Coronary Intervention (0-2 Stents)
EA36A Catheter 19 years and over
EA36B Catheter 18 years and under
EA49Z Percutaneous Coronary Interventions with 3 or more Stents, Rotablation, IVUS or Pressure Wire
Pacing/ Electrophysiology EA03Z Pace 1 – Single Chamber or Implantable Diagnostic Device
EA05Z Pace 2 – Dual Chamber
EA07Z Pace 3 – Biventricular and All Congenital Pacemaker Procedures – Resynchronisation Therapy
EA12Z Implantation of Cardioverter – Defibrillator only
EA27Z Percutaneous Standard EP or Ablation
EA29Z Percutaneous Complex Ablation (includes Atrial Fibrillation or Ventricular Tachycardia)
Non-coronary catheter procedures EA09Z Percutaneous Interventions: Percutaneous Transluminal ASD/VSD/PFO Closure and Valve Insertion
EA10Z Percutaneous Interventions: Balloon Valve Intermediate Interventions and Arterial Duct Closure
EA11Z Percutaneous Interventions: Other including Septostomy, Embolisations, Non-Coronary Stents and Energy Moderated Perforation
EA53Z Transcatheter Aortic Valve Implantation (TAVI)
EA35Z Other Percutaneous Interventions

Download response Cardiac equipment age and revenue 2014/2015 190416

Cardiac marker point of care tests. 251116

1. Please enter the name of your hospital or trust.
2. Does your trust use point-of-care testing for cardiac markers?
3. In what areas of the hospital is cardiac marker point-of-care testing used?
( ) ED
( ) Wards
( ) Intensive care
( ) Outpatient clinics
( ) Other (please specify)
4. For which cardiac markers does your trust use POCT?
( ) Troponin
( ) BNP
( ) D-dimer
( ) CK-MB
( ) Myoglobin
( ) Other (please specify)
5. For each POC cardiac marker test used in your trust, how many tests are performed every week?
Troponin –
BNP –
D-dimer –
CK-MB –
Myoglobin –
Other –
6. What is the average cost per test (excluding overheads) for each cardiac marker POCT?
Troponin –
BNP –
D-dimer –
Other –
7. How much is spent by your trust per year on cardiac marker point-of-care testing?
Total –
Troponin –
BNP –
D-dimer –
Other –

Download response Cardiac marker point of care tests. 251116

Cardiac Physiology. 160119

1- Do you currently have in place any recruitment and retention premiums or any other forms of incentive for Cardiac Physiologists (or similar AHPs working within the Cardiology Department)?
2- Please confirm the headcount of your Cardiac Physiology Department, split by NHS Agenda for Change Pay Bands
3- Please can you confirm the professional reporting lines for Cardiac Physiologists within your organisation?
4- Does your organisation have any other forms of recruitment and retention premiums or incentives for attracting other staff groups? This could include ‘golden handshakes’ or other salary uplifts/incentives?

Download response Cardiac Physiology. 160119

Cardio- respiratory diagnostics pathways.090223.docx

I would like to submit a FOI request to ask for the name and email address for the person(s) or team responsible for;
I. Cardio-respiratory pathways ( likely to be a clinical or business lead)? and
II. Community diagnostic centres ( CDC’s) for the Trust?

Cardio- respiratory diagnostics pathways.090223.docx

 

Cardiology.190423.docx

Please enter ‘No System Installed’ under supplier name if your trust does not use the system:
System type – Cardiology
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender

Cardiology.190423.docx

Cardiology. 220218

1. The name and email address of your Head of Cardiology
2. The name and email address of your Chief Cardiac technician / Head Cardiac technician or equivalent

Download response Cardiology. 220218

Cardiology. 240321

1. Your Guideline/Treatment Pathway for the pharmacological management of Heart Failure
2. Your Guideline/Treatment Pathway for the pharmacological management of Atrial Fibrillation

Download response Cardiology. 240321

Cardiology digital systems.241219

1) Regarding echocardiograms:
a) Which digital system is used by healthcare professionals in your trust to request echocardiograms?
b) On what digital system(s) are echocardiogram images stored?
c) On what system are echocardiograms reported?
d) On what system(s) are the reports for echocardiograms available for review?

2) Regarding coronary angiograms:
a) Which digital system is used by healthcare professionals in your trust to request coronary angiograms?
b) On what digital system(s) are images from coronary angiograms stored?
c) On what system are coronary angiograms reported?
d) On what system(s) are the reports from coronary angiograms available for review?

3) Regarding cardiac pacemakers:
a) Which digital system is used by healthcare professionals in your trust to request pacemaker insertion?
b) On what system are pacemaker procedure reports written?
c) On what system(s) are pacemaker procedure reports available for review?
d) On what system(s) are cardiac pacemaker routine outpatient checks available for review?

4) Regarding cardiology patient documentation:
a) On what system(s) are outpatient letters available for review?
b) On what system(s) are discharge letters available for review?
c) Are copies of ECGs stored electronically? If so, on what system(s) are they available?

5) Regarding CT coronary angiograms:
a) Which digital system is used by healthcare professionals in your trust to request CT coronary angiograms?
b) On what digital system(s) are images from CT coronary angiograms stored?
c) On what system are CT coronary angiograms reported?
d) On what system(s) are the reports from CT coronary angiograms available for review?

6) What RIS system does your hospital use?
7) What PACS system does your hospital use?

Download response Cardiology digital systems.241219

Cardiology referrals 1.210422.docx

Please can you provide the total number of patients that have been referred to the cardiology departments within your trust for the following years. If this data is available for individual age groups I would be grateful if you could provide.

2018
2019
2020
2021
2022 (to date)

Cardiology referrals 1.210422.docx

Cardiology referrals 2.210422.docx

Please can you provide the total number of patients that have been referred to the cardiology departments within your trust for the following years. If this data is available for individual age groups I would be grateful if you could provide.

2018
2019
2020
2021
2022 (to date)

Cardiology referrals 2.210422.docx

Cardiology referrals.200522.docx

Please can you provide the total number of patients that have been referred to the cardiology departments within your trust for the following years. If this data is available for individual age groups I would be grateful if you could provide.
2018
2019
2020
2021
2022 (to date)

Cardiology referrals.200522.docx

Cardiopulmonary Resuscitation of Elderly and Vulnerable Patients. 260820

I am making a formal written request for a complete copy of the Maidstone and Tunbridge Wells NHS Trust policy regarding the Cardiopulmonary Resuscitation of Elderly and Vulnerable Patients.

Download response Cardiopulmonary Resuscitation of Elderly and Vulnerable Patients. 260820

Caring for a patient who is a C Difficile carrier. 230620

Can I be clear what is the Trusts protocol for caring for a patient who is a C Difficile carrier?

Can you please send to me the Trusts policy and protocol please for a C Difficile carrier?

Download response Caring for a patient who is a C Difficile carrier. 230620

CAS card information. 041121.docx

With regard to your response (FOI/GS/ID 7019) sent this morning, I note that a response has not been provided in respect of the following request for information (FOI):

“1. Please can you explain: …what system this CAS card was used within by the Trust in April 2012. “

I therefore request the Trust provides a direct and explicit response to this question by the end of today.

Download response CAS card information. 041121.docx

Cell saver machines. 070717

1. How many cell savers do you have within the Trust? Please provide a breakdown of cell savers per hospital if possible.
2. For which surgical procedures were cell savers used in the year 2015 – 2016, breakdown by number if possible?
3. How many consumables were purchased for cell savers during the year 2015 – 2016?
4. How much was spent on cell saver consumables for the year 2015 – 2016?

Download response Cell saver machines. 070717

CGM technology. 270121

I am interested in the financial year 2019-2020 and, if it’s possible, I would like to know for this year:
1. The total spend by the Trust on CGM technology (excluding Freestyle Libre devices) for children and young people aged 0-17, or up to the age of discharge from Paediatrics
2. The number of children who were using CGM during this year (2019-20)
3. The number of transmitters, sensors, apps and receivers purchased by the Trust in that financial year
4. The number of items (transmitters, sensors, apps and receivers) and amount of spend that were paid for by:
a. The Trust only
b. Reimbursed to the Trust by the CCG
c. Reimbursed to the Trust by other means, such as payment by the voluntary sector

Download response CGM technology. 270121

Chemsex related admissions

1. The number of chemsex related admissions to hospital in each of the following periods:
– 2010/2011
– 2011/2012
– 2012/2013
– 2013/2014
– 2014/2015
2. The number of fatalities due to consumption of chemsex drugs (mephedrone, GHB, GBL, methamphetamine), in each of the following periods:
– 2010/2011
– 2011/2012
– 2012/2013
– 2013/2014
– 2014/2015
3. Number of emergency calls regarding a chemsex-related casualty /ies in each of the following periods:
– 2010/2011
– 2011/2012
– 2012/2013
– 2013/2014
– 2014/2015

Download response Chemsex related admissions 250716

Children attending A&E due to mental health. 120422.docx

1. Number of children attending A&E per month, since Jan 2019 due to a mental health related issue.
2. The top 10 longest stays in A&E of a child who is presenting a mental health issue over the last 12 months.

Children attending A&E due to mental health. 120422.docx

Chronic Kidney Disease. 081021.docx

Q1. How many patients have been treated in the last 6 months (for any disease) with the following products:
a. Aranesp & Aranesp SureClick (darbepoetin alpha)
b. Eprex (epoetin alfa)
c. NeoRecormon (epoetin beta)
d. Retacrit (epoetin zeta)
e. Mircera (methoxy polyethylene glycol-epoetin beta)
f. Ferinject (ferric carboxymaltose injection/infusion)
g. Diafer (ferric derisomaltose injection)
h. Monofer (ferric derisomaltose injection)
i. Cosmofer (iron dextran injection)
j. Venofer (iron sucrose injection)
Q2. In the past 6 months could you please state the number of patients treated for the following conditions:
a. Chronic kidney disease (ICD10 code – N.18)
b. Chronic kidney disease – Stages 4 & 5 (ICD10 codes – N.18.3 & N.18.4 & N.18.5)
c. Acquired cystic kidney disease (ICD10 code N28.1)
d. Chronic kidney disease – new patients (excluding previously treated patients)
e. Acquired cystic kidney disease – new patients (excluding previously treated patients)
Q3. Please indicate the number of patients treated in the last 6 months for chronic kidney disease ONLY with each of the following products:
a. Aranesp & Aranesp SureClick (darbepoetin alpha)
b. Eprex (epoetin alfa)
c. NeoRecormon (epoetin beta)
d. Retacrit (epoetin zeta)
e. Mircera (methoxy polyethylene glycol-epoetin beta)
f. Ferinject (ferric carboxymaltose injection/infusion)
g. Diafer (ferric derisomaltose injection)
h. Monofer (ferric derisomaltose injection)
i. Cosmofer (iron dextran injection)
j. Venofer (iron sucrose injection)

Download response Chronic Kidney Disease. 081021.docx

Chronic Kidney Disease (CKD). 260821.docx

Can you please provide me with the following document?
1. Your Guideline/Treatment Pathway for the pharmacological management of Chronic Kidney Disease (CKD)

Download response Chronic Kidney Disease (CKD). 260821.docx

Chronic Kidney Disease or Diabetic Kidney Disease.160323.docx

Does Maidstone and Tunbridge Wells NHS Trust have any local treatment guidelines, pathways or protocols for the treatment of Chronic Kidney Disease or Diabetic Kidney Disease?

Chronic Kidney Disease or Diabetic Kidney Disease.160323.docx

Chronic pain service 031016

1. The definition of calculation used for new to follow up ratios for chronic pain referrals.
2. The data for new to follow up for chronic pain referrals for your trust for the years April 2010 to April 2015
3. Is the calculation used for new and follow-up in Chronic Pain a local or national definition?
4. Can you provide the wording of the definition used?
5. Does the New to follow up ratio calculation that is used by your organisation for Chronic Pain also apply to other specialties?
6. If no – please explain the differences in the calculations.

Download response Chronic pain service 031016

Clinical Insourcing. 101120

1. Do you insource any clinical services and which ones?
2. Do you have a contract with any company and who is that and for which insourcing services?
3. Did you procure this under any current framework and if so which one?
4. How is this charged for by the third party service provider per patient/per tariff?
5. Are you currently being charged below, on or above NHS tariff?
6. Do you use substantively employed Trust staff to delivery all or part of the insourced service?
7. The total number of procedures completed by each supplier (named) in the following categories:
a. Endoscopy
b. Ophthalmology
c. ENT
d. Neurology
e. Dermatology
f. All Other
8. The total spend completed by each supplier (named) per service area
9. Please give an annual breakdown per annum of insourcing services per service area:
a. 15/16
b. 16/17
c. 17/18
d. 18/19

Download response Clinical Insourcing. 101120

Clinical Insourcing and Outsourcing. 111121.docx

1. Do you insource clinical services and if so, which ones?
2. Do you have any current contracts in place with a company for these insourced services, and if so which services?
3. How much have you spent on insourcing clinical services per annum for the past 3 years?
4. Do you outsource clinical services and if so, which ones?
5. Do you have any current contracts in place with a company for these outsourced services, and if so which services?
6. How much have you spent on outsourcing clinical services per annum for the past 3 years?

Download response Clinical Insourcing and Outsourcing. 111121.docx

Colonoscopy. 280420

2019 (if not available, 2018) surgical volumes for Colonoscopy (see attached excel file for detailed coding)

Download response Colonoscopy. 280420

Colorectal outpatient and Gastroenterology outpatient appointments. 170821.docx

1. Total number of attended Colorectal outpatient appointments from 1st Jan 2019 to the most recent data point available. Please provide a monthly breakdown.
2. Total number of attended Gastroenterology outpatient appointments from 1st Jan 2019 to the most recent data point available. Please provide a monthly breakdown.

Download response Colorectal outpatient and Gastroenterology outpatient appointments. 170821.docx

Community Neurology Specialist nurses Parkinson’s Disease. 060317

1) How many Community Neurology Specialist Nurses have been funded since April 2013 – please can the figures be broken down by year?
2) Who funded and provided the nurses each year?
3) Of these nursing positions, how many were solely dedicated to treating Parkinson’s Disease patients, broken down by financial year since April 2013?
4) And how many of the Community Neurology Specialist Nurses specialise in Parkinson’s Disease but treat other neurology patients, broken down by financial year since April 2013?
5) How many patients have been referred to specialist neurology nurses, broken down by financial year since April 2013?
6) Of these patients, how many have been referred because of having Parkinson’s Disease, broken down by financial year since April 2013?
7) What is the average waiting time for neurology patients to see a specialist neurology nurse, broken down by financial year since April 2013?
8) What is the average waiting time for Parkinson’s Disease patients to see a specialist neurology nurse, broken down by financial year since April 2013?
9) How much money has been spent by the provider(s) on specialist neurology nursing positions, broken down by financial year since April 2013?
10) How much money has been spent by the provider(s) on dedicated Parkinson’s Disease nursing positions, broken down by financial year since April 2013?
11) How many times have proposals been rejected to fund new Community Neurology Specialist Nurses, broken down by financial year since April 2013?
12) How many times have proposals been rejected to fund a dedicated Parkinson’s Disease nurse position, broken down by financial year since April 2013?

Download response Community Neurology Specialist nurses Parkinson’s Disease. 060317

Complex Regional Pain Care Syndrome (CRPS). 240317

What does your acute Complex Regional Pain Care Syndrome (CRPS) pathway look like for trauma and orthopaedic, rheumatology and hand acute services?

Download response Complex Regional Pain Care Syndrome (CRPS). 240317

Complications related to elective surgery undertaken outside the UK. 080923.docx

All questions are shown as received by the Trust.
1.) The number of patients treated by your NHS Trust from 2018 to 2023 so far (as much as recorded) for complications related to elective surgery undertaken outside the UK.
Please provide the numbers broken down year-by-year:
a) 2018
b) 2019
c) 2020
d) 2021
e) 2022
d) 2023 (to date)
If possible, please also:
2) indicate the original (outside the UK) medical treatment, and
3) the subsequent treatment the patient received in the UK, at your trust

Complications related to elective surgery undertaken outside the UK. 080923.docx

Continence and catheterisation. 220818

1. How many specialist urology/continence nurses were there within your Trust in each of the last five financial years?
2. How many hours of staff training were allocated in the last financial year, under the remit of continence care, to catheterisation?
3. Do you have a named continence lead within your Trust? If so, what is their name?
4. Are catheter passports used within your Trust?
a. If no, can you provide a reason as to why?
b. If yes, has the number of passports given to patients increased over the last 5 years?
5. If a catheter passport is used within your Trust does it contain a urine colour chart?
6. Do you have a urine colour chart on every toilet door within each hospital?
7. Do you test patients presenting with urinary bladder complications with a bladder ultrasound scanner?

Download response Continence and catheterisation. 220818

Continence Formulary. 100920

I would like to please request the Continence Formulary of the Maidstone and Tunbridge Wells NHS Trust. May I please have the Continence Formulary attached in a response or may I please be directed to where it is available online? By this, I am specifically interested in continence appliances (catheters etc.).

Download response Continence Formulary. 100920

Continuous glucose monitoring (CGM) devices for adults with Type 1 diabetes. 140421

For the calendar year 2020, please provide:
1. The total spend by the Trust on CGM devices that fall under the remit of adult diabetes teams (first priority for information).
2. The number of CGM devices funded by the Trust that fall under the remit of adult diabetes teams (second priority for information).
3. The number of devices, that fall under the remit of adult diabetes teams, funded by the Trust, whose costs are reimbursed by the CCG (third priority for information).

Download response Continuous glucose monitoring (CGM) devices for adults with Type 1 diabetes. 140421

Continuous renal replacement therapy (CRRT). 010217

1. How many machines do you have for continual renal replacement (CRRT) in the intensive care unit/critical care unit?
1. a. Can you split these by manufacturer and age of machine please?
2. Are you in a contract for your machines, if so when does the contract expire?
3. How many CRRT treatments were carried out in 2016 (or the latest 12 month period you have data for)?
4. How many bags of fluid did you use for CRRT in 2016 (or the latest 12 month period you have data for)?
5. Who is your current manufacturer of fluids for CRRT? And for Vascular access? (Double Lumen catheters)
6. Are you in a contract for fluids, if so, when does this expire and is it linked in with the machine contract?
7. What was your total spend on CRRT fluids in 2016 (or the latest 12 month period you have data for)?
8. What was your total spend on CRRT consumables (e.g. consumable sets for the machines) in 2016 (or the latest 12 month period you have data for)?
9. What is the typical renal dose you prescribe to the patients? (In ml/kg/h)
10. Are your units using Citrate Anticoagulation? If yes how frequent (in % vs. Heparin).

Download response Continuous renal replacement therapy (CRRT). 010217

Contract information for TNP and PAC.060317

Section 1
1) What are the Hospital names and locations that form part of the Trust? (Please provide details)
2) Which framework is utilized for purchasing such as SBS, NHS Supply Chain or other (please provide details of all that are used)
3) By which method is this procured? (Please state all that applies)
Section 2
1) What is the name of the manufacture used to provide Topical Negative Wound Therapy Treatment for each hospital location?
*Smith-Nephew
*KCI
*Talley
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) Is this equipment provided via Hire agreement, Purchase or other? (Please provide details)
4) Is the provision of this equipment contracted? Yes or No
5) If contracted is the service and maintenance of this equipment included as part of the contract? Yes or No
6) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
7) If 3rd party provider please state company name
8) Is the 3rd party service & maintenance contracted? Yes or No
9) If Yes what is the contract term? (Including any extension periods).
10) What is the expiry date of this contract?
The following questions are only applicable if the supply of Topical Negative Wound Therapy to the hospital trust is contracted.
1) As a result of the tender did you change provider? Yes or No (If Yes please provide name of previous supplier)
2) What date did your current contract start?
3) How long is the current contract? (Including any extension periods)
4) When does the current contract expire?
5) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
6) Please provide the financial value for the first 12 months of the current contract in place.
Section 3
1) What is the name of the manufacture used to provide pressure relief alternating dynamic surface air mattresses to the trust?
*Hill-Rom
*Smith-Nephew
*Talley
*Direct Healthcare
*Karomed
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) What is the total number of dynamic mattresses on-site?
4) Is this a managed service? Yes or No
5) Is the provision of dynamic surfaces contracted? Yes or No
6) If Yes is the service and maintenance of this equipment included as part of the contract? Yes or No
7) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
8) If 3rd party provider please state company name
9) Is this 3rd party service contracted? Yes or No
10) If Yes what is the contract term? (Including any extension periods).
11) What is the expiry date of this contract?
12) How is the decontamination of these products managed? In-house or 3rd party provider
13) If 3rd party provider please state company name
14) Is this 3rd party service contracted? Yes or No
15) If Yes what is the contract term? (Including any extension periods).
16) What is the expiry date of this contract
The following questions are only applicable if the supply of dynamic alternating air surface mattresses to the hospital trust is contracted.
1) Which method is used to tender the contract? (Please provide details)
2) What date did your current contract start?
3) What is the term of the contract? (including any extension periods)
4) When does the current contract expire?
5) Is the contract purchase, hire or other (please provide details)
6) If contracted, when did you last tender the contract?
7) As a result of the tender did you change provider? Yes or No (if Yes please provide previous supplier)
8) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
9) Please provide the financial value for the first 12 months of the current contract in place.
Section 4
1) What is the name of the manufacture used to supply profiling bed frames?
*Hill-Rom
*Sidhil
*Invacare
*Linet
*Huntleigh
*Other (please provide details)
2) By which method is this procured? (Please state all that applies)
3) Which products are used? (Please provide details)
4) What is the total number of hospital bed frames on-site?
5) Is the supply of bed frames contracted?
Yes or No?
The following questions are only applicable if the supply of profiling beds to the hospital trust is contracted.
1) What date did your current contract start?
2) How long is the current contract? (Including any extension periods)
3) When does the current contract expire?
4) When did you last tender the contract?
5) As a result of the tender did you change provider? Yes or No (if Yes please state previous supplier)
6) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
7) Please provide the financial value for the first 12 months of the current contract in place.

Download response Contract information for TNP and PAC.060317

COPD patients or patients with Heart Failure. 041120

1. Within your organisation or any service you commission, is there any use of the following: remote healthcare monitoring for COPD patients or patients with Heart Failure
(Definition for clarity: a patient has either an app, a website link and / or vital sign monitoring where they do this in one place and a clinician reviews their data in another)
2. Should there be use of the above listed programs, when these contracts due for review/renewal – and where possible please supply the provider company name.
3. In addition can you please tell me in which area of your organisation any similar programs are being used (for example for COVID-19 discharge patients, for patients with diabetes)

Download response COPD patients or patients with Heart Failure. 041120

Coronary angioplasty devices.241219

Please could you kindly advise on the following information in relation to coronary angioplasty devices that you purchase for use in the cardiac catheterization lab within the date frame of 1st January 2019 to YTD 2019?
1. Drug coated/eluting balloons
a. Supplier(s)
b. Brands(s)
c. Volume
2. Drug eluting stents
a. Supplier(s)
b. Brands(s)
c. Volume
3. Scoring/Cutting balloons
a. Supplier(s)
b. Brands(s)
c. Volume
4. Angiographic Packs
a. Supplier(s)
b. Brands(s)
c. Volume
d. Pack contents

Download response Coronary angioplasty devices.241219

Coronary CT Angiography scans. 311019

1) How many (if any) Coronary CT Angiography scans with non-invasive FFR analysis or HeartFlow analysis were performed in the financial year 2017-18?
2) How many (if any) Coronary CT Angiography scans with non-invasive FFR analysis or HeartFlow analysis were performed in the financial year 2018-19?
3) If this technology is available to the trust when did it become available?

Download response Coronary CT Angiography scans. 311019

Cost of flu treatment in A&E. 250117

a) How many people were admitted to Accident and Emergency with flu in each calendar year: 2010; 2011; 2012; 2013; 2014; 2015, and; 2016?

b) What is the total financial cost for people presenting with flu at Accident and Emergency in each calendar year in answer to Question A. Please provide this information broken down by calendar year, as follows: 2010; 2011; 2012; 2013; 2014; 2015, and 2016. This should include all costs incurred to treat the illness during the patients stay at the hospital, including all staff salaries and any other medical treatment costs.

Download response Cost of flu treatment in A&E. 250117

Cost of interventions for non-surgical cosmetic procedures.310124.docx

All questions are shown as received by the Trust.
I would like to request the following information regarding patients seeking treatment for physical complications from dermal filler and Botulinum toxin injections, such as nodule formation, discolouration, migration and herpetic outbreaks:

1) The total number of patients that have been treated at all your hospitals for botched non-surgical procedures for quarter 2 of 2023-2024.

2) The total cost of treating botched non-surgical procedures at all your hospitals for quarter 2 of 2023-2024.

3) The total number of patients that all of your hospitals have referred to private clinics to treat botched non-surgical procedures for quarter 2 of 2023-2024.

Cost of interventions for non-surgical cosmetic procedures.310124.docx

 

CRE infections. 181116

1. How many patients have been?
-colonised
-infected
With CRE infections for each of the past 10 years in your trust?
2. Does your trust have universal screening of patients for CRE when they are admitted, screening of patients with high risk factors or no formal screening policy?
3. How many patients were screened for CRE when they were admitted and deemed high risk for a CRE infection?
4. How many isolation rooms does your hospital have for isolating CRE patients?
5. How many isolation rooms have en suite bathrooms?
6. What is your policy if there is no side room available for isolating patients with CRE?

Download response CRE infections. 181116

Cryogenic freezing 061216

For the last five years, could you tell me how many, if any, patients have requested they are cryogenically frozen after death, in the hope they can be revived at a later date?

Download response Cryogenic freezing 061216

Deaths in A&E 2.220223.docx

Could you provide me with the number of patients to die in A&E at your trust, broken down by month from January 2010 to December 2022 please.

Deaths in A&E 2.220223.docx

Deaths in A&E.220223.docx

How many patient deaths occurred in the A&E department at your Trust in each of the following calendar years (rather than financial years): 2018, 2019, 2020, 2021, 2022, broken down by month?

Deaths in A&E.220223.docx

Defibrillators. 101120

1. Manual Defibrillator Machines manufacturer
2. Manual Defibrillator model
3. Year of purchase
4. Proposed timeframe for replacement
5. AED Defibrillator Machines manufacturer
6. AED Defibrillator model
7. Year of purchase
8. Proposed timeframe for replacement

Download response Defibrillators. 101120

Delirium assessment tool. 290720

1. Do you have use a delirium assessment tool as part of clinical practice for your non-ICU patients in your trust/hospital? YES / NO
2. If yes, in which clinical settings are they in place (please use X to indicate all that apply)?
3. Which, if any, validated tools are included in your written (paper or electronic) policies? Please use X to indicate all that apply.
4. Do you have a pathway or guidelines relating to delirium? YES / NO
If yes, in which year were they written?:
Please attach an electronic copy.
5. (Voluntary: not a formal part of the FOI request)
Have staff or students performed any audits or quality improvement projects on delirium detection?
If so, please attach an electronic copy of reports or posters.

Download response Delirium assessment tool. 290720

Delirium assessment tool. 290720

1. Do you have use a delirium assessment tool as part of clinical practice for your non-ICU patients in your trust/hospital? YES / NO
2. If yes, in which clinical settings are they in place (please use X to indicate all that apply)?
3. Which, if any, validated tools are included in your written (paper or electronic) policies? Please use X to indicate all that apply.
4. Do you have a pathway or guidelines relating to delirium? YES / NO
If yes, in which year were they written?:
Please attach an electronic copy.
5. (Voluntary: not a formal part of the FOI request)
Have staff or students performed any audits or quality improvement projects on delirium detection?
If so, please attach an electronic copy of reports or posters.

Download response Delirium assessment tool. 290720

Delirium protocols.201218

Could you send me a copy of your protocol/guidelines for the treatment of delirium in adults

Download response Delirium protocols.201218

Dementia 2014-2015

1. The number of patients aged 65 and over who have fallen in hospital in 2014-15 or the last year for which statistics are available?
2. Number of patients aged 65 and over with a coding of dementia who have fallen in hospital in financial year 2014-15 or the last year for which statistics are available?
3. The number of patients aged 65 and over discharged between the hours of 2300 and 0600 in financial year 2014-15 or the last financial year for which statistics are available?
4. The number of patients aged 65 and over with a coding of dementia discharged between the hours of 2300 and 0600 in financial year 2014-15 or the last financial year for which statistics are available?
5. The number of delayed discharges and delayed transfers of care for patients aged 65 and over in financial year 2014-15 or the last financial year for which statistics are available?
6. The number of delayed discharges and delayed transfers of care for patients aged 65 and over with a coding of dementia in financial year 2014-15 or the last financial year for which statistics are available?
7. The number of delayed discharges and delayed transfers of care for patients aged 65 and over in financial year 2014-15 or the last financial year for which statistics are available by reason e.g. awaiting completion of assessment?
8. The number of delayed discharges and delayed transfers of care for patients aged 65 and over with a coding of dementia in financial year 2014-15 or the last financial year for which statistics are available by reason e.g. awaiting completion of assessment?
9. The number of patients aged 65 and over with a coding of dementia admitted from home in financial year 2014-15 or the last financial year for which statistics are available?
10. The number of patients aged 65 and over with a coding of dementia admitted from home and discharged to a care home in financial year 2014-15 or the last financial year for which statistics are available?
11. The average length of stay for patients aged 65 and over for the three financial years 2012-13, 2013-14 and 2014-15 or the last three financial years that figures are available?
12. The average length of stay for patients aged 65 and over with a coding of dementia for the three financial years 2012-13, 2013-14 and 2014-15 or the last three financial years that figures are available?
13. The number of hospital readmissions within 30 days for patients aged 65 and over in financial year 2014-15 or the last financial year for which statistics are available?
14. The number of hospital readmissions within 30 days for patients aged 65 and over with a coding of dementia in financial year 2014-15 or the last financial year for which statistics are available?
15. The number of current a) board-level staff b) clinical staff c) non-clinical staff?

Download response Dementia 2014-2015 010216

Dementia services and therapies. 070920

1. Are patients with dementia able to access any of the following therapies (i.e. from dementia services, memory services, memory clinics or mental health services within the Trust)?
a. Group cognitive stimulation therapy
b. Group reminiscence therapy
c. Cognitive rehabilitation or occupation therapy
d. Multi-sensory stimulation
e. Cognitive training

Download response Dementia services and therapies. 070920

Dental distress.090224.docx

All questions are shown as received by the Trust.
1. The number of patients admitted to hospital with severe dental distress every month between 01/01/2023 and 31/07/2023.
2. The number of patients admitted to hospital with tooth decay every month between 01/01/2023 and 31/07/2023.
3. The total number of patients admitted to hospital every month between 01/01/2023 and 31/07/2023.
4. The number of patients admitted to hospital with severe dental distress every month between 01/01/2019 and 31/07/2019.
5. The number of patients admitted to hospital with tooth decay every month between 01/01/2019 and 31/07/2019.
6. The total number of patients admitted to hospital every month between 01/01/2019 and 31/07/2019.

Dental distress.090224.docx

Dental health attendances at A&E. 190320

1) In the financial year 2018-19, how many patients presented at your A&E departments (to include major A&E departments, minor injuries units and walk-in centres) with dental health problems?
Of these:
a) Of the patients presenting with dental health problems, how many received treatment at the hospital during that visit?
b) Of the patients presenting with dental health problems, can the numbers please be broken down by type of problem e.g. toothache, loss of teeth, bleeding from the mouth.
c) Of the patients presenting with dental health problems, can the numbers please be broken down by age of the patient e.g. 0-9, 10-19, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80-89, 90+
d) Of the patients presenting with dental health problems, how many were not registered with an NHS dentist?
2) Can we please get the figures above, but for the following financial years (separately):
2014-15
2015-16
2016-17
2017-18
2019-20 to Jan 1st 2020.

Download response Dental health attendances at A&E. 190320

Dental health problems.070923.docx

All questions are shown as received by the Trust.
1) In the two most recent financial years, please say how many patients presented at your A&E departments (including major A&E departments, minor injuries units and walk-in centres) with dental health problems? Of these:
a) Of the patients presenting with dental health problems, how many received treatment at the hospital during that visit?
b) Of the patients presenting with dental health problems, can the numbers please be broken down by type of problem (that is: e.g. toothache, loss of teeth, bleeding from the mouth, etc.;
c) Of the patients presenting with dental health problems, can the numbers please be broken down by age of the patient. That is: under 18 (child for the purposes of NHS dentistry), adult (18 and over); and
d) Of the patients presenting with dental health problems, how many were not registered with an NHS dentist?
2) I note that there was a similar Freedom of Information request made in 2020, to which the Trust responded: “The system used in our A&E departments does not have the detailed coding needed to answer this request. The code used in the department is facio-maxilliary which includes dental, broken jaws, broken noses sinusitis etc.” Has the Trust considered or discussed disaggregating these types of injury/ condition?

Dental health problems.070923.docx

Dental patients in A&Es, fourth quarter of 19-20. 020420

1) In the period January 1 to March 31, 2020, how many times did patients present at your A&E departments, minor injuries units or walk-in centres with dental health problems? (Please can you state which type(s) of services your response includes) If you have any specialist facilities for dental treatment, please exclude these.

Of these:
2) Can the numbers please be broken down by type of problem e.g. toothache, abscess/infection, loss of teeth, broken or loose teeth, gum disease/bleeding from the mouth, decay.

3) Of the patients presenting with dental health problems, can the numbers please be broken down by age of the patient e.g. 0-9, 10-19, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80-89, 90+

Download response Dental patients in A&Es, fourth quarter of 19-20. 020420

Dermatological and rheumatological conditions. 081021.docx

Q1. How many patients were treated in August 2021 (or latest available month) by the dermatology department with the following drugs:
1. Baricitinib (Olumiant)
2. Bimekizumab (Bimzelx)
3. Brodalumab (Kyntheum)
4. Dupilumab (Dupixent)
5. Ixekizumab (Taltz)
6. Risankizumab (Skyrizi)
7. Guselkumab (Tremfya)
8. Secukinumab (Cosentyx)
9. Tildrakizumab (Ilumetri)
10. Ustekinumab (Stelara)
Q2. How many patients were treated in August 2021 (or latest available month) by the rheumatology department with the following drugs:
1. Baricitinib (Olumiant)
2. Filgotinib (Jyseleca)
3. Guselkumab (Tremfya)
4. Ixekizumab (Taltz)
5. Secukinumab (Cosentyx)
6. Tofacitinib (Xeljanz)
7. Upadacitinib (Rinvoq)
8. Ustekinumab (Stelara)

Download response Dermatological and rheumatological conditions. 081021.docx

Dermatology Department

Does your dermatology department have nurses trained to draw bloods from outpatients in outpatient clinics?

Does your dermatology department have dermatologists trained to draw bloods from outpatients in outpatient clinics?

Does your dermatology department have access to tubes, syringes/needles in the department to draw bloods from outpatients in outpatient clinics and someone who collects or sends tubes to your bloods lab department etc?

Does your dermatology department draw either whole bloods, serum, plasma or draw only whole bloods but they put on the label that a whole blood-based test or serum-based test or plasma-based test is required to your bloods lab department etc? (by the way there are tubes with clot activator for serum after they are spun. There are tubes with clot inhibitor for plasma after they are spun)

Download response Dermatology Department 150416

Dermatology outpatient department.

Please tell me what are the clinics (ailment / ailment category clinics) for outpatients your dermatology department runs and what specific weekday they are run on.

Download response Dermatology outpatient department 270616

Dermatology Services

1. What is the composition of the multi-disciplinary team for dermatology in the Trust?
2. How many dermatology consultants work within the Trust?
3. How many speciality dermatology nurses work within the Trust (including dermatology clinical nurse specialists and dermatology nurse practitioners)?
4. Does the Trust have standards to support healthcare professionals to deliver psychodermatological care?
5. How many adult patients with Atopic Dermatitis (ICD-10-CM Diagnosis Code L20.9) have been referred for psychological support by the specialised dermatology multi-disciplinary team?
6. Does your Trust produce local guidelines to support the management of adult Atopic Dermatitis (L20.9)? (yes / no)
7. What is the ‘Friends and Family Test’ score for the Trust’s dermatology services?
8. What is the average time to treatment from referral for adults with Atopic Dermatitis (L20.9) in the Trust?
9. How many dermatology outpatient appointments occurred between 1st January and 31st December 2015 in your Trust for adult patients with diagnosed or suspected Atopic Dermatitis (L20.9) in each of the following categories:

a. first attendance – single professional
b. first attendance – multi-professional
c. follow up attendance – single professional
d. follow up attendance – multi-professional
10. If data on the number of dermatology outpatient appointments in your Trust for adult patients with diagnosed or suspected Atopic Dermatitis is not available for the period 1st January to 31st December 2016, please provide the most recent summary data available for each of the following categories:
a. first attendance – single professional
b. first attendance – multi-professional
c. follow up attendance – single professional
d. follow up attendance – multi-professional.
11. Please outline which of the following treatments are available to adult patients with Atopic Dermatitis (L20.9) in the Trust, according to the local formulary.
12. How many adult patients with Atopic Dermatitis (L20.9) in your Trust received prescriptions for the following treatments between 1st January and 31st December 2015?

Download response Dermatology Services 270616

Dermatology services. 300620

Question 1
a. Please confirm how many (i) dermatology consultants and (ii) dermatology specialist nurses are currently in post in your NHS Trust
b. Please confirm how many (i) dermatology consultant and (ii) dermatology specialist nurse posts are currently vacant in your NHS Trust
Question 2
a. Please confirm whether your NHS Trust has a dedicated service/clinic for the prescribing and administration of biologic therapies for atopic dermatitis (Yes/No)
b. If ‘No’ answered to question 2a, please confirm how the initiation of biologic therapies are managed locally in patients with atopic dermatitis
c. If ‘Yes’ answered to question 2a, and an alternative provider delivers this service, please confirm (i) the name of the provider and (ii) how many dermatology consultants and dermatology specialist nurses are involved in this service
Question 3
Please confirm how many (i) dermatology consultants and (ii) dermatology specialist nurses are responsible for delivering biologic treatment for atopic dermatitis within your trust
Question 4
a. Please confirm whether your NHS Trust has a documented protocol/pathway for the treatment of atopic dermatitis (Yes/No)
b. If ‘Yes’ answered to 4a, please confirm whether that protocol/pathway includes provision for the use of biologic therapies as a treatment option for moderate/severe atopic dermatitis (Yes/No)
c. If ‘Yes’ answered to 4a, please provide a copy of the treatment protocol/pathway
Question 5
a. Please confirm whether your NHS Trust has a multi-disciplinary team in place to treat patients diagnosed with atopic dermatitis (Yes/No)
b. If ‘Yes’ answered to 5a, please outline what interventions and services the multi-disciplinary team can offer patients (e.g. psychodermatology service)
Question 6
a. Please confirm whether you have taken up any Free of Charge (FOC) Medicine Schemes from 2018 – 2020 (Yes/No)
b. Please provide a copy of your organisations policy on free-of-charge schemes

Download response Dermatology services. 300620

Dermatology services. 300620

Question 1
a. Please confirm how many (i) dermatology consultants and (ii) dermatology specialist nurses are currently in post in your NHS Trust
b. Please confirm how many (i) dermatology consultant and (ii) dermatology specialist nurse posts are currently vacant in your NHS Trust
Question 2
a. Please confirm whether your NHS Trust has a dedicated service/clinic for the prescribing and administration of biologic therapies for atopic dermatitis (Yes/No)
b. If ‘No’ answered to question 2a, please confirm how the initiation of biologic therapies are managed locally in patients with atopic dermatitis
c. If ‘Yes’ answered to question 2a, and an alternative provider delivers this service, please confirm (i) the name of the provider and (ii) how many dermatology consultants and dermatology specialist nurses are involved in this service
Question 3
Please confirm how many (i) dermatology consultants and (ii) dermatology specialist nurses are responsible for delivering biologic treatment for atopic dermatitis within your trust
Question 4
a. Please confirm whether your NHS Trust has a documented protocol/pathway for the treatment of atopic dermatitis (Yes/No)
b. If ‘Yes’ answered to 4a, please confirm whether that protocol/pathway includes provision for the use of biologic therapies as a treatment option for moderate/severe atopic dermatitis (Yes/No)
c. If ‘Yes’ answered to 4a, please provide a copy of the treatment protocol/pathway
Question 5
a. Please confirm whether your NHS Trust has a multi-disciplinary team in place to treat patients diagnosed with atopic dermatitis (Yes/No)
b. If ‘Yes’ answered to 5a, please outline what interventions and services the multi-disciplinary team can offer patients (e.g. psychodermatology service)
Question 6
a. Please confirm whether you have taken up any Free of Charge (FOC) Medicine Schemes from 2018 – 2020 (Yes/No)
b. Please provide a copy of your organisations policy on free-of-charge schemes

Download response Dermatology services. 300620

Dermatology services. 300721.docx

1. What is the annual contract value for community dermatology services provided by the trust to CCGs for the following years? If not available, please provide data for any available years.
a. YE 31 March 2019
b. YE 31 March 2020
c. YE 31 March 2021
2. What is the annual contract value for secondary care/acute dermatology services provided by the trust to CCGs for the following years? If not available, please provide data for any available years.
a. YE 31 March 2019
b. YE 31 March 2020
c. YE 31 March 2021
3. Does the trust subcontract community dermatology services to 3rd party providers?
a. Which 3rd party organisation(s) currently provide a community dermatology service to the trust?
b. What is the total spend with these organisations (YE 31-Mar-21, or last available year)?
c. Do these organisations also provide services to the trust outside of dermatology? If so, which areas?
d. On what date does the contract for community dermatology services expire?
4. Does the trust subcontract secondary care/acute dermatology services to 3rd party providers?
a. Which 3rd party organisation(s) currently provide secondary care/acute dermatology services to the trust?
b. What is the total spend with these organisations (YE 31-Mar-21, or last available year)?
c. Do these organisations also provide services to the trust outside of dermatology? If so, which areas?
d. On what date does the contract for acute dermatology services expire?
5. Are contracts for dermatology services in partnership with any other trust(s)? If so, please provide a list of the trusts that share this contract.
6. Do you insource any dermatology services?
a. Which provider(s) do you use for insourcing dermatology services?

Download response Dermatology services. 300721.docx

Dermatology Surgery. 190121

1. Is dermatological surgery (skin surgery including e.g. punch biopsies and excisions) carried out routinely at your trust under Dermatology?
2. If so, is consent undertaken for these using either of:
a. Dermatology-specific consent form or procedure-specific consent forms pre-filled with a list of benefits and complications specific to either skin procedures in general, or the skin procedure being carried out?
b. Pre-filled consent labels specifying the risks/benefits attached to the Trust generic consent form?
3. If either a Dermatology or procedure specific consent form, or a pre-filled consent label is being used, please could you supply me with a copy? In the case of different procedure-specific consent forms used within skin surgery, please could you provide a copy of each form for each procedure?

Download response Dermatology Surgery. 190121

Diabetes. 091117

1. The number of patients with Type 1 diabetes that are currently treated as an outpatient in the hospitals in Maidstone and Tunbridge Wells NHS Trust.
2. The number of patients with Type 2 diabetes that are currently treated as an outpatient in the hospitals in Maidstone and Tunbridge Wells NHS Trust.
3. The number of patients with Type 1 diabetes in the hospitals in Maidstone and Tunbridge Wells NHS Trust with an Insulin Infusion Pump.
4. The number of patients with Type 2 diabetes in the hospitals in Maidstone and Tunbridge Wells NHS Trust with an Insulin Infusion Pump.
5. The number of Diabetes Specialist Nurses that are employed in Maidstone and Tunbridge Wells NHS Trust as of the 1st October 2017. Please break down the response to this question by pay band e.g. band 6, band 7.
6. Is structured education for patients with Type 1 diabetes offered within Maidstone and Tunbridge Wells NHS Trust?
7. The number of patients with Type 1 diabetes that have received structured education within Maidstone and Tunbridge Wells NHS Trust between the period October 1st 2016 to October 1st 2017.

Download response Diabetes. 091117

Diabetes Inpatient Specialist Nurses. 140421

1. How many dedicated wte Diabetes Inpatient Specialist Nurses do you have in your Trust?
2. Of these, how many were redeployed due to the COVID 19 pandemic?
a. First wave
b. Second wave
3. Do you have any provisions in your Trust for mental health and well-being?
4. If yes, which service?
5. Has any of the DISN been referred or self-referred to the mental health and well-being services?
6. If yes, how many?
7. How many acute beds do you have in your Trust (excluding maternity and paediatrics)?
8. Have all the Diabetes Inpatient Specialist Nurses been COVID risk assessed?

Download response Diabetes Inpatient Specialist Nurses. 140421

Diagnosis and treatment figures. 241220

Please could you give the following figures for the six month period May 15 to November 15, separately, for the three years 2018, 2019 and 2020.
1. The number of referrals to your trust for extraction of teeth in children (up to age of 18), over the six month periods?
2. The number of cancers of any type diagnosed in patients of all ages, broken down by stage of cancer, over the six month periods?
3. The number of operable cancers of any type diagnosed in patients of all ages in the six month periods?
4. The number of inoperable cancers of any type diagnosed in patients of all ages in the six month periods
Could you please also tell me what the current figures are for:
5. How many children have been waiting more than one year for extraction of teeth at your trust?
6. The age range of children waiting more than one year for extraction of teeth at your trust?
7. How many children have waited for more than two years for extraction of teeth at your trust?
8. What is the age range of children who have waited more than two years for extraction of teeth at your trust?
9. How many patients of all ages have been waiting more than six months for cardiology appointments at your trust?
10. How many patients of all ages have been waiting for more than a year for cardiology appointments at your trust?

Download response Diagnosis and treatment figures. 241220

Diagnostic Assessment for Adult ASD (Autism Spectrum Disorder).131123.docx

All questions are shown as received by the Trust.
Please tell me of the length of the current waiting time between referral acceptance and Diagnostic Assessment for Adult ASD ( Autism Spectrum Disorder) in your Trust.

Diagnostic Assessment for Adult ASD (Autism Spectrum Disorder).131123.docx

Digital sepsis alerts. 161221.docx

a) Does your Trust use an electronic health/patient record? YES/NO
If YES
b) Who is the provider of the electronic health/patient record?
e.g. EPIC and Cerner
i) If you use more than one system in the hospital could you provide details of the system used for adult inpatients and adult emergency departments.
c) When was the electronic health/patient record introduced?
d) Does your Trust use a digital sepsis alert [1]? YES/NO
If YES
e) Please give details on the hospital departments in which the alert is active.
f) Please provide details of the algorithm [2] and/or thresholds [3] in use in the digital sepsis alert.

Download response Digital sepsis alerts. 161221.docx

Dinitrophenol (DNP)

1. For each of the past five financial years (2010/11 to 14/15) please list the number of patients who have attended accident and emergency after suffering ill effects from taking Dinitrophenol (DNP).

2. For each of the past five financial years please list the number of patients admitted to a ward after taking DNP.

3. For each of the past five years please list the number of patients who have died in hospital after taking DNP.

Download response Dinitrophenol (DNP) 150416

Discharges to care homes. 280720

1) Please could you state how many patients were discharged to care homes after a positive Covid-19 test between March 17th and April 16th 2020
2) Please could you state how many patients were discharged to care homes without being tested for Covid-19 between March 17th and April 16th 2020
3) Please could you state how many patients were discharged to care homes with a negative test for Covid-19 between March 17th and April 16th 2020
4) Please state whether you have reviewed any of these discharges between March 17th and April 16th to check if they led to any further transmission of Covid-19. If so, please state the number that were recorded as leading to further transmission.
5) Please provide a copy of any reports in which the trust’s discharge of patients to care homes during the March 17th to April 16th 2020 is analysed in relation to the Covid-19 pandemic.

Download response Discharges to care homes. 280720

Discrete cylinder regulators. 070921.docx

Name of Trust:
Please note, ALL the following questions relate to Medical Oxygen cylinders ONLY
1. Does your Trust use Medical Oxygen cylinders that have a pin index cylinder valve and require a discrete (removable) regulator to function?
If ‘Yes’ please continue
2. On average, how many discrete regulator cylinders are rented each month on an annual basis?
3. On average, how many of this particular cylinder type is replenished each month?
4. How many discrete regulators are held on inventory for use with this type of cylinder?
5. Do you also rent ‘integrated valve’ cylinders? (e.g. cylinders with regulators already fitted as an integral part of the package – BOC CD cylinder for example)
6. If you have answered ‘yes’ to question 1. And question 5., what is the proportion of each type of cylinder in use? A ratio or percentage would do. (E.g. 70:30 in favour of discrete or 70% discrete, 30% integrated)
7. Has your Trust ever reported a failure to supply or an unexpected cylinder ‘runout’ whilst using a discrete regulator on a cylinder?

Download response Discrete cylinder regulators. 070921.docx

DNACPR orders. 300321

1. How many DNACPR orders were issued between 23rd March 2019 – 1st August 2019 (period 1)?
2. How many DNACPR orders were issued between 1st October 2019 – 31st January 2020 (period 2)?
3. How many DNACPR orders were issued between 23rd March 2020 – 1st August 2020 (period 3)?
4. How many DNACPR orders were issued between 1st October 2020 – 31st January 2021 (period 4)?
5. Please provide aggregate data for each period as follows:
a. Patient sex/gender (whichever term you use)
b. Patient age category (16 or under; 17-24; 25-29; 30-34; 35-39; 40-44; 45-49; 50-54; 55-59; 60-64; 65-69; 70-74; 75-79; 80-84; 85-89; 90 or above)
c. Patient ethnicity (as per government categories https://www.ethnicity-facts-figures.service.gov.uk/style-guide/ethnic-groups and see attached table)
d. Underlying health conditions (cancer; chronic kidney disease; chronic obstructive pulmonary disease; heart conditions; obesity; other; none)
e. Diagnosed learning disability (number of patients with a diagnosed learning disability)
f. Number of DNACPR orders issued with and without patient consultation/knowledge
g. Number of patients who died within 8 weeks of DNACPR order

Download response DNACPR orders. 300321

Dog attacks and dog related injuries.060722.docx

1. Emergency department attendance for dog attacks and dog related injuries broken down by (calendar) year for the years 2017, 2018, 2019, 2020, 2021
2. A breakdown of the ages of patients in question 1 broken down by (calendar) year for the years 2017, 2018, 2019, 2020, 2021
3. Hospital admissions for dog attacks and dog related injuries broken down by (calendar) year for the years 2017, 2018, 2019, 2020, 2021
4. A breakdown of the ages of patients in question 3 broken down by (calendar) year for the years 2017, 2018, 2019, 2020, 2021

Dog attacks and dog related injuries.060722.docx

Dog bites. 170821.docx

1. For 2021; by the Hospitals in your trust please can I receive a monthly breakdown on the number of people visiting hospitals having been “Bitten or stuck by a dog”
2. For 2020; by the Hospitals in your trust please can I receive a monthly breakdown on the number of people visiting hospitals having been “Bitten or stuck by a dog”
3. For 2019; by the Hospitals in your trust please can I receive a monthly breakdown on the number of people visiting hospitals having been “Bitten or stuck by a dog”

Download response Dog bites. 170821.docx

Dog bites or attacks 2013 – 2016. 100717

1. How many persons have been admitted to hospitals in your Trust for injuries caused by dog bites or attacks?
2. How many persons required inpatient treatment for injuries caused by dog bites or attacks?
3. How many persons required surgery for injuries caused by dog bites or attacks?
4. How many persons suffered fatal injuries for injuries caused by dog bites or attacks?
5. What the total cost of treating injuries caused by dog bites or attacks was to your trust?
Please provide information for the following calendar years:
2013
2014
2015
2016 to date

Download response Dog bites or attacks 2013 – 2016. 100717

Dog bites or attacks.270123.docx

Please can you provide me with the following information for the (calendar) years:
i)2017 ii) 2018 iii) 2019 iv) 2020 v) 2021 vi) 2022
*If possible, can an age or age range be provided for each?
1) The number of persons who visited A&E in your NHS Trust (Maidstone and Tunbridge Wells) for injuries caused by dog bites or attacks?
2) How many persons required inpatient treatment for injuries caused by dog bites or attacks?
3) How many persons required surgery for injuries caused by dog bites or attacks?
4) How many persons suffered fatal injuries caused by dog bites or attacks?

Dog bites or attacks.270123.docx

Dravet syndrome. 281021.docx

1. What services are provided by your hospital for patients with Dravet syndrome?
a. Treatment initiation
b. Titration of dose (consider both starting and maintenance treatment)
c. Monitoring (incl. echocardiographies, liver function tests, etc.)
d. Review of clinical presentations (frequency, duration)
e. On-going prescription of treatments
f. Completing the Blueteq forms
g. Other ….
2. If services are not provided at your hospital
a. Where are patients referred to?
b. What services do they receive at the other location (see above list for examples)?

Download response Dravet syndrome. 281021.docx

Drug abuse related illness. 220119

In the last FIVE years to most recent figures:
1. How many patients have been admitted to MTW Hospitals with drug abuse related illnesses?
2. How many of these cases were linked to synthetic cannaboids (Spice)?
3. How many deaths came as a result of synthetic cannaboids (Spice)?
4. The number of these people were homeless (no fixed abode) or not?
Could this please be arranged into separate tables for each year.

Download response Drug abuse related illness. 220119

Drug abuse related illness. 220119

In the last FIVE years to most recent figures:
1. How many patients have been admitted to MTW Hospitals with drug abuse related illnesses?
2. How many of these cases were linked to synthetic cannaboids (Spice)?
3. How many deaths came as a result of synthetic cannaboids (Spice)?
4. The number of these people were homeless (no fixed abode) or not?
Could this please be arranged into separate tables for each year.

Download response Drug abuse related illness. 220119

Drug and alcohol admissions for homeless patients 2014-2016. 300317

1. How many homeless people (i.e. People with no fixed abode) have been admitted to hospitals within Maidstone and Tunbridge Wells NHS Trust for problems related to drugs? Could you please provide these figures for each of the last three calendar years?
2. How many homeless people (i.e. people with no fixed abode) have been admitted to hospitals within Maidstone and Tunbridge Wells NHS Trust for problems related to alcohol? Could you please provide these figures for each of the last three calendar years?

Download response Drug and alcohol admissions for homeless patients 2014-2016. 300317

Drug and alcohol abuse.111122.docx

1. In the years 2019, 2020, 2021 and 2022 so far, how many under 18-year olds have been admitted to A&E for drug abuse?
2. In the years 2019, 2020, 2021 and 2022 so far, how many under 18-year olds have been admitted to A&E for alcohol abuse?
3. In each year, what was the youngest age of someone who was admitted to A&E for drug abuse?
4. In each year, what was the youngest age of someone who was admitted to A&E for alcohol abuse?

Drug and alcohol abuse.111122.docx

Drug coated balloons 060317

1. How many Drug Coated Balloons were used by your Trust for Peripheral Vascular interventions in 2016?
2. What was the total spend by the Trust on Drug Coated Balloons for Peripheral Vascular interventions in 2016?
3. How many Drug Coated Balloons were used by your Trust for Arterio-venous (AV) percutaneous interventions in 2016?
4. What was the total spend by the Trust on Arterio-venous (AV) percutaneous interventions in 2016?
5. What was the total spend by the Trust on Drug coated balloons for Arterio-venous (AV) percutaneous interventions in 2016?

Download response Drug coated balloons 060317

Drug related admissions.160822.docx

1. The number of hospital admissions for drug-related mental and behavioural disorders in
(a) 2020/21
(b) 2021/22
and if possible, broken down by drug type
2. The number hospital admissions for poisoning by drug misuse in
(a) 2020/21
(b) 2021/22
and if possible, broken down by drug type
3. The number of admissions with a primary or secondary diagnosis of drug-related mental and behavioural disorders in
(a) 2020/21
(b) 2021/22
and if possible, broken down by drug type

Drug related admissions.160822.docx

Drug related A&E admissions. 210218

1. The number of A&E attendances where the word ‘cocaine’ appears in the free-text diagnosis field.
2. The number of A&E attendances where the word ‘ecstasy’ appears in the free-text diagnosis field.
3. The number of A&E attendances where the word ‘ketamine’ appears in the free-text diagnosis field.
4. The number of A&E attendances diagnosed as F14 under the ICD-10 classification system.
5. The number of A&E attendances diagnosed as F15 under the ICD-10 classification system.
6. The number of A&E attendances diagnosed as F16 under the ICD-10 classification system

Download response Drug related A&E admissions. 210218

Drug related deaths. 121119

How many drug-related deaths were recorded by Maidstone and Tunbridge Wells NHS Trust each year, for the years?
2016, 2017, 2018 and 2019

Download response Drug related deaths. 121119

E-scooter and cycling admissions.270922.docx

1i. How many people were treated for injuries relating to e-scooters at your hospitals’ A&E departments in each of the following years:
a. 2020
b. 2021
c. 2022 (up to and including 31st August)
1ii. In each of the following years, how many of the people treated for injuries relating to e-scooters had consumed alcohol:
a. 2020
b. 2021
c. 2022 (up to and including 31st August)
2i. How many people were treated for injuries relating to cycling at your hospitals’ A&E departments in each of the following years:
a. 2020
b. 2021
c. 2022 (up to and including 31st August)
2ii. In each of the following years, how many of the people treated for injuries relating to cycling had consumed alcohol:
a. 2020
b. 2021
c. 2022 (up to and including 31st August)
3i. How many people were treated for injuries relating to motorbikes at your hospitals’ A&E departments in each of the following years:
a. 2020
b. 2021
c. 2022 (up to and including 31st August)
3ii. In each of the following years, how many of the people treated for injuries relating to motorbikes had consumed alcohol:
a. 2020
b. 2021
c. 2022 (up to and including 31st August)
4. How many people were treated for head injuries relating to e-scooters at your hospitals’ A&E departments in each of the following years:
a. 2020
b. 2021
c. 2022 (up to and including 31st August)
5. How many people were treated for head injuries relating to cycling at your hospital’s A&E department in each of the following years:
a. 2020
b. 2021
c. 2022 (up to and including 31st August)

E-scooter and cycling admissions.270922.docx

 

E scooter injuries.180823.docx

All questions are shown as received by the Trust.
Please can you tell me, for each of the last three calendar years, up to and including this one to date:
1. How many children (under 18) have been treated for injuries caused as a result of riding an e scooter or being involved in a collision with one?
2. How many of these children died?
3. In each case, please give brief details of injuries sustained and length of stay required in hospital

E scooter injuries.180823.docx

Eating Disorders in Accident and Emergency. 080621

1. The number of patients that presented to Accident & Emergency/the Emergency Department due to issues relating to Eating Disorders from 01/01/16 to 31/12/20. Data given separately for each calendar year 2016-2020.
2. The number of patients from point 1 who were discharged home without being seen by psychiatry, and the number of patients from point 1 who were discharged home without being referred to another service. Data given separately for each calendar year 2016-2020.
3. The number of patients from point 1 who died within 28 days of being discharged from A&E, for each year since 2016.Data given separately for each calendar year 2016-2020.

Download response Eating Disorders in Accident and Emergency. 080621

Effects of heat and light and sunburn.121222.docx

1. The number of A&E attendances and/or admission episodes between 1 June 2022 and 31 August 2022 with a diagnosis of sunburn and/or effects of heat and light. For each instance recorded please specify the diagnosis, the date of the episode and age of the patient.
2. The number of A&E attendances and/or admission episodes between 1 June 2021 and 31 August 2021 with a diagnosis of sunburn and/or effects of heat and light. For each instance recorded please specify the diagnosis, the date of the episode and age of the patient.
3. The number of A&E attendances and/or admission episodes between 1 June 2020 and 31 August 2020 with a diagnosis of sunburn and/or effects of heat and light. For each instance recorded please specify the diagnosis, the date of the episode and age of the patient.

Effects of heat and light and sunburn.121222.docx

Electronic database to manage the follow up of implanted cardiac devices and pacemakers.300922.docx

1 – Is the Trust currently using an electronic database to manage the follow up of implanted cardiac devices and pacemakers?
2 – If yes:
a) What is the name of the system?
b) When is the contract renewal date?

Electronic database to manage the follow up of implanted cardiac devices and pacemakers.300922.docx

Electronic Management System for Implanted Cardiac Devices. 111120

Is the Trust currently using an Electronic Management System for Implanted Cardiac Devices?
If so, which system are you using?
If so, what is the contract end date?

Download response Electronic Management System for Implanted Cardiac Devices. 111120

Electrophysiology equipment. 300317

1. Does your Trust have an Electrophysiology Lab or perform Electrophysiology Procedures?
2. How many 3D Mapping Systems are installed in your Trust?
3. How many Electrophysiology Recording Systems are installed in your Trust?
On average, what is the lifespan of these EP Recording systems?
What brands are they?
Were there any EP Recording systems purchased in the last 12 months?
If yes, how many?
Were these to replace old machines or new purchases?
4. How many Intracardiac Echocardiography (ICE) Systems are installed in your Trust?
5. How many Radiofrequency (RF) Ablation Generators are installed in your Trust?
6. How many cardiac stimulators are installed in your Trust?
7. How many Remote Navigation Systems (from Stereotaxis) are installed in your Trust?

Download response Electrophysiology equipment. 300317

Emergency admissions for Asthma, Epilepsy and Diabetes 2014 – 2016. 270317

1. For the last 4 quarters from January 2016 – December 2016, please provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
2. For the last 4 quarters from January 2016 – December 2016, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
3. For the 4 quarters January 2015 – December 2015, please could you provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
4. For the 4 quarters January 2015 – December 2015, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.
5. For the 4 quarters January 2014 – December 2014, please could you provide a breakdown of the number of emergency admissions by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2.

6. For the 4 quarters January 2014 – December 2014, please could you provide a breakdown of the number of emergency attendances by age group, broken down by quarter, for the following conditions: (a) asthma (b) epilepsy (c) diabetes type 1 & type 2?

Download response Emergency admissions for Asthma, Epilepsy and Diabetes 2014 – 2016. 270317

Emergency admissions for people over 65. 120422.docx

In your NHS Trust, monthly from January 2015 to December 2021
1. how many emergency admissions were recorded for
a) people over 65
b) people over 65 with dementia?
2. separately over 65’s with the following as their primary reason for emergency admission:
a. a fall
b. a Urinary Tract Infection
c. Delirium
d. Dehydration
e. Gastroenteritis
f. Influenza
g. Chest Infections/ Pneumonia
h. Ear, nose or throat infections
3. For each category above – how many were care home residents, ideally broken down by LA, NHS or Private?

Emergency admissions for people over 65. 120422.docx

Emergency admissions from private hospitals. 031219

1. Please provide the number of emergency admissions to your trust from independent sector hospitals for the past 3 years (2016/17 to 2018/19 inclusive).
2. Please provide the number of elective admissions to your trust from independent sector hospitals over the same period
3. If possible, please indicate provide an estimate of the cost of treatment for elective and emergency admissions from independent sector hospitals over the same period

Download response Emergency admissions from private hospitals. 031219

Emergency centres. 260821.docx

1. How many patients arrived at the trust via ambulance in 2019/20?
2. How many patients arrived at the trust via ambulance in 2020/21?
3. How many patients were seen in total in the Type 1 emergency centre in 2019/2020?
4. How many patients were seen in total in the Type 1 emergency centre in 2020/2021?
5. How many patients were seen in total in the Type 3 & 4 emergency centres in 2019/2020?
6. How many patients were seen in total in the Type 3 & 4 emergency centres in 2020/2021?

Download response Emergency centres. 260821.docx

Emergency department closures 2010-2017. 240817

1. On how many occasions have your emergency departments been closed to new admissions during financial years 2010/2011, 2014/15, 2015/16 and 2016/17?

2. For each emergency department closure, please state the duration of and the reason for the closure.

3. For each emergency department closure, please also state the number of patients which were diverted elsewhere as a result of the department closing.

Download response Emergency department closures 2010-2017. 240817

Emergency department delays.040422.docx

For each month in 2021 (January – December inclusive)
1. How many patients spent 6 hours or more in the emergency department in your Trust from the time of arrival?
2. How many patients spent 8 hours or more in the emergency department in your Trust from the time of arrival?
3. How many patients spent 12 hours or more in the emergency department in your Trust from the time of arrival?
4. What percentage of type 1 attendances spent 12 hours or more in the emergency department from time of arrival?

Emergency department delays.040422.docx

Emergency General Surgery 2022 Survey. 160322.docx

1. What is the name of the hospital the following questions will relate to?
2. How many acute inpatient beds did this hospital have for 2021?
3. How many emergency (unplanned) admissions did this hospital have under the acute general surgery services in 2021?
4. How many cases did this hospital submit to the National Emergency Laparotomy Audit (NELA) in 2021?
5. Which of the following organisation systems describes how emergency general surgical admissions are organised in this hospital?
a. Mixed general surgical take under a non-specific general surgery consultant
b. Daily allocation of acute admissions to a general surgery subspeciality (Upper GI / Colorectal / Hepatobiliary)
c. Dedicated Emergency General Surgery consultants / service during weekdays only (Monday to Thursday, or Monday to Friday)
d. Dedicated Emergency General Surgery consultants / service weekdays and weekend
e. Other (please state)
6. If your hospital runs a dedicated emergency general surgery service (answers c or d above), how many dedicated emergency general surgery consultants form the rota for this service?
7. If this hospital does not already have an emergency general surgery service, does it plan to change its service to this form in the next 5 years?

Emergency General Surgery 2022 Survey. 160322.docx

Emergency Re-admissions 2012-2017. 200917

1. EMERGENCY READMISSIONS BROKEN DOWN BY DAY FOR THE LAST FIVE YEARS

2. REASONS RECORDED FOR EMERGENCY READMISSION

Download response Emergency Re-admissions 2012-2017. 200917

Emergency readmission rates. 160119

1. Emergency readmissions broken down by day 2012/13 – 2017/18
2. How is the data collected on emergency readmissions used or analysed to i) prevent emergency readmissions; or ii) improve patient experience?

Download response Emergency readmission rates. 160119

Emergency transfers from private hospitals.

I am writing to you under the Freedom of Information Act 2000 to request the following information from your hospital trusts.
How many patients arrived in A&E as an emergency transfer from Kent’s private hospitals, for the following financial years 2010-11, 2011-12, 2012-13, 2013-14, and 2014-15?

Would it be possible to list which private hospitals the patients were transferred from for each of the financial years above?

Would it be possible to list some of the conditions that the patients were admitted with?
I have identified the following list of private hospitals in Kent:
1. KIMS Maidstone
2. Nuffield Health Tunbridge Wells
3. Spire Tunbridge Wells
4. Spire Alexandra Walderslade
5. BMI Somerfield Maidstone
6. BMI Chaucer Canterbury
7. BMI Fawkham Manor
8. BMI Sloane Beckenham
9. BMI Chelsfield Park Orpington
10. Spencer Ashford
11. Spencer Margate
12. Benenden

Download response Emergency transfers from private hospitals 080116

End of Life payments. 260619

1. The percentage of patients who have died on the Trust’s end-of-life care plan against the Trust’s target for the number of patients who should die on this plan over the last three years, divided by the year.
E.g. between 1 January 2016 and 31 December 2016, 43 per cent of patients died on the plan against a target of 35 per cent.
Note: If no such target exists, please make this clear.
2. The amount received by the Trust, via the Commissioning for Quality and Innovation (CQUIN) system or similar, for hitting targets related to its end-of-life care plan for the last three years, divided by the year.
E.g. between 1 January 2016 and 31 December 2016, the Trust received £X via CQUIN for achieving goals involving its ICP.
Note: If no such payments were made, please make this clear.

Download response End of Life payments. 260619

Endoscopy services. 160518

I understand your trust uses external providers to deliver some aspects of your trusts Endoscopy service. Please kindly outline which suppliers you utilise and the total amount spent for Insourced or outsourced Endoscopy services during the months of November 2017 – March 2018.

Download response Endoscopy services. 160518

Endoscopy, Urology, Ophthalmology and Dermatology. 251120

Endoscopy
1. How many patients are on the endoscopy waiting list?
2. Do you use any insourcing companies for the following?
a. Gastroenterology Outpatients clinics
b. Diagnostic Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. What are the average and maximum number of JAG points completed per list (i.e. per endoscopist per day)?
9. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
10. The total number of procedures completed by each supplier
11. The total spends completed by each supplier
12. How many endoscopy rooms do you have in your trust?
13. Please can you provider the contact information for your service delivery or general managers for endoscopy
14. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20
Urology Surgery
1. How many patients are on the urology waiting list?
2. Do you use any insourcing companies for the following?
a. Urology Outpatients Surgical clinics
b. Urology Diagnostic and therapeutic surgical Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
9. The total number of procedures completed by each supplier
10. The total spends completed by each supplier
11. Please can you provider the contact information for your service delivery or general managers for Urology services
12. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20
Ophthalmology Surgery
1. How many patients are on the ophthalmology waiting list?
2. Do you use any insourcing companies for the following?
a. Ophthalmology Outpatients Surgical clinics
b. Ophthalmology Diagnostic and therapeutic surgical Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
9. The total number of procedures completed by each supplier
10. The total spends completed by each supplier
11. Please can you provider the contact information for your service delivery or general managers for Ophthalmology services
12. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20
Dermatology Surgery
1. How many patients are on the dermatology waiting list?
2. Do you use any insourcing companies for the following?
a. Dermatology Outpatients Surgical clinics
b. Dermatology Diagnostic and therapeutic surgical Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
9. The total number of procedures completed by each supplier
10. The total spends completed by each supplier
11. Please can you provider the contact information for your service delivery or general managers for Dermatology services
12. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20

Download response Endoscopy, Urology, Ophthalmology and Dermatology. 251120

Enforced DNR. 300317

The number of patients who have been taken to the Royal Courts of Justice Court of Protection, to have a DNR placed upon their lives by your hospital. I would like to know if the patient had a Lasting Power of Attorney and the sex, age, ethnicity of the patients and the length of time each case took & outcomes of each case. From when the hospital opened to the present day.

Download response Enforced DNR. 300317

Epilepsy Treatment.270223.docx

In the last 12 months of available data:
1a. What number of unique patients have been treated for Lennox-Gastaut syndrome, Dravet Syndrome and Tuberous Sclerosis Complex? Please give answers for each condition separately.
1b. For each indication (Lennox-Gastaut syndrome, Dravet Syndrome and Tuberous Sclerosis Complex), what number of these have been treated in a paediatric environment?
2a. How many patients have been treated with Epidyolex in a paediatric environment?
3a. Can you please detail which NHS Trusts/ Health Boards these patients have been referred from?

Epilepsy Treatment.270223.docx

Escalation procedures for ITU/ICU/HDU.

This is FOI request, please tell me what happens if you get patients for ITU / ICU / HDU but they are full with other patients, what do you do?

Download response Escalation procedures for ITU/ICU/HDU 190416

EVAS for AAA repairs. 220920

Has your Trust ever used the Nellix Endovascular Aneurysm Sealing (EVAS) System in patients to treat abdominal aortic aneurysms (AAA)?

Download response EVAS for AAA repairs. 220920

Eye damage caused by lasers

The number of patients admitted for eye damage caused by lasers over the last three financial years. To clarify, this is from hand-held lasers, not complications from laser eye surgery.

2013-14

2014-15

2015-16

Download response Eye damage caused by lasers 060916

Four hours A&E performance.131023.docx

All questions are shown as received by the Trust.
Could you provide data for each site, for both admitted and non admitted patients, T1 activity only?

Four hours A&E performance.131023.docx

Four hours A&E performance.310823.docx

All questions are shown as received by the Trust.
For each of your type one A&E departments, please provide site-specific data on four hours A&E performance (so xx% for A&E 1, xx% for A&E 2 etc)

For each site, please split this between a) admitted patients b) all patients (both admitted and non admitted)

Please provide this by month from the start of 2022/23, including for 2023/24 up to 29 June 2023 (or the latest date possible). Please also provide aggregate four hours performance data for both 2022/23 and 2023/24 so far.

Please provide the data on the template provided.

Four hours A&E performance.310823.docx

Frequent attenders of ED services.280423.docx

• Does Maidstone Hospital have a frequent attenders service? Or a case management meeting only?
• What date (month and year) did the frequent attenders service or case management meeting start at Maidstone Hospital?
• If there used to be one and it does not exist anymore, what date did it start and what date did it cease?
• Is the service run by the liaison team (or was if the service is now closed) or by the ED team? What professionals make (or made) part of the service team/meeting?

• Does Tunbridge Wells Hospital have a frequent attenders service? Or a case management meeting only?
• What date (month and year) did the frequent attenders service or case management meeting start at Tunbridge Wells Hospital?
• If there used to be one and it does not exist anymore, what date did it start and what date did it cease?
• Is the service run by the liaison team (or was if the service is now closed) or by the ED team? What professionals make (or made) part of the service team/meeting?

Frequent attenders of ED services.280423.docx

Genetic haemochromatosis 1 January 2015 to 31st December 2015 111116

For the period 1 January 2015 to 31st December 2015 (or the most recent full 12 month period if more recent data is available) :

A. The number of patients diagnosed with genetic haemochromatosis who have been provided with genetic testing for haemochromatosis and/or genetic counselling in relation to their condition.

B. The number of marriage or civil partners of patients diagnosed with genetic haemochromatosis who have been provided with genetic testing for haemochromatosis and/or genetic counselling in relation to their partners’ condition.

C. The number of siblings of patients diagnosed with genetic haemochromatosis who have been provided with genetic testing for haemochromatosis and/or genetic counselling in relation to their sibling’s condition.

D. A copy of your protocol or pathway applicable to the provision of genetic testing/counselling for families of patients diagnosed with genetic haemochromatosis.

Download response Genetic haemochromatosis 1 January 2015 to 31st December 2015 111116

GP’s in A&E. 110118

1. Is the Trust planning to use GPs within any of its emergency departments over the winter months?

2. Has the Trust recruited/is the Trust planning to recruit GPs to staff its emergency departments over the winter months? If so, how many will be/have been recruited? If so, please confirm (i) the cost of recruitment and (ii) the planned duration of the post(s).

3. If the Trust is planning to use GPs in A&E departments, how will they fit into the current system/how will they be used?

4. If the Trust is planning to use GPs in A&E departments, why is this necessary?

5. If the Trust is NOT planning to use GPs in A&E departments, will it be necessary to employ more consultants/nurses/locums for this coming winter? If so, why?

Download response GP’s in A&E. 110118

Growth Hormone and Spasticity. 310821.docx

1. How many patients has your trust treated in the last 12 months with the following drugs?
a. Genotropin
b. Humatrope
c. Norditropin
d. Nutropin
e. Omnitrope
f. Saizen
g. Zomacton
h. Any other Somatropin (please specify)
2. Please provide the number of patients under the age of 16 that were treated in the last 12 months with each of the following drugs:
a. Genotropin
b. Humatrope
c. Norditropin
d. Nutropin
e. Omnitrope
f. Saizen
g. Zomacton
h. Any other Somatropin (please specify)
3. Within your trust, how many patients have been diagnosed (primary or secondary diagnosis) in the past 12 months for the following conditions:
a. Neuromuscular dysfunction of bladder (ICD-10 Code N31.9)
b. Cervical dystonia (ICD-10 code G24.3)
4. For patients diagnosed with neuromuscular dysfunction of bladder as per question 3 above, how many patients have been treated in the last 3 months with the following products:
a. Botox
b. Dysport
c. Xeomin
5. For patients diagnosed with cervical dystonia as per question c above, how many patients have been treated in the last 3 months with the following products:
a. Botox
b. Dysport
c. Xeomin

Download response Growth Hormone and Spasticity. 310821.docx

Haemochromatosis. 261016

A. the number of patients treated with Haemochromatosis in 2015 who are in maintenance phase of the treatment (*)
B. the number of patients treated with Haemochromatosis in 2015 who are in PRE-maintenance phase of the treatment (+)
C. a copy of the clinical protocol(s) used to treat haemochromatosis
D. a copy of the clinical protocol(s) for therapeutic venesection

(*) “Maintenance phase” relates to patients whose ferritin is <=50 ug/L
(+) “PRE-maintenance phase” relates to patients whose ferritin is in excess of 50 ug/L

Download response Haemochromatosis. 261016

Haemofiltration or continuous renal replacement therapy (CRRT). 020518

Please provide me with the following information relating to the provision of haemofiltration or continuous renal replacement therapy (CRRT) within the intensive care units (ICU’s) of your NHS Trust:
1. The name of your Trust.
2. The names of the hospitals within your Trust.
3. The ICU’s conducting haemofiltration / CRRT within your Trust.
4. The number of patients treated with CRRT per year within your Trust.
5. Current provider of CRRT services to your Trust.
6. The preferred CRRT modality.
7. The name of the Lead Clinician, in each hospital, responsible for CRRT services.
8. The name of the person in Procurement responsible for the CRRT contract in your Trust.
9. Date of the next tender for CRRT services.
10. A copy of the previous successful tender for CRRT services.

Download response Haemofiltration or continuous renal replacement therapy (CRRT). 020518

Haemofiltration or continuous renal replacement therapy (CRRT).260623.docx

1. The name of your Trust.
2. The ICU’s conducting haemofiltration / CRRT within your Trust.
3. Current provider of CRRT services to your Trust?
4. Did you purchase additional CRRT machines during the covid-19 pandemic?
5. Date of the current contract for CRRT services.
6. What is the model of CRRT machine you are using in ICU?
7. The number of haemofiltration/CRRT machines you have in ICU?

Haemofiltration or continuous renal replacement therapy (CRRT).260623.docx

Headaches and Chronic Migraines. 091018

1.) Does your trust run a headache clinic? YES/NO
If YES how many per week/month [delete as appropriate]
2.) Does your trust run a migraine clinic? YES/NO
If YES how many per week/month [delete as appropriate]
3.) Does your trust run a botulinum A [botox] clinic (regardless of any indication or department)? YES/NO
4.) In the past 6 months how many patients have been treated for chronic migraine?
5.) Could you please provide me with the following numbers of patients treated in the last 6 months, with the following drugs for Chronic Migraine. If none, please state None.
• Botox
• Dysport
• Xeomin
• Topiramate / anticonvulsant
• Beta-blocker
• Calcium channel blocker
• Anti-serotonergic
• Tricyclic anti-depressant

Download response Headaches and Chronic Migraines. 091018

 

Endoscopy

Clinical Insourcing. 090320

1. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the current 2019/20 financial year to date. Please state number of periods (i.e. 9 months).
2. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2018/19 financial year.
3. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2017/18 financial year.
4. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2016/17 financial year.
5. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2015/16 financial year.

Download response Clinical Insourcing. 090320

Clinical Insourcing. 101120

1. Do you insource any clinical services and which ones?
2. Do you have a contract with any company and who is that and for which insourcing services?
3. Did you procure this under any current framework and if so which one?
4. How is this charged for by the third party service provider per patient/per tariff?
5. Are you currently being charged below, on or above NHS tariff?
6. Do you use substantively employed Trust staff to delivery all or part of the insourced service?
7. The total number of procedures completed by each supplier (named) in the following categories:
a. Endoscopy
b. Ophthalmology
c. ENT
d. Neurology
e. Dermatology
f. All Other
8. The total spend completed by each supplier (named) per service area
9. Please give an annual breakdown per annum of insourcing services per service area:
a. 15/16
b. 16/17
c. 17/18
d. 18/19

Download response Clinical Insourcing. 101120

Clinical Insourcing. 190320

1. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the current 2019/20 financial year to date. Please state number of periods (i.e. 9 months).
2. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2018/19 financial year.
3. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2017/18 financial year.
4. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2016/17 financial year.
5. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2015/16 financial year.

Download response Clinical Insourcing. 190320

Clinical Insourcing. 260521

1. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the current 2020/21 financial year. Please breakdown this FY only into each month.
2. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2019/20 financial year.
3. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2018/19 financial year.
4. Total spend on the use of clinical insourcing (not agency/locum or outsourcing) in the 2017/18 financial year.

Download response Clinical Insourcing. 260521

Clinical Insourcing and Outsourcing. 111121.docx

1. Do you insource clinical services and if so, which ones?
2. Do you have any current contracts in place with a company for these insourced services, and if so which services?
3. How much have you spent on insourcing clinical services per annum for the past 3 years?
4. Do you outsource clinical services and if so, which ones?
5. Do you have any current contracts in place with a company for these outsourced services, and if so which services?
6. How much have you spent on outsourcing clinical services per annum for the past 3 years?

Download response Clinical Insourcing and Outsourcing. 111121.docx

Company spend. 270520

Under the FOI request please provide total spend for the 2018/19 and the 2019/20 financial years (to date and periods stated) for the following organisations:
• 18 Week Support (including LLP variants)
• The Endoscopy Group
• Gutcare
• Endocare Diagnostics
• Medicare Insourcing
• Skin Cancer Care UK
• Eden Uk Clinical Services
• Glanso
• Alliance Medical
• Synaptik
• Elective Services Limited
• Ics Insourcing / Diagnostics
• Totally Healthcare
• Your Medical Services
• Remedy Healthcare Solutions
• Medinet Clinical Services Limited( (including Medinet Wales)
• SHS Partners
• DMC Healthcare
• The Aberdeen Clinic
• Diagnostic World
• Omnes Healthcare
• Healthcare Business Solutions

Download response Company spend. 270520

Consultant grade doctors who undertake independent ERCP in your endoscopy units. 190421

1) How many consultant grade doctors undertake independent ERCP in your endoscopy units?
2) How many consultant grade doctors undertaking independent ERCP in your endoscopy units are women?

Download response Consultant grade doctors who undertake independent ERCP in your endoscopy units. 190421

Contracted provision of endoscopy specialised staff.300822.docx

We would like to get the number of contracts your trust has with staffing agencies for the provision of endoscopy specific staff including but not limited to consultant gastroenterologists, general surgeons, nurses (and specialist nurses) and other support staff.
Could you please provide:
a. The name of the provider
b. Start and End date of contract
c. Staff contracted (FTE)
d. Split of staff by level – FTE (consultant gastroenterologist, nurse, specialist nurse, anaesthesiologist, etc)
e. Value of contract
f. JAG accredited staff (Y/N is enough)

Contracted provision of endoscopy specialised staff.300822.docx

Contracted provision of endoscopy staff and facilities.260822.docx

I am writing with a Freedom of Information request regarding the contracted provision of endoscopy staff and facilities, from the independent sector, at your trust. We would like to get data on the contracts your trust has with independent providers that result in:
1. Your Trust’s staff using independent provider facilities (rooms, instruments and scopes, decontamination equipment) to perform endoscopies, or
2. Complete outsource of full service, i.e., your Trust is paying for patients to get endoscopies by independent sector staff in independent sector facilities.
For those contracts, could you please provide:
– The name of the provider
– Start and End date of contract
– Type of contract (facilities only, facilities and staff (service model))
– Value of contract
– JAG accreditation (Y/N is enough) – refers to either facilities or staff and facilities depending on contract
– Number of endoscopies (or number of rooms and number of FTE staff) outsourced (if full service contract type)
– Number of beds (and/or) rooms contracted (if facilities contract)

Contracted provision of endoscopy staff and facilities.260822.docx

Endoscope repair and service contract 2015-2016.

1) Between 1st April 2015 and 31st March 2016, in monetary terms, how much did your Trust spend by individual hospital, on either repairing flexible endoscopes and/or spend on service contracts for the following equipment:
• Gastroscopes
• Colonoscopes
• Duodenoscopes
• Bronchoscopes
• Flexible cystoscopes

Download response Endoscope repair and service contract 2015-2016.

Endoscopes.011122.docx

1. Approximately how many endoscopes does the trust own?
2. What brands of endoscope does the Trust own?
3. On average how old are the endoscopes that the Trust owns?
4. Does the trust subcontract the maintenance of endoscopes and associated equipment such as stack systems and monitors to an outside provider(s) or does it maintain the devices using internal engineers?
5. If an external provider(s) is used, what is the name of the company(s)?
6. If an external provider(s) is used, what was the value of the contract when awarded?
7. If an external provider(s) is used, what is the contract type – PPM/ Fully-Comprehensive / Ad-hoc support?
8. If an external provider(s) is used, what is the contract renewal date(s)?
9. Does your contract include the provision of loan endoscopes to temporarily replace endoscopes that are in for repair?
10. Please provide the name, email address and phone number of the role responsible for managing endoscopy equipment within the trust.

Endoscopes.011122.docx

Endoscopes.281022.docx

1. Does the Trust rent endoscopes or stack systems?
2. What make/brand/manufacturer of endoscopes does the Trust rent?
3. On average, how long would the Trust rent an endoscope for?
4. How many endoscopes would the Trust rent at any given time?
5. Which company supplies the Trust with rental endoscopes?
6. Please provide the name, job title, email address and phone number for the person at the Trust responsible for sourcing/managing rental endoscopes.
7. If the Trust does not rent endoscopes or stack systems, would it be a service the trust is interested in?

Endoscopes.281022.docx

Endoscopic Retrograde Cholangiopancreatography (ERCP).031122.docx

1. Do you perform Endoscopic Retrograde Cholangiopancreatography (ERCP)?
2. How many ERCP procedures have you performed in the following financial years: – 2018/19, 2019/20, 2020/21?
3. How many ERCP lists are run per week?
4. How many practitioners perform ERCP?
5. How many are: – Physicians/Surgeons/Radiologists/Other (please specify)?
6. Do trainees perform ERCP?
7. Is there dedicated lists?

Endoscopic Retrograde Cholangiopancreatography (ERCP).031122.docx

Endoscopy. 100521

1. a. How many endoscopy procedure rooms do you have in your Trust?
b. Are patients able to be separated by gender from admission through to recovery? (Y/N)
c. Do you use single sex lists? (Y/N)
2. a. Approximately, how old is your endoscopy decontamination suite?
b. When was it last refurbished?
c. Will the Trust need to procure new scopes in the next 12 months? (Y/N)
3. a. Have you used a mobile endoscopy service in the last 12 months? (Y/N)
b. Approximately how many endoscopy procedures were undertaken in a mobile unit over the last 12 months?
4. Is in-house endoscopy capacity in the Trust near or fully utilised? (Y/N)

Download response Endoscopy. 100521

Endoscopy Procedures

1. Current waiting list time(s) for the below Endoscopy procedures in line with Joint Advisory Group (JAG) guidelines?
· OGD – Gastroscopy
· Flexible Sigmoidoscopy
· Colonoscopy
· EUS
· ERCP
2. Do you currently require assistance with a locum Consultant to help clear your current backlog / waiting list?
3. Number of Endoscopy sessions run weekly, and how many theatres available?
4. Do you operate over 5 days (Mon-Fri) or do you offer a full 7 day service?
5. The rate per session (or per hour) for Endoscopy waiting list initiative work that the Trust has paid to Consultant?
6. Please could you also tell me the sessional rate (or per hour) for Endoscopy waiting list initiative work paid to Locum Consultants between the same time period?
7. Please could you also tell me whether the hospital has ever used agencies to supply Endoscopy Consultants?
If so, which agencies have been used?

Download response Endoscopy Procedures 111115

Endoscopy systems 060317

1. Do you currently have endoscopy reporting software installed?
2. if the answer to Q1 is yes, who is the software provider?
3. If the answer to Q1, is yes, was the software installed under a fixed term contract or on an annual renewal basis?
4. if the software was installed under a fixed term contract,when does this contract expire?
5. If the answer to Q1 is no, are there any plans to install endoscopy reporting software?
6. if the answer to Q1 is no, is this because you do not provide endoscopy to patients?

Download response Endoscopy systems 060317

Endoscopy, Urology, Ophthalmology and Dermatology. 251120

Endoscopy
1. How many patients are on the endoscopy waiting list?
2. Do you use any insourcing companies for the following?
a. Gastroenterology Outpatients clinics
b. Diagnostic Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. What are the average and maximum number of JAG points completed per list (i.e. per endoscopist per day)?
9. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
10. The total number of procedures completed by each supplier
11. The total spends completed by each supplier
12. How many endoscopy rooms do you have in your trust?
13. Please can you provider the contact information for your service delivery or general managers for endoscopy
14. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20
Urology Surgery
1. How many patients are on the urology waiting list?
2. Do you use any insourcing companies for the following?
a. Urology Outpatients Surgical clinics
b. Urology Diagnostic and therapeutic surgical Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
9. The total number of procedures completed by each supplier
10. The total spends completed by each supplier
11. Please can you provider the contact information for your service delivery or general managers for Urology services
12. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20
Ophthalmology Surgery
1. How many patients are on the ophthalmology waiting list?
2. Do you use any insourcing companies for the following?
a. Ophthalmology Outpatients Surgical clinics
b. Ophthalmology Diagnostic and therapeutic surgical Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
9. The total number of procedures completed by each supplier
10. The total spends completed by each supplier
11. Please can you provider the contact information for your service delivery or general managers for Ophthalmology services
12. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20
Dermatology Surgery
1. How many patients are on the dermatology waiting list?
2. Do you use any insourcing companies for the following?
a. Dermatology Outpatients Surgical clinics
b. Dermatology Diagnostic and therapeutic surgical Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
9. The total number of procedures completed by each supplier
10. The total spends completed by each supplier
11. Please can you provider the contact information for your service delivery or general managers for Dermatology services
12. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20

Download response Endoscopy, Urology, Ophthalmology and Dermatology. 251120

Flexible endoscope repair and maintenance.210323.docx

– When does the existing maintenance contract(s) expire for the Trust’s flexible endoscope inventory?
– Who is your current service provider of flexible endoscope repair & maintenance?

Flexible endoscope repair and maintenance.210323.docx

Flexible endoscope repair & maintenance.030222.docx

1. When does the existing maintenance contract(s) expire for the Trust’s flexible endoscope inventory?
2. Who is the current service provider of flexible endoscope repair & maintenance?

Flexible endoscope repair & maintenance.030222.docx

Flexible endoscope repair & maintenance. 190521

1. When does the existing maintenance contract(s) expire for the Trust’s flexible endoscope inventory?
2. Who is your current service provider of flexible endoscope repair & maintenance?

Download response Flexible endoscope repair & maintenance. 190521

Flexible Endoscopes. 191018

1. Who is your current service provider of Flexible Endoscope repair & maintenance?
2. How many Flexible endoscopes do you have in your inventory?

Download response Flexible Endoscopes. 191018

Gastrointestinal endoscopy procedures. 021020

1. How many endoscopists were employed?
2. How many endoscopists were colorectal surgeons, upper gastrointestinal surgeons, gastroenterologists or nurse endoscopists? Please include any details of any other groups of endoscopists that we have not mentioned above.
3. For each group of endoscopists listed above (i.e. colorectal surgeons, upper gastrointestinal surgeons, gastroenterologists, nurse endoscopists, etc.):
a. How many endoscopy lists were performed in total by each group in the 12 month period?
b. What procedures (i.e. oesophagogastroduodenoscopy (OGD), colonoscopy, flexible sigmoidoscopy etc.) and how many procedures were performed by each group in the 12 month period?
4. How many endoscopy procedures were performed in theatres and what were these procedures?
5. How many endoscopy procedures were performed in the radiology department, what were these procedures and who performed them (i.e. colorectal surgeons, gastroenterologists etc.)?

Download response Gastrointestinal endoscopy procedures. 021020

 

Estates & Facilities

Accommodation Provision. 071118

1. Do you provide an accommodation service to employees & new starters
2. If answer is yes to Q1 – please provide how many rooms you have available to staff
3. How much do you charge per night for short lets, and how much per month for longer lets
4. Do you have any packages in place for new starters to the organisation in regards to accommodation? If so, please provide details
5. Do you work in partnership with other organisations to provide an accommodation service? I.e. Housing association
6. How much is your annual spend on Trust owned accommodation services? For 16/17, 17/18, 18/19

Download response Accommodation Provision. 071118

Active beds across your Trust. 070921.docx

As of 1st of July 2021 (or most recent available data):
1. How many active beds were in service? If possible, please break this down by sector as delineated by NHS England in the KH03 quarterly collection (General & Acute, Maternity, Learning Disability and Mental Health – please note, if you are a mental health trust, no additional breakdown is needed)
2. How many beds were not in service? If possible, please break this down by sector as delineated by NHS England in the KH03 quarterly collection.
3. Please clarify why these beds were not in service.
In the first week of July 2019:
1. How many active beds were in service? If possible, please break this down by sector as delineated by NHS England in the KH03 quarterly collection.
2. How many beds were not in service? If possible, please break this down by sector as delineated by NHS England in the KH03 quarterly collection.
3. Please clarify why these beds were not in service.

Download response Active beds across your Trust. 070921.docx

Air handling units. (AHU). 081117

Would be possible to obtain by email the total number of air handling units in operating theatres in the hospitals managed by the trust and the age of the air handling units (as in how long they have been installed).

Download response Air handling units. (AHU). 081117

Air pollution cases

“I would be interested in seeing a report regarding any statics about how many people have suffered of any complications/ died due to air pollution or water pollution in the area in the last 2-3 years.”

Download response Air pollution cases 311215

Alleged offences on Trust property. 310821.docx

My question regards alleged criminal offences which have taken place on Trust property and is as follows:
Between 2017 and 2021 so far how many of the following alleged incidents have been reported on Trust property:
Sexual offences
Offences involving firearms
Offences involving knives
Public nuisance offences
Hate crime offences
For each of the above, would you be able to provide a breakdown of how many incidents resulted in police being called to the Trust?
Would you also be able to provide a breakdown of whether the incidents were directed towards members of staff, patients or visitors?

Download response Alleged offences on Trust property. 310821.docx

Anaesthesia machines. 190721.docx

What type of anaesthesia machines you are using within each site and how old the machines are roughly?

Download response Anaesthesia machines. 190721.docx

Annual Security Reports.040522.docx

The NHS Business Services Authority formerly had an integral organisation “NHS Protect”. In 2017 NHS Protect was replaced by the NHS Counter Fraud Authority.
Security provisions were not included in the superseding organisation.

I would be grateful if I could receive electronically a copy of the MTW Trust Annual Security Reports for the years 2018,2019,2020.

Annual Security Reports.040522.docx

Artwork. 100920

1. How much money did Maidstone and Tunbridge Wells NHS Trust spend on artwork which was then displayed in its building(s) in 2016?
2. How much money did Maidstone and Tunbridge Wells NHS Trust spend on artwork which was then displayed in its building(s) in 2017?
3. How much money did Maidstone and Tunbridge Wells NHS Trust spend on artwork which was then displayed in its building(s) in 2018?
4. How much money has Maidstone and Tunbridge Wells NHS Trust spent on artwork so far this year?

Download response Artwork. 100920

Asbestos. 020518

1. Do any of your hospitals currently contain asbestos?
2. How many reported incidents of asbestos exposure have there been in any of your hospital buildings over the past five years (between January 2013 – December 2017).
3. How many claims have ever been made against your trust for asbestos related exposure/disease including but not exclusively for mesothelioma.
4. How many of these claims have been settled?
5. What is the amount of money that has been paid in settlement of these claims where your Trust did not go through NHS Resolution (formerly the NHS Litigation Authority)? Please include claims with and without your trust/board accepting responsibility and claims made through any other insurance schemes excluding the NHSLA/NHS Resolutions.

Download response Asbestos. 020518

Asbestos Contract 091216

Please can we make a freedom of information request to see a copy of the winning tender / contract for asbestos surveys within your NHS authority?

Download response Asbestos Contract 091216

 

Assaults on staff. 010322.docx

The number of reports registered to this Trust in each calendar year between 2015 – 2021 of physical violence and/or verbal abuse committed by patients or members of the public within this Trust’s premises against individuals employed at this Trust:

Assaults on staff. 010322.docx

Asset Valuation Services. 151118

You asked:

1. When was the Trust’s last asset valuation carried out?
2. Can you confirm which company carried the valuation out?
3. What was the value of the Trust’s assets at the last valuation date?
4. What was the gross internal area of the Trust assets which formed part of the last valuation?
5. When is the Trust’s next asset valuation due?

Download response Asset Valuation Services. 151118

Bariatric Beds. 151019

Would you please be able to confirm the following information in relation to rental of specialist bariatric beds and bariatric air mattresses?
– Number of rental episodes year to date 2019
– Total of installation charges year to date 2019
– Total of equipment removal charges year to date 2019
If this level of information is not available, please advise the total number of bariatric patient admissions year to date 2019.

Download response Bariatric Beds. 151019

Bariatric contracts and equipment. 041120

1. Bariatric contracts in place if any
2. Usage data of any bariatric equipment – Beds, Mattresses, and accessories
3. Cost data of bariatric equipment used at each site

Download response Bariatric contracts and equipment. 041120

Bariatric equipment. 181019

Please send me data on your Trust’s spend (in GBP) on specialist bariatric equipment (e.g. bariatric beds, seating, wheelchairs, hoists and scale systems) split by spend type and year:
• Capital expenditure vs rentals/leases
• Financial years 14/15, 15/16, 16/17, 17/18, 18/19
I would like the above information to be provided to me in electronic form

Download response Bariatric equipment. 181019

Bariatric equipment. 220218

1. I wish to know how much your trust has spent on specialist equipment for bariatric patients (patients over 160kg) during the last three years?
2. Please give a breakdown of the type of specialist bariatric equipment used by the trust and the amounts spent, split between Rental Expenditure and Purchased Equipment?
a. If equipment used is on a Rental basis, please specify if this was under a contract basis or ad hoc?
b. If under contract, when is this due for renewal?
c. If known, who is the contract with?
3. How many bariatric beds does the Trust own?
4. How many bariatric patients have been admitted to your hospital/hospitals during the past 12 & 24 months for all procedures?

Download response Bariatric equipment. 220218

Bed cleaning.221223.docx

All questions are shown as received by the Trust.
1. Does the trust have a bed cleaning facility in place? Please specify details where possible.
2. Please specify how beds are cleaned (please specify any differences between infected and non-infected beds)
a. at what frequency (i.e. daily, weekly)
b. and who cleans the beds (please specify if an external company or by trust nurses, healthcare assistants, etc)
3. Please provide the trust’s C-diff status – i.e. under trajectory, on trajectory, over trajectory
4. Please also provide copies of any recent IPC audits (from January 2023 to date) carried out by NHS England

Bed cleaning.221223.docx

Bed numbers.131023.docx

All questions are shown as received by the Trust.
Please could you provide the following information;The number of beds at each hospital location within your organisation.

Bed numbers.131023.docx

Bed stock. 120717

We require the number of beds at each hospital within your trust.

Download response Bed stock. 120717

Bed stock 2012 and 2017. 280217

1a How many beds did the Trust have for NHS services on 1 January 2012?
1b How many beds does the Trust have for NHS services on 1 January 2017?
2a How many beds did the Trust have for private patients on 1 January 2012?
2b How many beds does the Trust have for private patients on 1 January 2017?

Download response Bed stock 2012 and 2017. 280217

Bed stocks 2012 and 2017. 080217

1- How many beds did the trust have for NHS services in 2012?

2- How many beds does the trust have for NHS services in 2017?

3- How many beds did the trust have for private patients in 2012?

4- How many beds does the trust have for private patients in 2017?

Download response Bed stocks 2012 and 2017. 080217

Blood Gas Analysis contracts.140323.docx

Can you please provide the following for any Blood Gas Analysis contracts your trust holds that include analysers, consumables, reagents or accessories?
1. Contract end date
2. Any extension options available
3. Anticipated annual value of the contract
4. Details of what is included

Blood Gas Analysis contracts.140323.docx

Body worn cameras or video recording devices. 011217

The details of your use of body cameras in your organisation –

1. Does anyone (staff or contractors) in your organisation use/wear body cameras or body worn video recording devices while performing their duties?
If yes, please detail:
2. Who provides the body cameras and footage/evidence management used by your organisation?
3. How many staff members use body cameras and what capacities/teams do they work in? Are they staff or contractors (for e.g. outsourced security personnel) How many body cameras in all are currently owned and/or used by your organisation?
4. Were the cameras bought as a one off purchase and if so, how much did they cost your organisation?
5. If they are part of an ongoing contract – what is the current contract term (how long is it and when does it expire) and what is the value of said contract?
6. Where is the data recorded stored – on premises locally or on cloud?
7. Who is the point of contact for your body camera programme?

Download response Body worn cameras or video recording devices. 011217

C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

For the years 2014, 2015, and 2016 please details the following:

How many people and inpatients have been infected with and treated for a superbug.

List which superbug people were infected with.

In which hospital did they contract the infection?

How many of these people later died of the infection?

Download response C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

Car leasing, grey fleet and salary sacrifice schemes. 270721.docx

Car Leasing
1) Does your organisation offer staff the ability to lease a car for private use? If so, please provide the following information for each supplier contract:
2) Please provide the contact details of the individual within the organisation responsible for the car leasing contract:
Grey Fleet (employees that drive their own cars for business)
3) Do any employees at your organisation claim Grey Fleet mileage reimbursement?
4) If applicable, please state the total cost to the organisation in 19/20 of paying Grey Fleet reimbursements to employees who opt not to have lease cars (excluding employee salaries)
5) Does your organisation have a Grey Fleet Policy?
6) In the table below, please state when your organisation last undertook the following Duty of Care checks on your grey fleet drivers?
Salary Sacrifice Benefits
7) For each of the following Salary Sacrifice benefits offered to staff at your organisation, please state the name of the supplier, contract start and end dates, framework the provider was procured through and number of staff using the benefit.
8) Does your organisation have an external Employee Assistance Programme (EAP)?

Download response Car leasing, grey fleet and salary sacrifice schemes. 270721.docx

Car parking. 030719

1. Number of Car Parking Spaces across your Trust, broken down by:
a. General or Staff bays
b. Patient and Visitor bays
c. Designated Disabled (blue badge) bays
d. Other (such as drop-off or on-call – if not counted elsewhere)
e. Total number of parking spaces
This data is only required at Trust level, please do not break down to site level
2. Does the trust apply any eligibility criteria to the allocation of staff permits?
a. And if so what is it?
3. What staff parking charging structure does your Trust apply?
4. Do you have ANPR coverage in any of your car parks?
5. Does your Trust grant any relaxation of parking rules (e.g. staff permitted to park in patient bays out of hour hours)
a. If so, what rules do you apply to them?
6. How may staff do you employ?
a. Figure for total staff (including part timers)
b. Figure for WTE total.
7. What rationale/logic does your Trust apply to ERIC* question S09_06: Average fee charged per hour for staff parking?
a. We would like to know the formula used for this specific calculation, including the sums used to come to your final sum.

Download response Car parking. 030719

Car parks. 130819

1. How many carparks does your trust have? How many spaces overall are there?
2. What system do you use for cashless (pay by phone) parking and when does the current contract end?
3. What software do you use for Fixed Penalty Notice enforcement (FPN issue and processing) and when does the current contract end?
4. What software do you use to issue parking permits and season tickets and when does the current contract end?

Download response Car parks. 130819

Carbon footprint and sustainability. 200120

1) Does your Trust measure its total carbon footprint? If so, what is it? Please provide in tCO2e and specify the date of measurement.
2) If your Trust has measured its total carbon footprint previously, what was it in:
• 2015-16
• 2016-17
• 2017-18
• 2018-19
Please provide in tCO2e.
3) How many full-time equivalent (FTE) staff are employed by your Trust?
4) Does your Trust have any targets for reducing carbon emissions? If so, please outline.
5) What percentage of your Trust energy consumption comes from fossil fuels?
6) Is your Trust taking any steps to reduce its energy consumption from fossil fuels? If so, please outline these steps.
7) What percentage of your Trust’s vehicle fleet uses:
• Petrol or diesel vehicles
• Hybrid vehicles
• Electric vehicles
8) Does your Trust have a policy on reducing the use of single-use plastics (including for clinical and/or non-clinical items)? If so, please provide this policy.
9) Has your Trust received any funding to spend specifically on sustainability? If so, please provide the details.

Download response Carbon footprint and sustainability. 200120

Carbon footprint, sustainability and decarbonisation. 100122.docx

1. Does your Trust measure its total carbon footprint?  If yes, what is the carbon footprint of your Trust? (Please provide in tCO2e and specify the date of measurement)
2. What steps has your Trust taken towards meeting the Greener NHS target of Net Zero by 2045?
3. What percentage of your Trust energy consumption comes from fossil fuels?
4. What steps is your Trust taking to reduce its fossil fuel consumption?
5. How many vehicles are in your Trust’s fleet?
6. How many of your Trust’s fleet uses:
A. Petrol/Diesel
B. Hybrid
C. Electric
7. Does your Trust have a policy on reducing the use of single-use plastics (including for clinical and/or non-clinical items)?  If yes, please provide details of this policy and the reduction achieved to date.
8. Has your Trust received funding to spend specifically on sustainability and decarbonisation? If yes, please provide details on how much and over what time period.
9. How much has your Trust spent in 2021 (including specific funding received and any other expenditure) on activities related to sustainability and decarbonisation?

Download response Carbon footprint, sustainability and decarbonisation. 100122.docx

Carbon reduction information relating to travel. 190320

(1) What is the current carbon reduction strategy and policy for your Trust relating to transport used by staff? Please supply a copy of your transport policy.
(2) What proportion of staff in community services travelled by public transport, walking or by bicycle in 2019? (Please provide documentation excel format)
(3) What was the spending on mileage for staff travelling by car in 2019 (please include spending on commute and spending on travel within shifts separately if possible) (Please provide documentation excel format)
(4) What was the spending on mileage for staff travelling by public transport in 2019 (please include spending on commute and spending on travel within shifts separately if possible)? Please provide documentation excel format)

Download response Carbon reduction information relating to travel. 190320

Catering 2015-2017. 250117

1. For the two past financial years (2015/16 and 2016/17 to date), please provide the following data, breaking it down month by month:
a. The number of inpatient main meals requested in the Trust
b. The number of inpatient main meals left untouched
c. The total cost of providing inpatient main meals
d. The cost of feeding one inpatient per day

2. Please name the catering companies and food suppliers used by the Trust in 2015/16 and 2016/17 to date

3. Please provide details of what changes, if any, the Trust has made or plans to make to inpatient catering and food procurement contracts with suppliers and/or catering companies in response to rising food commodity costs.

4. Please state:
a. Whether the Trust currently meets the following Government Buying Standards for food and catering services: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/418072/gbs-food-catering-march2015.pdf

b. Whether the Trust currently uses or has made plans to use the provisions in the Government Buying Standards that allow an authority to depart from mandated production and/or animal welfare standards to avoid a “significant increase in costs”. If so, please set out the date this decision what taken and the details of what was decided.

Download response Catering 2015-2017. 250117

Catering and vending services. 040920

Vending Services
1. Is the catering, retail catering and/or patient dining services on site out-sourced to any third-party soft facilities providers?
2. If out-sourced, please name the external supplier that provides these services, along with the contract start/end date?
3. Are the vending services on site managed by an external operated vending provider?
4. If so, please provide details of the supplier of vending services along with details of contract start/end date.
5. Are all products provided through the vending machines fully compliant with CQUIN guidelines?
6. Please provide a planogram of products currently for sale in the snack and cold drinks vending machines within the trust.
7. The total number of vending machines currently on trust grounds split between specification of snacks, cold drinks, snack/cold drinks combi and hot beverages.
8. The amount of NET revenue generated through the vending machines in the financial year 2019/20.
9. The amount of rebate paid back to the trust as a result of vending machine sales in the financial year 2019/20.
10. The amount of NET revenue generated through the vending machines in the financial year 2018/19.
11. The amount of rebate paid back to the trust as a result of vending machine sales in the financial year 2018/19.
12. Total rebate paid back to trust as a result of vending sales in the past five years.
Tabletop Coffee/Hot Beverage Machines
13. Does the Trust own/rent and Tabletop Coffee/Hot Beverage machines for its dining areas?
14. If the Trust own/rent Tabletop Coffee/Hot Beverage machines please can you provide the age/contractual term for these and list make/manufacturer?
15. Can you please provide details as to who supplies the Coffee/Ingredients for the aforementioned machines?
Ward Beverage Trolleys
16. Does the Trust use a ward beverage trolley service to serve hot beverages to in-patients throughout the trust?
17. If so, please provide details of the number of ward beverage trolleys on site along with details of the equipment provider and any contractual obligations currently in place including contract start/end date?
18. What department within the trust manages the above contracts and who within the trust is the key point of contact for the above contracts?

Download response Catering and vending services. 040920

Catering disposables. 020819

1. How much did your organisation spend on Catering Disposables in the past 12 months (or the most recent completed 12 months)?
2. What provider(s) did your organisation use for Catering Disposables in the past 12 months (or the most recent completed 12 months)?
3. Do you hold a contract with a supplier or suppliers of Catering Disposables?
4. If you answered yes to Q.3, who are the contracts with?
5. If you answered yes to Q.3, when do the contracts end?
6. Do you have a procurement planned for the provision of Catering Disposables in the next two years?
7. If you answered yes to Q.6, when is this process planned for commencement?
8. Who is the decision maker pertaining to Catering Disposables within your organisation?
9. How much did your organisation spend on Catering Equipment in the past 12 months (or the most recent completed 12 months)?
10. What provider(s) did your organisation use for Catering Equipment in the past 12 months (or the most recent completed 12 months)?
11. Do you hold a contract with a supplier or suppliers of Catering Equipment?
12. If you answered yes to Q.11, who are the contracts with?
13. If you answered yes to Q.11, when do the contracts end?
14. Do you have a procurement planned for the provision of Catering Equipment in the next two years?
15. If you answered yes to Q.14, when is this process planned for commencement?
16. Who is the decision maker pertaining to Catering Equipment within your organisation?

Download response Catering disposables. 020819

Catering services 020317

1. Are the catering services provided at your trust managed ‘in house’ or outsourced to a third party provider? If the organisation has a fully managed contract please state.
2. Who is the supplier for this contract? Please can you provide me with the contract information for each individual supplier? [
3. What is the contract duration? Please also provide me with any extensions that maybe offered to the supplier.
4. What is the contract expiry date? Please at least provide me with the month and year.
5. When will this contract be reviewed? Please at least provide me with the month and year.
6. Can you please provide me with the total number of sites the contract covers? An estimate will also be acceptable.
7. What services are provided under this contract? A brief description will be acceptable.
8. Who is the main contact from within the organisation responsible for reviewing this contract? Can you please provide me with their full name, actual job title, contact number and direct email address?
9. Who is the manufacturer and supplier of the trusts patient meals?
10. Notes: If the contract information provided is going to be expiring within the next 3 months it would be helpful to know if you’re going to renew or are planning to go to tender for a new contract for this particular service.

Download response Catering services 020317

Catering services at Tunbridge Wells Hospital (TWH) and Maidstone Hospital (MGH). 190417

1. Whether your site offers bulk or plated service?
2. Do you use plastic or china cutlery and plates?
3. When it comes to your purchasing process in the catering sector, do you have a centralized system with a purchasing department or are the individual people allowed to make their orders themselves (up to a certain limit)?
4. Do you get your information about the products you need from your go-to manufacturer, your local dealer, your hospital’s purchasing department, the internet or a price list you own?
5. Are those who you get your information from the ones you also buy from or do you use a different authority for that?
6. Last but not least would it be possible to get the contact details of your catering manager (as in first and surname, phone number and email address)?

Download response Catering services at Tunbridge Wells Hospital (TWH) and Maidstone Hospital (MGH). 190417 

CCTV. 111018

1. Supplier of the contract for CCTV maintenance and support
2. How much the Council spend annually with the supplier?
3. What is the renewal date of this contract?
4. What is the duration of the contract?
5. What is the review date of this contract? If possible the likely outcome of this review
6. The primary brand of the CCTV equipment. I don’t require the model just the brand.
7. The description of the services provided under this contract. Please state if this contract includes more than just CCTV services.
8. Contact details of the employee responsible for the contract between the supplier and the organisation. Can you please provide me with their full contact details?

Download response CCTV. 111018

CCTV. 160519

1. Supplier of the contract for CCTV maintenance and support
2. How much the Council spend annually with the supplier?
3. What is the renewal date of this contract?
4. What is the duration of the contract?
5. What is the review date of this contract? If possible the likely outcome of this review
6. The primary brand of the CCTV equipment. I don’t require the model just the brand.
7. The description of the services provided under this contract. Please state if this contract includes more that just CCTV services.
8. Contact details of the employee responsible for the contract between the supplier and the organisation. Can you please provide me with their full contact details?

Download response CCTV. 160519

CCTV. 290819

1. Supplier of the contract for CCTV maintenance and support
2. How much the Organisation spends annually with the supplier? (if multiple suppliers please list the annual spend for each)
3. What is the renewal date of this contract?
4. What is the duration of the contract?
5. What is the review date of this contract? If possible the likely outcome of this review
6. The primary brand of the CCTV equipment. I don’t require the model just the brand. If there are various brands could you please list?
7. The description of the services provided under this contract. Please state if this contract includes more than just CCTV services.
8. Contact details of the employee responsible for the contract between the supplier and the organisation. Can you please provide me with their full contact details
9. What is the total number of cameras in use/under this contract?

Download response CCTV. 290819

CCTV and Access Control. 151118

You asked:
CCTV Equipment
1. The total spend on CCTV Systems & Equipment in the last two years FEB 2015 – FEB 2018
2. Can you provide any current supplier names for the above equipment?
3. Please outline details of any current framework or preferred supplier list in place for the supply of CCTV Systems along with details on any renewal dates or plans to re-procure the agreements.
4. Please outline the members of staff responsible for procuring this equipment
Access Control/Security Solutions
5. The total spend and the types of Access Control Systems & Equipment on site in the in the last two years FEB 2015 – FEB 2018 (e.g. Proximity readers, key fob/keypad entry, biometric solutions, pin pad entry systems, NFC or retina identification)
6. Can you provide any current supplier names for the above equipment?
7. Please outline details of any current framework or preferred supplier list in place for the supply of Access control Systems along with details on any renewal dates or plans to re-procure the agreements.
8. Please outline the members of staff responsible for Procuring this equipment

Download response CCTV and Access Control. 151118

CCTV maintenance and support contract.080622.docx

1. Supplier of the contract for CCTV maintenance and support
2. How much the Organisation spend annually with the supplier? (if multiple suppliers please list the annual spend for each)
3. What is the expiry date of this contract?
4. What is the duration of the contract?
5. What is the review date of this contract? If possible the likely outcome of this review
6. The primary brand of the CCTV equipment. I don’t require the model just the brand. If there is various brands could you please list?
7. What is the total number of cameras in use/under this contract?
8. The description of the services provided under this contract. Please state if this contract includes more than just CCTV services.
9. Contact details of the employee responsible for the contract between the supplier and the organisation. Can you please provide me with their full contact details.
If there is no CCTV maintenance contract in place
1. What is the brand of CCTV cameras in use? if there is variety could you please send me a list? I do not need the serial number or model just the brand.
2. How much is the average annual spend on the in-house maintenance?
3. How many cameras are in use?
4. Is there a plan to review this at any point, if so what would the date be?
5. Who is in charge of overseeing the in-house maintenance?
If there is no maintenance contract or in-house maintenance in place, is there an ad-hoc agreement?
If yes,
1. Who is the supplier? Is this varies could you please list?
2. What is the brand of CCTV cameras in use? if there is variety could you please send me a list? I do not need the serial number or model just the brand.
3. How many cameras are in use?
4. How much is the average annual spend on the ad-hoc agreement?
5. What is the date it is to be reviewed?

CCTV maintenance and support contract.080622.docx

Cell saver machines. 070717

1. How many cell savers do you have within the Trust? Please provide a breakdown of cell savers per hospital if possible.
2. For which surgical procedures were cell savers used in the year 2015 – 2016, breakdown by number if possible?
3. How many consumables were purchased for cell savers during the year 2015 – 2016?
4. How much was spent on cell saver consumables for the year 2015 – 2016?

Download response Cell saver machines. 070717

Chemical leak incidents.270623.docx

1) The number of chemical leak incidents recorded at your NHS hospital(s) over the past twelve months?
2) If there were chemical leaks, the wards where these incidents took place.

Chemical leak incidents.270623.docx

Cladding. 010319

1. if any of the trust’s buildings have any type of cladding on the outside
2. If so, how many buildings have cladding, how tall are the buildings with cladding and what type of cladding is it
3. how many of the trust’s buildings are of timber frame construction

Download response Cladding. 010319

Cleaning audits.260224.docx

All questions are shown as received by the Trust.
a. Who is responsible for your cleaning audit surveys?
b. Can you outline how cleaning audit surveys are completed?
c. What software, if any, is used to complete and report on cleaning surveys?
d. If you use software to complete cleaning audits, what was the original contract start and end date?
e. If you use software to complete cleaning audits, what was the contract cost per year?
f. If you use software to complete cleaning audits, how was this procured (Direct award/tender etc).

Cleaning audits.260224.docx

Cleaning contract. 080419

Can you please tell me when the night cleaning contract is due for renewal and what is the value of the current contract.
Also, does the same contractor hold the cleaning contracts for both Hospitals, Maidstone and Pembury.

Download response Cleaning contract. 080419

Clinical Service Incidents 2015-2017. 250517

Please provide details of all clinical service incidents caused by estates and infrastructure failure at your hospital trust in 2015/16 and 2016/17 to date.

This is the definition of clinical service incidents: Incidents caused by estates and infrastructure failure which caused clinical services to be delayed, cancelled or otherwise interfered with owing to problems or failures related to the estates and infrastructure failure. Exclude failures relating to non-estates causes e.g. nursing availability, but include where external incidents which estates and infrastructures should have mitigated e.g. utility power failures where the Trusts backup power system failed to offset. An incident is considered to be a delay of at least 30 minutes to clinical services affecting at least 5 patients or equivalent. Both inpatient and outpatient service incidents should be included. Such incidents will include, but are not limited to: • Power and/or heating failures including overheating • Fires and false alarms (where caused by equipment faults or malfunction, deliberate/malicious causes should be excluded) • Water and/or sewage supply • Food production and/or delivery • Pest control

For each incident, please provide a summary of the incident and the impact on services. Please include what the problem was and how clinical services were affected, including details of how many patients were affected, what the service was and how long the service was delayed or whether it was cancelled.

Download response Clinical Service Incidents 2015-2017. 250517

Clinical service incidents caused by estates and infrastructure failure. 100419

Please provide details of clinical service incidents caused by estates and infrastructure failure at your hospital trust in 2018/19.
A “clinical service incident” is defined as follows: Number of incidents caused by estates and infrastructure failure which caused clinical services to be delayed, cancelled or otherwise interfered with owing to problems or failures related to the estates and infrastructure failure. Exclude failures relating to non-estates causes e.g. nursing availability, but include where external incidents which estates and infrastructures should have mitigated e.g. utility power failures where the Trusts backup power system failed to offset. An incident is considered to be a delay of at least 30 minutes to clinical services affecting at least 5 patients or equivalent. Both inpatient and outpatient service incidents should be included.
Such incidents will include, but are not limited to: • Power and/or heating failures including overheating • Fires and false alarms (where caused by equipment faults or malfunction, deliberate/malicious causes should be excluded) • Water and/or sewage supply • Food production and/or delivery • Pest control
For each incident, please provide a summary of the incident and the impact on services. Please provide details of the problem and in what way clinical services were affected, including the number of patients affected, the service and how long the service was delayed/if it was cancelled.

Download response Clincial service incidents caused by estates and infrastructure failure. 100419

Clinical service incidents caused by estates and infrastructure failure. 211020

Please provide details of clinical service incidents caused by estates and infrastructure failure at your hospital trust in 2019/20.
For each incident, please provide:
A summary of the incident and the impact on services.
Please provide details of the problem.
What way clinical services were affected, including the number of patients affected, the service and how long the service was delayed/if it was cancelled.

Download response Clinical service incidents caused by estates and infrastructure failure. 211020

Clinical service incidents caused by estates and infrastructure failure.220322.docx

Please provide details of clinical service incidents caused by estates and infrastructure failure at your hospital trust in 2020/21.
A “clinical service incident” is defined as follows: Number of incidents caused by estates and infrastructure failure which caused clinical services to be delayed, cancelled or otherwise interfered with owing to problems or failures related to the estates and infrastructure failure. Exclude failures relating to non-estates causes e.g. nursing availability but include where external incidents which estates and infrastructures should have mitigated e.g. utility power failures where the Trusts backup power system failed to offset. An incident is considered to be a delay of at least 30 minutes to clinical services affecting at least 5 patients or equivalent. Both inpatient and outpatient service incidents should be included.
Please note that the information provided will not always capture the length of delay or the total number of patients affected.
Such incidents will include, but are not limited to: • Power and/or heating failures including overheating • Fires and false alarms (where caused by equipment faults or malfunction, deliberate/malicious causes should be excluded) • Water and/or sewage supply • Food production and/or delivery • Pest control
For each incident, please provide a summary of the incident and the impact on services. Please provide details of the problem and in what way clinical services were affected, including the number of patients affected, the service and how long the service was delayed/if it was cancelled.

Clinical service incidents caused by estates and infrastructure failure.220322.docx

Clinical waste.180124.docx

All questions are shown as received by the Trust.
1) Who is your current contractor for clinical waste collections? This will usually be one contractor for offensive/hazardous waste (tiger and orange bags) as well as sharps however if you have more than one contractor, please could you name them all
2) Please could you confirm if you are in a specific contract for clinical waste management or if clinical waste is collected as part of a wider total waste management solution. If a part of a total waste management solution, the TWM provider should be named in question 1
3) If in contract for clinical waste management, please could you confirm the start date and the term of the contract? Could you please state if you contractually have the option extend past the standard duration and if so by how long?
4) If known, please could you confirm how many separate sites clinical waste is collected from across your estate?

Clinical waste.180124.docx

Clinical waste. 250321

1. How many tonnes of clinical waste did hospitals under your jurisdiction incinerate each month between March 2020 and January 2021?

Download response Clinical waste. 250321

Clinical waste contract. 070122.docx

Please can you provide the following:
Q1: Annual tonnage data broken down by the following waste streams per site:
– Waste for incineration
– Alternative treatment
– Offensive waste
Q2. Contract start date
Q3. Contract term including any extensions
Q4. Annual contract value; overall and split by Waste Stream per site
Q5. Current service provider

Download response Clinical waste contract. 070122.docx

Clinical waste contract. 170921.docx

Q1: Annual tonnage data broken down by the following waste streams:
– Waste for incineration
– Alternative treatment
– Offensive waste
Q2. Contract start date
Q3. Contract term including any extensions
Q4. Annual contract value; overall and split by Waste Stream
Q5. Current service provider

Download response Clinical waste contract. 170921.docx

Clinical waste contract.181022.docx

1. What are the contractual performance KPI’s for this contract?
2. Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages
3. Actual spend on this contract/framework (and any sub lots), from the start of the contract to the current date
4. Start date & duration of framework/contract?
5. Could you please provide a copy of the service/product specification given to all bidders for when this contract was last advertised?
6. Is the trust using or considering the use of disposable sharps
7. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
8. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
9. Who is the senior officer (outside of procurement) responsible for this contract?
10. Who is the procurement officer responsible for this contract

Clinical waste contract.181022.docx

Clinical Waste Contract.190123.docx

I would be most grateful if you would provide me, under the Freedom of Information Act, details in respect to the Clinical Waste Contract/s that your trust currently has in place.
The details we require are:
1. Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages
2. Actual spend on this contract/framework (and any sub lots), from the start of the contract to the current date
3. Start date & duration of framework/contract?
4. Could you please provide a copy of the service/product specification given to all bidders for when this contract was last advertised?
5. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
6. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
7. Who is the senior officer (outside of procurement) responsible for this contract?
8. Who is the Infection Control Lead responsible for the Trust + contact information?
9. Who is the Procurement Lead for Clinical Waste contracts for the Trust + contact information?
10. Who is the Environmental/Sustainability lead for the Trust + contact information
11. Who is the Waste management Lead for the trust + contact information
12. Who is the Health and Safety lead for the Trust + contact information?
13. Who is the Clinical waste incumbent?
14. Does the Trust make use of reusable or disposable sharps containers?

Clinical Waste Contract.190123.docx

Clinical Waste Contract.230124.docx

1. Suppliers who applied for inclusion on each framework/contract and were successful and not successful at the PQQ & ITT stages
2. Actual spend on this contract/framework (and any sub lots), from the start of the contract to the current date
3. Start date and duration of framework/contract
4. Could you please provide a copy of the service/product specification given to all bidders for when this contract was last advertised?
5. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
6. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
7. Who is the Senior Officer (outside of procurement) responsible for this contract + contact information?
8. Who is the Infection Control Lead responsible for the Trust + contact information?
9. Who is the Procurement Lead for Clinical Waste contracts for the Trust + contact information?
10. Who is the Environmental/Sustainability Lead for the Trust + contact information?
11. Who is the Waste Management Lead for the Trust + contact information?
12. Who is the Health and Safety Lead for the Trust + contact information?
13. Who is the current Clinical Waste incumbent (service provider)?
14. Does the Trust make use of reusable or disposable sharps containers and who is the service provider?

Clinical Waste Contract.230124.docx

Clinical Waste Contract. 251121.docx

I would be most grateful if you would provide me, under the Freedom of Information Act, details in respect to the Clinical Waste Contract/s that your trust currently has in place.

The details we require are:

1. Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages
2. Actual spend on this contract/framework (and any sub lots), from the start of the contract to the current date
3. Start date & duration of framework/contract?
4. Could you please provide a copy of the service/product specification given to all bidders for when this contract was last advertised?
5. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
6. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
7. Who is the senior officer (outside of procurement) responsible for this contract?
a. Who is the Infection Control Lead responsible for the Trust?
b. Who is the Procurement Lead for Clinical Waste contracts for the Trust?
c. Who is the Environmental/Sustainability lead for the Trust?
d. Who is the Waste management Lead for the trust?

Download response Clinical Waste Contract. 251121.docx

Clinical waste or sharps container provider. 210422.docx

1. Who is your current clinical waste / sharps container provider?
2. Do you have a contract with the sharps container provider and if so when does this contract end?
3. Can you provide your current annual spend on sharps containers?
4. Who is your current waste management provider for the disposal/collection of sharps & clinical waste and when does this contract end?

Clinical waste or sharps container provider. 210422.docx

Coal burning. 100519

I would like to know if your hospital or hospitals burn coal for fuel, electricity or heating. And if so, how much was used during 2016, 2017 and 2018.

Download response Coal burning. 100519

Commercial properties. 310821.docx

Details of all current empty commercial properties within your authority which includes Shops, Office and Industrial premises, if possible on an excel spreadsheet containing the following information:
• Property Billing Reference
• Property Type
• Rateable Value
• Property Vacant Date
• Property Address
• Liable Party Name

Download response Commercial properties. 310821.docx

Community Diagnostic Centre.080922.docx

Please could you provide me with a copy of the business case for the Trust’s Community Diagnostic Centre project, including the capital budget for the entire project.

Community Diagnostic Centre.080922.docx

Confidential waste. 250321

1. Has confidential waste being procured via tender or framework or another means?
2. If a framework, could you confirm the name of the framework please?
3. Actual contract values of each framework/contract (& any sub lots)
4. Start date & duration of contract
5. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
6. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
7. Who is the procurement officer responsible for this contract and could you provide their email address and phone number please?
8. Who is the senior officer (outside of procurement) responsible for this contract and could you provide their email address and phone number please?
9. Who is the current supplier?
10. If your current supplier is a Facilities Management/Waste Company, which sub-contractor services your organisation?

Download response Confidential waste. 250321

Construction and maintenance projects. 141221.docx

1. (a) Who is the head of procurement at your trust responsible for approving construction and maintenance projects?
(b)Secondly, who is the staffing lead responsible for the management of this service.
2. Please can you provide the contact information in relation to both question 1 (a) and (b)
3. Who is the staffing lead responsible for the Estates & Technical Services such as Contract Co-ordinator?
4. Please can you provide the contact information in relation to question 3

Download response Construction and maintenance projects. 141221.docx

Construction projects. 061021.docx

1. Identification of all construction projects (classified specifically as a refurbishment or new build) within your estate since 2010, where the project value exceeded £1m
2. Project cost (cost accuracy to the nearest £m) and the year of completion
3. Confirmation of the trust appointed project team (organisation name only), namely:
a. Selected Contractor
b. Architect
c. Structural Engineer
d. M&E Engineer

Download response Construction projects. 061021.docx

Consumables. 250321

Thank you for your response, can I kindly clarify under suppliers you’ve states NHSSC. Although the products purchasing would be facilitated by NHSSC that wouldn’t be the supplier or brand. Would you kindly confirm which brand the products are?

Download response Consumables. 250321

Copy paper 041116

1. What was the latest price paid per ream (500 sheets) of standard white A4 copier paper (80 gsm or equivalent)?
2. If the answer to question 1. is not representative of a usual price paid, what is the average price paid per ream of copier paper during financial year 2015/16?
(Could you please specify whether VAT is included or not in the prices you give?)
3. How many reams of copy paper were purchased during the 2015/16 financial year?

Download response Copy paper 041116

Cost of the smoke free and vape free signage. 130220

How much was the total cost for all the smoke free and vape free sign on the Tunbridge Wells Hospital site?

Download response Cost of the smoke free and vape free signage. 130220

Costa Coffee. 090617

Please can you supply me with information regarding all the Trust’s cost benefits (both financial and kind), commitments and agreements with Costa Coffee over the past 36 months at each of the Trust’s locations?

Download response Costa Coffee. 090617

Courier Service Contract. 250821.docx

Please send me details for the period 2020-2021 on the following:
a) The total value of the courier service contracts that were outsourced
b) The name of your primary courier supplier
c) The value of your primary supplier’s contract
d) The expiry date of that contract
e) The total cost of the courier services that were not outsourced but managed in-house?
f) The number of staff employed in managing the in-house contracts
g) The number of vehicles either owned or leased to meet the in-house courier requirement
h) The name and email of the person responsible for the management of courier services

Download response Courier Service Contract. 250821.docx

Courier service contracts. 090418

1. The total value of the courier service contracts that were outsourced?
2. The name of your primary and any secondary Courier supplier
3. The value of your primary supplier contract, its expiry date and the services they provide (e.g. same day/next-day/overnight)
4. The value of your secondary supplier’s contract, its expiry date and the and services they provide (e.g. same day/next-day/overnight)
5. The total cost of the courier services that were managed in-house?
6. The number of staff employed in managing those contracts
7. The number of vehicles owned or leased to meet the in-house courier requirement
8. The name and email of the person responsible for the procurement/management of these services?

Download response Courier service contracts. 090418

Courier service contracts. 250417

Please send me details for the period 2016-17 on the following:

1. The total value of the courier service contracts that were outsourced?
2. The name of your primary and any secondary Courier supplier
a) The value of your primary supplier contract, its expiry date and the services they provide (e.g. ad hoc/same day/overnight/GP route)
b) The value of your secondary supplier’s contract, its expiry date and the and services they provide (e.g. ad hoc/same day/overnight/GP route)
3. The total cost of the courier services that were managed in-house?
a) The number of staff employed in managing those contracts
b) The number of vehicles owned or leased to meet the in-house courier requirement
4. The name and email of the person responsible for the procurement/management of these services

Download response Courier service contracts. 250417

Couriers, taxis, and non-patient transport services.281022.docx

1. The amount spent on courier/taxi/non-patient transport services in each of the following financial years:
a. 2021-22
b. 2020-21
c. 2019-20
d. 2018-19
e. 2017-18
2. A breakdown of the amount spent on taxis and courier services by department (for example pathology, pharmacy, sterile services, medical records etc) in each of the following financial years:
a. 2021-22
b. 2020-21
c. 2019-20
d. 2018-19
e. 2017-18
3. A breakdown of the amount spent on taxis and courier services by reason for spend (for equipment, specimens, medicine etc) in each of the following financial years:
a. 2021-22
b. 2020-21
c. 2019-20
d. 2018-19
e. 2017-18
4. The name of your courier/taxi/non-patient transport services suppliers
5. The annual value of your courier/taxi/non-patient transport services suppliers’ contracts
6. The expiry dates of your courier/taxi/non-patient transport services suppliers’ contracts
7. The name of the framework(s) used to procure your courier/taxi/non-patient transport services suppliers’ contracts
8. The total cost of the courier/taxi/non-patient transport services that are not outsourced but are managed in-house
9. The number of staff employed in managing the in-house contracts
10. The number of vehicles either owned or leased to meet the in house courier requirements
11. The name(s) and email(s) of the person(s) responsible for the management of courier/taxi/non-patient transport services
12. The name(s) and email(s) of the person(s) responsible for the procurement of courier/taxi/non-patient transport services

Couriers, taxis, and non-patient transport services.281022.docx

CT scanner. 301117

Q1. Does your trust have a 64-slice (or above) CT scanner?
Q2. Does your trust perform Coronary CT angiography?
Q3. How many Coronary CT Angiography scans have you performed in the past financial year? (2016-2017)
Q4. Does your Trust have access to Coronary CT Angiography with non-invasive FFR analysis or HeartFlow technology?
Q5. If so how many CT FFR scans have been performed in total in the past financial year (2016-2017)?

Download response  CT scanner. 301117

Current construction projects. 070219

Under the Freedom of Information Act please could you let me know your top 10 construction projects (in terms of value) that are due for completion in the next 6 months along with the expected completion date, Value, and Main Contractor Employed?
(You can leave out any or all projects you have if they are under £1 Million).

Download response Current construction projects. 070219

Current policy for nuisance, disturbance, violence, aggression. 190821.docx

On July 14 2021 you requested the following information:
1. Would you please provide me with a copy of your current policy for nuisance / disturbance / violence / aggression?
please provide the details of the authorised officer/officers for each hospital.

On July 16 2021 you requested additional information as follows:
2. please provide the details of the authorised officer/officers for each hospital or a list of the replacement positions, training, certification required for each person which replaced the authorised officer.
3. The requirements of the person or persons that replaced the authorised officer, as stated in the Guidance on provisions to deal with nuisance or disturbance behaviour on NHS premises in England.
4. please provide the record and report for the alleged nuisance/disturbance dated 21 January 2021

Download response Current policy for nuisance, disturbance, violence, aggression. 190821.docx

Dangerous and/or illegal items confiscated by staff during 2013, 2014 and 2015

1. How many dangerous and/or illegal items have been confiscated by staff at hospitals across your trust over the last three years?

2. For each year, please provide a full breakdown of items.

Please send the information in calendar years (i.e. January-December, for 2013, 2014, and 2015).

This may include illegal drugs, and weapons/ potential weapons.

Download response Dangerous and/or illegal items confiscated by staff during 2013, 2014 and 2015 020316

Decarbonisation in healthcare. 190221

1. Do you have on-site Electric Vehicle (EV) charging infrastructure for staff, patients and the wider community?
a. Yes, we already have EV infrastructure on-site
b. No, but we plan to have on-site EV infrastructure in the near future (within the next 5 years)
c. No, but we are in the early planning phases of implement EV infrastructure
d. No, we have no current plans to introduce on-site EV charging infrastructure
e. Other, please specify
2. What if any impact do you think Electric Vehicle (EV) charging would have on your existing electrical infrastructure (please select all those that apply)?
a. I do not foresee any impact
b. I will need greater electrical capacity in my infrastructure
c. I may incur additional energy costs through a greater peak demand
d. I have the potential to create new revenue streams from my infrastructure
3. What other decarbonisation technology have you/will you be adopting in the near future (within the next 5 years) Tick all that apply
a. Lighting upgrades
b. Increased building control and automation
c. Upgrades in insulation
d. We don’t have any decarbonisation initiatives in place/planned in the near future (within the next 1-5 years)
4. Is your hospital currently participating in selling energy back to the grid through energy storage technology?
a. Yes, we are
b. No, we are not but we plan to in the near future (next 1-5 years)
c. No, we are not and we don’t currently plan to
5. Is your NHS Trust on track to meet its emissions reduction / decarbonisation targets as part of the overall NHS commitment to achieve a ‘net zero’ national health service?”
a. Yes – we’re actually tracking ahead at the moment
b. Yes – we’re on track to meet our decarbonisation targets
c. No – we’re behind on our decarbonisation targets at the moment
d. I don’t know – we don’t have clear or set emissions reduction (or decarbonisation) targets / we don’t have a specific plan in place to reduce emissions

Download response Decarbonisation in healthcare. 190221

Decontamination and sterilisation service. 300719

1. Is decontamination/sterilization handled in-house or outsourced?
2. What is the total number of trays process on a daily/monthly/yearly basis?
3. How much does it cost to process and deliver trays?
4. How much time is taken fully process one tray?
5. How many times a day are surgical trays collected and processed?
6. How many individual instruments are cleaned?
7. How many times can an individual instrument be reused?
8. What are the different surgical tray dimensions?
9. What is the cost of the surgical equipment?
10. How much staff is required to process surgical trays?
11. What is the cleaning cost of surgical instruments?
12. How many surgical admissions occur each year?
13. What is the average number of trays per operation?
14. What machines are required to reprocess surgical trays? How many?
15. How many operations are cancelled each year due to inadequate decontamination/sterilization?
16. How many hospital-acquired infections occur each year due to inadequate decontamination/sterilization?
17. How much does inadequate decontamination/sterilization cost each year?

Download response Decontamination and sterilisation service. 300719

Defibrillators. 101120

1. Manual Defibrillator Machines manufacturer
2. Manual Defibrillator model
3. Year of purchase
4. Proposed timeframe for replacement
5. AED Defibrillator Machines manufacturer
6. AED Defibrillator model
7. Year of purchase
8. Proposed timeframe for replacement

Download response Defibrillators. 101120

Demand side response agreements. 181219

1. Details of any demand side response (DSR) agreements between your organisation and National Grid, including the dates of those agreements
2. Copies of any of the above agreements, or relevant letters/emails exchanged with National Grid if you do not hold a formal agreement document

I am only seeking details/copies of agreements made in the last two years.

Download response Demand side response agreements. 181219

Director of Estates. 021019

Please may I have details of all Directors of Estates in your Trust – names, telephone numbers, email addresses?

Download response Director of Estates. 021019

Disinfection and decontamination services. 260619

1. What cleaning methods does the Trust currently use for room and theatre disinfection?
2. Does the Trust employ an external cleaning company and if so who is this?
3. Does the Trust currently have UVC machines for decontamination? If so how many units and which supplier or manufacturer?
4. When were these purchased or rented and when are these contracts due to expire?
5. Are there any tenders outstanding for either UVC or Vaporised Hydrogen Peroxide (HPV) and what are the closing dates?

Download response Disinfection and decontamination services. 260619

Disinfection and Detergent Surface Wipes.260523.docx

1. Please provide your total annual consumption of all (2-in-1) Disinfection & Detergent Surface Wipes. In units and total value.
1a. Please also provide the breakdown of pack sizes and include the NHS product order code (if ordered through NHS procurement)
2. Please provide your annual consumption of all Detergent only Surface Wipes.
2a. Please also provide the breakdown of pack sizes and include the NHS product order code (if ordered through NHS procurement)
3. If your facilities are contracted to a third party, Sodexo, Medirest etc, please state.
4. Please confirm how your facilities management team order their surface wipes, if through a distributor like Bunzl, please state.

Disinfection and Detergent Surface Wipes.260523.docx

Disinfection systems. 150721.docx

1. Does your organisation currently purchase any of the following or similar disinfection systems:
· Hydrogen Peroxide Vapour Disinfection Systems
· Mobile Ultraviolet Light Disinfection Systems
· Electrostatic Disinfection Systems
2. From which suppliers do you obtain these systems, and can you confirm the spend in the last 2 years?
3. Were these systems purchased through a tender or framework? If so, which one? Please provide the following details:
· Name
· Reference
· Where this was published
More
4. Are you under contract with your current supplier(s) for the above? If so, what are the start and end date(s) of the contract(s)?
5. Can you provide the name and contact details for the person(s) responsible for procuring these systems?
6. Can you provide contact details for the department responsible for managing this service or more broadly infection, prevention, and control?
7. Within this sector, are peer-reviewed studies considered a part of your selection for suppliers?
8. Many ultraviolet disinfection systems use Mercury bulbs – can you confirm if your systems use these alongside your associated environmental management procedures?

Download response Disinfection systems. 150721.docx

Disposable cutlery and plates. 290118

United Kingdom-Maidstone: Disposable cutlery and plates
2015/S 021-033596
The details we require are:
• Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages*
• Contract values of each framework/contract (& any sub lots), year to date
• Start date & duration of framework
• Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
• Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
• Who is the senior officer (outside of procurement) responsible for this contract?

Download response Disposable cutlery and plates. 290118

Disposable drinking cups. 290118

How many disposable drinking cups has your trust purchased in each year for the last five years?

Download response Disposable drinking cups. 290118

Disposal and treatment of municipal, healthcare and clinical waste. 080422.docx

Please could you provide the following information relating to the amount, cost, methods and reporting of the disposal and treatment of municipal, healthcare and clinical waste across the years 2017-2018 and 2018-2019?

Disposal and treatment of municipal, healthcare and clinical waste. 080422.docx

Dyson products purchased in the last five years. 151216

How many Dyson products has your trust bought in the last five years?

What are these products and models?

A breakdown of how many items of each Dyson product was bought in the last five years, e.g. how many fans, vacuum cleaners, hand dryers etc.

How much money has been spent on all Dyson products for the last five years for your trust?

Please could I have a breakdown for how much has been spent on each type of product, e.g. vacuum cleaners, fans, hand dryers etc., for the last five years?

Download response Dyson products purchased in the last five years. 151216

E-cigarette policy. 130918

1. Is smoking and / or vaping allowed inside any buildings?
2. Is smoking and / or vaping allowed directly outside any buildings (including details of exclusion zones)?
3. Is smoking and / or vaping allowed in any other outside spaces?
4. Are there designated spaces for smoking and / or vaping?
5. Is there one policy for smoking and vaping or are there separate policies?
6. Is there any variation in these policies across different sites?

Download response E-cigarette policy. 130918

Effective decontamination. 020817

For each of your hospitals separately, please could you provide me with?

1. How many bed days were lost in financial year 2016/17 whilst undertaking effective decontamination (Hydrogen Peroxide vaporising/fogging/UV): –
a) Following discharge/transfer of patient/s with known/suspected infections e.g. Cdiff/ Multi drug infections (i.e. proactive)
b) Following an outbreak of infection

2. a. Make and number of hydrogen peroxide vaporising fogging machines currently in use
b. Make and number of ultraviolet machines currently in use
c. Make and number of “other” (please state) types of decontamination machines currently in use

3 Is decontamination undertaken internally or through a managed service? If a managed service, please state which company.

4. If applicable, please specify the length of down time post room decontamination following hydrogen peroxide vaporising fogging for:
a. single side rooms
b. 4 bedded rooms.

Download response Effective decontamination. 020817

Electric Vehicle charging points.

1) Does your organisation already offer charging facilities (Electric Vehicle Charging Points EVCP) for electric vehicles and if so, how many charge points?
2) If there is currently no charging provision, what plans do you have to install EVCP and when?
3) Will the charge points be for fleet usage or public charging?
4) Within your organisation, which department is responsible for the selection and installation of EVCP?

Download response Electric Vehicle charging points 060916

Electrical Materials 2015-2016. 290317

1. Please state what your estimated annual spend is on electrical materials and associated products for the financial year 2015/2016. This might be against the agreement RM3747 – Building Materials and Associated Services, Lot 3 Electrical

2. Where possible please state the suppliers you have bought from and the spend against them.

3. Where possible please state the products bought and the price paid.

Download response Electrical Materials 2015-2016. 290317

Electronic invoices. 270317

1) Do you currently receive electronic invoices? Yes/No
2) If so, are these received in EDI format (not PDF)? Yes/No
3) If not, would you have a date when you could be ready to test/receive EDI Invoices?

Download response Electronic invoices. 270317

Electronic patient menu ordering system.030322.docx

Could you please confirm if you have an electronic patient menu ordering system and if so please confirm the current provider?

Electronic patient menu ordering system.030322.docx

Emergency vehicle breakdowns.

1) How many instances of emergency vehicles (E.G police cars, fire engines, ambulances) needing roadside assistance were recorded between 2004-15? If the data doesn’t stretch back to 2004, please use the earliest you have.

2) In such cases, was the cost of recovery paid to a 3rd party? If so, what is the current call out charge?

Download response  Emergency vehicle breakdowns 180416

Energy. 071221.docx

1. Whether the Trust is on a fixed rate tariff contract for energy.
2. The Trust’s annual energy budget for 2021/22.
3. Whether the Trust anticipates any additional energy costs in the second half of 2021/22.
4. If yes to the above, the value of any estimated additional energy costs for the second half of 2021/22.

Download response Energy. 071221.docx

Energy efficiency 2015-2016. 250517

1. Who is the energy manager at the organisation? Please state the individual’s name and job title
2. For the financial year 2015/16 please provide the following:
a. Overall Energy Performance Certificate (EPC) rating
b. Total internal floor area (m2)
c. Of which, the total occupied floor area (m2)
d. Total energy consumed (kWh)
Please also provide the individual total figures for:
e. Electricity consumed
f. Gas consumed
g. Please state the annual lighting usage for the organisation
h. Total energy cost (£)
Please also provide the individual total costs for:
i. Electricity cost
j. Gas cost
k. Please state the annual lighting cost for the organisation

Download response Energy efficiency 2015-2016. 250517

Energy efficiency. 241221.docx

1. Total capital expenditure plan for financial year 2020-21:
2. Total forecast capital expenditure (including already spent / committed) for financial year 2020/21 on energy efficiency schemes:
3. Do you have LED lighting in place across estate?
4. Planned capital expenditure on LED lighting scheme(s) for financial year 2020/21:
5. Expenditure on LED light bulbs in this financial year to date
6. Expenditure on all light bulbs in this financial year to date
7. Latest total annual carbon footprint
8. Financial efficiency target (financial year 2020-21)
9. Forecast financial efficiency delivery (financial year 2020-21)

Download response Energy efficiency. 241221.docx

Energy Efficiency of Hospital Buildings. 121021.docx

1. How much have you spent on electricity and gas bills for each hospital in your trust for the years
a) 2018
b) 2019
c) 2020
d) 2021 so far
2. What the energy certificates were for each hospital building at each hospital in your trust for the year
a) 2018
b) 2019
c) 2020
d) 2021

Download response Energy Efficiency of Hospital Buildings. 121021.docx

Energy initiatives. 280717

1) Please state the organisation’s carbon reduction target

2) Lighting
a. Has the organisation updated any of its lighting to energy efficient LEDs?
b. What % of lighting assets have been upgraded?
c. How many bulbs, tubes etc. does this represent?
d. What date did these upgrades take place?
e. What was the total value of the initial investment?
f. How did you fund the investment? Please include the name of any third party finance providers.
g. What are the projected annual savings?
a. budgeted
b. Actual
h. Over how many years is this project expected to break even?
i. Does the organisation have further plans to upgrade lighting?
j. If so, has all the required funding been secured?
k. When is the project due to start?
l. Are there any further plans identified where funding has not yet been secured?
m. Who at the organisation is accountable for securing the funding and management of these projects (please provide name and job title)?

3) Other Energy-Saving Initiatives
What other efficiency projects have you engaged with? Please list all current and planned projects and provide the following information:
Project

4) Third Party Providers
Has the organisation engaged with any third party providers, either a company offering energy efficiency financing (Green Investment Bank, Salix Finance etc.) or through energy performance contracts (EPCs) with energy service providers, to fund the organisations energy efficiency initiatives? Please provide the following details for all arrangements, including any already listed in responses to previous questions:

Download response Energy initiatives. 280717

Energy Management. 070618

1. The supplier who provides the software to the organisation?
2. The cost associated with the software. Please provide me with the annual spend.
3. What is the brand of the software?
4. What is the duration of the contract?
5. When does this contract expire?
6. When does the organisation plan to review this contract?
7. Can you please provide me with the contract description of the services provided under the agreement with the supplier?
8. What is the organisation’s annual energy spend for the following:
a. Electricity
b. Gas
c. Water
9. What is the total number of meter points for Electricity for?
a. Non Half Hourly (NHH) meter points
b. Half Hourly (HH) meter points
10. What is the total number of Gas meter points?
11. What is the total number of Water meter points?
12. What is the total number of meter points for specialist gases and liquids?
13. Can you please provide me with the contact details of the key person responsible for this contract or around energy management?
14. Can you please send me the organisations’ energy management strategy/plan that covers 2018?

Download response  Energy Management. 070618

Energy meters.070622.docx

1. I would like to know the number of electric, gas, fuel & water sub meters that the trust has.
2. I would also like to know the number of sub meters that are manually read & recorded.
3. I would also like to know the number of all electric, gas, fuel & water meters that are smart meters. This relates to any meters where the energy/water consumption is logged automatically e.g. AMR.

Energy meters.070622.docx

Energy meters. 200422.docx

1. I would like to know the number of electric, gas, fuel & water meters that the trust has.
2. I would also like to know the number of those meters that are manually read & recorded.
3. I would also like to know the number of those meters that are smart meters.

Energy meters. 200422.docx

Energy Supplies. 060718

• The name of the Hospital’s Gas & Electricity supplier
• The name of the Hospital’s energy broker (if you have one)
• Annual Gas & Electricity consumption of the Hospital (kWH separate figures)
• Amount of Gas & Electricity supplies (no. of sites supplied and the cost of consumption in ££s)
• The renewal date of each energy contract

Download response Energy Supplies. 060718

Energy supplies. 140618

• The Trust’s total annual expenditure on a) gas and b) electricity for the two most recent years for which data is held

Download response Energy supplies. 140618

Energy supply. 070618

1. The name of your supplier for electricity and gas, for each year as far back as possible without incurring unreasonable cost or working time for you.
2. The unit rate and standing charge you are currently being charged by your energy supplier.
3. The cost of your energy bill for the past 12 months, for electricity and gas.

Download response Energy supply. 070618

Energy use

1. Could you please provide a contact name, telephone number and email address for the person who deals with Energy Management in your Trust.
2. Could you please provide a full list of all sites that your Trust operates, along with number of beds?

Download response Energy use 060916

Enhanced Disinfection Methods to Eliminate HAIs in Theatres, Clinical Areas and Wards.290422.docx

1. What process/products do you use for disinfection/decontamination additional to a manual cleaning programme, for instance for a terminal clean or an outbreak?
2. Do you use Hydrogen Peroxide Vapour (HPV Fogging) or Ultraviolet (UVC) for decontamination?
3. What companies do you use and how many units do you have in operation for both HPV and UVC?
4. Is the equipment operated by NHS staff, or by an outsourced Contract Cleaning Company? If the latter, who is the contractor?
5. Were these systems purchased via a tender or mini competition?
6. Were these systems purchased through a framework agreement or direct sale?
7. Were these systems purchased outright, or via a lease rental package?
8. What were the costs of the systems when new?
9. Who is your current supplier and are you under contract?
10. What is the annual value of this contract, including consumables, extended warranties and maintenance agreements?
11. What is the start and end date of the contract?
12. Do you use a managed service in addition to your own operation?
13. Could you provide me with the contact details for the person/s responsible for the fields below?
a. Infection Prevention and Control
b. Estates & Facilities / Domestics
c. Procurement
d. Housekeeping

Enhanced Disinfection Methods to Eliminate HAIs in Theatres, Clinical Areas and Wards.290422.docx

Environmental and Sustainability Policy. 170322.docx

Could the trust please confirm which individual is responsible for managing the trust’s environmental and sustainability policy? Please provide this by pdf attachment including their email address.

Environmental and Sustainability Policy. 170322.docx

Environmental and waste management. 040117

1. Who is the Trust’s waste manager and what are their contact details?
2. How much is spent on clinical waste per annum? (£)
3. How many tonnes of clinical waste are sent for alternative treatment (last financial year/12 months if possible)?
4. How many tonnes of clinical sharps waste are produced of per annum?
5. How many tonnes of offensive waste is produced per annum?
6. How many tonnes of waste is sent for landfill/waste to energy?
7. How many tonnes of waste is sent for recycling?
8. When does the domestic waste and recycling contract expire?
9. Who currently provides the domestic and recycling waste services?
10. Who currently provides the clinical waste services?
11. When does the clinical waste contract expire?
12. How much is spent on domestic waste per annum? (£)
13. How much is spent on recycling waste per annum?
14. How many tonnes of food waste is segregated and recycled per annum?
15. How much is spent on food waste recycling per annum? (£)
16. How much does the Trust spend on sharps containers per annum? (£)
17. Who currently supplies the sharps containers to the Trust?
18. Does the trust use e-learning for waste management?
19. Does the trust have its own procurement department?
20. Who is the infection control lead and what is their email address?
21. Who is the procurement lead and what is their email address?
22. Who is environmental lead and what is their email address?
23. Who is health and safety lead and what is their email address?
24. Who is the education lead and what is their email address?
25. Is the waste contract linked to a procurement framework?

Download response Environmental and waste management. 040117

Estates and Facilities. 091018

1 What is the name of your NHS Trust?
2 Where does accountability for Estates and Facilities sit within the Trust’s exec team portfolio?
3 What is the current Estates and Facilities team structure?
4 Has this Estates and Facilities team been through organisational change/a restructure in the last 3 years?
5 Are there any intentions to go through organisational change/an Estates and Facilities team restructure in the next 3 years?
6 Is there a documented Estates Strategy
7 Was this Strategy developed/authored internally or has it been outsourced to an organisation and/or specialist contractor
8 What is the job title and pay band of the most senior position* within the Estates and Facilities team
9 How long has the current post holder been in this* position
10 How was the current post holder recruited to this* position
11 If the current post holder* is acting up or has been promoted/seconded internally, what is/was their substantive/previous job title, band and department
12 Is it detailed in the person specification for this position* that the post holder should be a chartered member of a recognised estate management institution. If yes, is this categorised essential or desirable
13 Is the current post holder chartered or working towards becoming chartered in the next 2 years?
14 If yes or working towards it, with which institution
15 For which other senior management roles grades 8a and above is it detailed in the essential person specification that the post holder should be “chartered” or equivalent
16 For which other senior management roles grades 8a and above is it detailed in the desirable person specification that the post holder should be “chartered” or equivalent
17 Of your current senior management team grades 8a and above, who is chartered and with which institution (CIOB, BIFM, RICS etc.). Please detail appropriate membership qualification/pathways
18 Has the Trust financially supported any of the current senior management team who are chartered in pursuing their chartered status
19 Is there a HR policy which supports professional development? Particularly in respect of roles where there is an “essential” element to the person specification which requires a certain qualification or membership
20 If yes, does this HR policy support or prohibit financial assistance for employees
21 Does the Trust have a graduate scheme or work with any Universities to employ newly qualified Estates professionals
22 How many freehold property interests does the Trust have?
23 How many leasehold premises (documented and undocumented) does the Trust have
24 How much land does the Trust own in Hectares
25 Has the Trust acquired any new freehold interests in the last 3 years?
26 Has the Trust acquired any new leasehold interests in the last 3 years?
27 Has the Trust acquired any land for development in the last 3 years?
28 Has the Trust disposed of any freehold interests in the last 3 years?
29 Has the Trust disposed of leasehold interests in the last 3 years?
30 Has the Trust disposed of any surplus land in the last 3 years?
31 Has the Trust acquired/merged with any other NHS Trusts in the last 3 years
32 Does the Trust have any 3rd party tenants?
33 Do 3rd party tenants generate income for the trust?
34 What is the value in £m of the Trust’s current capital development programme (new build)
35 What is the value in £m of the Trust’s current capital investment programme (existing buildings)
35 Are all estates budgets centrally managed by the Estates and Facilities team or are budgets for rent etc. clinically/service owned?

Download response Estates and Facilities. 091018

Estates and Facilities Management. 020819

I would like to request information regarding the organisational structure of the estates and facilities department, specifically, who is responsible for managing the estates team?

Download response Estates and Facilities Management. 020819

Estates and Facilities structure chart. 030222.docx

Please can you send me an organogram for your Estates and Facilities department including names, job titles, contact numbers and NHS email addresses.

Estates and Facilities structure chart. 030222.docx

Estates and Capital Projects Managers. 300317

Please can you provide the contact details, name, telephone number, email address, of the Head of Estates, Estates Managers and Capital Project Managers for your trust?

Download response Estates and Capital Projects Managers. 300317

Existing contracts relating to facilities management

Please can you provide me with the organisation’s existing contracts relating to facilities management for each of the categories below:
A. Property and Building Services Maintenance
B. Cleaning and Janitorial Services
C. Security Services- From building and car park security to prisoner escorting services
D. Catering Services
For each of the contract above can you please provide me with the organisation’s primary/main contracts that are above £1,000.00. If there isn’t
1. What is the type of contract please pick from one of the categories above? If the organisation has a fully managed contract please state “Managed”.
2. Who is the supplier for this contract? Please can you provide me with the contract information for each individual supplier?
3. What is the annual average spend? Please can you provide me with the contract information for each individual supplier?
4. What is the contract duration? Please also provide me with any extensions that maybe offered to the supplier.
5. What is the contract expiry date? Please at least provide me with the month and year.
6. When will this contract be reviewed? Please at least provide me with the month and year.
7. Can you please provide me with the total number of sites the contract covers? An estimate will also be acceptable.
8. What services are provided under this contract? A brief description will be acceptable
9. Who is the main contact from within the organisation responsible for reviewing this contract? Can you please provide me with their full name, actual job title, contact number and direct email address?
10. Notes: If the contract information provided is going to be expiring within the next 3 months it would be helpful to know if you’re going to renew or are planning to go to tender for a new contract for this particular service.

Download response Existing contracts relating to facilities management 280815

Exterior cladding. 070120

1. Please state the total number of hospital buildings managed by your NHS Trust.
2. Please state the total number of hospital buildings managed by your NHS Trust that have any type of exterior cladding.
3. Of those, please state the total number that are known to have*:
a) Combustible cladding
b) Aluminium composite material (ACM) cladding
c) High-pressure laminate (HPL) cladding
4. Please state the total number of hospital buildings with exterior cladding (any type) that have undergone cladding fire safety tests, since June 2017.
5. Of all those that have been tested , please state the outcome of that test in the following categories:
a) Passed test
b) Failed test and remedial work completed
c) Failed test and remedial work ongoing
d) Failed test and remedial work not yet started

Download response Exterior cladding. 070120

External courier use. 250122.docx

1. Does your Trust use external courier firms?
2. If so, how much did your Trust spend on external couriers in the past 12 months?
3. Who is the person responsible for your Trust’s courier spend?
4. What is the name of your Transformation Manager?

Download response External courier use. 250122.docx

Face Masks. 110321

1. How many face masks the trust uses per day (if you don’t have data broken down by day, a total number of masks used since the start of the pandemic, accompanied by the specific time period, will serve the same purpose)
2. How these masks are disposed of
3. If these masks are incinerated, please provide me with any information the trust has on the emissions produced by doing so. This could include estimates/data/reports/memos – and if you only have information for PPE generally during the pandemic, I’m happy to receive that.

Download response Face Masks. 110321

Facilities. 161120

1. How many designated cycle parking spaces are available on Trust property? (Please provide the answer as the total number of cycles that could be accommodated in designated spaces)
2. How many showers are available exclusively for staff use?
3. How many changing rooms are available exclusively for staff use?
4. Which of the following are available to staff within the Trust: (A yes/no response is sufficient)
· Mindfulness and wellbeing sessions
· Talking therapy
· Exercise classes/on site gym
· Staff physiotherapy service
· Complementary therapies (massage, reflexology etc.)
5. How many working days were lost due to staff sickness for mental health/stress during the 2019-20 year?
6. How many people where employed by the Trust on permanent and fixed term contracts at the end of the 2nd quarter, 2019-20?

Download response Facilities. 161120

Facilities management. 031121.docx

General waste services contracts – The organisation’s primary general waste service contract.
1. Supplier/Provider of the services
2. Total Annual Spend – The spend should only relate to each of the service contracts listed above.
3. A description of the services provided under this contract please includes information if other services are included under the same contract.
4. The number of sites the contract covers
5. The start date of the contract
6. The end date of the contract
7. The duration of the contract, please include information on any extensions period.
8. Who within the organisation is responsible for each of these contracts? name, Job Title, contact number and email address.

Download response Facilities management. 031121.docx

Facilities management. 170921.docx

General waste services contracts – The organisation’s primary general waste service contract.
1. Supplier/Provider of the services
2. Total Annual Spend – The spend should only relate to each of the service contracts listed above.
3. A description of the services provided under this contract please includes information if other services are included under the same contract.
4. The number of sites the contract covers
5. The start date of the contract
6. The end date of the contract
7. The duration of the contract, please include information on any extensions period.
8. Who within the organisation is responsible for each of these contracts? name, Job Title, contact number and email address.

Download response Facilities management. 170921.docx

Facilities Management. 200120

For each of the different contracts below, can you please provide me with all the information using the questions below
1. Office and building cleaning – Service contract that is focus around office, commercial and building cleaning services.
2. Lift service and maintenance – Service contract for lift service and maintenance.
3. Food – Service contract that is focused around catering services.
4. General waste services contracts – The organisation’s primary general waste service contract.
5. Laundry services where clothes and linen can be washed and ironed.
Contract profile questionnaire for each type of contract:
a. Supplier/Provider of the services
b. Total Annual Spend – The spend should only relate to each of the service contract listed above.
c. A description of the services provided under this contract please includes information if other services are included under the same contract.
d. The number of sites the contract covers
e. The start date of the contract
f. The end date of the contract
g. The duration of the contract, please include information on any extensions period.
h. Who within the organisation is responsible for each of these contracts? Name, Job Title, contact number and email address.

Download response Facilities Management. 200120

Facilities management. 220921.docx

1. Office and building cleaning – Service contract that is focused around office, commercial and building cleaning services.
a. Supplier/Provider of the services
b. Total Annual Spend – The spend should only relate to each of the service contracts listed above.
c. A description of the services provided under this contract please includes information if other services are included under the same contract.
d. The number of sites the contract covers
e. The start date of the contract
f. The end date of the contract
g. The duration of the contract, please include information on any extensions period.
h. Who within the organisation is responsible for each of these contracts? name, Job Title, contact number and email address.
2. Food – Service contract that is focused around catering services.
a. Supplier/Provider of the services
b. Total Annual Spend – The spend should only relate to each of the service contracts listed above.
c. A description of the services provided under this contract please includes information if other services are included under the same contract.
d. The number of sites the contract covers
e. The start date of the contract
f. The end date of the contract
g. The duration of the contract, please include information on any extensions period.
h. Who within the organisation is responsible for each of these contracts? name, Job Title, contact number and email address.
3. Laundry services where clothes and linen can be washed and ironed.
a. Supplier/Provider of the services
b. Total Annual Spend – The spend should only relate to each of the service contracts listed above.
c. A description of the services provided under this contract please includes information if other services are included under the same contract.
d. The number of sites the contract covers
e. The start date of the contract
f. The end date of the contract
g. The duration of the contract, please include information on any extensions period.
h. Who within the organisation is responsible for each of these contracts? name, Job Title, contact number and email address.

Download response Facilities management. 220921.docx

Facilities Management. 241121.docx

1. How many facilities management staff (both contracted and agency) has your trust had each year for the last 5 years?
2. How many cleaning staff (both contracted and agency) has your trust had each year for the last 5 years?
3. How much has been spent on facilities management salaries (both contracted and agency) by your trust, each year for the last 5 years?
4. How much has been spent on cleaning salaries (both contracted and agency) by your trust, each year for the last 5 years?
5. How many pieces of software do you use to run your facility? Please name the software (if possible).
6. How much has been spent on new technology investments for facilities management each year, for the last 5 years?
7. How much is spent on paper and ink each year, for the last 5 years?
8. How many new pieces of software have you implemented in the last 5 years?

Download response Facilities Management. 241121.docx

Facilities management details. 260221

Please give me the direct email for your facilities management team or your facilities manager, or specifically somebody in charge of cleaning supplies/facilities.

Download response Facilities management details. 260221

Facilities Management Services. 130819

1. Who is responsible for the provision and management of estates for the trust?
2. What current model of facilities management delivery does the trust use?
a. Outsourcing of single services (maintenance, cleaning, security and associated services) b. Total Facilities Management model c. Self-delivery with contractor support d. Maintained as part of a PFI.
3. What are your future plans for outsourcing of the Facilities Management services?
4. What is the current facilities management budget for 2018/2019?
5. Would the trust provide their current estates strategy?
6. Please supply the companies and current lengths of your existing supplier contracts for maintenance, cleaning, security and associated services.
7. Has the trust entered into an Energy Performance Contract?

Download response Facilities Management Services. 130819

Facilities Management Services. 171121.docx

Under the Freedom of Information Act 2000, I would like to request the following information regarding Facilities Management Services provided to your Estate:-
1. Service Delivery, Service Provider, Contract Start Date, Contract Expiry Date and Annual Expenditure
a. Cleaning
b. Portering
c. Security
d. Patient Catering
e. Retail Catering
2. Where services are outsourced, please could you share the procurement framework (if any) from which these services are let:-
Procurement Framework:
3. For services attracting such benefits, please could you share the appropriate wage rate / indexing mechanism utilised for base salaries payable to frontline and associated personnel (please circle):-
AFC LLW NLW NMW Other
4. Please could you also confirm the contact details for the relevant officer in the Trust with overarching responsibility for these services:-

Download response Facilities Management Services. 171121.docx

Facilities management services.230621

1. Please could you provide the information requested in the table for each of your main sites as identified below.
Hard FM
Cleaning
Portering
Patient Catering
Staff / Visitor Catering
Security
2. Please could you also confirm the contact details including name, job title and email address for the relevant officer in the Trust (e.g. Director of Estates and Facilities) for these services?

Download response Facilities management services.230621

Fax machines. 040118

1. Do you have an electronic fax management system (a fax server)?
2. How many manual fax machines do you have? Please answer this as of 1 April 2017 and as of 1 April 2010?
3. What is the annual maintenance cost of the fax machines within your Trust or associated sites? Please answer this as of 1 April 2017 and as of 1 April 2010?
4. How old is your oldest manual fax machine currently in use? What date was it purchased?

Download response Fax machines. 040118

Fire Risk Assessment. 180817

I would be grateful if you could send me the most recent fire risk assessment for your trust.

Download response Fire Risk Assessment. 180817

Fire safety. 070417

I would like to make the following request under the FoI Act

1. In the last five years, has your organisation been served with any enforcement notices relating to fire safety? If so, please give details.
2. Please direct me to your latest fire safety risk assessment (or attach if not online). When was this last updated? What has been done in response to any areas of concern in the assessment?
3. Have you assessed backlog maintenance related to fire safety? If so, what is needed and have you estimated the cost of doing these and do you have any plans to carry out this work and when? Please direct me to the most recent board papers and/or send me any report related to this backlog.

Download response Fire safety. 070417

Fires in the hospital.160623.docx

1) How many fires have been reported at the hospital over the past twelve months?
2) How many faulty fire alarms have been reported at the hospital over the past twelve months?

Fires in the hospital.160623.docx

Fleet vehicles. 160519

Please can I have the following information for vehicles currently on your fleet and vehicles sold by you between January 2016 & April 2019?
Vehicle registration number
Vehicle Make
Vehicle Model

Download response Fleet vehicles. 160519

Fleet vehicles.241123.docx

All questions are shown as received by the Trust.
Please can you supply me with the following information?
Registration number:
Make:
Model:
of all vehicles currently on your fleet list and all vehicles sold between
14/11/2022 – 05/09/2023

Fleet vehicles.241123.docx

Fleet vehicles. 241221.docx

Please can you supply me with the following information?
Registration number:
Make:
Model:
of all vehicles currently on your fleet and those sold between 1st March 2019 and 26th November 2021.

Download response Fleet vehicles. 241221.docx

Food and Allergen labelling and information. 151118

You asked:
Referring to UK Food Standards Agency requirements in respect of :-
Food and Allergen Labelling and Information Requirements under the information for consumers regulation 1169/211
1.) Does your Trust have a policy document, please supply a copy?
2.) Has a Risk Assessment been carried out? Please comment.
3.) Are all food supply contractors including franchised or otherwise cafes and restaurants on your site aware of and required to adhere to these regulations?
4.) Is there a staff training and awareness programme in place?
5.) Total number of staff: a.) Trained b.) Awaiting training
6.) What information and alerting notices are available to Patients, Visiting Public and Staff please supply some sample copies.
7.) Please supply a copy of a specimen patient menu demonstrating how allergen alerts are communicated to patients, or describe the alternative means of imparting this information.
8.) Please confirm that all patients are asked if they have any food allergies and describe how this information is recorded and communicated to staff throughout the Patient’s journey.
9.) Please confirm that there is a process in place to provide a wholesome alternative meal if the patient is unable to choose a suitable alternative dish from the days menu.
10.) Additionally please detail what arrangements are in place to enable patients who have dietary restrictions (Such as diabetics) to choose a wholesome meal in relation to the daily menu, time of day and medication.

Download response Food and Allergen labelling and information. 151118

Food hygiene.120224.docx

All questions are shown as received by the Trust.
For each Trust, please can you provide all Food Hygiene inspection results/reports, details of subsequent enforcement actions taken, and all supporting documents relating to the inspection and any subsequent actions.

I am primarily interested in the main Trust hospital, or hospitals, but if there are inspection reports from other sites managed by the Trust, please provide these as well.

Please can you provide all the information, reports, and documentation, going back three years.

Food hygiene.120224.docx

Food quality. 090719

1. The trust’s daily cost on food per patient for the financial years:
2017
2018
2019
2: The total number of food quality complaints reported by patients and/or their families during or after their treatment at your NHS trust regarding the quality of food provided by the trust in the financial years: 2017
2018
2019
Please detail the specific food which has received the most complaints for this financial year only.
3. Please provide the total number of Listeriosis cases documented which developed because of food provided to them during their treatment at your NHS trust for the financial years:
2017
2018
2019
4. Please tell me the number of deaths caused by malnutrition as the underlying cause or contributing factor for the financial years:
2017
2018
2019

Download response Food quality. 090719

Food wastage. 011221.docx

1. For the financial years 2019/20, 2020/21 and 2021/22 (so far) how many tonnes of food was wasted by your trust?
2. For the financial years 2019/20, 2020/21 and 2021/22 (so far) how much did the wasted food cost the trust?
3. Under the Government’s new blueprint for better hospital food launched October 2020 it was recommended every hospital should implement a digital meal ordering system by 2022 to collate food choices, manage allergies and diets, and minimise waste. Please explain what steps, if any, the trust has taken to implement a digital ordering system?
4. The blueprint also recommended NHS trusts should agree on a common method of monitoring food waste. Please explain what steps, in any, the trust has taken to implement a method of monitoring food waste?

Download response Food wastage. 011221.docx

Food wastage. 190919

1. How many patients and staff do you cater for?
2. How much food waste is generated every day?
3. How do you dispose of it?
4. Do you have it collected or do you use a macerator?
5. Do you have an approximate monthly cost for disposing of food waste?

Download response Food wastage. 190919

Food waste generated by the Trust per site. 120820

1. Do you prepare all catering for patients and visitors in-house or outsourced or buy in precooked meals per site, please state sites details for the all requested information below.
2. If catering is outsourced please provider contractors details
3. Please explain in detail process involved in disposal of food waste and cost associated with this for the following scenario i.e.
3.1 If food waste macerated please provide detailed breakdown of cost analysis including running costs of macerated machines, annual service contract; electricity and water tariff charges. Do you have ppm for the unblocking of foul drainage contract and how many times foul drainage were blocked over last 3 years due to food waste stemming from main trust kitchen.
3.2 If food waste is treated off-site by contractor please state what happens to food waste and please provide detailed breakdown of all charges associated with this service including cost of bags, porter cost to transfer the food waste to a secured area, frequency of collection of food waste, carbon emissions and length of contract.
3.3 Has your organisation ever been cautioned by public body/EA for causing pollution from food waste.
3.4 State process involved in recording food waste data as part of annual ERIC disclosure and please state on average how much food is wasted per kg/day.
3.5 Does your organisation track the food ordered for each patient as patients are transferred to another ward during their stay in the Hospital for the treatment or recovery.
4. Please provide name and email details of Trust Chief Executive, Board Directors responsible for the estates and finance.
5. Does your organisation has Sustainability management Plan and Carbon neutral plan by 2030/2050, please forward both documents.

Download response Food waste generated by the Trust per site. 120820

Framework contracts. 010519

I am writing to make an open government request for all the information to which I am entitled under the Freedom of Information Act 2000.
Regarding your organisation’s current awarded or in procurement framework contracts relating to works in the Built Environment, including but not limited to professional services, design, consultancy/advisory services, construction and operation/maintenance, please send me:

1. The value of each of these framework contracts;
2. The set up date of each of these contracts;
3. The projected duration of each these contracts;
4. The financial limit of each of these contracts;
5. Descriptive information for any services provided in connection to the Built Environment, Construction, Consultancy Services or Professional Services in any capacity;
6. Details of any lots/sub lots of the contract;
7. The names of the organisations currently appointed to the contracts.

Download response Framework contracts. 010519

Gamma cameras in the Trust Nuclear Medicine Department.080318

• The number of Gamma Cameras in your Nuclear Medicine Department together with the make, model and date of installation.
• The anticipated date of replacement of the above
• Gamma Camera purchase outcome data for gamma cameras in the past 5 years
• Name and email address of Nuclear Medicine Consultants
• Name and email address of Nuclear Medicine physicist and chief technologist

Download response Gamma cameras in the Trust Nuclear Medicine Department.080318

Gas and electricity contracts and energy management system.260124.docx

All questions are shown as received by the Trust.
Gas and Electricity Contracts:
1. Energy Provider
2. Annual Spend for each provider for the past 3 financial years.
3. Contract Duration (Including any extensions)
4. Contract start date
5. Contract Expiry Date
6. Contract Review Dates
7. Contact details of the person responsible, including job title
8. Total Consumption of Gas, please provide me with the latest figure in cubic metres.
9. Total Consumption of Electricity (NHH), please provide me with latest figure in kWh for the past 3 financial years.
10. Total Consumption of Electricity (HH), please provide me with latest figure in kWh for the past 3 financial years.
11. Contact details of the person responsible, including job title at the very least

Energy Management System Provider
1. Annual Spend
2. Contract Duration (Including any extensions)
3. Contract Expiry Date
4. Contract start date
5. Contract Review Date
6. Contract Description – A description of the services provided.
7. Brand of the software
8. Total number of meter points for electricity:
a. Non-Half Hourly (NHH) meter points
b. Half Hourly (HH) meter points
9. Total number of Gas meter points
10. Total number of meter points for specialist gases and liquids
11. Contact details of the person responsible, including job title

Gas and electricity contracts and energy management system.260124.docx

Gender-neutral toilets. 060422.docx

Please include the information for each of the following periods; 2018-19, 2019-20, 2020-21, 2021-22:
1. The number of gender-neutral toilets installed at the Trust during this time or the number of pre-existing toilets which have been converted into gender neutral toilets. Please do not include disabled toilets in this list.
2. The cost of installing these toilets or the cost of converting the pre-existing toilets
3. Copies of any complaints made to the Trust about these toilets, with any necessary redactions

Gender-neutral toilets. 060422.docx

Gender neutral toilets. 070717

Please can you tell me if you have any gender neutral toilets in your hospital? If so how many?

Download response Gender neutral toilets. 070717

Gluten-free products

1. How many coeliacs in your trust currently receive free gluten-free products on prescription?

2. Could you indicate which of the following products your trust prescribes, and if applicable the total cost per product to your trust (including admin, procurement, VAT and delivery costs)

3. How much does your trust spend annually on prescribing gluten-free food products for coeliac sufferers, including procurement, admin costs and delivery?

Download response Gluten-free products 060916

Glyphosate weedkiller. 300519

Please can you tell me how much the trust has spent on glyphosate weedkiller in each financial year over the past five years? Please include the product name.

Please can you also tell me where on the trust’ premises this product is used.

Download response Glyphosate weedkiller. 300519

Goods and services (2013/14) (2014/15) and (2015/16) 011216

In each of the last three financial years (2013/14) (2014/15) and (2015/16) please state how much your organisation has paid for goods and services from each of the following companies
* ACADEMY OF FABULOUS STUFF COMMUNITY INTEREST COMPANY (10189968)
* LINDUM LOFTS & EXTENSIONS LIMITED (06083403)
* HEALTH MANAGERS NETWORK LIMITED (08234437)
* WOUND SPECIALIST LIMITED (08188747)
* CARBON HEALTH NETWORK LIMITED (06887536)
* UK HEALTHGATEWAY LIMITED (06319587)
* GRASMERE MANAGEMENT COMPANY LIMITED (05685001)

Please provide me with copies of each invoice (accepting that personal details will have to be redacted) so that I can see how much was paid and a description of what it was paid for.

Download response Goods and services (2013/14) (2014/15) and (2015/16) 

GP practice acquisition. 301121.docx

I am requesting the following information:
1. A list of all general practitioner (GP) practices owned by Maidstone and Tunbridge Wells NHS Trust
2. The date each GP practice was acquired by the trust
3. What, if any, amount of money was paid as a part of the acquisition of each GP practice

Download response GP practice acquisition. 301121.docx

Green space and CO2 emissions. 190919

1. The total of trust owned green space(s) available in 2019 in m2.
2. The total of trust owned green space(s) available in 2009 in m2.
3. What was the trusts total greenhouse gas emissions output (CO2e) in 2018/19, and the percentage change against 2008/9.

Download response Green space and CO2 emissions. 190919

Greener NHS National Programme. 190821.docx

Has your trust produced a Green Plan detailing its approach to reducing its emissions in line with the national trajectories?
If so, please provide a copy of your Green Plan.

Download response Greener NHS National Programme. 190821.docx

Hand drying systems. 260619

1. Trust/health Board name.
2. Number of hospitals managed.
3. What type of hand drying systems do you provide in the washrooms located in the following areas of your hospitals? Please tick all that apply.
a. Clinical
b. Public areas
c. Other e.g. catering, back office
4. If electrical dryers are used please state type. Tick all that apply.
a. Clinical
b. Public areas
c. Other e.g. catering, back office
5. If other drying systems are used, or a combination of systems are employed, please give details.
a. Clinical
b. Public areas
c. Other e.g. catering, back office
6. What were the main reasons for choosing the hand drying systems you use in?
a. Clinical
b. Public areas
c. Other e.g. catering, back office
7. Have you changed your hand drying methods in the past year? If so please give details of the changes and the reasons why.
8. Do you have any plans to change your hand drying systems? If so what do you plan to change to and why?
9. In your opinion which is the most hygienic method of hand drying for hospital environments? Please tick one.
10. Any other comments you would like to make about hand drying?

Download response Hand drying systems. 260619

Hand Sanitiser. 210720

1. Does the Trust purchase hand sanitiser through a tender process?
2. Is the Trust currently procuring hand sanitiser?
3. If the Trust purchases hand sanitiser on an individual basis, what would be the relevant department to speak to and could you provide the contact details?

Download response Hand Sanitiser. 210720

Hand sanitiser. 260121

Q1) What hand sanitiser brand do you currently use?
Q2) How many bottles and litres of hand sanitiser purchased in 2020?
Q3) Annual spend for 2020 on hand sanitiser?
Q4) Usage and spend projections for 2021 and 2022?

Download response Hand sanitiser. 260121

Hand sanitizer dispensers. 070318

1. Is there a contract in place in your trust with a third party (such as Carillion or Serco) to replenish hand sanitizer dispensers in your hospital?
2. If so, how much is your trust billed for each such replenishment?
3. If not, how much does it cost the trust to replenish such a dispenser?

Download response Hand sanitizer dispensers. 070318

Hard and soft facilities management.260219

Please would you be able to tell me which providers you use for your hard and soft Facilities Management, and what the annual contract values are, and how long is left on the contracts?

Download response Hard and soft facilities management.260219

Hard and Soft Facilities Management. 281021.docx

1. Are any of your sites part of a PFI arrangement? If so, which site and what is the name of the special purpose company (ProjectCo) for the PFI?
2. For all of your sites (both PFI/Non-PFI), please can you outline who provides/delivers Hard Facilities Management services?
3. For all of your sites (both PFI/Non-PFI), please can you outline who provides/delivers the Soft Facilities Management services (if delivered in-house please state this):
a. Cleaning and Domestic Services
b. Patient Catering
c. Retail and staff & Visitor Catering Services
d. Portering and Logistics
e. Non-Emergency Patient Transport
f. FM Helpdesk
g. Hospital Switchboard
h. Security/manned guarding
i. Car Park Management
j. Linen & Laundry Services
k. Waste Management – off-site disposal
4. If these services (both Hard and Soft Facilities Management) are outsourced, please can you outline
i. when these contracts were awarded
ii. for how long,
iii. the contract value
iv. when they are due to expire?

Download response Hard and Soft Facilities Management. 281021.docx

Hard FM – (Electrical, mechanical, plumbing maintenance).021222.docx

Hard FM – (Electrical, mechanical, plumbing maintenance)
1. Who is the current provider of Hard Facilities Management across your estate? Or perhaps this is managed by an inhouse team?
2. If an outsourced provider, when was this contract awarded and what length is the contract? Is an extension available?
3. If an outsourced provider, when do you expect this contract to come back out to tender?
4. If managed inhouse, is there an incumbent supplier supplying electrical products? If so, when does this contract expire? After receiving clarification this is just in relation to the electrical products supplied to the in-house Team.

Hard FM – (Electrical, mechanical, plumbing maintenance).021222.docx

 

Finance

2016-2017 Budget. 140617

Under the FOI Act please can you let me know your organisations budget for?
2016
2017
This is the total operating budget for your organisation across all departments etc.

Download response 2016-2017 Budget. 140617

Accounting and budgeting software. 090418

1.) What financial accounting software do you use?
2.) Who supplies this software (name of vendor or supplier)?
3.) What was the original date of purchase or contact start date for this product (please provide the exact date if possible)?
4.) When is the contact renewal or expiry date for this product?
5.) If relevant, what is the cost of annual support and maintenance (last financial year April 2016- March 2017)?
6.) What is the name of your budgeting and forecasting system?
7.) Does your budgeting and forecasting system add on to your FMS (financial management system) or is it a standalone system?
8.) When was your budgeting and forecasting system purchased (please provide the exact date if possible)?
9.) What is the cost of annual support and maintenance for your budgeting and forecasting system?
10.) Do you currently use an online procurement or EMarketplace system, if so which system do you use?

Download response Accounting and budgeting software. 090418

Accounts payable.110124.docx

All questions are shown as received by the Trust.
1. Does the authority share accounts payable or procurement functions with another authority or shared service function? If yes, who?
2. Which ERP system is used by the authority (e.g. Oracle, SAP, Advanced, Civica)?
3. Please state the total number and value of supplier transactions (invoices and credit notes) processed by Accounts Payable in the last financial year?
5. Does the authority utilise any 3rd party software to identify or protect against supplier payment errors (including duplicate, erroneous payments or potential fraud) before payment is made?
5a. If yes, please state the name of the software, the engagement date, the current contract end date and the annual value of the contract awarded to the external organisation (or total value and contract length)
6. Does the authority utilise any 3rd party or 3rd party software to identify historical payment errors (including duplicate, erroneous payments or potential fraud)?
6a. If yes, please state the name of the software or partner, the engagement date and the current contract end date and frequency of engagement (if not continuous.) Please also provide the contract value or terms of engagement (if not a fixed fee)
6b. Please provide the value of monies recovered by the software or partner for the most recent financial year
7. Does the authority utilise any 3rd party or 3rd party software to reconcile supplier statements and identify overpayments or unclaimed credits on a regular basis?
7a. If yes, please provide the name of the provider/software and a brief description of frequency/level of support.
7b. Please provide the current contract end date and the annual value of the contract awarded to the external organisation (or total value and contract length)
8. Does the authority make any checks, either directly or via any 3rd party or 3rd party software to identify sanctioned suppliers, both directly and indirectly owned, within the supplier master file?
8a. If yes, please provide the name of the provider/software and confirm the frequency of checking

Accounts payable.110124.docx

Acquascience. 070318

Please supply the following information, has your hospital trust have had dealings or contacts with a company call Acquascience who might have been under contact to Leica, for the supply and removal of the following during the past 2 years and the approximate quantities removed.”

Supply Removal and safe disposal

• Xylene
• IDA / IMS 99%
• IDA / IMS 95%
• IDA / IMS 70%
• Methanol
• Neutral Buffered Formalin 10%
• Formaldehyde 37% – 40%
• Formal Saline 10%
• Deionised Water
• Formic Acid
• Acid Alcohol • Xylene
• IDA / IMS (all %)
• Methanol
• Tissue Fixative (NBF / FS)
• Formic Acid
• Alcohol Stains
• Aqueous Stains
• Paraffin Wax
• Used Histology Pots
• Other Plastic Containers

Download response Acquascience. 070318

Administration costs 2008-2017. 200417

1. What are the administration costs for each year since 2008, or since the establishment of the Trust, of:
a. The Trust as a whole.
b. Each of the Hospitals within your Trust.
2. Please identify each of the organisations within your Trust (ie. Hospitals, Community based NHS and private providers) that have a business, corporate or related department.
3. The total operating budget for each year since 2008, or since the establishment of the Trust, of:
a. The Trust as a whole.
b. Each of the Hospitals within your Trust.

Download response Administration costs 2008-2017. 200417

AES (Anti-Embolism Stockings).120124.docx

All questions are shown as received by the Trust.
1. How many AES (Anti-Embolism Stockings) does the Trust purchase per year for the period 2022-2023?
2. Which brand?
3. Where from?

AES (Anti-Embolism Stockings).120124.docx

Agency and Bank Medical spend. 130918

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Agency and Bank Medical spend.

You asked:
Can you please provide me with the following information?
1. Medical and Dental agency spend for 17/18
2. Medical and Dental bank spend for 17/18

Download response Agency and Bank Medical spend. 130918

Agency Locum Doctor spend for 2015-2016.

• The total amount you spend on Agency Locum Doctors for the financial year 15/16 (April – March)
• For the above information to be broken down by grade and specialty (example provided below)

Download response Agency Locum Doctor spend for 2015-2016 270616

Agency locum doctors and consultants spend for 2015-2016.

Please can you let us know what the Trust as a whole (including hospitals that are run by you) spent on employing agency locum Doctors and Consultants last year.

Download response Agency locum doctors and consultants spend for 2015-2016 010716

Agency locum spend 2015-2016.

Please could you send me the agency locum spend for the trust for the last financial year. I would like the spend for doctors only.

Please include the agency spend in each specialty breaking it down into the different grades (SHO, Middle Grade, Consultant).

Please could you also provide the spend on introductory fees for doctors for each specialty based on Doctors taken onto NHS contracts.

Download response Agency locum spend 2015-2016 050816

Agency nurse and locum doctor expenditure. 261020

1. On how many occasions in the 2019/20 financial year did you spend £1,500 or more to employ an agency nurse for a single shift? For each occasion, please state the amount paid, how many hours they were asked to work as well as the job title and department the nurse was deployed in.
2. On how many occasions in the 2019/20 financial year did you spend £3,000 or more to employ an agency doctor for a single shift? For each occasion, please state the amount paid, how many hours they were asked to work as well as the job title and department the nurse was deployed in.

Download response Agency nurse and locum doctor expenditure. 261020

Agency nurse expenditure for 2015-2016.

• The total amount you spend on Agency Nurses for the financial year 15/16 (April – March)
• For the above information to be broken down by banding and specialty (example provided below)

Download response Agency nurse expenditure for 2015-2016 010716

Agency and staff cost and numbers. 210918

1. Staff Numbers – Average headcount of permanent and non-permanent staff over the entire 2017/18 financial year or just the headcount as at Saturday, March 31st 2018). Can you please split this into the major staff groups used by the trust? (E.g. Medical, Nursing, Admin, AHP etc.)

2. Staff Cost – Total staff cost during the 2017/18 financial year split into permanent and non-permanent staff.

3. Agency Hours – Hours worked by agency staff in the 2017/18 financial year split by staff groups (E.g. Medical, Nursing, Admin, etc.) and speciality/grade (E.g. Consultants, GP, ICU Nurse, Acute Nurse, Occupational therapists, Pharmacists, Health Care Assistants, etc.) depending on how you report this within your trust.

4. Agency Spend – Total amount spent on agency staff in the 2017/18 financial year split into the Trusts’ staff groups (E.g. Medical, Nursing, Admin, etc.) and speciality/grade (E.g. Consultants, GP, ICU Nurse, Acute Nurse, Occupational therapists, Pharmacists, Health Care Assistants, etc.) depending on how you report this within your trust.

Download response Agency and staff cost and numbers. 210918

Ahmedia Ltd 011216

1. Costs claimed by Ahmedia Ltd for NHS England staff unable to attend their Health Care Strategy Forum for the financial year 2015/16?

Download response letter Ahmedia Ltd 011216

All transactions over £25,000 from March 2023.300623.docx

I’d like to make a request under the Freedom of Information act for all transactions over £25,000 from March to at most a month in arrears from the date at which you publish in response to this request.

All transactions over £25,000 from March 2023.300623.docx

Amazon contracts.010722.docx

1. As of 1 June 2022, what is the current number of contracts held by your NHS Trust with Amazon[dot]com, Inc. and/or its subsidiaries?
2. What is the total value of those contracts in GBP?
3. What is the nature of the services provided under these contracts?
4. Please provide these contracts.

Amazon contracts.010722.docx

Annual Report and Accounts production. 151217

1. How much it cost to commission, design and produce your Annual Report and Accounts in each of the following years: 2013, 2014, 2015, 2016 and 2017.
2. How much it cost to print your Annual Report and Accounts in each of the following years: 2013, 2014, 2015, 2016 and 2017.
3. How much it cost to distribute your Annual Report and Accounts in each of the following years: 2013, 2014, 2015, 2016 and 2017.

Download response Annual Report and Accounts production. 151217

Annual Report and Business Plan 16/17.

Please provide the following information:
1. Most current Annual Report
2. Most current organisation Business Plan

Download response Annual Report and Business Plan 16/17 060916

Annual spend for suppliers. 230921.docx

Please could you provide the annual spend for the below suppliers from your last financial year April 2020 – March 2021? Please note this information is not commercially sensitive as all you will be providing is the total money spent with each supplier not any detail of what you bought.
Alan Wilson Electrical Supplies
Albion Electric
AN Supplies Ltd
B E D ELECTRICAL DISTRIBUTIONS
Bennett & Fountain
Bridge Electrical Supplies
C & K Supplies
CEL Electrical
City Electrical Factors
Contact Electrical Distributor
CRS Electrical Supplies Ltd
CUMBERLAND ELECTRICAL WHOLESALERS LTD
DINNING ELECTRICAL WHOLESALE
Edmundson Electrical
Electric Base
Electric Centre
ELECTRICAL WHOLESALE SUPPLIES LTD (EWS)
Electrical Wholesale Supplies Swansea Ltd
EXPERT ELECTRICAL SUPPLIES LTD
Eyre and Elliston Ltd
FYLDE ELECTRICAL SUPPLIES LTD
GCG ELECTRICAL WHOLESALERS LIMITED,
GILBEY ELECTRICAL WHOLESALERS LTD
GILTBROOK ELECTRICAL DISTRIBUTORS LTD
Hardings Electrical
IMPACT ELECTRICAL DISTRIBUTORS LTD
Independent Electrical Supplies
Juice Electrical Supplies
KEW ELECTRICAL DISTRIBUTORS LTD
LH Evans
LINCS ELECTRICAL WHOLESALERS LTD (LEW)
Links Electrical Supplies
MAINS ELECTRICAL DISTRIBUTORS LTD
Medlock
Newey & Eyre
NORTHERN & CENTRAL ORMSKIRK ELECTRICAL LTD
Park Electrical Distribution
Phase Electrical Distributors
QUALITY ELECTRICAL SUPPLIES AND TECHNOLOGY LTD
R & M Electrical
Rexel
Roblett Electrical Supplies Ltd
RS Components
Ryness Electrical
S & A Electrical Distribution
Screwfix
Service Electrical Wholesale
Smith Brothers
Stearn Electrical
SWIFT ELECTRICAL SUPPLIES
THE WHOLESALE LIGHTING & ELECTRICAL COMPANY
TJ ELECTRICAL WHOLESALE LTD
TLC Electrical Supplies
TN Robinson
TRAFFORD ELEC WHOLESALERS
Upex Electrical Distributors Ltd
WF Senate
Wilson Electrical Distibutors Ltd
Wilts Wholesale
Wyeverne Electrical
YESSS Electrical

Download response Annual spend for suppliers. 230921.docx

Apprenticeship Levy. 190722.docx

Please could you provide data on the following:

1) Total amount of apprenticeship levy funds paid into your apprenticeship service account from May 2017 to April 2022.

2) Total amount of apprenticeship levy funds withdrawn from your apprenticeship service account and used for training and/or assessment from May 2017 to April 2022

Apprenticeship Levy. 190722.docx

Arconic and Kingspan. 260121

Between July 2017 to the date of this email, please tell me how many contracts have been signed by your authority with 1) Arconic and 2) Kingspan. Please disclose the total value of contracts signed with each of these two companies, as well as details about the services/products provided.

Download response Arconic and Kingspan. 260121

Asset Valuation Services. 151118

You asked:

1. When was the Trust’s last asset valuation carried out?
2. Can you confirm which company carried the valuation out?
3. What was the value of the Trust’s assets at the last valuation date?
4. What was the gross internal area of the Trust assets which formed part of the last valuation?
5. When is the Trust’s next asset valuation due?

Download response Asset Valuation Services. 151118

Bank spend.2702223.docx

I would like to request the following information:

The total amount spent by your hospital bank on payments to doctors and nurses, from January 2022 to January 2023.

Bank spend.2702223.docx

Benchmarking tool. 240719

1. Please mark an ‘X’ against each benchmarking tool you currently pay for in your trust/ if the benchmarking tool you pay for is not listed play write the benchmarking tool name in the ‘Other’ box.
2. Please mark an ‘X’ for the total amount you spend each year on each benchmarking tool you have access tool
3. When does the current license expire?
4. Who is the main contact?

Download response Benchmarking tool. 240719

Bereavement Services. 260318

1. Are the Bereavement Services at this Trust run by the trust or an external party?
a. If it’s an external party, who are they?
2. Who is the primary contact for bereavement services at the Trust?
a. What is their correspondence address, email and phone number?
b. Is this their sole responsibility or do they have other job roles?
3. Is there a Bereavement Office at the Trust’s Hospital(s)?
a. Where are the Bereavement Offices located?
4. Is the Bereavement Office always open (24/7), a 9-5 service or by appointment only?
a. If it is not a 24/7 open office, is there a cover for this service out of hours?
5. Are the Bereavement Services only utilised within the Trust, or do they also cover community work (under agreement with other Trusts/CCGs)?
6. Does your Trust present Bereavement Books to the bereaved?
a. Are these produced in-house?
b. Are these produced by an external agency under contract (such as RNS publications)?
7. If under contract;
a. how long is the contract term;
b. when does it end;
c. are there additional benefits in the contract beyond the literature (ie, a cash rebate, other products);
d. does the literature provided contain advertisements;
e. who can sign the contract?

Download response Bereavement Services. 260318

Biopsy and coaxial needles. 160518

1 – References: size (length, diameter) and type (manual, semi-automated, automated) of the different biopsy needles used;
2 – Quantities of biopsy needles annually purchased for every reference;
3 – References: size (length, diameter) of the different coaxial needles used;
4 – Quantities of coaxial needles annually purchased for every reference;
5 – Quantities provided by each needle manufacturer;
6 – Prices for every different needle, both biopsy and coaxial

Download response Biopsy and coaxial needles. 160518

Blood pressure cuffs and needles and syringes. 170621

Blood pressure cuffs:
1. Annual spend on blood pressure monitor cuffs as follows:
a. Disposable blood pressure cuffs
b. Re-usable blood pressure cuffs
2. List of your current purchase price for blood pressure cuffs
3. List of your current models of blood pressure monitors
4. Contact (Name, email, phone number) details for the ward consumables purchaser(s) responsible for placing orders for blood pressure cuffs.
Needles and Syringes:
1. Annual spend on needles and syringes as follows:
a. Needles and syringes in total
b. Specifically
i. Hypodermic needles (non-safety)
ii. Safety hypodermic needles
iii. Syringes
iv. Combined Insulin needles and syringes
v. Insulin pen needles
vi. NR Fit needles and syringes
vii. Anaesthesia needles and syringes
viii. Soft tissue biopsy needles
ix. Bone marrow biopsy needles
2. Biopsy needles
a. Do you consider that you mainly use manual, semi-automatic or fully automatic needles?
3. List of your current purchase price for needles and syringe products
4. Contact (Name, email, phone number) details for the ward consumables purchaser(s) responsible for placing orders for needles and syringes.

Download response Blood pressure cuffs and needles and syringes. 170621

Breathing Circuits.051022.docx

Would it be possible to request the following information?
1. Current breathing circuit supplier
2. Procurement contacts for breathing circuits.

Breathing Circuits.051022.docx

Budget information. 160617

1) The trust’s total annual budget.
2) The annual cost to the trust of any spending associated with using buildings owned by, leased from or built by private providers – including interest payments.
3) The maintenance and any other associated costs the Trust has paid (during the last three years) to private providers for these buildings. And the expected associated costs for the current financial year.
4) The total value of any contracts the trust holds with private providing services and any commercially viable details of these.

Download response Budget information. 160617

Business Intelligence. 190618

1. Which Bi tool does your trust predominantly use?
2. What’s the secondary predominantly used?
3. What’s the tertiary predominantly used?
4. How much did your Trust spend on a BI tool in last three financial years? (£)
5. What tool does your Trust use for benchmarking?
6. How much did your Trust spend on a benchmarking tool in last three financial years?
7. How many employees were there in your BI team?
8. Please breakdown the BI staff by their job (such as analyst, architect, developer etc.)
9. What tool does your Trust use to save data?

Download response Business Intelligence. 190618

Business Intelligence and Benchmarking Tools. 240921.docx

1. Does your organisation use a Business Intelligence (BI) solution*? If yes, please mark an x in the table below against the BI tool/tools the organisation uses
2. What was the annual cost of the BI solution for 20/21 (April 2020- March 2021)?
3. How many users in the organisation use the BI Tool?
4. Does the organisation have a dedicated in-house BI/informatics team? If yes, how many FTEs are in the BI/informatics team?
5. Which department do the BI/informatics team report into in the organisation?
6. Could you please provide the name and job title of the person who leads the BI/informatics team?
7. Does the organisation use a benchmarking tool**? If yes, please mark an x in the table below against the benchmarking tool/tools the organisation uses
8. What was the annual cost of the benchmarking tool for 20/21 (April 2020- March 2021)?
9. Does the organisation subscribe to any benchmarking services? e.g. Dr Foster
10. Which departments / specialties are the biggest users of a) BI tools and b) benchmarking tools in the organisation? e.g. Finance, HR
11. Does your organisation have a data warehouse***? If yes, please state if the data warehouse is on premise or in- cloud?
12. Does the organisation use any other third-party systems to provide managed reporting? If yes, please state the name/names of the other third-party system/systems used? e.g. Beautiful Information, Public View
*A Business Intelligence tool is a type of application designed to retrieve, analyse, transform, and report data for business intelligence normally in the form of interactive dashboards
**A Benchmarking tool is used to compare the performance of the business processes and products with the best performances of other companies inside and outside the industry.
***A data warehouse is a type of data management system/central repository of information that is designed to enable and support BI activities, especially analytics.

Download response Business Intelligence and Benchmarking Tools. 240921.docx

Business rates mitigation and appeals.041023.docx

All questions are shown as received by the Trust.
Please could you provide the name of the firm that is currently contracted by your Trust to provide advice in respect of business rates mitigation and appeals on your own properties. May you also provide the date that this contract started and the contract expiry.

Business rates mitigation and appeals.041023.docx

Butterfly wing needles. 150421

Supplier
Brand
Product Information
NPC Code
Number purchased 1st April 2017 to 31st March 2018
Number purchased 1st April 2018 to 31st March 2019
Number purchased 1st April 2019 to 31st March 2020

Download response Butterfly wing needles. 150421

Capped expenditure process. 240717

Under the Freedom of Information Act I wish to request the following information:

• Any official documents your organisation/s hold relating to the Capped Expenditure Programme/Process (CAP) – should include board documents, draft guidelines for process, consultation documents, timelines, memos etc.
• Any correspondence between senior leaders in the area/senior member of staff charged with responsibility for the CAP and NHS leaders at NHS England or NHS Improvement
• Please provide a copy of your ‘final return’ detailing your plans for delivering CEP savings locally – provided to NHS England by the original deadline of 5th May.

Download response Capped expenditure process. 240717

Catalogue and P2P system. 200418

1. Do you currently have a Catalogue system at the Trust?
2. Which supplier do you use for your Catalogue system?
3. How long have you had this system in place? 2016
4. Are you under contract for your current catalogue system?
5. What is the annual spend on this catalogue system?
6. What is your % catalogue compliance?
7. Which P2P system do you use?
8. How long have you had this system in place?
9. Are you under contract for your P2P system?
10. What is the annual spend on this P2P system?
11. Which Inventory Management system do you use?

Download response Catalogue and P2P system. 200418

Charitable donations. 270418

1. What was the hospital’s total income from charitable donations/funding in the 2017/18 tax year, the 2016/17 tax year and the 2015/16 tax year? For each tax year, please state where the charitable donations/funding came from (e.g. hospital league of friends, charities, etc). And for each tax year, please state what percentage of the hospital’s total revenue came from charitable donations/funding.
2. For the 2017/18 tax year, please provide the breakdown of charitable donations/funding for each of the hospital’s departments (some examples of departments are listed underneath my questions) If time still allows, please specify what the charitable donations/funding paid for, e.g. liver FibroScan machine
3. For the 2016/17 tax year, please provide the breakdown of charitable donations/funding for each of the hospital’s departments If time still allows, please specify what the charitable donations/funding paid for, e.g. liver FibroScan machine
4. For the 2015/16 tax year, please provide the breakdown of charitable donations/funding for each of the hospital’s departments If time still allows, please specify what the charitable donations/funding paid for, e.g. liver FibroScan machine

Download response Charitable donations. 270418

Charitable funds for Critical Care directorate.241123.docx

All questions are shown as received by the Trust.
1. How much money is held in the charitable funds for Critical Care directorate; specifically intensive care, as of the date of this email.
2. Is this is a communal amount or separate amounts for the units at Maidstone and Tunbridge Wells?
3. If so can you provide a figure for each unit; being the Maidstone ITU, and the Tunbridge Wells ITU if applicable.
4. Can you provide the figures (for each unit if applicable) for the financial years of:
a. 2020-2021
b. 2021-2022
c. 2022-2023
d. 2023-to date
5. The breakdown of what the monies was used for, for each of these years (for each unit if applicable).

Charitable funds for Critical Care directorate.241123.docx

CHS Healthcare. 070219

1. What services CHS Healthcare provide to the trust?
2. How much the trust pays CHS Healthcare per month for their services?
3. How long the trust are contracted in to the service provided?
4. When the contract is up for renewal, which procurement portal would it be advertised on?

Download response CHS Healthcare. 070219

Clinical benchmarking. 010719

1. Can you provide details of your current clinical benchmarking supplier (If any) examples such as HED, Doctor Foster or CHKS?
2. Can you provide details of the current renewal/end date of this contract?
3. Who is the main point of contact for this contract and their title and contact details?
4. Which board member has responsibility for benchmarking?
5. Do you have BI solutions such as ClikView or ClikSense?
6. Do you use any companies to provide remote clinical coding services? If Yes,
7. What was the procurement method used?
8. How long is the contract?
9. Can you provide details of the current renewal/end date of this contract?

Download response Clinical benchmarking. 010719

Clinical Coding Departments.190423.docx

1. Do you use an Electronic Patient Record (EPR)?
2. If you do use an EPR which one do you use?
3. When did you go live with your EPR?
4. How long did it take to bed in within your Clinical Coding Department/ trust?
5. How user friendly is your EPR for your Clinical Coders?
6. What systems were you using before?
7. How helpful was the EPR training provided to Clinical Coders before go live?
8. Is any paperwork still generated on wards that is required for Clinical Coding?
9. How did implementation go for Clinical Coding?
10. What was done well?
11. What could have been done better?
12. What were your biggest challenges as a Clinical Coding Department relating to your EPR?
13. What are still your biggest challenges as a Clinical Coding Department relating to your EPR?
14. Has EPR impacted your Clinical Coding Departments KPI’s – quality, backlog, engagement?
15. What are the positives of your EPR system for your Clinical Coding Department?
16. Are there any negative impacts from your EPR for your Clinical Coding department?
17. How are you tackling these?
18. Did you have any Clinical Coding clerical support before EPR go live and do you have clerical support now?
19. Has the change been positive or negative for your Clinical Coding Department?
20. Do you have you any advice for a Clinical Coding Department planning on purchasing the same EPR as you?
21. Would you recommend other trusts select your EPR solution?

Clinical Coding Departments.190423.docx

Clinical Insourcing. 260419

1. The total amount spent on clinical insourcing companies for the financial year 18/19 (April – March)
2. Please highlight which of the following companies were used:

Download response Clinical Insourcing. 260419

Clinical waste bag seals.080318

• I would like to know what the trust currently uses to seal clinical waste bags and the annual quantity purchased (as well as the annual cost to the Trust if possible)?
• I would also like to know where the trust purchases these products from, i.e. is it direct from a supplier or from the NHS Supply Chain?
• Who is responsible for purchasing this product?
• How does the trust provide an audit trail for their clinical waste?

Download response Clinical waste bag seals.080318

Coding. 020320

We are conducting a research project exploring the epidemiology and management of patellofemoral instability. As such we would be grateful if you could provide us with the following information under the Freedom of Information Act, relating to the codes used in your hospital to document this condition and its treatment:

Coding relating to diagnosis:
a. patellar dislocation
b. recurrent patella dislocation
c. patellar instability

Coding relating to treatment:
a. Lateral release
b. Trochleoplasty
c. Tibial tubercle osteotomy including Elmslie Trillat / Maquet
d. Medial patello-femoral ligament (MPFL) reconstruction
e. Proximal realignment
f. -Allograft (at the time of MPFL reconstruction)

If your trust does not manage this condition, I would be grateful if you could send a reply to this effect.

Download response Coding. 020320

Company spend. 270520

Under the FOI request please provide total spend for the 2018/19 and the 2019/20 financial years (to date and periods stated) for the following organisations:
• 18 Week Support (including LLP variants)
• The Endoscopy Group
• Gutcare
• Endocare Diagnostics
• Medicare Insourcing
• Skin Cancer Care UK
• Eden Uk Clinical Services
• Glanso
• Alliance Medical
• Synaptik
• Elective Services Limited
• Ics Insourcing / Diagnostics
• Totally Healthcare
• Your Medical Services
• Remedy Healthcare Solutions
• Medinet Clinical Services Limited( (including Medinet Wales)
• SHS Partners
• DMC Healthcare
• The Aberdeen Clinic
• Diagnostic World
• Omnes Healthcare
• Healthcare Business Solutions

Download response Company spend. 270520

Compromise agreements January 2011 and December 2015

Please advise in relation to the 5 years between January 2011 and December 2015 inclusive:
1) How many compromise agreements has the Trust entered into with staff or former staff? Please include all COT3 agreements in this figure.
2) How many of these compromise agreements require staff members not to disclose the existence of the compromise agreement itself?
3) How many of these compromise agreements contain non-disparagement clauses that require staff members not to criticise the employees of the Trust?
4) How many of these compromise agreements were entered into by the Trust with staff who had previously made public interest disclosures, (whether or not these were raised by formally invoking the Trust’s whistleblowing policy)?
5) If staff who have entered into a compromise agreement with the Trust were to voice concerns about reprisal by the Trust for whistleblowing, would the Trust consider this to be an actionable breach of non-disparagement clauses, or would it consider the raising of such concerns to be qualifying disclosures under PIDA?

Download response Compromise agreements January 2011 and December 2015 270616

Consultancy spending.281123.docx

All questions are shown as received by the Trust.
For the purpose of clarity, ‘management consulting services’ are defined as any external advisory services provided to support decision making and strategic planning, change management, operational efficiency, and other related areas.

Specifically, I am requesting the following information:

1. Total expenditure on management consulting services for each year within the past five years within your trust.
2. The names of the consulting firms that were contracted, if this does not breach any privacy or contractual clauses.
3. The specific areas or projects for which these consulting services were employed.

Consultancy spending.281123.docx

Consultancy usage.191023.docx

All questions are shown as received by the Trust.
1. Between January 1 2020 and today (September 14 2023), on how many occasions did the trust pay for/use the services of any of the following consultancy firms: Deloitte, KPMG, PricewaterhouseCoopers (PwC) and EY (Enrst & Young)?
2. For each occasion please give me: the date, the payments made for their services (dated and with exact cost given), and the reason for that payment/service. I would like specific detail on the reasons – ie what a consultant was called in for, whether it be management restructuring advice, redundancy plans, operational advice on procurement of equipment etc, and so on.

Consultancy usage.191023.docx

Consumables. 190321

In line with Freedom of Information, can you kindly provide the following information regarding the consumables currently used at the Trust?

Reusable Blood Pressure Cuffs (all sizes)
Single use blood pressure cuffs (all sizes)
Single use SpO2 sensors (all sizes)
All Procedure Packs
All Ward Packs
Syringes (all sizes)
Needles (all sizes)
Product Description
Current supplier/suppliers
Across Which site are these used
Spend figures in 2019-2020 per site (GBP)
Are these products provided under a contract
If yes, when is the contract up for renewal

Download response Consumables. 190321

Consumables. 210623.docx

The information I’m looking for is;

• The top 30 products that your trust consumes on a regular basis. For example, reams of printer paper, pens, pencils, pads etc. I’m assuming that this list may well include clinical items such as gowns, scalpel blades, scrubs etc.
• The volume of each item bought per annum (either over a 12 month period or a financial year)
• The unit cost of each item (or an average price)

Consumables. 210623.docx

Contract information for TNP and PAC.060317

Section 1
1) What are the Hospital names and locations that form part of the Trust? (Please provide details)
2) Which framework is utilized for purchasing such as SBS, NHS Supply Chain or other (please provide details of all that are used)
3) By which method is this procured? (Please state all that applies)
Section 2
1) What is the name of the manufacture used to provide Topical Negative Wound Therapy Treatment for each hospital location?
*Smith-Nephew
*KCI
*Talley
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) Is this equipment provided via Hire agreement, Purchase or other? (Please provide details)
4) Is the provision of this equipment contracted? Yes or No
5) If contracted is the service and maintenance of this equipment included as part of the contract? Yes or No
6) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
7) If 3rd party provider please state company name
8) Is the 3rd party service & maintenance contracted? Yes or No
9) If Yes what is the contract term? (Including any extension periods).
10) What is the expiry date of this contract?
The following questions are only applicable if the supply of Topical Negative Wound Therapy to the hospital trust is contracted.
1) As a result of the tender did you change provider? Yes or No (If Yes please provide name of previous supplier)
2) What date did your current contract start?
3) How long is the current contract? (Including any extension periods)
4) When does the current contract expire?
5) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
6) Please provide the financial value for the first 12 months of the current contract in place.
Section 3
1) What is the name of the manufacture used to provide pressure relief alternating dynamic surface air mattresses to the trust?
*Hill-Rom
*Smith-Nephew
*Talley
*Direct Healthcare
*Karomed
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) What is the total number of dynamic mattresses on-site?
4) Is this a managed service? Yes or No
5) Is the provision of dynamic surfaces contracted? Yes or No
6) If Yes is the service and maintenance of this equipment included as part of the contract? Yes or No
7) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
8) If 3rd party provider please state company name
9) Is this 3rd party service contracted? Yes or No
10) If Yes what is the contract term? (Including any extension periods).
11) What is the expiry date of this contract?
12) How is the decontamination of these products managed? In-house or 3rd party provider
13) If 3rd party provider please state company name
14) Is this 3rd party service contracted? Yes or No
15) If Yes what is the contract term? (Including any extension periods).
16) What is the expiry date of this contract
The following questions are only applicable if the supply of dynamic alternating air surface mattresses to the hospital trust is contracted.
1) Which method is used to tender the contract? (Please provide details)
2) What date did your current contract start?
3) What is the term of the contract? (including any extension periods)
4) When does the current contract expire?
5) Is the contract purchase, hire or other (please provide details)
6) If contracted, when did you last tender the contract?
7) As a result of the tender did you change provider? Yes or No (if Yes please provide previous supplier)
8) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
9) Please provide the financial value for the first 12 months of the current contract in place.
Section 4
1) What is the name of the manufacture used to supply profiling bed frames?
*Hill-Rom
*Sidhil
*Invacare
*Linet
*Huntleigh
*Other (please provide details)
2) By which method is this procured? (Please state all that applies)
3) Which products are used? (Please provide details)
4) What is the total number of hospital bed frames on-site?
5) Is the supply of bed frames contracted?
Yes or No?
The following questions are only applicable if the supply of profiling beds to the hospital trust is contracted.
1) What date did your current contract start?
2) How long is the current contract? (Including any extension periods)
3) When does the current contract expire?
4) When did you last tender the contract?
5) As a result of the tender did you change provider? Yes or No (if Yes please state previous supplier)
6) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
7) Please provide the financial value for the first 12 months of the current contract in place.

Download response Contract information for TNP and PAC.060317

Contract Register. 111019

The contract register should display all the organisations existing/live contracts I would like the register to display the following columns/headings:

1. Contract Reference
2. Contract Title
3. Procurement Category
4. Supplier Name
5. Spend (Total or Annual)
6. Contract Duration
7. Contract Extensions
8. Contract Starting Date
9. Expiration Date
10. Contract Description [Please provide me with as much detail as possible.]
11. Contact Owner (Full contact details if possible.)
12. CPV codes/ProClass
13. Contract Reference
Contract Data/API Contact Details
14. Can you also provide me with contact details of the person responsible for the actual contract’s register or someone responsible for API? [Name, Job Title, Telephone, Email Address] At the very least provide me with their actual job title.

(Meaning of API “a set of functions and procedures that allow the creation of applications which access the features or data of an operating system, application, or other service.”)
IMPORTANT
1. For those organisation planning to make an exemption, the spend information I have requested is an overall figure and I am not requesting a complete breakdown of services relating to the spend.
2. If the organisation has a CRM or Contract system or a similar system there should be a facility to download and extract contract data.
3. You may forward me a Weblink to a portal to download the contract register, please make sure all of the organisation’s contracts are provided as doing prior research I have found that most organisations have only uploaded a small portion of all of their contracts.
Please do not think that this is the only information I require if you could provide me with more information that would be great.
Please provide me with the contract’s register file in an excel format.

Download response Contract Register. 111019

Contract Register. 140618

I want to submit a request for some information from the Trust in relation to their contract’s register.
The contract register should display all the Trust existing/live contracts this includes medical and non-medical. I would like the register to display the following columns:
1. Contract Reference
2. Contract Title
3. Supplier Name
4. Spend (Total or Annual)
5. Contract Duration
6. Contract Extensions
7. Contract Dates
8. Contract Description
9. Contact Owner (Full contact details if possible.)
10. CPV codes/ProClass
11. Framework or Tender Reference
IMPORTANT
You may forward me a Weblink to a portal to download the contract register, please make sure all of the Trust’s contract are provided.

Contract Data/API Contact Details
12. Can you also provide me with contact details of the person responsible for the actual contract’s register or someone responsible for API? Name, Job Title, Telephone, Email Address

Download response Contract Register. 140618

Contract register.200123.docx

I would like to submit a request for some information from the organisation, in relation to their contract’s register.
The FULL contract register should display all the organisations existing/live contracts I would like the register to display the following columns/headings:
1. Contract Reference -Unique reference number associated with the contract.
2. Contract Title
3. Procurement Category –Please state the category name of the contract, I wish to know the category the contract is under.
4. Supplier Name
5. Spend (Total, Annual or contract value)
6. Contract’s Duration
7. Contract’s Extensions
8. Contract’s Start Date
9. Contract’s Expiry Date
10. Contract Description [Please provide me with as much detail as possible.]
11. Contact Owner (Person that manages the contract register)
12. Contract details of section 151 officer
13. CPV codes/Pro-Class

Contract Data/API Contact Details
1. Can you also provide me with contact details of the person responsible for the actual contract’s register or someone responsible for API? [Name, Job Title, Telephone, Email Address] At the very least provide me with their actual job title.

Contract register.200123.docx

Contracts. 090621

Do you use the following systems?
Yes/NO
Contract/Framework/DPS
End Date
Proposed Tender Date
Expenditure 1 April 2020 to 31 March 2021
Anticipated expenditure 1 April/March 2022
Accr RX
Andor Health
Attend Anywhere
Canley Digital Health Care
Capri Healthcare
Cinos (Stellaris)
Clinic.co (Instant.Help)
Definition Health Limited
Doctorlink
DrDoctor
Flabba
GoodSam (Instant Health)
Google Conferencing/Meeting
Healthcall solutions
Healthcare Business Solutions UK Limited
Hospital Services Limited
Huma Therapeutics
IMI Mobile Europe
Inhealthcare Limited
Knock Healthcare
Medstars Ltd
Modality Systems
MS Teams
NB Data
Oris Health Limited
OXDH Health
Pinnaca
Q Doctor
Refero
SCC Ltd
StarLeaf
T-Pro
Visconn Limited
Visionable
ZOOM
Other collaborative/video platforms
System Name of Supplier
Yes/NO
Contract/Framework/DPS
End Date
Proposed Tender Date
Expenditure 1 April 2020 to 31 March 2021
Anticipated expenditure 1 April/March 2022
Patient Records System e.g. EPR
Patient Check Kiosk

Download response Contracts. 090621

Contracts. 120521

We would like to know details of contracts awarded by the Trust; the vendor involved, the category e.g. equipment maintenance, date of award, value and contract length. We would like this information for the past 3 years.

Download response Contracts. 120521

Contracts.230823.docx

All questions are shown as received by the Trust.
Please could you provide a list of the names of all companies that currently have contracts with the Maidstone And Tunbridge Wells NHS Trust?
Although not necessary, if available I would also appreciate the inclusion of further descriptive fields such as Addresses, Telephone numbers or Company Registration data of these companies.

Contracts.230823.docx

Contracts and Tenders. 100720

1. How do you make the public aware of your contracts and tenders?
2. How do you commission architectural services?
3. Do you have a design and construction framework?
4. If you do have a framework, when is it due for renewal?

Download response Contracts and Tenders. 100720

Contracts register. 040320

I want to submit a request for some information from the organisation, in relation to their contract’s register.
The contract register should display all the organisations existing/live contracts I would like the register to display the following columns/headings:

1. Contract Reference
2. Contract Title
3. Procurement Category
4. Supplier Name
5. Spend (Total or Annual)
6. Contract Duration
7. Contract Extensions
8. Contract Starting Date
9. Expiration Date
10. Contract Description [Please provide me with as much detail as possible.]
11. Contact Owner (Full contact details if possible.)
12. CPV codes/ProClass

Download response Contracts register. 040320

Contracts Register. 081021.docx

I want to submit a request for some information from the organisation, in relation to their contract’s register.
The FULL contract register should display all the organisations existing/live contracts I would like the register to display the following columns/headings:
1. Contract Reference -Unique reference number associated with the contract.
2. Contract Title
3. Procurement Category –Please state the category name of the contract, I wish to know the category the contract is under.
4. Supplier Name
5. Spend (Total, Annual or contract value)
6. Contract Duration
7. Contract Extensions
8. Contract Starting Date
9. Expiration Date
10. Contract Description [Please provide me with as much detail as possible.]
11. Contact Owner (Full contact details if possible.)
12. CPV codes/Pro-Class
Contract Data/API Contact Details
13. Can you also provide me with contact details of the person responsible for the actual contract’s register or someone responsible for API? [Name, Job Title, Telephone, Email Address] At the very least provide me with their actual job title.

Download response Contracts Register. 081021.docx

Contracts register. 101120

The contract register should display all the organisations existing/live contracts I would like the register to display the following columns/headings:
1. Contract Reference
2. Contract Title
3. Procurement Category
4. Supplier Name
5. Spend (Total or Annual)
6. Contract Duration
7. Contract Extensions
8. Contract Starting Date
9. Expiration Date
10. Contract Description [Please provide me with as much detail as possible.]
11. Contact Owner (Full contact details if possible.)
12. CPV codes/ProClass
Contract Data/API Contact Details
13. Can you also provide me with contact details of the person responsible for the actual contract’s register or someone responsible for API? [Name, Job Title, Telephone, Email Address] At the very least provide me with their actual job title.
(Meaning of API “a set of functions and procedures that allow the creation of applications which access the features or data of an operating system, application, or other service.”)

Download response Contracts register. 101120

Contract’s register.130522.docx

I would like to submit a request for some information from the organisation, in relation to their contract’s register.
The FULL contract register should display all the organisations existing/live contracts I would like the register to display the following columns/headings:
1. Contract Reference -Unique reference number associated with the contract.
2. Contract Title
3. Procurement Category –Please state the category name of the contract, I wish to know the category the contract is under.
4. Supplier Name
5. Spend (Total, Annual or contract value)
6. Contract’s Duration
7. Contract’s Extensions
8. Contract’s Start Date
9. Contract’s Expiry Date
10. Contract Description [Please provide me with as much detail as possible.]
11. Contact Owner (Person that manages the contract register)
12. CPV codes/Pro-Class
Contract Data/API Contact Details
13. Can you also provide me with contact details of the person responsible for the actual contract’s register or someone responsible for API? [Name, Job Title, Telephone, Email Address] At the very least provide me with their actual job title.

Contract’s register.130522.docx

Contracts register. 190320

I want to submit a request for some information from the organisation, in relation to their contract’s register.
The contract register should display all the organisations existing/live contracts I would like the register to display the following columns/headings:
1. Contract Reference
2. Contract Title
3. Procurement Category
4. Supplier Name
5. Spend (Total or Annual)
6. Contract Duration
7. Contract Extensions
8. Contract Starting Date
9. Expiration Date
10. Contract Description [Please provide me with as much detail as possible.]
11. Contact Owner (Full contact details if possible.)
12. CPV codes/ProClass
IMPORTANT
1. For those organisation planning to make an exemption around spend, the spend information I have requested is an overall figure and I am not requesting a complete breakdown of services relating to the spend.
2. If the organisation has a CRM system or a similar system there should be a facility to download and extract contract data.
3. You may forward me a Weblink to a portal to download the contract register, please make sure all of the organisation’s contracts are provided as doing prior research I have found that most organisations have only uploaded a small portion of all of their contracts.
Please do not think that this is the only information I require if you could provide me with more information that would be great.

Contract Data/API Contact Details
13. Can you also provide me with contact details of the person responsible for the actual contract’s register or someone responsible for API? [Name, Job Title, Telephone, Email Address] At the very least provide me with their actual job title.

(Meaning of API “a set of functions and procedures that allow the creation of applications which access the features or data of an operating system, application, or other service.”)

Please provide me with the contract’s register file in an excel format.

Download response Contracts register. 190320

Contracts register. 300621

The FULL contract register should display all the organisations existing/live contracts I would like the register to display the following columns/headings:
1. Contract Reference -Unique reference number associated with the contract.
2. Contract Title
3. Procurement Category –Please state the category name of the contract, I wish to know the category the contract is under.
4. Supplier Name
5. Spend (Total or Annual)
6. Contract Duration
7. Contract Extensions
8. Contract Starting Date
9. Expiration Date
10. Contract Description [Please provide me with as much detail as possible.]
11. Contact Owner (Full contact details if possible.)
12. CPV codes/ProClass
Contract Data/API Contact Details
13. Can you also provide me with contact details of the person responsible for the actual contract’s register or someone responsible for API? [Name, Job Title, Telephone, Email Address] At the very least provide me with their actual job title.

Download response Contracts register. 300621

Contractual and supply chain arrangements. 250121

• Provision of online payment acceptance – e.g. online website payments or payment portals
• Provision of point of sale card/EPOS machines – e.g. as found in payment offices or reception areas
• Provision of MOTO (Mail Order and Telephone Order) payment acceptance
• Provision of Direct Debit services
• Provision of over the counter payment services, e.g. as used to make payments in Post Office & Pay Point outlets (if relevant)
• Merchant Acquirer services
I would appreciate you providing the following for each of the above points, by completing the attached spreadsheet:
• Current supplier/s names
• Scope of current Contract
• Contract End Date
• Approximate date of your next sourcing/tender exercise
• Annual Value of the Contract
• Annual transaction volume & value, where known
• Contact details of the member(s) of Staff responsible for payment collection

Download response Contractual and supply chain arrangements. 250121

Cost of flu treatment in A&E. 250117

a) How many people were admitted to Accident and Emergency with flu in each calendar year: 2010; 2011; 2012; 2013; 2014; 2015, and; 2016?

b) What is the total financial cost for people presenting with flu at Accident and Emergency in each calendar year in answer to Question A. Please provide this information broken down by calendar year, as follows: 2010; 2011; 2012; 2013; 2014; 2015, and 2016. This should include all costs incurred to treat the illness during the patients stay at the hospital, including all staff salaries and any other medical treatment costs.

Download response Cost of flu treatment in A&E. 250117

Cost Improvement Plan. 181218

I would like to request information about the trust’s saving mentioned below:
• Cost Improvement Plan % (2018-19 and 2017-18)
• Cost Improvement Plan Total (2018-19 and 2017-18)

Download response Cost Improvement Plan. 181218

Cost Improvement Programme (2021-22 & 2022-23).260423.docx

1. Total Cost Improvement Plan (£ millions) 2021-22
2. Total Cost Improvement Plan as a proportion of controllable operating expenditure (%) 2021-22 (excluding PFI costs, for example)
3. Total Cost Improvement Plan (£ millions) 2022-23
4. Total Cost Improvement Plan as a proportion of controllable operating expenditure (%) 2022-23 (excluding PFI costs, for example)

Cost Improvement Programme (2021-22 & 2022-23).260423.docx

Cost Improvement Programme (2023-24).250523.docx

Org Code
Org Name
Total Cost Improvement Plan (£ millions) 2023-24
Total Cost Improvement Plan as a proportion of controllable operating expenditure (%) 2023-24 (excluding PFI costs, for example)%

The Trust asked for clarification and you replied:
I would appreciate it if you could provide me with the details of the planned Cost Improvement figures for the year 2023-24.

Cost Improvement Programme (2023-24).250523.docx

Cost Improvement Programme (CIP). 031121.docx

We are trying to seek the figures for the CIPs that were delivered for 2020-21.

Download response Cost Improvement Programme (CIP). 031121.docx

Cost Improvement Programme (CIP). 221119

I would like to request some financial information under the freedom of information laws – around the trust’s cost improvement programmes over the last ten years.
We have attached a spreadsheet to fill in with the request numbers.
For the avoidance of doubt, we are requesting the Cost Improvement Programme figures under the same definition through which the trust submits data to NHS Improvement.
1. Cost improvement plan (£)
a. of which non-recurrent (£)
b. of which Income Generation (£)
2. Cost improvement plan (% of expenditure)

Download response  Cost Improvement Programme (CIP). 221119

Covid-related capital bids. 091220

I would like to know how many Covid-related capital bids have been approved centrally since March 17 and was hoping you could answer a few questions.

To avoid confusion, covid-19 related capital refers to bids submitted in respect of the covid-19 capital expenditure scheme https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/04/COVID-19-capital-reimbursement-process-27-04-20.pdf. All other types of capital bids should not be included.

In addition, can you please tell me?

• The total value of your Covid-related capital bids
• The total in funding you’ve received for Covid-related capital bids.
• How many bids you have made and how many are awaiting central approval.

Download response Covid-related capital bids. 091220

Darktrace. 290421

1. Please provide the following details of any and all gifts and/or hospitality provided by the cybersecurity company Darktrace (also known as Darktrace Limited, Darktrace Holdings and Darktrace Plc):
a. The monetary value;
b. The description;
c. The date;
d. The unit, office or department in which the recipients of the gifts/hospitality worked;
e. Whether the gifts/hospitality were accepted, rejected, or otherwise donated;
2. Please provide this information for any gifts/hospitality received from June 2013 onwards inclusive in the form of an itemised list for each instance of a gift and/or hospitality.
3. Please also disclose whether you were using Darktrace’s services in May 2017.

Download response Darktrace. 290421

Data analytics capabilities. 200220

1. Does your data analytics software have the following capabilities?
a. Machine learning
b. Artificial intelligence
c. Conversational interaction e.g. natural language interface
d. Open APIs
e. Mobile application
f. Near real time analysis
g. Interactive dashboards
2. Please confirm whether data analytics technology is used in the following ways at your hospital:
a. To access near real-time patient flow information
b. To forecast demand and resources required
c. To identify population health patterns and risk stratification
d. To manage purchasing levels of medical supplies
e. To inform patient diagnosis
f. To inform the creation of clinical pathways
g. To inform resource and recruitment
3. Does your data analytics solution provide alerts for the following?
a. Performance and compliance metrics
b. Key operational issues, e.g. emergency department demand
4. Across how many different systems does your hospital hold data?
a. 1-10
b. 20-50
c. 50-100
d. 100-300
e. 300+

Download response Data analytics capabilities. 200220

Data visualisation tools. 050718

1. Please could you provide me with a list of dashboards* the organisation uses and how many users per dashboards there are?
2. Please could you provide the monthly agency spend for Business Intelligence for the financial year 2017/2018?
1. April 2017 –
2. May 2017 –
3. June 2017 –
4. July 2017 –
5. August 2017 –
6. September 2017 –
7. October 2017 –
8. November 2017 –
9. December 2017 –
10. January 2018 –
11. February 2018 –
12. March 2018 –

Download response Data visualisation tools. 050718

Debt collection services. 241017

1. How much money has your trust spent on debt-collection services over the last three financial years?
Please provide this information broken down by financial year for 2014-15, 2015-16, and 2016-17.

2. For the same three financial years, please state how much money was collected by these debt-collection services?
Please break down by the same years as above.

3. At the end of the financial year, what was the largest outstanding debt owed by a single patient? (to clarify, this question refers only to individuals, not companies). Please provide the sum, and state whether the patient was a British patient who had undergone private treatment, or a patient from overseas. Please state what services treatment they received.

Download response Debt collection services. 241017

Debt collection services. 241017

1. How much money has your trust spent on debt-collection services over the last three financial years?
Please provide this information broken down by financial year for 2014-15, 2015-16, and 2016-17.

2. For the same three financial years, please state how much money was collected by these debt-collection services?
Please break down by the same years as above.

3. At the end of the financial year, what was the largest outstanding debt owed by a single patient? (to clarify, this question refers only to individuals, not companies). Please provide the sum, and state whether the patient was a British patient who had undergone private treatment, or a patient from overseas. Please state what services treatment they received.

Download response Debt collection services. 241017

Declarations of Conformity for PPE.280922.docx

I am requesting the Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff since 15 June 2020. Regulation (EU) 2016/425 states that the Declarations of Conformity must be provided physically with the PPE or a weblink printed on the PPE packaging.

Declarations of Conformity for PPE.280922.docx

Disposable cutlery and plates. 290118

United Kingdom-Maidstone: Disposable cutlery and plates
2015/S 021-033596
The details we require are:
• Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages*
• Contract values of each framework/contract (& any sub lots), year to date
• Start date & duration of framework
• Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
• Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
• Who is the senior officer (outside of procurement) responsible for this contract?

Download response Disposable cutlery and plates. 290118

Disposable drinking cups. 290118

How many disposable drinking cups has your trust purchased in each year for the last five years?

Download response Disposable drinking cups. 290118

Doctors’ strike labour cost.040723.docx

Pursuant to my previous FOI “cost of strike cover”, sent on April 25, please could you confirm the amount of money the trust would have expected to spend (or estimates it would have spent) paying the wages of staff junior doctors who took BMA strike action if those who took action had worked their shifts as normal?
I want to work out if the trust spent more money to cover striking doctors’ shifts with additional labour than it would have done had the striking staff worked the shifts.
Please can I have information corresponding to these dates of industrial action by the British Medical Association:
A) March 13-15 2023
and
B) April 11-15 2023
Please provide as much detail as possible on the department of the hospital and the day(s) of employment.

Doctors’ strike labour cost.040723.docx

Dressings and bandages. 020518

Can you please provide your organisation’s total spend for either the last calendar year (2017) or last full financial year with NHS Supplies in respect of Dressings and Bandages. This is either direct spend by yourselves or as part of any contract, you let for these services.

Download response Dressings and bandages. 020518

Drug Patient Level Contract Monitoring (DrPLCM) report.110823.docx

(1) Drug Patient Level Contract Monitoring (DrPLCM) report
Data fields from the DrPLCM report, as specified in table 1 (below). Please do not send patient IDs or cost data, as I appreciate this would compromise data privacy and commercial sensitivity.

Drug Patient Level Contract Monitoring (DrPLCM) report.110823.docx

Drug Patient Level Contract Monitoring (DrPLCM) report.251023.docx

All questions are shown as received by the Trust.
1. Drug Patient Level Contract Monitoring (DrPLCM) report
An extract of records from this report for all hospitals in the Trust for the three months between Jul 2023 and Sep 2023
Sourced from NHS Digital, DrPLCM Technical Specification V2.6 document
https://digital.nhs.uk/data-and-information/information-standards/information-standards-and-data-collections-including-extractions/publications-and-notifications/standards-and-collections/contract-monitoring

Field number Data Element
1 FINANCIAL MONTH
2 FINANCIAL YEAR
5 ORGANISATION IDENTIFIER (CODE OF PROVIDER)
6 ORGANISATION SITE IDENTIFIER (OF TREATMENT)
9 ORGANISATION IDENTIFIER (CODE OF COMMISSIONER)
19 ACTIVITY TREATMENT FUNCTION CODE
22 CLINICAL INTERVENTION DATE (DRUG DISPENSED)
23 THERAPEUTIC INDICATION CODE (SNOMED CT)
26 DRUG NAME (HIGH COST TARIFF EXCLUDED DRUG)
27 ROUTE OF ADMINISTRATION (SNOMED CT DM+D)
28 DRUG STRENGTH (HIGH COST TARIFF EXCLUDED DRUG)
29 DRUG VOLUME (HIGH COST TARIFF EXCLUDED DRUG)
30 DRUG PACK SIZE (HIGH COST TARIFF EXCLUDED DRUG)
31 DRUG QUANTITY OR WEIGHT PROPORTION (HIGH COST TARIFF EXCLUDED DRUG)
32 UNIT OF MEASUREMENT (SNOMED CT DM+D)
33 DISPENSING ROUTE (HIGH COST TARIFF EXCLUDED DRUG)
34 PROVIDER REFERENCE NUMBER
35 COMMISSIONED SERVICE CATEGORY CODE
36 SERVICE CODE
37 NATIONAL CANCER DRUGS FUND FORM CODE
44 LOCAL CONTRACT MONITORING CODE
45 LOCAL CONTRACT MONITORING DESCRIPTION
46 CONTRACT MONITORING ADDITIONAL DETAIL (FIRST)
47 CONTRACT MONITORING ADDITIONAL DESCRIPTION (FIRST)
51 VALUE ADDED TAX CHARGED INDICATOR (CONTRACT MONITORING)

Drug Patient Level Contract Monitoring (DrPLCM) report.251023.docx

Drug Patient Level Contract Monitoring (DrPLCM) report.280224.docx

All questions are shown as received by the Trust.
Please could I have a copy of the spreadsheets previously provided in response to the following Freedom of Information requests:

FOI/GS/ID 8816 – referred to in Drug Patient Level Contract Monitoring (DrPLCM) report.300124.docx
FOI/GS/ID 8566 – referred to in Drug Patient Level Contract Monitoring (DrPLCM) report.251023.docx
FOI/GS/ID 8368 – referred to in Drug Patient Level Contract Monitoring (DrPLCM) report.110823.docx
FOI/GS/ID 7424 – referred to in Drug Patient Level Contract Monitoring (DrPLCM) report and SACT Cancer report.090623.docx
The zip file provided in response to FOI/GS/ID 7006 – referred to in “Usage of medicines by diagnosis. 250122.docx”

Drug Patient Level Contract Monitoring (DrPLCM) report.280224.docx

Drug Patient Level Contract Monitoring (DrPLCM) report.300124.docx

All questions are shown as received by the Trust.
(1) Drug Patient Level Contract Monitoring (DrPLCM) report
Data fields from the DrPLCM report, as specified in table 1 (below). Please do not send patient IDs or cost data, as I appreciate this would compromise data privacy and commercial sensitivity.
Appendices – specification
Please include the data fields specified within table 1:
1. Drug Patient Level Contract Monitoring (DrPLCM) report

An extract of records from this report for all hospitals in the Trust for the three months between Oct 2023 and Dec 2023
Sourced from NHS Digital, DrPLCM Technical Specification V2.6 document
https://digital.nhs.uk/data-and-information/information-standards/information-standards-and-data-collections-including-extractions/publications-and-notifications/standards-and-collections/contract-monitoring

Field number Data Element
1 FINANCIAL MONTH
2 FINANCIAL YEAR
5 ORGANISATION IDENTIFIER (CODE OF PROVIDER)
6 ORGANISATION SITE IDENTIFIER (OF TREATMENT)
9 ORGANISATION IDENTIFIER (CODE OF COMMISSIONER)
19 ACTIVITY TREATMENT FUNCTION CODE
22 CLINICAL INTERVENTION DATE (DRUG DISPENSED)
23 THERAPEUTIC INDICATION CODE (SNOMED CT)
26 DRUG NAME (HIGH COST TARIFF EXCLUDED DRUG)
27 ROUTE OF ADMINISTRATION (SNOMED CT DM+D)
28 DRUG STRENGTH (HIGH COST TARIFF EXCLUDED DRUG)
29 DRUG VOLUME (HIGH COST TARIFF EXCLUDED DRUG)
30 DRUG PACK SIZE (HIGH COST TARIFF EXCLUDED DRUG)
31 DRUG QUANTITY OR WEIGHT PROPORTION (HIGH COST TARIFF EXCLUDED DRUG)
32 UNIT OF MEASUREMENT (SNOMED CT DM+D)
33 DISPENSING ROUTE (HIGH COST TARIFF EXCLUDED DRUG)
34 PROVIDER REFERENCE NUMBER
35 COMMISSIONED SERVICE CATEGORY CODE
36 SERVICE CODE
37 NATIONAL CANCER DRUGS FUND FORM CODE
44 LOCAL CONTRACT MONITORING CODE
45 LOCAL CONTRACT MONITORING DESCRIPTION
46 CONTRACT MONITORING ADDITIONAL DETAIL (FIRST)
47 CONTRACT MONITORING ADDITIONAL DESCRIPTION (FIRST)
51 VALUE ADDED TAX CHARGED INDICATOR (CONTRACT MONITORING)

Drug Patient Level Contract Monitoring (DrPLCM) report.300124.docx

Drug spend 2014-15 and 2015-16. 081117

a) Total drug spend for financial years 2014-15, and 2015-16
b) Total Off-tariff drug spend for financial years 2014-15, and 2015-16
c) Total Homecare drug spend for financial years 2014-15, and 2015-16

Download response Drug spend 2014-15 and 2015-16. 081117

Dyson products purchased in the last five years. 151216

How many Dyson products has your trust bought in the last five years?

What are these products and models?

A breakdown of how many items of each Dyson product was bought in the last five years, e.g. how many fans, vacuum cleaners, hand dryers etc.

How much money has been spent on all Dyson products for the last five years for your trust?

Please could I have a breakdown for how much has been spent on each type of product, e.g. vacuum cleaners, fans, hand dryers etc., for the last five years?

Download response Dyson products purchased in the last five years. 151216

EHIC cards.170723.docx

Please include the following information for the 2020/21, 2021/22 and 2022/23 financial years:
1. How much has the organisation spent (broken down by financial year) on providing treatment to foreign patients supplying an EHIC card
2. How much has been recovered (broken down by financial year) from the relevant health authorities for treatment provided through EHIC

EHIC cards.170723.docx

Electronic invoices. 270317

1) Do you currently receive electronic invoices? Yes/No
2) If so, are these received in EDI format (not PDF)? Yes/No
3) If not, would you have a date when you could be ready to test/receive EDI Invoices?

Download response Electronic invoices. 270317

End of Life payments. 260619

1. The percentage of patients who have died on the Trust’s end-of-life care plan against the Trust’s target for the number of patients who should die on this plan over the last three years, divided by the year.
E.g. between 1 January 2016 and 31 December 2016, 43 per cent of patients died on the plan against a target of 35 per cent.
Note: If no such target exists, please make this clear.
2. The amount received by the Trust, via the Commissioning for Quality and Innovation (CQUIN) system or similar, for hitting targets related to its end-of-life care plan for the last three years, divided by the year.
E.g. between 1 January 2016 and 31 December 2016, the Trust received £X via CQUIN for achieving goals involving its ICP.
Note: If no such payments were made, please make this clear.

Download response End of Life payments. 260619

End User Devices as a Service contract. 150721.docx

http://ted.europa.eu/udl?uri=TED:NOTICE:457507-2019:TEXT:EN:HTML
The details we require are:
1. Suppliers who applied for inclusion on each framework/contract and were successful & not successful at the PQQ & ITT stages
2. Actual spend on this contract/framework (and any sub lots), from the start of the contract to the current date
3. Start date & duration of framework/contract?
4. Could you please provide a copy of the service/product specification given to all bidders for when this contract was last advertised?
5. Is there an extension clause in the framework(s)/contract(s) and, if so, the duration of the extension?
6. Has a decision been made yet on whether the framework(s)/contract(s) are being either extended or renewed?
7. Who is the senior officer (outside of procurement) responsible for this contract?

Download response End User Devices as a Service contract. 150721.docx

eProcurement system. 200417

Where different and distinct systems are in use at separate Trust sites, please disclose this. Where this is the case, please answer the following sections in a site-specific format.
Where any/all of the procurement functions are outsourced to another party/parties (e.g. a private company or a distinct NHS body) please disclose the structure of this relationship.
1. Does the Trust have/have use of an eProcurement system(s)?
If so, please name the provider(s).
2. What is the length (in years) of the contract(s) in place with such provider(s)?
3. What is the end/renewal date (dd/mm/yyyy) of the contract(s)?
4. What Finance/E.R.P (enterprise resource planning) system does the Trust use?
5. How many members of staff work in the procurement/purchasing department(s) at the Trust?
6. How many members of staff across the Trust have permission/access to raise requisitions and purchase orders through the eProcurement system(s) in place? (estimate)

The following section of this FOI request concerns the capability of any/all eProcurement systems being used by the Trust.
1. Does the system(s) in place cover the sourcing (auctioning/tendering) of goods/services used by the Trust?
2. Does the system(s) in place cover the management of contracts with chosen suppliers?
3. Does the system(s) in place cover the enablement of electronic catalogues to allow buyers within the Trust to purchase goods/services sourced by the Trust?
4. Does the system(s) in place cover the payment to suppliers for goods/services sourced by the Trust? This includes the management of electronic Purchase Orders, Goods Receipts and Invoices.
5. Does the system(s) in place cover the management of supplier relationships and performance?
6. Does the system(s) in place have the capability to analyse current and/or historical procurement spend by the Trust?
7. Does the system(s) in place have the capability to report and demonstrate data relating to procurement spend by the Trust?
8. Does the system(s) in place have the capability to integrate with the Finance/E.R.P (enterprise resource planning) system?
9. Are updates (free or paid) offered for the incumbent system(s), either on a regular or irregular basis?
10. Are there any formalised projects or initiatives currently underway to review/upgrade current procurement practices within the Trust? If yes, please provide details.

Download response eProcurement system. 200417

ERP (Enterprise Resource Management).280323.docx

1. Which ERP (Enterprise Resource Management) or Finance system is currently used?
2. What was the total value of the contract?
3. What is the annual contract value?
4. What is the duration of the contract?
5. When does your contract expire?
6. Do you have any planned upgrades of the software? If so, when?
7. Are you planning to go to market for a different ERP/ Finance system? If so, when?
8. Who is the person responsible for your ERP / Finance system? Please provide full name, title and contact information if possible.

ERP (Enterprise Resource Management).280323.docx

Estates and Capital Projects Managers. 300317

Please can you provide the contact details, name, telephone number, email address, of the Head of Estates, Estates Managers and Capital Project Managers for your trust?

Download response Estates and Capital Projects Managers. 300317

External management, business consultants and recruitment agency fees.060224.docx

All questions are shown as received by the Trust.
1) Since the beginning of the calendar year 2023, how much has the trust spent on external management/business consultants, including commitments that cover the rest of the calendar year?
2) Since the beginning the calendar year 2023, how much has the trust spent fees to recruitment agencies, including commitments that cover the rest of the calendar of the calendar year?

External management, business consultants and recruitment agency fees.060224.docx

External supplier payments. 281021.docx

What I am requesting is a compiled list, ideally in Microsoft Excel format, of your external suppliers which contains the following variables:-
1. The name of the supplier
2. The supplier’s VAT identification number
3. The total amount paid to the supplier during the year 2020 for purchases of goods and services. The amounts can either be including or excluding VAT.
This request only regards suppliers to whom the organisation has paid £5,000 or more during 2020. If information about any specific supplier is too sensitive to produce, feel free to remove it from any potential list.

Download response External supplier payments. 281021.docx

February 2019 transactions over £25k.100523.docx

Thank you for providing up to date Expenditure reports detailing your trust’s transactions over £25,000.

The file for February 2019, found on the following page, appears to be a duplicate of the file for February 2018. Please could you provide me with a file detailing the expenditure of your trust for February 2019?

February 2019 transactions over £25k.100523.docx

Finance and Procurement systems.280223.docx

1. Please can you provide information relating to the types of software (and suppliers) you may be using for:
o FMS System
o Budgeting System
o Online procurement System
o Contract & Supplier Management Software
In addition to this please include details relating to contract renewal dates and information regarding the support and maintenance of each product.
2. Are any of the applications above provided through/part of a shared service?
3. In addition, could I please receive the overall software spend and non-pay spend from your organisation?

Finance and Procurement systems.280223.docx

Finance Department Structure chart. 151020

Please could you provide a structure chart of your Finance Department via email, where possible including the names of each staff member.

Download response Finance Department Structure chart. 151020

Finance Directorate. 210519

Could you please provide a detailed organisation chart for the Finance Directorate, confirming the name, position and contact details of the individuals within the directorate?

Download response Finance Directorate. 210519

Finance and human resources IT systems. 221217

Human Resources
1. The name of the business system your Human recourses department use?
2. The name of the supplier of this system?
3. The procurement method that was used to obtain this system i.e. what framework?
4. The current contract status and procurement intentions, are you in procurement or have you already procured?
5. Your current contract start date?
6. Your current end data?
7. Are you looking to renew this system?
8. The total contract Value?
9. Do you have mobile access to this system yes or no
10. The name and email address of your Director of Human Resources?
Finance
1. The name of the business system your Finance department use?
2. The name of the supplier of this system?
3. The procurement method that was used to obtain this system i.e. what framework?
4. The current contract status and procurement intentions, are you in procurement or have you already procured?
5. Your current contract start date?
6. Your current end data?
7. Are you looking to renew this system?
8. The total contract Value?
9. Do you have mobile access to this system yes or no
10. The name and email address of your Director of Finance?

Payroll
1. The name of the business system your Payroll department use?
2. The name of the supplier of this system?
3. The procurement method that was used to obtain this system i.e. what framework?
4. The current contract status and procurement intentions, are you in procurement or have you already procured?
5. Your current contract start date?
6. Your current end data?
7. Are you looking to renew this system?
8. The total contract Value?
9. Do you have mobile access to this system yes or no

Download response Finance and human resources IT systems. 221217

Financial Accounts 2015-2016

I am requesting an electronic copy of your 2015/16 financial accounts.

Download response Financial Accounts 2015-2016 280716

Financial interests register for 2019 and 2020. 180920

Please could you provide a copy or link to the register of financial interests register for 2019 and 2020?

Download response Financial interests register for 2019 and 2020. 180920

Financial management system.100522.docx

1. Could you provide details on your current financial management system supplier: For example, “Oracle”, “One Advanced”, “Integra”, or “Other” (If “Other”, please provide details)?
2. How many users are licensed for the financial management system?
3. Is your financial management system licensed on a subscription basis?
4. Does your current financial management system provide a procurement solution? For example, the “Purchase to pay” capability.
5. Is your financial management system currently using multi-company functionality, i.e., providing separate accounting functionality for more than one business entity?
6. Do you use any third-party business intelligence software alongside your financial management system? For example, “Qlik”, “Microsoft Power BI”, or “Other”. (If “Other”, please provide details)?
7. What is the delivery platform for your current financial management system? For example, “Oracle Cloud”, “AWS”, “Microsoft Azure”. Alternatively, please confirm if the system is hosted on-premises?
8. Does your financial management system supplier provide other management services in addition to product support and maintenance?
9. Can you provide details of the current length/renewal/end date of this contract?
10. Who is the main point of contact for this contract? Please provide their name, title, and contact details.
11. Which board member has responsibility for the finance department. Please provide their name, title, and contact details.

Financial management system.100522.docx

Financial Management Team structure chart. 060421

Please can I request an up-to-date structure chart of the Financial Management team?

Download response Financial Management Team structure chart. 060421

Financial penalties. 111019

Since 2011, NHS Trusts in England are subjected to financial penalties for higher than expected 30-day hospital readmission rates. However, information on trust-specific financial penalties is not currently available in the public domain. I hereby request an annual breakdown of all financial penalties imposed on your Trust, starting with financial year 2011/12 and ranging to financial year 2017/18. Specifically, I am requesting the following items listed for each financial year (2011/12; 2012/13; 2013/14; 2014/15; 2015/16; 2016/17; 2017/18):
1. Total amount withheld (in £) in a respective financial year (i.e. the amount of the penalty)
2. Total amount of readmission costs reimbursed in a respective financial year

Download response Financial penalties. 111019

Financial position 2014 to 2017

1. The trust’s reported financial position (its surplus or deficit)
For the year to March 31, 2014
For the year to March 31, 2015
For the year to March 31, 2016
For the current 2016/17 year to July 31
2. The trust’s planned surplus or deficit
For the year to March 31, 2014
For the year to March 31, 2015
For the year to March 31, 2016
For the current 2016/17 year

Download response 060916

Financial position of the Trust 2014-2016.

Please provide information on the financial position, for 2014/15 and 2015/16 for i) the trust/CCG ii) all NHS hospitals within the trust and iii) the mental health trusts. Please set out the gross assets and liabilities in each case and whether the Trust was in surplus or deficit and the level thereof.

Download response Financial position of the Trust 2014-2016 180516

Financial services

Could you please send me contract information relating to Banking Services, Audit Services and Card Processing Services? If you do not understand what each of these mean please see below:
· Banking Services- contract information relating to the organisation banking services.
· Audit Services (Financial) – contract relating to internal and external audit services.
· Accountancy – Contracts relating to TAX advisory services.
· Card Processing Services / Merchant services- a wide range of payment processing options. Most automatically associate merchant services with debit and credit card processing.
Can you please provide me with the following contract information for each of the contract category specified above?
1. Contract Category: Please see select from the categories provided; Banking Services; Financial Audit Services; Card Processing Services
2. Existing Supplier Name for each contract
3. Contract Description: Please do not just state two to three words can you please provide me detail information about this contract and please state if upgrade, maintenance and support is included. Please also include the modules included within the contract.
4. Annual Average Spend for each contract
5. Contract Duration: What is the duration of the contract please include any available extensions within the contract.
6. Contract Start Date: What is the start date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
7. Contract Expiry: What is the expiry date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
8. Contract Review Date: What is the review date of this contract? Please include month and year of the contract. If this cannot be provided, please provide me estimates of when the contract is likely to be reviewed. DD-MM-YY or MM-YY
9. Contact Details: I require the full contact details of the person within the organisation responsible for this particular contract.
10. Notes: Please provide me with any further information with regards to this contract this could include any contract extension available as well as information on renewals or plans for future tenders.

Download response Financial services 060916

Financial Services. 230817

• Banking Services- contract information relating to the organisation banking services.
• Audit Services (Financial) – contract relating to internal and external audit services.
• Accountancy – Contracts relating to TAX advisory services.
• Card Processing Services This is a contract the organisation may have that relates to the use debit/credit cards used by staff to make payments to suppliers. This also includes procurement cards.
• Merchant services This is a contract where by people make payments to the organisation via a machine or terminal. This also includes machines that have chip and pin and contact less
1. Contract Category: Please see select from the categories provided; Banking Services; Financial Audit Services; Card Processing Services
2. Existing Supplier Name for each contract
3. Contract Description: Please do not just state two to three words can you please provide me detail information about this contract and please state if upgrade, maintenance and support is included. Please also include the modules included within the contract.
4. Annual Average Spend for each contract
5. Contract Duration: What is the duration of the contract please include any available extensions within the contract.
6. Contract Start Date: What is the start date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
7. Contract Expiry: What is the expiry date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
8. Contract Review Date: What is the review date of this contract? Please include month and year of the contract. If this cannot be provided, please provide me estimates of when the contract is likely to be reviewed. DD-MM-YY or MM-YY
9. Contact Details: I require the full contact details of the person within the organisation responsible for this particular contract.
10. Notes: Please provide me with any further information with regards to this contract this could include any contract extension available as well as information on renewals or plans for future tenders.

Download response Financial Services. 230817

Financial services – June 2016

1) What is the accounting software that the Trust uses?
2) Who is the Trust’s service provider (in-house or 3rd party provider)?
a. If outsourced to a 3rd party provider, what is the name of the service provider you use?
b. If outsourced to a 3rd party provider, how long did the transition to the service provider take?
c. If outsourced to a 3rd party provider, was the transition fee paid prior to the service start date and what was the transition price paid?
d. If outsourced to a 3rd party provider, what is the value of the service contract per annum?
e. If outsourced to a 3rd party provider, when did the contract start and when is the contract due to expire?
f. If outsourced to a 3rd party provider, is the Trust’s intention to re-procure these services through a Trust run OJEU procurement exercise when the current contract expires?
i. If not, what is the route through which you will contract these services?
g. If the Trust provide these services in-house, does the Trust intend to investigate outsourcing these services in the next 12 months
3) What is the volume of Accounts Payable invoices processed per annum by the Trust?
4) What is the volume of Accounts Receivable invoices processed per annum by the Trust?

Download response Financial services – June 2016 060616

Financial year (2023-2024).051223.docx

All questions are shown as received by the Trust.
My request is as follows:
• Firstly, please could you tell me the NHS agency/locum spending cap/ceiling agreed at the start of this financial year.
• Secondly, please could you send me the following data from the financial plans submitted at the start of the year, giving the planned positions for each month from M1 to M12:
1. Trust financial position (revenue expenditure)
a. Planned surplus/deficit
b. Planned expenditure
2. Workforce expenditure
a. Planned agency/locum spend
b. Planned bank spend
c. Planned total staff expenditure
3. Efficiency savings
a. Planned efficiency savings
• Finally, please could you send me the following data for each month of this financial year to date:
1. Trust financial position
a. Actual surplus/deficit, and forecast outturn for M12
b. Actual expenditure, and forecast outturn for M12
2. Workforce expenditure
a. Actual agency/locum spend, and forecast outturn for M12
b. Actual bank spend, and forecast outturn for M12
c. Actual spend relating to industrial action, and forecast outturn for M12
d. Actual total staff expenditure, and forecast outturn for M12
3. Efficiency savings
a. Achieved efficiency savings, and forecast outturn for M12
4. Prescribing costs
a. Actual spend relating to prescribing, and forecast outturn for M12

Financial year (2023-2024).051223.docx

Fiscal Technologies. 181220

1) What Accounts Payable/Internal Audit software do you currently use for overpayment identification/preventing (including, but not limited to duplicate invoices, fraud)
2) Are you currently contracted with Fiscal Technologies?
3) Have you ever been contracted with Fiscal Technologies?
4) If the answer is yes to 2 or 3, please provide:
a. Start Date, Review Date & End Date
b. Contract Value (Total & Annual)
c. Contact person for the contract

Download response Fiscal Technologies. 181220

Flexible endoscope repair & maintenance. 190521

1. When does the existing maintenance contract(s) expire for the Trust’s flexible endoscope inventory?
2. Who is your current service provider of flexible endoscope repair & maintenance?

Download response Flexible endoscope repair & maintenance. 190521

FOI requests.221122.docx

1. How many FOI Officer/s does your Trust have? If there is more than 1, please specify bandings.
2. Do you have software for monitoring requests? If you use Excel only, please confirm.
3. What was the total number of requests received in the last 3 FY years? 2019/2022, 2020/21, 2021/22
4. Can I obtain a (redacted if necessary) copy of your Trust FOI Policy?
5. Please explain any steps you have taken to reduce the number of requests needed? For example, publishing more data online

FOI requests.221122.docx

Foureyes Insight. 191121.docx

1. Do you use a software/solution in the Trust called Foureyes Insight?
2. If so when does the contract end for the Foureyes Insight system?
3. How many years is the Foureyes Insight system contract in place for?
4. How much do you spend on the support for the Foureyes Insight system on an annual basis?

Download response Foureyes Insight. 191121.docx

Fraud and scams. 161121.docx

1. The amount during each calendar year for the last five years your trust has lost to fraud and scams. This would include the year to date as one of those five years.
2. For each fraud or scam of more than £500 the nature of the fraud or scam, particularly:
a. The date the money was lost
b. How much was lost
c. How the money was lost – the precise methodology the scammers used
d. What efforts were made to reclaim the lost funds
e. How successful those efforts were.
f. Who the perpetrator was, if that is known
Should there be a large number of frauds which qualify for question 2, to the point where costs for the request are likely to over-run, I would like the details for the five largest in terms of losses, please.

Download response Fraud and scams. 161121.docx

Funding for strike cover.191023.docx

I would like to request information regarding the money spent by your trust on NHS strike cover, over doctor strike periods.
For the following strike dates (inclusive):
13/3/23 – 15/3/23
11/4/23 – 14/4/23
14/6/23 -16/6/23
13/7/23 – 18/7/23
20/7/23 – 21/7/23
11/8/23 – 14/8/23
24/8/23 – 25/8/23
19/9/23 – 22/9/23
02/10/23 – 04/10/23
Please can you provide:
1. The total temporary staff spend on each day in the periods requested
2. The total spend on strike cover on each day in the periods requested
3. The top five daily rates paid for i) doctor and ii) nurse on each day in the periods requested.

Funding for strike cover.191023.docx

Funding to charities and third sector bodies. 240821.docx

Please provide the following information for 2018-19, 2019-20 and 2020-21:
1. The value of grants made to each of the organisations listed below. Please provide the information for each of the three financial years separately, and list all grants separately.
2. The value of loans made to each of the organisations listed below. Please provide the information
for each of the three financial years separately, and list all loans separately.
3. The payments made to charities and third sector organisations relate to the following only:
a. Operation Black Vote
b. U.K. Black Pride
c. Mermaids
d. Ozanne Foundation
e. Gendered Intelligence
f. British Medical Association
g. ActionAid UK
h. Hope Not Hate
i. Led by Donkeys
j. Extinction Rebellion
k. Migrants Organise
l. CLASS
m. Black Lives Matter
n. Action on Smoking and Health
o. Action on Smoking and Health Scotland
p. Action on Smoking and Health Wales
q. Breath 2025
r. Association of Directors of Public Health
s. Improving Performance in Practice (previously Public Management Associates)

Download response Funding to charities and third sector bodies. 240821.docx

Gain share agreements

Are there any “gain share” agreements in place between you the provider and a CCG?
Please state “Yes” or “No”
If “Yes”, then please provide the following details:
1. Disease areas CCG included in the “gain share” agreement
2. Names of any specific drugs involved
3. How will savings be apportioned between you the provider and the CCG

Download response Gain share agreements 280716

Gainshare Agreements

1. Are there any Gainshare agreements in place between you the provider and a CCG?
If “No” – end.
If “Yes”, then please provide the following details:
Disease Area
CCG included in the Gainshare agreement
Names of any specific drugs involved
How will savings be apportioned between you and the CCG?
2. Who (what position) within the Trust is responsible for the agreement?
3. How and in what form are the savings from any Gainshare given to the CCG?
By Gainshare agreement I mean one where the benefits associated with more efficient us of medicines not reimbursed through national prices is shared between the provider and the clinical commissioning group party to the agreement.

Download response Gainshare Agreements 111115

Gift cards and gift vouchers.281123.docx

All questions are shown as received by the Trust.
Total NHS trust spending on gift cards and gift vouchers in:
2022/23
2021/22
2020/21
For each year please provide a breakdown of
Total spending on
Gift cards and vouchers for staff
Gift cards and vouchers for patients on health incentive schemes (such as losing weight, quitting smoking, cutting down or quitting alcohol).
If possible please break down the spending for each type of scheme.

Gift cards and gift vouchers.281123.docx

Good Governance Institute.020623.docx

1) The total amount that the trust has spent on the Good Governance Institute’s services since 2015.

2) A breakdown of the specific work that the Good Governance Institute has completed for the trust (e.g. well-led reviews).

3) The basis on which the trust chose the Good Governance Institute as an external facilitator for such reviews, should this be applicable.

Good Governance Institute.020623.docx

Goods and services (2013/14) (2014/15) and (2015/16) 011216

In each of the last three financial years (2013/14) (2014/15) and (2015/16) please state how much your organisation has paid for goods and services from each of the following companies
* ACADEMY OF FABULOUS STUFF COMMUNITY INTEREST COMPANY (10189968)
* LINDUM LOFTS & EXTENSIONS LIMITED (06083403)
* HEALTH MANAGERS NETWORK LIMITED (08234437)
* WOUND SPECIALIST LIMITED (08188747)
* CARBON HEALTH NETWORK LIMITED (06887536)
* UK HEALTHGATEWAY LIMITED (06319587)
* GRASMERE MANAGEMENT COMPANY LIMITED (05685001)

Please provide me with copies of each invoice (accepting that personal details will have to be redacted) so that I can see how much was paid and a description of what it was paid for.

Download response Goods and services (2013/14) (2014/15) and (2015/16) 

Goods or services suppliers.061123.docx

All questions are shown as received by the Trust.
I am trying to understand the number of SME suppliers the public sector purchases from so please can you send me a list of all suppliers you purchase goods or services from and the annual value you bought from them in your last financial year. Please note this information is not commercially sensitive as all you will be giving me is the total money spent with each supplier not any detail of what you bought.

Goods or services suppliers.061123.docx

Haemostat product usage. 040118

Name of haemostat PRODUCT MPC (Manufacturers product code) Pack/Unit size Quantity of packs used in 12 months from 1/4/16 to 31/3/17

Download response Haemostat product usage. 040118

Hand Sanitiser. 210720

1. Does the Trust purchase hand sanitiser through a tender process?
2. Is the Trust currently procuring hand sanitiser?
3. If the Trust purchases hand sanitiser on an individual basis, what would be the relevant department to speak to and could you provide the contact details?

Download response Hand Sanitiser. 210720

Hand sanitiser spend. 300519

Please could you tell me how much money Maidstone and Tunbridge Wells NHS Trust spends on hand sanitiser on an annual basis? Please could you supply figures for the past five years?

Download response Hand sanitiser spend. 300519

HCR Services. 100118

1) Does the Trust have an agreement to use HCR Services either under contract, via a purchase/supply order or some other agreement?
a. If yes, please would you answer the following questions?
i. Is this under contract?
ii. When did it start?
iii. When does it end?
iv. Is the Trust paid additional monies by HCR Services above the amounts to be recovered?
b. Is this via some other agreement?
i. What kind of Agreement?
ii. When did it start?
iii. When does it end?
iv. Is the Trust paid additional monies by HCR Services above the amounts to be recovered?
2) In relation to the HCR Services, what is required from the emergency department(s)?
a. To collect data on attendees who have suffered a 3rd party accident and send on to HCR services (with appropriate permission)?
i. If yes, how is the permission obtained?
b. To pass every patient a leaflet on HCR Services?
c. To only pass patients who have suffered a 3rd Party Accident a leaflet on HCR Services?
3) In relation to the HCR Services and the above, is there a requirement for this service to be operated elsewhere within the hospitals (Wards, Ambulatory, Outpatients?)
4) If possible please enclose a scan/copy of any literature that would be passed to a patient.
5) In brief please explain how HCR services improve the revenue to be recovered via the NHS Injury cost recovery scheme? (What else do they do that would not be done otherwise?)

Download response HCR Services. 100118

 

Friends and Family Test

Friends and Family Test

Please provide details of the Trust’s current Friends and Family Test supplier/system:
1. When the service was implemented and the specialties included?
2. Monthly values for the numbers of patients surveyed?
3. Specific details of any aims/targets set for the Friends and Family Test and whether or not these have been achieved?
4. Details of any patient complaints or technical difficulties encountered whilst the service is in operation?
6. Does the Trust survey patients by SMS?
7. Where are the SMS carriers servers located?
If the service uses automated IVR/IVM (Interactive Voice Response/Interactive voice Messaging) calls;
8. Where are the servers that undertake these calls located?
9. Do the IVR servers process patient identifiable data?
If the service uses agent calls;
10. What percentage of the overall service outcomes are completed by an agent?
11. What information do agents have access to?
12. Are all agents making the calls based in a call centre?
13. Where are the call centres situated?
14. If not what percentage of calls are made by home workers?
15. Geographically, where are the home based workers?
16. What security measures are in place to prevent home-based workers from replicating data locally?
17. Are all home based staff CRB checked?
18. Have you received any complaints at all regarding the agent call service (including but not limited to: manner, tone, ability to understand accents or dialects)?
19. Please provide details of the member(s) of staff responsible for the implementation and continued running of the service and their role within the Board?
21. How do you keep personal information secure when transferring to a third party supplier?
Supplier Details
Please provide details of:
25. Suppliers(s) of the above services:
26. Expected contract length:
27. Contract review date:
28. Cost of contract:
29. Details of the implementation costs and on-going support costs:
30. Details of the processes followed to procure The Friends and Family Test?
31. Details of the channels used to publish the notification of procurement, for the Friends and Family Test service?
Paper Surveys
32. Does the Trust use paper cards to survey patients and if so what departments?
33. Who keys in the data from paper surveys?
34. If this is outsourced, what company input this information?
Local surveys
35. Does the Trust carry out local surveys?
36. If so, what methods are used to survey patients?
37. If outsourced, what supplier is used?

Download response Friends and Family Test 021215

 

General Surgery, Head & Neck and Gynae Oncology

Agency locum spend within Ophthalmology.

Under the Freedom of Information act, can you please provide me with the total Agency Locum spend within Ophthalmology over the last 6 months within your Trust/Health board.

Download response Agency locum spend within Ophthalmology 250716

Abdominoplasty surgeries. 010221

I need the number of abdominoplasty surgeries done in the hospital in the last 5 years.

Download response Abdominoplasty surgeries. 010221

Acquired Brain Injury rehabilitation prescription. 230817

Can you please advise how many of your patients discharged from hospital with an Acquired Brain Injury (ABI) had a Rehabilitation Prescription?

1. This Trust has patients with an ABI who were discharged with a Rehabilitation Prescription. Yes/No

2. This Trust has [number to be inserted] patients with an ABI who were discharged with a Rehabilitation Prescription in the last financial year.

3. Of the patients who are issued with a Rehabilitation Prescription the following receive a copy
a. – GP [please tick]
b. – patient/family [please tick]
c. – other [please provide details]

Download response Acquired Brain Injury rehabilitation prescription. 230817

Acute Bowel Ischaemia. 020719

1. Various incident and mortality rates for acute bowel ischemia for each year over the period 2007 – 2018 (the table to be completed is attached).
2. An explanation of how the rates have been calculated.
3. Details of the formal processes, procedures, pathways and other means of diagnosing acute bowel ischemia used by the hospital and its health professionals (including but not limited to those used by the surgical team, nurses, radiologists, intensive care)?
4. Details of any informal processes, procedures, pathways and other means of diagnosing acute bowel ischemia used by the hospital and its health professionals (including but not limited to those used by the surgical team, nurses, radiologists, intensive care)?

Download response Acute Bowel Ischaemia. 020719

Adrenal Surgery 2015-2016. 020217

I would like to know the total number of adrenal surgical procedures carried out at Maidstone Hospital and Tunbridge Wells / Pembury Hospital (TWH) during the financial year April 2015 to March 2016.
This would include all adrenalectomies and other operations on the adrenal glands
I understand the relevant OPCS codes are as follows:

B22.1, B22.2, B22.3, B22.4, B22.8, B22.9, B23.1, B23.2, B23.8, B23.9, B25.1,
B25.2, B25.3, B25.4, B25.8, B25.9

Download response Adrenal Surgery 2015-2016. 020217

Adult hearing care. 251017

Q1. Name of your organisation?
Q2. How many Hearing Aid Dispensers (HADs), registered with the Health and Care Professions Council, work for you? (Please include the headcount, regardless of type of cover HADs provide. For example if you have a HAD that only covers one session on a self-employed basis, note 1. If you have a HAD that works full time, note 1).
Q3. Do you offer a private adult hearing aid service?

Download response Adult hearing care. 251017

Adult hearing services. 010719

1. Your details
a. State your organisations official name here
b. Please list all sites where you provide audiology services
2. About adult audiology services
a. At what age can people access your Direct Access Audiology (DAA) service?
b. Please provide the clinical criteria used to determine who is eligible for your DAA service.
c. Please provide the clinical criteria used to decide which DAA service patients require onward referral to ENT, Audiovestibular physicians or other consultant led service.
d. Please provide the clinical criteria used to decide which patients accessing the DAA service require referral back to their GP.
e. Do you have an audiologist led clinic – i.e. non-consultant led – to manage tinnitus that falls outside of the DAA service above?
f. Please provide details of the service.
g. Do you have an audiologist led clinic – i.e. non-consultant led – to manage asymmetric hearing loss that falls outside of the DAA service above?
h. Please provide details of the service including:
i. Does your audiology clinic manage earwax?
3. About how audiology services work with GP’s, ENT and other services.
a. What proportion (%) of all adult hearing assessments that you did in 2017/18 were
– referred by ENT/Audiovestibular physicians
– referred by GP’s (i.e. Direct Access Audiology)
– self-referred/patient initiated
– other route(s)
b. What proportion (%) of all DAA pathways in 2017/18 resulted in
– assessment only
– Hearing aids fitted and no referral required
– other outcomes
c. What proportion (%) of all DAA pathways in 2017/18 resulted in
– referral back to GP
– referral to ENT/Audiovestibular physician
4. About adult hearing loss and adult hearing aid fits
a. What proportion (%) of all adults that you fitted with hearing aids in 2017/18
– had age-related hearing loss
– had noise-induced hearing loss
– had a different cause of hearing loss
b. What was the average (mean) age of the adults you fitted with hearing aids in 2017/18
c. What proportion (%) of adults that you fitted with hearing aids were provided with two hearing aids?
5. About payment and coding
a. This is only consultant-led clinics. When an audiologist supports a consultant-led clinic are the costs allocated to the consultant-led clinic?
Yes
No
None of the above
b. This is only about your audiology, non-consultant led clinics. Tick all funding models that applied in 2017/18
c. Do you assign the code CA37A to hearing assessments performed in the DAA clinic?
Yes
No
d. Who is responsible for assigning the codes AS05 and AS06 at your organisation?
Tick all that apply.
e. How is the adult hearing service – hearing assessment, hearing aid fits, ongoing care etc. – commissioned?
Please tick which option applies at your organisation.
f. Please provide the process for coding AS05 and AS06 at your organisation?
6. About material changes during the 2018/19 financial year?
Have there been any material changes to your local audiology services in the 2018/19 financial year so far?
Yes
No

Download response Adult hearing services. 010719

Adult hearing services 2015

INFORMATION REQUESTED

NOTES:

• Adult refers to patients aged 18 and over that are managed by audiology (e.g. noise and age-related hearing loss and people discharged from ENT). NB. we appreciate that in most cases this will simply cover Direct Access Audiology patients
• Prices and activity refer to the NHS financial year 2014/15 – i.e. historical data

Download response Adult hearing services 2015 060416

Alzheimer Disease 2012-2016

For the years between 2012 and 2016
1. How many people has your trust/hospital diagnosed with Alzheimer Disease for each of the years mentioned above? If possible could this be broken down by gender?
2. How many people are seen within 12 weeks of being referred by a GP?

Download response Alzheimer Disease 2012-2016 150317

Ambulatory ECG’s 2015-2016. 090217

1. Total number of Ambulatory ECG’s (aka Holter tests, R-Tests, etc) performed in 2015 and to date in 2016 calendar year.
2. If possible, please indicate how many were for ≤24-hour duration; 24-72 hour duration; ≥ 72 hour duration.
3. Please also indicate what current waiting time is for fitting of device and reporting results.

Download response Ambulatory ECG’s 2015-2016. 090217

Amputation operations. 201119

1. A list of every amputation operation at your hospital over the past ten years.
2. The amount of cases of the above that have resulted in claims of medical negligence.
3. The amount of cases of the above that have resulted in your informing your insurers of a possible claim for medical negligence.
4. The details of each incident.

Download response Amputation operations. 201119

Amputations. 170118

Please could you provide me with the number of patients at your trust that underwent an amputation due to an infection?

Could you please provide the information broken down for each year since 2012?

Download response Amputations. 170118

Amputations due to infection. 291118

You asked:
Are you able to provide the same data for all of 2017 and then the figure for 2018 to date (specifying which months this covers?)

Download response Amputations due to infection. 291118

Anaemia and blood transfusions. 290118

1. Number of RBC units utilised by ward and/ or department in a) 2015 and b) 2016
2. Number of elective surgical procedures cancelled in 2016 due to the patient being identified as anaemic
3. Number of elective surgical procedures occurring for patients who were anaemic on the day of surgery
4. Of the above, the number of these procedures that required a blood transfusion
5. Following the NICE Quality Standards published in December 2016 on blood transfusion, is able to meet Quality Standard 1? Please see Quality Standard Review form attached. We are partially compliant with Standard 1. The Pre-Assessment Teams are referring patients for IV iron if they are found to be anaemic at Clinic, if there is time pre-operatively. Post-op iron therapy does not appear to be standard practice as yet.

Download response Anaemia and blood transfusions. 290118

Anaesthesia machines. 190721.docx

What type of anaesthesia machines you are using within each site and how old the machines are roughly?

Download response Anaesthesia machines. 190721.docx

Annual Departmental activity statistics 2011-2013. 030117

In your trust in each of the following years (in 2011, 2012 & 2013)
– Financial year 2011/2012 and financial year 2012/2013
– Or Calendar year 2011, Calendar year 2012 and Calendar year 2013
Annual departmental activity statistics for Obstetrics & Gynaecology Department for the following data:
Obstetrics (Maternity)
1- Annual total number of all types of deliveries
2- Annual total number Instrumental/operative vaginal deliveries
3- Annual total number of Caesarean sections
4- Annual total number of vaginal deliveries
5- Annual total number of Antenatal out-patients
6- Annual total number of maternity inpatients admitted to wards/hospital
Gynaecology:
7- Annual total number of gynaecological surgical procedures undertaken annually
8- Annual total number of Gynaecology out-patients
9- Annual total number of gynaecology inpatients admitted to wards/hospital
As a Trust in general:
10- Annual total number of theatre cases (surgical procedures), across all specialties
11- Annual total number of patients attended or booked in the outpatient clinics, across all specialties
12- Annual total number of patients admitted to the hospital wards, across all specialties

Download response Annual Departmental activity statistics 2011-2013. 030117

Annual suture usage. 040117

I require suture manufacturer codes with description and total boxes/pack ordered annually/per year. An excel sheet will be ideal.

Any year in the last three year will be suitable.

Download response Annual suture usage. 040117

Anti-VEFG treatments for eye conditions. 011221.docx

1. For the 4-month period from January to April 2021, how many patients has your trust treated with the following anti-VEGF treatments:
2. For the patients above, how many were new to anti-VEGF therapy? Please provide the patient numbers by the treatments listed below, excluding patients who previously had any anti-VEGF therapy.
3. Within your trust, how many intra-vitreal injections/implants of each the following treatments have been used (for any eye condition) in the four-month period from January to April 2021:
4. If your trust is able to identify intra-vitreal injections/implants by eye condition, please provide the number of injections/implants used in the four-month period from January to April 2021 for each of the following conditions:
Diabetic Macular Oedema (DMO)
Retinal Vein Occlusion – Central (CRVO) or Branch (BRVO)

Download response Anti-VEFG treatments for eye conditions. 011221.docx

Anti-VEFG treatments for eye conditions. 081221.docx

1. For the 4-month period from September to December 2020, how many patients has your trust treated with the following anti-VEGF treatments:
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Fluocinolone acetonide
f. Ranibizumab
2. Within your trust how many intra-vitreal injections/implants of each of the following treatments have been used in the four-month period from September to December 2020:
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Fluocinolone
f. Ranibizumab
3. If your trust is able to identify intra-vitreal injections/implants by eye condition, please provide the number of injections/implants used in the four-month period from September to December 2020 for each of the following conditions:
Wet Age Related Macular Degeneration (wAMD)
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Ranibizumab
Diabetic Macular Oedema (DMO)
a. Aflibercept
b. Bevacizumab
c. Dexamethasone
d. Ranibizumab
Retinal Vein Occlusion – Central (CRVO) or Branch (BRVO)
a. Aflibercept
b. Bevacizumab
c. Dexamethasone
d. Ranibizumab

Download response Anti-VEFG treatments for eye conditions. 081221.docx

anti-VEFG treatments for eye conditions. 161220

1. Within your trust how many patients over the last 12 months (November 2019 to October 2020 or latest available) have received the following anti-VEGF treatments:
• Aflibercept
• Bevacizumab
• Brolucizumab
• Dexamethasone
• Fluocinolone acetonide
• Ranibizumab
2. For the patients above, how many were new to anti-VEGF therapy? Please provide the patient numbers by the treatments listed below, excluding patients who previously had any anti-VEGF therapy.
• Aflibercept
• Bevacizumab
• Brolucizumab
• Dexamethasone
• Fluocinolone acetonide
• Ranibizumab

Download response anti-VEFG treatments for eye conditions. 161220

Anti-VEFG treatments for eye conditions. 221221.docx

1. For the 4-month period from May to August 2021, how many patients has your trust treated with the following anti-VEGF treatments:
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Fluocinolone acetonide
f. Ranibizumab
2. For the patients above, how many were new to anti-VEGF therapy? Please provide the patient numbers by the treatments listed below, excluding patients who previously had any anti-VEGF therapy.
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Fluocinolone acetonide
f. Ranibizumab
3. Within your trust, how many intra-vitreal injections/implants of each following treatments have been used (for any eye condition) in the four-month period from May to August 2021:
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Ranibizumab
4. If your trust is able to identify intra-vitreal injections/implants by eye condition, please provide the number of injections/implants used in the four-month period from May to August 2021 for Wet Age Related Macular Degeneration (wAMD) ONLY
a. Aflibercept
b. Bevacizumab
c. Brolucizumab
d. Dexamethasone
e. Ranibizumab

Download response Anti-VEFG treatments for eye conditions. 221221.docx

Antiseptic preparations applied to the skin prior to a surgical procedure. 010518

Please would you tell me the number of units of the following products purchased by your hospital over the past 12 months:

Chlorhexidine 2% in IPA Biocide (Nex-Clorex 2%) Available in 200ml and 500ml bottles – Fannin UK Ltd

Chlorhexidine 2% in IPA Biocide Available in 200ml and 500ml bottles – Ecolab Ltd

Chlorhexidine 2% in IPA Licenced Medicine (ChloraPrep) Available in various sizes – Carefusion / BD

Red Staining Dye / Liquid Available in 12 x 12ml – Ecolab Ltd

Please would you tell me the pre-operative skin preparation (ie the name of the specific product) that you use for the following procedures? Please will you specify whether the manufacturer and whether the product is a biocide or a licensed medicine.

Procedure

• Abdominal hysterectomy –
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Breast surgery
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Caesarean section
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Gastric surgery
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Hip replacement
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Knee replacement
o Products used?
o Biocide or licensed medicine?
o Brand name?
• Spinal surgery
o Products used?
o Biocide or licensed medicine?
o Brand name?

Download response Antiseptic preparations applied to the skin prior to a surgical procedure. 010518

Antiseptic skin preparation prior to invasive surgery. 150721.docx

1) Please confirm if Maidstone and Tunbridge Wells NHS Trust follows NICE guidance 125 (Surgical Site Infections: Prevention and Treatment) when carrying out antiseptic skin preparation?
a. If yes, please provide a copy of Maidstone and Tunbridge Wells NHS Trust s most up-to-date surgical site infection prevention protocol.
2) How does Maidstone and Tunbridge Wells NHS Trust communicate the category difference between antiseptic products that are medicines vs biocides and their intended use?
a. Please share any communication materials.
3) Can you please specify which antiseptic skin preparation products are used in Maidstone and Tunbridge Wells NHS Trust s operating theatres for the purposes of prevention of surgical site infections?
4) Does Maidstone and Tunbridge Wells NHS Trust obtain patient consent prior to surgical procedures?
a. If yes, please provide the written material that Maidstone and Tunbridge Wells NHS Trust uses to obtain consent.

Download response Antiseptic skin preparation prior to invasive surgery. 150721.docx

Arthroplasty (joint replacement services) 2011 – 2014.

1. Does the NHS Trust provide arthroplasty (joint replacement services)?
2. a) How many patients has the Trust treated for hip replacement in 2011, 2012, 2013, 2014, 2014? Please provide 5 answers, in calendar years.
b) How many patients has the Trust treated for hip replacement revision in 2011, 2012, 2013, 2014, and 2014? Please provide 5 answers, in calendar years.
c) How many patients has the Trust treated for knee replacement in 2011, 2012, 2013, 2014, and 2014? Please provide 5 answers, in calendar years.
d) How many patients has the trust treated for knee replacement revision in 2011, 2012, 2013, 2014, and 2014? Please provide 5 answers, in calendar years.
3. a) What is the average length of time patients wait for a hip replacement from referral?
b) What is the average length of time patients wait for a hip replacement revision from referral?
c) What is the average length of time patients wait for a knee replacement from referral?
d) What is the average length of time patients wait for a knee replacement revision from referral?
4. a) What is the maximum length of time patients wait for a hip replacement from referral?
b) What is the maximum length of time patients wait for a hip replacement revision from referral?
c) What is the maximum length of time patients wait for a knee replacement from referral?
d) What is the maximum length of time patients wait for a knee replacement revision from referral?
5. a) Has the Trust been asked to reduce the number of arthroplasty procedures it carries out at any point over the last five years, by commissioners?
b) If Yes, by how many?
6. a) Has the Trust been asked to change the criteria by which patients are selected for arthroplasty procedures?
b) If Yes, in what way?

Download response Arthroplasty (joint replacement services) 2011 – 2014 090916

Assistive devices following total hip replacement (THR). 300317

Has your hospital discontinued provision of hip precautions and/or assistive devices/equipment such as raised toilet seats, long-handled aids, long-handled shoe horns, sock-aids, long-handled sponges, bath benches, wedge pillows and perching stools to patients following total hip replacement (THR)?

Download response Assistive devices following total hip replacement (THR). 300317

Audiology services. 030719

Contractual Arrangements
1. Is your routine audiology service for those 18 and above commissioned via an AQP contract or other contract?
2. Is there more than one contract in place for those aged 18 and above requiring routine audiology?
Patients
3. How many direct access audiology patients do you see per year? –if there is more than one contract please break down by contract
4. How many AQP patients do you see per year? (Please provide breakdown by location)
Access to Services
5. What locations do you provide services from?
6. How many clinics and what days do you provide at each location?
7. Do you provide a same day hearing aid assessment & fit pathway?
8. Do you provide a walk in aftercare service for your patients?
9. Are aftercare services available across all locations?
10. How are patients referred into your service?
11. What referral forms are available?
Audiology Waiting Times
12. Using your latest recorded figures please state the percentage (%) of patients that were seen within the national target waiting time and the time period to which this figure refers.
13. Please confirm the waiting times to the following parts of your pathway:
a. First assessment
b. Fitting
Domiciliary service
14. Do you offer a home visiting service to patients?
15. How many days per month are available for home visits?
16. Do you provide follow ups at home once patients have been fitted?
17. How do you provide aftercare for home visiting patients?
Lost hearing aids
18. Do patients pay for lost or damaged aids?
19. How many replacement aids are patients allowed?
Re-assessment
20. Do you offer a re-assessment of patients’ hearing needs and after how long?
21. When patients are eligible for a new aid, are they able to self-refer back into the service or is a new GP referral sought?

Download response Audiology services. 030719

Audiology services. 080417

1. What is the present staffing structure for Audiology services at the trust?
2. How many substantive members of staff are there at each AfC pay scale?
3. How many vacancies currently exist within the Audiology team?
4. Have the vacancies been recruited for? If so, why do any persist? When will the vacancies be advertised again?
5. Does the Audiology team within the trust make use of locums?
6. How many locums presently work within Audiology?
7. What band are the locums employed at? How is the band of the locum determined? Are the rates capped? If not, why not? Are there plans to look at capping the excessive charges?
8. Has the trust sought to lower the cost associated with locums to maximise taxpayer money?
9. What are the charges associated with each locum for the trust?
10. What was the overall spend on locum’s within Audiology in the last financial year? What was the overall spend for the months of April, May, June 2017?
11. What are the trust’s plans with regards to staffing within Audiology and the persistent use of costly locums?
12. What is the process of hiring locums in terms of pay scale selected, governance and competency checks within Audiology at MTW NHS Trust?

Download response Audiology services. 080417

Audiology Services. 230322.docx

Section 1: Your service
1.1 Please answer the questions below based on the situation as of July 2021.
1.2 Please give the name of your audiology service/s. If you provide services on behalf of another Trust/s please provide details of all the Trusts that you provide services for below. Please write names in full and expand acronyms:
Section 2: Your caseload of people with intellectual disabilities and autistic people
2.1 Does your hospital or audiology service have a mechanism for identifying and flagging people with intellectual disabilities who use the service?
If yes, please specify how you store and use this information?
2.2 Does your hospital or audiology service have a mechanism for identifying and flagging autistic
If yes, please specify how you store and use this information?
Please include the following information for your service. We understand that you may not record all these numbers. Please only fill in the numbers your service records or provide an estimate if possible (noting with an E). If you do not record these numbers and cannot make a reasonable estimate, please state ‘not recorded’:
Section 3: Transition to adult services
3.1 How do you prepare young people with intellectual disabilities and/or autistic young people for transition to adult services? Please select all that apply.
Section 4: Reasonable Adjustments
Reasonable adjustments: According to The Equality Act 2010, service providers should make ‘reasonable adjustments’ to their provision, to allow disabled people to access the same services as non-disabled people. These adjustments will be different for different services. What is reasonable for one provider may not be possible or relevant for another provider.
4.1 Do you make any of the following reasonable adjustments to facilitate accessibility to audiology services? Select all that apply:
4.2 Do you make any of the following reasonable adjustments to facilitate appointment flexibility? Select all that apply:
4.3 Do you make any of the following reasonable adjustments to testing procedures? Select all that apply:
4.4 What attempts are made to find out what the individual’s needs are prior to the appointment (e.g., communication, physical, behavioural needs)?
4.5 Do you make any of the following reasonable adjustments to facilitate communication? Select all that apply:
4.6 Do you make any of the following reasonable adjustments to providing patient information? Select all that apply:
4.7 Do you currently provide a choice of coloured moulds to people with intellectual disabilities and/or autistic people at no extra charge? Please select one answer:
4.8 Does your service offer any of the following adaptions people with intellectual disabilities and/or autistic people?
Section 5: Wax management
5.1 How is problematic wax managed in people with intellectual disabilities and/or autistic people in your service? Select all that apply:
Section 6: Specialist Services
Specialist Services: By specialist services, we mean audiological services which are provided separately from your mainstream provision, specialised for people with intellectual disabilities and/or autistic people. This might mean an entirely separate service for these groups, or the opportunity to be seen by professionals who specialise in working with these groups, in a mainstream setting.
6.1 Of the people with intellectual disabilities and autistic people that you saw between 1st May and 31st July 2021, how many were seen by a specialist service as opposed to your mainstream service
6.2 Of the people with intellectual disabilities and autistic people that you saw between 1st May and 31st July 2021, what review processes were available (please select all that apply)?
6.3 Of the people with intellectual disabilities and/or autistic people that you saw between 1st May and 31st July 2021, how many were offered the following services (please give a number for all that apply).
Section 7: Meeting Relevant Guidance
7.1 How closely do you work to the following relevant guidance?
Section 8: Your policies
8.1 What documentation do you currently have specific to people with intellectual disabilities and autistic people? Select all that apply and indicate whether ‘in place’ or ‘in progress’. These documents may be trust/hospital-specific or may be specific to your department/service.
8.2 Do you carry out the following risk assessments? Select all that apply:
8.3 How does your ‘Did Not Attend’ policy differ for people with intellectual disabilities and/or autistic people to that of the wider patient population?
Section 9: Referral Routes
9.1 Of the new referrals of people with intellectual disabilities and autistic people, that you received between 1st May and 31st July 2021, where did the referrals originate from? Please select all that apply.
Section 10: Multidisciplinary Working
10.1 Of the people with intellectual disabilities that you saw between 1st May and 31st July 2021, how often did you make referrals to the following professionals when they are required. Please select all that apply and indicate estimate of frequency of referral.
10.2 Of the autistic people that you saw between 1st May and 31st July 2021, how often did you make referrals to the following professionals when they are required. Please select all that apply
10.3 Do you have access to any of the following? Select all that apply:
Section 11: Staffing and Training
11.1 Are the staff (e.g., audiologists, receptionists) in your service able to access the CPD necessary for working with people with intellectual disabilities and/or autistic people?
11.1b If CPD is not available for all staff in your service, necessary for working with people with intellectual disabilities and/or autistic people, please indicate why not (select all that apply):
11.2 If you offer a specialist service for people with intellectual disabilities and/or autistic people, how many full-time equivalent staff were routinely involved on 31st July 2021? (Please select all that apply).
11.3 What training have the staff in your service been offered for working with people with intellectual disabilities and/or autistic people? (Please select all that apply)
Section 12: Patient engagement and service evaluation
Please answer the questions in this section based on the situation as of 31st July 2021.
12.1 What patient feedback mechanisms do you have in place for services for people with intellectual disabilities and/or autistic people?
a. What have been the most recent outcomes of patient feedback regarding services for people with intellectual disabilities and/or autistic people?
12.2 Do you audit/evaluate your service practices for people with intellectual disabilities and/or autistic people? Please give a brief explanation (1 or 2 sentences).
12.3 Are there any aspects of service delivery that you adapted during the Coronavirus pandemic, which you intend to retain beyond the end of restrictions (e.g., tele-audiology, telephone reviews)? Please give brief details and an explanation of why.
12.6 Are there plans to develop your service for people with intellectual disabilities and autistic people in the near future? Please give a brief description of any planned changes.

Audiology Services. 230322.docx

Audiology services. 270619

1. Do you have a hearing/audiology service at your Trust?
2. If yes, can patients contact the service by?
a. Email
b. Fax machine

Download response Audiology services. 270619

Audiology services for children and young people.150317

1. Thinking about the 2015/16 financial year, did your service experience longer waiting times for?
2. Were there any changes in policy or practice in what your audiology service provided in 2015/16?
3. If you have ticked yes to any of the above, please tell us what has changed and the reasons for the
Change
4. At what age does your service transfer deaf young people to adult services?
5. Were there any changes to how your audiology service for deaf children is commissioned in 2015/16?
6. Were there any changes in the number and skill-mix of full time equivalent (FTE) staff in your team, including administrative staff, in 2015/16?
7. If you have ticked yes to any of the above, please describe in more detail what has changed (including the number of staff reductions, if any) and the reasons for the change.
8. Was there a training programme in place for audiologists in your service in 2015/16?
9. If yes, were there any changes to the availability of training in 2015/16?
10. Looking ahead to the 2016/17 financial year, are you aware of any planned changes to any of the below?
11. Did your service provide informal family support services such as parent coffee mornings, playgroups, use of voluntary sector, etc. in 2015/16?
12. If yes, were there any reductions in informal family support services in 2015/16?
13. Is anyone from the audiology team involved in the development of Education Health and Care plans?
14. Have you faced any barriers to being involved in developing Education Health and Care plans?
15. If yes, what were the barriers?
16. Did your service provide any assistive listening devices or take any action to ensure they work effectively with the child’s personal amplification in 2015/16?
17. If you have ticked any of the above, were there any reductions in the provision of assistive learning devices or services to ensure they work effectively with the child’s personal amplification in 2015/16
18. Has your service gained accreditation with (Improving Quality in Physiological Diagnostic Services) IQIPS?
19. Has your service registered for the IQIPS process?
20. Has your service started using the Self-Assessment and Improvement Tool (SAIT)?
21. Has your service applied to UKAS to begin the accreditation peer review process?
22. Has your service booked or completed its onsite assessment with UKAS?
23. If you have not registered with the SAIT for IQIPS, what are your reasons for not doing so?
24. What are the most successful aspects of your audiology service at the moment?
25. What are main challenges or problems facing your audiology service at the moment?
26. Is there anything else you would like to tell us about the audiology service and any future plans?
* 27. Your name:
* 28. Your role:
* 29. Name of audiology service (please don’t use abbreviations):
* 30. Name of Trust that provides the paediatric audiology service (please don’t use abbreviations):
* 31. Sites where paediatric audiology is delivered by your service (please don’t use abbreviations):

Download response Audiology services for children and young people.150317

Audiology services providing diagnostic hearing assessments and hearing aid provision for children. 191618

Please answer the questions below based on the situation as of 31 March 2018.
1. Please provide the following information:
Your name:
Your role:
Your email address:
Your telephone number:
Please give the name of your audiology service/s. If you provide services on behalf of another Trust/s please provide details of all the Trusts that you provide services for below.
If you provide the services for another Trust/s, do these include diagnostic hearing assessments and hearing aid provision for children in any of these locations?
2. We have included below, the locations where previously you, or a CCG for your area, have told us that paediatric audiology services are provided. Please complete the table by:
Section 2: Waiting times
3. On average, in the last quarter, (1 January – 31 March 2018) how many days did patients wait for the following?
If you are not sure please estimate.
Section 3: Your policies
Please answer the questions in this section based on the situation as of 31 March 2018.
4. What options are included in your current management pathway for temporary conductive hearing loss? Select all that apply:
5. Are there any groups of children that you don’t currently provide hearing instruments for?
6. Do you currently provide free batteries for children’s hearing aids? Please select one answer:
7. Do you currently provide a choice of coloured moulds to children at no extra charge?
8. What appointment times do you offer? Please select all that apply:
Section 4: Your caseload
9. How many deaf children were on your case load?
10. How many of the children on your caseload were referred to your service from the Newborn Hearing Screen?
Section 5: Quality improvement
Please put a cross next to the relevant answer/s.
11. Have you ever registered for (Improving Quality in Physiological Services) IQIPS?
12. Which of the below best describes your current status with regard to IQIPS?
13. If you are not registered with IQIPS, what is the main reason? Please select one answer:
14. If you are registered with IQIPS but have not progressed in the last year, what is the main reason? Please select one answer:
15. Has your service booked its onsite assessment with UKAS? Please select one answer:
16. What colour are you currently at on the UKAS traffic light system?
Section 6: Staffing and training
17. How many full time equivalent staff does your children’s audiology service have at the following levels as on 31 March 2018 and how many did it have on 31 March 2017?
18. If there has been a reduction in the number or skill level of staff in the table above, what are the reasons for this?
19. Are you aware of any planned changes to staffing in 2018/19?
20. Thinking about permanent posts in the service as of 31 March 2018, what was the split of clinical and non-clinical sessions for audiology staff?
21. Are all staff able to access the CPD necessary for their roles? Select all that apply:
Section 7: Children’s Hearing Services Working Groups
Please answer the questions in this section based on the situation as of 31 March 2018.
22. Does the Children’s Hearing Services Working Group (CHSWG) in your area include at least one parent representative? Please select one answer:
23. Do you use the Children’s Hearing Services Working Group Guidance (2010)?
Section 8: Technology
24. As of 31 March 2018 which organisation provides the following technology:
25. As of 31 March 2018 do you balance or pair streamers purchased by:
26. Are there any plans to stop the provision of hearing equipment or accessories for hearing equipment in 2018/19? Please select one answer:
Section 9: Patient engagement
27. How do you prepare young people for transition to adult services?
28. What was your service’s most recent score in the family and friends test?
29. What was your average ‘Did Not Attend (DNA)’ for the 2017/18 financial year in percent?
Section 10: Funding and commissioning
30. What was the annual budget for your paediatric hearing aid service for the 2017/18 financial year, from the organisations below?
31. How is your funding provided? Please select all that apply.
32. If you selected tariff per child, how much money do you receive for each service below?
33. If you run a joint paediatric and adult service, are your budgets shared?
34. Was your audiology service for deaf children commissioned differently in the 2017/18 financial year when compared to the 2016/17 financial year?
35. Is your audiology service being commissioned differently or reviewed in 2018/19?
Section 12: Anything else
36. Is there anything else you would like to tell us about your audiology service and any future plans?

Download response Audiology services providing diagnostic hearing assessments and hearing aid provision for children. 191618

Audiology waiting times.160623.docx

1) What is the approximate waiting time between a hearing test and the provision of hearing aids at Maidstone Hospital?
2) Is the waiting list for hearing aids run on a strictly “first come, first served” basis, or are patients inserted at the head of the queue under any circumstances?

Audiology waiting times.160623.docx

AUS implant 2014-2017. 010617

I am trying to find out, for each of the last three years of available data, how many AUS’ were implanted by the Trust and how many were infected.

Download response AUS implant 2014-2017. 010617

Bacterial meningitis following a spinal anaesthetic.050523.docx

I write to ask for information on bacterial meningitis following a spinal anaesthetic and the incidences in your hospital from 2018 to date please.

Should you have any cases I would be interested to understand how this happened.

Bacterial meningitis following a spinal anaesthetic.050523.docx

Bariatric procedures 2013-2017. 260417

Please can you tell me the following information for the last three financial years and current numbers i.e.; 2016/17, 2015/16, 2014/15 and 2013/14
1) Number of bariatric procedures carried out
2) Cost of procedure (s)
3) Age of those who had a bariatric procedure
4) Weight of those who have had a bariatric procedure

Download response Bariatric procedures 2013-2017. 260417

Bariatric Surgery.150923.docx

All questions are shown as received by the Trust.
1. How long is the queue time (in average) for a patient to get bariatric surgery at the trust in your area?
2. How does the primary care trust and/or NHS trust in your area prioritize and manage the queue for bariatric surgery?
3. What is the overall capacity in your trust(s) to handle bariatric surgeries in terms of infrastructure and personnel?

Bariatric Surgery.150923.docx

Bariatric surgery 2013-2017. 260417

1) Can you please provide a breakdown of the number of people given bariatric surgery in each of the following years by the health board – 2013, 2014, 2015, 2016, so far 2017?
2) For each year, can you please provide the sexes and age groups (twenties, thirties, forties, etc.) of each person who had the surgery. Please provide the number of people under 21 for each year, with the exact age of each.
3) For each year, please provide the number of people with a medical condition, which meant they needed bariatric surgery, including those with none (can the data please be displayed so that their age groups are given also).
4) Please provide the number of people for each year with a BMI of 35 or less, and of 30 or less, again giving their medical condition and age group (or exact age for under-21s) for each.
5) Please provide a list of the criteria the health board has for offering people bariatric surgery, and if this has changed in the last five years, state when it changed and what it changed from and to.
6) If the health board’s target for the number of people undergoing bariatric surgery has changed in the last five years, please state what it changed from and to, and when this happened.

Download response Bariatric surgery 2013-2017. 260417

Bladder and kidney infections. 071217

Request 1
The number of patients aged between 16 and 65 presenting at A and E with upper and lower urinary tract infections also referred to as bladder and kidney infections between Jan 2012 to Dec 2016. These are also known as pyelonephritis or cystitis.
Request 2
The number of patients aged between 16 and 65 admitted into hospital with upper and lower urinary tract infections (bladder and kidney infections) including via A&E between Jan 2012 and Dec 2016. These infections are also known as pyelonephritis (Kidney Infection) or cystitis (Urinary Tract Infection). Admittance can be as a result of a primary diagnosis or secondary.
Request 3
The number of patients aged between 16 and 65 diagnosed with urinary sepsis between Jan 2012 and Dec 2016.
Request 4
The number of patients aged 65 and over presenting at A and E with upper and lower urinary tract infections also referred to as bladder and kidney infections between Jan 2012 to Dec 2016. These are also known as pyelonephritis or cystitis.
Request 5
The number of patients aged 65 and over admitted into hospital with upper and lower urinary tract infections (bladder and kidney infections) including via A&E between Jan 2012 and Dec 2016. These infections are also known as pyelonephritis (Kidney Infection) or cystitis (Urinary Tract Infection). Admittance can be as a result of a primary diagnosis or secondary.
Request 6
The number of patients aged 65 and over diagnosed with urinary sepsis between Jan 2012 and Dec 2016.
If I could receive this information on two separate excel spreadsheets showing the data for ages 16-65 and 65 and over via email this would be appreciated.

Download response Bladder and kidney infections. 071217

Bladder scanners 2015-2016. 150217

1. How many bladder scanners are registered and in working order with your equipment library (or equivalent)?
2. How many ultrasound bladder scanners did your Trust buy in the 2015/16 financial year?
3. Is there a hospital training record for those healthcare workers that are trained to use ultrasound bladder scanners?
4. Do you have a hospital policy which includes the indications for use of ultrasound bladder scanners across all departments and ward areas?
5. How many incontinence nurses or clinical nurse specialists are employed by your Trust?
6. How many urology nurse specialists are employed by your Trust?

Download response Bladder scanners 2015-2016. 150217

Blue-light filtering intraocular lenses. 061217

1. How many blue-light filtering intraocular lenses did your Trust implant during cataract surgery in 2016?

1a. How many patients does this correspond to?

2. What is the total figure of all lenses that were implanted during cataract surgery by your Trust in 2016?

2a. What proportion of these lenses were blue-light filtering intraocular lenses?

3. On how many occasions in 2016 was your Trust required to replace blue-light filtering intraocular lenses that were implanted during cataract surgery?

3a. How many patients does this correspond to?

4. Does the Trust have a policy on whether or not to use blue-light filtering intraocular lenses?

4a. If so, can you provide details of this policy?

5. Has the Trust increased or decreased its use of blue-light filtering intraocular lenses in the last five years? Please provide a breakdown of usage over the last five years.

Download response Blue-light filtering intraocular lenses. 061217

Bowel preparation for colonoscopy. 071019

All of the questions refer to colonoscopy procedures performed between 1st January 2018 and 1st January 2019.
1. What is the first line bowel preparation laxative that is offered to patients undergoing colonoscopy?
2. Do you offer any alternative bowel preparation laxatives for patients undergoing colonoscopy?
3. How many patients received each bowel preparation laxative between 1st January 2018- 1st January 2019?
4. What were the number of patients receiving each bowel preparation laxative who had inadequate bowel preparation between 1st January 2018- 1st January 2019?
5. Are patients undergoing colonoscopy advised to take the bowel preparation at a single time or split over two different times?
6. During the period of 1st January 2018- 1st January 2019, what times were patients advised to consume the bowel preparation for a morning colonoscopy appointment?
7. During the period of 1st January 2018- 1st January 2019, what times were patients advised to consume the bowel preparation for an afternoon colonoscopy appointment?
8. During the period of 1st January 2018- 1st January 2019, what times were patients advised to consume the bowel preparation for an evening colonoscopy appointment?
9. Are patient’s advised to consume a particular diet prior to their colonoscopy? If so what diet are they advised to consume? How many days are they advised to consume it for?
10. Do any of your patients attend a specific pre assessment clinic after they are referred for colonoscopy, but before they attend on the day of their endoscopy to receive more detailed endoscopy information? What is the criteria for referral to this pre assessment clinic?
11. How many patients are seen in this pre assessment clinic between 1st January 2018- 1st January 2019?
12. How many colonoscopies did you perform in the last year (1st January 2018- 1st January 2019)
13. During the period of 1st January 2018- 1st January 2019:
a. How many patients were documented as having excellent bowel preparation?
b. What was the polyp detection rate in patient with excellent bowel preparation?
c. How many patients were documented as having good bowel preparation?
d. What was the polyp detection rate in patient with good bowel preparation?
e. How many patients were documented as having fair bowel preparation?
f. What was the polyp detection rate in patient with fair bowel preparation?
g. How many patients were documented as having inadequate bowel preparation?
h. What was the polyp detection rate in patient with inadequate bowel preparation?
14. How many patients had a morning appointment during the period of 1st January 2018- 1st January 2019?
15. How many patients who had a morning appointment during the period of 1st January 2018- 1st January2019 had inadequate bowel prep?
16. How many patients had an afternoon appointment during the period of 1st January 2018- 1st January 2019?
17. How many patients who had an afternoon appointment during the period of 1st January 2018- 1st January 2019 had inadequate bowel prep?
18. How many patients had an evening appointment during the period of 1st January 2018- 1st January 2019?
19. How many patients who had an evening appointment during the period of 1st January 2018- 1st January 2019 had inadequate bowel prep?
20. If a patient has a repeat colonoscopy due to inadequate bowel preparation, do you have a specific bowel preparation regime for those patients? If so what is it?

Download response Bowel preparation for colonoscopy. 071019

Breast reconstruction surgery.220922.docx

Part A- Delayed reconstructive surgery backlog
1. Following the suspension of reconstructive surgery in March 2020 as a result of the pandemic, when was reconstructive surgery restarted within your trust, for:
a. Immediate reconstruction?
b. delayed reconstructive surgery (by delayed reconstructive surgery we mean reconstructive surgery that happens after a mastectomy as opposed to immediate reconstructive surgery which occurs concurrently)?
2. What percentage of patients who have been on the waiting list since March 2020 to May 2022 have had their reconstructive breast surgery, for:
a. immediate reconstruction?
b. delayed reconstruction?
3. At what proportion of capacity (i.e. average number of patients operated on per month) is the service currently operating at for:
a. immediate reconstruction?
b. delayed reconstructive surgery?
4. At what capacity (average number of patients operated on per month) was the service operating at pre-pandemic for (January 2019 – January 2020)?
a. immediate reconstruction?
b. delayed reconstructive surgery?
5. What was the average waiting time for receiving reconstruction in your trust between 2018-2019 (in weeks) for:
Free- flap reconstruction
a. Immediate?
b. Delayed?
Implant reconstruction
a. Immediate?
b. Delayed?
6. What is the current average waiting time for receiving delayed reconstruction in your trust (in weeks) for:
Free- flap reconstruction
a. Immediate?
b. Delayed?
Implant reconstruction
a. Immediate?
b. Delayed?
7. What is the current average wait time for additional surgeries (i.e. balancing and correction surgeries) in your trust?
Part B- Reconstructive and balancing breast surgery- procedural limits
1. Does your trust operate under any policies or guidance which place limitations on the number of reconstructive surgical procedures a breast cancer patient is able to access, including limiting the number of balancing surgeries (procedures to the unaffected breast to ensure it matches the reconstructed breast)?
a. If so, could you please provide details of the limitations and how long they have been in place?
Part C- Reconstructive and balancing breast surgery- time limits
1. Does your trust operate under any policies or guidance which place limitations on the timescale for surgical procedures a breast cancer patient is able to access, including for balancing surgeries?
a. If so, could you please provide details of the policy and how long it has been in place?

Breast reconstruction surgery.220922.docx

Breathing circuits and filters. 271021.docx

1. How many Breathing Circuits (such as parallel circuits, coaxial circuits etc) does the Trust use in theatres per annum based on 2019-2020 figures
2. How many Breathing filters (such as HME filters) does the Trust use in theatres per annum based on 2019-2020 figures
3. Who is the current supplier for breathing circuits and filters and is there a contract in place, if so when is it up for renewal?
4. What is the brand of anaesthetic machines used?

Download response Breathing circuits and filters. 271021.docx

Bronchial challenge testing 040117

Can you please advise if the trust performs Bronchial challenge testing? If the trust does perform these tests could you also advise?
1) The number of tests performed in the last 12 months?
2) Which products are used to perform the test?
3) Contact details for the sites performing the test?

Download response Bronchial challenge testing 040117

Business continuity plan for the Ophthalmology Department.180821.docx

I found out that the laser machine in the Ophthalmology department was broken and I was on a long list and the machine was very expensive to replace.
What is your business continuity plan for such an event?

Download response Business continuity plan for the Ophthalmology Department.180821.docx

Cataract lenses, equipment and custom PAKS. 070317

Intra-occular Lenses
• When is your current Intraocular lens contract for Ophthalmology up for renewal?
• Who is your current Intraocular lens provider/providers?
• How long will your future Intraocular tender contract run for?
• What is the value of your current intraocular lens contract?
• What is the price of your most used IOL?
• Do you use Toric Lenses for NHS patients or for private?
• Who is your current Toric Lens supplier?
• Do you have a Toric pathway?
• What is the price of your most used Toric IOL?
– Do you currently have a managed service in place for Ophthalmology?

Cataract Equipment
• When is your Phaco machinery contract up for renewal?
• How many Phaco machines do you currently have at your sites?
• Who is your current provider of the Phaco machinery?
• How long will the future Phaco contract run for?
• What is the value of your Phaco machinery?

Vitro Retinal (VR) Equipment
• When is your Vitro retinal machinery contract up for renewal?
• How many Vitro retinal machines do you currently have at your sites?
• Who is your current provider of your vitro retinal machinery?
• How long will the Vitro retinal contract run for?
• What is the value of your Vitro retinal machinery?

Cataract and VR Custom PAKS
• When is your cataract custom PAKS contract up for renewal?
• Who is your current custom PAKS provider?
• How long will your custom PAKS contract run for?
• What is the value of your Cataracts custom PAKS for the current contract?
• What products are in your standard cataract custom PAK?
• When is your VR custom PAKS contract up for renewal?
• Who is your current VR custom PAK provider?
• How long will the VR custom PAKS contract run for?
• What is the value of your VR custom PAKS for the current contract?
• What products are in your standard VR custom PAK?

– How many cataract procedures did you do in the financial year 2015 – 2016?
– How many VR procedures did you do in the financial year 2015 – 2016?

Download response Cataract lenses, equipment and custom PAKS. 070317

Cataract operations.060423.docx

1) The number of NHS funded cataract operations which the Trust was commissioned to deliver in the financial years 2016/17 to 2021/22 inclusive.
2) The number of NHS funded cataract operations which the Trust delivered in the financial years 2016/17 to 2021/22 inclusive.
3) The amount of income generated from NHS funded cataract operations for each of the financial years 2016/17 to 2021/22 inclusive
4) The total income received by the Trust’s Eye Care Department/Unit/Service (i.e. that part of the hospital which has a specific budget for the delivery of both inpatient and outpatient eye care services) for each of the financial years 2016/17 to 2021/22 inclusive
5) The total expenditure by the Eye Care Department/Unit/Service for each of the financial years 2016/17 to 2021/22 inclusive
6) The number of consultant ophthalmologists below retirement age who have ceased to work for the Trust for each of the financial years 2016/17 to 2021/22 inclusive.
7) The number of advertised vacancies for consultant ophthalmologists and ophthalmic nurses for each of the financial years 2016/17 to 2021/22 inclusive.

Cataract operations.060423.docx

Cataract operations. 070917

Please can you tell me what proportion of cataract surgery cases are done with local anaesthetic without an anaesthetist allocated.

Download response Cataract operations. 070917

Cataract operations. 141217

1. In the last 3 years, how many cataract operations were performed at your NHS Trust?
2. Are toric intraocular lenses available for NHS patients with astigmatism undergoing cataract surgery at your NHS Trust?
3. If yes to Qu2, please list the criteria under which toric intraocular lenses are available to patients, and please send us copies of any policy documentation.
4. If yes to Qu2, how many toric intraocular lenses were implanted at your NHS Trust in the last 12 months, for which data is available?
5. How many corneal limbal relaxing incision operations were performed as part of cataract surgery at your NHS Trust in the last 12 months, for which data is available?

Download response Cataract operations. 141217

Cataract operations. 180920

1. How many people are currently on the waiting list for cataract surgery? How does this compare with each year for the past five years?

2. What is the average time a patient is on the waiting list for cataract surgery before having the procedure?

3. How long has the patient who has had the longest wait for cataract surgery been waiting?
4. How has Covid-19 affected waiting times for cataract operations?

5. How many cataract surgeries have you carried out each month this year?

6. How many cataract surgeries have you carried out each month last year?

7. How many cataract surgeries did you carry out each month five years ago in 2015?

Download response Cataract operations. 180920

Cataract procedures. 181019

1. How many cataract procedures did you do in 2018 and what were the rates of posterior capsular rupture?

Download response Cataract procedures. 181019

Cataract referrals.160623.docx

Please may you provide me with an answer to the following:

Please detail the number of referrals to cataract clinics at your Trust in each of the following years:
a. 23/24 (YTD)
b. 22/23
c. 21/22
Please could the above be split by referrer/referral source (i.e. by GP practice, optometric practice etc)

Cataract referrals.160623.docx

Cataract services – June 2016

1)
In the 12 months to January 2016 (or to the most recent month available), what was the average waiting time in days (referral to treatment time) for patients awaiting cataract surgery through Maidstone and Tunbridge Wells NHS Trust?
2a)
In the last 3 years, how many patients underwent cataract removal surgery at Maidstone and Tunbridge Wells NHS Trust?
2b)
In each of the last 3 years, how many individual cataract removal procedures were performed at Maidstone and Tunbridge Wells NHS Trust?
2c)
Does Maidstone and Tunbridge Wells NHS Trust operate a criteria for determining the priority/eligibility of patients for cataract surgery? If so, please specify.
2d)
Under what circumstances are NHS cataract patients ineligible for ‘second eye surgery’ – i.e. cataract removal from both eyes?
3a)
Are toric intraocular lenses available for patients with astigmatism undergoing cataract surgery at Maidstone and Tunbridge Wells NHS Trust?
3b)
If yes to 3a, please list the conditions and criteria under which toric intraocular lenses are available to patients.
3c)
If yes to 3a, are toric intraocular lenses available for NHS patients with astigmatism undergoing NHS-provided cataract surgery at Maidstone and Tunbridge Wells NHS Trust?

3d)
If yes to 3c, please list the conditions and criteria under which toric intraocular lenses are available to NHS patients.
3e)
If yes to 3a and/or 3c, how many patients have been fitted with toric intraocular lenses in the last 12 months, for which data is available?

Download response Cataract services – June 2016 060616

Cataract surgery

I am aware that you are restricting cataract surgery and that you are offering cataract surgery to those able to pay.

Would you kindly forward to me the number of people who on your list currently awaiting cataract surgery by your trust? If possible I would like the number of people in the whole of the Kent area who await this surgery.

Download response Cataract surgery 260116

Cataract surgery. 071021.docx

Please provide details, for the most recent full year available:
1. The number of CCG cataracts performed within the past 12 months
2. Current waiting times for cataract surgery
Can I also ask for?
3. Confirm the organizations commissioned by the CCG provide Ophthalmology services to your patients?
4. The end dates of your current commissioned ophthalmology providers.
5. How many of your existing contract providers contract arrangements are now in their extension period?
6. Who (if any) providers are providing ophthalmology services to patients without a contract where a patient has exercised their right to choose a provider?
7. How can new providers offer the service to patients who are still awaiting cataract surgery

Download response Cataract surgery. 071021.docx

Cataract surgery. 080222.docx

1. Please provide the total number of patients waiting for Cataract surgery within your trust.
2. Please provide the total number of patients waiting for cataract surgery between 18 weeks – 51 weeks within your trust.
3. Please provide the total number of patients waiting for cataract surgery between 52 weeks – 103 weeks within your trust.
4. Please provide the total number of patients waiting for cataract surgery over 104 weeks within your trust.
5. Please answer yes or no. Are you currently using sub-contractors to support with any backlog of Cataract patients within your trust.
6. If yes to question 5, please provide the name and location of the provider (s) you are using.
7. If yes to question 5, please provide the total number of completed cataract surgeries they have done for you in 2020/21 and 2021/22 (to date).
8. If no to question 5, do you intend to use other providers to support you with any backlog within your trust.
9. If no to question 8, please provide a reason for not using other providers to support with any backlog within your Trust.
10. Please provide the name and contact details for the individual (s) accountable for contracting these services within your Trust.

Cataract surgery. 080222.docx

Cataract surgery 150217

1. Is the treatment listed below routinely available to patients according to its NICE TAG?
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion [TA409]

2. Please could you send your commissioning policy for cataract surgery. Please indicate the review date of this policy.

Download response Cataract surgery 150217

Cataract surgery 2006-2016

1. Catchment population of your trust by age (in brackets of 10 years) – e.g. total of 250,000 people of which 20,000 are within 10-20 years old
2. Number of patients in each age bracket of 10 years (e.g. 50-60, 60-70) undergoing cataract surgery.

3. Source of referrals (GP, optician, hospital, other) for cataract surgery for each financial year between 2006 and 2016
o Has e-Referrals (i.e. choose and book) been implemented?
o What is the nature of your referral management system (if any)?
o How many referrals by GPs, Opticians, Hospital Doctors or Others are received by the referral management system for cataract surgery, and how many of these are declined?

4. Mean and median waiting times from referral to cataract surgery for each financial year between 2006 and 2016

5. Total volume of injections for macular degeneration performed per financial year – between 2006 and 2016
o If recorded, please also provide number of unique patients receiving injections per financial year

Download response Cataract surgery 2006-2016 250716

Cataract Surgery. 240920

1. Does the Trust Sub-Contract any or all Cataract Surgery?
2. If Yes, who too?
3. What was the Trusts Cataract Surgery Average Waiting Time in May 2020?
4. What was the Trusts Cataract Surgery Average Waiting Time in May 2019?
5. What was the Trusts Cataract Surgery Average Patient Waiting Numbers in May 2020?
6. What was the Trusts Cataract Surgery Average Patient Waiting Numbers in May 2020?
7. If unable to provide at that level please state and provide information at Ophthalmology Specialty?

Download response Cataract Surgery. 240920

Cataract surgery. 280720

1. Number of patients waiting for a cataract surgery, by month or by year for FY17, FY18, and FY19
2. Number of patients waiting over 10 weeks for a cataract surgery, by month or by year for FY17, FY18, and FY19
3. Number of patients waiting over 18 weeks for a cataract surgery, by month or by year for FY17, FY18, and FY19
4. Referral-to-Treatment time for cataract surgery (C71 to C77), by month or by year for FY17, FY18, and FY19
5. Average time waited before a first appointment with an ophthalmologist as a new patient, by month or by year for FY17, FY18 and FY19
6. Number of new patients waiting for over 10 weeks for a first appointment with an ophthalmologist as a new patient, by month or by year for FY17, FY18, and FY19
7. Number of new patients waiting for over 18 weeks for a first appointment with an ophthalmologist as a new patient, by month or by year for FY17, FY18, and FY19

Download response Cataract surgery. 280720

Cholesteatoma procedures 01 April 2014-31 March 2015

Question 1: Please complete the following table for your patients, showing the number of procedures in the first, second or third position (please sum all instances) for a diagnosis of cholesteatoma in any position, per consultant, split into 18 and over and under 18s and then into whether the spell involved an overnight stay or was a daycase, from 1st April 2014 – 31st March 2015.
For your ease the following have been provided:
· Template to complete – attached
· Procedure codes – as a tab on the spreadsheet
· ICD codes for cholesteatoma – H71, H604, H950
· An example SQL code has been provided to answer this query – as a tab on the spreadsheet

Please note patients may have more than one relevant procedure code in the first three procedure codes, please sum all instances where these codes appear even if patients are double counted. This is because we are looking at the number of procedures and not the number of patients.

The example table attached has been completed as if you had 2 consultants at one hospital. The numbers in this template are not a true account of any consultant, there are only there to make the table easier to read.

Question 2: Please include a separate count of the number of individual inpatients with a recorded diagnosis of cholesteatoma in any position for the same time period, split by 18 and over, and under 18. Please put the data in the question 2 template.
If you have less than 5 patients, would you consider giving the exact number of patients as we want to work out the national prevalence of cholesteatoma?

Question 3: Please could you put the total number of patients having a procedure in the last year (ie the number of patients used for question 1) into the question 2 template in the relevant column, broken down by 18 and over and under 18?

Question 4: This data will be summarised to provide national trends, lists and statistics, and put on a website whose aim is to support patients with cholesteatoma. Do you consent to the data being used in this way? Please put your answer in column in the question 2 template.

Download response Cholesteatoma procedures 01 April 2014-31 March 2015 150416

Cholesteatoma surgery – laser

1. Do you have a KTP laser for use in Cholesteatoma surgeries?
2. If you are planning on getting one soon, what date are you planning on getting one?
3. If you already have the KTP laser for cholesteatoma surgeries:
a), is it routinely available for cholesteatoma surgeries?
b) is it maintained and staff trained to use it?
4. Are there any issues that are preventing you from routinely using the KTP laser?
5 Are you doing your tympanoplasty surgery for cholesteatoma as a day case or overnight stay? For adults. For Children.
6. If as a day case, why is it not an overnight stay?
7 Are you doing your mastoidectomy surgery for cholesteatoma as a day case or overnight stay? For adults. For Children.
8. If as a day case, why is it not an overnight stay?
9. What is your standard follow up period of time for a ‘second look’ following tympanoplasty?
10. Are you routinely using CT or MRI to gauge the extent of cholesteatoma growth?
11. Do you have a cholesteatoma leaflet? Yes/No If so, please attach.

We are in the process of setting up a not for profit group to support patients with Cholesteatoma.

12. Would you like to be involved in the clinical advisory group? – If yes – put name.
13. Would you find a leaflet for patients explaining cholesteatoma helpful if we could provide one? Yes/No
14. If we provided a poster about the support group would you be happy to display this in ENT/Audiology? Yes/No
15. Do your ENT surgeons feel that cholesteatoma surgery could be more effective if delivered as a regional service to enable the surgeons to have access to the laser and have more experience in c-toma opearations?Yes/No

16. We wish to put some of this information on our website, do we have permission to publish the data in raw format?

17. We wish to summarise the national trends, lists and statistics from the data returned from all hospitals and put this on our website, do we have permission to summarise the data?

Download response Cholesteatoma surgery – laser 190416

Cholesteatoma Surgery – Regional centres.

The previous Freedom of Information request showed that a number of regional centres for cholesteatoma surgery already exist. I want to make sure that I have captured all of these regional centres.

If you have a number of hospitals please only complete for your acute hospitals. Please list each acute hospital separately.

Name of hospital. Please complete Post code of hospital. Please complete Do you have an ENT department at your acute hospital? Do you perform inpatient or daycase ENT procedures at your hospital? Do you perform cholesteatoma surgery at your hospital?

If you do not perform cholesteatoma surgery at your hospital, which hospital do you refer patients to? Full name please

If you refer patient to another hospital for cholesteatoma surgery, do they have their follow ups at your hospital or at the other hospital?

If you refer patient to another hospital for cholesteatoma surgery, do they have their audiology appointments at your hospital or at the other hospital?

If you refer your cholesteatoma patients to another hospital, please state the reasons.

If you receive referrals for cholesteatoma surgery from other hospitals, please list the full names of the hospitals that refer to you.

Download response Cholesteatoma Surgery – Regional centres 150416

Chronic Fatigue Syndrome 140217

1. Please name the NHS Trust(s) that you represent. Where more than one NHS Trust is represented, please respond to the following requests for information for each Trust individually.
2. For the financial year 1st April 2015 – 31st March 2016, please indicate the number of patients in your NHS Trust with Chronic Fatigue Syndrome. If your Trust deals with both adults and children, then please indicate numbers for both of these patient groups.
3. For the financial year 1st April 2015 – 31st March 2016, please indicate the number of patients in your NHS Trust with Chronic Fatigue Syndrome who have been seen by a Dietitian.
4. Please indicate whether Dietitians within your NHS Trust have a specific nutritional care plan / care pathway for the management of Chronic Fatigue Syndrome. Where this exists, please provide all documentation.

Download response Chronic Fatigue Syndrome 140217

Chronic pain service 031016

1. The definition of calculation used for new to follow up ratios for chronic pain referrals.
2. The data for new to follow up for chronic pain referrals for your trust for the years April 2010 to April 2015
3. Is the calculation used for new and follow-up in Chronic Pain a local or national definition?
4. Can you provide the wording of the definition used?
5. Does the New to follow up ratio calculation that is used by your organisation for Chronic Pain also apply to other specialties?
6. If no – please explain the differences in the calculations.

Download response Chronic pain service 031016

Circumcisions. 020621

I am writing to discern the number of circumcisions that have been done to treat phimosis (N47.1) in the UK.

I would like to know how many such circumcisions that were carried out by your NHS trust in the years of 2018 and 2019, or any similar time period for which the records are readily available. If your trust does not carry out circumcision to treat phimosis then please just reply to say so.
If possible I would like to be provided with a breakdown of the ages of the patients at the time of the procedure; either in the way in which this information is already recorded by yourselves, or alternatively in the following way:

a. Between the ages 0-4
b. Between the ages 5-8
c. Between the ages 9-12
d. Between the ages 13-16
e. Between the ages 16 to 20
f. Ages 21+

Download response Circumcisions. 020621 

Clinical Insourcing and Outsourcing. 111121.docx

1. Do you insource clinical services and if so, which ones?
2. Do you have any current contracts in place with a company for these insourced services, and if so which services?
3. How much have you spent on insourcing clinical services per annum for the past 3 years?
4. Do you outsource clinical services and if so, which ones?
5. Do you have any current contracts in place with a company for these outsourced services, and if so which services?
6. How much have you spent on outsourcing clinical services per annum for the past 3 years?

Download response Clinical Insourcing and Outsourcing. 111121.docx

Clinical insourcing and waiting lists. 270721.docx

1. Do you currently contract with third-party providers to insource clinical services?
If you answered yes to question 1, please also provide the following detail:
1a. The name of your insourcing provider(s) and the specialities covered in this contract (if you use more than one supplier please also provide detail)
1b. The contract start and end dates (if multiple please list all)
1c. If your substantive staff are used as part of the insourcing team or if a full external team is used
1d. If you are charged per patient, per procedure, per healthcare resource group or a block or volume-based price
1e. If Trust/Health Board consumables (e.g. medical gloves, dressings, stationery, etc) are used in the facilitation of the insourcing service and if any charge is levied for using them?
1f. If your provider follows your operating procedures to facilitate the service
a) If yes, please detail the steps you take to ensure they are followed
b) If no, please detail how you ensure that the service is compliant and protects patient safety
1g. What days of the week your clinical insourcing services are provided on (please detail if this differs by speciality)
1h. Please detail your annual spend on clinical insourcing by speciality
2. Please detail your current average surgical and outpatient treatment waiting time by speciality (or direct to this information if it is publicly available)

Download response Clinical insourcing and waiting lists. 270721.docx

Colonoscopy. 280420

2019 (if not available, 2018) surgical volumes for Colonoscopy (see attached excel file for detailed coding)

Download response Colonoscopy. 280420

Colposcopy appointments. 140421

I was wondering if you’d be able to share with me a copy of the letter and information leaflet that you send out to patients who receive a colposcopy appointment.

Download response Colposcopy appointments. 140421

Communication aid devices for adults with speech difficulties. 291221.docx

1. Do you have a budget for providing low and mid tech communication aid devices for adults (18 or over) with speech difficulties (e.g. iPads and tablets, text to speech apps, keyboard-based communication aids), and if yes how much was this budget for this and the last two financial years (2021, 2020, 2019)?
2. If yes, how many adults (18 or over) with speech difficulties were provided with a low or mid tech communication aid (e.g. iPads and tablets, text to speech apps, keyboard-based communication aids) that was funded or provided by your Trust in this and the last two financial years (2021, 2020, 2019), and what devices were provided?
3. If yes, how many adults (18 or over) with a diagnosis of motor neurone disease were provided with a low or mid tech communication aid (e.g. iPads and tablets, text to speech apps, keyboard-based communication aids) that was funded or provided by your Trust in this and the last two financial years (2021, 2020, 2019), and what devices were provided?
4. If you do not have a budget for providing low and mid tech communication aid devices (e.g. iPads and tablets, text to speech apps, keyboard-based communication aids) how should a local, community or acute based speech and language therapist working for your organisation make available assessment and provision of these devices for adults (18 or over) living with speech difficulties?

Download response Communication aid devices for adults with speech difficulties. 291221.docx

Complex Regional Pain Care Syndrome (CRPS). 240317

What does your acute Complex Regional Pain Care Syndrome (CRPS) pathway look like for trauma and orthopaedic, rheumatology and hand acute services?

Download response Complex Regional Pain Care Syndrome (CRPS). 240317

Continuous renal replacement therapy (CRRT). 010217

1. How many machines do you have for continual renal replacement (CRRT) in the intensive care unit/critical care unit?
1. a. Can you split these by manufacturer and age of machine please?
2. Are you in a contract for your machines, if so when does the contract expire?
3. How many CRRT treatments were carried out in 2016 (or the latest 12 month period you have data for)?
4. How many bags of fluid did you use for CRRT in 2016 (or the latest 12 month period you have data for)?
5. Who is your current manufacturer of fluids for CRRT? And for Vascular access? (Double Lumen catheters)
6. Are you in a contract for fluids, if so, when does this expire and is it linked in with the machine contract?
7. What was your total spend on CRRT fluids in 2016 (or the latest 12 month period you have data for)?
8. What was your total spend on CRRT consumables (e.g. consumable sets for the machines) in 2016 (or the latest 12 month period you have data for)?
9. What is the typical renal dose you prescribe to the patients? (In ml/kg/h)
10. Are your units using Citrate Anticoagulation? If yes how frequent (in % vs. Heparin).

Download response Continuous renal replacement therapy (CRRT). 010217

Contract information for TNP and PAC.060317

Section 1
1) What are the Hospital names and locations that form part of the Trust? (Please provide details)
2) Which framework is utilized for purchasing such as SBS, NHS Supply Chain or other (please provide details of all that are used)
3) By which method is this procured? (Please state all that applies)
Section 2
1) What is the name of the manufacture used to provide Topical Negative Wound Therapy Treatment for each hospital location?
*Smith-Nephew
*KCI
*Talley
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) Is this equipment provided via Hire agreement, Purchase or other? (Please provide details)
4) Is the provision of this equipment contracted? Yes or No
5) If contracted is the service and maintenance of this equipment included as part of the contract? Yes or No
6) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
7) If 3rd party provider please state company name
8) Is the 3rd party service & maintenance contracted? Yes or No
9) If Yes what is the contract term? (Including any extension periods).
10) What is the expiry date of this contract?
The following questions are only applicable if the supply of Topical Negative Wound Therapy to the hospital trust is contracted.
1) As a result of the tender did you change provider? Yes or No (If Yes please provide name of previous supplier)
2) What date did your current contract start?
3) How long is the current contract? (Including any extension periods)
4) When does the current contract expire?
5) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
6) Please provide the financial value for the first 12 months of the current contract in place.
Section 3
1) What is the name of the manufacture used to provide pressure relief alternating dynamic surface air mattresses to the trust?
*Hill-Rom
*Smith-Nephew
*Talley
*Direct Healthcare
*Karomed
*Other (please provide names)
2) By which method is this procured? (Please state all that applies)
3) What is the total number of dynamic mattresses on-site?
4) Is this a managed service? Yes or No
5) Is the provision of dynamic surfaces contracted? Yes or No
6) If Yes is the service and maintenance of this equipment included as part of the contract? Yes or No
7) If No – How is service & maintenance of this equipment dealt with – 3rd party provider or in-house?
8) If 3rd party provider please state company name
9) Is this 3rd party service contracted? Yes or No
10) If Yes what is the contract term? (Including any extension periods).
11) What is the expiry date of this contract?
12) How is the decontamination of these products managed? In-house or 3rd party provider
13) If 3rd party provider please state company name
14) Is this 3rd party service contracted? Yes or No
15) If Yes what is the contract term? (Including any extension periods).
16) What is the expiry date of this contract
The following questions are only applicable if the supply of dynamic alternating air surface mattresses to the hospital trust is contracted.
1) Which method is used to tender the contract? (Please provide details)
2) What date did your current contract start?
3) What is the term of the contract? (including any extension periods)
4) When does the current contract expire?
5) Is the contract purchase, hire or other (please provide details)
6) If contracted, when did you last tender the contract?
7) As a result of the tender did you change provider? Yes or No (if Yes please provide previous supplier)
8) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
9) Please provide the financial value for the first 12 months of the current contract in place.
Section 4
1) What is the name of the manufacture used to supply profiling bed frames?
*Hill-Rom
*Sidhil
*Invacare
*Linet
*Huntleigh
*Other (please provide details)
2) By which method is this procured? (Please state all that applies)
3) Which products are used? (Please provide details)
4) What is the total number of hospital bed frames on-site?
5) Is the supply of bed frames contracted?
Yes or No?
The following questions are only applicable if the supply of profiling beds to the hospital trust is contracted.
1) What date did your current contract start?
2) How long is the current contract? (Including any extension periods)
3) When does the current contract expire?
4) When did you last tender the contract?
5) As a result of the tender did you change provider? Yes or No (if Yes please state previous supplier)
6) Please provide the financial value of the contract in the last 12 months of the previous contract including total value and periods covered.
7) Please provide the financial value for the first 12 months of the current contract in place.

Download response Contract information for TNP and PAC.060317

Correcting cosmetic procedures. 280421

1. Please can you tell me, for each of the last five calendar years, including this one to date, how much has been spent by your trust on correcting cosmetic procedures?

2. In addition, if possible, can you break down the type of operation or procedure, and specify where the original operation took place, either in the UK or abroad.

Download response Correcting cosmetic procedures. 280421

Deaf & Hard of Hearing patients. 170118

Question 1
In the last 3 1/2 fiscal years how many of the Deaf / Hard of Hearing patients have been referred to the hospital by their GP requiring them to have an appropriate interpreter?
2014/15:
2015/16:
2016/17:
2017/18 (April to September):
Question 2
In relation to Question 1 above – how many of the Deaf / Hard of Hearing patients did not have an interpreter that was required to attend?
2014/15:
2015/16:
2016/17:
2017/18 (April to September):
Question 3
In relation to Question 2 above – please give reasons and the number of incidents for the omission of interpreters at the appointment e.g.
a. The hospital / surgery IT booking system does not facilitate for interpreting requests (flag up).
b. Overlooked by the GP.
c. Overlooked by the hospital.
d. Overlooked by interpreting agency.
e. Overlooked by interpreter.
f. Incorrect booking date.
g. Interpreting cost not accounted for in the budget
h. Interpreting budget overspent
i. Other (please state).
Question 4
In relation to Question 3 above – how was each incident dealt with?
Question 5
If an appointment is cancelled in advance – do the hospitals have the necessary mechanism in place to ensure that the interpreter is informed of the cancellation and the new appointment date agreed with the patient?
Question 6
If the answer to Question 5 above is no – what measures do you have in place?
Question 7
Do you give an extra time slot when a Deaf / Hard of Hearing patient attends an appointment with an interpreter?
Question 8
a. Do you train your existing members of staff including CEO, senior, junior officers, GPs and front-line staff to understand and implement the Accessibility Information Standard (AIS) accordingly?
b. Is AIS also included in the new staff induction pack?
c. When was the last time you conducted a Deaf Awareness Course?

Download response Deaf & Hard of Hearing patients. 170118

Dedicated continence staff. 110222.docx

(A) For the financial year 2018-2019
(i) how many dedicated continence staff were employed by [Insert trust name]
(ii) whether a named continence lead was in place
(iii) to provide the name and contact details of any continence lead in place and
(iv) what budget allocations were made for continence services during this financial year.
(B) For the financial year 2019 – 2020
(i) how many dedicated continence staff were employed
(ii) How many continence staff were redeployed to other services as a result of COVID19
(iii) whether a named continence lead was in place
(iv) to provide the name and contact details of any continence lead in place and
(v) what budget allocations were made for continence services during this financial year.
(C) For the financial year 2020 – 2021
(i) how many dedicated continence staff were employed
(ii) How many continence staff were redeployed to other services as a result of COVID19
(iii) whether a named continence lead was in place
(iv) to provide the name and contact details of any continence lead in place and
(v) what budget allocations were made for continence services during this financial year.
(D) For the financial year 2021 – 2022
(i) how many dedicated continence staff were employed
(ii) How many continence staff were redeployed to other services as a result of COVID19
(iii) how many continence staff are still redeployed as a result of COVID19
(iv) whether a named continence lead was in place
(v) to provide the name and contact details of any continence lead in place and
(vi) what budget allocations were made for continence services during this financial year.

Dedicated continence staff. 110222.docx

Dental Treatment under general anaesthetic. 141220

1. Do you record activity or code patients on your clinical system e.g. ‘Theatreman’ or similar theatre management system which specifically relates to patients receiving dental treatment under general anaesthetic in your theatre(s)?
2. Do you receive a surgical tariff for those patients receiving dental treatment under general anaesthetic in your theatre(s)?
3. How many patients have received dental treatment under general anaesthetic in your theatre(s) within the last 12 months?
4. How many dental general anaesthetic sessions have been provided in your theatre(s) in the past 12 months?
5. What is the average number of dental general anaesthetic sessions provided in your theatre(s)
a. each week?
b. each month?
6. How many patients receiving dental treatment under general anaesthetic in your theatre(s) are seen on each general anaesthetic session list?
7. Are both adult and paediatric dental patients treated on the same general anaesthetic list/session?
8. Do you operate separate general anaesthetic lists for
a) Adults receiving dental treatment under GA?
b) Paediatrics receiving dental treatment under GA?
If so how many patients are on each of these lists?
9. How many patients receiving dental treatment under general anaesthetic in your theatre(s) were in-patient stays in the last 12 months?

Download response Dental Treatment under general anaesthetic. 141220

Dental treatments. 170817

• Number of deaths per year since 2000 (including the full year 2000) from general anaesthetic for dental procedures, either under the care of the Public Dental Service (PDS) or Oral and Maxillofacial Surgery (OMFS)
• The age of the patients that died.

Download response Dental treatments. 170817

Diabetes related amputations 2011,2012,2013,2014 & 2015

How many diabetes-related amputations have there been over the last five years?

Please break down by calendar year, for:
2011
2012
2013
2014
2015

2. Of the diabetes related amputations above, how many of the patients were aged 25 or under? Please break down by years stated above.

3. How many diabetes related amputations were recorded in patients under the age of 18?
Again, please break down by the years stated above.

If possible, I would like this information (just for under 18’s) broken down individually by age for the last five years.

However, if this is not possible – please include the age of the youngest patient to have a diabetes related amputation at your trust.

Download response Diabetes related amputation 2011,2012,2013,2014 & 2015 170216

Diagnosed eye conditions – wetAMD. 120717

Within your trust how many patients have been treated, in the past 6 months January to June, 2017 by diagnosed eye condition? Of these patients how many are new to treatment [they have not previously received an injection /implant]?
If you do not have full records an estimate would be helpful.

Download response Diagnosed eye conditions – wetAMD. 120717

Dialysis services. 100419

1 Please enter the name of the location
2 Is the location a hub or satellite?
3 If the location is a satellite, what is the associated hub?
Operational details
4 How many haemodialysis patients does the location cover?
5 How many peritoneal dialysis patients does the location cover?
6 How many home dialysis patients are served from this location?
7 Who provides the service – internal (NHS) or external (private provider e.g. Freseneus)?
If internal:
8 Do you plan to publicly tender this service?
9 If yes, when do you plan to do this by? Please provide the year
If external:
10 What is the name of the provider who delivers the service?
11 When was the contract start date?
12 When is the contract expiry date?
13 If there is an extension period to this contract?
14 How long is the extension period in years?
15 What is the total value of the contract, in pounds?
Capacity
16 How many dialysis stations does the centre have?
17 How many days per week is the centre open?
18 How many sessions per day can the centre do?
19 How many sessions per week does the centre do on average?

Download response Dialysis services. 100419

Diastasis Recti operations

I am writing to request under the freedom of information act some details regarding surgery carried out across NHS Trusts in the last five years
1. Please advise how many Diastasis Recti operations have been carried out in your health trust the last five years, with a breakdown of how many per year?
2. How many abdominoplasty Surgeries have been carried out in your health trust in the last five years, with a breakdown of how many per year?
3. Please advise how many Diastasis Recti operations with a hernia have been carried out in your health trust in the last five years, with a breakdown of how many per year?

Download response Diastasis Recti operations 280716

Diseases of the eye and treatment options and volumes March 2015-February 2016

The total patients treated with the following conditions:
· Wet age-related macular degeneration (AMD)
· Diabetic macular oedema (DMO)
· Macular oedema secondary to retinal vein occlusion, branch (branch RVO)
· Macular oedema secondary to retinal vein occlusion, central (central RVO)
· Myopic choroidal neovascularization (mCNV)
The volume of use of the following treatment options:
· Ranibizumab
· Bevacizamab
· Aflibercept
· Dexamethasone intravitreal implant
· Fluocinolone acetonide intravitreal implant
· Laser Therapy
I would like this information for the period March 2015 to February 2016, broken down by month

Download response Diseases of the eye and treatment options and volumes March 2015-February 2016 060416

Drug coated balloons 060317

1. How many Drug Coated Balloons were used by your Trust for Peripheral Vascular interventions in 2016?
2. What was the total spend by the Trust on Drug Coated Balloons for Peripheral Vascular interventions in 2016?
3. How many Drug Coated Balloons were used by your Trust for Arterio-venous (AV) percutaneous interventions in 2016?
4. What was the total spend by the Trust on Arterio-venous (AV) percutaneous interventions in 2016?
5. What was the total spend by the Trust on Drug coated balloons for Arterio-venous (AV) percutaneous interventions in 2016?

Download response Drug coated balloons 060317

Elective operations. 280221

1. The number of elective operations scheduled. I would like this information for January 2019 to November 2020, broken down by month i.e. the total number of elective operations that were scheduled for January 2019, February 2019 etc.
2. The number of elective operations performed. I would like this information for January 2019 to November 2020, broken down by month.
3. The number of elective operations cancelled at the “last minute”, as defined by the NHS when providing data on cancelled elective operations. I would like this information for January 2019 to November 2020, broken down by month.
The NHS defines “last minute” as “on the day the patient was due to arrive, after the patient has arrived in hospital or on the day of the operation or surgery”. See files available at: http://www.england.nhs.uk/statistics/cancelled-elective-operations/cancelled-ops-data/
4. The number of breaches of the standard, as defined by the NHS when providing data on cancelled elective operations. I would like this information for January 2019 to November 2020, broken down by month.
The NHS defines “breaches of the standard” as the “number of patients not treated within 28 days of the last minute cancellation” of an elective operation. See files available at: http://www.england.nhs.uk/statistics/cancelled-elective-operations/cancelled-ops-data/
5. The total number of elective operations cancelled, regardless of how long cancellations were made before scheduled operation times, if this information is also collected. I would like this information for January 2019 to November 2020, broken down by month i.e. the total number of elective operations cancelled in January 2019, February 2019 etc.

Download response Elective operations. 280221

Elective theatres and scans.300124.docx

All questions are shown as received by the Trust.
1. Which hospitals in your Trust open elective theatres at the weekend? (please list the name of the hospital followed by a Y/N as to whether elective theatres are open at the weekend)
2. How many of the following scans has your Trust carried out in the last year, broken down by daily activity?
a. CT Scans
b. MRI Scans
c. X Rays

Elective theatres and scans.300124.docx

Emergency General Surgery 2022 Survey. 160322.docx

1. What is the name of the hospital the following questions will relate to?
2. How many acute inpatient beds did this hospital have for 2021?
3. How many emergency (unplanned) admissions did this hospital have under the acute general surgery services in 2021?
4. How many cases did this hospital submit to the National Emergency Laparotomy Audit (NELA) in 2021?
5. Which of the following organisation systems describes how emergency general surgical admissions are organised in this hospital?
a. Mixed general surgical take under a non-specific general surgery consultant
b. Daily allocation of acute admissions to a general surgery subspeciality (Upper GI / Colorectal / Hepatobiliary)
c. Dedicated Emergency General Surgery consultants / service during weekdays only (Monday to Thursday, or Monday to Friday)
d. Dedicated Emergency General Surgery consultants / service weekdays and weekend
e. Other (please state)
6. If your hospital runs a dedicated emergency general surgery service (answers c or d above), how many dedicated emergency general surgery consultants form the rota for this service?
7. If this hospital does not already have an emergency general surgery service, does it plan to change its service to this form in the next 5 years?

Emergency General Surgery 2022 Survey. 160322.docx

Emergency Robotic Surgery in General Surgery.150923.docx

All questions are shown as received by the Trust.
If possible, I would like to make an FOI request to obtain the following information email for the time period of 2019-2022:

1. The total numbers of Emergency general surgery operations performed between January 1st 2019-January 1st 2023. Broken down by: Open, laparoscopic and robotic
2. Type of robot available in your trust and used in emergency general surgery cases (Examples include Da Vinci, Versius, Freehand, Soloassist, Microhand S, AESOP, Zeus).
3. Number of robotic general surgery cases performed between January 1st 2019-January 1st 2023.
4. Number the following performed between January 1st 2019-January 1st 2023. Broken down by: Open, laparoscopic and robotic
1. hot cholecystectomies
2. laparotomies
3. appendectomies
4. hernia repairs
5. abscess
6. scrotal explorations (which may be under torsions or orchidopexy)
5. Mean length of stay of patients who have undergone the following performed between January 1st 2019-January 1st 2023. Broken down by: Open, laparoscopic and robotic.
1. hot cholecystectomies
2. laparotomies
3. appendectomies
4. hernia repairs
5. abscess
6. scrotal explorations (which may be under torsions or orchidopexy)
6. The number and type of complications that occurred in robotic emergency general surgery cases between January 1st 2019-January 1st 2023. Including but not limited to conversions to another type of surgery, device-related complications, injury to surrounding structures or tissue, serums, infection, leakage, hernias.
7. Number of staff trained to assist with robotic cases.
8. The average (Over 4 weeks) number of staff trained to assist n robotic surgery available out of hours (weekends/nights).

To elaborate emergency general surgery would include robotic assisted operations in any of: Acute surgical diseases of the abdomen, mesenteric ischaemia, appendectomies, cholecystectomies, hernias, bowel obstruction, adhesiolysis, diverticular disease, diverticulitis, incarceration, perforation, peritonitis, and acute conditions of the gastrointestinal tract.

Emergency Robotic Surgery in General Surgery.150923.docx

Endo urological procedures. 070921.docx

1. Please can you let us know how many of each of these procedures you actually delivered in19/20 and 20/21?
2. Please can you also tell us how many of each of these procedures were cancelled on the planned day of delivery as a result of the patient having a UTI, in 19/20 and 20/21?

Intermediate Endoscopic Ureter Procedures, 18 years and under
Intermediate Endoscopic Ureter Procedures, 19 years and over
Major Endoscopic Bladder Procedures with CC Score 7+
Major Endoscopic Bladder Procedures with CC Score 5-6
Major Endoscopic Bladder Procedures with CC Score 2-4
Major Endoscopic Bladder Procedures with CC Score 0-1
Intermediate Endoscopic Bladder Procedures
Minor Bladder Procedures, 18 years and under
Minor Bladder Procedures, 19 years and over
Urinary Incontinence or Other Urinary Problems, with Interventions, with CC Score 7+
Urinary Incontinence or Other Urinary Problems, with Interventions, with CC Score 3-6
Urinary Incontinence or Other Urinary Problems, with Interventions, with CC Score 0-2
Urinary Incontinence or Other Urinary Problems, without Interventions, with CC Score 8+
Urinary Incontinence or Other Urinary Problems, without Interventions, with CC Score 5-7
Urinary Incontinence or Other Urinary Problems, without Interventions, with CC Score 2-4
Urinary Incontinence or Other Urinary Problems, without Interventions, with CC Score 0-1
Introduction of Therapeutic Substance into Bladder
Attention to Suprapubic Bladder Catheter
Ureteric or Bladder Disorders, with Interventions, with CC Score 4+
Ureteric or Bladder Disorders, with Interventions, with CC Score 0-3
Ureteric or Bladder Disorders, without Interventions, with CC Score 5+
Ureteric or Bladder Disorders, without Interventions, with CC Score 2-4
Ureteric or Bladder Disorders, without Interventions, with CC Score 0-1
Infection or Mechanical Problems Related to Genito-Urinary Prostheses, Implants or Grafts, with Interventions, with CC Score 4+
Major Laparoscopic, Prostate or Bladder Neck Procedures (Male)
Transurethral Prostate Resection Procedures with CC Score 6+
Transurethral Prostate Resection Procedures with CC Score 3-5
Transurethral Prostate Resection Procedures with CC Score 0-2
Intermediate Endoscopic, Prostate or Bladder Neck Procedures (Male and Female), with CC Score 2+
Intermediate Endoscopic, Prostate or Bladder Neck Procedures (Male and Female), with CC Score 0-1
Non-Malignant Prostate Disorders with Interventions, with CC Score 4+
Major Open Urethra Procedures, 19 years and over
Major Open Urethra Procedures, between 2 and 18 years
Major Open Urethra Procedures, 1 year and under
Urinary Tract Stone Disease with Interventions, with CC Score 3+
Urinary Tract Stone Disease with Interventions, with CC Score 0-2
Urinary Tract Stone Disease without Interventions, with CC Score 6+
Urinary Tract Stone Disease without Interventions, with CC Score 3-5
Urinary Tract Stone Disease without Interventions, with CC Score 0-2
Dynamic Studies of Urinary Tract, 19 years and over
Dynamic Studies of Urinary Tract, 18 years and under
Implantation of Artificial Urinary Sphincter (Male and Female)
Minor or Intermediate, Urethra Procedures, 19 years and over
Major, Open or Laparoscopic, Bladder Neck Procedures (Female)
Complex, Open or Laparoscopic, Kidney or Ureter Procedures, with CC Score 7+
Complex, Open or Laparoscopic, Kidney or Ureter Procedures, with CC Score 4-6
Complex, Open or Laparoscopic, Kidney or Ureter Procedures, with CC Score 2-3
Complex, Open or Laparoscopic, Kidney or Ureter Procedures, with CC Score 0-1
Major, Open or Percutaneous, Kidney or Ureter Procedures, 19 years and over, with CC Score 10+
Major, Open or Percutaneous, Kidney or Ureter Procedures, 19 years and over, with CC Score 7-9
Major, Open or Percutaneous, Kidney or Ureter Procedures, 19 years and over, with CC Score 4-6
Major, Open or Percutaneous, Kidney or Ureter Procedures, 19 years and over, with CC Score 2-3
Major, Open or Percutaneous, Kidney or Ureter Procedures, 19 years and over, with CC Score 0-1
Major Laparoscopic, Kidney or Ureter Procedures, 19 years and over, with CC Score 3+
Major Laparoscopic, Kidney or Ureter Procedures, 19 years and over, with CC Score 0-2
Major, Open or Laparoscopic, Kidney or Ureter Procedures, 18 years and under, with CC Score 2+
Major, Open or Laparoscopic, Kidney or Ureter Procedures, 18 years and under, with CC Score 0-1
Complex Endoscopic, Kidney or Ureter Procedures, 19 years and over, with CC Score 5+
Complex Endoscopic, Kidney or Ureter Procedures, 19 years and over, with CC Score 2-4
Complex Endoscopic, Kidney or Ureter Procedures, 19 years and over, with CC Score 0-1
Complex Endoscopic, Kidney or Ureter Procedures, 19 years and over, with CC Score 0-1
Major Endoscopic, Kidney or Ureter Procedures, 19 years and over, with CC Score 5+
Major Endoscopic, Kidney or Ureter Procedures, 19 years and over, with CC Score 3-4
Major Endoscopic, Kidney or Ureter Procedures, 19 years and over, with CC Score 0-2
Complex or Major, Endoscopic, Kidney or Ureter Procedures, 18 years and under
Complex Endoscopic Bladder Procedures with CC Score 3+
Complex Endoscopic Bladder Procedures with CC Score 0-2
Major Robotic, Prostate or Bladder Neck Procedures (Male)
Complex Endoscopic, Prostate or Bladder Neck Procedures (Male and Female), with CC Score 2+
Complex Endoscopic, Prostate or Bladder Neck Procedures (Male and Female), with CC Score 0-1
Diagnostic Flexible Cystoscopy, 19 years and over
Diagnostic Flexible Cystoscopy, 18 years and under
Diagnostic Flexible Cystoscopy using Photodynamic Fluorescence
Diagnostic Hysteroscopy
Diagnostic Hysteroscopy with Biopsy
Diagnostic Hysteroscopy with Biopsy and Implantation of Intrauterine Device
Diagnostic Hysteroscopy with Implantation of Intrauterine Device

Download response Endo urological procedures. 070921.docx

Endomyocardial Biopsy (EMB).

1. Does your Hospital perform Endomyocardial (EMB) Biopsy procedures?
2. If yes, How many Endomyocardial (EMB) Biopsy procedures were performed in:
a. 2014
b. 2015
3. What was your Trust’s spend on Endomyocardial Biopsy in:
a. 2014
b. 2015
4. Does your Hospital perform Biopsy to diagnose Amoeloid Cardiomyopathy?
5. If yes, How many Amoeloid Biopsy procedures were performed in:
a. 2014
b. 2015

Download response Endomyocardial Biopsy (EMB) 250516

Endoscopic Retrograde Cholangiopancreatography (ERCP).031122.docx

1. Do you perform Endoscopic Retrograde Cholangiopancreatography (ERCP)?
2. How many ERCP procedures have you performed in the following financial years: – 2018/19, 2019/20, 2020/21?
3. How many ERCP lists are run per week?
4. How many practitioners perform ERCP?
5. How many are: – Physicians/Surgeons/Radiologists/Other (please specify)?
6. Do trainees perform ERCP?
7. Is there dedicated lists?

Endoscopic Retrograde Cholangiopancreatography (ERCP).031122.docx

Endoscopy.140722.docx

Q1) Who is the current Endoscopy lead for your Endoscopy Management System?
Q2) Who is your Endoscopy Service Manager for the Department?
Q3) Who is your current Endoscopy reporting software provider?
Q4) How long is your current contract and when will that contract expire?
Q5) What functionality would make you move to a new system?
Q6) Is NEDi2 & JAG Accreditation important to your department?
Q7) Do you prefer software installed onsite or in the cloud?
Q8) Do you run Endoscopy services from multiple sites?
Q9) Do you have a department scheduling/booking system?
Q10) Do you currently purchase through a framework, direct award or tender your software requirements?

Endoscopy.140722.docx

Endoscopy services. 160518

I understand your trust uses external providers to deliver some aspects of your trusts Endoscopy service. Please kindly outline which suppliers you utilise and the total amount spent for Insourced or outsourced Endoscopy services during the months of November 2017 – March 2018.

Download response Endoscopy services. 160518

Endoscopy, Urology, Ophthalmology and Dermatology. 251120

Endoscopy
1. How many patients are on the endoscopy waiting list?
2. Do you use any insourcing companies for the following?
a. Gastroenterology Outpatients clinics
b. Diagnostic Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. What are the average and maximum number of JAG points completed per list (i.e. per endoscopist per day)?
9. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
10. The total number of procedures completed by each supplier
11. The total spends completed by each supplier
12. How many endoscopy rooms do you have in your trust?
13. Please can you provider the contact information for your service delivery or general managers for endoscopy
14. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20
Urology Surgery
1. How many patients are on the urology waiting list?
2. Do you use any insourcing companies for the following?
a. Urology Outpatients Surgical clinics
b. Urology Diagnostic and therapeutic surgical Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
9. The total number of procedures completed by each supplier
10. The total spends completed by each supplier
11. Please can you provider the contact information for your service delivery or general managers for Urology services
12. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20
Ophthalmology Surgery
1. How many patients are on the ophthalmology waiting list?
2. Do you use any insourcing companies for the following?
a. Ophthalmology Outpatients Surgical clinics
b. Ophthalmology Diagnostic and therapeutic surgical Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
9. The total number of procedures completed by each supplier
10. The total spends completed by each supplier
11. Please can you provider the contact information for your service delivery or general managers for Ophthalmology services
12. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20
Dermatology Surgery
1. How many patients are on the dermatology waiting list?
2. Do you use any insourcing companies for the following?
a. Dermatology Outpatients Surgical clinics
b. Dermatology Diagnostic and therapeutic surgical Procedures
3. Do you have an active contract with any providers, please list the name of the providers?
4. Please list the length of contracts
5. How are these contracts awarded? (Tender, Direct award or no process)
6. How is this charged for by the third-party service provider per patient/per tariff/sessional
7. Are you currently being charged below, on or above NHS tariff?
8. Does a floor price apply to the contract? If so, on how many occasions has the floor price per room per day charge been applied?
9. The total number of procedures completed by each supplier
10. The total spends completed by each supplier
11. Please can you provider the contact information for your service delivery or general managers for Dermatology services
12. Please give an annual breakdown per annum of insourcing services per service area:
a. 18/19
b. 19/20

Download response Endoscopy, Urology, Ophthalmology and Dermatology. 251120

ENT waiting lists.250322.docx

ENT waiting lists as at 16 March 2022
Please send to me full details of all waiting lists for your Ear Nose and Throat department including a breakdown of the different services offered and the criteria used to prioritise patients.

ENT waiting lists.250322.docx

Enteral feeding devices.020223.docx

1. Please provide total amount of money spent (£) by your trust on each of the following sub-categories (as stated on the NHS supply chain website) stated below for the following Financial Years (FY) (2017, 2018, 2019, 2020, 2021, 2022):
1i. Enteral Feeding, Bile Bags and Associated Products
1. Lot 1 – Enteral Feeding Syringes and Accessories
2. Lot 2 – Enteral Feeding Devices
3. Lot 3 – Enteral Feeds, Drinks and Giving Sets
4. Lot 4 – Bile Bags, Ryles Tubes and Levin Tubes
1ii. Infant Feeding and Associated Accessories
1. Lot 1 – Infant Food
2. Lot 2 – Infant Feeding Accessories
2. Please provide total volumes (Units Purchased) of each of the categories (as stated on the NHS supply chain website) below for the following Financial Years (FY) (2017, 2018, 2019, 2020, 2021, 2022), at your trust:
2iii. Enteral Feeding, Bile Bags and Associated Products
1. Lot 1 – Enteral Feeding Syringes and Accessories
2. Lot 2 – Enteral Feeding Devices
3. Lot 3 – Enteral Feeds, Drinks and Giving Sets
4. Lot 4 – Bile Bags, Ryles Tubes and Levin Tubes
2iv. Infant Feeding and Associated Accessories
1. Lot 1 – Infant Food
2. Lot 2 – Infant Feeding Accessories
3Please provide a list of suppliers your trust has purchased from under the following categories (as stated on the NHS supply chain website) for the following Financial Years (FY) (2017, 2018, 2019, 2020, 2021, 2022):
3v. Enteral Feeding, Bile Bags and Associated Products
1. Lot 1 – Enteral Feeding Syringes and Accessories
2. Lot 2 – Enteral Feeding Devices
3. Lot 3 – Enteral Feeds, Drinks and Giving Sets
4. Lot 4 – Bile Bags, Ryles Tubes and Levin Tubes
3vi. Infant Feeding and Associated Accessories
1. Lot 1 – Infant Food
2. Lot 2 – Infant Feeding Accessories
3vii. How much money per supplier within each category

Enteral feeding devices.020223.docx

EUS-FNB procedures.300822.docx

Separated by the hospitals within your trust could you please provide me with the total number of EUS-FNB procedures you have performed overall in the past year (2021) and how many have been done so far in 2022?

EUS-FNB procedures.300822.docx

Extracorporeal Shockwave Lithotripsy (ESWL). 190719

• What (if any) Extracorporeal Shockwave Lithotripsy (ESWL) system does your Urology Department use for removal of kidney stones?
• When was it purchased?
• When will it be renewed?
Would it also be possible to obtain the contact details of the person dealing with managing the ESWL system?

Download response Extracorporeal Shockwave Lithotripsy (ESWL). 190719

Eye damage caused by lasers

The number of patients admitted for eye damage caused by lasers over the last three financial years. To clarify, this is from hand-held lasers, not complications from laser eye surgery.

2013-14

2014-15

2015-16

Download response Eye damage caused by lasers 060916

Eye procedures 010317

1a. The number of cataract operations carried out by the trust annually for the last three years.
1b. At which hospitals the operations were carried out, and the number at each hospital.
2a. The number of glaucoma filtering surgeries (to include trabeculectomy, deep sclerectomy & viscocanalostomy) carried out by the trust annually for the last three years.
2b. At which hospitals the operations were carried out, and the number at each hospital.
3a. The number of glaucoma tube implantation surgeries carried out by the trust annually for the last three years.
3b. At which hospitals the operations were carried out, and the number at each hospital.

Download response Eye procedures 010317

Flexible cystoscopies. 240222.docx

We are interested in receiving insights from the current calendar year, from 01.01.21 until today (December 2021).
Clinic Sizes & Flexible Cystoscopies
1. How many urology units currently perform flexible cystoscopies in your Trust for investigatory purposes?
2. How many patients are seen in urology in your Trust per week/month/year for investigatory flexible cystoscopies?
3. Is an initial investigation the only reason for cystoscopies with flexible cystoscopes or they can be used for other reasons too? (e.g. laser, taking biopsies).
4. How many flexible, and how many rigid cystoscopes are currently in use across the Trust?
5. How many flexible and how many rigid cystoscopies are performed – on average – per week/month/year across the Trust?
6. Which cystoscope models do you use and how many are there of them currently in practice?
7. What cleaning/sterilisation process for flexible cystoscopes is currently in place?
Protective sheaths
1. Do you currently use a protective sheath on your cystoscopes? If yes, for which cystoscope model?
2. If the answer for the question above is no, are you considering using protective sheaths for flexible cystoscopes in the future?
Single use cystoscopes:
1. Have you ever used a single-use cystoscope in your practice, or are you considering to? Please provide details on model and reason.

Flexible cystoscopies. 240222.docx

Flexible endoscope repair and maintenance. 021020

1. When does the existing maintenance contract(s) expire for the Trust’s flexible endoscope inventory?
2. Who is your current service provider of flexible endoscope repair & maintenance?

Download response Flexible endoscope repair and maintenance. 021020

Foley catheters. 200418

1. How many female patients in your Trust had a Foley catheter during the last 12 months?
2. How many Foley catheters were used in your Trust during the last 12 months?
3. How many of those Foley catheters were used for a female patient?
4. Of your total Foley catheter usage, what percentage was used on females?
5. How many Foley catheters are used per patient during their total hospital stay?
6. Of your patients who have a Foley catheter, how long do they stay in hospital on average?
7. Of your patients who have a Foley catheter, what percentage would be longer term patients? i.e. stay over the above stated average in hospital
8. Of the total number of female patients using a Foley catheter, what percentage has any of the following:
a) Faecal incontinence
b) Obstruction / atonic bladder
c) Surgery in perineal area

Download response Foley catheters. 200418

Foot protection team. 020617

1. Does your trust operate a foot protection service, as recommended by NICE guideline NG19 on ‘Diabetic foot problems: prevention and management’?

2. If the answer to Q1 is yes, please state the number of podiatrists and orthotists employed within this service.

3. If the answer to Q1 is yes, is this service led by a podiatrist with specialist training in diabetic foot problems, as recommended by NICE guideline NG19 on ‘Diabetic foot problems: prevention and management’?

4. If the answer to Q1 is no, please provide a reason for this.

Download response Foot protection team. 020617

Foreign objects stuck inside their anus or rectum. 020721

How many patients have had foreign objects stuck inside their anus or rectum over the past 3 years from your NHS trust.
I would like information on how many patients have been admitted into A&E to have an item (foreign object) removed from their rectum since the 26th of April 2018.
If possible, I would like to have details as to what this object was, and whether the patient was male or female. Any other information you can provide is always grateful.

Download response Foreign objects stuck inside their anus or rectum. 020721

Fractured nose operations August 2016 – February 2017. 080517

Would it be possible for you to send me a list of patients who have had operations for fractured noses over the period of August 1 to February 1? Is it also possible to extract how long each operation took? Or rather how long the patient was in theatre for? We are looking to find out how much each costs the trust.

Download response Fractured nose operations August 2016 – February 2017. 080517

Fundus and Optical Biometer. 220421

1. Fundus Camera
a. How many devices do you have and which model?
b. When were these devices installed?
c. When are these due to be replaced?
d. Is there a replacement budget allocated?
e. Do you have a service contract? When does it expire?
2. Optical Biometer
a. How many devices do you have and which model?
b. When were these devices installed?
c. When are these due to be replaced?
d. Is there a replacement budget allocated?
e. Do you have a service contract? When does it expire?
3. Capsular Tension Ring
a. Which Brand do you use?
b. How many did you use in 2019?

Download response Fundus and Optical Biometer. 220421

Gallbladder removal surgery. 290617

Do you have anything you could please send me which shows the statistics (number of operations performed, complication and mortality rates etc.) for each of the surgeons who does this type of operation at Maidstone to help me decide?

Download response Gallbladder removal surgery. 290617

Gender reassignment surgery 031016

1) Please state the number of patients who have undergone gender reassignment operations in the following financial years:
i) 2010/2011
ii) 2012/2013
iii) 2014/2015
iv) 2015/2016
2) Please state the number of patients currently on the waiting list for gender reassignment operations. Please also provide a breakdown of those on the waiting list for each year of:
a) Patients who were born male who are transitioning to become female.
b) Patients who were born female who are transitioning to become male.
Please provide information for the following financial years:
i) 2010/2011
ii) 2012/2013
iii) 2014/2015
iv) 2015/2016
3) Please state the average waiting time from first appointment to first operation for patients who have elected for gender reassignment surgery in the following financial years:
i) 2010/2011
ii) 2012/2013
iii) 2014/2015
iv) 2015/2016
4) Please state the five longest waiting times of those on the waiting list for a gender reassignment operation for:
a) Patients who were born male who are transitioning to become female.
b) Patients who were born female who are transitioning to become male.
Please provide information for the following financial years:
i) 2010/2011
ii) 2012/2013
iii) 2014/2015
iv) 2015/2016
5) Please state the overall numbers of operations for patients undergoing reassignment in the following financial years.
i) 2010/2011
ii) 2012/2013
iii) 2014/2015
iv) 2015/2016
6) Please state how many consultants/surgeons currently work for your trust who carry out gender reassignment operations or gender reassignment related surgery – and the type of surgery and operations they will carry out when doing gender reassignment operations.

Download response Gender reassignment surgery 031016 

General anaesthesia (GA) paediatric dental waiting times. 050418

Could you please provide the following information relating to general anaesthesia (GA) paediatric dental waiting times for children under 18 in hospitals managed by the Trust:
1. Total number of children currently on your waiting lists and for each of the past five years. Please also break this data down by age e.g. age 1, age 2 etc.
2. Average waiting time from referral by year for each of the past 5 years.
3. Total number of children who have waited more than 6 months currently and for each of the past five years. Please also break this data down by age e.g. age 1, age 2 etc.

Download response General anaesthesia (GA) paediatric dental waiting times. 050418

Glaucoma. 111019

1) Can you please confirm the number of patients that you saw in 2016/2017, 2017/2018, and 2018/2019 for each of the following:
a. Total Ophthalmology monitoring/follow-up appointments
b. New glaucoma diagnosis appointments
c. Routine glaucoma monitoring/follow-up appointments
d. Urgent glaucoma monitoring/follow-up appointments
2) Please confirm how many patients are currently under the care of the hospital trust for the monitoring of their glaucoma
3) Please confirm how many of the glaucoma patients under your care are classified as:
a. Routine/Stable
b. Urgent/non-stable
4) Of the patients seen for glaucoma within the last 12 months, can you please confirm how many patients:
a. Were seen on or within 2 weeks of their review date.
b. Were seen within 2-4 weeks of their review date.
c. Were seen within 1-3 months of their review date.
d. Were seen within 3-6 months of their review date.
e. Were seen within 6-12 months of their review date.
f. Were seen, but over 12 months of their review date.
g. Were not seen, and were over 12 months from their review date.
h. Were not seen, as they were not due their review appointment yet.
5) Please confirm how many glaucoma patients are currently outstanding their review appointment on the following basis:
a. Currently between 0-1 month past their scheduled review date.
b. Currently between 1-3 months past their scheduled review date.
c. Current between 3-6 months past their scheduled review date.
d. Currently between 6-12 months past their scheduled review date.
e. Currently over 12 months past their scheduled review date.
f. Are currently past their review date, but you are not certain of how far past their review date the patient is.
6) Please confirm where you are paid by your CCG(s) on a block contract, on a tariff payment per episode basis, or on an alternative payment method for glaucoma services. If you are paid on an alternative method, please provide details.
7) Please confirm the patient pathway in your trust for Glaucoma Diagnosis and Glaucoma Monitoring within your service?
8) Please confirm whether this service the patient pathway in your trust for Glaucoma Diagnosis and Glaucoma Monitoring is delivered wholly by staff employed by your hospital trust, or whether this is partially or wholly delivered by another provider. If this is delivered by another provider, please also confirm:
a. What proportion is delivered by other providers?
b. Who is the provider delivering this service on your behalf?
c. Where is this service delivered?
d. What elements of the service do they deliver? Is this the diagnostics only, consultant oversight, treatment or all elements?
9) Please confirm the address of all locations that the service the patient pathway in your trust for Glaucoma Diagnosis and Glaucoma Monitoring is delivered from.

Download response Glaucoma. 111019

Glaucoma services at Maidstone Hospital. 020617

Glaucoma Treatment Pathway – (possible responsible person is Director/Clinical Manager for Ophthalmology)
1) On average, how many follow up visits would a patient have in their first year following a glaucoma surgery procedure?
2) How many follow up visits would a patient have in the first year following a minimally invasive glaucoma surgery procedure?
3) Could your hospital provide a specific minimally invasive glaucoma pathway?

HES Data – (Business Manager for Ophthalmology)
4) What is the total number of minimally invasive glaucoma surgery procedures performed in your Trust from April 2015-2016?
5) How many combined glaucoma surgery with Phacoemulsification and lens extraction procedures were performed in your hospital from April 2015-2016?
6) How many glaucoma surgeries were performed in your Trust from April 2015-2016?
7) How many minimally invasive glaucoma surgery procedures were performed in conjunction with Phacoemulsification Cataract Extraction and Lens implant procedures from April 2015-2015?

Surgeon Information – (Director/Clinical Manager for Ophthalmology)
8) How many surgeons perform glaucoma surgery in your hospital? Of the surgeons who perform glaucoma surgery in your hospital, how many perform
minimally invasive glaucoma surgery?
9) Does your hospital Trust have a block contract with its affiliate CCG (Health Board)?

Reimbursement – (Business Manager for Ophthalmology)
10) What OPSC4 code(s) is being used to code for the implantation of Minimally invasive glaucoma surgery devices at your Trust?
11) What is the HRG coding and 2017/18 National Tariff reimbursement for minimally invasive glaucoma surgery procedures performed in conjunction with Phacoemulsification Cataract Extraction and Lens implant procedures?

Procurement – (Business Manager or Procurement Officer for Ophthalmology)
12) What was your Trusts budget for minimally invasive glaucoma surgery procedures from April 2015 – 2016? What price does your Trust pay for its most commonly used minimally invasive glaucoma surgery device?
13) What minimally invasive glaucoma surgery device(s) is your hospitals using? E.g. iStent, Xen Gel, etc
14) What was the process for gaining approval for a minimally invasive glaucoma device(s) at your hospital?

Download response Glaucoma services at Maidstone Hospital. 020617

Glaucoma surgical procedures. 061020

1. How many Glaucoma surgical procedures have taken place in 2019 and how many have taken place in 2020?
2. How many of the 2019/2020 Glaucoma procedures have taken place in combination with a Cataract procedure?
3. How many MIGS devices were bought in 2019 and how many in 2020?
4. How many Glaucoma drainage devices were bought in 2019 and how many have been bought in 2020?
5. How many trabeculectomy procedures took place in 2019 and how many in 2020?
6. What is the reimbursement code and value for both the Gonioscopy and trabulectomy procedures?

Download response Glaucoma surgical procedures. 061020

Gynae cytology. 011118

Please can your provide us with the % of gynaecological cytology requests which are received and reported on ICE in the Cytology laboratory.

Download response Gynae cytology. 011118

Head and Neck Cancer (Squamous cell carcinoma).

1. Within your health trust how many patients are currently [within the past 6 months] being treated for head and neck cancer (Squamous cell carcinoma)?
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
A. Locally advanced
B. Recurrent and/or metastatic
Of the these patients please split by their current drug treatment;
Carboplatin (Only or in combination with 5-FU)
Cetuximab (Erbitux) and chemotherapy or radiotherapy
Cetuximab (Erbitux) Only
Cisplatin (Only or in combination with 5-FU)
Docetaxel (Taxotere), (Only or in combination with 5-FU)
Fluorouracil (5FU)
Radiotherapy Only
Other – Specify
3. Does your health trust participate in any ongoing clinical trials for the treatment of head and neck cancer patients, if so please could you provide details?
4. Within your health trust how many patients are currently [within the past 6 months] being treated for metastatic Colorectal Cancer?
Of those patients please split by their current drug treatment;

Bevacizumab
Cetuximab
Panitumumab
Aflibercept
Oxaliplatin
Irinotecan
5-Fluorouracil
Irinotecan with 5-fluorouracil (5FU) and folinic acid [FOLFIRI]
Oxaliplatin with 5-fluorouracil (5FU) and folinic acid [FOLFOX]
Capecitabine and oxalipatin (CAPOX / XELOX)
Capecitabine and irinitecan (CAPIRI)
Other – Specify

Download response Head and Neck Cancer (Squamous cell carcinoma) 270616

Headaches and Chronic Migraines. 151217

1.) Could you please provide me with the following numbers of patients treated in the last 6 months, with the following drugs for Chronic Migraine? If none, please state none.
· Botox
· Dysport
· Xeomin
2.) Does your trust treat migraine with any of the following treatments? If so, how many patients in the last 6 months?
• Topiramate / anticonvulsants
• Beta-blockers / propranolol
• Calcium channel blockers
• Anti-serotonergics
• Tricyclic anti-depressants / amitriptyline
• Candesartan / angiotensin II inhibitors
3.) Does your trust run any botulinum A [Botox] clinics (regardless of any indication or department)? YES/NO
4.) Does your organisation run any Clinics where patients have treatment for Headaches and Chronic Migraines? YES/NO
IF YES PLEASE PROVIDE THE FOLLOWING.
a. What is the name of these clinics?
b. Which department runs the clinic?
c. At which locations are these clinics run? Please provide address and postcode where possible.
d. How frequently are these clinics run?
e. What is the average number of Chronic Migraine (CM) patients seen per clinic (based on last 6 months data)?
f. Do any of these clinics use Botulinum A [Botox] to manage the pain of headaches and chronic migraines? YES/NO
i. If Yes to 4F
Within this/these clinic(s) please provide the number of current Health Care Professionals who are active injectors (within the past 6 weeks) of Botox Treatment for Headaches and Chronic Migraines – If possible please break down by role (Consultant, Other Hospital Doctor (non-consultant), GP, Specialist Nurse, Pharmacists, Other). If this is not possible please state the overall total of current Active Injectors

Download response Headaches and Chronic Migraines. 151217

 

Governance

Allegations of misconduct. 081117

For each of the past five financial years (12/13 – 16/17) please tell me the following:

The total number of allegations of misconduct made by employees of your trust against another employee, broken down by:
• The job category of the complainant, for example doctor, nurse, porter, receptionist.
• The nature of the alleged misconduct. For example sexual harassment, sexual assault, physical assault, theft, bullying, racism.
• The outcome of the complaint. For example, unsubstantiated, written warning, dismissed, training requirement, police informed.

Download response Allegations of misconduct. 081117

Allegations of sexual harassment review. 040118

For each of the past five financial years (2012/13-16/17) please tell me the following:
1. The total number of allegations of sexual harassment your trust has recorded in each of the last five years broken down by year.
2. For each of the five years please break those totals down to the following:
Patient on staff sexual harassment
Staff on staff sexual harassment
Staff on patient sexual harassment
Patient on patient sexual harassment
3. Alongside each of the categories listed in 2, please state the outcome of the complaint. For example unsubstantiated, written warning, dismissed, training requirement, police informed.

Download response Allegations of sexual harassment review. 040118

Alleged sexual harassment from patients towards staff in 2022.220523.docx

1) Please tell me how many times your Trust has logged an incident of alleged sexual harassment from patients towards staff in 2022.

2) For the five most recent cases, please tell me

a) the job title of the member of staff against whom the behaviour was levelled
b) a brief summary of the content of the complaint (patient said “you can warm your hands up on me” during a physical examination, patient wolf-whistled at nurse, etc.)

c) the action taken by the Trust.

Alleged sexual harassment from patients towards staff in 2022.220523.docx

Ambulance deaths.051222.docx

The number of patients per week who have died while waiting inside an ambulance – on hospital property – to be admitted to the emergency department. I would like this information between the dates 01/11/2021 and 15/11/2022.

Ambulance deaths.051222.docx

Blinded surgical glove trial.290823.docx

All questions are shown as received by the Trust.
I request that if you have undertaken any blinded surgical glove trial since 2008, wherein sterile surgical gloves have been trialled, compared, or changed, with or without the awareness of the operating surgeons; or any information regarding the qualitative and quantitative results of a surgical glove trial including a subsequent change of sterile glove brand, that this could anonymously be released for the purpose of a national study.

Blinded surgical glove trial.290823.docx

Candida Auris (C. Auris). 160821.docx

1. Which hospitals within your Trust have reported Candida Auris (C. Auris) cases since January 2019?
2. Broken down by month, how many patients have been infected with Candida Auris within your Trust since January 2019?
a. In how many of these cases was the C. Auris found to be drug-resistant?
3. Broken down by month, how many patients have died after being infected with Candida Auris whilst being under the care of your Trust since January 2019?
a. In how many of these cases was the C. Auris found to be drug-resistant?

Download response Candida Auris (C. Auris). 160821.docx

Clinical Audits. 070318

1. A list of the titles of all clinical audits registered between 1/1/17 and 31/12/17 (please exclude non-clinical audits e.g. infection control, pharmacy and financial audits)
2. Whether they are a local audit (i.e. only involving your trust) or part of a national audit
3. Whether they are a new audit or re-audit

Download response Clinical Audits. 070318

Clinical Effectiveness and Audit provision. 290720

1. Has your organisation had any ‘areas of outstanding practice’ documented in CQC inspection reports directly related to Clinical Effectiveness and Audit and what were they?
2. What resource do you have in your organisation specifically for Clinical Effectiveness and Audit (i.e. wte and banding)
3. Are these staff within a central Governance or Quality team?
4. Do you have a senior medical lead for Clinical Effectiveness and Audit at Associate / Deputy Medical director level
5. If answer to 3. is Yes,
a. is this as a standalone or within a wider remit (e.g. Associate medical director of Quality)
b. How many PAs are allocated to Clinical Effectiveness and Audit

Download response Clinical Effectiveness and Audit provision. 290720

Clinical governance review.260124.docx

I would like to appeal this decision please.
If the incident warranted an external investigation then it is clearly in the public interest and a version that has been suitably redacted to avoid identifying the patient should be provided.

Clinical governance review.260124.docx

Clinical incidents.221223.docx

All questions are shown as received by the Trust.
Please provide the following information, preferably in an electronic format, for the period of the last five years. Please note, here “clinical incident” is defined as “An event that causes a loss, injury or a near miss to a patient, staff or others.”
1) The total number of medical doctors employed at your institution, broken down by professional grade (e.g., FY1, FY2, CT1, CT2, SpR, Associate Specialist, Consultant). If you cannot provide this break down, please provide the total for doctors of all grades.
2) The total number of clinical incidents reported involving medical doctors, categorized by each professional grade. If you can not provide this break down, please provide the total for doctors of all grades.
3) The number of Physician Associates (PAs) employed, and the number of clinical incidents reported involving PAs within the specified time frame.
4) The number of Advanced Clinical Practitioners (ACPs) and/or Advanced Nurse Practitioners (ANPs) employed, as well as the number of clinical incidents reported involving each of these roles.
5) The breakdown of reported clinical incidents resulting in no harm, low harm, moderate harm, severe harm, and death for each clinician category mentioned above.

The Trust received clarification from you as follows:
I need to make a clarification to the question of my previous email as the wording has caused some confusion. My apologies for this confusion.
The questions as amended are as follows and cover the period of 1st September 2018 to 1st September 2023:
1) The total number of medical doctors employed at your institution, broken down by professional grade (e.g., FY1, FY2, CT1, CT2, SpR, Associate Specialist, Consultant). If you cannot provide this break down, please provide the total for doctors of all grades.
2) The total number of clinical incidents reported where after investigation it was found that a medical doctor was responsible for the incident. If possible, please categorized by each professional grade. If you cannot provide this break down, please provide the total for doctors of all grades.
3) The number of Physician Associates (PAs) employed at your institution.
4) The number of clinical incidents where after investigation it was found that a PA was responsible for the incident within the specified time frame.
5) The number of Advanced Clinical Practitioners (ACPs) and/or Advanced Nurse Practitioners (ANPs) employed at your institution.
6) The number of clinical incidents where after investigation it was found that an ACP/ANP was responsible for the incident within the specified time frame.
7) For questions 2, 4 and 6, the breakdown of reported clinical incidents resulting in no harm, low harm, moderate harm, severe harm, and death for each clinician category mentioned above.

Clinical incidents.221223.docx

Clinical negligence claims.250823.docx

All questions are shown as received by the Trust.
How much did your Trust spend on clinical negligence claims in the following years:

• 2019
• 2020
• 2021
• 2022- April 2023

Clinical negligence claims.250823.docx

Counter fraud. 040422.docx

1.
a) Amount spent on counter fraud services in the financial year 2019/20
b) How much of this was spent on:
(i) Strategic Governance
(ii) Involve & Inform
(iii) Prevent & Deter
(iv) Hold to Account
(v) Other
c)
(i) Number of successful civil sanctions obtained in respect of fraud and fraud-related offences
(ii) Amount recovered as a result of these civil sanctions
d)
(i) Number of successful criminal sanctions obtained in respect of fraud and fraud-related offences
(ii) Amount recovered as a result of these criminal sanctions
2.
a) Amount spent on counter fraud services in the financial year 2020/21
b) How much of this was spent on:
(i) Strategic Governance
(ii) Involve & Inform
(iii) Prevent & Deter
(iv) Hold to Account
(v) Other
c)
(i) Number of successful civil sanctions obtained in respect of fraud and fraud-related offences
(ii) Amount recovered as a result of these civil sanctions
d)
(i) Number of successful criminal sanctions obtained in respect of fraud and fraud-related offences
(ii) Amount recovered as a result of these criminal sanctions

Counter fraud. 040422.docx

Counter fraud provision. 230920

1. Staff headcount at your organisation?
2. Annual budget of your organisation for the financial year 2019-2020?
3. What is your organisation provider type (as recorded on your SRT submission – i.e. Acute teaching, Ambulance)?
4. Who provides your organisations counter fraud provision? (In house – NHS consortium – Private provider)
5. How many days were recorded for proactive counter fraud work (Strategic governance, Inform and Involve & Prevent & Deter) carried out at your organisation during the financial year 2019-20?
6. How many days were recorded for carrying out reactive investigation work at your organisation during the financial year 2019-20 (hold to account)?
7. How many counter fraud referrals did your organisation receive during the financial year 2019-2020?
8. What was the recorded fraud loss identified by your organisation during the financial year 2019-2020?
9. What was the amount of fraud losses recovered by your organisation during the financial year 2019-2020?
10. How many criminal sanctions relating to fraud, bribery and corruption did your organisation apply during the financial year 2019-2020?
11. How many disciplinary sanctions relating to fraud, bribery and corruption did your organisation apply during the financial year 2019-2020?
12. What was the cost of counter fraud staffing or outsourced counter fraud provision to your organisation during 2019-2020 for – Strategic Governance, Inform and Involve and Prevent and Deter?
13. What was the cost of counter fraud staffing or outsourced counter fraud provision to your organisation during 2019-20 for – Hold to Account?

Download response Counter fraud provision. 230920

Data Breaches. 171120

We are conducting research on the protection of data stored within the public sector and wish to know the following:
1. How many cloud data breaches have occurred within your organisation in 2019 and 2020?
2. How many cyber attacks have occurred within your organisation in 2019 and 2020?
3. How many ransomware attacks have occurred within your organisation in 2019 and 2020?
4. How many data loss incidents have occurred as a result of lost or stolen devices storing your organisation’s data (such as USB flash drives, Hard Drives, Solid State Drives, mobile phones or laptops) within your organisation in 2019 and 2020?
Please split any data supplied separately for 2019 and 2020.

Download response Data Breaches. 171120

Data breaches. 230821.docx

I would like to receive information about the number of data breaches your NHS foundation has experienced. This can be, for example, an email sent out to the wrong recipient, fail to BCC in an email or other human errors that caused data breach.

Can. I please receive the number of data breaches for the past 5 financial years meaning financial year 2020/2021,2019/2020.2018/2019, 2017/2018 and 2016/2017.

Can the information supplied be broken down by year?

Download response Data breaches. 230821.docx

Data Privacy Compliance Tools.070823.docx

1. Does your organisation use any applications or software to record Record of Processing Activity (ROPA)?
If so, please state the product name(s) and version numbers(s) (if known)
2. Does your organisation use any applications or software to support preparation for, or maintenance of ISO 27001 and/or ISO 27701 compliance?
If so, please state the product name(s) and version numbers(s) (if known)
3. Does your organisation use any applications or software associated with data breach management?
If so, please state the product name(s) and version numbers(s) (if known)
4. Does your organisation use any applications or software for Policy Management?
If so, please state the product name(s) and version numbers(s) (if known)
5. Does your organisation use any applications or software associated with handling FOI requests?
If so, please state the product name(s) and version numbers(s) (if known)
6. Does your organisation have any plans to explore the market regarding data privacy compliance tools? If so, please describe
7. Who is responsible for procuring ICT applications that support your organisation’s Information Governance teams? A job-title & directorate will be sufficient

Data Privacy Compliance Tools.070823.docx

Data Protection Officer.130622.docx

1. Do you have a post at your organisation that is entitled or encompasses roles associated with a Data Protection Officer?
2. If yes, please could you provide a current job description for that role.
3. If you are an NHS organisation, please could you also provide the detailed ‘Agenda for Change’ evaluation match analysis that supports the job description.

Data Protection Officer.130622.docx

Data Security and Protections Toolkit. 200721.docx

For the Data Security and Protection Toolkit you were required to have an independent audit on your toolkit return.
Please confirm:-
1. Did you have an audit on your DSP Toolkit in line with the Strengthening Assurance Framework from NHS Digital?
2. How much did this cost?
3. What was the audit?
4. What was the score?

Download response Data Security and Protections Toolkit. 200721.docx

Data sharing agreements. 281021.docx

1. Please can you confirm whether any data sharing agreements for research purposes are currently in place between the NHS Trust and any external third parties (e.g. universities, or any also relating to any other individuals or institutions with whom a data sharing agreement has been created).
2. Please provide detail of the dataset(s) being shared, including:
a. Details of the data sharing agreement covers and, if possible, who the third-party with whom the dataset is being shared with is;
b. The type of data contained in the dataset;
c. The size of the dataset;
d. The time period covered by the dataset (e.g. is it historic or current);
3. Please can you also provide copies of any such data sharing agreements.

Download response Data sharing agreements. 281021.docx

Datix incidents. 201119

I would like to request information on the number of incidents that have been recorded on the DATIX system in each of the last three financial years and broken down by category of incident.

Download response Datix incidents. 201119

Decontamination and Infection Control.230522.docx

1. Does the Trust have a Decontamination Lead(s), and which site are they based?
1.a Can you provide an email address for the above contact?
2. Does the Trust have an Infection Control Lead(s), and which site are they based?
2a. Can you provide an email address for the above contact?
3. Does the Trust hold a regular Decontamination Risk Assessment Group meeting, and when was the last one undertaken?
4. Which other roles also attend the Decontamination Risk Assessment Group meeting?

Decontamination and Infection Control.230522.docx

Decontamination and sterilisation service. 300719

1. Is decontamination/sterilization handled in-house or outsourced?
2. What is the total number of trays process on a daily/monthly/yearly basis?
3. How much does it cost to process and deliver trays?
4. How much time is taken fully process one tray?
5. How many times a day are surgical trays collected and processed?
6. How many individual instruments are cleaned?
7. How many times can an individual instrument be reused?
8. What are the different surgical tray dimensions?
9. What is the cost of the surgical equipment?
10. How much staff is required to process surgical trays?
11. What is the cleaning cost of surgical instruments?
12. How many surgical admissions occur each year?
13. What is the average number of trays per operation?
14. What machines are required to reprocess surgical trays? How many?
15. How many operations are cancelled each year due to inadequate decontamination/sterilization?
16. How many hospital-acquired infections occur each year due to inadequate decontamination/sterilization?
17. How much does inadequate decontamination/sterilization cost each year?

Download response Decontamination and sterilisation service. 300719

Disinfection and decontamination services. 260619

1. What cleaning methods does the Trust currently use for room and theatre disinfection?
2. Does the Trust employ an external cleaning company and if so who is this?
3. Does the Trust currently have UVC machines for decontamination? If so how many units and which supplier or manufacturer?
4. When were these purchased or rented and when are these contracts due to expire?
5. Are there any tenders outstanding for either UVC or Vaporised Hydrogen Peroxide (HPV) and what are the closing dates?

Download response Disinfection and decontamination services. 260619

Electronic system to record and manage clinical and non-clinical incidents. 141218

1. Does your Trust use an electronic system to record and manage clinical and non-clinical incidents including patient safety incidents?
2. If yes to question 1, what is the name of the system you use to record and manage clinical and non-clinical incidents within the Trust?
3. In relation to the system named in question 2, do you use the system for any other functions other than the reporting and management of incidents?
4. If yes to question 3, could you please detail what additional functions the system is used for (i.e complaints management and risk management)?
5. Could you please provide the cost of the system named in question 2 for the last financial year (2017/18)?
6. If possible, could you please provide the cost of the system named in question 2 for the last 5 financial years?

Download response Electronic system to record and manage clinical and non-clinical incidents. 141218

Exception reports. 261020

1. Does your Trust use “Exception Reports” for doctors flag when day-to-day work varies significantly and/or regularly from the agreed work schedule?
2. If so, how many exception reports were logged as raising an immediate safety in the 2019/20 financial year?
3. For each occurrence please state
(a) when the incident took place,
(b) which Trust site did it relate to
(c) provide a detailed, verbatim account of how the doctor described the concern as per the level of detail in the two examples below:

Download response Exception reports. 261020

Exception Reports. 311017

Does your Trust use “Exception Reports” that are used by doctors when day-to-day work varies significantly and/or regularly from the agreed work schedule?

If so, how many exception reports were logged as raising an immediate safety concern since 1.1.16 to the date of this e-mail?

For each occurrence please state (a) when the incident took place, (b) which Trust site did it relate to and (c) provide a detailed, verbatim account of how the doctor described the concern as per the level of detail in the two examples:

Download response Exception Reports. 311017

Extravasation injuries.110124.docx

All questions are shown as received by the Trust.
1. Yearly incidence of extravasation injury in your trust from the last 10 years.
2. The roles and numbers of staff involved in extravasation management per case in your trust.
3. Whether your trust has an extravasation treatment algorithm/protocol and what it entails?
4. Whether your trust has compulsory DATIX reporting of extravasation injuries?
5. If your trust has compulsory DATIX reporting of extravasation injuries, how many incidents have been reported for the last 5 years (1st January 2018 to 1st January 2023)?

Extravasation injuries.110124.docx

FOI requests.131023.docx

All questions are shown as received by the Trust.
1. The Number of FOIs you received in the last financial year 2022/2023?
2. Your compliance numbers for the 20 working days for 2022/23?
3. The number of FOI staff full-time equipment staff broken down by banding?
4. Who do the FOI team report to, ie dept or directorate?
5. Do you have a company secretary?

FOI requests.131023.docx

FOI requests. 160621

1) Of the FOI requests that are currently outstanding, what percentage of them are outside the 20 working day time limit
A) For clarity, we are not asking for the exact number of request, but only the percentage number
2) If the outstanding requests over 20 working days are perceived to be related to the impact of COVID-19, can we have a copy of the remedial action plan for how you will be dealing with these (there should be one developed in line with ICO guidance)

Download response FOI requests. 160621

FOI requests. 270218

1. In the calendar year 2017-2018 how many FOI requests were received by your organisation? I would like this broken down by month.

2. In the Calendar year 2017-2018 how many FOI requests were disclosed after the 20 working day time limit? This can be a total figure for the year.

3. Are there still any outstanding requests from the calendar year 2017-2018? This can be a total figure for the year.

4. What was the longest length of time it took for your organisation to disclose the information for a FOI request in the calendar year 2017 – 2018?

Download response FOI requests. 270218

FOI requests.300124.docx

All questions are shown as received by the Trust.
“In regards to the past 12 months or past calendar year:
1. How many FOI requests have you received in your organisation?
2. How many of these requests have not been completed within the 20 working day timescale?
3. How many staff log/process FOI requests?
4. What system is used to log and record Freedom of Information Requests? e.g. Ulysses, Excel
5. Please provide the reasons that these requests were not completed within 20 working day timescale? E.g. lack of engagement, delay from departments who have the information, availability of staff, delay in approval process.
6. Do all staff in your organisation have training on what a Freedom of Information Request is?
7. Have you implemented any changes to improve the Freedom of Information Request response rate within your organisation? E.g. staff awareness, invested in better systems, hired more employees.
8. If you have any other comments about responding to FOI requests or completing the requests within 20 working days, please write them here.”

FOI requests.300124.docx

Four hours A&E performance.310823.docx

All questions are shown as received by the Trust.
For each of your type one A&E departments, please provide site-specific data on four hours A&E performance (so xx% for A&E 1, xx% for A&E 2 etc)

For each site, please split this between a) admitted patients b) all patients (both admitted and non admitted)

Please provide this by month from the start of 2022/23, including for 2023/24 up to 29 June 2023 (or the latest date possible). Please also provide aggregate four hours performance data for both 2022/23 and 2023/24 so far.

Please provide the data on the template provided.

Four hours A&E performance.310823.docx

GDPR. 060718

1. Have you invested in technology specifically to comply with GDPR?
o Yes
o No
2. Which information security framework(s) have you implemented?
3. Have you signed contractual assurances from all the third-party organisations you work with requiring that they achieve GDPR compliance by 25 May 2018?
o Yes
o No
4. Have you completed an audit to identify all files or databases that include personally identifiable information (PII) within your organisation?
o Yes
o No
5. Do you use encryption to protect all PII repositories within your organisation?
o Yes
o No
6. As part of this audit, did you clarify if PII data is being stored on, and/or accessed by:
a. Mobile devices
b. Cloud services
c. Third party contractors
7. Does the organisation employ controls that will prevent an unknown device accessing PII repositories?
o Yes
o No
8. Does your organisation employ controls that detect the security posture of a device before granting access to network resources – i.e. valid certificates, patched, AV protected, etc.
o Yes
o No
9. Should PII data be compromised, have you defined a process so you can notify the relevant supervisory authority within 72 hours?
o Yes
o No
10. Have you ever paid a ransom demand to have data returned / malware (aka ransomware) removed from systems?
o Yes
o No
11. To which positions/level does your data protection officer report? i.e. CISO, CEO, etc.

Download response GDPR. 060718

GDPR and data destruction services. 290118

1. How would you describe your GDPR preparedness?
2. Have you identified all your data processing partners?
3. Do you have contracts in place with all your data processing partners?
4. Do you use a third party to provide data erasure or destruction services on your end of life IT infrastructure?
5. If you use a third party, do you have a contract in place with them?
6. How have you assessed “sufficient guarantees” from this company? (Please tick all that apply)
7. Does this contract include clarification on process for dealing with: (Please tick all that apply)?
8. If you use a third party what is their name?
9. How regularly do you or an independent third party, audit this company?

Download response GDPR and data destruction services. 290118

General Data Protection Regulation (GDPR). 061217

I am interested to know what agreements the organisation has around General Data Protection Regulation (GDPR) compliance services, replaces the 1995 EU directive (Directive 95/46/EC) and was introduced in May 2016 with full enforcement due in May 2018.
If the organisation does have agreement in place, please can you provide me with the information below?
a) Supplier- name of the supplier
b) Contract Spend- The total annual spend of the agreement.
c) Contract Duration- please provide me with the number of years and any potential extensions on the agreement.
d) Contract Description- Brief description sentence of the service provided under the agreement.
e) Start Date- When the agreement went like please provide me with the month and year.
f) Expiry Date- When the agreement is likely to be expired. Month and year.
g) Review Date- When is it likely the contract will be reviewed? Month and year.
h) Contact details of the responsible for the contract(s) above. Name, Job Title, Contact Number and Email ID.
If the organisation does not yet have the GDPR agreement in place please can you provide me with the following information?
1. When does the organisation plan to have this agreement in place?
2. When do you plan to go out to market for GDPR?
3. Who within the organisation will be responsible for this agreement?
4. Any other notes the organisation can provide in relation to the future procurement of compliance services.

Download response General Data Protection Regulation (GDPR). 061217

 

Health Informatics

3D Printing technology.110423.docx

Q1
a. Is 3D printing technology being used at your facilities?
☐Yes
☐No
If the answer to Q1a is Yes then skip to Q2.
If the answer to Q1a is No then:
b. Do you plan on utilising 3D Printing technology in the near future?
☐Yes
☐No
If the answer to Q1b is No then you may skip the rest of the questionnaire.
If the answer to Q1b is Yes then:
c. What part(s) do you intent to 3D print (e.g. Prosthetic limbs, hearing aids etc.)?
Q2) What 3D Printers are being used for producing the parts (Brand name & model)?
Q3) What type of parts/products are being printed (e.g. Prosthetic hand, prosthetic leg, splint, hip joint etc.) Please be specific.
Q4) What materials are being commonly used for 3D printing at your facilities?
Q5) What ISO standards and/or other ASTM/BS standards are being followed when producing the parts/products?
Q6) Please briefly describe the ethics process that is required for using 3D printing parts in patients?

3D Printing technology.110423.docx

3rd party hosting. 170919

The type of contract I wish to see is below:
1. Dedicated hosting- Managed environment
2. Co-Location- hosting allows a business to still own their own server equipment; however, instead of storing it in their own data centre, they instead are able to store it in rented space in a colocation hosting centre.
3. Cloud Hosting- Cloud hosting services provide hosting for websites on virtual servers, which pull their computing resource from extensive underlying networks of physical web servers.
Not all of these will be applicable to the organisation.
For the different types of hosting services, can you provide me with the following information?
1. Type of hosting – Dedicated, Co-Location, Cloud Hosting, Other?
2. Who is the supplier of the contract? If possible can you also provide me with the name of vendor, if applicable?
3. What is the annual contract value for each contract?
4. What type of cloud environment?
Private Cloud- a distinct and secure cloud based environment in which only the specified client can operate.
Public Cloud – where cloud services are provided in a virtualised environment, constructed using pooled shared physical resources, and accessible over a public network such as the internet.
Hybrid- integrated cloud service utilising both private and public clouds to perform distinct functions within the same organisation.
5. What is the original start date of the contract agreement? If there are more than one contract please provide me with the start date for each contract.
6. What is the actual expiry date of the contract agreement? If there are more than one contract please provide me with the expiry date for each contract.
7. When will the organisation plan to review this contract? If there are more than one contract please provide me with the review date for each contract.
8. What is the contract period in years? Please include whether the agreement has any extension periods?
9. What services are provided under the contract? Please do not put hosting, information such as web hosting, file storage, hosted application. The more information the better,
10. Can you please provide me with the contract officer responsible for this contract? Complete contact details if possible name, title, contact email and number.

Download response 3rd party hosting. 170919

3rd party hosting. 170919 1

1. Dedicated hosting- Managed environment
2. Co-Location- hosting allows a business to still own their own server equipment; however, instead of storing it in their own data centre, they instead are able to store it in rented space in a colocation hosting centre.
3. Cloud Hosting- Cloud hosting services provide hosting for websites on virtual servers, which pull their computing resource from extensive underlying networks of physical web servers.
Not all of these will be applicable to the organisation.
For the different types of hosting services, can you provide me with the following information?
1. Type of hosting – Dedicated, Co-Location, Cloud Hosting, Other?
2. Who is the supplier of the contract? If possible can you also provide me with the name of vendor, if applicable?
3. What is the annual contract value for each contract?
4. What type of cloud environment?
Private Cloud- a distinct and secure cloud based environment in which only the specified client can operate.
Public Cloud – where cloud services are provided in a virtualised environment, constructed using pooled shared physical resources, and accessible over a public network such as the internet.
Hybrid- integrated cloud service utilising both private and public clouds to perform distinct functions within the same organisation.
5. What is the original start date of the contract agreement? If there are more than one contract please provide me with the start date for each contract.
6. What is the actual expiry date of the contract agreement? If there are more than one contract please provide me with the expiry date for each contract.
7. When will the organisation plan to review this contract? If there are more than one contract please provide me with the review date for each contract.
8. What is the contract period in years? Please include whether the agreement has any extension periods?
9. What services are provided under the contract? Please do not put hosting, information such as web hosting, file storage, hosted application. The more information the better,
10. Can you please provide me with the contract officer responsible for this contract? Complete contact details if possible name, title, contact email and number.

Download response 3rd party hosting. 170919 1

A&E, Document Management, Digital Dictation and Scheduling Systems.011122.docx

System type – Accident & Emergency
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System definitions:
Accident & Emergency – A specialist system used to manage patients and patient clinical notes in the Emergency Department (ED)
System type – Digital Dictation
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System definitions:
Digital Dictation – Device used for recording and managing natural speech, allowing staff to verbally input a patients’ note into a system without having to manually input it.
System type – Document Management
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System definitions:
Document Management – Converts records into electronic format so that they can be viewed, moved around, and managed electronically on screen. Acts as a live filing system.
System type – Scheduling
1. Supplier name –
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System definitions:
Scheduling – Enterprise level systems that are designed to effectively and efficiently allocate resources (staff, equipment, treatment and even data) to patients at the necessary time and place. Systems in this area range from appointment booking, typically for clinic slots, through to far more sophisticated SAP-style resource allocation and scheduling systems.

A&E, Document Management, Digital Dictation and Scheduling Systems.011122.docx

A&E Urgent Care and Technology. 200917

1. TOTAL Number of Attenders to A&E for the year 2015/2016
a. Of these attenders – how may attended Majors?
b. Of these attenders – how many attended Minors?
c. Of these attenders – how many attended Children’s Paed A&E?
d. Of the TOTAL attenders, how may were conveyed by ambulance?
e. Of the TOTAL attenders, how many self-presented (made their own way to A&E)
f. Of the TOTAL attenders, how many were discharged with advice only/self-discharged without being seen (metrics can be added together)
g. How many 12 hour breaches did you have?
h. How many 4 hour breaches did you have?
i. What was the primary cause of the breaches?
2. TOTAL Number of Attenders to A&E for the year 2016/2017
a. Of these attenders – how may attended Majors?
b. Of these attenders – how many attended Minors?
c. Of these attenders – how many attended Children’s Paed A&E?
d. Of the TOTAL attenders, how may were conveyed by ambulance?
e. Of the TOTAL attenders, how many self-presented (made their own way to A&E)
f. Of the TOTAL attenders, how many were discharged with advice only/self-discharged without being seen (metrics can be added together)
g. How many 12 hour breaches did you have?
h. How many 4 hour breaches did you have?
i. What was the primary cause of the breaches? Was this reason different from 2015/16?
3. TOTAL Number of Attenders to A&E for year 2017/18 – to-date
4. Please describe how your patients are triaged, what is their typical journey? Is there a streaming model? If yes, how effective is it and who streams e.g. GP or Nurse?
5. What would you like to see implemented in your health economy to deter avoidable admissions? I.e. those who have attended A&E but could have been seen and treated in a walk-in centre/MIU, Pharmacy or GP etc.
6. Do you have Self Check-in Kiosks in your A&E area?
7. Do you have publicly available WiFi in your A&E waiting areas?
a. What is the bandwidth?
b. If you don’t have publicly available WiFi in your A&E waiting area, is there a plan to install this? If yes, when? Is it on trajectory for delivery and what is the planned bandwidth? Please comment
8. Do you think technology has a role to play in preventing avoidable admissions?
If yes, please comment on what the value of technology would be.

Download response A&E Urgent Care and Technology. 200917

Allscripts. 170919

1. We have noted down that your trust uses an Allscripts Oasis system. Has it replaced any of your following systems?
System Type
Dep A&E
Dep Pathology
Diagnostic reporting
Document management
Dep Maternity
2. If so when was the installation date and the current contract expiration date?

Download response Allscripts. 170919

Allscripts EPR system. 130720

1. Does your main hospital Allscripts EPR system have the HL7 FHIR API’s enabled? (Yes/No)
2. If no, do you have plans to enable this at present?
3. What is the specific product name of the EPR product you currently use for your Oncology department (e.g. ARIA, FLATIRON etc.)?
4. Is your Oncology EPR HL7 FHIR enabled? (Yes/No) 5. If no, can it be HL7 FHIR enabled? (Yes/No) 6. If no, why can it not be HL7 FHIR enabled? (e.g. technology is not capable, cost related reasons etc.) We look forward to hearing from you.

Download response Allscripts EPR system. 130720

Amazon Web Services (AWS).180722.docx

1. I would like to know the total spend of the Trust on information technology between June 1st 2019 and June 1st 2022.
2. What proportion of that total spend was awarded to Amazon Web Services (AWS)?
3. What is the total value of those contracts with AWS (please provide the amount in GBP)?
4. What is the nature of the service provided by AWS under these contracts?
5. Please provide any documentation that pertains to the above questions.

Amazon Web Services (AWS).180722.docx

Analytics and staff details.161122.docx

1. Who is your Chief Operations Officer?
2. Who is your Chief Nurse?
3. Who is your Responsible Officer for Performance?
4. Who is your Responsible Officer for Transformation?
5. Who is your Responsible Officer for Informatics and Reporting?
6. Who is your Director of Finance?
7. What stage of analytics are you in – Descriptive, Predictive, Prescriptive?
8. Do you currently use predictive analytics in your Organisation? If yes, do you use it for any of the following: bed modelling, theatres, staffing and productivity (better use of resources)?
9. Is it an internal or external team that does your predictive analytics? If external, please mention their name.

Analytics and staff details.161122.docx

Android devices.040123.docx

1. What brands of Android devices are used in your Trust?
2. How many devices of each brand are in use in your Trust?

Android devices.040123.docx

Annual IT budget 2016/2017

Please provide the following information:
1. Annual IT Budget
Please provide split between:
a. Capital Expenditure
b. Revenue Expenditure
2. How much of your capital expenditure is spent on outsourced IT services?
Provide split between:
a. Capital Expenditure
b. Revenue Expenditure
3. What is your anticipated capital refresh budget for data centre investment?

Download response Annual IT budget 2016/2017 270516

Apple Macbook. 300421

1. Do any members of your organisation use Apple iMacs or Macbooks?
2. Where these purchased by the organisation / BYOD (Bring Your Own Device) or a mixture of the two?
3. What professions, staff groups or departments use them the most?
4. Number of Apple Macs purchased in the last 12 months?
5. Number of Apple Macbooks purchased in the last 12 months?

Download response Apple Macbook. 300421 

Application, Software Development, Websites and Technical innovation. 200720

1. Does your Trust have teams/departments that handle any of the following: Application/Software Development, Websites, Technical innovation? Yes/No, If Yes please name these teams/departments:
2. How many members are in these teams/departments? And what roles are the teams/departments made up of?
3. What technologies do the teams/departments use? For example: HTML5, C#, SQL, .NET Core 2.0
4. Are the developments of the teams/departments open source? Yes/No, If Yes, please give any details you may be able to disclose regarding this.
5. What software methodology do the teams/departments use?
6. Do the teams/departments develop front facing service user websites/apps? Yes/No, If Yes, please give any details you may be able to disclose regarding this.
7. Do the teams/departments work with clinical staff to formulate any innovative ideas they may have? Yes/No, If Yes, please give any details you may be able to disclose regarding this.
8. Have the teams/departments ever gone for external tenders for healthcare system developments? Yes/No, If Yes, please give any details you may be able to disclose regarding this.
9. Have the teams/departments ever done developments for other trusts/external entities? Yes/No, If Yes, please give any details you may be able to disclose regarding this.
10. Have the teams/departments ever sold a development it has produced commercially? Yes/No, If Yes, please give any details you may be able to disclose regarding this.
11. Have the teams/departments ever attempted to secure an innovation grant? Yes/No If Yes, please give any details you may be able to disclose regarding this.
12. Were the teams/departments used during the COVID-19 crisis? Yes/No If Yes, please give any details you may be able to disclose regarding this. If No, why wasn’t it used?
13. Does your service provide mental health services? Yes/No If Yes, have the teams/departments been involved in developing these digitally/online?
14. Do the teams/departments feel they have good visibility within the Trust regarding the services they can offer? Yes/No, please give any details you may be able to disclose regarding this.

Download response Application, Software Development, Websites and Technical innovation. 200720

Appointment booking systems. 070219

1. Please provide details of the Trust’s current Letter printing service supplier/system.
2. What is the Trusts annual cost for the printing and postage of patient letters?
3. Please provide monthly values for the number of patient letters sent?
4. Does the Trust use the services of an external printer for patient and non-patient letters?
YES / NO
If No, go to question 5. If Yes, go to question 7.
5. What are the Trusts costs for the service and support of onsite printing equipment?
6. Have you previously considered using outsourced services? Please provide details of why you chose not to use them.
7. Please provide when the service was implemented, and the services included?
8. Please provide specific details of any aims/targets set of the print service and whether these have been achieved?
9. Please provide details of the member(s) of staff responsible for the implementation and continued running of the service and their role within the Trust?
10. Please provide details of:
a. Supplier
b. Expected contract length
c. Contract review date
d. Cost of contract to date
11. Please provide details of the implementation costs and on-going/support costs?
12. Please provide details of the processes followed to procure an external print service?
13. Please provide details of the channels used to publish the notification of procurement, for an external print service?

Download response Appointment booking systems. 070219

Artificial Intelligence. 221119

1. In which health services has your Trust use Artificial Intelligence technologies? [Tick all that apply]
a. Clinical care
b. Patient diagnosis
c. Patient outreach/liaison
d. Drug development
e. Laboratory research
f. Other, please state
g. Our Trust is not using Artificial Intelligence
2. If your Trust does not use Artificial Intelligence technologies for health services today, when do you plan to deploy Artificial Intelligence? [Tick one only]
a. Within the next 12 months
b. Between 13 and 24 months
c. Between 25 and 36 months
d. Beyond 37 months
3. Which Artificial Intelligence technologies does your Trust use today? [Tick all that apply]
a. Chatbots
b. Machine Learning
c. Robotic Process Automation (RPA)
d. Speech recognition
e. Computer vision
f. Other, please state
4. How much has your Trust invested in Artificial Intelligence in the last two years? [Tick one only]
a. Under £100,000
b. Between £100,001 and £499,999
c. Between £500,000 and £999,999
d. Between £1,000,000 and £4,999,999
e. Over £5,000,000
5. Do you have a data strategy in place allowing your Trust to use the data for Artificial Intelligence projects? [Tick one only]
a. Yes, we can use our data for Artificial Intelligence projects
b. No, we have data challenges in our Trust (e.g. too many data silos, lacking the skillsets, lack of strategy)
6. How is your Trust reviewing your data policy with regards to governance and using data for Artificial Intelligence projects? [Tick one only]
a. We have already reviewed our policy
b. We plan to review our policy
c. We have no plans to review our policy
7. What is the job title of the most senior person responsible for Artificial Intelligence in your Trust?

Download response Artificial Intelligence. 221119

Artificial Intelligence (AI). 090721

1. Is your NHS organisation currently using any software/apps that include artificial intelligence (AI)?
If answer to Q1 is yes:
2. Please provide a list of any AI-based software that is currently in use within your organisation. Please include the brand name of the software and the name of the company that sells it.
3. For each of the AI-based software products currently in use, please state whether:
a. it is only being used within the context of a research study or pilot project OR
b. it has been purchased/commissioned by your organisation for routine use.

Download response Artificial Intelligence (AI). 090721

Audio Visual and video conferencing. 280120

1. Who are your current supplier(s) of Audio Visual (AV) and Video Conferencing (VC) equipment and services?
2. How many video enabled MDT’s, Boardrooms and meeting / training rooms do you have within your organisation and when was the last upgrade or refresh to these rooms?
3. Do you have a support contract in place for these rooms and if so, when is the expiry date(s)?
4. What has been your annual spend over the last 3 years (16/17 17/18 18/19) on AV / VC hardware, services and support?
5. Specifically in terms of MDT’s, do you use a N3/HSCN service to allow connectivity to other internal / external MDT’s / remote participants? If yes, which service do you use?
6. Do you have a Digital strategy in place around Video based consultations? If so have you implemented a service and if yes, which service do you use?
7. Could you provide a name and contact details for who is responsible for your MDT rooms?
8. Do you have a Digital Lead for the organisation? If so, could you provide a name and contact details?
9. Could you provide a name and contact details for your IT lead / manager?

Download response Audio Visual and video conferencing. 280120

Bank and agency systems.080323.docx

1. Please confirm which model is in place for managing each staff group: preferred supplier list, master vendor or neutral vendor
Locum
Nurse
Allied Health Professionals
Non-medical/non-clinical
2. If you have a master vendor or neutral vendor in place, please confirm who this contract is with
3. Please confirm the contract end date with the provider
4. Is your bank managed by an external bank provider (e.g., NHS Professionals,
Bank Partners).
5. Please confirm who is the external bank provider and when the contract expires if relevant
6. Is your bank managed via software? If so, please confirm which software.

Bank and agency systems.080323.docx

Bed Management, Diagnostic Reporting, Discharge Letters, and Integration Platform systems.280422.docx

System type – Bed Management
1. Supplier name –
2. System name –
3. Date installed –
4. Contract expiration –
5. Notes – e.g. we are currently out to tender
6. Is this contract annually renewed? – Yes/No
7. Do you currently have plans to replace this system? – Yes/No
System type – Diagnostic Reporting
1. Supplier name –
2. System name –
3. Date installed –
4. Contract expiration –
5. Notes – e.g. we are currently out to tender
6. Is this contract annually renewed? – Yes/No
7. Do you currently have plans to replace this system? – Yes/No
System type – Discharge Letters
1. Supplier name –
2. System name –
3. Date installed –
4. Contract expiration –
5. Notes – e.g. we are currently out to tender
6. Is this contract annually renewed? – Yes/No
7. Do you currently have plans to replace this system? – Yes/No
System type – Integration Platform
1. Supplier name –
2. System name –
3. Date installed –
4. Contract expiration –
5. Notes – e.g. we are currently out to tender
6. Is this contract annually renewed? – Yes/No
7. Do you currently have plans to replace this system? – Yes/No

Bed Management, Diagnostic Reporting, Discharge Letters, and Integration Platform systems.280422.docx

Bleep and Pager system. 180220

1. What is the total cost per annum (over the last 3 years) that your NHS trust spends upon your bleep/ pager system?
2. What is the total cost per annum (over the last 3 years) that your NHS trust spends upon replacing equipment pertaining to your hospital bleep/ pager system (such as bleeps, transmitters, and expendables such as batteries for bleeps)?
3. From which company or companies does your Trust currently buy and/ or hire its pager system from?
4. What is the length of the contract that your Trust has with this company/ these companies and when do these contracts expire?

Download response Bleep and Pager system. 180220

Bring Your Own Devices to Work. 070120

1. Does Maidstone and Tunbridge Wells NHS Trust allow staff to use their own devices to access work email? Please answer Yes or No.
2. Does Maidstone and Tunbridge Wells NHS Trust allow staff to use their own devices for any other work-related activities? Please answer Yes or No.
3. If you answered yes to question 2 please provide a list of the types of systems that staff can access from personally owned devices?
4. Does Maidstone and Tunbridge Wells NHS Trust have a policy that covers BYOD or the use of personal devices at work? Please answer Yes or No.
5. If you answered yes to question 4 please could you provide a copy of your policy that covers BYOD or personal device usage at work?

Download response Bring Your Own Devices to Work. 070120

Cardiology digital systems.241219

1) Regarding echocardiograms:
a) Which digital system is used by healthcare professionals in your trust to request echocardiograms?
b) On what digital system(s) are echocardiogram images stored?
c) On what system are echocardiograms reported?
d) On what system(s) are the reports for echocardiograms available for review?

2) Regarding coronary angiograms:
a) Which digital system is used by healthcare professionals in your trust to request coronary angiograms?
b) On what digital system(s) are images from coronary angiograms stored?
c) On what system are coronary angiograms reported?
d) On what system(s) are the reports from coronary angiograms available for review?

3) Regarding cardiac pacemakers:
a) Which digital system is used by healthcare professionals in your trust to request pacemaker insertion?
b) On what system are pacemaker procedure reports written?
c) On what system(s) are pacemaker procedure reports available for review?
d) On what system(s) are cardiac pacemaker routine outpatient checks available for review?

4) Regarding cardiology patient documentation:
a) On what system(s) are outpatient letters available for review?
b) On what system(s) are discharge letters available for review?
c) Are copies of ECGs stored electronically? If so, on what system(s) are they available?

5) Regarding CT coronary angiograms:
a) Which digital system is used by healthcare professionals in your trust to request CT coronary angiograms?
b) On what digital system(s) are images from CT coronary angiograms stored?
c) On what system are CT coronary angiograms reported?
d) On what system(s) are the reports from CT coronary angiograms available for review?

6) What RIS system does your hospital use?
7) What PACS system does your hospital use?

Download response Cardiology digital systems.241219

Cardiology, E-Rostering (staffing), Order Communications, Pathology, and Pharmacy systems.010722.docx

Please enter ‘No System Installed’ under supplier name if your trust does not use the system:
System type – Cardiology
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System type – E-Rostering (staffing)
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System type – Order Communications
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System type – Pathology
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System type – Pharmacy
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
Cardiology, E-Rostering (staffing), Order Communications, Pathology, and Pharmacy systems.010722.docx

Centralised patient administrative service.311023.docx

1. Do you have a centralised patient administrative service within your Trust? Y / N
a. If not then how do you run your patient services? Please provide a description (i.e. are these admin functions delivered by different services within the Trust).
2. What are the activities delivered by that centralised administrative service (e.g. referrals, bed management)? Please provide a complete list.
3. What percentage of referrals (i.e. RTTs) are managed by that central administrative? Please provide an accurate estimate.
4. What is the size, structure and budget of that central administrative? Please provide an outline of team structure as it currently stands and the total number of people in that team, with NHS salary bands, as well as its yearly budget for the past 5 financial years.

Centralised patient administrative service.311023.docx

Chief Clinical Information Officer and the Director of Health Informatics.

1. Can you please provide the name and email of your Chief Clinical Information Officer or the person who holds the equivalent role in your trust?
Name:
Contact Details:

2. Can you please provide the name and email of the Trust Director of Informatics or the person who holds the equivalent role in your trust?
Name:
Contact Details:

Download response Chief Clinical Information Officer and the Director of Health Informatics  230916

Clinic Software Solutions. 210322.docx

1. What IT solutions do you currently use to manage the following Clinic’s?
a. Pre-Assessment
b. Fracture
c. Radiology
d. Oncology
e. Ophthalmology
f. Gynaecology
g. Haematology
h. Neurology
i. Urology

Clinic Software Solutions. 210322.docx

Clinical benchmarking. 010719

1. Can you provide details of your current clinical benchmarking supplier (If any) examples such as HED, Doctor Foster or CHKS?
2. Can you provide details of the current renewal/end date of this contract?
3. Who is the main point of contact for this contract and their title and contact details?
4. Which board member has responsibility for benchmarking?
5. Do you have BI solutions such as ClikView or ClikSense?
6. Do you use any companies to provide remote clinical coding services? If Yes,
7. What was the procurement method used?
8. How long is the contract?
9. Can you provide details of the current renewal/end date of this contract?

Download response Clinical benchmarking. 010719

Clinical benchmarking. 240920

Can you provide details of your current clinical benchmarking supplier: examples such as HED, Doctor Foster or CHKS?
Can you provide details of the current renewal/end date of this contract?
Who is the main point of contact for this contract and their title and contact details?
Which board member has responsibility for benchmarking?

Download response Clinical benchmarking. 240920

Clinical decision support in e-prescribing, Observations – vital signs, Oncology e-prescribing and Diagnostic imaging Systems.170323.docx

System type – Clinical decision support in e-prescribing
a. Supplier name
b. System name –
c. Date installed –
d. Contract expiration –
e. Is this contract annually renewed? – Yes/No
f. Do you currently have plans to replace this system? – Yes/No
g. Procurement framework –
h. Other systems it integrates with? –
i. Total value of contract (£) –
j. Notes – e.g. we are currently out to tender
System definitions:
Clinical decision support in e-prescribing – within, or in conjunction with, its e-prescribing systems, Clinical Decision Support (CDS) assists prescribing clinicians in safely identifying suitable medicines, doses and titrations, for individual patients.

System name -Observations – vital signs
a. Date installed –
b. Contract expiration –
c. Is this contract annually renewed? – Yes/No
d. Do you currently have plans to replace this system? – Yes/No
e. Procurement framework –
f. Other systems it integrates with? –
g. Total value of contract (£) –
h. Notes – e.g. we are currently out to tender
System definitions:
Observations – vital signs – a system for electronic recording at the bedside of patient vital sign data, together with a mechanism to include in the patient’s electronic record.

System type –Oncology e-prescribing
a. Supplier name
b. System name –
c. Date installed –
d. Contract expiration –
e. Is this contract annually renewed? – Yes/No
f. Do you currently have plans to replace this system? – Yes/No
g. Procurement framework –
h. Other systems it integrates with? –
i. Total value of contract (£) –
j. Notes – e.g. we are currently out to tender
System definitions:
Oncology e-prescribing – module or functionality that supports electronic chemotherapy prescribing, medication administration and dispensing activities.

System type – Diagnostic imaging
a. Supplier name
b. System name –
c. Date installed –
d. Contract expiration –
e. Is this contract annually renewed? – Yes/No
f. Do you currently have plans to replace this system? – Yes/No
g. Procurement framework –
h. Other systems it integrates with? –
i. Total value of contract (£) –
j. Notes – e.g. we are currently out to tender
System definitions:
Diagnostic imaging – electronic medical imaging systems providing the core capabilities to manage diagnostic images and associated reports.

Clinical decision support in e-prescribing, Observations – vital signs, Oncology e-prescribing and Diagnostic imaging Systems.170323.docx

Clinical decision support systems. 210920

1. Does the trust operate any clinical decision support systems (examples above?)
◦ If so, which ones?
2. What is the cost of licences (and any other support) the Trust paid on clinical decision support systems in the financial years 2017-18 & 2018-19
3. Has the trust developed their own electronic clinical decision support system(s)?
4. If so, what were the WTE and total funding costs incurred in development of their own clinical decision support system(s) for the financial years 2017-18 & 2018-19 respectively?
5. What was the Trusts’ total operating budget for financial years 2017-18 & 2018-19 respectively?

Download response Clinical decision support systems. 210920

Clinical Software. 010217

1. What is your Current Healthcare information system?
2. Which solutions are you using as an Electronic Patient Record?
3. Which solutions are you using as a PACS? Does it have an integrated RIS?
4. Do you have an operating theatre management software? (If yes, which one?)
5. Do you have an anaesthesia management software? For the pre-anaesthesia consultation? Anaesthesia management during the procedure? PACU surveillance? (If yes, which one?)
6. Do you have an ICU management software? (If yes, which one?)
7. Is medical data recovered from medical devices and added to the patient record?
8. Is there a plan to change any of your existing systems? (If yes, do you have a determined budget for it?)
9. What is your procurement process? Do you go through tenders? Use professional buying organisations?
10. Who is the person in charge of Anaesthesia?
11. Who is the person in charge of OR management?
12. Who is your IT manager for clinical software?

Download response Clinical Software. 010217

Clinical systems.030124.docx

All questions are shown as received by the Trust.
Please provide information regarding the following systems:
1. Document Management
2. ePOA
3. EPR
4. Finance
5. Finance BI and analytics system
6. HR
7. Maternity
8. Pathology PACS
9. Payroll
10. Population health management
11. Procurement Software
12. Voice recognition

Please enter ‘No System Installed’ or ‘No Department’ under supplier name if your trust does not use the system or have the department:
a) System type –
b) Supplier name –
c) System name –
d) Date installed –
e) Contract expiration –
f) Is this contract annually renewed? – Yes/No
g) Do you currently have plans to replace this system? – Yes/No
h) Procurement framework –
i) Other systems it integrates with? –
j) Total value of contract (£) –
k) Notes – e.g. we are currently out to tender

Please provide your answer in the above format for each system.

System definitions:
Document Management: Converts records into electronic format so that they can be viewed, moved around, and managed electronically on screen. Acts as a live filing system.

ePOA: ePOA, short for Electronic Pre-Operative Assessment, is a digital tool that streamlines the pre-surgery assessment process, replacing traditionally paper-based administrative tasks with electronic data collection for efficiency. Some suppliers include, AireLogic, Definition Health, OpenMedical.

EPR: An electronic patient/health record is an electronic record of periodic health care of a single individual, provided mainly by one institution. A digital version of a patient’s paper chart.

Finance: This is a financial management and accounting solution used alongside HR software. Suppliers here include Unit4.

Finance BI and analytics system: Tools used for transforming and analysing financial and related data sets.

Maternity: It is the specialist maternity system in use for maternity care.

Clinical systems.030124.docx

Clinical systems.040723.docx

Please proved information regarding the following systems:
1. Analytics (PLICS)
2. BI & Data Warehousing
3. Blood tracking
4. Cardiology
5. Clinical data warehouse
6. Clinical workflow engine/integrated care pathways
7. Integration Platform
8. Main Community System
9. Patient Engagement Portal
10. Pathology
11. Theatres
12. Video Consulting
13. Virtual Wards

Please enter ‘No System Installed’ or ‘No Department’ under supplier name if your trust does not use the system or have the department:
a) System type –
b) Supplier name –
c) System name –
d) Date installed –
e) Contract expiration –
f) Is this contract annually renewed? – Yes/No
g) Do you currently have plans to replace this system? – Yes/No
h) Procurement framework –
i) Other systems it integrates with? –
j) Total value of contract (£) –
k) Notes – e.g. we are currently out to tender

Please provide your answer in the above format for each system.
System definitions:
Analytics (PLICS): A business intelligence tool that provides patient level costing information, systematically analysing electronic patient data to monitor patient level costing (may include healthcare resource groups).

BI & Data Warehousing: Integrates data and information collected from various sources, e.g. electronic patient/health records, enterprise resource planning systems, radiology and lab databases, wearables etc, into one comprehensive database.

Blood tracking: A system that electronically tracks and matches blood products with the correct patient (from fridge to vein).

Cardiology: A specialist clinical information system is used for cardiology.

Clinical data warehouse: A centralized repository for a healthcare organization’s data retrieved from disparate sources, processed, and structured for analytical querying and reporting.

Clinical workflow engine/integrated care pathways: A system implemented that enables it to create rules driven electronic care pathways mapped to standardised treatment protocols.

Integration Platform: Software that supports the integration and interoperability of various clinical and management IT systems and services.

Main Community System: A main community system is a software system that supports the delivery of community health services by enabling electronic patient records (EPR) and case management. They help to improve patient outcomes by providing a single view of patient information, supporting multi-disciplinary team working, integrated health and social care services, and online and offline mobile working.

Patient Engagement Portal: The patient engagement platform is used by healthcare providers across the system to securely share data and interact with patients/carers to better support/manage patient’s health and wellbeing.

Pathology: Pathology testing is managed electronically.

Theatres: A specialist theatres system is used to manage patients and surgical procedures in theatres.

Video Consulting: Is a system that is used when a patient speaks to a doctor or healthcare professional using the video camera in their smartphone, tablet or computer.

Virtual Wards: Virtual wards, also known as virtual care wards or hospital-at-home programs, are healthcare models that aim to provide hospital-level care to patients in their own homes. These programs typically utilize telehealth technologies and remote monitoring systems to deliver medical care and supervision to patients who would otherwise require hospitalization.

Clinical systems.040723.docx

Clinical and IT systems. 090418

1. Do you use electronic patient record systems for any part of your clinical records? If so, please provide the names of all the systems used and what they are used for?
2. Do you use paper notes for any part of your clinical records? If so, please detail what they are used for?
3. Do you use an electronic system for the majority (>50%) of clinical note-taking for each of these encounters (part B)? If so, please detail the system(s) used; if not, please state if/when you intend to implement an electronic system for these encounters?
4. Do you use an electronic system for each of the following purposes (part B)? If so, please detail the system(s) used; if not, please state if/when you intend to implement an electronic system for this purpose?
5. How many desktop or portable computers are currently managed by the trust? (An estimate is sufficient)
6. Are there desktop or portable computers running Microsoft Windows XP or Microsoft Windows Vista in the trust? If so, please detail how many of each? (An estimate is sufficient)
7. Have computers or servers managed by the trust been affected by malware in the last 2 years? If so, please detail the names of the malware involved (such as “Wannacry”)?
8. Do you have a policy for selecting Microsoft security updates to be applied? If so, is the policy to apply all security updates or only a subset?
9. Have all Microsoft security updates described as “critical” in the past 2 years been applied within 1 month? If not, please detail how many were not applied within this time? (An estimate is sufficient)

Download response Clinical and IT systems. 090418

Clinical Systems. 200617

Please confirm the following pieces of information:
1. Who is the Trust’s current supplier for their Electronic Patient Record (EPR)?
2. What is the contract start and end date for the Electronic Patient Record?
3. Who is the Trust’s current supplier for your Patient Administration System?
4. What is the contract start and end date for the Patient Administration System?
5. When are you due to start looking to re-procure your clinical systems?
6. Who is the Trust’s current Chief Clinical Information Officer?
7. Which member of the board is responsible for IT?
8. As part of planning for the replacement of PAS how much has your organisation assigned a specifically for data migration to offset the risks to revenue generation post go-live of the new system?
9. How many FTEs does the Trust employ to clean data and handle data quality problems?
10. Does the Trust use any external organisation to provide tools and /or services for data quality improvements?
11. What is the estimated cost of cleaning data for statutory reporting ?
12. What is the estimated cost of cleaning data for clinical risk avoidance?
13. Who is responsible within your organisation for identifying the technical requirements for systems that support sustainability plans as described in the Five Year Forward View?

Download response Clinical Systems. 200617

Clinical Systems. 240717

1. Please confirm the systems in use in the following areas:
a. EPR
b. PAS
c. A&E
d. Order Comms
e. Maternity
f. Theatres
g. ePrescribing
h. ITU/anaesthetics
i. eObservations/Early Warning Signs

2. Can you please confirm when this contract expires?
a. EPR
b. PAS

3. Is the trust planning an EPR procurement?

4. If so, what are the timescales?
a. What procurement route are you planning, e.g. OJEU, SBS, LPP?
b. Have you done any market assessment, and if so, which solutions do you think are a good fit for your organization?

5. Have you allocated budget for this project/migration?
a. Apart from budget, are there any other factors affecting whether this procurement proceeds?
6. Who are the main stakeholders involved in the review and decision-making process?
a. Apart from within the trust, are there outside stakeholders, eg STP, NHS
Improvement, GDE, neighbouring trust?

7. Did you/have you expressed an interest in being a GDE (Global Digital Exemplar) Fast Follower, and if yes, which GDE would you be following?

Download response Clinical Systems. 240717

Clinical systems and supplies. 200617

1. Please provide details of which system you use and which supplier provides your Trust with the following functionality:
• PAS
• Scheduling
• Letters creation
• ePrescribing
• PACS
• RIS
• Pharmacy
• LIMS
• Observations
• Order Communications
For the same areas, please provide details of when each of these contracts is due for renewal.
2. Is the Trust currently in the process of early fact finding, OBC, Procurement, FBC or implementation for an EPR?
3. Is the Trust currently in the process of early fact finding, OBC, Procurement, FBC or implementation for an RIS and/or PACS?

Download response Clinical systems and supplies. 200617

Commercial IT software products.

1. Have you deployed commercial IT software products to automate your policies around patient observation and the capturing of vital signs for early-warning of deterioration?
2. If your answer to Question 1 is YES, please confirm the commercial names of these software products and confirm the date when their current support contracts will expire.

Download response Commercial IT software products 280716

Communication Systems

Please can you provide the following information with regards to the Trust’s communication systems?

1 Which types of telephony system does the Trust utilise? (E.g. PBX, VOIP, Unified Communication (UC) – please specify all that apply).
2 Brand of the PBX, VOIP and UC
3 Are these systems on premise or hosted?
4 How are the systems maintained (Maintenance Contract, Outsourced Managed Service, Shared Service or internal Trust resource)
5 Existing Supplier/s of above referenced service contracts (if there is more than one supplier please name each)
6 Contract Description: please provide a brief description of the overall service provided under this contract
7 Contract Durations (please include any extension periods)
8 Contract Expiry Dates (please provide the day/month/year)
9 Contract Review Date (please provide the day/month/year)
10 Annual Average Spend (the annual average spend for each contract)
11 Number of users on each system or PBX
12 Application(s) running on PBX/VOIP systems
13 Who maintains the Local Area Network (Trust or external party – if so please specify names of associated parties) and what is the brand of the associated network hardware?
14 Which company provides and maintains the Wi-Fi network (Trust or external party – if so please specify names of associated parties) and what is the brand of the associated network hardware?
15 Which company provides the Wide-Area-Network?
16 Contact Detail of the person from with the organisation responsible for each contract including full Contact details

Download response Communication Systems 060916

Communications. 080422.docx

How many patients in total is your trust responsible for
1. What is the total number of letters you post a year
2. Which Postal carrier(s) do you use?
a. Royal Mail Yes / No
b. Whistl Yes / No
c. UKMail Yes / No
d. Other (please specify)
a. What percentage of your patient letters are sent 1st Class?
b. What percentage of your patient letters are sent 2nd Class (or equivalent)?
4. Do you still use franking machines? Yes/No
a. If Yes, who is the manufacturer of your franking machines?
b. Pitney Bowes Yes/No
c. Quadient Yes/No
d. Other (please specify)?
5. Do you use Hybrid mail to send patient letters
If Yes,
a. What percentage of your total postal volumes (question 1) are sent via hybrid mail?
b. what is the name of your hybrid mail supplier?
c. What framework did you use to procure hybrid mail?
d. When was the contract signed?
e. What is the duration (Term) of the contract?
6. Do you currently use a Patient portal or App for some or all of your patient communications?
a. If Yes, who is the supplier of your web portal or App technology?
b. When did you first implement your patient portal or App technology (Year/Month)?
c. How many patients have registered to use your patient portal or App?
d. How many letters a year are currently being sent via your web portal or App?
7. Do you currently use Email to communicate with your patients?
a. If yes, who supplies your email service?
b. How many emails do you send to patients a year?
c. What is the cost of each email communication?
8. Do you currently use SMS to communicate with your Patients?
a. If yes, who supplies your email service?
b. How many emails do you send to patients a year?
c. What is the cost of each email communication?
9. Who has responsibility for digital transformation in your organisation?
Name:
Email Address:
10. Who is responsible for your post room (i.e. who is your post room manager?
Name:
Email Address:
11. Who is the Director of IT in your organisation?
Name:
Email Address:
12. Who is the procurement manager responsible for print and post solutions in your organisation?
Name:
Email Address:

Communications. 080422.docx

Communications & Services. 101221.docx

Telephony and UC/ Collaboration
1. Please confirm the manufacturer of your telephony system(s) that are currently in place
2. When was the installation date of your telephony equipment?
3. When is your contract renewal date?
4. Who maintains your telephony system(s)?
5. Please confirm the value of the initial project
6. Please confirm the total ongoing annual spend on telephony
7. Please confirm the annual support cost for your telephony system
8. Do you use Unified Communications or Collaboration tools, if so which ones?

Contact Centre
1. Please confirm the manufacturer of your contact centre system(s) that are currently in place?
2. When was the installation date of your contact centre infrastructure?
3. When is your contract renewal date?
4. Who maintains your contact centre system(s)?
5. Please confirm value of the initial project?
6. Please confirm the value of annual support/maintenance services (in £)? And overall annual spend for the contact centre
7. How many contact centre agents do you have?
8. Do agents work from home? Or just your offices?
9. Do you use a CRM in the contact centre? What platform is used?
10. Do you use a knowledge base / knowledge management platform? What platform is used?

Connectivity and Network Services
1. Who provides your WAN and internet connectivity and the annual spend on each
2. Have you, or do you plan to deploy SD Wan services
3. Have you got SIP trunks, if so who from and confirm annual spend?
4. Please confirm who provides your LAN, WIFI and Security infrastructure
5. Please confirm your annual spend on each
6. Please confirm your data centre switching and security infrastructure and have you deployed cloud based security and threat management

Organisation
1. How many employees do you have overall within your organisation?
2. Can you provide contact details for your procurement lead / category manager for these services?
3. Can you provide names and contact details for the following people within your organisation?
• CIO / IT Director
• Head of IT
• Head of Digital Transformation
• Head of Customer services

Download response Communications & Services. 101221.docx

Compliance requirements for any potential suppliers of software. 191120

What are the pre-requisite compliance requirements for any potential suppliers of software at your NHS Trust? Kindly list the specific requirements for your Trust, which includes but is not limited to the following:
• Data governance policies that suppliers must prescribe to in order to secure tenders;
• Compliance requirements;
• ISO standards (i.e. ISO 2701);
• Frameworks;
Any other badges or accreditation required.
For context, this FOI request is in reference to non-clinical software (not a medical device) for senior management that aggregates data around patient flow (i.e. breaches, patient journeys, medical records, and resources consumed) across departments scraped from the ERP and other software.

Download response Compliance requirements for any potential suppliers of software. 191120

Computer systems. 291020

Therefore, I would be very much appreciative if you, or someone else from Maidstone and Tunbridge Wells Trust, would be able to point me towards the different computer systems your trust uses for:
1. Electronic Health Records
2. Imaging
3. Medication/prescriptions
4. Accident and Emergency

Download response Computer systems. 291020

Connectivity and Network Services.230623.docx

Connectivity and Network Services
a. Who provides your WAN and internet connectivity and the annual spend on each
b. Who provides your SIP trunks and what is the annual spend
c. Who provides your WAN services, is this MPLS, SD WAN or Internet, and what is the annual spend
d. Who provides your LAN infrastructure and what is your annual spend
e. Who provides your WIFI infrastructure and what is your annual spend
f. Please confirm the manufacturer(s) of your wired network core and edge switching?
g. When was your core network installed?
h. Has it been updated subsequently?
i. Who maintains your core network?
j. When is the contract renewal date?
k. Please confirm value of the initial project?
l. Please confirm the value of annual support/maintenance services (in £)?

Connectivity and Network Services.230623.docx

Contact centre, call centre and inbound network services contracts

I wish to submit to the organisation a freedom of information request relating to the organisations :
1. contact centre/call centre contracts
2. inbound network services contracts

Please send me the following information for each provider:

1. Incumbent Supplier: For each of the contract(s) please can you provide me with the supplier of the contract.
2. Annual Average Spend: the annual average (over 3 years) spend for each supplier
3. Contract Expiry: the date of when the contract expires.
4. Contract Review: the date of when the contract will be reviewed.
5. Contract Description: a brief description of the services provided of the overall contract.
6. Contact Details: The person from within the organisation responsible for the contract. Please provide me with their full name, actual job title, contact number and direct email address.
7. Number of Agents; please provide me with the total number of contact centre agents;
8. Number of Sites; please can you provide me with the number of sites the contact centre covers.
9. Manufacturer of the contact centre: Who is the manufacturer of the contact centre system that you operate?
10. Busy Periods: Please state the month(s) which the contact centre is at its highest/busiest during the year. This can be based upon the number of calls. Your provider may be able to tell you quicker. E.g. JAN-MAR, APR, JUNE.
11. Do you use Microsoft Exchange 2003 as your email server? If not, then which product do you use?
12. Number of email users: Approximate number of email users across the organisations.

Download response Contact centre, call centre and inbound network services contracts 271015

Contact centre, call centre and inbound network services contracts April 2016

I wish to submit to the organisation a freedom of information request relating to the organisations:
1. Contact centre/call centre contracts
2. Inbound network services contracts

Please send me the following information for each provider:

1. Incumbent Supplier: For each of the contract(s) please can you provide me with the supplier of the contract.
2. Annual Average Spend: the annual average (over 3 years) spend for each supplier
3. Contract Expiry: the date of when the contract expires.
4. Contract Review: the date of when the contract will be reviewed.
5. Contract Description: a brief description of the services provided of the overall contract.
6. Contact Details: The person from within the organisation responsible for the contract. Please provide me with their full name, actual job title, contact number and direct email address.
7. Number of Agents; please provide me with the total number of contact centre agents;
8. Number of Sites; please can you provide me with the number of sites the contact centre covers.
9. Manufacturer of the contact centre: Who is the manufacturer of the contact centre system that you operate?
10. Busy Periods: Please state the month(s) which the contact centre is at its highest/busiest during the year. This can be based upon the number of calls. Your provider may be able to tell you quicker. E.g. JAN-MAR, APR, JUNE.
11. Do you use Microsoft Exchange 2003 as your email server? If not, then which product do you use?
12. Number of email users: Approximate number of email users across the organisations.

Download response Contact centre, call centre and inbound network services contracts April 2016 180416

Contact centre contract(s) and inbound network services contract(s).090224.docx

All questions are shown as received by the Trust.
I wish to submit to the organisation a freedom of information request relating to the organisation’s ICT contracts, specifically around:
1. contact centre contract(s)
2. inbound network services contract (s)
Please send me the following information for each provider:
contact centre contract(s)
1. Incumbent Supplier: For each of the contract(s) please can you provide me with the supplier of the contract.
2. Annual Average Spend: For each supplier, please state the annual average (over 3 years) spend for each supplier
3. Contract Duration: For each supplier, please state the contract duration of the contract expires. If available please also include any contract extensions.
4. Contract Expiry: For each supplier, please state the date of when the contract expires.
5. Contract Review: For each supplier, please state the date of when the contract will be reviewed.
6. Contract Description: For each supplier, please state a brief description of the services provided of the overall contract.
7. Contact Details: For each supplier, please state the person from within the organisation responsible for the contract. Please provide me with their full name, actual job title, contact number and direct email address. At the very least please provide me with their actual job title.
8. Number of Agents; please provide me with the total number of contact centre agents;
9. Number of Sites; please can you provide me with the number of sites the contact centre covers.
10. Manufacturer of the contact centre: Who is the manufacturer of the contact centre system that you operate?
11. Do you use Microsoft Exchange 2003 as your email server? If not, then which products do you use?
12. Number of email users: Approximate number of email users across the organisations.
inbound network services contract (s)
1. Incumbent Supplier: For each of the contract(s) please can you provide me with the supplier of the contract.
2. Annual Average Spend: For each supplier, please state the annual average (over 3 years) spend for each supplier
3. Contract Expiry: For each supplier, please state the date of when the contract expires.
4. Contract Review: For each supplier, please state the date of when the contract will be reviewed.
5. Contract Description: For each supplier, please state a brief description of the services provided of the overall contract.
6. Contact Details: For each supplier, please state the person from within the organisation responsible for the contract. Please provide me with their full name, actual job title, contact number and direct email address.

Contact centre contract(s) and inbound network services contract(s).090224.docx

Contact centre contract(s) and inbound network services contract(s).121222.docx

I wish to submit to the organisation a freedom of information request relating to the organisation’s ICT contracts, specifically around:
1. contact centre contract(s)
2. inbound network services contract (s)
Please send me the following information for each provider:
contact centre contract(s)
1. Incumbent Supplier: For each of the contract(s) please can you provide me with the supplier of the contract.
2. Annual Average Spend: For each supplier, please state the annual average (over 3 years) spend for each supplier
3. Contract Duration: For each supplier, please state the contract duration of the contract expires. If available please also include any contract extensions.
4. Contract Expiry: For each supplier, please state the date of when the contract expires.
5. Contract Review: For each supplier, please state the date of when the contract will be reviewed.
6. Contract Description: For each supplier, please state a brief description of the services provided of the overall contract.
7. Contact Details: For each supplier, please state the person from within the organisation responsible for the contract. Please provide me with their full name, actual job title, contact number and direct email address. At the very least please provide me with their actual job title.
8. Number of Agents; please provide me with the total number of contact centre agents;
9. Number of Sites; please can you provide me with the number of sites the contact centre covers.
10. Manufacturer of the contact centre: Who is the manufacturer of the contact centre system that you operate?
11. Do you use Microsoft Exchange 2003 as your email server? If not, then which products do you use?
12. Number of email users: Approximate number of email users across the organisations.
inbound network services contract (s)
1. Incumbent Supplier: For each of the contract(s) please can you provide me with the supplier of the contract.
2. Annual Average Spend: For each supplier, please state the annual average (over 3 years) spend for each supplier
3. Contract Expiry: For each supplier, please state the date of when the contract expires.
4. Contract Review: For each supplier, please state the date of when the contract will be reviewed.
5. Contract Description: For each supplier, please state a brief description of the services provided of the overall contract.
6. Contact Details: For each supplier, please state the person from within the organisation responsible for the contract. Please provide me with their full name, actual job title, contact number and direct email address.

Contact centre contract(s) and inbound network services contract(s).121222.docx

Contact Centre, CRM, and AI & Automation.030223.docx

1. Contact Centre – target to organisations we know have a CC a. Do you have a customer/ citizen facing contact centre? If not please skip these questions.
b. Do you employ and manage your own agents, or do you outsource to a third party? If you outsource who to?
c. How many contact centre agents do you have?
d. Do agents work from home? Or just your offices?
e. Please confirm the manufacturer of your contact centre system(s) that are currently in place?
f. When is your contract renewal date?
g. Who maintains your contact centre system(s)?
2. CRM
a. Do you use a CRM in the contact centre? What platform is used?
b. Do you use the same CRM for the rest of the organisation? What platform is used?
c. Do you use a knowledge base / knowledge management platform? What platform is used?
3. AI & Automation
a. Does your organisation have a customer or citizen facing chatbot? If so, who provides this chatbot technology?
b. Does your organisation utilise RPA technology? If so which RPA technology provider do you use?

Contact Centre, CRM, and AI & Automation.030223.docx

Contact Centre or Call Centre Contracts and Inbound Network Services Contracts. 070422.docx

Contact centre/call centre contracts
Please send me the following information for each provider:
1. Incumbent Supplier: For each of the contract(s) please can you provide me with the supplier of the contract.
2. Annual Average Spend: the annual average (over 3 years) spends for each supplier
3. Contract Expiry: the date of when the contract expires.
4. Contract Review: the date of when the contract will be reviewed.
5. Contract Description: a brief description of the services provided of the overall contract.
6. Contact Details: The person from within the organisation responsible for the contract. Please provide me with their full name, actual job title, contact number and direct email address.
7. Number of Agents; please provide me with the total number of contact centre agents.
8. Number of Sites; please can you provide me with the number of sites the contact centre covers.
9. Manufacturer of the contact centre: Who is the manufacturer of the contact centre system that you operate?
10. Busy Periods: Please state the month(s) which the contact centre is at its highest/busiest during the year. This can be based upon the number of calls. Your provider may be able to tell you quicker. E.g., JAN-MAR, APR, JUNE.
11. Do you use Microsoft Exchange 2003 as your email server? If not, then which product do you use?
12. Number of email users: Approximate number of email users across the organisations.
Please add any further comments attached to this contract if there are any changes coming to the organisation with regards to contact centres.
Inbound network services contracts:
Which could relate to one of the following:
1. 0800, 0845, 0870, 0844, 0300 number
2. Routing of calls
3. Caller Identifier
4. Caller Profile- linking caller details with caller records
5. Interactive voice response (IVR)
For contract relating to the above please can you provide me with?
1. Incumbent Supplier: For each of the contract(s) please can you provide me with the supplier of the contract.
2. Annual Average Spend: the annual average (over 3 years) spends for each supplier
3. Contract Expiry: the date of when the contract expires.
4. Contract Review: the date of when the contract will be reviewed.
5. Contract Description: a brief description of the services provided of the overall contract.
6. Contact Details: The person from within the organisation responsible for the contract. Please provide me with their full name, actual job title, contact number and direct email address.

Contact Centre or Call Centre Contracts and Inbound Network Services Contracts. 070422.docx

Contact Centre or Call Centre Contracts, Inbound Network Services Contracts and Website Traffic Spend Analysis.241121.docx

1. Contact Centre/Call Centre Contracts (Contracts and Costs associating to all/any systems used to manage Inbound Contact from Patients. (i.e. Call/Telephony Management Systems, Email Management Services/software, Help Desk Agents and Hotlines etc.)
a) Do you have a call centre?
b) If yes, how many call centre/support agents do you have?
c) What is your average cost per call (annual)?
d) How many calls does your call centre receive (annual)?
1.1. Incumbent Supplier: For each of the contract(s) can you please provide me with the supplier of the Contract?
1.2. Annual Average Spend: the annual average (over 3 years) spend for each supplier?
1.3. Who is the senior officer (outside of procurement) responsible for these contract areas (including website)?

2. Inbound Network Services Contracts (by “Inbound Network Services”, I am referring to Inbound Call, Telephony and Email Management Services, and any other inbound channels used by Patients to make contact.)
2.1. Incumbent Supplier: For each of the contract(s) can you please provide me with the supplier of the Contract?
2.2. Annual Average Spend: the annual average (over 3 years) spend for each supplier?
2. 3. Who is the senior officer (outside of procurement) responsible for these contract areas (including website)?

3. Website Traffic Spend/Analysis (even if hosted by an Agency)
a) Number of Visits per month (Average)
b) Who is the supplier/agency/internal stakeholder responsible for hosting/maintaining and managing the website(s)?
c) Does your organisation’s website(s) have an on-site search bar?
i. What Content Management System is your site-search connected to (if so)?
ii. What is the Search Bar Utilisation? (If known, % of Website visitors)
iii. Who is the Supplier/Owner of the on-site search on your website?
3.1. Incumbent Supplier: For each of the contract(s) can you please provide me with the supplier of the Contract?
3.2. Annual Average Spend: the annual average (over 3 years) spend for each supplier?
3.3. Who is the senior officer (outside of procurement) responsible for these contract areas (including website)?

Please send me the following information:
1. Incumbent Supplier: For each of the contract(s) can you please provide me with the supplier of the Contract?
2. Annual Average Spend: the annual average (over 3 years) spend for each supplier?
3. Who is the senior officer (outside of procurement) responsible for these contract areas (including website)?

Download response Contact Centre or Call Centre Contracts, Inbound Network Services Contracts and Website Traffic Spend Analysis.241121.docx

IT contracts and infrastructure. 060717

Please send me information with regard to the following:
1. Number of employees
2. URL Filtering vendor
3. URL Filtering annual cost
4. URL Filtering expiry date
5. Firewall vendor
6. Firewall annual cost
7. Firewall expiry date
8. Sandboxing vendor
9. Sandboxing annual cost
10. Sandboxing expiry date
11. Guest WiFi vendor
12. Guest WiFi annual cost
13. Guest WiFi expiry date
14. Number of Egress Points
15. VPN Vendor
16. Number of IT Security Breaches in past 12 months
17. Are you using Office 365?
18. Are you scanning SSL traffic?
19. What are your MPLS costs per year?
20. How many locations do you have connected to your MPLS Network?
21. Who are the people responsible for Network Security?
22. Which cloud Platform or platforms as a Service (PAAS) are you using / looking to use? (AWS, Azure, Google)
23. Who is your Head of Security or Chief Information Security Officer?
24. Who is your Chief Information Officer or Chief Technology Officer?
25. Who is your Senior Cloud Architect?
26. What VPN / RAS solution do you use?
27. How much is your VPN / RAS solution renewal cost?
28. When is your VPN / RAS solution due to be renewed?

Download response IT contracts and infrastructure. 060717

Coronary CT angiography scans. 270918

1) How many Coronary CT angiography scans were performed in the trust in the financial year 2011-12?
2) How many Coronary CT angiography scans were performed in the trust in the financial year 2012-13?
3) How many Coronary CT angiography scans were performed in the trust in the financial year 2013-14?
4) How many Coronary CT angiography scans were performed in the trust in the financial year 2014-15?
5) How many Coronary CT angiography scans were performed in the trust in the financial year 2015-16?

Download response Coronary CT angiography scans. 270918

Corporate software and enterprise applications. 260820

A. Enterprise Resource Planning Software Solution (ERP) -this is the organisation’s main
ERP system and may include service support, maintenance and upgrades.
B. Primary Customer Relationship Management (CRM) Solution-this is the organisation’s main
CRM system and may include service support, maintenance and upgrades. Example of CRM systems the organisation may use could include Microsoft Dynamics, Front Office, Lagan CRM, Firmstep
C. Primary Human Resources (HR) and Payroll Software Solution-this is the organisation’s main
HR/payroll system and may include service support, maintenance and upgrades. In some cases the HR contract maybe separate to the payroll contract please provide both types of contracts. Example of HR/Payroll systems the organisation may use could include iTrent, Resourcelink.
D. The organisation’s primary corporate Finance Software Solution-this is the organisation’s main
Finance system and may include service support, maintenance and upgrades. Example of finance systems the organisation may use could include E-Business suite, Agresso (Unit4), eFinancials, Integra, SAP
In some cases you may come across contracts that provides service support maintenance and upgrades separate to the main software contract, please also provide this information in the response following the requested data below.
For each of the categories above can you please provide me with the relevant contract information listed below:
1. Software Category:
2. Name of Supplier: Can you please provide me with the software provider for each contract?
3. The brand of the software: Can you please provide me with the actual name of the software. Please do not provide me with the supplier name again please provide me with the actual software name.
4. Description of the contract: Please do not just state two to three words can you please provide me with detailed information about this contract and please state if upgrade, maintenance and support is included.
Please also include any modules included within the contract as this will support the categories you have selected in question 1.
5. Number of Users/Licenses: What is the total number of user/licenses for this contract?
6. Annual Spend: What is the annual average spend for each contract?
7. Contract Duration: What is the duration of the contract please include any available extensions within the contract.
8. Contract Start Date: What is the start date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
9. Contract Expiry: What is the expiry date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
10. Contract Review Date: What is the review date of this contract? Please include month and year of the contract. If this cannot be provide please provide me estimates of when the contract is likely to be reviewed. DD-MM-YY or MM-YY.
11. Contact Details: I require the full contact details of the person within the organisation responsible for this particular software contract (name, job title, email, contact number).

Download response Corporate software and enterprise applications. 260820

Corporate software systems. 061117

1) Which system do you use for?
Finance
HR
Payroll
2) When does the current contract expire?
Finance
HR
Payroll
3) What procurement method do you use for?
Finance
HR
Payroll
4) Director name, job title, departmental telephone number and email address for Finance
HR
Payroll

Download response Corporate software systems. 061117

Corporate software/applications

1. Enterprise Resource Planning Software Solutions (ERP)

2. Customer Relationship Management (CRM) Solutions

3. Human Resources (HR) and Payroll Software Solutions

4. Finance Software Solutions (FSS)

Along with the actual contract information for the above can you also provide me with the maintenance and support contract associated with each of the categories above if it not already within the existing contract.

For each of the categories above can you please provide me with the relevant contract information listed below:

1. Software Category: ERP, CRM, HR, Payroll, Finance

2. Software Supplier: Can you please provide me with the software provider for each contract?

3. Software Brand: Can you please provide me with the actual name of the software. Please do not provide me with the supplier name again please provide me with the actual software name.

4. Contract Description: Please do not just state two to three words can you please provide me detail information about this contract and please state if upgrade, maintenance and support is included.
Please also include the modules included within the contract.

5. Number of Users/Licenses: What is the total number of user/licenses for this contract?

6. Annual Spend: What is the annual average spend for each contract?

7. Contract Duration: What is the duration of the contract please include any available extensions within the contract.

8. Contract Start Date: What is the start date of this contract?
Please include month and year of the contract. DD-MM-YY or MM-YY.

9. Contract Expiry: What is the expiry date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.

10. Contract Review Date: What is the review date of this contract?
Please include month and year of the contract. If this cannot be provided please provide me estimates of when the contract is likely to be reviewed. DD-MM-YY or MM-YY.

11. Contact Details: I require the full contact details of the person within the organisation responsible for this particular software contract.

Download response Corporate software/applications 080216

Current software systems in urgent care centres. 160119

Question 1
How many Tier 3 A&Es does your trust currently have?
[Could you list each Tier 3 A&E and their specialty if any]
Question 2
2a) Who set up the Tier 3 A&Es?
2b) Are they run in partnership with an out-of-hours care provider like Care UK or Vocare?
2c) Is there a contract in place for partnership?
[Yes or No]
2d) If yes, what is the expiry date of the contract?
Question 3
3a) What Patient Management Software system is used to document the details of an individual presenting at your Tier 3 A&E?
[Please acknowledge that if different systems are used, which Tier 3 A&£ uses which system]
3b) Who is the provider of the Patient Management Software system?
3c) When does your current Patient Management Software contract expire?
3d) What is the annual cost for using your chosen Patient Management Software?
3e) With which other systems in your trust is the Patient Management Software interoperable with?
[Please list all which are interoperable]
3f) Does your Patient Management Software interoperate with any Primary Care
Systems (e.g.SystemOne or EMIS Web)?
3g) Does your Patient Management Software interoperate with any Electronic
Patient Record Systems within your trust or outside it? [Yes or No]
3g1) If yes, which can you name the Electronic Patient Record Systems it interoperates with?
3h) What does the Patient Management Software permit in terms of data sharing (push data / pull data)?
Question 4
4a) Which patient triage system is used in the Tier 3 A&E?
[Please indicate if this is different from the Patient Management Software]
4b) When does the contract with your current provider expire?
4c) What is the annual cost for using your chosen patient triage system?
Question 6
6a) Does your trust use a Patient-Level Resource Management Software?
6b) Who is the provider of the Patient-Level Resource Management Software?
6c) When does your current Patient-Level Resource Management Software contract expire?
6d) What is the annual cost for using your chosen Patient-Level Resource Management Software?
6e) With which other systems in your trust is the Patient-Level Resource Management Software interoperable with?
[Please list all which are interoperable]
Question 7
7a) Does your trust use a Staff Planning Software?
7b) Who is the provider of the Staff Planning Software?
7c) When does your current Staff Planning Software contract expire?
7d) What is the annual cost for using your chosen Staff Planning Software?
7e) With which other systems in your trust is the Staff Planning Software interoperable with?
[Please list all which are interoperable]
Question 8
8a) How many Tier 2 A&Es does your trust currently have?
[Could you list each Tier 2 A&E and their specialty if any]
8b) Does the Tier 2 A&E have a Patient Management Software system?
[Yes or No]
If yes, please answer the following questions
8b1) Who is the provider of the Patient Management Software?
8b2) When does your current Patient Management Software contract expire?
8b3) What is the annual cost for using your chosen Patient Management Software?
8b4) With which other systems in your trust is the Patient Management Software interoperable with?

Download response Current software systems in urgent care centres. 160119

Customer Service Requirements and Helpline services.040822.docx

1. Does the Authority Outsource its Customer Service Requirements / Helpline services which may include the provision of staff and / or the telephony used?
2. If yes which services are outsourced and how many staff deliver each of these services?
3. If yes, which company or companies are contracted to provide these services (if multiple please specify each supplier)?
4. What is the contract start and expiry date (if multiple contracts exist please specify for each)?
5. Is there an extension period within the contract? If yes, what is the period (if multiple contracts exist, please specify for each)?
6. What is the annual contract value (if it is a zero-value contract eg. based on activity, what has been the average spend or budgeted amount and if multiple contracts exist, please specify for each)?
7. Is the authority partnering / working with any other Authorities / Partners on developing services which cover larger geographic areas (if yes, please specify service, location, and partners)?
8. Does the Authority have an efficiency target for this financial year 2022/23, if yes please specify % of overall budget and amount to save?
9. Does the Authority provide in-house or outsource Patient Transport Services (if outsourced please specify contract start / expiry dates inc contract extensions, provider name, annual contract value and number of staff to deliver the service, please split by back-office and direct staff)?
10. Is the Authority investing in Digital Solutions in 2022-23, for it’s patients and are you working with any other partners to this effect (if yes, please specify nature of solution and partners name(s) (if any))?
11. What, if any, Digital Technologies would you like to see the Authority implement and/or adopt, if money was no barrier, to improve quality of service internally and externally?
12. What was the total number of patients the Authority treated (in all it’s meanings) in: 2021 – 2022 / 2020 – 2021 / 2019 – 2020 / 2018 – 2019?
13. Who is responsible for Digital Transformation within your organisation (name, title, email address) and what is the budget for this in 2022-2023 and where known, in subsequent years eg. part of a 5-year plan?
The Trust requested clarification as follows:
Can you please clarify exactly what you mean by customer service requirement/helpline services – Patient Contact Centres / Interactive Mobile Apps / On-line portals etc
Are these services used by employees only? Patients only? Employees and patients? Both
Are you asking for details of our switchboard services? The IT service desk details or other services? If so which services? Switchboard / IT service desk / other digital solutions you use or are considering implementing.

Customer Service Requirements and Helpline services.040822.docx

Cyber and ransomware attacks. 281116

1. How many times has your organisation been a victim of a cyber-attack in the last two years?
2. How many times has your organisation been a victim of a ransomware attack in the last two years? In each case, was a ransom paid and if so how much was paid?
3. For each of the cyber and ransomware attacks, please provide a summary of the incident. This should including details of who was targeted, how they were targeted, what the immediate impact was, for instance was patient or staff data targeted, and if so in what way and how many people’s data was affected? For each of the attacks, please also detail whether the police became involved, and whether the perpetrator or perpetrators were caught?

Download response Cyber and ransomware attacks. 281116

Cyber and software systems. 181021.docx

1. In the past three years has your organisation:
a. Had any ransomware incidents? (An incident where an attacker attempted to, or successfully, encrypted a computing device within your organisation with the aim of extorting a payment or action in order to decrypt the device?)
i. If yes, how many?
b. Had any data rendered permanently inaccessible by a ransomware incident (i.e. some data was not able to be restored from back up.)
c. Had any data rendered permanently inaccessible by a systems or equipment failure (i.e. some data was not able to be restored from back up.)
d. Paid a ransom due to a ransomware incident / to obtain a decryption key or tool?
i. If yes was the decryption successful, with all files recovered?
e. Used a free decryption key or tool (e.g. from https://www.nomoreransom.org/)?
i. If yes was the decryption successful, with all files recovered?
f. Had a formal policy on ransomware payment?
i. If yes please provide, or link, to all versions relevant to the 3-year period.
g. Held meetings where policy on paying ransomware was discussed?
h. Paid consultancy fees for malware, ransomware, or system intrusion investigation
i. If yes at what cost in each year?
i. Used existing support contracts for malware, ransomware, or system intrusion investigation?
j. Requested central government support for malware, ransomware, or system intrusion investigation?
k. Paid for data recovery services?
i. If yes at what cost in each year?
l. Used existing contracts for data recovery services?
m. Replaced IT infrastructure such as servers that have been compromised by malware?
i. If yes at what cost in each year?
n. Replaced IT endpoints such as PCs, Laptops, Mobile devices that have been compromised by malware?
i. If yes at what cost in each year?
o. Lost data due to portable electronic devices being mislaid, lost or destroyed?
i. If yes how many incidents in each year?
2. Does your organisation use a cloud based office suite system such as Google Workspace (Formerly G Suite) or Microsoft’s Office 365?
a. If yes is this system’s data independently backed up, separately from that platform’s own tools?
3. Is an offsite data back-up a system in place for the following? (Offsite backup is the replication of the data to a server which is separated geographically from the system’s normal operating location site.)
a. Mobile devices such as phones and tablet computers
b. Desktop and laptop computers
c. Virtual desktops
d. Servers on premise
e. Co-located or hosted servers
f. Cloud hosted servers
g. Virtual machines
h. Data in SaaS applications
i. ERP / finance system
j. We do not use any offsite back-up systems
4. Are the services in question 3 backed up by a single system or are multiple systems used?
5. Do you have a cloud migration strategy? If so is there specific budget allocated to this?
6. How many Software as a Services (SaaS) applications are in place within your organisation?
a. How many have been adopted since January 2020?

Download response Cyber and software systems. 181021.docx

Cyber-attack in May 2017. 010617

1) Please provide the total financial cost to the trust caused by/associated with the ‘cyber-attack’ of May 2017 (please include any costs including processes changed, e.g. cost of couriers to send scans to other hospitals, external assistance required, additional staffing, revenue lost)
2) Please provide details of the amount, and nature/rough description, of any cancelled appointments or operations.

Download response Cyber-attack in May 2017. 010617

Cyber-attacks. 171120

A list of all cyber-attacks (both failed and successful) on NHS hospitals falling under your remit, in each year since 2015 (including broader cyber-attacks which include these hospitals). Where possible, please could you split the data as follows:
• Ideally, I am requesting only those cyber-attacks identified as or suspected of a) coming from a source within Russia or China; or b) emanating from any individual(s) or group(s) known to have, or suspected of having, links to the Russian or Chinese state. In each instance, please could you make clear which country the attack relates to.
• If this is not possible, please could you make clear whether an attack is thought to have come from inside/outside the UK.
In each instance, I am also requesting the following information:
• The severity of the attack, where it has been noted (e.g. low, medium, high).
• The outcome of successful attacks. For example: were documents stolen (and how many)? Was confidential data stolen (and how much)? Were any operations or other NHS processes cancelled or delayed as a result (and how many)?
• The cost to the NHS, where that cost is easily deductible/accessible. This could include but is not limited to a) delayed or cancelled operations, lost data, etc.; b) the security/staffing cost of defending against an attack; c) any consequent legal costs e.g. lawsuits filed successfully against the NHS as a result of personal data theft. If this part of the request is unduly onerous, please disregard.

Download response Cyber-attacks. 171120

Cyber attacks 2013 – 2016 060317

1) How many cyber attacks have been conducted against the Trust in the past three years?
2) Please detail the date of each attack.
3) Please detail in each instance what services were disrupted and for how long.
4) Please detail the estimated cost to the Trust of cyber attacks in the past three years.

Download response Cyber attacks 2013 – 2016 060317

Cyber-attacks 2014-2017. 010617

Please could you answer the following:-
1. Does your organisation keep an incident log of cyber-attacks?
2. How many cyber-attacks – attempted and successful – were recorded against your organisation in the last three financial years, year-by-year (i.e. 2014/15, 2015/16, 2016/17)?
3. Where cyber-attacks were successful, what kind of data and what amount of data, if any, was lost or stolen? Was it confidential?
4. For each case, please confirm:- the type of attack (e.g. ransomware, denial of service etc.)
5. What demand, if any, was made to resolve the attack? Did the organisation comply?
6. Whether the attack was reported to police or other responsible authority? Was the attacker traced/convicted?

Download response Cyber-attacks 2014-2017. 010617

Cyber-attacks. 260617

1. How many cyber-attacks were registered against your hospital’s computers and website pages in each of the last five financial years, including 2017-18 to date?
• Could you please provide a figure broken down for each financial year?
• Can you please list examples of the types of cyber-attack, for instance ransomware, phishing attacks, malware virus incidents and social engineering attacks?
2. From which countries did the cyber-attack originate?
3. Where possible, can you give details of the nature of any security breaches or operational impact which resulted from cyber-attacks or e-crimes against your hospitals?
• Could you please list whether diagnostic equipment such as scanners, including MRI scanners were affected and for how long?
4. Is your hospital trust using external companies to help them prevent cyber-attacks and if so how much is the trust paying for their services?

Download response Cyber-attacks. 260617

Cyber attacks. 270821.docx

1. How many cyber-attacks (incidents) did your organisation experience in the last 3 years?
2. If these statistics are available within the cost limit, how many of those incidents involved
a) Malware
b) Ransomware
c) Hacking
d) Phishing emails
3. How many incidents over the last 3 years were reported to the Department of Health and Social Care, whether under the Security of Network and Information Systems Regulations 2018, or otherwise?
4. How many incidents over the last 3 years resulted in a notification to the Information Commissioner’s Office?
5. How many incidents over the last 3 years were reported to both DHSC and the ICO?

Download response Cyber attacks. 270821.docx

Cyber Essentials Accreditation. 151121.docx

“1. Does your organisation have Cyber Essentials Accreditation/Certification in place?
1.1 Where the answer to the above is Yes’ – when does it expire?
1.2 Where the answer to the above is a ‘No’, (a)are you planning on achieving the Cyber Essentials (CE) certification and (b)by which date?
2. Does your organisation have Cyber Essentials Plus Accreditation/Certification in place?
2.1 Where the answer to the above is Yes’ – when does it expire?
2.2 Where the answer to the above is ‘No’ – (a)are you planning on achieving the Cyber Essentials Plus (CE+) certification and (b)by which date?”

Download response Cyber Essentials Accreditation. 151121.docx

Cyber Insurance Spending.080223.docx

SECURITY / CYBER SECURITY Insurance
1. Does your organisation currently have cyber insurance or plan to invest in cyber insurance in the next 12 months?
2. If you have cyber insurance who is the policy with?
3. If you have cyber insurance when does the policy come up for renewal?
4. If you have cyber insurance what is the cost of your current policy or renewal?

Cyber Insurance Spending.080223.docx

Cyber security. 011217

1. What was your total annual spend on cyber security in tax years?
– 2014-2015
– 2015-2016
– 2016-2017
– 2017-2018
2. If any, how many successful and unsuccessful cyber-attacks did you have during the above years?
3. For the above years, what types of attacks or attempted attacks happened
4. If any attacks were successful how did this happen and how was this dealt with?
5. What is your current cyber security strategy?

Download response Cyber security. 011217

Cyber security. 020617

ID 4037 -. How many computers across your Trust use Windows XP?
ID 4038 – What the predicted/estimated cost to your trust is/for/against cyber-attacks across 2017?
ID 4039 – How many patients had to be notified of an appointment being cancelled due to the cyber-attack on NHS systems on the 12th May 2017?
ID 4040 – Could you advise how many attempted cyber-attacks have been directed at your trust in 2016 and 2017 to date?
ID 4041 – How many computer infection attempts have been cleared/stopped by your firewall or antivirus software by day for the month of May 2017 so far?

Download response Cyber security. 020617

Cyber security. 030517

1. Has your organisation completed all of the government’s ’10 steps to cyber security’?
O Yes
O No

2. Have you suffered Distributed Denial of Service (DDoS) cyber-attacks on your network in the last year?
O Yes
O No

3. If so, how many DDoS attacks did you experience during 2016?
a. Attacks occur weekly or even daily
b. Attacks occur monthly
c. Less than a handful of attacks during the entire year

4. Has your organisation ever been the victim of a DDoS attack which was used in combination with another type of cyber-attack, such as a demand for ransom/ransomware, network infiltration or data theft?
O Yes
O No

5. How does your IT team detect that your organisation has suffered a DDoS attack?
O End-users complain of a service issue
O High bandwidth spikes with other network security tools
O Infrastructure outages/failures, (e.g. firewalls went down)
O Application failures, eg. Websites going down

6. Does your method of DDoS mitigation detect sub-saturating DDoS attacks of less than 30 minutes in duration, which do not typically overwhelm the network?
O Yes
O No

Download response  Cyber security. 030517

Cyber security. 070121

1. The total amount spent by the Trust on data security and cyber security training in the 12 months to the 1st of December 2020 (or the last year for which data was available); and the breakdown of these costs in terms of the training undertaken.
2. The total amount spent by the Trust on private cyber security contractors and/or consultants/consultancies the last 12 months to the 1st of December 2020.
3. The total number of ransomware attacks (or other cyber attacks) in the last 12 months to the 1st of December 2020.
4. The total amount spent by the Trust in recovery costs from ransomware (or other cyber-attacks) the last 12 months to the 1st of December 2020.
5. The total number of qualified cyber security and data security professionals employed by the Trust.

Download response Cyber security. 070121

Cyber security.080623.docx

1. For each year (2020 – 2022), please confirm how many cyberattacks your Trust has suffered?
2. For each year (2020 – 2022), please confirm how many cyberattacks have resulted in the halting of or delay in delivery of care or services to patients?
For each year (2020-2022), please confirm:
3. The GBP (£) value of budget allocated to cybersecurity
4. What percentage of the Trust’s entire budget for the financial year was spent on cybersecurity?
5. How many times in the last 12 months have you audited your third-party suppliers’ cybersecurity measures?

Cyber security.080623.docx

Cyber security.100523.docx

1. What was the total number of cyber-attack incidents that have been recorded in your trust in the past 24 months?
2. What is the classification of your policy regarding breach response?
3. Of the devices running Windows operating systems, what is the number and percentage of devices running Windows 11, Windows 10, Windows 7, Windows XP?
4. What are the top 20 cyber security risks in your Trust, and how are they managed?
5. Do you continue to use the Unified Cyber Risk Framework, is so how many risks are still identified/managed.
6. What is your Patch Management Cycle and how is it implemented on old Operating systems (e.g., for Windows, Windows XP)?
7. What is your current status on unpatched Operating Systems?
8. Of the devices running Windows Servers operating systems, what is the number and percentage of devices running Windows 2000, Windows 2003, Windows 2008, Windows 2012, Windows 2016, Windows 2019, Windows 2022?
9. Has your Trust signed up to and implemented the NHS Secure Boundary managed service to strengthen cyber resilience? If so, how many cyber security threats has the NHS Secure Boundary detected within your NHS Trust since its implementation?
10. Does your Trust hold a cyber insurance policy? If so:
a. What is the name of the provider;
b. How much does the service cost; and
c. By how much has the price of the service increased year-to-year over the last three years?
11. When did the current Board last receive a briefing on cybersecurity threats within healthcare, and when did they last participate in cyber security training? How frequently, if at all, do these briefings and trainings occur, and are they carried out by cyber security technology professionals?
12. Has your NHS Trust completed a Connection Agreement to use the Health and Social Care Network (HSCN)? If so, did you pass, and is there a copy of the code of connection?
13. Have there been any incidents of staff members or personnel within your Trust being let go due to issues surrounding cyber security governance?
14. How many open vacancies for cyber security positions are there within your Trust, and is their hour capacity affected by a shortage of qualified applicants?
15. Are there mandatory minimum training requirements for those transferred internally to work in cybersecurity within your Trust, and if so, how often is the training updated and revised to reflect the evolving nature of the industry?
16. How much money is spent by your Trust per year on public relations related to cyber-attacks? What percentage of your overall budget does this amount to?
17. Does your Trust have a Chief Information Risk Officer? If so, who do they report to?
18. When was the last time your Trust underwent a security audit? At what frequency do these audits occur?
19. What is your strategy to ensure security in cloud computing?
20. Do you purchase additional / enhanced support from a Supplier for end-of-life software (Operating Systems / Applications)? If so, what are the associated costs per year per Operating System /Application, and the total spend for enhanced support?

Cyber security.100523.docx

Cyber Security 2012-2017 221216

1. How much money has the Trust spent on cyber security measures in the following financial years:
a. 2016-17 (so far)
b. 2015-16
c. 2014-15
d. 2013-14
e. 2012-13
i. If data for the current financial year is incomplete or unavailable, please provide the data for the most recent financial years. If these exceed the cost limit of FoI requests, then please provide the data for as many recent years as possible.
2. How many cyber-attacks has the Trust experienced in the following financial years:
a. 2016-17 (so far)
b. 2015-16
c. 2014-15
d. 2013-14
e. 2012-13
i. If data for the current financial year is unavailable, please provide the data for the most recent financial years. If these exceed the cost limit of FoI requests, then please provide the data for as many recent years as possible.
3. How were each of these cyber threats dealt with? If this request exceeds the FOI cost limit, then please provide as much explanation as possible of how the Trust dealt with the most recent cyber threats.
4. What was your Trust’s total spending budget for the following financial years:
a. 2016-17
b. 2015-16
c. 2014-15
d. 2013-14
e. 2012-13

Download response Cyber Security 2012-2017 221216

Cyber security. 210218

1. Does your organisation adhere to the Network Security guidance outlined by the National Cyber Security Centre, within its’10 Steps to Cyber Security’?
o Yes
o No
2. Do you ensure that security patches for critical vulnerabilities are routinely patched within 14 days, as recommended by the National Cyber Security Centre?
o Yes
o No
3. Have you suffered from any service outages on your network in the last two years, however small?
o Yes
o No
4. Did any of these outages cause a loss, reduction or impairment to your organisation’s delivery of essential services?
o Yes
o No
5. Was the root cause of the service outage identified and confirmed – at the time or afterwards?
o Yes
o No
6. Is it possible that any service outages you have suffered in the last two years was caused by a cyber-attack – such as ransomware, DDoS attack, or malware?
o Yes
o No
7. Are you aware that Distributed Denial of Service (DDoS) attacks are a significant contribution to service interruptions, outages and downtime?
o Yes
o No

Download response Cyber security. 210218

Cyber Security. 221119

1. Could you please tell me whether you have had a CHECK test in i) 2016/17, ii) 2017/18 and iii) 2018/19?
2. Could you also tell me what cyber security do you have aside from CHECK work including the following i) user education ii) other penetration tests iii) internal security team iv) other.
3. Could you please tell me how many incidents of cyber-attacks you have recorded since the beginning of 2017?
4. Of these can you tell me how many incidents were referred to external sources including the police, the National Crime Agency and the National Cyber Security Centre?
5. How many of these incidents were handled internally?

Download response Cyber Security. 221119

Cyber Security. 280120

1. The total amount spent by the Trust on data security and cyber security training in the 12 months to the 1st of November 2019; and the breakdown of these costs in terms of the training undertaken.
2. The total amount spent by the Trust on private cyber security contractors and/or consultants/consultancies in the last 12 months.
3. The total number of qualified cyber security and data security professionals employed by the Trust.

Download response Cyber Security. 280120

Cyber security. 291020

NHS Trust name:
Region:
1. The total number of full-time and part-time employees employed by your trust (as of 1st October 2020 or latest figures available)
2. The total number of full-time and part-time employees employed by your trust with professional data security / cybersecurity qualifications (as of 1st October 2020 or latest figures available) – Common qualifications may include any cyber or IT security related qualifications such as CISSP, SSCP, CSA, CEH, CISA, CISM, Security+
3. The total number of full-time and part-time employees employed by your trust who have completed cyber security training over the last 12 months (prior to 1st October 2020 or latest figures available)
4. How much money (in pounds sterling) has been spent on cyber security training during the last 12 months (prior to 1st October 2020 or latest figures available) this may include GDPR-related training
5. How many penetration tests has your organisation had from an external third-party in the last 12 months? (prior to 1st October 2020 or latest figures available)
6. How many data breaches did your trust report to the ICO between 1st January 2019 and 1st October 2019 How many data breaches did your trust report to the ICO between 1st January 2020 and 1st October 2020

Download response Cyber security. 291020

Cyber Security. 300620

1. Standard Firewall (Network) – Firewall service protects your corporate Network from unauthorised access and other Internet security threats
2. Anti-virus Software Application – Anti-virus software is a program or set of programs that are designed to prevent, search for, detect, and remove software viruses, and other malicious software like worms, trojans, adware, and more.
3. Microsoft Enterprise Agreement – is a volume licensing package offered by Microsoft.
The information I require is around the procurement side and we do not require any specifics (serial numbers, models, location) that could bring threat/harm to the organisation.
For each of the different types of cyber security services can you please provide me with:
a. Who is the existing supplier for this contract?
b. What does the organisation annual spend for each of contract?
c. What is the description of the services provided for each contract? Please do not just state firewall.
d. Primary Brand (ONLY APPLIES TO CONTRACT 1&2)
e. What is the expiry date of each contract?
f. What is the start date of each contract?
g. What is the contract duration of contract?
h. The responsible contract officer for each of the contracts above? Full name, job title, contact number and direct email address.
i. Number of Licenses (ONLY APPLIES TO CONTRACT 3)

Download response Cyber Security. 300620

Cyber security contract data. 141218

1. Standard Firewall (Network) – Firewall service protects your corporate Network from unauthorised access and other Internet security threats
2. Anti-virus Software Application – Anti-virus software is a program or set of programs that are designed to prevent, search for, detect, and remove software viruses, and other malicious software like worms, Trojans, adware, and more.
3. Microsoft Enterprise Agreement – is a volume licensing package offered by Microsoft.
The information I require is around the procurement side and we do not require any specifics (serial numbers, models, location) that could bring threat/harm to the organisation.
For each of the different types of cyber security services can you please provide me with?
1. Who is the existing supplier for this contract?
2. What does the organisation spend for each of contract?
3. What is the description of the services provided for each contract?
4. Primary Brand (ONLY APPLIES TO CONTRACT 1&2)
5. What is the expiry date of each contract?
6. What is the start date of each contract?
7. What is the contract duration of contract?
8. The responsible contract officer for each of the contracts above? Full name, job title, contact number and direct email address.
9. Number of License (ONLY APPLIES TO CONTRACT 3)

Download response Cyber security contract data. 141218

Cyber Security Services 181116

1. Standard Firewall (Network) – Firewall service protects your corporate Network from unauthorised access and other Internet security threats
1. Who is the existing supplier for this contract?
2. What does the organisation spend for each of contract?
3. What is the description of the services provided for each contract?
4. What is the expiry date of each contract?
5. What is the start date of each contract?
6. What is the contract duration of contract?
7. What is the hardware brand? If available.
8. What is the software brand? If available?
9. The responsible contract officer? Full name, job title, contact number and direct email address.
2. Intrusion Detection – network intrusion detections systems (IDS) and network intrusion prevention systems (IPS) services that detect Web application attacks and include anomaly-awareness in addition to handling older threats that haven’t disappeared.
1. Who is the existing supplier for this contract?
2. What does the organisation spend for each of contract?
3. What is the description of the services provided for each contract?
4. What is the expiry date of each contract?
5. What is the start date of each contract?
6. What is the contract duration of contract?
7. What is the hardware brand? If available.
8. What is the software brand? If available?
9. The responsible contract officer? Full name, job title, contact number and direct email address.
3. Web Applications Firewall – A Web application firewall (WAF) is a firewall that monitors, filters or blocks the HTTP traffic to and from a Web application.
1. Who is the existing supplier for this contract?
2. What does the organisation spend for each of contract?
3. What is the description of the services provided for each contract?
4. What is the expiry date of each contract?
5. What is the start date of each contract?
6. What is the contract duration of contract?
7. What is the hardware brand? If available.
8. What is the software brand? If available?
9. The responsible contract officer? Full name, job title, contact number and direct email address.
4. Threat Monitoring – organizations and security analysts to identify and protect against security threats.
1. Who is the existing supplier for this contract?
2. What does the organisation spend for each of contract?
3. What is the description of the services provided for each contract?
4. What is the expiry date of each contract?
5. What is the start date of each contract?
6. What is the contract duration of contract?
7. What is the hardware brand? If available.
8. What is the software brand? If available?
9. The responsible contract officer? Full name, job title, contact number and direct email address.
5. Anti-virus Software Application – Anti-virus software is a program or set of programs that are designed to prevent, search for, detect, and remove software viruses, and other malicious software like worms, trojans, adware, and more.
1. Who is the existing supplier for this contract?
2. What does the organisation spend for each of contract?
3. What is the description of the services provided for each contract?
4. What is the expiry date of each contract?
5. What is the start date of each contract?
6. What is the contract duration of contract?
7. What is the hardware brand? If available.
8. What is the software brand? If available?
9. The responsible contract officer? Full name, job title, contact number and direct email address.
6. Encryption Facilities – s a host based software solution designed to encrypt sensitive data before transferring it to tape for archival purposes or business partner exchange.
1. Who is the existing supplier for this contract?
2. What does the organisation spend for each of contract?
3. What is the description of the services provided for each contract?
4. What is the expiry date of each contract?
5. What is the start date of each contract?
6. What is the contract duration of contract?
7. What is the hardware brand? If available.
8. What is the software brand? If available?
9. The responsible contract officer? Full name, job title, contact number and direct email address.

Download response Cyber Security Services 181116

Cybersecurity. 110319

1. Are you aware of the Minimum Cyber Security Standard, published 25th June 2018?
2. What is your annual dedicated budget for cybersecurity (including personnel and technology)?
3. Approximately how many cyber-attacks (of any kind) have you experienced in your organisation in these 12-month periods?
4. Which of the following attack / cybersecurity threat types have been detected by your organisation?
5. Which of the following form part of your cybersecurity defence technology strategy?
6. Which of these obstacles has your organisation experienced in maintaining or improving IT security?

Download response Cybersecurity. 110319

Cybersecurity. 180817

1. Do the Trust’s clinical systems share username and password combinations? [Yes, all/Yes, some/No]
2. For clinical systems, are users required to change their passwords at pre-defined regular intervals? [Yes, all/Yes, some/No]
3. For clinical systems, are minimum requirements set regarding users’ passwords’ composition e.g. mandating that they containing ‘special’ characters, contain upper and lowercase letters or contain numbers and letters (please do not include rules regarding password length in this answer)? [Yes, all/Yes, some/No]
4. For clinical systems, are minimum length requirements set regarding users’ passwords e.g. that they must be more than a pre-specified number of characters? [Yes, all/Yes, some/No]
5. For clinical systems, are maximum length requirements set regarding users’ passwords e.g. that they must be less than a pre-specified number of characters? [Yes, all/Yes, some/No]
6. Are users provided with an indicator of password strength when they are choosing passwords for clinical systems? [Yes, all/Yes, some/No]
7. For clinical systems, are passwords checked against published databases of known compromised passwords e.g. those available at haveibeenpwned.com? [Yes, all/Yes, some/No]
8. For clinical systems, are passwords stored as plain text? [Yes, all/Yes, some/No]
9. For clinical systems where passwords are stored hashed, are password hashes salted? [Yes, all/Yes, some/No/Not applicable]
10. For clinical systems, when incorrect passwords are entered, do further attempts eventually result in either throttling of further access attempts or account lock-out? [Yes, all/Yes, some/No]
11. For clinical systems, when users log in successfully, are they shown details of recent logins to that account? [Yes, all/Yes, some/No]
12. For clinical systems with web browser based interfaces, is login compatible with password management software (for example 1Password or Last Pass)? [Yes, all/Yes, some/No]
13. For clinical systems, does the Trust employ two-factor authentication? [Yes, all/Yes, some/No]
14. Does the Trust provide access to clinical systems from outside Trust premises e.g. using virtual private network technology? [Yes/No]
15. Is access to clinical systems from outside the Trust premises restricted to Trust-owned devices? [Yes/No/Not applicable]
16. Does access to the Trust’s network from outside Trust premises require two-factor authentication? [Yes, all/Yes, some/No/Not applicable]
17. For devices with access to the Trust’s network, are manufacturers’ passwords changed from default on installation? [Yes, all/Yes, some/No]
18. Do users of the Trust’s clinical systems receive specific training on cybersecurity in general? [Yes, all/Yes, some/No]
19. Do users of the Trust’s clinical systems receive specific training in choosing and maintaining appropriate passwords? [Yes, all/Yes, some/No]
20. Do users of the Trust’s clinical systems receive specific advice not to share passwords between clinical systems and other accounts? [Yes, all/Yes, some/No]

Download response Cybersecurity. 180817

Da Vinci robots. 271119

1. How many Intuitive Surgical DaVinci Robots do you have in your Trust and which model are they? I.e. DaVinci Si, X, XI, SP etc.
2. How many and which procedures did you complete with each model of DaVinci robot in the last 3 financial years and year to do date?
3. Which surgeons use the Da Vinci Robot in your Trust?
4. What is your total spend by financial year for the last two years with Initiative Surgical with the following product codes:-

Download response Da Vinci robots. 271119

Darktrace. 290421

1. Please provide the following details of any and all gifts and/or hospitality provided by the cybersecurity company Darktrace (also known as Darktrace Limited, Darktrace Holdings and Darktrace Plc):
a. The monetary value;
b. The description;
c. The date;
d. The unit, office or department in which the recipients of the gifts/hospitality worked;
e. Whether the gifts/hospitality were accepted, rejected, or otherwise donated;
2. Please provide this information for any gifts/hospitality received from June 2013 onwards inclusive in the form of an itemised list for each instance of a gift and/or hospitality.
3. Please also disclose whether you were using Darktrace’s services in May 2017.

Download response Darktrace. 290421

Data analytics capabilities. 200220

1. Does your data analytics software have the following capabilities?
a. Machine learning
b. Artificial intelligence
c. Conversational interaction e.g. natural language interface
d. Open APIs
e. Mobile application
f. Near real time analysis
g. Interactive dashboards
2. Please confirm whether data analytics technology is used in the following ways at your hospital:
a. To access near real-time patient flow information
b. To forecast demand and resources required
c. To identify population health patterns and risk stratification
d. To manage purchasing levels of medical supplies
e. To inform patient diagnosis
f. To inform the creation of clinical pathways
g. To inform resource and recruitment
3. Does your data analytics solution provide alerts for the following?
a. Performance and compliance metrics
b. Key operational issues, e.g. emergency department demand
4. Across how many different systems does your hospital hold data?
a. 1-10
b. 20-50
c. 50-100
d. 100-300
e. 300+

Download response Data analytics capabilities. 200220

Data analytics to support in the management of the response to Covid 19. 220620

1) Is your Trust using data analytics to support in the management of its response to Covid 19?
2) If so, please could you confirm the use cases (i.e. medical resource management, monitoring patients that have tested for the virus and those that have tested positive, tracking the patient journey for those that have tested positive for the virus, ward management for patients that have test positive for the virus, identifying which healthcare workers have been exposed to the virus, etc.)?
3) If so, please could you confirm which roles in the Trust will have access to your Trust’s data analytics results regarding Covid 19 (please confirm for each of the following roles listed): Physician, Nurse, Pharmacist, Management, Accountant/Finance, HR and Recruitment, IT Office, Administrative Assistants, Data analyst/scientist (including roles such as Performance Reporting and Informatics)

Download response Data analytics to support in the management of the response to Covid 19. 220620

Data and Digital Infrastructure.270722.docx

As part of building our understanding of current infrastructure within each acute trust or provider, would you please be able to answer the following: –

1. What PAS (Patient Administration System) are you using?
a. Do you see this changing in the near future?
2. What LIMS (Laboratory Information Management System(s)) are you using?
a. Do you see this changing in the near future?
3. What RIS (Radiology Information System(s)) are you using?
a. Do you see this changing in the near future?
4. What PACS (Picture Archiving Communication System(s)) are you using? a. Do you see this changing in the near future?
5. What alternative datasets are you using i.e. specific dashboards and periodic sitreps?
a. Do you see this changing in the near future?
6. Lastly, what is your data warehousing situation? Is it on-site, off-site or cloud based – and who is the hosting provider?
a. Do you see this changing in the near future?

Data and Digital Infrastructure.270722.docx

Data Breaches. 171120

We are conducting research on the protection of data stored within the public sector and wish to know the following:
1. How many cloud data breaches have occurred within your organisation in 2019 and 2020?
2. How many cyber attacks have occurred within your organisation in 2019 and 2020?
3. How many ransomware attacks have occurred within your organisation in 2019 and 2020?
4. How many data loss incidents have occurred as a result of lost or stolen devices storing your organisation’s data (such as USB flash drives, Hard Drives, Solid State Drives, mobile phones or laptops) within your organisation in 2019 and 2020?
Please split any data supplied separately for 2019 and 2020.

Download response Data Breaches. 171120

Data breaches 2014-2016. 020617

Please could you provide me with the number of data breaches recorded by your trusts for each of the past three years? Please give a breakdown for each year.

Could you please provide a spreadsheet giving details of each incident?

For example please provide information on the type of data breach (e.g. communications being sent to the wrong person, breaches of confidentiality, loss or theft of data and unauthorised access to data) and specific details of what happened.

Download response Data breaches 2014-2016. 020617

Data breaches. 230821.docx

I would like to receive information about the number of data breaches your NHS foundation has experienced. This can be, for example, an email sent out to the wrong recipient, fail to BCC in an email or other human errors that caused data breach.

Can. I please receive the number of data breaches for the past 5 financial years meaning financial year 2020/2021,2019/2020.2018/2019, 2017/2018 and 2016/2017.

Can the information supplied be broken down by year?

Download response Data breaches. 230821.docx

Data breaches and cyber security 2014 and 2015 111016

1. How many data breaches you detected in 2015
2. How many of those breaches were cyber incidents
3. How many data breaches you detected in 2014
4. How many of those breaches in 2014 were cyber incidents
5. How much your trust spent on cybersecurity in 2015?
6. How much your trust spent on cybersecurity in 2014?

Download response Data breaches and cyber security 2014 and 2015 111016

Data hosting. 080517

1. Do you host your data in-house or with external providers?
2. Is any of your data stored in the cloud? If so, do you use private or public cloud?
3. Are you considering moving any data into the cloud during the next 12 months?

Download response Data hosting. 080517

Data integration and data analytics technology. 180220

For the following question, we understand data integration technology to be a solution that automates the moving of data in near real time to a data warehouse, Data Lake or in the cloud.
1. Does your hospital have a data integration technology and what is it?
For the following questions, we understand data analytics technology to mean software that aggregates and analyses data to identify patterns and deliver insights.
2. Which roles in the hospital currently have access to data analytics technology (please confirm for each of the following roles listed): Physician, Nurse, Pharmacist, Management, Accountant/Finance, HR and Recruitment, IT Office, Administrative Assistants, Data analyst/scientist (including roles such as Performance Reporting and Informatics)
3. Of those that have access to data analytics technology, please confirm whether people in the following roles are able to access the technology on mobile devices (please confirm for each of the following roles listed): Physician, Nurse, Pharmacist, Management, Accountant/Finance, HR and Recruitment, IT Office, Administrative Assistants, Data analyst/scientist (including roles such as Performance Reporting and Informatics)
4. If your data analytics technology is not available on mobile devices, please confirm whether people in the following roles must access it on desktop computers (please confirm for each of the following roles listed): Physician, Nurse, Pharmacist, Management, Accountant/Finance, HR and Recruitment, IT Office, Administrative Assistants, Data analyst/scientist (including roles such as Performance Reporting and Informatics)

Download response Data integration and data analytics technology. 180220

Data management systems. 141221.docx

Please list the supplier and system name of all data management systems in use for point of care testing devices within your hospital/trust.

A Point of Care (POC) testing device is used throughout the hospital to provide near patient testing at the patient point of care instead of testing in the Laboratory. These devices are typically managed by the Laboratory, Point of Care team or Medical Physics. A POC Data Management System (DMS) is used to manage these devices and gather their patient test data so it can be sent to other Hospital Systems. We would like to know the supplier and system name of any POC DMS systems used by the Trust.

Download response Data management systems. 141221.docx

Data Quality Framework. 020821.docx

I am writing to see if you currently have a Data Quality Framework in place. if so, would you please share and provide me with a copy of it?

Download response Data Quality Framework. 020821.docx

Data security and cyber awareness. 110119

1. Does the organisation have training that covers:
a. Recognising and reporting Phishing emails
b. Recognising Tailgating and how to respond (challenging strangers, checking for ID etc.)
c. Disposal of confidential information
d. Dangers of using USB sticks being given away or finding one that looks like it has been dropped
2. Does the organisation allow the use of USB sticks?
3. Does the organisation deliver specialised training to key staff (those staff that could be targeted as part of a phishing email campaign, i.e. finance, execs etc.)?
4. Does the organisation perform confidentiality audits as per the Data Security & Protection Toolkit?
Can you also answer relating to the audits:
a. Where the audits are undertaken would these be organised with the local team manager or the head of department i.e. the director etc.?
b. Would an audit ever be carried out unannounced?
c. Do you have a policy / procedure of how to conduct the audit? – if so can you supply a copy.
d. Do you record the results on a checklist / report and return the key contact? – if so can you supply a blank copy.
5. Does the organisation have confidential waste receptacles placed through the entire organisation and are they regularly emptied?
6. Does the organisations Exec board receive board level training relating to Cyber Awareness?
7. How does the organisation provide Data Security & Protection Training to staff, does the organisation use (please select all the options that are applicable):

Download response Data security and cyber awareness. 110119

Data sharing agreements with private organisations.

1 – How many data sharing agreements or information sharing agreements does the trust currently have with private organisations to share patient files or records?

2 – For each, please state i) the organisation concerned, ii) the number of patients involved and iii) the purpose of the agreement.

3 – Please also specify whether patients were asked beforehand if their information could be shared or whether the agreement was made on the basis of implied consent.

Download response Data sharing agreements with private organisations 180516

Data sharing and data skills. 130220

1. Is your hospital part of a multi-agency integrated network that shares data for analysis? If so, please confirm with which agencies you share data (i.e. police, social services, fire services, etc.)
2. Is your hospital part of any of the following networks and, if so, do you share data for analysis with other organisations in this network:
a. Integrated Care Partnership
b. Integrated Care System
c. Primary care groups, e.g. GP’s
d. Local Integrated Care Record Exemplars
3. If your hospital is part of a multi-agency integrated network that shares data for analysis, does the network conduct analysis for the following use cases:
a. To understand key population health issues
b. To allocate funding for key preventative work
c. To identify vulnerable and high-risk people for support interventions
For the following questions, we define a data literacy programme as a training programme for employees that helps them learn how to read, understand, question and analyse data.
4. Do you have a data literacy programme?
5. If so, is the data literacy programme made available to people in the following roles (please confirm for each of the following roles listed): Physician, Nurse, Pharmacist, Management, Accountant/Finance, HR and Recruitment, IT Office, Administrative Assistants, Data analyst/scientist (including roles such as Performance Reporting and Informatics)

Download response Data sharing and data skills. 130220

Data Storage. 070720

1. Who is responsible for Data Centre technology?
2. What data storage vendor(s) do you currently use?
3. What technology resellers do you work with?
4. When was the installation date of above storage vendor(s)? (Month/year)
5. When is your planned (or estimated) storage refresh date? (Month/year)

Download response Data Storage. 070720

Data Storage.270622.docx

Can you please provide an update on the following 4 questions regarding your Trust’s Infrastructure as it relates to the Data Storage element?
1. Please provide the following details about your Data Storage Cloud Provider:
a. Does your Data Storage use Cloud Provision (Yes / No)? –
b. Who is your main Cloud provider? –
c. Annual Spend 2020-21 (£’s) –
d. Contract end date –
e. Additional Notes – e.g. currently out for tender
2. Does your organisation plan to move your Data Storage to a cloud-based service in the next 2 years (Yes or No)? –
a. Main Supplier –
b. Additional Notes –
3. For each element detailed below, how does your organisation manage its data storage?
In-house data centre:
a. On Premise OR Off Premise (N/A if does not apply) –
b. Main Supplier –
c. Annual Spend 2020-21 (£’s) –
d. Contract end date –
e. Additional Notes –
Shared service:
a. On Premise OR Off Premise (N/A if does not apply) –
b. Main supplier –
c. Annual Spend 2020-21 (£’s) –
d. Contract end date –
e. Additional Notes –
Data Storage Management:
a. On Premise OR Off Premise (N/A if does not apply) –
b. Main supplier –
c. Annual Spend 2020-21 (£’s) –
d. Contract end date –
e. Additional Notes –
Other (please specify)
a. On Premise OR Off Premise (N/A if does not apply) –
b. Main supplier –
c. Annual Spend 2020-21 (£’s) –
d. Contract end date –
e. Additional Notes –
4. Does your Trust have an on-site data centre (Yes / No)? –
a. Do you plan to build an on-site data centre (Yes / No) –
b. If yes, what is the timeframe for this (Years) –
c. Who is your preferred supplier –

Data Storage.270622.docx

Desktop Network Helpdesk Support.

I wish to submit a freedom of information request relating to the following contractual information the organisation may hold with regards to the organisation’s primary contracts relating to support services around help/service desk, desktop support and network support:
1. Help / service desk support:
The single point of contact between a service provider and users within an organisation. A typical service desk manages incidents and service requests, and also handles communication with the users.
2. Desktop support:
The technical services offered by a support organisation to a user(s) experiencing problems with their computers. Support may be on either hardware or software running on the affected computing device. Support may include but is not limited to installations, moves, adds, changes and disposition, and local remote services.
3. Network support:
The technical services offered by a support organisation to a user(s) experiencing problems with their network. Support may be on either hardware or software running on the affected computing device. Support may include but is not limited to installations, moves, adds, changes and disposition, and local remote services.
For each of the contract type above can you please provide me with the following information set out below:
1. Contract Type: Please choose from above the type of contract this is related to.
2. What is the Support for Hardware, Software or other please state?
3. Who is this supplier: If there is more than one supplier please input their contract information in another contract profile.
4. What is the annual average spend this can be over 3 or 5 years?
5. What is the duration of the contract please also include any extension periods?
6. When does the contract expire?
7. When will this contract be reviewed by the organisation?
8. Please can you provide me with specific contact details of the person responsible for reviewing/owner of each contract. I’d like their full name, job title, contact number and direct email address.

Download response Desktop Network Helpdesk Support 080216

Dictation and audio typing service. 081117

1: What dictation and audio typing service the Trust currently uses.

2: How long is the contract for and when is it up for renewal.

Download response Dictation and audio typing service. 081117

Digital Communications with Patients.200722.docx

1. Do you use any applications or tools to communicate with your patients digitally?
I am interested in all aspects of patient communication, but particularly:
– Pre- and post-operative communication
– eConsent
– Outpatients
– Emergency Care
– Patient engagement at home
– Patient satisfaction
2. Please advise of the individual(s) (name and/or job title) with responsibility for developing digital communications with patients.
3. Do you have performance targets for monitoring patient satisfaction?
4. If so, please advise of the individual(s) (name and/or job title) with responsibility for monitoring or reporting on these targets.

Digital Communications with Patients.200722.docx

Digital Dictation. 160519

1. Does your Trust use digital dictation? If yes please could you answer the following?
• Name of solution
• Name of supplier
• Date installed
• Which departments currently use digital dictation?
• Are you planning to replace current digital dictation solution?
• What are the timescales for replacement?
2. Does your Trust have an in-house transcription service / typing pool?
3. Does the Trust outsource transcription services? If you do, please could you tell me when your current contract is due to be reviewed?
4. The name, job title of the person responsible within the Trust for clinical work flow?

Download response Digital Dictation. 160519

Digital dictation.180722.docx

1. Do you currently use digital dictation? Yes/No
2. If yes, who is your provider for digital dictation?
3. If no, what is your process for letter production?
4. What is the contract end date for your current digital dictation provider?
5. Do you use outsourced transcription or speech recognition or both?
6. Who are your suppliers for each?
7. What is the contract end date for these suppliers?
8. What EPR and PAS system is used?
9. What is your current letter turnaround time target (from appointment to letter sent to the GP)?
10. Are you compliant with this target?
11. Do your teams suffer from letter backlogs due to capacity?
12. How many secretarial/admin staff are employed to support outpatient letter production?

Digital dictation.180722.docx

Digital Dictation and Voice Recognition systems. 141221.docx

We are currently updating data on your trust’s Digital Dictation and Voice Recognition systems. Can you please complete the fields below with what you currently hold?
System type can also be ‘No System Installed’ if your trust does not use the system:
1. System type – Digital dictation
a. Supplier name –
b. System name –
c. Date installed –
d. Contract expiration –
Notes –
2. System type – Voice Recognition
a. Supplier name –
b. System name –
c. Date installed –
d. Contract expiration –
Notes –
3. If applicable,
a. Can you let us know who supplies your digital dictation hardware devices?
b. How many digital dictation devices does your trust have?
c. When was the procurement date of the digital dictation devices?

System definitions:
Digital Dictation – Device used to record audio and share recordings digitally.
Voice Recognition – Identifies and translates spoken words into text. Used to complete tasks or transcribe documents.

Download response Digital Dictation and Voice Recognition systems. 141221.docx

Digital Dictation or Speech Recognition solutions. 230921.docx

1. If any, which Digital Dictation/Speech Recognition solutions you (The Trust) use
2. Contract end date for any current solution (as named above)
3. What your plans are, if any, to replace your Digital Dictation or Speech Recognition solutions

Download response Digital Dictation or Speech Recognition solutions. 230921.docx

Digital dictation software. 061119

1.Does the Trust utilise digital dictation software?
a. In which departments is the technology installed?
b. Who are the current suppliers of this technology?
c. When do these contracts expire?
d. Was this contract awarded via any Frameworks e.g. SBS?
e. Who in the trust is responsible for the contract management and procurement of these technologies?
f. Please supply contact details for the Chief Operating Officer.
2. Does the Trust utilise any EPMA (Electronic Prescribing) software?
a. In which departments is the technology installed?
b. Who are the current suppliers of this technology?
c. When do these contracts expire?
d. Was this contract awarded via any Frameworks e.g. SBS?
e. Who in the trust is responsible for the contract management and procurement of these technologies?
f. Please supply contact details for the Chief Pharmacist.
3 . Does the Trust utilise voice recognition software?
a. In which departments is the technology installed?
b. Who are the current suppliers of this technology?
c. When do these contracts expire?
d. Was this contract awarded via any Frameworks e.g. SBS?
e. Who in the trust is responsible for the contract management and procurement of these technologies?
4. Does the Trust utilise electronic whiteboard functionality on wards?
a. In which departments is the technology installed?
b. Who are the current suppliers of this technology?
c. When do these contracts expire?
d. Was this contract awarded via any Frameworks e.g. CCS SBS?
e. Who in the trust is responsible for the contract management and procurement of these technologies?
5. Can you please provide the contact details including email address/format of the trust’s IT Director?
a. If the IT Director is not responsible for digital transformation, please supply contact details, including email address/format of the person(s) who are.
6. Could you please supply a current organisational chart for medical records, operations management and digital transformation programmes?

Download response Digital dictation software. 061119

Digital dictation, speech recognition and outsourced transcription services.010317

Part 1 – Generic, non-commercially sensitive information:
1. Please confirm when your current contract for the provision of digital dictation expires;
2. Please confirm when your current contract for the provision of Speech Recognition expires;
3. Please confirm when your current contract for the provision of Outsourced Transcription expires.

Part 2 – Specific information:
1. Digital Dictation
a. Please confirm how many licences the Trust currently has; and
b. Please confirm annual expenditure on Annual Support Fees.
2. Speech Recognition
a. Please confirm how many licences the Trust currently has; and
b. Please confirm annual expenditure on Annual Support Fees.
3. Outsourced Transcription
a. Please confirm how many lines or minutes he Trust currently sends to Outsourced Transcription; and
b. Please confirm annual expenditure.

Download response Digital dictation, speech recognition and outsourced transcription services.010317

Digital Dictation, Speech Recognition, Outsourced Transcription, Telehealth and Health Information Systems. 181220

Digital Dictation
1. Do you use Digital Dictation? If yes, could you please answer the following questions:
a. Name of the supplier & product:
b. What procurement method (if any) was used to obtain this system i.e. what framework:
c. The contract start date:
d. The contract end date:
e. Total contract value:
f. Is the product integrated with PAS or EPR:
g. What is the name and position of the key internal stakeholder for this service:
h. What would you like to see in this product that is currently not being delivered:
Speech Recognition
2. Do you use Speech Recognition? If yes, could you please answer the following questions:
a. Name of the supplier & product:
b. What procurement method (if any) was used to obtain this system i.e. what framework:
c. The contract start date:
d. The contract end date:
e. Total contract value:
f. Is the product integrated with PAS or EPR:
g. What is the name and position of the key internal stakeholder for this service:
h. What would you like to see in this product that is currently not being delivered:
Outsourced Transcription
3. Do you use Outsourced Transcription? If yes, could you please answer the following questions?
a. Name of the supplier:
b. What procurement method (if any) was used to obtain this system i.e. what framework:
c. The contract start date:
d. Volume of letters per month:
e. What is the name and position of the key internal stakeholder for this service:
Telehealth
4. Do you use Telehealth? If yes, could you please answer the following questions?
a. Name of the supplier & product:
b. What procurement method (if any) was used to obtain this system i.e. what framework:
c. The contract start date:
d. The contract end date:
e. Total contract value:
f. Is the product integrated with PAS or EPR:
g. What is the name and position of the key internal stakeholder for this service:
Health Information Systems
5. What suppliers do you use for the following?
a. PAS (Patient Administration System)
b. EPR (Electronic Patient Record)
c. eDMS (Electronic Document Management System)
d. RIS (Radiology Information System)
e. Outward mailing service provider

Download response Digital Dictation, Speech Recognition, Outsourced Transcription, Telehealth and Health Information Systems. 181220

Digital Dictation, Speech Recognition, Outsourced Transcription, Telehealth, Online Clinic – Video Consultation and Health Information Systems.070122.docx

Digital Dictation
1. Do you use Digital Dictation? If yes, could you please answer the following questions:
a. Name of the supplier & product:
b. What procurement method (if any) was used to obtain this system i.e. what framework:
c. The contract start date:
d. The contract end date:
e. Total contract value:
f. Is the product integrated with PAS or EPR:
g. What is the name, position and contact email/telephone number of the key internal stakeholder for this service:
h. What is the name, position and contact email/telephone number of the key procurement personnel for this service:
i. Which departments in the trust are currently using digital dictation?
j. Outpatient or department secretarial/admin manager contact details?
Speech Recognition
2. Do you use Speech Recognition? If yes, could you please answer the following questions:
a. Name of the supplier & product:
b. What procurement method (if any) was used to obtain this system i.e. what framework:
c. The contract start date:
d. The contract end date:
e. Total contract value:
f. Is the product integrated with PAS or EPR:
g. What is the name, position and contact email/telephone number of the key internal stakeholder for this service:
h. What would you like to see in this product that is currently not being delivered:
Outsourced Transcription
3. Do you use Outsourced Transcription? If yes, could you please answer the following questions:
a. Name of the supplier:
b. What procurement method (if any) was used to obtain this system i.e. what framework:
c. The contract start date:
d. Volume of letters per month:
e. Volume of letters (hard copies) sent out per month?
f. What is the name, position and contact email/telephone number of the key internal stakeholder for this service:
g. How much is being spent on outsourced transcription per annum?
Online Clinic / Video Consultation
4. Do you use Online Clinic / Video Consultation? If yes, could you please answer the following questions:
a. Name of the supplier & product:
b. What procurement method (if any) was used to obtain this system i.e. what framework:
c. The contract start date:
d. The contract end date:
e. Total contract value:
f. Is the product integrated with PAS or EPR:
g. What is the name, position and contact email/telephone number of the key internal stakeholder for this service:
h. What would you like to see in this product that is currently not being delivered:
Health Information Systems
5. What suppliers do you use for the following?
a. PAS (Patient Administration System)
b. EPR (Electronic Patient Record)
c. eDMS (Electronic Document Management System)
d. RIS (Radiology Information System)
e. Outward mailing service provider

Download response Digital Dictation, Speech Recognition, Outsourced Transcription, Telehealth, Online Clinic – Video Consultation and Health Information Systems.070122.docx

Digital Dictation, Speech Recognition Software and Outsourced Transcription Services.220223.docx

1. Do you use any digital dictation software within your trust?
a. If yes:
i. Which provider do you use? (please provide supplier and system names)
ii. How many users / licences do you currently have and what is your yearly spend?
1. Please split spend by fixed annual licence fee vs any volume-based usage fees if possible
iii. How long have you been with this provider? What was the date of your most recent contract and when does this expire? Who was your previous provider?
b. If no:
i. Do you use any analogue solutions (eg. Dictaphone)?
ii. What solutions do you use and who provides those?
iii. What is your approximate yearly spend on these solutions?
2. Do you use any speech recognition software within your trust?
a. If yes:
i. Which provider do you use? (please provide supplier and system names)
ii. How many users / licences do you currently have and what is your yearly spend?
1. Please split spend by fixed annual licence fee vs any volume-based usage fees if possible
iii. How long have you been with this provider? What was the date of your most recent contract and when does this expire? Who was your previous provider?
3. Do you use any outsourced transcription services within your trust?
a. If yes:
i. Which provider do you use?
ii. How many users / licences do you currently have and what is your annual spend and volume usage (eg. lines per year)?
1. Please split spend by fixed annual fee vs any volume-based usage fees is possible (eg. spend on lines per year)
iii. How long have you been with this provider? What was the date of your most recent contract and when does this expire? Who was your previous provider?
b. If no:
i. Do you do transcription in-house?
ii. If so who does this? (ie. the clinician, admin staff, IT team etc.)

Digital Dictation, Speech Recognition Software and Outsourced Transcription Services.220223.docx

Digital dictation systems. 141020

We have the following information about your trust’s digital dictation system status.
System type – Digital dictation
Supplier name – No System installed
System name – No System installed
Date installed – No System installed
Contract expiration – No System installed
Can you confirm if the digital dictation information above is still correct? If applicable, what is the current contract expiration date with your supplier?
If there has been a system replacement, or a new system implementation, please can you let us know the new supplier and system name? Also, when was the new system installed and when will the current contract expire?
If applicable,
– can you let us know who supplies your digital dictation hardware devices?
– how many digital dictation devices does your trust have?
– when was the procurement date of the digital dictation devices?

Download response Digital dictation systems. 141020

Digital Dictation, Voice Recognition, and medical transcription suppliers.181122.docx

1. Digital Dictation
System definitions
Digital Dictation: Device used to record audio and share recordings digitally.
(Please specify the information by department that has the service, e.g., radiology, dermatology, etc.)
a. Supplier name
b. System name
c. Contract initiation date
d. Contract expiration date
e. Is it a rolling (annual) contract? (Y/N)
f. What is the annual or contract cost? (Please specify one option)
2. Voice recognition
System definitions
Voice Recognition: Identifies and translates spoken words into text. Used to complete tasks or transcribe documents.
(Please specify the information by department that has the service, e.g., radiology, dermatology, etc.)
a. Supplier name
b. System name
c. Contract initiation date
d. Contract expiration date
e. Is it a rolling (annual) contract? (Y/N)
f. What is the annual or contract cost? (Please specify one option)
3. Outsourced Medical transcription
System definitions
Medical transcription: The manual processing of voice reports dictated by physicians and other healthcare professionals into text format
a. Supplier name(s)
b. Contract initiation
c. Contract expiration
d. Is it a rolling (annual) contract? (Y/N)
e. Total spending 2019
f. Total spending 2020
g. Total spending 2021

Digital Dictation, Voice Recognition, and medical transcription suppliers.181122.docx

Digital health record management. 080119

1. Does the trust have an electronic patient record?
2. How many clinical applications does your organisation use?
3. How many applications are fully digital i.e. no paper output to the physical health record?
4. How many applications produce an output that is stored in the physical health record?
5. How does the Trust manage compliance against data retention legislation for physical health records?
6. How does the trust manage compliance against data retention legislation for digital health records?
7. Do your clinical application systems facilitate automated monitoring and measurement of data retention compliance?
8. Does the trust have a data migration strategy?
9. Does the trust have a legacy application management policy?
10. Does the trust engage with patients around the management of their health record data? If so, how?
11. Does the trust currently provide or have plans to introduce any of the following? Please complete table below.
Patient portal
Patient correspondence via email, e.g. appointment and clinic letters
Video consultations, e.g. Skype, Facetime
Online appointment management
12. Is the trust working with other partner organisations regionally to provide patient access to their digital health record online?
13. Does the trust have a strategy to ensure that it meets the target to deliver a paperless NHS by 2020?
14. Does the Trust have patient engagement groups?
15. Has the trust conducted a data growth assessment for the next 5 years? If so, by what percentage does the trust anticipate its storage requirements will increase?
16. Does the Trust currently utilise cloud services to store patient data?
17. Did the trust consult patient groups before employing cloud services?
18. If not currently in place, does the trust plan to utilise cloud services to store patient data? (Please provide timescales for implementation.)
19. If not currently in place, will the trust consult patient groups before employing cloud services?
20. How many trust owned devices were impacted by the Wannacry cyber-attack? Please include medical devices.

Download response Digital health record management. 080119

Digital health records

With regards to the government’s plans to digitise the NHS by 2018 – namely, Health Secretary Jeremy Hunt’s appeal for the NHS to go paperless by 2018, relying instead on digital records…

1) Do your patients currently have online access to their own digital health records?
2) Can clinician’s access the full patient records – including scan’s, letters, notes and results – digitally?
3) Can you create and send/share digital discharge packs with GP’s?
4) How much of your back office is digitised, i.e. where tasks dedicated to running the Trust itself take place, e.g. IT, HR and accounts?
5) How far into your digitalisation journey is your Trust?

Download response Digital health records 010216

Digital health records. 020518

With reference to Jeremy Hunt’s directive for a paperless NHS by 2020, I would like to establish where Maidstone and Tunbridge Wells NHS Trust are within that process and would be grateful if you could respond to the following questions:

1.) Where do you store your physical paper medical records? Please indicate all types relevant from below.
In house library
Offsite storage
We do not have any paper records

2.) Have you already started to digitise your medical records? YES/NO
If yes, then which records have you digitised?
” Legacy records: Yes/No
If Yes: Is this being done in-house or is this outsourced (if outsourced, what is the name of the provider, and what is the length of this contract?)
” Day Forward Records: Yes/No
If yes: Is this being done in-house or is this outsourced? (if outsourced, what is the name of the provider, and what is the length of this contract?)

3.) If you have already started to scan your records how do you host your images?
EDMS (Electronic Document Management System): Yes/No
If yes: Which EDMS do you use and what is the length of the contract/licence for this service?
Shared drives: Yes/No
If yes: Are the shared drives managed internally by the Trust or externally by an outside provider? (What is the name of the outside provider, and what is the length of this contract?)
Online portal: Yes/No
If yes: What online portal does the Trust currently use and what is the length of the contract/licence for this service?
Other not mentioned above: please provide details of the service used.

4.) If you have not started to scan your medical records when do you expect to start this project?
No Plans, Within 6 months, Within 12 months, Within 18 months, Within 24 months

5.) If you do plan to start scanning your medical records how will you manage the procurement?
OJEU: Yes/No
Framework: Yes/No –
If yes: Which framework will you use?
LPP, ESPO, SBS, H.T.E (Health Trust Europe), NOE CPC
Procurement stage already complete: Yes/No

6.) Who is the person responsible at your organisation for medical record digitisation projects?

Download response Digital health records. 020518

Digital maturity assessments. 011018

Please provide all of results of the Digital Maturity Assessment (hereafter DMA) for your trust, which you should be able to access through the DMA portal. Each measure is represented as a score out of 100. Where possible, please also include the figures for the last (2016) digital maturity assessment.
This will include, but may not be not limited to:
• The overall digital “readiness” of the trust
• The overall digital “capability” of the trust
• The overall digital “infrastructure” of the trust
• Records, Assessment, & Plans
• Orders & results management
• Transfer of care
• Medicines Optimisation
• Decision Support
• Remote & Assistive Care
• Asset & Resource Optmisation
• Business & Clinical Intelligence
• Standards
• Enabling Infrastructure

Download response Digital maturity assessments. 011018

Digital services.280423.docx

– In your trust what digital services are used in the running of the trust/patient care?
– For each of these services, what is the funding structure of these systems? (Eg. licensing / one-off purchase / monthly or yearly subscription)
– For each of these services what is the corresponding cost of these services (Eg. cost per license / cost of one-off purchase / cost of monthly or yearly subscription)
– What is your overall spend on digital services in the last year (either financial year or calendar year 2022 is fine – whatever is easier with your data)

Digital services.280423.docx

Digital Transformation of Care.121022.docx

Could you provide me a contact email address for the team or person who is responsible for Digital Transformation of Care; that could include initiatives such Virtual Wards, Remote Monitoring, Hospital at Home, Community Diagnostic Hubs etc?

Digital Transformation of Care.121022.docx

Discharge Letters, Diagnostic Reporting, Digital Dictation and Bed Management.150523.docx

System type – Discharge Letters
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System definitions:
Discharge Letters – the ability to electronically generate and send detailed discharge letters to GPs and other relevant HCPs, when a patient is discharged from hospital-based services.

System name – Diagnostic Reporting
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System definitions:
Diagnostic Reporting – test results which are electronically transmitted to the clinician who ordered them, with receipt acknowledgement.

System type –Digital Dictation
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System definitions:
Digital Dictation – device used for recording and managing natural speech, allowing staff to verbally input a patients’ note into a system without having to manually input it.

System type –Bed Management
1. Supplier name
2. System name –
3. Date installed –
4. Contract expiration –
5. Is this contract annually renewed? – Yes/No
6. Do you currently have plans to replace this system? – Yes/No
7. Procurement framework –
8. Other systems it integrates with? –
9. Total value of contract (£) –
10. Notes – e.g. we are currently out to tender
System definitions:
Bed Management – real-time bed states are viewable and accessible, enabling more efficient management of bed occupancy and patient movements.

Discharge Letters, Diagnostic Reporting, Digital Dictation and Bed Management.150523.docx

Document management system. 300721.docx

We are currently updating data on your trust’s document management system. Can you please complete the fields below with what you currently hold?

Please enter ‘No System Installed’ under supplier name if your trust does not use the system:
System type – Document Management
1. Supplier name –
2. System name –
3. Date installed –
4. Contract expiration –
Notes – e.g. we are currently out to tender
5. Do you currently have plans to replace this system? – Yes/No

Download response Document management system. 300721.docx

DPIA conducted for Sunrise EPR. 120320

The questions on your original request are as follows:
Please provide copies of any DPIA conducted for your Sunrise EPR implementation

Having carried out a review of your request the Trust is able to supply the information detailed below/attached. Please note this is a draft document.

Download response DPIA conducted for Sunrise EPR. 120320

Dr Foster software. 150917

Information Description; Could you please advise whether your trust/organisation currently license Dr Foster software along with the date of expiry for the license and the value of the contract.

Download response Dr Foster software. 150917

E-mail usage.281123.docx

All questions are shown as received by the Trust.
Over the one-year period from 1st September 2022 until 31st August 2023 please provide the following details from the primary IT system for Trust e-mail for the following groups:

1) Consultants – please break down results by clinical specialty.
2) Managers – please include Operational Service Managers and Deputy Operational Service Managers in this category, along with any equivalent roles/grades in your organisation.

For each group (i.e. for each clinical speciality, and for Managers), please provide the following aggregated data items:

• Total number of individuals in the group
• Male/Female proportion within the group
• Total number of e-mails received
• Total number of e-mails sent
• Total number of internal vs external e-mails received
• Total number of internal vs external e-mails sent
• Mean number of e-mails received in that specialty/group [i.e. by any individual]
• Mean number of e-mails sent in that specialty/group
• Standard deviation of e-mails received in that specialty/group
• Standard deviation of e-mails sent in that specialty/group
• Median number of e-mails received in that specialty/group
• Median number of e-mails sent in that specialty/group
• Maximum number of e-mails received by any individual in that specialty/group
• Maximum number of e-mails sent by any individual in that specialty/group
• Minimum number of e-mails received by any individual in that specialty/group
• Minimum number of e-mails sent by any individual in that specialty/group

E-mail usage.281123.docx

e-Rostering software

Who your current contract is with for e-Rostering software?
When this is due to expire?

Download response e-Rostering software 270616

EAT Service (Electronic Assistive Technology). 070720

1. Does your NHS Trust have an EAT Service (Electronic Assistive Technology)?
2. Could you tell us where referrals to your service come from? (e.g.: wards, departments, hospital social workers, community NHS staff, GP’s, Local Authorities)
3. Is the service you offer part of the Trusts routine offering to aid early discharge from hospital/prevent delayed transfers of care?
4. Who is the Manager for that service and what are their contact details?
5. Who is the budget holder for that service and what are their contact details?

Download response EAT Service (Electronic Assistive Technology). 070720

Electronic document management and EPR. 191219

1. Does the trust currently have an Electronic Document Management System (EDMS) in place?
2. If so, what EDMS is deployed?
3. When was the system deployed?
4. When does the contract with the EDMS supplier end or when is the review date?
5. What is the rough spend on the EDMS either annually or total contract value (TCV)?
6. How was the EDMS procured, i.e. via framework and if so, which one?
7. .Does the trust have an Electronic Patient Record (EPR) system in place?
8. If so, what EPR is deployed?
9. When was the EPR deployed?
10. What is the value of the EPR contract, either annually or total contract value (TCV)?
11. When is the current EPR contract due for renewal?
12. Does the trust store active physical patient files in-house or off-site
13. If off-site, who is the current storage provider?
14. How many files/boxes are stored off-site
15. If physical files are stored on-site, roughly how many files/boxes are in the trusts library?
16. How many WTE/FTE work within the library
17. How many clinical appointments does the trust average each day/week/month?

Download response Electronic document management and EPR. 191219

Electronic Document Management solution. 221220

1. If any, which Electronic Document Management solution you use
2. Contract end date for any current solution (as named above)
3. What your plans are, if any, to replace your Electronic Document Management solution

Download response Electronic Document Management solution. 221220

Electronic Document Management Strategy

Under the Freedom of Information Act 2000 I seek the following information about the Trust’s EDM strategy:

1) Which of the following best describes your current situation?
2) If applicable, which option best describes your scanning strategy
3) Roughly how many physical case notes do you have?
4) If known, what is the average sheet count per case note?
5) How many scanned patient records do you have?
6) Who is your EDM Supplier?
7) Who is your PAS/EPR Supplier?
8) What is the name of your CCIO?

Download response Electronic Document Management Strategy 290116 

Electronic Document Management System. 140421

1. Have you already started digital conversion of your paper medical records? YES/NO
If YES, which outsource provider do you use?
1. a) Do you undertake any scanning in-house? YES/NO
2. If you have not yet started to digitise your medical records do you have a timescale for when you would like to start this project? Please advise one of the following.
a. Within 6 months
b. Within 12 months
c. Within 18 months
d. Within 24 months
e. Other (please state estimated timescale)
f. No plans
3. If you are planning a digital transformation project, how will you manage the procurement?
a. OJEU
b. Framework
c. Other (please advise which)
3. a) If the answer is Framework, which framework will you use? Please advise one of the following.
a. LPP
b. ESPO
c. SBS
d. H.T.E.
e. NOE CPC
f. Other (please advise which)
4. Who has responsibility for digital transformation/medical records digitisation within the Trust? Please provide:
a. Name
b. Job title
c. Contact details
5. Does the Trust have an EDMS (Electronic Document Management System)?
If YES:
a. Which system is in use?
b. When does the contract expire?
If NO, does the Trust have a plan to procure an EDMS?
6. What are the timescales to procure an EDMS? Please advise one of the following.
a. Within 6 months
b. Within 12 months
c. Within 18 months
d. Within 24 months
e. Other (please state estimated timescale)
f. No plans
7. Which EPR (Electronic Patient Record) systems does the Trust use?
8. Does the Trust have the ability to deliver “Virtual Clinics”?

Download response Electronic Document Management System. 140421

Electronic Document Management System.241123.docx

All questions are shown as received by the Trust.
Can you confirm if you have an Electronic Document Management System to store scanned copies of medical records?
If no, thank you. No further information is needed.
If yes:
a. What is the name of the system?
b. What is the name of the company that supplies and supports the system?
c. What is the annual contract cost of the system?

Electronic Document Management System.241123.docx

Electronic document management system for medical records.

1. Do you have/use an Electronic Document Management System for your Medical Records? If so, what is the name of it? How many users currently use the Electronic Document Management System?
2. Are your Medical Records currently being scanned? If so, is this being done within your organisation or by an external company? If scanning is being done by an external company can you provide their name?
3. Do you have/use an Electronic Patient Record (EPR) system? If so, what is the name of it?
4. Do you have/use a Clinical Portal or/and a Patient Portal? If so, what are the name(s) of it?

Download response Electronic document management system for medical records 280716

Electronic health record (EHR) vendors. 110717

We are currently researching what electronic health record (EHR) vendors NHS trusts are using to manage the following records for these departments:

– Cardiology
– Diabetes
– Neuroscience & Neurology
– Infection, Immunology, Inflammatory and Immunity
– Oncology
– Musculoskeletal

We would be very grateful if The Trust could let us know the vendors that are currently being used.

Download response Electronic health record (EHR) vendors. 110717

Electronic health records. 090418

What is the name of the software used to store the electronic records and on what date did the Hospital introduce this software?

Was this software the first form of electronic storage the Hospital used to store records and if not, what was the first model of electronic storage and on what date did electronic storage begin?

Download response Electronic health records. 090418

Electronic Health Records (EHR). 141119

Our request is limited to systems holding patient clinical records as an electronic health record (EHR), and excludes systems such as Patient Administration Systems (PAS), Portals, and other back office corporate systems that are not used by clinicians to handle patient clinical records.
For each system, please list both the system name and the manufacturer or vendor. Where there is an in-house IT application, please provide contact details for the person responsible for this application.
Department/ Speciality
Clinical oncology
Clinical radiology
Community sexual and reproductive health
Dentistry – Community Dentistry
Dentistry – General Dentistry
Emergency medicine
Intensive care medicine
Medicine – Cardiology
Medicine – Dermatology
Medicine – Endocrinology and diabetes
Medicine – Gastroenterology
Medicine – Medical oncology
Medicine – Medical ophthalmology
Medicine – Neurology
Medicine – Renal medicine
Medicine – Respiratory medicine
Medicine – Rheumatology
Medicine – Sport and exercise medicine
Medicine – Stroke medicine
Nursing Specialities – Ambulatory care nursing
Nursing Specialities – Community health nursing
Nursing Specialities – Health visiting
Nursing Specialities – Hospice and palliative care nursing
Nursing Specialities – Maternal-child nursing
Nursing Specialities – Medical case management
Nursing Specialities – Neonatal nursing
Nursing Specialities – Nurse midwifery
Nursing Specialities – Observations
Nursing Specialities – School nursing
Nursing Specialities – Telephone triage nursing
Obstetrics and gynaecology
Occupational medicine
Ophthalmology
Paediatrics – Paediatric cardiology
Paediatrics – Paediatrics
Pan-speciality – Prescribing
Pathology – Chemical pathology
Pathology – Haematology
Pathology – Histopathology
Pathology – Medical microbiology and virology
Professions Allied to Medicine – Dietitian
Professions Allied to Medicine – Occupational therapist
Professions Allied to Medicine – Osteopath
Professions Allied to Medicine – Paramedic
Professions Allied to Medicine – Physiotherapist
Professions Allied to Medicine – Podiatrist
Psychiatry – General psychiatry
Psychology & Talking Therapies – Clinical Psychology
Psychology & Talking Therapies – IATP
Surgery – General surgery
Surgery – Neurosurgery
Surgery – Otorhinolaryngology (ear, nose and throat)
Surgery – Trauma and orthopaedic surgery
Surgery – Urology

Download response Electronic Health Records (EHR). 141119

Electronic Health Records (EHR EPR). 081221.docx

Regarding Electronic Health Records (EHR):
1a) What primary EHR system does your Trust use, if any?
1b) Are electronic inpatient notes implemented in all sites within your Trust? If no, please state which sites do not have electronic notes.
1c) Is electronic recording of patient vital signs (i.e. including but not limited to blood pressure, oxygen saturations, etc) implemented in all sites within your Trust? If no, please state which sites do not have electronic observation recording.
1d) Are electronic drug charts and prescribing implemented in all sites within your Trust? If no, please state which sites do not have electronic prescribing.
Regarding EHR commissioning:
2a) Have you received any direction from a Clinical Commissioning Group (CCG) or Integrated Care System (ICS) regarding provision of past, present or future EHR systems?
2b) Have you ever undertaken any formal negotiations with other hospital Trusts about jointly procuring an EHR system, and if so, have negotiations resulted in joint procurement of an EHR system?
Regarding EHR interoperability:
3a) Assuming your Trust contains multiple hospital sites, are your EHR users able to directly access inpatient electronic notes from different hospital sites within your Trust?
3b) Aside from NHS spine summary care records (SCR), are your EHR users able to directly access patient records held by local primary care EHRs (e.g. by using an EHR web portal, or healthcare information exchange etc)? If yes, please specify the name of the system that enables this.
3c) Aside from NHS spine summary care records (SCR), are your EHR users able to directly access patient records held on a separate hospital Trust’s EHR? If yes, please specify which Trust’s EHR where this interoperability is enabled.

Download response Electronic Health Records (EHR EPR). 081221.docx

Electronic Medical Record (EMR). 010217

1. Please provide the supplier (company) name of Electronic Medical Records system currently in use at your Trust/hospital. Please provide all suppliers if more than one system is in place.
2. Please supply the brand name of the Electronic Medical Record system currently in use at your Trust/hospital. Please provide all suppliers if more than one system is in place.

Download response Electronic Medical Record (EMR). 010217

Electronic medical record (EMR) 06.04.16.

1. With regards to the way medical records are currently used in your Trust, which EMRAM* stage are you?

2. If you are unable to tell us the above, can you tell us if your Trust is running, or has signed a contract to run an electronic medical records system that meets the following criteria:
Electronic clinical documentation interacts with clinical decision support systems (based on both discrete data elements)
AND
Electronic closed loop medication administration system.

3. If not, is your trust planning to commission an EMR (which meets criteria set out in Question 2)

4. If you are currently utilizing an EMR, or have commissioned an EMR which is awaiting implementation, did you consider franchising an already implemented EMR from another NHS institution in the UK?

5. If you are currently utilizing an EMR, or have commissioned an EMR which is awaiting implementation: does your EMR allow functional interoperability i.e. transfer of information from at least one other EMR used regionally in primary, secondary or tertiary care?

6. If your trust is planning to commission an EMR or currently has an open tender for an EMR, are you inviting applications for franchised systems from other NHS trusts?

7. If your trust currently utilizes an EMR, does the contract with the software provider allow for franchising your system to other trusts?

8. Regarding direction from Clinical Commissioning Group(s) that commission services in your local area, have you had formal or informal direction regarding EMR provision?

9. Regarding coordination with other acute hospital trusts, have you had any formal or informal discussions regarding coordination of EMR purchasing?

Download response Electronic medical record (EMR) 06.04.16.

Electronic medical records and inpatient care programme. 090418

1. Is there an electronic system used for the clinical management of in-patients?
If yes:
• Does it include and connect all the clinical (nursing, medical, physiotherapy etc.) assessments, drug chart, MEWS chart and documentation electronically, or are they completed in paper and then scanned in?
• Is the same program used in all the clinical wards?
• Is this provided by an external supplier, or has it been developed internally? If it’s an external supplier, which company is it and what is the name of the program?
• Was the supplier chosen through a bidding process, and if yes, which other companies took part in it?
• How can I have a view of it?
• How much does it cost for purchase, service and technical support?
2. Are Electronic Medical Records operating in the Trust?
If yes:
• Do they include and connect all the stages of a patient’s journey, from referral to discharge, including in-patient and out-patient spells and details?
3. Is the Trust operating with ‘preferred suppliers’, or could any supplier present a new product, after meeting the requirements of the ‘Suppliers Access Policy’?

Download response Electronic medical records and inpatient care programme. 090418

Electronic observations system. 250222.docx

1. Which electronic observations system do you use? (if any)
2. Are there automatic escalations at set scores to doctors? Y/N
If yes so what is the NEWS2 cut off for
i) automatic escalation to the registrar?
ii) other team member junior doctor/matron/CCOT?

Electronic observations system. 250222.docx

Electronic patient record EPR. 040221

1. Who is the Trust’s current supplier for their Electronic Patient Record?
2. What are the contract start and end dates for the Electronic Patient Record?
3. Do you have a digital system for Order Communications within the hospital? If so, could you please provide the name of the supplier?
4. Do you use this Order Comms system for your hospital at night process?
5. When was the Order Comms solution implemented?
6. Is the Trust working on or have they achieved a HIMMS level to support clinical use of technology? If so, what level and when was it achieved/when will it be achieved?

Download response Electronic patient record EPR. 040221

Electronic Patient Record (EPR).050522.docx

We are currently updating data on your trust’s EPR system. Can you please complete the fields below with what you currently hold?
Please enter ‘No System Installed’ under supplier name if your trust does not use the system:
System type – EPR
1. Supplier name –
2. System name –
3. Date installed –
4. Contract expiration –
5. Total value of contract (£) –
6. Is this contract annually renewed? – Yes/No
7. Do you currently have plans to replace this system? – Yes/No
8. Procurement framework –
9. Other systems it integrates with? –
Notes – e.g. we are currently out to tender

Electronic Patient Record (EPR).050522.docx

Electronic Patient Record (EPR).260623.docx

1. System type – EPR
2. Current EPR / EHR supplier name:
3. Current EPR / EHR system name:
4. Date Current EPR / EHR system installed:
5. Current EPR / EHR system’s contract expiration:
6. Is this contract annually renewed? – Yes / No
7. Do you currently have plans to replace this EPR system? – Yes / No
8. Are you currently out to tender to replace this EPR system? – Yes / No
9. If you have recently awarded a new EPR / EHR replacement supplier and system, what is the new supplier and system and when is the current planned go-live date please:
10. Is your current or future EPR contract in a joint-partnership with any other NHS Trust? If yes, which Trust(s):
11. Is your recruitment handled and managed by heads of department or by a resourcing/recruitment team?
12. What frameworks do you currently use for recruitment?

System definition: Electronic Patient Record (EPR) – An electronic patient / health record is a digital version of a patient’s paper chart.

Electronic Patient Record (EPR).260623.docx

Electronic Patient Record (EPR).270923.docx

All questions are shown as received by the Trust.
1. Does the trust use an Electronic Health Record (EHR) for clinical documentation?
2. If yes to (1), who is the principal software provider for this record system?
3. If yes to (1), which EHR system is currently in use?
4. If yes to (1), is this EHR system used across all clinical departments and sites in the trust?
5. If no to (1), does the trust have a timeline to implement an EHR system?
6. If the trust has plans to implement a new EHR system, which software provider has been chosen to provide an EHR system?

Electronic Patient Record (EPR).270923.docx

Electronic Patient Record (EPR) and portal solutions.230622.docx

1. The name of the trust’s Electronic Patient Record (EPR) solution, if you have one.
2. The name of the trust’s Patient Portal solution, if you have one.
3. The name of the trust’s Clinical Portal solution, if you have one.
4. The name of your Trust Integration Engine.
5. The name of the trust’s Healthcare Information Exchange (HIE) platform, if you have one.
6. Please confirm if the trust uses any digital solutions that support Multidisciplinary Teams (MDTs),
if so, which ones?

Electronic Patient Record (EPR) and portal solutions.230622.docx

Electronic Patient Record system.120822.docx

Which Electronic Patient Record system is in use by the hospital(s) in your trust?

Electronic Patient Record system.120822.docx

Electronic Patient Records.050324.docx

All questions are shown as received by the Trust.
1. What Electronic Patients Records System(s) do you use and when was it implemented?
2. Does the Trust scan paper records? If yes, do you
a. scan day forward and legacy records? or
b. just day forward records?
3. Is above handled
a. In house by your own scanning team?
b. Outsourced to an off site external service provider?
c. On site by an external provider?
d. Combination of above?
4. If any of the above outsourced, please name provider(s) and details of when the contract(s) ends
5. What route to market used to obtain these services (a) open tender (b) framework – if yes, which one?
6. Do you have a published road map for paper-free at point of care ‘Digital at point of care’? If yes, please provide a copy or link to this document
7. Finally, please advise names of any individuals involved in this process including your Medical Records Manager (b) Chief Information Officer (c) Digital Project Lead?

Electronic Patient Records.050324.docx

Electronic patient records. 160321

1. Could you confirm if you have a sexual health EMR installed at your trust?
a. When does the contract end?
b. Who is your current provider?
2. Could you confirm if you have a colposcopy EMR installed at your trust?
a. When does the contract end?
b. Who is your current provider?
3. Could you confirm if you have an ophthalmology EMR installed at your trust?
a. When does the contract end?
b. Who is your current provider?
Could you provide contact details with whom we can liaise with in the Trust who has responsibility for these systems?

Download response Electronic patient records. 160321

Electronic Patient Records. 200718

Question One
Does the Trust have an Electronic Patient Record (EPR)?
If Yes:
Who is the principle software provider?
Are clinicians able to access patient records at the point of care (eg: at the bedside by cart, mounted PC etc) across all applicable locations?
If no:
Does the trust have a timetable to implement EPR?
Question Two
Has the trust fully implemented Electronic Prescribing Medicines Administration (ePMA)?
If no, does the trust have an anticipated timescale for full implementation?
Question Three
Has the trust implemented PSAG (Patient Status at a glance/ Electronic white boarding for bed management)?
If Yes, fully or partially?
If partially or No, Does the trust have an anticipated timescale for full implementation?

Download response Electronic Patient Records. 200718

Electronic Patient Records (EPR). 090418

1. Who is, or will be, your EPR systems provider?
2. What are the names and titles of the 2 main contacts within the Trust responsible for your EPR system?
3. What are the names and titles of the 2 main points of contact for EPR budgets and cost saving initiatives?
4. Who is responsible for Quality Assurance and Testing for the Trust’s IT & Applications?
5. What is your forecasted spend on EPR testing annually starting from 2017 onwards?
6. How many scripts are you manually executing for your EPR regression testing?
7. How long does it take to run a master regression test for EPR? i.e to execute all your regression scripts?
8. How many in-house testers do you have? Permanent staff and contractors today?
9. What modules do you have in your EPR currently?
10. What modules are you planning on implementing or upgrading in the next 18 months?
11. Is your EPR hosted by a third party or managed directly by the Trust.
12. What is your total annual EPR budget?
13. What % of your EPR budget is allocated for testing?
14. In man-days, what is your total projected effort for systems testing in 2018? All systems.
15. How many changes do you implement each month for your EPR?
16. How much of your regression testing is covered by automation?
17. Who is your CCIO?
18. Who is your CIO?
19. What is required to become an IT Services supplier to your Trust?

Download response Electronic Patient Records (EPR). 090418

Electronic Patient Records (EPR).281123.docx

All questions are shown as received by the Trust.
1. Do you monitor and log potential patient harms as a result of problems with your Electronic Patient Record (EPR) system?
2. Overall, how many letters to GPs, or documents, have not been sent out as a result of EPR problems?
3. Please give the date/s when you discovered these letters were not sent?
4. Overall, how many incidents of potential patient harm have been connected to your EPR system?
5. Overall, how many incidents involving EPR at your trust have been declared as “serious harm” or a “serious incident”?
6. Overall, how many patient deaths have been connected to EPR?
7. How much have you spent on your EPR system overall?
8. How much do you anticipate spending on EPR in the next five years?
9. What is the anticipated cost of running the EPR system at your trust annually?

Electronic Patient Records (EPR).281123.docx

Electronic prescribing and medicines administration system (ePMA). 151221.docx

1. Does your Trust have an electronic prescribing and medicines administration system (ePMA)?
Please tick one option
a. Yes (go to Q2)
b. No (go to Q4)
2. What is the full name of this ePMA system?
Please specify the system name and supplier
3. Which of the following statements best describes the status the data integration of (i) the system that manages clinical patient notes and records and (ii) the pharmacy dispensing system at your Trust?
Please tick one option for (i) and one option for (ii).
(i) Clinical patient records / medical notes (ii) Pharmacy Dispensing System (PDS)
a. Electronic and fully integrated
b. Electronic and partially integrated
c. Electronic and not integrated
d. On paper
4. Which of the following statements best describes your Trust’s overall implementation of the ePMA system?
Please tick one option
a. ePMA system is fully implemented (Go to Q5)
b. ePMA system is partially implemented and progress is ongoing to complete it (Go to Q5)
c. ePMA system has been procured from a named supplier and awaiting implementation (Go to Q5)
d. Selection of suppliers and procurement of ePMA system is underway (Go to Q5)
e. Awaiting funding (Go to Q17)
f. No ePMA systems or plans in place (Go to Q17)
g. Other – please specify below
5. To the best of your knowledge when will an ePMA system be fully implemented at your Trust?
Estimated date of full implementation
6. Which of the following statements best describes the interface between the patient record system and the pharmacy dispensing system?
Please tick one option
a. Patient records are electronic and fully integrated with pharmacy dispensing system.
b. Patient records are electronic and partially integrated with pharmacy dispensing system.
c. Patient records are electronic, but not integrated with the pharmacy dispensing system. □=
d. On paper
7. What is the name of the pharmacy dispensing system at your Trust?
Please specify the system name and supplier
8. Can the Trust export data from these systems and, if so, in which of the following formats?
Please tick all that apply
(i) Patient records system (ii) Pharmacy Dispensing System (PDS)
a. .xls (Excel)
b. .csv or .txt (Text)
c. Not possible
9. In principle are the prescribing systems capable of producing an anonymised report of the number of patients treated by specific drug treatment and by diagnosis a single report?
Please tick one option
a. Yes
b. No
10. In the case of drugs with multiple indications, e.g., a drug indicated for rheumatoid arthritis and haematology, does the system record sufficient detail to report on how much is used for each indication?
Please tick one option
a. Yes
b. No
11. In the case of drugs that are used to treat more than one type of cancer, can the system produce a single report that shows the quantity of drug used for each tumour type?
Please tick one option
a. Yes
b. No
12. In the case of drugs that are used to treat more than one type of cancer, can the system produce a single report that shows the quantity of drug used for each tumour type by cancer stage?
Please tick one option
a. Yes
b. No
13. Which, if any, of the following fields can be exported from the ePMA system?
Please indicate yes or no per item
a. Date (month year)
b. Diagnosis or indication
c. Drug name (&/or SNOMED ID)
d. Drug formulation
e. Drug strength
f. Drug unit of measure (e.g., milligrams, micrograms, vials)
g. Quantity dispensed (in UOM)
h. Quantity prescribed (in UOM)
i. Number of patients treated
14. Do you already produce a report such as this within the Trust?
Please tick one option
c. Yes
d. No
15. What is the name of this report?
Please specify
16. Which team or department is responsible for producing this report?
17. In September 2021 we understand that a new standard is being implemented for the Drugs Patient Level Contract Monitoring (DrPLCM) report, which is submitted monthly by every NHS Trust. Please see DCB2212 Drugs Patient Level Contract Monitoring (DrPLCM) Version 2.0 released 8th April 2021.
To what extent will your Trust be able to submit the data field named ‘Therapeutic indication code (SNOMED CT)’, or a description of the indication, alongside details of drug treatment, as stipulated by NHS England by the end of 2021?
a. Fully
b. Partially
c. Not at all
18. Which of the following diagnoses or indications are detailed in the latest DrPLCM report for your Trust?
We are interested in the level of detail (e.g., medical oncology versus ovarian cancer) as well as the specific diagnoses.
Please indicate yes or no for each diagnosis description
Immunology
Atopic dermatitis
Crohn’s disease
Plaque psoriasis
Rheumatoid arthritis
Severe asthma
Ulcerative colitis
Multiple sclerosis
Primary progressive multiple sclerosis
Relapsing remitting multiple sclerosis
Ophthalmology
Wet age-related macular degeneration
Dry age-related macular degeneration
Diabetic macular oedema
Medical oncology
Breast cancer
Lung cancer
NSCLC
SCLC
Melanoma
Ovarian cancer
Prostate cancer
Renal carcinoma
Haematology
Non Hodgkin Lymphoma
Hodgkin’s Disease
Acute Myeloid Leukaemia
Chronic Lymphocytic Leukaemia
Multiple Myeloma

Download response Electronic prescribing and medicines administration system (ePMA). 151221.docx

Email archive.170423.docx

1) Do you have on-premise Microsoft Exchange? If yes:
a. Which version?
b. Do you have public folders?
c. Do you manage the infrastructure yourselves? If not, who is your partner?
2) Do you have a 3rd party email archive solution such as Enterprise Vault, EMC Source One or Quest Archive Manager?
a. If yes, which one?
3) Do you have PST files?
4) If you have not already, are you planning to migrate to Office 365?
5) Which person is responsible for your email infrastructure?

Email archive.170423.docx

Email encryption and E-signatures.080923.docx

All questions are shown as received by the Trust.
please can you provide the following information in relation to your past, present and future suppliers of the following services:

Email encryption
• Do you have a product or supplier for email encryption?
• If so, please can you supply details of the contractual arrangements in place including date of award, details of any Framework used or link to the advertisement, contract value and duration.
• If so, please can you indicate the plans for future procurement of this product?
• If not, please can you indicate what evaluation of the requirement for email encryption has been undertaken?
• Please can you confirm the individual responsible for managing your email encryption contract or wider cyber security contracts and provide their contact details and role title?
E-signatures
• Do you use a specific product or solution for electronic signatures?
• If so, please can you confirm the name of the supplier from which this solution is purchased
• If so, please can you supply details of the contractual arrangements in place including date of award, details of any Framework used or link to the advertisement, contract value and duration.
• If so, please can you indicate the plans for future procurement of this product?
• If not, please can you indicate what evaluation of the requirement for email encryption has been undertaken?
• Please can you confirm the individual responsible for managing your e-signature solution contract or wider cyber security and provide their contact details and role title?

Email encryption and E-signatures.080923.docx

Enterprise applications software. 181019

A. Enterprise Resource Planning Software Solution (ERP) -this is the organisation’s main ERP system and may include service support, maintenance and upgrades.
B. Primary Customer Relationship Management (CRM) Solution-this is the organisation’s main CRM system and may include service support, maintenance and upgrades. Example of CRM systems the organisation may use could include Microsoft Dynamics, Front Office, Lagan CRM, Firmstep
C. Primary Human Resources (HR) and Payroll Software Solution-this is the organisation’s main HR/payroll system and may include service support, maintenance and upgrades. In some cases the HR contract maybe separate to the payroll contract please provide both types of contracts. Example of HR/Payroll systems the organisation may use could include iTrent, Resourcelink.
D. The organisation’s primary corporate Finance Software Solution-this is the organisation’s main Finance system and may include service support, maintenance and upgrades. Example of finance systems the organisation may use could include E-Business suite, Agresso (Unit4), eFinancials, Integra, SAP

In some cases you may come across contracts that provide service support maintenance and upgrades separate to the main software contract, please also provide this information in the response following the requested data below.

For each of the categories above can you please provide me with the relevant contract information listed below:
1. Software Category: ERP, CRM, HR, Payroll, Finance
2. Name of Supplier: Can you please provide me with the software provider for each contract?
3. The brand of the software: Can you please provide me with the actual name of the software. Please do not provide me with the supplier name again please provide me with the actual software name.
4. Description of the contract: Please do not just state two to three words can you please provide me with detailed information about this contract and please state if upgrade, maintenance and support is included.

Please also include any modules included within the contract as this will support the categories you have selected in question 1.
5. Number of Users/Licenses: What is the total number of user/licenses for this contract?
6. Annual Spend: What is the annual average spend for each contract?
7. Contract Duration: What is the duration of the contract please include any available extensions within the contract.
8. Contract Start Date: What is the start date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
9. Contract Expiry: What is the expiry date of this contract? Please include month and year of the contract. DD-MM-YY or MM-YY.
10. Contract Review Date: What is the review date of this contract? Please include month and year of the contract. If this cannot be provide please provide me estimates of when the contract is likely to be reviewed. DD-MM-YY or MM-YY.
11. Contact Details: I require the full contact details of the person within the organisation responsible for this particular software contract (name, job title, email, contact number).

Download response Enterprise applications software. 181019

EPR. 221119

Paper
1. Do the clinical areas in the Trust still use paper records?
2. Do the clinical areas in the trust still use paper to record medical observations?
3. Do any paper documents get scanned into the Electronic record?
4. How many documents get scanned into the Electronic document per annum?
5. How much is the trust spending on scanning paper documents into the Electronic record per annum inclusive of resources and hardware?
6. Is the Trust still using paper for patient questionnaires?
7. Is the trust still using paper for procedural consent documentation?
EPR
8. Has the current system got the functionality to store photographs and videos within the patient record?
9. Does the patient record system include digital signature for patients signing legal documentation?
10. Does the current system have a function where patients can access their own health record?
11. Does the EPR have a function for clinical noting used on ward rounds?
12. Does the system have Medical documentation templates that can be changed to suit specialised needs?
13. Does the system have an Administration Function?
14. Does the system have Administration dashboards that feed outcomes from medical documentation?
15. Does the system contain different modules, if so, what modules are they?
16. What are the System costs per user if applicable?
17. Cost of application?
18. What are your On-going maintenance costs or SLA?
19. How many staff are using the system?
BI
20. Does the system have Medical OPC Coding Information and storage?
21. Does the system have its own Business information analysis tools?
General
22. What is your approximate Outpatient activity per annum?
23. What is your approximate Inpatient Activity per annum?
24. TIE costs per annum?
25. What PAS system do you use?
26. What are your PAS costs per annum?
27. Self-Check In – Yes/No
Theatre
28. Does the EPR have an integrated Theatre logistics system?
29. Is the Theatre logistics system into the Patient record system or does the users need to log into a separate system to plan Theatre lists and complete Theatre Documentation?
30. What system is used to produce Operation notes and is this system integrated into the patient record?
31. What is the Theatre system cost per annum?
Order Communications
32. Order Communication system for Radiology?
33. Order Communications system for Laboratory?
34. Results/Diagnostic system or alerting Radiology?
35. Results/Diagnostic system or alerting Laboratory?
36. Is the Order Communications system integrated into the Patient record system or does the user need to log into a separate system to order diagnostics?

Download response EPR. 221119

EPR. 290819

1. What is the name of the trust’s existing EPR?
2. The name of the supplier
3. When is contract end date?
4. Is the trust planning to go out to procurement within the next 6 months for a new EPR solution?
5. If the trust is planning to go out to procurement, which framework does it plan to use?
6. Does the trust’s existing EPR contain an integrated order communications and results reporting solution?
7. If the trust is planning to go out to procurement within the next 6 months for a new EPR solution, will it include an integrated order communications and results reporting solution?
8. Has the trust implemented a patient portal solution that enables patients to access and see their results?
9. If so, which solution and who is the supplier?
10. If not, does the trust plan to procure a patient portal solution that enables patients to access and see their results?
11. The name and email address of the Trust CIO/ Director of IT

Download response EPR. 290819

EPR and ICB.170323.docx

1. What Electronic Patient Record (EPR) system do you use? Please state if your EPR is an In-house built system.
a. If your EPR is supplied externally, when does your contract expire?
b. Do you have any intention to replace the EPR?
c. What is the timescale for the replacement to be in place?
d. Has a replacement EPR system been chosen. If, yes, please name the chosen EPR.
2. What Patient Administration System (PAS) do you use? Please state if your PAS is an In-house built system.
a. If your PAS is supplied externally, when does your contract expire?
b. Do you have any intention to replace the PAS?
c. What is the timescale for the replacement to be in place?
d. Has a replacement PAS system been chosen. If, yes, please name the chosen PAS.
3. What Document Management System (DMS) do you use? Please state if your DMS is an In-house built system.
a. If your DMS is supplied externally, when does your contract expire?
b. Do you have any intention to replace the DMS?
c. What is the timescale for the replacement to be in place?
d. Has a replacement DMS system been chosen. If, yes, please name the chosen DMS.
4. What ICB does your organisation fall under?
5. Do you have a shared care record (SCR) across your ICB?
6. If the answer to question 2 is, yes:
a. What is the name of the system?
b. When does the contract expire for the current system?
c. Does your ICB have any intention to replace the SCR?
d. Does your ICB have any timescale for the replacement to be in place?
e. Has a replacement SCR system been chosen. If, yes, please name the chosen system.
7. If the answer to question 6 is, no:
a. Are there any plans to create a shared care record?
EPR and ICB.170323.docx

EPR and PAS. 280121

1. When will the Trust be looking to procure a new EPR?
2. What is the contract end date for the Trust’s existing EPR or PAS?
3. Please supply a copy of the Trust’s latest Digital Strategy.
4. What digital maturity model is being used or considered to support the Trust’s Digital Strategy/Roadmap?

Download response EPR and PAS. 280121

EPR, electronic patient record. 081221.docx

1) Does your Trust operate, or contribute data to, an EHR-linked data warehouse that holds patient-level clinical data that can be used for research purposes? This includes EHR-linked data warehouses where the Trust is the data controller, or academic collaborations where an EHR-linked data warehouse is maintained by an academic institute. This does NOT include NHS Digital Secondary Use Service (SUS) data submissions.
2) If yes, please specify who the data controller organisation is for the data warehouse.
3) If yes, please specify which EHR vendor software(s) the data warehouse receives data from.
4) Apart from your EHR vendor company, is any commercial third party contracted to enable this data warehouse (e.g. by handling data aggregation and linkage, or handling data storage solutions etc)?
5) If yes, which third party commercial company is involved?
6) Does the Trust store any patient data on a “cloud” platform (e.g., including, but not limited to, Google Cloud Platform, Amazon Azure or Amazon Web Services)?
7) If yes, which cloud platform solution is used?
8) Does the Trust use an automated, EHR-linked system for NHS Digital Secondary Use Service (SUS) data collation and submission, or is SUS data submitted by manual upload?

Download response EPR, electronic patient record. 081221.docx

EPR Electronic Patient Record.140223.docx

To support with this can you please complete the below fields with your Trust’s current information:
System type – EPR
1. Current EPR / EHR supplier name:
2. Current EPR / EHR system name:
3. Date Current EPR / EHR system installed:
4. Current EPR / EHR system’s contract expiration:
5. Is this contract annually renewed? – Yes / No
6. Do you currently have plans to replace this EPR system? – Yes / No
7. Are you currently out to tender to replace this EPR system? – Yes / No
8. If you have recently awarded a new EPR / EHR replacement supplier and system, what is the new supplier and system and when is the current planned go-live date please:
9. Is your current or future EPR contract in a joint-partnership with any other NHS Trust? If yes, which Trust(s):
System definition: Electronic Patient Record (EPR) – An electronic patient / health record is a digital version of a patient’s paper chart.

EPR Electronic Patient Record.140223.docx

EPR or PAS. 221119

1. What are your plans regarding procuring EPR functionality (either via an integrated EPR or departmental systems as best-of-breed) or PAS?
2. Will you be procuring new EPR functionality or PAS in the next 2 years?
3. What is the contract expiry date for your existing EPR and PAS services?
4. What are your plans regarding implementing ePMA functionality?
5. What plans do you have for procuring other digital capability in the next 2 years?

Download response EPR or PAS. 221119

EPR, PAS, Pharmacy Stock and E-Prescribing systems.

1. Who is the supplier of your EPR or PAS system across the Trust for plus which version:
A) A&E
B) Inpatient
C) Outpatient

2. Who is the supplier of your Pharmacy Stock or E-Prescribing system?

3. Can you supply a organisation chart for all your Execs plus Divisional Directors plus e-mail address.

Download response EPR, PAS, Pharmacy Stock and E-Prescribing systems 270616

EPR system. 070618

1. Trust name
2. Type of trust
3. Do you currently have an EPR system(s) in place?
4. Can you provide a name for the system(s)?
5. How much are you currently spending on this system annually for licensing and support fees?
6. What is the date of contract expiry for the system(s)?
7. Do you intend to go to tender for a new EPR (if applicable)?
8. How many users? (an estimation if unsure)
9. How is your system hosted?
10. Who is responsible for your local implementation of the objectives set out by the NHS in the Five Year Forward View?
11. Can you please provide the name and email of your Chief Clinical Information Officer or the person who holds the equivalent role in your trust?
12. Can you please provide the name and email of your Director of Informatics or the person who holds the equivalent role in your trust?

Download response EPR system. 070618

EPR system.311023.docx

1. Does the trust have an EPR system or systems in place?
2. If so, what EPR systems are deployed?
3. Is the Trust looking to purchase an EPR systems?
4. If so, when is the Trust looking to deploy the new EPR systems?
5. Is the Trust looking to develop an EPR systems in house or with third parties?
6. If so, when is the Trust looking to deploy the new EPR systems?

EPR system.311023.docx

ERP Systems Information

Could you please respond to the following questions?
1. Who is you current provider of Financial Systems support and implementation services?
2. When does the contract expire?
3. Who should I contact if I wish to supply training on your financials systems?
4. Who is you current provider of Procurement Systems support and implementation services?
5. When does the contract expire?
6. Who should I contact if I wish to supply training on your procurement systems?
7. Who is you current provider of Human Resources Systems support and implementation services?
8. When does the contract expire?
9. Who should I contact if I wish to supply training on your Human Resources systems?

Download response ERP Systems Information 200416

ERP Systems Information. 280217

Could you please respond to the following questions?
1. Who is you current provider of Financial Systems support and implementation services?
2. When does the contract expire?
3. Who should I contact if I wish to supply training on your financials systems?
4. Who is you current provider of Procurement Systems support and implementation services?
5. When does the contract expire?
6. Who should I contact if I wish to supply training on your procurement systems?
7. Who is you current provider of Human Resources Systems support and implementation services?
8. When does the contract expire?
9. Who should I contact if I wish to supply training on your HRMS systems?
10. What Applications are you running for:
o Finance?
o HR?
o Payroll?
o Project?
o CRM?
o Manufacturing?
o Sourcing?
o Invoice Scanning Tool?
o Are you using Config Snapshot?
o What BI Tool are you using?
11. What versions of the above Applications are you running?
12. When was your last Application upgrade?
13. Are you planning another upgrade in the next 12-18 months?
14. Do you have an Oracle support partner for applications? If so who?
15. What kind of support is included in the contract (functional/technical/etc.?)
16. What is the value of the application support contract?
17. When does it expire?
18. Where do you advertise any Oracle procurement opportunities?
19. Who is responsible for looking after the contract for the Oracle estate?
20. Who is responsible for looking after the licenses for the Oracle estate?
21. How much do you pay annually for Oracle Support & Maintenance?
22. When does this contract renew?
23. Do you work with off-shore partners?
24. Who are your off –shore partners for ERP Systems Implementation and support?

Download response ERP Systems Information. 280217

EWS readiness. 070618

1. Institution details
2. Institution name
3. Number of hospitals in institution
4. Total number of inpatient beds in institution
5. No of Critical care or level 3 beds in institution
6. No of HDU or level 2 beds in institution
7. No of operating theatres in institution
8. Last CQC fundamental standard rating for Safety (pick from list)
9. Last CQC fundamental standard rating for Premises and Equipment (pick from list)
10. Are computerised systems for recording patient vital signs in use? (E.g. Heart rate, respiration rate, temperature, SpO2)
a. System status (pick from list)
b. Total number of beds in institution covered by computerised systems for recording vital signs (or NA if not implemented)
c. Supplier name(s) and system name(s) of most significant systems (or NA if not implemented)
d. Year of first implementation Actual or planned (or NA if not implemented)
e. Patient monitoring (approx. number of devices or connected beds)
Capital programmes
11. Does the institution have a planned capital replacement programme for IT systems and IT equipment? (pick from list) Yes
a. Total capital spend for IT in year (software, hardware, project management), nearest £100K
b. Approximate capital spend on networking to improve WiFi coverage and performance (core systems, edge systems, cabling, access points, controllers and software), nearest £100K
2017-2018
2018-2019 (planned)
2019-2020 (projected)
2021-2022 (projected)
12. Capital spend on clinical software applications used for direct patient care at the bedside by nursing and medical staff (i.e. recording vital signs, medical and nursing notes, medications, care record) EXCLUDING imaging systems
a. All systems, nearest £100K
b. Of which, patient at risk applications (e.g. for NEWS), nearest £5K
2017-2018
2018-2019 (planned)
2019-2020 (projected)
2021-2022 (projected)
13. Does the institution have a planned capital replacement programme for Medical Equipment? (pick from list)
a. Capital spend in year, nearest £100K. NB Medical equipment including portable medical equipment for diagnosis, therapy or treatment. Excluding large scale installed equipment such as radiotherapy, CT, MRI
2017-2018
2018-2019 (planned)
2019-2020 (projected)
2021-2022 (projected)
14. IT Networking Infrastructure
a. Wired network access at the bedside (pick from list)
b. Wireless access coverage for suitable medical software applications (pick from list)
Level 1 beds
Critical care level 3 beds
HDU level 2 beds
Operating theatres
A&E
15. Ration of handheld devices per bed i.e. smart phones, tablets (approx.)
16. Ratio of bedside PCs to beds (approx.)
17. Do the PCs in this area comply with the IEC6061 standard for medical equipment (pick from list)
Level 1 beds
Critical care level 3 beds
HDU level 2 beds
Operating theatres
A&E
18. Early warning scores (NEWS, NEWS2 etc.)
19. Which early warning score for the deteriorating patient is in use in the institution?
20. No. of admissions to level 1 care per year (latest figure available)
21. Number of level 1 patient bed days per year (latest figure available)
22. % of level 1 patients monitored using a patient at risk scoring system such as NEWS
23. Standards operating in the Trust (pick from list)
24. Is the network run to the ISO80001 standard ?
25. Does the IT department operate to the ITIL standard?
26. Does the Trust operate a formal bring your own device policy regarding smartphones or tablets?
27. Does Clinical Engineering (BME) hold ISO9001?
28. Does Clinical Engineering (BME) hold ISO13485?

Download response EWS readiness. 070618

External consultancy services, data analysists and statisticians.210323.docx

1. How much money was spent on external consultancy services to help improve hospital processes and efficiency for the tax years 2012 to 2022?
2. Has your organisation directly employed during the period of 2012 to 2022 data analysists and or statisticians (not through consultancy services nor through academic access)?
Statisticians: Yes or No
Data analysts: Yes or No
3. If yes, to question 2, did they facilitate non-research hospital governance and improvement activity and/or data analytics for the NHS?
4. Does your hospital currently have an improvement/development team?
No
Yes, and it does not include data analysts or statisticians
Yes, and it includes data analysts or statisticians.
5. Which group of employees carries out the majority of governance and improvement projects? a) doctors, b) nurses, c) doctors and nurses, d) a specific team.

External consultancy services, data analysists and statisticians.210323.docx

Fax and Operating Systems. 27.01.21

1) How many Fax Machines are currently a) owned and b) used by your Trust,
2) What operating system does your Trust currently use (Windows 8, etc.) for its Computers and Laptops?

Download response Fax and Operating Systems. 27.01.21

Fax machines. 040118

1. Do you have an electronic fax management system (a fax server)?
2. How many manual fax machines do you have? Please answer this as of 1 April 2017 and as of 1 April 2010?
3. What is the annual maintenance cost of the fax machines within your Trust or associated sites? Please answer this as of 1 April 2017 and as of 1 April 2010?
4. How old is your oldest manual fax machine currently in use? What date was it purchased?

Download response Fax machines. 040118

Fax machines.060722.docx

How many fax machines are in use at your Trust (as of July 2022)?

Fax machines.060722.docx

Fax machines.150223.docx

How many fax machines are currently a) owned and b) used by your Trust (as of February 2023)?

Fax machines.150223.docx

Fax machines. 270618

How many fax machines does your Trust own?

Download response Fax machines. 270618

Fax machines and printers

1. Do you have an Electronic Fax Management System (A Fax Server)?
2. How many manual fax machines do you have?
3. Who is the Manufacturer of your MultiFunction Printers, and who maintains them?
4. Who is the manufacturer of your Telephony system and who maintains it?
5. What is the job title of the person responsible for your Fax policy/strategy?

Download response Fax machines and printers 290616

Feral and Shadow IT systems in the NHS. 040319

1. Does your Trust have a policy relating to shadow IT and feral systems? If yes, can you provide a copy of that policy?

2. Has your Trust carried out a recent audit of shadow IT and feral systems?

3. If Yes, can we have a copy of that audit? If No, will you provide an estimate of the number of such systems in your Trust?

4. If you are unable to identify ALL shadow IT and feral systems, will you explain how you intend to meet your obligations under GDPR?

5. Do you have a picture of how many feral systems adhere to NHS national data standards?

6. Are shadow systems currently covered under your trust’s Cyber Security policies and IG Toolkit?

Download response Feral and Shadow IT systems in the NHS. 040319

Finance and human resources IT systems. 221217

Human Resources
1. The name of the business system your Human recourses department use?
2. The name of the supplier of this system?
3. The procurement method that was used to obtain this system i.e. what framework?
4. The current contract status and procurement intentions, are you in procurement or have you already procured?
5. Your current contract start date?
6. Your current end data?
7. Are you looking to renew this system?
8. The total contract Value?
9. Do you have mobile access to this system yes or no
10. The name and email address of your Director of Human Resources?
Finance
1. The name of the business system your Finance department use?
2. The name of the supplier of this system?
3. The procurement method that was used to obtain this system i.e. what framework?
4. The current contract status and procurement intentions, are you in procurement or have you already procured?
5. Your current contract start date?
6. Your current end data?
7. Are you looking to renew this system?
8. The total contract Value?
9. Do you have mobile access to this system yes or no
10. The name and email address of your Director of Finance?

Payroll
1. The name of the business system your Payroll department use?
2. The name of the supplier of this system?
3. The procurement method that was used to obtain this system i.e. what framework?
4. The current contract status and procurement intentions, are you in procurement or have you already procured?
5. Your current contract start date?
6. Your current end data?
7. Are you looking to renew this system?
8. The total contract Value?
9. Do you have mobile access to this system yes or no

Download response Finance and human resources IT systems. 221217

Finance and Information Technology. 230817

1. Who provides the organisations BACS payments and Direct Debit collection software?
2. Please provide a list of your suppliers of the above software.
3. How you came to the decision to choose these companies?
4. Are these solution(s) hosted on premise or cloud hosted?
5. Please provide expenditure on computer software used for Bacs payment processing and Direct Debit collection. For financial years 2014/2015 and 2015/2016.
6. When does your current contract(s) with BACs payment and direct debit collection software expire?
7. Will this service(s) be tendered and if so where?
8. What is the total value of your current BACS payment and Direct Debit collection software contract(s) and over what period?
9. With whom does the organisation hold its primary bank account?
10. Does the organisation, acting as a Bureau, provide Bacs processing on behalf on any other organisation?
11. What payments types does the organisation use? (e.g Bacs (Direct Credit), Direct Debit, Faster Payments, etc.).
12. Who is the person responsible for BACS processing and Direct Debit collection software?
o Name
o Position
o Telephone Number
o Email

Download response Finance and Information Technology. 230817

Firewall, Anti-virus, and Enterprise Agreement. 090621

Standard Firewall (Network) – Firewall service protects your corporate Network from unauthorised access and other Internet security threats
1. Who is the existing supplier for this contract?
2. What does the organisation annually spend for each of the contracts?
3. What is the description of the services provided for each contract?
4. Primary Brand
5. What is the expiry date of each contract?
6. What is the start date of each contract?
7. What is the contract duration of contract?
8. The responsible contract officer for each of the contracts above? Full name, job title, contact number and direct email address.
Anti-virus Software Application – Anti-virus software is a program or set of programs that are designed to prevent, search for, detect, and remove software viruses, and other malicious software like worms, trojans, adware, and more.
1. Who is the existing supplier for this contract?
2. What does the organisation annually spend for each of the contracts?
3. What is the description of the services provided for each contract?
4. Primary Brand
5. What is the expiry date of each contract?
6. What is the start date of each contract?
7. What is the contract duration of contract?
8. The responsible contract officer for each of the contracts above? Full name, job title, contact number and direct email address.
Microsoft Enterprise Agreement – is a volume licensing package offered by Microsoft.
1. Who is the existing supplier for this contract?
2. What does the organisation annually spend for each of the contracts?
3. What is the description of the services provided for each contract?
4. What is the expiry date of each contract?
5. What is the start date of each contract?
6. What is the contract duration of contract?
7. The responsible contract officer for each of the contracts above? Full name, job title, contact number and direct email address.
8. Number of Licenses

Download response Firewall, Anti-virus, and Enterprise Agreement. 090621

Fixed Telecommunications and Internet Services

Contract 1

1. Current Fixed Line (Voice Circuits) Provider- Supplier’s name

2. Fixed Line- Contract Renewal Date- please provide day, month and year (month and year is also acceptable). If this is a rolling contract please provide me with the rolling date of the contract. If there is more than one supplier please split the renewal dates up into however many suppliers

3. Fixed Line- Contract Duration- the number of years the contract is for each supplier.

4. Type of Lines- PSN, Analogue, SIP

5. Number of Lines- Please can you split the number of lines per each supplier? SIP trunks, PSN Lines, Analogue Lines

Contract 2

6. Minutes/Landline Provider- Supplier’s name (Fixed Voice not Mobiles)

7. Minutes/Landline Contract Renewal Date- please provide day, month and year (month and year is also acceptable). If this is a rolling contract please provide me with the rolling date of the contract.

8. Minutes Landline Monthly Spend- Monthly average spend. An estimate or average is acceptable

9. Minute’s Landlines Contract Duration: the number of years the contract is with the supplier.

10. Number of Extensions- Please state the number of telephone extensions the organisation currently has. An estimate or average is acceptable.

Contract 3

11. Fixed Broadband Provider- Supplier’s name

12. Fixed Broadband Renewal Date- please provide day, month and year (month and year is also acceptable). If this is a rolling contract please provide me with the rolling date of the contract. If there is more than one supplier please split the renewal dates up into however many suppliers

13. Fixed Broadband Annual Average Spend- Annual average spend. An estimate or average is acceptable.

14. VOIP/PBX Installation Date of the organisation’s primary telephone system: – please provide day, month and year (month and year is also acceptable).

Contract 4

15. WAN Provider- please provide me with the main supplier(s)

16. WAN Contract Renewal Date- please provide day, month and year (month and year is also acceptable). If this is a rolling contract please provide me with the rolling date of the contract. If there is more than one supplier please split the renewal dates up into however many suppliers

17. WAN Annual Average Spend- Annual average spend. An estimate or average is acceptable.

18. Internal Contact: please can you send me there full contact details including contact number and email and job title.

Download response Fixed Telecommunications and Internet Services 190416

Flexible Endoscopes. 191018

1. Who is your current service provider of Flexible Endoscope repair & maintenance?
2. How many Flexible endoscopes do you have in your inventory?

Download response Flexible Endoscopes. 191018

FOI requests 041116

1. What software do you use for FOI requests?
2. What are the modules it provides e.g. run reports etc.
3. Who is the contractor (company name)?
4. How long have you been using the software?
5. What is the annual cost?
6. How many FOI requests did you process (2015/16)?
7. How many staff processes your organisational FOIs?
8. Please provide the information governance service structure

Download response FOI requests 041116

FOI requests 2012-2017. 250517

1. How many FOI requests have been received by your trust on a year by year basis for the past 5 years?
2. How many of the FOI requests have breached the 20 working day limit stipulated by the act in the past 5 years?
3. How many times was your trust reported to the ICO because of breaches and if they issued fines/how much, etc. – for past 5 years?
4. Please can you able to advise how long the average FOI request takes to complete?
5. Please can you advise the minimum time and cost and the maximum time and cost of an FOI request?
6. Please can you advise how many staff you have in your department working on FOI requests and WTE?
7. Please can you confirm what computer systems do you use to manage your FOIs, (Citrix, Proteus, etc.)?
8. What is your estimated cost in terms of consultant time, admin staff, secs, managers spent on FOI requests?

Download response FOI requests 2012-2017. 250517

FOI requests 2014 – 2016.280217

1. How many requests you have received under the FOI Act in the calendar years 2014, 2015, 2016?
2. How many staff members, their full time equivalent, and their AfC bandings are allocated to the management of the requests?

Download response FOI requests 2014 – 2016.280217

FOI requests 2014 – 2016.280217

1. How many requests you have received under the FOI Act in the calendar years 2014, 2015, 2016?
2. How many staff members, their full time equivalent, and their AfC bandings are allocated to the management of the requests?

Download response FOI requests 2014 – 2016.280217

FOI requests.300124.docx

All questions are shown as received by the Trust.
“In regards to the past 12 months or past calendar year:
1. How many FOI requests have you received in your organisation?
2. How many of these requests have not been completed within the 20 working day timescale?
3. How many staff log/process FOI requests?
4. What system is used to log and record Freedom of Information Requests? e.g. Ulysses, Excel
5. Please provide the reasons that these requests were not completed within 20 working day timescale? E.g. lack of engagement, delay from departments who have the information, availability of staff, delay in approval process.
6. Do all staff in your organisation have training on what a Freedom of Information Request is?
7. Have you implemented any changes to improve the Freedom of Information Request response rate within your organisation? E.g. staff awareness, invested in better systems, hired more employees.
8. If you have any other comments about responding to FOI requests or completing the requests within 20 working days, please write them here.”

FOI requests.300124.docx

FOI requests. 300317

1. The software systems you use to monitor/process FOI requests.
2. The job title and pay band of staff employed in the administration and processing of FOI requests.
3. The number of FOI requests received for each month of January and February 2017.

Download response FOI requests. 300317

Freedom of Information requests. 181218

1. The number of requests made in each of the financial years 2015-16, 2016-17 and 2017-18;
2. The percentage of requests that have been accepted, rejected or held pending in each of the financial years 2015-16, 2016-17 and 2017-18;
3. A breakdown of the form, size and sector type of the entities that made the requests in each of the financial years 2015-16, 2016-17 and 2017-18; and
4. A breakdown of the form, size and sector type of the entities whose requests were successful in each of the financial years 2015-16, 2016-17 and 2017-18; and
5. A percentage of those successful requests which resulted in the trust, or its constituent hospitals, entering into a commercial or financial relationship with the requestor or its affiliates in each of the financial years 2015-16, 2016-17 and 2017-18.
6. Notwithstanding the above, can the trust confirm whether it, or one of its constituent hospitals, has entered into a commercial or financial relationship with any of the following entities as a result of the requests made in each of the financial years 2015-16, 2016-17 and 2017-18? Google; DeepMind; Sensyne Health; Benevolent AI; Orion Health; IBM;
7. Can the trust supply a copy of the trust’s intellectual policy document/s, if any covering the period 2015-present?

Download response Freedom of Information requests. 181218

Gadget purchases. 170919

I would like to know the following under the FOI act please:
Breakdown of the number of laptops, mobile phones and tablet computers purchased by your organisation for staff over the last three full financial years.
FY 16-17, FY 17-18 and FY 18-19.
Please break the information down as follows, example:
FY 16-17
Laptops: 240
Mobiles: 130
Tablet computers: 160
If possible, please provide detail of the make and model of the device e.g. Apple iPhone 6.

Download response Gadget purchases. 170919

GDPR. 060718

1. Have you invested in technology specifically to comply with GDPR?
o Yes
o No
2. Which information security framework(s) have you implemented?
3. Have you signed contractual assurances from all the third-party organisations you work with requiring that they achieve GDPR compliance by 25 May 2018?
o Yes
o No
4. Have you completed an audit to identify all files or databases that include personally identifiable information (PII) within your organisation?
o Yes
o No
5. Do you use encryption to protect all PII repositories within your organisation?
o Yes
o No
6. As part of this audit, did you clarify if PII data is being stored on, and/or accessed by:
a. Mobile devices
b. Cloud services
c. Third party contractors
7. Does the organisation employ controls that will prevent an unknown device accessing PII repositories?
o Yes
o No
8. Does your organisation employ controls that detect the security posture of a device before granting access to network resources – i.e. valid certificates, patched, AV protected, etc.
o Yes
o No
9. Should PII data be compromised, have you defined a process so you can notify the relevant supervisory authority within 72 hours?
o Yes
o No
10. Have you ever paid a ransom demand to have data returned / malware (aka ransomware) removed from systems?
o Yes
o No
11. To which positions/level does your data protection officer report? i.e. CISO, CEO, etc.

Download response GDPR. 060718

General Trust enquiries. 070720

1. Who is the Trust’s current supplier for their Electronic Patient Record?
2. What are the contract start and end dates for the Electronic Patient Record?
3. Who is the Trust’s current supplier for their Patient Administration System?
4. What are the contract start and end dates for the Patient Administration System?
5. When is the trust due to start looking to re-procure their clinical systems?
6. Who supplies the Trust’s integration system?
7. How often does the Trust evaluate their Clinical Systems?
8. Please supply a copy of the Trust’s latest Digital Strategy
9. How regularly does the Trust review their Digital Strategy?
10. Who is the Trust’s current Chief Clinical Information Officer?
11. Who is the Trust’s current CIO/ IT Director?
12. Which member of the board is responsible for IT?
13. Please provide an organisation chart for the trust’s IM&T department
14. Please provide a link to the trust’s latest Board Assurance Framework
15. Which member of the Trust is the SRO for the STP engagements?
16. What proportion of the Trust’s IM&T Department is made up of interim staff and permanent staff?
17. How many beds does the trust have?
18. How many staff does the trust employ?
19. What is the trust’s current NHSI Rating via the NHS Oversight Framework?
20. What is the trust’s current Digital Maturity Score?
21. Does the trust outsource their IT services to an external provider, if so please provide details of provider and contract dates
22. Is the Trust looking to migrate to the cloud in the next 2 years?
23. Is the Trust considering their options of outsourcing their IT Services in the next 3 years?

Download response General Trust enquiries. 070720

GS1 Compliance Officer 151216

Please can you supply the contact details of the Organisations GS1 Coordination AND / OR GS1 Compliance Officer?

Download response GS1 Compliance Officer 151216

Health Apps. 210218

1) Does your trust have a policy on the use of health apps?
2) If yes, please provide the policy (or policies) and contact details.
3) Do you currently have specific budgets for the use of health apps within your trust?
4) If yes, please provide a contact for any budgets related to the use of health apps.
5) Are there individual health apps specified for patient use? Please provide a list of these.
6) If yes, please specify which of these health apps is paid for by the trust.
7) Please specify who is responsible for the funding of each app that is paid for by the trust and provide contact details?

Download response Health Apps. 210218

Health Records. 010720

1 How many on-site libraries does the trust have?
2 What volume of notes are held on-site?
3 Does the Trust have any external storage contracts? If so, how many and who are the providers?
4 What volume of notes are held off site by Third parties?
5 If applicable, which Electronic Document Management systems does the Trust have?
6 What are the start and end dates for any storage and / or software contracts?
7 How many staff work in the health records department?
8 How many staff work in clinical prep?
9 How much does the Trust spend annually on pre-printed forms?

Download response Health Records. 010720

Health records digitalisation. 050719

1. Has your Trust digitised its active Health Records by scanning them to an Electronic Document Management (EDM) System?
If Yes, please proceed to Question 2.
If No, please proceed to Question 3.
Question 2)
2.1) When did the Trust procure the system?
2.2) When did the system go-live within the Trust?
2.3) If the projects roll-out has completed, when did the Trust reach a Business as Usual (BAU) state?
2.4) Which EDM vendor has the Trust contracted with?
2.5) Which scanning provider delivered the scanning contract? If this was delivered by an internal Trust scanning bureau or the Trust transitioned to internal scanning, please provide detail.
2.6) At the point of scanning records, was the vendor or internal bureau accredited to BS10008?
2.7) Which of the following statements best represents the scanning approach undertaken:
a. All physical Health Records have been scanned to the EDM system.
b. Only records required for upcoming attendances (On-demand) were scanned, all other records remained as paper and were destroyed in-line with their retention profile.
c. A mixture of On-demand scanning and scanning notes which had been historically active recently, leaving inactive notes as paper.
d. No historic notes were scanned, instead only new records are digitised. The entire Heath Records library is retained until each records retention profile is met.
2.8) What, if any, benefits has the system provided and over what timeframe? Please define each benefit as Cash Releasing (CR), Non-Cash Releasing (NCR), Qualitative (Q) or Societal (S).
2.9) Is the Trust still capturing new information by scanning or have electronic forms been implemented? (eForms)
2.10) If eForms are in use, are these created within the EDM system or another application(s) such as an EPR / eObs or both?
2.11) If the Trust is still scanning new content into the EDM, are the forms themselves barcoded (bForms) or are separate barcoded sheets used (Classification / Index / Separator Sheets)?
2.12) Who is responsible for the EDM System and any scanning activities?
Question 3)
3.1) Is the Trust currently considering options for implementing an EDM and/or scanning activities for Health Records.
3.2) Has the Trust prepared a Business Case to consider the benefits and costs of implementing an EDM solution?
3.2) Is the Trust waiting for opportunities for central funding support before committing to approving any business case?

Download response Health records digitalisation. 050719

Health Records Management Code of Practice. 141216

Following the Records Management Code of Practice for Health & Social Care 2016 which was published by the Information Governance Alliance in July ’16 on behalf of the Department of Health, has your Trust made any changes to retention practice under ‘record type’ to retain records for either 30 years or 8 years after patient death for long term illnesses or an illness that may re-occur?

Download response Health Records Management Code of Practice. 141216

 

Industrial Action

BMA rate card.300823.docx

All questions are shown as received by the Trust.
The questions relate to how much the trust paid consultants during recent industrial action by junior doctors and whether the paid rates in line with the BMA’s ‘rate card’.
Please answer the following questions:
1.Did the trust pay the hourly rates outlined on the BMA rate card for consultants’ non-contractual work, during either of the junior doctors’ strikes in July or August? Please answer Yes or No. Please provide a further explanation if the trust wants to expand on the answer.
2. If the trust answered “No” to question 1, what was the maximum hourly rate (£/hour) the trust paid for non-contractual shifts, or for consultants to act down during contractual shifts required to cover junior doctors’ shifts during either the July or August junior doctors’ strike? If you answered “yes” to question 1, please leave this answer blank. Please provide a further explanation if the trust wants to expand on the answer
3. Does the trust pay the hourly rates outlined on the BMA rate card for consultants’ non-contractual shifts as of August 2023 for extra shifts taking on by consultants when there is not a strike on? Please answer Yes or No. Please provide a further explanation if the trust wants to expand on the answer
4. If the trust answered “No” to question 3, what is the maximum hourly rate (£/hour) the trust paid consultants for non-contractual shifts as of August 2023? If the trust answered “yes” to question 3, please leave this answer blank. Please provide a further explanation if the trust wants to expand on the answer

BMA rate card.300823.docx

BMA strikes.240823.docx

All questions are shown as received by the Trust.
The number of cancelled, delayed or missed appointments at your Trust as a result of British Medical Association strikes w/c 11th – 15th April, broken down by
1. 1. Type of appointment, e.g. checkup, treatment, surgery
2. 2. Type of care the appointment/surgery was required for, e.g. cancer – please specify which department too

BMA strikes.240823.docx

Funding for strike cover.191023.docx

I would like to request information regarding the money spent by your trust on NHS strike cover, over doctor strike periods.
For the following strike dates (inclusive):
13/3/23 – 15/3/23
11/4/23 – 14/4/23
14/6/23 -16/6/23
13/7/23 – 18/7/23
20/7/23 – 21/7/23
11/8/23 – 14/8/23
24/8/23 – 25/8/23
19/9/23 – 22/9/23
02/10/23 – 04/10/23
Please can you provide:
1. The total temporary staff spend on each day in the periods requested
2. The total spend on strike cover on each day in the periods requested
3. The top five daily rates paid for i) doctor and ii) nurse on each day in the periods requested.

Funding for strike cover.191023.docx

 

Insourcing & Outsourcing

Agency and insourcing spend.260723.docx

1. What is the total value of spend by your NHS Trust with on-framework and off-framework recruitment agencies by staff group (see staff groups below) on a temporary basis? Please provide this information for the following years (please fill in the tables below).
Note: Please provide total spend inclusive of salaries and agency margin / fees.
Note: If cannot provide split of spend by on- vs off- framework agencies, please provide total spend.
2. Do you use insourcing providers?
Note: Insourcing definition: Insourcing of Clinical Services – NHS SBS
3. If yes to previous question (use of insourcing providers), what is the total value of spend, listed by speciality and insourcing provider used for Apr-22 to Mar-23?
Note: If an insourcing provider covers multiple specialities, please list that provider multiple times (one row for each speciality).

Agency and insourcing spend.260723.docx

Clinical Insource and Outsource Spend – 2021-22.201222.docx

1. I would like to know the full amount spent by MAIDSTONE AND TUNBRIDGE WELLS NHS TRUST on the Insourcing of Clinical Services and the full amount spent on the Outsourcing of Clinical Services in the 2021/22 Financial Year.

2. If possible, please can you also provide me with the amount the Trust spent on Insourcing and the amount spent on Outsourcing across the following clinical services in the 2021/2022 Financial Year:
a. Cardiology Service
b. Cardiothoracic Surgery Service
c. Dermatology Service
d. Ear Nose and Throat Service
e. Elderly Medicine Service
f. Gastroenterology Service
g. General Internal Medicine Service
h. General Surgery Service
i. Gynaecology Service
j. Neurology Service
k. Neurosurgical Service
l. Ophthalmology Service
m. Oral Surgery Service
n. Plastic Surgery Service
o. Respiratory Medicine Service
p. Rheumatology Service
q. Trauma and Orthopaedic Service
r. Urology Service
Clinical Insource and Outsource Spend – 2021-22.201222.docx

Clinical Insourcing.170124.docx

All questions are shown as received by the Trust.
• Please provide details on the specialties for which the trust utilised clinical insourcing during Jan 2023 – December 2023
• Please specify the suppliers or service providers the trust engaged for clinical insourcing during Jan 2023 – December 2023
• Kindly disclose the details of the decision-maker(s) responsible for choosing clinical insourcing across the specified specialties.
• Please kindly confirm the amount spent on this contract to date.

Clinical Insourcing.170124.docx

External CT, MRI and PET-CT scanning providers.030523.docx

1. Does the Trust currently or has the Trust used any staffed mobile CT, MRI or PET-CT scanning providers since 1st April 2022?
If so, please provide the following details:
1.1. Provider Name
1.2. Contract Start Date
1.3. Contract End Date (if the contract is currently active, please confirm the end date specified in the contract)
1.4. Total spend (per modality/mobile service) since 1st April 2022
1.5. Please state where the mobile scanner is located.
(i.e., at an Acute Hospital, a Non-Acute Hospital, a Community Diagnostic Centre site or elsewhere)
2. Has the Trust made contractual arrangements with a staffed mobile CT, MRI or PET-CT scanning service with a provider (not listed above) for a future date?
2.1. Provider Name
2.2. Contract Start Date
2.3. Contract duration (please specify whether your answer is in days, weeks, months or years)
3. Does the Trust own and operate any of its own mobile scanners? If so, please confirm:
3.1. Location
4. Excluding staffed mobile CT, MRI or PET-CT scanning services, does the Trust use a Managed Equipment Services (MES) provider for CT, MRI or PET-CT imaging?
4.1. Provider Name
4.2. Contract Start Date
4.3. Contract End Date (if the contract is currently active, please confirm the end date specified in the contract)
4.4. Location
4.5. Is the Trust restricted to only using this provider for all outsourced scanning solutions?

External CT, MRI and PET-CT scanning providers.030523.docx

 

Integrated Care Board (ICB) & Shared Care Record (SCR)

EPR and ICB.170323.docx

1. What Electronic Patient Record (EPR) system do you use? Please state if your EPR is an In-house built system.
a. If your EPR is supplied externally, when does your contract expire?
b. Do you have any intention to replace the EPR?
c. What is the timescale for the replacement to be in place?
d. Has a replacement EPR system been chosen. If, yes, please name the chosen EPR.
2. What Patient Administration System (PAS) do you use? Please state if your PAS is an In-house built system.
a. If your PAS is supplied externally, when does your contract expire?
b. Do you have any intention to replace the PAS?
c. What is the timescale for the replacement to be in place?
d. Has a replacement PAS system been chosen. If, yes, please name the chosen PAS.
3. What Document Management System (DMS) do you use? Please state if your DMS is an In-house built system.
a. If your DMS is supplied externally, when does your contract expire?
b. Do you have any intention to replace the DMS?
c. What is the timescale for the replacement to be in place?
d. Has a replacement DMS system been chosen. If, yes, please name the chosen DMS.
4. What ICB does your organisation fall under?
5. Do you have a shared care record (SCR) across your ICB?
6. If the answer to question 2 is, yes:
a. What is the name of the system?
b. When does the contract expire for the current system?
c. Does your ICB have any intention to replace the SCR?
d. Does your ICB have any timescale for the replacement to be in place?
e. Has a replacement SCR system been chosen. If, yes, please name the chosen system.
7. If the answer to question 6 is, no:
a. Are there any plans to create a shared care record?
EPR and ICB.170323.docx

 

Major Incident

Ambulance deaths.051222.docx

The number of patients per week who have died while waiting inside an ambulance – on hospital property – to be admitted to the emergency department. I would like this information between the dates 01/11/2021 and 15/11/2022.

Ambulance deaths.051222.docx

Antibiotic resistant NDM 2014-2016. 280217

Can you please send details of any cases of antibiotic resistant NDM (New Delhi metallo-ß-lactamase) “superbugs” you have reported to Public Health England in 2014, 2015 and 2016.

We are particularly interested in NDM-1, but would appreciate details of any other NDM incidents if available.

Please break the information down into the three years listed.

Download response Antibiotic resistant NDM 2014-2016. 280217

Breaches of the Data Protection Act.

1a.Approximately how many members of staff do you have?
1b.Approximately how many contractors have routine access to your information?

2a.Do you have an information security incident/event reporting policy/guidance/management document(s) that includes categorisation/classification of such incidents?
2b.Can you provide me with the information or document(s) referred to in 2a? (This can be an email attachment of the document(s), a link to the document(s) on your publicly facing web site or a ‘cut and paste’ of the relevant section of these document(s))

3a.Do you know how many data protection incidents your organisation has had since April 2011? (Incidents reported to the Information Commissioners Office (ICO) as a Data Protection Act (DPA) breach)
Answer: Yes, No, Only since (date):
3b.How many breaches occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

4a.Do you know how many other information security incidents your organisation has had since April 2011? (A breach resulting in the loss of organisational information other than an incident reported to the ICO, eg compromise of sensitive contracts or encryption by malware. )
Answer: Yes, No, Only since (date):
4b.How many incidents occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

5a.Do you know how many information security events/anomaly your organisation has had since April 2011? (Events where information loss did not occur but resources were assigned to investigate or recover, eg nuisance malware or locating misfiled documents.)
Answer: Yes, No, Only since (date):
5b.How many events occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

6a.Do you know how many information security near misses your organisation has had since April 2011? (Problems reported to the information security teams that indicate a possible technical, administrative or procedural issue.)
Answer: Yes, No, Only since (date):
6b.How many near-misses occurred for each Financial Year the figures are available for?
Answer FY11-12: FY12-13: FY13-14: FY14-15:

Download response Breaches of the Data Protection Act 230516

C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

For the years 2014, 2015, and 2016 please details the following:

How many people and inpatients have been infected with and treated for a superbug.

List which superbug people were infected with.

In which hospital did they contract the infection?

How many of these people later died of the infection?

Download response C.Difficile, MRSA, Klebsiella Pneumoniae Carbapenemase and E.coli. 300317

Clinical Service Incidents 2015-2017. 250517

Please provide details of all clinical service incidents caused by estates and infrastructure failure at your hospital trust in 2015/16 and 2016/17 to date.

This is the definition of clinical service incidents: Incidents caused by estates and infrastructure failure which caused clinical services to be delayed, cancelled or otherwise interfered with owing to problems or failures related to the estates and infrastructure failure. Exclude failures relating to non-estates causes e.g. nursing availability, but include where external incidents which estates and infrastructures should have mitigated e.g. utility power failures where the Trusts backup power system failed to offset. An incident is considered to be a delay of at least 30 minutes to clinical services affecting at least 5 patients or equivalent. Both inpatient and outpatient service incidents should be included. Such incidents will include, but are not limited to: • Power and/or heating failures including overheating • Fires and false alarms (where caused by equipment faults or malfunction, deliberate/malicious causes should be excluded) • Water and/or sewage supply • Food production and/or delivery • Pest control

For each incident, please provide a summary of the incident and the impact on services. Please include what the problem was and how clinical services were affected, including details of how many patients were affected, what the service was and how long the service was delayed or whether it was cancelled.

Download response Clinical Service Incidents 2015-2017. 250517

Correspondence in relation to the Frances Cappuccini case

* Please provide copies of all emails sent and received by Glenn Douglas between (and including) January 25, 2016, and (including) today which relate in any way to the Frances Cappuccini case;
* Please provide copies of all emails sent and received by Paul Sigston between (and including) January 25, 2016, and (including) today which relate in any way to the Frances Cappuccini case;
Please include copies of all attachments sent with emails.

Download response Correspondence in relation to the Frances Cappuccini case 020316

Datix incidents. 201119

I would like to request information on the number of incidents that have been recorded on the DATIX system in each of the last three financial years and broken down by category of incident.

Download response Datix incidents. 201119

EPRR Coordination of emergency and disaster management activities.300522.docx

Under the provisions of the Freedom of Information Act 2000, I am writing to request the following information. This information relates to the NHS England Emergency Preparedness, Resilience and Response (EPRR) Framework in general and section 10, “Cycle of preparedness”, section 13, “Concepts of command and control” and section 14, “NHS command and control”, in particular.

Please note that the much of the information requested is only the records of the existence of committee membership, a meeting, training and responsibilities, and activities, list(s), procedures, mechanisms, arrangements and exercises and not the contents of the membership, meeting, training, responsibilities, activities, list(s), procedures, mechanisms, arrangements and exercises themselves.

Given the potentially sensitive nature of this information, I ask you to redact any exempt information instead of refusing disclosure. This would be in accordance with guidance on best practice from the Information Commissioner’s Office.

If you do not hold some of this information then I ask you to confirm explicitly that you do not hold it.

Coordination of emergency and disaster management activities

Hospital Emergency / Disaster Committee
Any record of the current existence of a multi-departmental and multidisciplinary committee to coordinate EPRR measures. If such a committee exists then any record of which departments and disciplines are represented on it and the date the committee most recently met.

Committee member responsibilities and training
If such a committee above exists then any record that committee members have received training for their role on the committee and any record that committee members have been assigned specific responsibilities.

Designated emergency and disaster management coordinator
Any record of the current existence of a hospital emergency / disaster management coordinator. If such a co-ordinator exists then any record of what whole time equivalent of their time is devoted to emergency and disaster management.

Preparedness programme for strengthening emergency and disaster response and recovery

Any record that activities to strengthen EPRR have been implemented in the past 12 months.

Hospital incident management system
Any record of the current existence of list(s) of key personnel roles in a hospital incident management system for the command, control and coordination in an emergency or disaster response. If such list(s) exists then any record of the existence of corresponding key personnel role action procedure documents.

Emergency Operations Centre (EOC)
Any record of the current existence of a designated Incident Coordination Centre. If such an Incident Coordination Centre exists then any record of whether it has full immediate operational capacity in an emergency.

Coordination mechanisms and cooperative arrangements with local emergency / disaster management agencies
Any record of the existence of current formal co-ordination or co-operation mechanisms or arrangements between the Trust and emergency/disaster management agencies (e.g. local authorities, police services, fire and rescue services, civil society organisations) in order to support Trust functions in time of emergency or disaster.

If such mechanisms or arrangements above exist then any record of the most recent exercise(s) to test them, including date(s) of exercise(s).

Coordination mechanisms and cooperative arrangements with the healthcare network
Any record of the existence of current formal co-ordination or co-operation mechanisms or arrangements between the Trust and other healthcare providers in order to support Trust functions in time of emergency or disaster.

If such mechanisms or arrangements above exist then any record of the most recent exercise(s) to test them, including date(s) of exercise(s).

EPRR Coordination of emergency and disaster management activities.300522.docx

Falls prevention/monitors 2013-2015

1. Which hospitals in the trust have the following wards:
Elderly Care
Stroke
Dementia
Names:
2. What are your published figures for reported in-patient falls for the period January 2013 – December 2015?
Year 2013:
Year 2014:
Year 2015:
3. Do any of the hospitals within the trust use any of the following (please state which product for which hospital):
Turun TABS Falls Monitor
Alert-It
Sensorcare Bed Systems
Other (please name)
4. Has there been a significant number of false alarms with any of the falls prevention devices?
Turun TABS Falls Monitor yes/no
Alert-It yes/no
Sensorcare Bed Systems yes/no
Other yes/no

If significant, is the hospital/s still using the equipment?
Yes No
5. Have there been any reported issues of pressure sores/bed sores due to using any of the falls prevention devices?
Turun TABS Falls Monitor Severe Average Minor
Alert-It Severe Average Minor
Sensorcare Bed Systems Severe Average Minor
Other Severe Average Minor
6. What is the name of the Ward Manager/s of the ward/s that use the falls prevention device? ¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬
7. What named types of beds are used in the ward/s that the falls monitor is used on?

Download response Falls prevention/monitors 2013-2015 260216

Fire and Rescue.200622.docx

I would be very grateful if you could please send me details of the Trust’s spending on services and goods provided by Fire & Rescue Services between 1st April 2021 and 31st March 2022?

Fire and Rescue.200622.docx

 

Mental Health Services

ADHD Services.301222.docx

I am writing to you under the Freedom of Information Act (2000) to request information relating to the provision of ADHD (Attention deficity hyperactivity disorder) services by Maidstone and Tunbridge Wells NHS Trust.
Please provide the following information to the email address specified below.
1. Please name the organisation(s) that deliver(s) CYP (children and young people) ADHD assessment / diagnoses in your Trust area
a. When did the contract(s) begin and when is the contract(s) due to end
b. What is the annual spend for this service for 2022, and for the last 5 years?
c. How is the service contracted – is it Block, Activity-based, or AQP contracting?
d. If the service is commissioned with other CCGs, ICSs or Trusts, which are these?
e. At what prevalence (% of the child population) have the contracts been commissioned against?
2. Does the same organisation as for Question 1 also deliver CYP ADHD prescriptions and post-diagnosis ADHD support in your Trust area? If not, please provide the same information for this organisation.
3. Please outline the CYP ADHD pathway in your area, including key referral sources
4. How many children and young people are currently waiting for a CYP ADHD assessment in your area? What is the longest and median wait time from a referral?
a. Within the last year, how many children and young people were assessed within 12 weeks of referral?
b. Within the last year, how many children and young people were discharged without assessment?
c. Please answer Questions 4, 4a, 4b for as many historic years as possible, up to 5 years
5. For the last 5 years, please give the number of CYP patients per year in the Trust who were:
a. Referred for ADHD assessment
b. Given an ADHD assessment
c. Given an ADHD assessment from a ‘Right to Choose’ provider, outside the service contracted
d. Diagnosed with ADHD
6. For the last 5 years, what was the average number of ADHD-qualified staff delivering services in the area? How does this split by role:
a. Qualified psychiatrists
b. Paediatricians
c. Speech and Language therapists
d. Clinical Psychologists
e. For a-d, please also give numbers of trainees
Please provide equivalent answers for Questions 1-6, but for Adult ADHD services in the Trust. If the Trust does not distinguish between CYP and Adult ADHD services, please answer Questions 1-6 for all patients collectively
Please provide equivalent answers for Questions 1-6, but for Adult ADHD services in the Trust. If the Trust does not distinguish between CYP and Adult ADHD services, please answer Questions 1-6 for all patients collectively

ADHD Services.301222.docx

Borderline Personality Disorder.050124.docx

All questions are shown as received by the Trust.
1. Please provide your trust policy for borderline personality disorder diagnosis and treatment.
2. How much funding is received for the care of borderline personality disorder and how is this money spent?
3. How many adult patients are there within the trust with a diagnosis of borderline personality disorder?
4. What specialist treatments or therapeutic interventions do the trust facilitate for all patients diagnosed with borderline personality disorder?
5. How much does it cost the trust per year to provide medication to adults diagnosed with borderline personality disorder?
6. How many patients/service users with borderline personality disorder require in-patient care and what is the cost of this?
7. Does the trust provide dialectical behaviour therapy? If so, please provide the numbers of patients/service users who have used this service. If not, is there a plan to implement this treatment?
9. How many suicides of patients diagnosed with borderline personality disorder have there been each year?
10. How many complaints have been lodged in relation to borderline personality disorder treatment?

Borderline Personality Disorder.050124.docx

CAMHS.110123.docx

• The proportion of referrals to the mental health service deemed inappropriate or rejected in the 2019/2020 financial year and the 2020/2021 financial year
• The reasons for referrals to the mental health services being rejected in these years
• The median and maximum waiting times between initial assessment and the start of treatment in these years

CAMHS.110123.docx

Child and Adolescent Mental Health Services (CAMHS) Assessment, Neurodevelopment Assessment and Psychological Therapies.170124.docx

All questions are shown as received by the Trust.
1. Child and Adolescent Mental Health Services (CAMHS) Assessment:
• What is the current number of people waiting for a CAMHS assessment?
• What is your average waiting time for CAMHS treatment?
• Who is the person responsible for managing these waiting lists?
• Has Maidstone and Tunbridge Wells NHS Trust used independent providers to carry out work on the waiting list?
2. Neurodevelopment Assessment:
• What is the average waiting time for a Neurodevelopmental assessment for children and adults?
• What is the current number of children and adults waiting for a Neurodevelopmental assessment?
• Who is the person responsible for managing this waiting list?
• Has Maidstone and Tunbridge Wells NHS Trust used independent providers to carry out work on the waiting list?
3. Psychological Therapies:
• What is the average waiting time for psychological therapies?
• What is the current number of adults awaiting psychological therapy?
• Who is the person responsible for managing this waiting list?
• Has Maidstone and Tunbridge Wells NHS Trust used independent providers to carry out work on the waiting list?

Child and Adolescent Mental Health Services (CAMHS) Assessment, Neurodevelopment Assessment and Psychological Therapies.170124.docx

Community mental health service(s).201222.docx

A. Adult eating disorders services:
1. Does your Trust provide a service to adults with anorexia nervosa or bulimia nervosa? YES/ NO (if No please proceed to section B)
2. How many adults with anorexia nervosa or bulimia nervosa were on the Trust caseload at 31st March 2022?
3. How many adults with anorexia nervosa or bulimia nervosa were referred to the service over the 1 year period (1st April 21- 31st March 22)?
4. How many registered dietitians (in WTE/ FTE) were working exclusively with this caseload to adults with anorexia nervosa or bulimia nervosa at 31st March 2022?
5. What percentage of adults with anorexia nervosa or bulimia nervosa received into the service were seen by a dietitian over the 1 year period (1st April 21- 31st March 22)?
B. Adolescent/ child eating disorder services
6. Does your Trust provide a service to adolescents/ children with anorexia nervosa or bulimia nervosa? YES/ NO (If No, no further responses are required)
7. How many adolescents/ children with anorexia nervosa or bulimia nervosa were on the Trust caseload at 31st March 2022?
8. How many adolescents/ children with anorexia nervosa or bulimia nervosa were referred to the service over the 1 year period (1st April 21- 31st March 22)?
9. How many registered dietitians (in WTE/ FTE) were working exclusively with this caseload to adolescents/ children with anorexia nervosa or bulimia nervosa at 31st March 2022?
10. What percentage of adolescents/ children with anorexia nervosa or bulimia nervosa received into the service were seen by a dietitian over the 1 year period (1st April 21- 31st March 22)?

Community mental health service(s).201222.docx

Detention under the Mental Health Act.180823.docx

All questions are shown as received by the Trust.
Q1. Between 1 January 2018 and 31 December 2022, how many people were detained under the Mental Health Act? Alongside the total, please provide a breakdown by calendar year.
Q2. How many people detained under the Mental Health Act between 1 January 2018 and 31 December 2022 were asylum seekers? Alongside the total, please provide a breakdown by calendar year.
Q3. Between 1 January 2022 and 31 May 2023, how many people were detained under the Mental Health Act? Alongside the total, please provide a breakdown by month.
Q4. How many people detained under the Mental Health Act between January 2022 to May 2023 were asylum seekers? Alongside the total, please provide a breakdown by month.

Detention under the Mental Health Act.180823.docx

Eating disorder services and ADRTs.150523.docx

1. Do any patients at your Trust’s adult eating disorder service have ‘Advance Decisions/Directives to refuse medical treatment’ (ADRTs) recorded on their electronic records? (It is NHS policy that all ADRTs must be recorded on patients electronic records).

2. How many adult eating disorder patients ADRTs have ‘Advance Decisions/Directives to refuse medical treatment’ (ADRTs) currently recorded on their electronic records?

Eating disorder services and ADRTs.150523.docx

 

Obesity

Bariatric Beds. 151019

Would you please be able to confirm the following information in relation to rental of specialist bariatric beds and bariatric air mattresses?
– Number of rental episodes year to date 2019
– Total of installation charges year to date 2019
– Total of equipment removal charges year to date 2019
If this level of information is not available, please advise the total number of bariatric patient admissions year to date 2019.

Download response Bariatric Beds. 151019

Bariatric Equipment. 181021.docx

1. I wish to know how much your trust has spent on specialist bariatric equipment for obese/bariatric patients (patients over 160kg) during the last three financial years?
2. Please give a breakdown of the type of equipment used by the trust and the amounts spent, split between Rental expenditure and Purchased Equipment?
2.1. If equipment used is on a Rental basis, please specify if this was under a contract basis or ad hoc?
2.2. When is the contract due for renewal?
2.3. If known, who is the contract with?
2.4. If under a contract, please supply the means of contract award, i.e. framework or direct award.
3. How many Bariatric beds does the Trust own?

Download response Bariatric Equipment. 181021.docx

 

Overseas visitors and foreign nationals

A&E beds and upfront charging. 250417

Accident and Emergency

1. As of April 2010, the total number of Accident and Emergency beds within the Trust (including predecessor Trusts)
2. As of March 2011, the total number of Accident and Emergency beds within the Trust (including predecessor Trusts)
3. As of April 2017, the total number of Accident and Emergency beds within the Trust
Please split the figures for questions 1-3 into overnight beds and day-only beds. This request includes beds that were temporarily unavailable.
4. Please list any Accident and Emergency wards or units that have been permanently closed since April 2010. Please state how many A&E beds they included at point of closure.
5. Please provide the business case or management report/review underpinning each closure listed in response to question 4
6. Please list any Accident and Emergency wards or units that have been permanently opened since April 2010. Please state how many A&E beds they include.

In this request, Accident and Emergency beds, wards and units are those whose primary usage is for Accident and Emergency cases.

Upfront charging of non-residents

7. What is the Trust’s policy on treating overseas patients who are eligible to be charged upfront for care but are not able or willing to pay upfront?
8. What is the Trust’s policy on upfront charging for overseas patients where it is not possible to establish the cost of care upfront?
9. What is the Trust’s policy towards clinical staff who refuse to enforce upfront payment?
10. What is the Trust’s policy on identifying which patients need to be asked for proof of residency in relation to upfront charging, and what form does that proof take?

Download response A&E beds and upfront charging. 250417

Asylum seekers.131223.docx

All questions are shown as received by the Trust.
1. How many refused asylum seekers hold NHS debt in your trust?
2. How many female refused asylum seekers hold NHS debt in your trust?
3. How many female refused asylum seekers hold NHS debt due to accessing maternity care on the NHS in your trust?
4. What is the total amount of NHS debt refused asylum seekers hold in GBP in your trust?
5. What is the total amount of NHS debt female refused asylum seekers hold in GBP in your trust?
6. What is the total amount of NHS debt female refused asylum seekers hold due to accessing maternity care on the NHS in GBP in your trust?

Asylum seekers.131223.docx

Audio-visual translation services. 020317

1. Select type of health care provider
2. Select type(s) of population treated at the hospital/clinic
3. Does your institution produce or contribute to provide patients with audio-visual content (e.g., contraception campaign videos, documentaries, etc.)?
4. Does your institution produce or take part in any of the following?
5. How is that audio-visual content adapted for patients at a disadvantage? Select as many options as needed.
6. Who carries out this type of tasks? Select as many options as needed.
7. Which of the following practitioners collaborate with your institution? Select as many as needed.
8. What is the name of your institution?

Download response Audio-visual translation services. 020317

Charges made in accordance with the Immigration Act 2014.

I would like to know about charges made in accordance with the
Immigration Act 2014 within your trust during the period from the
1st of January 2015 until the 1st of January 2016.
1. The amount invoiced for overseas visitors’ care during that
period. Of this, I would like to know, if possible, the amount
invoiced to a UK address.
2. The amount of money that was recouped by the overseas visitor
management team during the same period.

Download response Charges made in accordance with the Immigration Act 2014 080216

Charges to overseas visitors and migrants. 250122.docx

I write to request information regarding decisions made under the National Health Service (Charges to Overseas Visitors) Regulations 2015, as amended, in your Trust. I seek to ascertain your Trust’s application of the UK Government’s current guidance which states:
Overseas visitors to England, including anyone living in the UK without permission, will not be charged for:
• testing for COVID-19 (even if the test shows they do not have COVID-19
• treatment for COVID-19, including for a related problem called multisystem inflammatory synd